data_1jdq_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1jdq _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.5 t . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.787 0.327 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.6 -65.21 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.078 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.411 ' HB2' HD13 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -118.11 169.77 9.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.097 -179.714 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.684 HG21 ' HB3' ' A' ' 57' ' ' GLU . 83.3 m -135.51 130.85 35.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.808 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.1 tp -106.37 113.08 26.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.845 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.68 123.33 42.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.888 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.4 47.62 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.079 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.752 179.842 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.799 0.333 . . . . 0.0 110.694 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.462 ' O ' ' HB3' ' A' ' 48' ' ' GLN . 5.3 mmtt -56.79 -41.89 78.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.514 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.62 -30.74 71.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.946 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.53 -54.34 47.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.967 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.782 ' HB3' ' HG2' ' A' ' 71' ' ' GLU . 0.4 OUTLIER -77.24 -37.31 53.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.768 -179.492 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.462 ' HB3' ' O ' ' A' ' 44' ' ' LYS . 1.4 tt0 -68.14 -31.18 70.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.396 -178.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -134.96 72.18 1.45 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.064 0.459 . . . . 0.0 110.932 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.18 140.73 31.53 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.846 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.508 ' HG2' ' HD2' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -94.17 151.48 39.61 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.778 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.508 ' HD2' ' HG2' ' A' ' 51' ' ' LYS . 50.0 Cg_exo -38.23 -86.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.366 2.71 . . . . 0.0 114.027 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.44 ' H ' ' HB2' ' A' ' 52' ' ' PRO . . . -103.89 59.05 0.5 Allowed Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.989 -0.624 . . . . 0.0 113.124 -177.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -90.7 156.42 18.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.104 0.478 . . . . 0.0 111.705 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.4 mp -135.05 117.75 22.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.992 178.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.411 HD13 ' HB2' ' A' ' 27' ' ' LYS . 4.6 mp -122.77 164.05 19.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.209 0.528 . . . . 0.0 111.753 -178.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.684 ' HB3' HG21 ' A' ' 28' ' ' THR . 37.2 tt0 -114.38 161.27 18.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.131 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 57' ' ' GLU . 22.1 t -142.7 113.92 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.808 0.337 . . . . 0.0 111.221 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.6 103.25 8.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.786 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -158.11 -166.19 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.029 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -103.04 -2.5 27.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.015 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -137.58 148.12 60.13 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.927 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.69 104.4 1.88 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.601 2.201 . . . . 0.0 112.624 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 8.4 tpp -68.1 -19.95 64.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.108 0.48 . . . . 0.0 110.617 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.808 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 3.6 p -58.85 -10.84 2.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.215 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.458 ' HG3' ' H ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -56.75 -44.69 81.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.789 0.328 . . . . 0.0 110.727 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.547 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 0.7 OUTLIER -86.64 -24.88 25.15 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.085 0.469 . . . . 0.0 110.055 178.398 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.808 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 1.0 OUTLIER -61.69 -41.34 97.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.233 179.565 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.739 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 12.9 mt -54.59 -56.67 24.54 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.739 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 76.1 Cg_exo -51.87 -36.96 65.38 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.288 1.992 . . . . 0.0 112.682 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.782 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 0.6 OUTLIER -71.92 -64.46 0.93 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.782 0.325 . . . . 0.0 111.66 -179.2 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.444 ' HG1' ' HG2' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -55.9 -30.6 61.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.555 -178.515 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.462 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 6.6 p -73.47 -28.89 26.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.905 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.4 tptp -58.57 -42.11 87.23 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.45 -77.51 0.4 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.226 177.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.559 HD12 ' HB2' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -98.79 -98.52 0.22 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.786 178.358 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.34 -79.71 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.249 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.68 157.32 43.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.803 0.335 . . . . 0.0 111.014 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.698 ' HB2' ' H ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -101.18 55.89 0.84 Allowed 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.135 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.6 p -98.31 123.49 50.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.269 -176.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.474 ' HG ' ' N ' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -133.31 -36.12 1.0 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.186 -179.687 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.53 ' HB3' ' HB2' ' A' ' 94' ' ' TYR . 0.5 OUTLIER -153.51 145.49 23.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.999 0.428 . . . . 0.0 111.826 -179.711 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.494 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 3.0 mp -142.44 136.11 27.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.414 178.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -157.47 179.04 9.63 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.038 0.447 . . . . 0.0 111.421 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -133.67 166.14 23.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.854 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.3 t -127.28 -64.4 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.133 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -124.83 -147.14 7.02 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.825 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -60.81 -77.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.757 2.305 . . . . 0.0 112.616 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.2 -1.74 35.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.419 -178.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.47 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 0.7 OUTLIER -93.26 120.26 33.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.746 179.442 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 7.0 m0 -130.46 166.08 21.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.904 0.383 . . . . 0.0 111.187 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -127.04 129.91 48.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.612 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.7 mp -125.79 149.52 30.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.296 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.53 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 9.3 m-85 -118.68 127.97 54.07 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.202 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.642 HG13 ' HB2' ' A' ' 79' ' ' GLU . 1.1 tp -124.49 149.81 28.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.519 -177.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.698 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -151.11 109.47 3.78 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 120.523 -0.471 . . . . 0.0 112.132 -178.455 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.413 ' H ' HG23 ' A' ' 97' ' ' VAL . 2.1 t -64.41 111.16 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.266 178.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.559 ' HB2' HD12 ' A' ' 76' ' ' LEU . 16.5 mmtt . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.097 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.649 HG21 HG22 ' A' ' 55' ' ' ILE . 87.5 t . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.766 0.317 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.17 -48.2 4.7 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.945 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -121.33 148.57 44.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.098 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.417 HG22 ' HB3' ' A' ' 57' ' ' GLU . 28.3 m -132.98 140.86 47.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.825 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.6 tp -112.03 110.98 21.58 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.905 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.512 ' HB3' ' HE1' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -104.86 113.34 26.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.741 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.61 HG23 HG22 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -131.09 61.6 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.274 -179.593 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.41 ' H ' ' HG3' ' A' ' 32' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.332 179.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.462 HG22 ' N ' ' A' ' 44' ' ' LYS . 14.3 t . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.665 0.269 . . . . 0.0 110.81 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.462 ' N ' HG22 ' A' ' 43' ' ' THR . 0.1 OUTLIER -54.05 -41.56 68.25 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.839 179.603 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 45' ' ' ARG . 3.5 tmm_? -67.95 -32.56 73.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.801 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.54 -49.38 77.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.207 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.811 ' HB3' ' HG2' ' A' ' 71' ' ' GLU . 2.5 mm? -58.67 -42.72 89.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.063 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -75.54 -15.5 60.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.036 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.19 61.68 0.77 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.92 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.483 ' HB3' HG23 ' A' ' 97' ' ' VAL . 10.1 mmt -108.32 146.76 32.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.859 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.624 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 2.2 mtpp -102.81 164.21 16.04 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.767 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.61 ' HD2' ' HB3' ' A' ' 51' ' ' LYS . 2.2 Cg_endo -46.2 -73.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.119 2.546 . . . . 0.0 113.398 -178.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.27 58.78 0.49 Allowed Glycine 0 C--N 1.329 0.192 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.278 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.624 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 3.8 mm-40 -90.34 151.35 21.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.09 0.472 . . . . 0.0 111.525 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.649 HG22 HG21 ' A' ' 25' ' ' VAL . 3.7 mp -134.75 113.51 16.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.815 178.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.558 HD13 ' C ' ' A' ' 55' ' ' ILE . 0.4 OUTLIER -118.71 145.35 45.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.164 0.506 . . . . 0.0 111.846 -176.825 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.449 ' C ' HG22 ' A' ' 58' ' ' VAL . 58.9 tt0 -111.07 135.49 51.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.987 177.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.449 HG22 ' C ' ' A' ' 57' ' ' GLU . 2.0 t -134.82 126.5 47.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.512 ' HE1' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -122.97 115.33 21.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.879 176.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.61 HG22 HG23 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -147.42 -170.52 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.303 -178.027 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.02 -11.71 16.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.419 178.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.4 ' O ' HD12 ' A' ' 60' ' ' ILE . 64.9 m-85 -129.76 143.92 50.95 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.55 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.88 93.73 0.39 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.532 2.155 . . . . 0.0 112.481 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.06 -16.33 63.98 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.042 0.448 . . . . 0.0 110.585 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.401 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -62.04 -15.58 45.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.793 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.506 ' HG3' ' N ' ' A' ' 67' ' ' GLU . 1.2 ptpp? -57.58 -32.88 67.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.772 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.506 ' N ' ' HG3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -94.54 -27.95 15.68 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.169 0.509 . . . . 0.0 110.401 178.737 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.619 ' HA ' HD11 ' A' ' 47' ' ' LEU . 54.3 mtt-85 -65.78 -32.68 74.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.175 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.489 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 26.6 mt -63.62 -55.33 35.31 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.493 ' HG2' ' O ' ' A' ' 67' ' ' GLU . 12.2 Cg_endo -56.97 -32.23 92.22 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.182 1.921 . . . . 0.0 112.566 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.811 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 0.4 OUTLIER -74.13 -60.83 2.09 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.873 0.368 . . . . 0.0 111.296 -179.818 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.468 HG22 ' OE1' ' A' ' 79' ' ' GLU . 0.2 OUTLIER -61.26 -25.0 66.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.314 -179.028 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.495 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 4.5 p -75.23 -28.95 21.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.274 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.46 -43.51 88.89 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.603 ' HG3' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -86.85 -78.18 0.3 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.164 176.7 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.603 HD23 ' HG3' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -98.73 -98.59 0.22 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.848 0.356 . . . . 0.0 110.659 177.947 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.28 -80.98 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.865 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -146.2 149.64 34.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.889 0.376 . . . . 0.0 110.922 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.623 ' HB2' ' H ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -97.87 58.93 1.42 Allowed 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.018 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.4 p -98.9 125.84 52.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.022 -177.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.565 HD12 ' HB2' ' A' ' 82' ' ' GLU . 0.6 OUTLIER -133.53 -35.79 0.99 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.043 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.565 ' HB2' HD12 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -153.52 144.61 22.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.985 0.421 . . . . 0.0 111.906 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 82' ' ' GLU . 3.5 mp -143.96 128.55 14.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.346 178.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -149.87 -178.25 6.36 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.239 0.542 . . . . 0.0 111.552 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.505 ' HB3' ' HD1' ' A' ' 91' ' ' TRP . 0.9 OUTLIER -133.2 163.67 28.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.616 -179.738 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 56.9 t -124.65 -73.76 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.427 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -122.73 -139.37 5.51 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.795 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.464 ' HB2' ' H ' ' A' ' 89' ' ' SER . 37.1 Cg_exo -60.82 -82.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.557 2.171 . . . . 0.0 112.5 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.464 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 59.9 p -100.15 1.51 42.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.249 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.413 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 1.2 pt-20 -93.15 119.51 32.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.747 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.505 ' HD1' ' HB3' ' A' ' 85' ' ' GLU . 4.4 m-90 -132.24 164.99 25.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.92 0.391 . . . . 0.0 111.112 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.96 140.71 51.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.795 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.1 mp -136.76 143.78 34.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.974 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.445 ' HB3' ' HG ' ' A' ' 81' ' ' LEU . 12.3 m-85 -118.54 127.56 53.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.379 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.603 HG22 ' HB2' ' A' ' 79' ' ' GLU . 32.8 mm -124.86 144.94 33.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.26 -177.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.623 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -152.12 111.2 3.86 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.157 -0.617 . . . . 0.0 112.156 -178.441 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.483 HG23 ' HB3' ' A' ' 50' ' ' MET . 2.2 t -63.69 121.39 12.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.56 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.2 tttp . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.006 -179.913 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.3 t . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.748 0.309 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.51 -52.22 3.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.508 -178.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.88 149.89 41.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.905 0.384 . . . . 0.0 111.462 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 83.2 m -129.12 122.58 30.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.699 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 2.9 tt -109.23 125.37 52.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.081 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -130.79 123.39 29.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.726 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.449 ' HB ' HG23 ' A' ' 60' ' ' ILE . 8.4 t -118.45 64.3 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.128 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 32' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.099 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.484 HG22 ' SD ' ' A' ' 64' ' ' MET . 14.6 t . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.762 0.315 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.483 ' N ' HG23 ' A' ' 43' ' ' THR . 0.3 OUTLIER -59.98 -46.95 87.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.968 0.413 . . . . 0.0 110.451 179.25 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.39 -31.65 72.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.878 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.25 -43.45 86.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.047 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.49 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 1.2 mp -58.77 -39.26 80.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.744 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.404 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 1.5 tt0 -81.2 -23.29 38.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.944 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -119.12 62.18 0.8 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.63 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.4 ptp -103.65 145.32 30.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.593 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.912 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 10.7 mttm -90.73 160.09 39.29 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.178 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -43.7 -70.78 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.098 2.532 . . . . 0.0 113.901 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.46 59.79 0.45 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.9 -0.667 . . . . 0.0 113.264 -178.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.912 ' HG3' ' HB2' ' A' ' 51' ' ' LYS . 7.2 mt-10 -90.89 151.41 21.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.02 0.438 . . . . 0.0 111.572 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.66 HG12 ' HG3' ' A' ' 96' ' ' LYS . 7.4 mt -135.66 103.7 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.114 178.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.9 mt -118.73 160.51 21.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.072 0.463 . . . . 0.0 111.659 -177.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -130.6 139.64 50.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.365 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.508 HG12 HG12 ' A' ' 60' ' ' ILE . 11.7 t -120.04 136.45 57.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.136 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -122.57 110.8 16.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.677 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.508 HG12 HG12 ' A' ' 58' ' ' VAL . 0.4 OUTLIER -158.66 -177.75 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.581 -179.428 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -97.68 2.38 49.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.72 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -139.22 149.63 61.58 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.566 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.76 95.64 1.08 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.488 2.125 . . . . 0.0 112.856 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.484 ' SD ' HG22 ' A' ' 43' ' ' THR . 0.0 OUTLIER -68.22 -15.43 63.57 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.172 0.51 . . . . 0.0 110.539 178.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.727 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 23.9 p -61.34 -12.2 12.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.719 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.3 pttm -56.36 -36.05 68.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.899 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.564 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.8 OUTLIER -94.25 -27.39 16.17 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.218 0.532 . . . . 0.0 110.018 178.209 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.727 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 4.7 mtt85 -61.91 -37.14 83.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.008 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.696 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 14.7 mt -62.15 -55.83 36.88 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.369 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.696 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 83.3 Cg_exo -47.19 -37.43 23.71 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.447 2.098 . . . . 0.0 112.717 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.49 ' HG3' ' HB3' ' A' ' 47' ' ' LEU . 15.7 mm-40 -70.86 -54.05 12.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.056 0.455 . . . . 0.0 111.106 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.617 HG23 ' HG2' ' A' ' 79' ' ' GLU . 0.6 OUTLIER -60.75 -38.23 84.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.771 -178.605 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.491 HG21 ' N ' ' A' ' 74' ' ' LYS . 20.2 m -67.5 -27.84 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-O 120.688 0.28 . . . . 0.0 110.84 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.491 ' N ' HG21 ' A' ' 73' ' ' VAL . 0.1 OUTLIER -58.04 -43.98 87.11 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.61 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.53 ' HG2' ' O ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -90.2 -78.36 0.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.483 176.85 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.406 ' H ' ' CG ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -99.57 -97.37 0.24 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.967 0.413 . . . . 0.0 110.954 178.469 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.555 ' O ' ' HB ' ' A' ' 72' ' ' THR . . . -144.89 -84.33 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.195 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.95 152.65 39.75 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 122.723 -0.281 . . . . 0.0 110.778 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.753 ' HB2' ' H ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -96.96 71.27 2.47 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.034 0.445 . . . . 0.0 109.849 179.609 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.6 t -98.58 122.04 49.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.575 -177.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.508 ' HG ' ' N ' ' A' ' 82' ' ' GLU . 0.5 OUTLIER -133.53 -37.85 0.93 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.174 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.508 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -153.56 141.98 20.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.003 0.43 . . . . 0.0 111.866 -179.701 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.449 HG13 ' C ' ' A' ' 82' ' ' GLU . 2.7 mt -143.53 129.93 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.222 178.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.414 ' OE2' ' HE2' ' A' ' 92' ' ' LYS . 4.8 pt-20 -156.78 179.77 8.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.184 0.516 . . . . 0.0 111.689 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -133.55 159.56 40.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.413 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.9 t -120.8 -66.97 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.398 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -122.84 -145.43 6.92 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.666 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.478 ' HB2' ' H ' ' A' ' 89' ' ' SER . 46.2 Cg_exo -56.44 -82.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.672 2.248 . . . . 0.0 112.509 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.478 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 61.8 p -100.07 -3.75 31.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.831 0.348 . . . . 0.0 111.151 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.425 ' OE2' ' HD2' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -86.05 117.72 25.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.669 179.743 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 2.9 m-90 -130.83 164.21 25.68 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.1 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.414 ' HE2' ' OE2' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -124.28 129.51 50.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.537 179.538 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -125.8 143.39 39.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.002 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.489 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 13.6 m-85 -118.95 129.59 55.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.675 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.59 HG21 ' HE ' ' A' ' 68' ' ' ARG . 1.0 OUTLIER -124.13 149.03 28.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.68 -179.051 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.753 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -150.85 109.97 3.93 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.289 -0.564 . . . . 0.0 112.161 -178.117 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.8 t -62.75 118.86 5.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.262 177.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.457 ' HG2' ' HD3' ' A' ' 96' ' ' LYS . 6.9 mtmt . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.986 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.466 HG11 ' O ' ' A' ' 55' ' ' ILE . 80.6 t . . . . . 0 CA--C 1.529 0.143 0 CA-C-O 120.624 0.25 . . . . 0.0 110.586 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -98.82 -66.0 0.93 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.964 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.466 ' CB ' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -105.53 148.24 27.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.892 0.377 . . . . 0.0 110.941 179.6 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.474 HG22 ' HG2' ' A' ' 57' ' ' GLU . 86.4 m -133.9 110.47 9.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.863 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.5 tt -100.15 100.87 11.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.87 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -119.46 99.89 6.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.575 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.1 p -132.9 70.06 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.457 0.646 . . . . 0.0 111.179 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.794 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.453 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 2.2 t . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.687 0.279 . . . . 0.0 111.019 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -56.23 -45.16 80.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.89 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.47 -33.09 75.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.707 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.65 -36.89 85.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.192 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.648 HD22 ' HG2' ' A' ' 68' ' ' ARG . 4.9 mt -65.55 -43.33 90.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.693 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -71.81 -26.57 62.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.481 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -117.26 57.08 0.81 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.998 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.3 ptm -96.01 150.06 20.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.831 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 5.6 mttt -104.24 156.35 35.91 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.872 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.05 -55.41 3.91 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.004 2.469 . . . . 0.0 113.277 -178.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.21 59.57 0.47 Allowed Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.844 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.831 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 3.6 mm-40 -90.8 146.39 23.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.041 0.448 . . . . 0.0 111.779 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.466 ' O ' HG11 ' A' ' 25' ' ' VAL . 5.3 mt -135.53 102.53 3.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.894 177.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.466 HD23 ' CB ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -119.89 143.86 47.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.04 0.447 . . . . 0.0 112.031 -177.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.474 ' HG2' HG22 ' A' ' 28' ' ' THR . 2.8 pt-20 -118.62 130.97 56.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.448 176.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.6 t -114.77 129.49 70.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.016 0.436 . . . . 0.0 111.906 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -122.44 106.39 11.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.349 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.402 ' HB ' ' H ' ' A' ' 61' ' ' ASP . 1.0 OUTLIER -158.29 -163.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.439 -178.874 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.402 ' H ' ' HB ' ' A' ' 60' ' ' ILE . 1.0 OUTLIER -109.41 -34.49 6.52 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.664 179.315 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.08 114.47 65.49 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.625 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.85 97.49 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.535 2.157 . . . . 0.0 112.429 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.9 mtt -68.3 -11.17 59.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.943 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.576 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.5 OUTLIER -61.57 -15.11 35.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.993 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -32.74 71.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.036 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.569 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 1.0 OUTLIER -94.22 -27.95 15.89 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.191 0.519 . . . . 0.0 110.365 178.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.648 ' HG2' HD22 ' A' ' 47' ' ' LEU . 14.3 mtt85 -62.88 -38.0 89.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.894 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.711 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 17.0 mt -59.37 -55.79 42.51 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.686 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.711 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 72.6 Cg_exo -50.21 -38.85 52.03 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.307 2.005 . . . . 0.0 112.781 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.555 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -68.56 -56.38 8.48 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.957 0.408 . . . . 0.0 111.518 -179.285 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.628 HG23 ' HG3' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -58.96 -45.58 90.17 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.269 -178.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.483 HG13 ' N ' ' A' ' 74' ' ' LYS . 8.2 p -58.69 -28.67 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.682 -0.236 . . . . 0.0 110.939 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.555 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 5.1 mmtt -58.42 -42.99 88.5 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 176.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.38 -82.84 0.21 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.872 176.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.466 HD21 ' O ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -98.59 -106.32 0.2 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.274 177.071 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -134.87 -83.15 0.18 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.104 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.07 170.71 16.59 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.78 0.324 . . . . 0.0 111.071 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.858 ' HB2' HG13 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -110.09 72.77 0.81 Allowed 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.39 117.51 43.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.491 -176.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.581 HD21 ' HB3' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -133.73 -40.69 0.86 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.092 179.715 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.58 ' HB3' ' HB2' ' A' ' 94' ' ' TYR . 0.3 OUTLIER -153.85 144.98 22.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.027 0.441 . . . . 0.0 111.924 -179.743 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.528 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 3.4 mp -144.04 130.65 16.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.275 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -149.78 178.57 8.76 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.042 0.448 . . . . 0.0 111.428 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.6 pm0 -133.35 159.07 41.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.663 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.6 t -124.28 -63.37 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.284 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -126.87 -144.7 6.1 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.654 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.455 ' HB2' ' H ' ' A' ' 89' ' ' SER . 37.3 Cg_exo -61.37 -82.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.601 2.201 . . . . 0.0 112.416 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.455 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 2.1 p -98.59 -1.33 41.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.025 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -92.93 116.28 28.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.511 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 4.2 m-90 -130.65 167.59 18.52 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.983 0.42 . . . . 0.0 111.37 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.7 128.52 49.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.29 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.419 HG21 ' N ' ' A' ' 94' ' ' TYR . 3.8 mp -125.67 146.15 31.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.172 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.58 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 24.8 m-85 -118.81 123.84 45.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.576 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.858 HG13 ' HB2' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -124.79 144.68 33.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.848 -179.112 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.626 ' C ' ' HB3' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -150.77 115.86 5.32 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.961 -178.793 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.0 t -65.69 125.67 23.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.359 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.8 tttp . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.004 -179.486 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.7 t . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.826 0.346 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.4 m -99.61 -62.06 1.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.933 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -118.56 158.63 25.05 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.011 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.7 m -127.45 151.72 48.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.865 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.446 HD22 HG21 ' A' ' 31' ' ' VAL . 5.2 tt -131.52 121.04 23.8 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.25 119.0 31.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.532 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.656 HG22 ' HE3' ' A' ' 64' ' ' MET . 0.0 OUTLIER -124.33 19.67 4.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.553 -179.093 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.667 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.668 0.27 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.16 -43.04 73.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.949 0.404 . . . . 0.0 110.544 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.508 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 0.2 OUTLIER -64.09 -31.31 72.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.796 179.048 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.553 ' HB3' HH12 ' A' ' 68' ' ' ARG . . . -60.62 -48.7 80.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.335 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.613 HD11 ' HE2' ' A' ' 50' ' ' MET . 2.2 mm? -59.06 -42.65 90.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.051 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -81.14 9.79 6.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.443 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.508 ' HB2' ' O ' ' A' ' 45' ' ' ARG . 0.9 OUTLIER -135.07 32.97 3.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.785 0.326 . . . . 0.0 111.202 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.613 ' HE2' HD11 ' A' ' 47' ' ' LEU . 26.0 mtt -109.18 143.61 38.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.122 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.766 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 23.0 mttp -95.41 163.15 22.3 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 51' ' ' LYS . 74.1 Cg_exo -41.83 -69.03 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.01 2.473 . . . . 0.0 113.508 -178.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 97' ' ' VAL . . . -103.95 56.91 0.56 Allowed Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.023 -178.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.766 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 14.4 mm-40 -90.92 157.17 17.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.001 0.429 . . . . 0.0 111.815 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.532 ' C ' HD11 ' A' ' 56' ' ' LEU . 3.0 mp -135.04 110.31 12.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.973 178.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.532 HD11 ' C ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -118.74 148.22 43.03 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.164 0.506 . . . . 0.0 111.985 -177.243 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -111.69 135.31 52.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.863 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 t -125.78 144.22 36.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.114 0.483 . . . . 0.0 112.006 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.457 ' C ' HG13 ' A' ' 60' ' ' ILE . 18.4 t90 -131.04 107.93 9.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.235 178.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.511 HG22 HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -144.24 -166.64 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.009 -178.875 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -145.13 27.47 1.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.144 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.668 ' H ' ' HA ' ' A' ' 63' ' ' PRO . 1.2 m-85 -101.06 -56.34 0.13 Allowed Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.368 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.668 ' HA ' ' H ' ' A' ' 62' ' ' TYR . 72.1 Cg_endo -94.19 171.24 17.49 Favored 'Cis proline' 0 C--N 1.356 0.949 0 C-N-CA 124.912 -0.87 . . . . 0.0 112.374 -0.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.656 ' HE3' HG22 ' A' ' 31' ' ' VAL . 6.0 tpp -68.32 -26.35 65.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.356 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.639 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -59.71 -17.44 34.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.188 -179.405 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.7 pttp -59.73 -34.8 73.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.629 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.565 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 4.9 mt-10 -90.21 -22.55 21.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.169 0.509 . . . . 0.0 110.222 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.639 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 0.4 OUTLIER -62.03 -46.4 89.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.041 179.318 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.71 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 5.1 mt -54.52 -54.6 46.9 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.71 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 75.1 Cg_exo -51.36 -37.05 59.98 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.412 2.075 . . . . 0.0 112.61 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.555 ' HG3' ' HG ' ' A' ' 47' ' ' LEU . 4.8 tm-20 -71.24 -58.17 3.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.866 0.365 . . . . 0.0 111.525 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.443 HG23 HD12 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -58.89 -31.9 69.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.463 -178.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.532 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 8.6 p -73.52 -26.46 22.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.709 0.29 . . . . 0.0 110.731 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.432 ' N ' HG13 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -58.69 -46.53 87.08 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.042 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.738 ' HG3' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -88.7 -74.32 0.47 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.565 177.463 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.738 HD22 ' HG3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -98.21 -102.31 0.2 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.85 0.357 . . . . 0.0 110.482 178.19 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.532 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.27 -85.51 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.866 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.444 ' HB2' HG21 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -147.6 155.74 42.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.731 0.3 . . . . 0.0 111.076 178.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.691 ' HB2' ' H ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -103.87 69.24 0.95 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 177.396 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.444 HG21 ' HB2' ' A' ' 78' ' ' HIS . 0.2 OUTLIER -98.67 121.52 49.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.88 -175.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.599 HD21 ' HB3' ' A' ' 96' ' ' LYS . 1.5 pt? -139.71 -35.5 0.53 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.677 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.6 ' HB3' ' HB2' ' A' ' 94' ' ' TYR . 0.8 OUTLIER -153.01 142.55 21.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.19 0.519 . . . . 0.0 112.009 179.574 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.502 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 3.7 mp -144.19 135.87 22.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.263 178.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -157.79 179.87 8.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.073 0.463 . . . . 0.0 111.28 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -133.5 161.25 35.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.555 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.0 t -120.7 -62.83 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.318 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -125.37 -146.52 6.77 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.787 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -57.11 -83.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.768 2.312 . . . . 0.0 112.513 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.73 -3.09 46.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.876 0.37 . . . . 0.0 111.184 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -93.16 133.89 35.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.713 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.11 168.81 20.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.929 0.395 . . . . 0.0 111.09 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.3 mttt -120.74 128.11 52.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.534 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.407 HG21 ' N ' ' A' ' 94' ' ' TYR . 4.4 mp -125.28 145.11 33.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.885 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.6 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 13.0 m-85 -118.17 129.05 55.29 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.441 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.594 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -123.97 142.14 41.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.291 -179.697 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.691 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -144.04 110.57 5.56 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.755 -176.752 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.43 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 3.2 t -61.26 118.48 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.314 178.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.591 ' HE3' ' HD3' ' A' ' 96' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.937 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.6 t . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.79 0.328 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.73 -56.62 2.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.134 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.432 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -113.4 139.53 48.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.085 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.3 m -133.85 117.47 16.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.802 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 11.7 tp -109.92 115.41 29.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.033 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.667 ' HB3' ' HB3' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -132.9 102.11 5.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.705 179.774 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.85 75.04 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.298 0.57 . . . . 0.0 111.19 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 32' ' ' ARG . 2.1 mtp180 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.001 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.428 ' O ' HD11 ' A' ' 47' ' ' LEU . 11.9 t . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.766 0.317 . . . . 0.0 110.678 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.72 -43.45 90.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.316 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.24 -39.54 92.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.81 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.46 -31.39 65.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.967 0.413 . . . . 0.0 110.52 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.471 HD23 ' HB3' ' A' ' 67' ' ' GLU . 2.9 mp -77.62 -51.73 10.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.486 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -81.46 -3.34 52.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.195 -177.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -134.96 71.2 1.44 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.822 0.344 . . . . 0.0 110.915 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.674 ' HB3' HG22 ' A' ' 97' ' ' VAL . 11.9 mtm -106.62 137.79 43.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.013 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.807 ' HG2' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -92.56 150.73 40.34 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.301 178.817 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.807 ' HD2' ' HG2' ' A' ' 51' ' ' LYS . 56.1 Cg_exo -37.28 -70.19 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.249 2.633 . . . . 0.0 113.992 -178.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.53 60.74 0.42 Allowed Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.121 -178.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.474 ' HG2' ' HB3' ' A' ' 51' ' ' LYS . 4.5 mm-40 -90.53 147.54 23.3 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.089 0.471 . . . . 0.0 111.753 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.667 HG23 ' HB2' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -130.84 114.65 27.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.065 178.418 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.432 HD22 ' HB3' ' A' ' 27' ' ' LYS . 4.0 mt -119.56 151.35 38.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.314 0.578 . . . . 0.0 112.095 -177.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -124.25 121.4 34.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.582 177.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.462 HG11 HG12 ' A' ' 60' ' ' ILE . 4.5 t -114.31 139.3 40.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.069 0.461 . . . . 0.0 111.987 -177.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.667 ' HB3' ' HB3' ' A' ' 30' ' ' ASP . 6.3 t90 -133.33 107.23 7.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.372 178.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.462 HG12 HG11 ' A' ' 58' ' ' VAL . 0.9 OUTLIER -156.95 -166.77 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.278 -178.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -111.52 -2.2 15.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.934 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -131.08 126.65 21.69 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.841 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.91 98.63 0.1 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.477 2.118 . . . . 0.0 112.377 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.469 ' HB3' ' NH1' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -67.98 -17.6 64.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.021 0.439 . . . . 0.0 110.885 179.637 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.512 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 5.1 p -64.0 -11.15 26.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.897 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.7 pttt -60.05 -39.67 86.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.981 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.544 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 6.1 mt-10 -89.93 -26.24 20.52 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.25 0.548 . . . . 0.0 110.207 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.512 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 28.7 mtt85 -63.71 -43.06 97.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.993 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.715 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 24.1 mt -51.83 -55.63 28.51 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.695 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.715 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 53.1 Cg_exo -53.18 -40.74 76.27 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.189 1.926 . . . . 0.0 112.603 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -61.04 2.19 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.965 0.412 . . . . 0.0 111.534 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.745 HG21 ' HG3' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -57.14 -43.58 82.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.63 -178.546 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.529 HG13 ' N ' ' A' ' 74' ' ' LYS . 9.8 p -58.84 -30.04 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.784 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.529 ' N ' HG13 ' A' ' 73' ' ' VAL . 1.1 tppp? -58.65 -40.36 83.2 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.465 ' HB3' HD11 ' A' ' 76' ' ' LEU . 2.0 mtpt -87.97 -84.86 0.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.875 176.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.465 HD11 ' HB3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -98.46 -105.21 0.2 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.221 176.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -132.93 -83.64 0.23 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.083 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.417 ' HB2' HG23 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -146.96 168.79 20.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.869 0.366 . . . . 0.0 111.25 179.613 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.745 ' HG3' HG21 ' A' ' 72' ' ' THR . 0.1 OUTLIER -110.26 61.07 0.6 Allowed 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.702 178.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.417 HG23 ' HB2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -98.43 122.53 50.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.242 -177.533 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.456 ' HG ' ' N ' ' A' ' 82' ' ' GLU . 1.1 pp -133.64 -37.86 0.92 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.274 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.456 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -153.11 147.99 26.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.992 0.425 . . . . 0.0 111.9 -179.748 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.7 mp -144.15 132.96 18.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.331 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.436 ' HG3' ' HB3' ' A' ' 92' ' ' LYS . 15.0 pt-20 -154.59 175.93 13.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.01 0.433 . . . . 0.0 111.363 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.43 173.71 11.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.982 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.46 -48.41 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.063 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -128.27 -150.65 7.32 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.545 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.98 -74.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.561 2.174 . . . . 0.0 112.533 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.9 p -99.36 -5.44 29.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.921 0.391 . . . . 0.0 111.193 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.28 131.11 38.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.786 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -151.48 170.34 19.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.971 0.415 . . . . 0.0 111.259 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.436 ' HB3' ' HG3' ' A' ' 84' ' ' GLU . 5.3 tttt -120.67 132.87 55.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.461 179.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.502 HG21 ' N ' ' A' ' 94' ' ' TYR . 2.4 mp -125.64 149.81 30.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.105 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.502 ' N ' HG21 ' A' ' 93' ' ' ILE . 29.2 m-85 -118.57 125.29 49.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.486 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.712 HG21 ' HB2' ' A' ' 79' ' ' GLU . 16.1 mm -124.98 143.24 39.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.967 -177.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.678 ' C ' ' HB3' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -151.82 114.7 4.66 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 120.061 -0.656 . . . . 0.0 112.217 -178.797 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.674 HG22 ' HB3' ' A' ' 50' ' ' MET . 16.1 t -64.3 119.91 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.644 178.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.923 -179.777 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 47.2 t . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.654 0.264 . . . . 0.0 110.974 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -114.86 -60.2 1.92 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.416 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.27 159.18 23.1 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.03 0.443 . . . . 0.0 111.823 -178.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.5 m -135.77 108.16 7.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.554 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.663 HD21 HG22 ' A' ' 31' ' ' VAL . 5.5 tt -106.12 112.51 25.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.816 0.341 . . . . 0.0 111.126 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -133.29 107.74 8.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.457 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.663 HG22 HD21 ' A' ' 29' ' ' LEU . 2.0 t -137.93 72.87 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.505 -178.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.707 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.458 -0.073 0 CA-C-O 120.794 0.33 . . . . 0.0 110.805 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.99 -45.13 93.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.643 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.0 -32.36 74.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.777 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.71 -39.32 84.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.943 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.514 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 2.2 mt -68.92 -34.15 74.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.606 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -81.16 -12.46 59.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.021 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -135.24 70.94 1.43 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.261 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.554 ' HB3' HG22 ' A' ' 97' ' ' VAL . 0.8 OUTLIER -99.82 126.33 45.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.071 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.535 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 1.3 mtpm? -81.88 150.1 64.84 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.964 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.19 -25.46 80.84 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.536 2.157 . . . . 0.0 112.499 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.59 39.21 2.94 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.564 -0.827 . . . . 0.0 113.118 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.758 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 28.5 mt-10 -90.75 123.43 34.33 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 117.198 0.499 . . . . 0.0 111.905 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 0.7 OUTLIER -135.2 84.5 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.625 177.741 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.464 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -119.27 -179.79 3.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.278 0.561 . . . . 0.0 112.301 -176.862 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -136.76 145.82 45.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.295 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.517 HG11 HG13 ' A' ' 60' ' ' ILE . 4.7 t -119.72 134.29 63.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.824 0.345 . . . . 0.0 111.413 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 11.7 t90 -122.47 96.17 4.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.079 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.652 HD11 ' HB2' ' A' ' 64' ' ' MET . 0.5 OUTLIER -148.97 -160.06 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.646 179.053 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.468 ' HB3' ' O ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -131.0 37.53 3.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.461 -179.452 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.586 ' H ' ' HA ' ' A' ' 63' ' ' PRO . 86.1 m-85 -115.94 -60.81 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.119 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.648 ' HG3' HD11 ' A' ' 93' ' ' ILE . 63.7 Cg_endo -97.22 -168.34 1.56 Allowed 'Cis proline' 0 C--N 1.356 0.939 0 CA-C-N 119.449 0.839 . . . . 0.0 111.881 -1.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.652 ' HB2' HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -68.69 -27.65 66.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.825 0.345 . . . . 0.0 111.024 179.176 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.532 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.7 OUTLIER -58.73 -16.01 14.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.275 -178.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.5 ' HG3' ' N ' ' A' ' 67' ' ' GLU . 5.6 pttt -59.61 -34.32 72.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.024 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.523 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 1.4 mm-40 -93.97 -25.31 17.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.078 0.466 . . . . 0.0 110.352 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.532 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 6.2 mtt85 -62.97 -38.62 91.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.939 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.707 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 8.9 mt -60.04 -56.58 34.11 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.484 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.707 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 82.5 Cg_exo -46.51 -47.23 15.9 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.507 2.138 . . . . 0.0 112.805 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.514 ' HG3' ' HB3' ' A' ' 47' ' ' LEU . 64.5 mm-40 -60.97 -47.21 87.49 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.051 0.453 . . . . 0.0 110.944 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.771 HG21 ' HG3' ' A' ' 79' ' ' GLU . 1.9 m -59.53 -46.34 89.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.508 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.612 HG12 ' O ' ' A' ' 77' ' ' GLY . 1.3 m -58.87 -29.4 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 121.119 -0.232 . . . . 0.0 111.004 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.439 ' N ' HG21 ' A' ' 73' ' ' VAL . 1.0 OUTLIER -58.52 -41.51 85.61 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 176.864 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.64 -81.46 0.31 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.487 177.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.42 -96.21 0.24 Allowed 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.81 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.612 ' O ' HG12 ' A' ' 73' ' ' VAL . . . -144.07 -85.02 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.853 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.18 147.61 31.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.762 0.315 . . . . 0.0 110.912 178.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.771 ' HG3' HG21 ' A' ' 72' ' ' THR . 0.0 OUTLIER -95.36 55.72 1.77 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.422 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.7 p -99.22 127.21 52.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.291 -177.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.47 ' HG ' ' N ' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -133.29 -35.75 1.02 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.986 179.665 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.47 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 0.3 OUTLIER -153.91 148.7 26.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.064 0.459 . . . . 0.0 111.925 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.2 mp -141.75 140.8 30.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.454 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -158.04 178.92 9.67 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.033 0.444 . . . . 0.0 111.454 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -133.68 170.1 16.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.716 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.1 t -130.23 -56.54 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.287 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -128.52 -145.98 6.13 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.721 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.453 ' HB2' ' H ' ' A' ' 89' ' ' SER . 32.8 Cg_exo -58.4 -80.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.671 2.247 . . . . 0.0 112.547 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.468 ' O ' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -100.1 -2.7 33.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.785 0.326 . . . . 0.0 111.201 -179.399 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -91.86 133.4 35.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.787 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -148.59 168.76 21.95 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.032 0.444 . . . . 0.0 111.387 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -120.62 146.81 46.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.523 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.648 HD11 ' HG3' ' A' ' 63' ' ' PRO . 0.8 OUTLIER -129.98 159.3 42.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.244 -179.229 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -125.58 124.01 40.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.731 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.765 HG22 ' HB2' ' A' ' 79' ' ' GLU . 31.0 mm -123.95 148.97 27.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.448 -176.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.607 ' C ' ' HB3' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -150.64 99.03 2.7 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 120.404 -0.519 . . . . 0.0 111.659 -177.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.758 ' HB ' ' HB2' ' A' ' 54' ' ' GLU . 48.6 t -70.63 89.58 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.532 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.2 pttm . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.273 -0.87 . . . . 0.0 111.041 -179.861 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.1 t . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.833 0.349 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.85 -65.98 0.93 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.096 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -108.67 149.23 29.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.112 -179.717 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.0 m -135.09 117.15 15.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.766 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.8 tp -103.52 109.79 21.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.922 0.391 . . . . 0.0 111.036 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.404 ' HB3' ' HB3' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -125.02 115.3 20.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.507 179.61 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.62 47.47 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.299 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.708 -179.887 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.6 t . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.611 0.244 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.25 -42.3 60.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.948 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.65 -33.95 73.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.743 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.25 -48.19 82.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.294 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.456 HD12 ' CE ' ' A' ' 50' ' ' MET . 1.1 mm? -61.24 -36.11 79.08 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.916 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -74.72 -9.61 58.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.073 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -134.98 49.83 2.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.037 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.733 ' HB2' HG21 ' A' ' 97' ' ' VAL . 16.1 ptp -88.48 146.64 25.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.875 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.564 ' HB3' ' HG3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -101.98 150.09 37.12 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.374 179.31 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.492 ' HD2' ' HG3' ' A' ' 51' ' ' LYS . 81.6 Cg_exo -31.19 -78.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.736 2.957 . . . . 0.0 114.137 -178.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.41 62.18 0.39 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.117 -178.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.564 ' HG3' ' HB3' ' A' ' 51' ' ' LYS . 8.6 mt-10 -89.21 150.49 22.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.027 0.441 . . . . 0.0 111.46 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.6 mp -135.64 106.55 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.687 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 1.2 mt -119.09 147.85 43.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.177 0.513 . . . . 0.0 112.194 -176.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -114.87 128.96 56.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.099 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.81 133.15 61.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.972 0.415 . . . . 0.0 111.529 -178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.527 ' HE1' HG22 ' A' ' 86' ' ' VAL . 13.7 t90 -122.57 109.36 14.21 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.815 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.486 HG12 ' HE3' ' A' ' 64' ' ' MET . 0.6 OUTLIER -156.9 -169.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.262 -179.536 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.589 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -109.24 -7.83 15.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.073 -179.598 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -126.25 122.42 24.05 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.606 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.05 92.48 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.572 2.181 . . . . 0.0 112.172 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.486 ' HE3' HG12 ' A' ' 60' ' ' ILE . 21.1 mtm -68.0 -15.58 63.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.606 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.49 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 2.4 p -63.92 -17.52 63.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.811 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.8 pttt -57.92 -32.12 67.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.841 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.55 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -94.12 -28.25 15.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.346 179.033 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.49 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 39.4 mtt180 -64.24 -39.56 94.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.207 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.679 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 12.5 mt -59.11 -54.77 53.12 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.509 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.679 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 80.6 Cg_exo -48.34 -44.06 30.46 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.307 2.005 . . . . 0.0 112.564 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.545 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 4.7 tt0 -69.11 -49.56 55.98 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.959 0.409 . . . . 0.0 111.433 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.536 HG23 ' HG3' ' A' ' 79' ' ' GLU . 6.6 m -58.74 -48.16 82.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.364 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.472 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 19.1 m -59.0 -28.81 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-O 120.504 0.193 . . . . 0.0 111.11 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.545 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.3 OUTLIER -58.02 -41.56 83.4 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.21 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.07 -80.55 0.31 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.176 176.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.85 -100.09 0.22 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.529 178.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.53 -86.56 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.835 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.466 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -146.67 152.56 39.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.751 0.31 . . . . 0.0 110.796 178.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.844 ' HB2' HG13 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -100.31 68.78 1.43 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.853 179.08 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.466 HG22 ' HB2' ' A' ' 78' ' ' HIS . 0.2 OUTLIER -98.96 124.01 51.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.724 -176.736 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.87 ' HB3' ' HG2' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -133.42 -37.51 0.95 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.933 179.05 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.56 ' HG3' ' N ' ' A' ' 83' ' ' ILE . 0.8 OUTLIER -154.05 146.34 23.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.946 0.403 . . . . 0.0 111.845 179.531 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.56 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 3.0 mt -141.55 135.31 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.35 178.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.621 ' HG3' ' HB3' ' A' ' 92' ' ' LYS . 6.2 pt-20 -158.05 -179.21 7.91 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.032 0.444 . . . . 0.0 111.321 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.22 162.59 31.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.814 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.527 HG22 ' HE1' ' A' ' 59' ' ' TRP . 60.3 t -123.21 -65.99 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.403 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -122.92 -153.14 8.71 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.743 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.41 ' HB2' ' H ' ' A' ' 89' ' ' SER . 52.8 Cg_exo -54.72 -75.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.7 2.267 . . . . 0.0 112.344 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.41 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 0.8 OUTLIER -99.58 -3.16 33.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.946 179.808 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.589 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 1.1 pm0 -93.56 138.15 32.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.809 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -151.53 171.05 18.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.993 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.621 ' HB3' ' HG3' ' A' ' 84' ' ' GLU . 2.3 ttpt -120.81 132.99 55.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.72 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.3 mp -125.43 144.95 33.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.84 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.466 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 10.5 m-85 -118.76 124.3 46.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.699 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.844 HG13 ' HB2' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -124.33 148.86 28.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.852 -178.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.87 ' HG2' ' HB3' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -150.93 108.54 3.65 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 120.239 -0.584 . . . . 0.0 112.506 -177.587 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.733 HG21 ' HB2' ' A' ' 50' ' ' MET . 5.0 t -58.15 119.54 3.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.587 178.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.84 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.0 t . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.76 0.315 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.08 -61.87 1.31 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.154 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.1 tptt -113.34 139.98 48.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.887 0.375 . . . . 0.0 111.161 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.0 m -130.2 134.74 47.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.859 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.15 127.97 56.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.915 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -120.01 108.51 14.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.783 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.426 HG23 HG21 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -128.2 68.49 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.05 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.061 179.956 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.424 ' O ' ' HB2' ' A' ' 46' ' ' ALA . 4.1 t . . . . . 0 C--O 1.23 0.04 0 CA-C-O 120.685 0.279 . . . . 0.0 110.864 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.76 -36.57 76.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.893 0.378 . . . . 0.0 110.318 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -66.06 -31.34 72.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.439 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.424 ' HB2' ' O ' ' A' ' 43' ' ' THR . . . -58.62 -53.0 63.29 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.018 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.668 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 0.8 OUTLIER -58.65 -35.44 72.54 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.144 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.06 -9.83 59.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.249 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -133.52 69.23 1.48 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.948 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.555 ' HB3' HG22 ' A' ' 97' ' ' VAL . 41.9 mtm -109.02 147.86 31.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.997 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.534 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.4 OUTLIER -91.93 153.85 43.53 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.391 179.466 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.534 ' HD2' ' HG3' ' A' ' 51' ' ' LYS . 53.9 Cg_exo -38.48 -71.31 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.148 2.565 . . . . 0.0 113.962 -178.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.17 57.37 0.54 Allowed Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.913 -0.661 . . . . 0.0 113.415 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.502 ' HG3' ' HB3' ' A' ' 51' ' ' LYS . 11.0 mt-10 -91.41 156.1 17.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.134 0.493 . . . . 0.0 111.984 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.538 ' C ' HD12 ' A' ' 56' ' ' LEU . 3.5 mp -135.55 115.71 17.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.008 178.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.538 HD12 ' C ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -118.52 154.29 32.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.035 0.445 . . . . 0.0 111.692 -177.624 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -114.74 145.9 41.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.376 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.484 HG12 HG13 ' A' ' 60' ' ' ILE . 16.7 t -131.01 131.52 64.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.858 0.361 . . . . 0.0 111.527 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.406 ' CD1' ' HG2' ' A' ' 92' ' ' LYS . 52.8 m0 -122.59 107.25 11.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.422 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.484 HG13 HG12 ' A' ' 58' ' ' VAL . 1.0 OUTLIER -158.67 -172.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-O 121.046 0.451 . . . . 0.0 111.334 -179.213 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -99.67 -25.59 14.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.106 178.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -120.62 121.06 29.31 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.445 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -45.68 105.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.651 2.234 . . . . 0.0 112.561 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.481 ' HG3' ' NH1' ' A' ' 68' ' ' ARG . 3.0 tpt -65.64 -15.09 62.43 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.808 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.743 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 14.8 p -55.79 -13.38 1.72 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.846 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.459 ' HZ2' ' HG3' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -55.66 -42.96 75.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 179.309 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.541 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 1.7 mt-10 -87.16 -26.07 23.77 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.225 0.536 . . . . 0.0 110.132 178.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.743 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 0.2 OUTLIER -61.48 -41.98 98.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.088 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.709 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 18.9 mt -55.33 -56.0 33.6 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.804 -178.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.709 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 78.3 Cg_exo -49.0 -41.27 40.44 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.216 1.944 . . . . 0.0 112.491 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.668 ' HG3' ' HB3' ' A' ' 47' ' ' LEU . 7.4 mm-40 -68.49 -55.2 12.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.571 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.468 ' O ' HD21 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -57.57 -49.01 77.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.468 -178.834 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.449 HG11 ' N ' ' A' ' 74' ' ' LYS . 10.2 p -58.36 -28.32 35.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.139 -178.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 2.8 mmtt -58.67 -43.25 89.82 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 176.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.429 ' HE2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -89.19 -80.81 0.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.118 176.686 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.468 HD21 ' O ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -99.02 -106.38 0.2 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.459 177.685 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -133.84 -80.92 0.16 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.365 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.482 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -146.14 165.6 28.67 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.775 0.322 . . . . 0.0 110.977 179.644 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.726 ' HB2' ' H ' ' A' ' 96' ' ' LYS . 0.1 OUTLIER -110.19 62.76 0.6 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.394 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.482 ' CG2' ' HB2' ' A' ' 78' ' ' HIS . 0.1 OUTLIER -98.77 123.05 51.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.69 -176.656 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.544 HD21 ' C ' ' A' ' 95' ' ' ILE . 0.8 OUTLIER -142.11 -36.42 0.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.223 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.471 ' HB3' ' HB2' ' A' ' 94' ' ' TYR . 2.3 tp10 -149.06 141.25 24.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.215 0.531 . . . . 0.0 112.348 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.8 mp -143.71 118.57 4.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.155 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -155.1 -176.05 5.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.164 0.507 . . . . 0.0 111.373 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -133.71 166.46 22.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.789 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.15 -47.74 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.17 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -123.39 -161.06 11.05 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.706 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.401 ' HB2' ' H ' ' A' ' 89' ' ' SER . 35.9 Cg_exo -58.1 -76.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.689 2.259 . . . . 0.0 112.424 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.401 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 0.8 OUTLIER -98.32 -2.48 39.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.101 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -93.34 119.84 32.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.402 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 14.4 m0 -120.79 167.66 12.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.03 0.443 . . . . 0.0 111.382 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.406 ' HG2' ' CD1' ' A' ' 59' ' ' TRP . 1.6 mttm -120.56 131.65 54.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.306 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -125.14 137.72 56.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.02 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.471 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 23.8 m-85 -118.27 123.44 45.42 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.384 178.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.661 HG13 ' HG3' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -123.95 142.53 40.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.251 -179.71 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.726 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -145.79 114.88 7.01 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.826 -176.844 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.555 HG22 ' HB3' ' A' ' 50' ' ' MET . 2.2 t -63.33 120.91 11.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.499 178.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 33.1 mttp . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.174 -0.917 . . . . 0.0 110.977 -179.631 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 20.9 t . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.813 0.34 . . . . 0.0 111.3 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.457 ' N ' HG11 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -118.52 -46.7 2.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.068 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.09 154.26 38.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.137 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 51.6 m -135.52 114.78 12.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.845 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 5.8 tt -102.96 117.01 33.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.709 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -132.77 115.83 15.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.113 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.51 65.79 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.828 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.9 ttm180 . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.091 -179.934 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.404 ' O ' HD13 ' A' ' 47' ' ' LEU . 7.6 t . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.772 0.32 . . . . 0.0 110.498 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -55.29 -38.96 69.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.493 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.87 -42.4 77.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.133 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.79 -38.47 78.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.1 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.404 HD13 ' O ' ' A' ' 43' ' ' THR . 2.2 mp -64.52 -44.55 90.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.956 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.35 -3.88 51.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -126.14 62.91 1.25 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.103 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.19 152.06 25.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.072 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.851 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -105.04 162.11 20.73 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.678 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.576 ' HD2' ' HB3' ' A' ' 51' ' ' LYS . 4.9 Cg_endo -47.47 -68.9 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.087 2.524 . . . . 0.0 113.451 -178.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.53 58.34 0.49 Allowed Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.442 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.851 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 13.1 mm-40 -90.63 143.29 26.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.032 0.444 . . . . 0.0 111.57 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 5.5 mt -135.81 96.27 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.198 178.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.91 175.12 5.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.285 0.564 . . . . 0.0 111.959 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -138.25 140.91 39.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.317 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.774 HG22 ' HE1' ' A' ' 64' ' ' MET . 2.8 t -114.12 135.72 52.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.991 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -121.75 107.84 12.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.69 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -157.97 -163.7 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.224 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -114.17 -5.88 13.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -125.84 132.57 24.36 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.803 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -58.36 91.2 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.61 2.207 . . . . 0.0 112.78 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.774 ' HE1' HG22 ' A' ' 58' ' ' VAL . 5.1 tmm? -68.53 -25.95 65.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.056 0.455 . . . . 0.0 110.449 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.633 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 67.5 m -64.05 -13.86 50.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.946 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.444 ' HG3' ' N ' ' A' ' 67' ' ' GLU . 2.1 pttp -57.69 -33.91 68.86 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.734 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.572 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -94.32 -27.13 16.27 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.186 0.517 . . . . 0.0 110.112 178.383 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.633 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -61.31 -34.34 75.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.942 179.126 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.709 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 11.3 mt -63.53 -56.75 23.84 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.342 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.709 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 83.4 Cg_exo -47.78 -32.39 16.89 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.307 2.004 . . . . 0.0 112.373 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.08 -58.26 3.73 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.061 0.457 . . . . 0.0 111.012 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.75 -30.0 68.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.557 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.587 HG12 ' HA ' ' A' ' 70' ' ' PRO . 5.7 p -72.72 -29.84 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.83 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.494 ' N ' HG11 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -58.68 -41.39 86.07 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -90.6 -78.67 0.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.446 177.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.48 -97.92 0.22 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.755 178.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.09 -82.4 0.05 OUTLIER Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.14 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.545 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -146.32 157.98 43.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.86 0.362 . . . . 0.0 111.234 179.449 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.683 ' HB2' ' H ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -104.72 63.4 0.72 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.491 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.545 HG22 ' HB2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -99.13 121.83 50.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.805 -176.863 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.727 ' HB3' ' HG2' ' A' ' 96' ' ' LYS . 2.2 pt? -139.79 -32.41 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.421 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.549 ' O ' HD12 ' A' ' 83' ' ' ILE . 0.4 OUTLIER -149.88 132.84 16.14 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -179.704 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.549 HD12 ' O ' ' A' ' 82' ' ' GLU . 1.0 OUTLIER -134.62 126.23 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.315 178.268 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -158.34 175.96 13.06 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.072 0.463 . . . . 0.0 111.554 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -134.51 178.04 7.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.738 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.5 p -138.73 -43.32 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.283 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -133.7 -148.4 5.85 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.726 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.07 -77.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.608 2.205 . . . . 0.0 112.346 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.8 p -97.89 -3.47 38.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.881 0.372 . . . . 0.0 110.886 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -93.23 130.8 38.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.766 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -147.45 168.95 20.57 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.971 0.415 . . . . 0.0 111.203 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.9 ttpt -126.38 127.45 45.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.448 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.6 mt -125.53 149.46 30.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.885 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.623 ' O ' HD22 ' A' ' 81' ' ' LEU . 6.8 m-85 -118.42 135.66 54.22 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.289 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.584 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -125.55 143.24 39.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.299 178.856 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.727 ' HG2' ' HB3' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -138.42 106.31 5.67 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 120.232 -0.587 . . . . 0.0 112.189 -177.514 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -64.43 118.97 7.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.424 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.918 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.626 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 85.6 t . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.512 0.196 . . . . 0.0 110.561 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.695 ' HB ' HD12 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -99.47 -37.37 9.22 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.846 -0.341 . . . . 0.0 111.82 -178.731 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.574 ' H ' ' CD1' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -145.52 162.23 37.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.407 0.622 . . . . 0.0 111.845 -178.723 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 83.1 m -136.17 125.99 25.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.715 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.517 HD23 ' HE3' ' A' ' 64' ' ' MET . 2.4 tt -107.64 120.38 42.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.575 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.32 112.44 8.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.861 0.362 . . . . 0.0 111.084 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.1 t -134.14 70.06 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.972 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.332 -0.18 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.45 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.561 HG21 ' N ' ' A' ' 44' ' ' LYS . 1.4 t . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.719 0.295 . . . . 0.0 110.44 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.561 ' N ' HG21 ' A' ' 43' ' ' THR . 8.0 tptt -59.69 -40.23 87.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.151 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -67.75 -29.79 69.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.99 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.88 -56.06 26.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.017 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.674 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 1.7 mm? -61.3 -62.0 2.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.58 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -58.7 -32.77 69.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.492 . . . . 0.0 112.184 -177.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -124.97 66.05 1.12 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.842 0.353 . . . . 0.0 111.24 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.516 ' HG3' HG11 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -98.78 158.18 15.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.921 179.775 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.12 144.86 29.21 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.648 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -49.87 -46.75 26.27 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.885 2.39 . . . . 0.0 113.573 -178.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.0 56.31 0.54 Allowed Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.622 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -90.86 136.01 33.35 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 117.18 0.49 . . . . 0.0 111.614 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.626 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 2.6 mp -136.4 81.41 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.613 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.695 HD12 ' HB ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -117.19 176.26 5.22 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.349 -0.541 . . . . 0.0 112.246 -173.481 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.42 ' C ' HG22 ' A' ' 58' ' ' VAL . 5.3 pt-20 -132.04 162.52 30.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.811 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.42 HG22 ' C ' ' A' ' 57' ' ' GLU . 6.2 t -135.3 139.59 46.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.815 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 9.1 t-105 -127.77 104.53 7.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.745 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.507 HD11 ' O ' ' A' ' 62' ' ' TYR . 0.5 OUTLIER -158.29 -177.31 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.27 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -97.26 0.23 47.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.64 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.507 ' O ' HD11 ' A' ' 60' ' ' ILE . 1.4 t80 -136.93 130.16 17.48 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.642 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.46 100.46 0.57 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.42 2.08 . . . . 0.0 112.304 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.517 ' HE3' HD23 ' A' ' 29' ' ' LEU . 1.3 mtt -68.01 -13.04 61.87 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.753 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 14.4 p -59.14 -11.01 3.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.363 178.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -55.09 -46.44 75.48 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.11 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.542 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -87.23 -25.19 24.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.171 0.51 . . . . 0.0 110.209 178.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.753 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -62.41 -35.6 79.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.915 179.343 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.74 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 16.6 mt -60.39 -56.89 30.91 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.513 -179.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.74 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 67.0 Cg_exo -52.09 -32.15 47.91 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.283 1.988 . . . . 0.0 112.47 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.674 ' HG3' ' HB3' ' A' ' 47' ' ' LEU . 30.1 mm-40 -72.46 -63.69 1.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.884 0.373 . . . . 0.0 111.338 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.452 ' HB ' ' HA ' ' A' ' 78' ' ' HIS . 0.2 OUTLIER -57.42 -28.36 63.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.479 -178.791 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.587 HG13 ' HA ' ' A' ' 70' ' ' PRO . 5.8 p -74.19 -29.49 25.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.803 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.487 ' N ' HG12 ' A' ' 73' ' ' VAL . 0.4 OUTLIER -58.67 -41.43 86.1 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 176.873 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.409 ' HD3' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -90.47 -78.38 0.38 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.283 177.104 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.54 -96.75 0.22 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.743 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.29 -79.52 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.1 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.452 ' HA ' ' HB ' ' A' ' 72' ' ' THR . 0.1 OUTLIER -146.12 158.55 43.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.769 0.319 . . . . 0.0 110.863 179.262 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.657 ' HB2' ' H ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -103.49 56.67 0.74 Allowed 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.822 179.44 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.712 HG13 HD13 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -98.88 125.36 52.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.236 -177.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.663 HD12 ' HB2' ' A' ' 82' ' ' GLU . 1.1 pp -133.43 -36.9 0.97 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.015 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.663 ' HB2' HD12 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -153.38 143.67 22.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.97 0.414 . . . . 0.0 111.724 179.823 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.712 HD13 HG13 ' A' ' 80' ' ' VAL . 3.4 mp -143.19 137.52 26.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.336 178.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.406 ' HG3' ' HB3' ' A' ' 92' ' ' LYS . 2.5 pt-20 -152.6 176.53 11.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.016 0.436 . . . . 0.0 111.214 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -133.49 163.59 29.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.681 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.406 HG21 ' HA ' ' A' ' 91' ' ' TRP . 2.8 t -127.46 -66.58 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.321 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -123.0 -141.08 5.83 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.671 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.71 -84.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.7 2.267 . . . . 0.0 112.329 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 85.1 p -100.05 -1.16 37.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.011 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -91.68 128.05 37.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.822 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.406 ' HA ' HG21 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -150.16 171.13 17.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.253 -179.682 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.406 ' HB3' ' HG3' ' A' ' 84' ' ' GLU . 12.0 tttt -121.36 141.69 50.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.491 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.602 HG23 ' H ' ' A' ' 94' ' ' TYR . 0.8 OUTLIER -131.16 165.17 32.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.186 -179.542 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.602 ' H ' HG23 ' A' ' 93' ' ' ILE . 12.7 m-85 -132.88 126.17 31.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.001 178.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.619 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 18.7 mm -124.76 145.73 31.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.078 -177.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.657 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -150.54 120.1 6.96 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 119.759 -0.776 . . . . 0.0 112.924 -178.62 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.516 HG11 ' HG3' ' A' ' 50' ' ' MET . 22.7 t -73.57 128.48 36.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.242 178.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.8 tttm . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.929 -179.708 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.488 HG11 ' N ' ' A' ' 26' ' ' THR . 6.7 t . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.772 0.32 . . . . 0.0 111.243 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.488 ' N ' HG11 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -99.29 -61.88 1.31 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.691 179.441 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.533 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 0.8 OUTLIER -115.56 157.83 23.53 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.801 179.117 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.0 m -135.49 125.72 26.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.066 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.0 tt -107.46 119.44 39.42 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.975 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -124.04 113.96 19.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.516 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.445 HG22 HG23 ' A' ' 60' ' ' ILE . 3.8 m -140.39 74.06 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.891 0.377 . . . . 0.0 111.543 -179.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.864 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.509 ' O ' HD11 ' A' ' 47' ' ' LEU . 8.4 t . . . . . 0 CA--C 1.526 0.053 0 CA-C-O 120.704 0.288 . . . . 0.0 111.085 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.67 -44.3 77.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.665 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.56 -35.25 79.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.75 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.8 -36.4 84.2 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.997 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.509 HD11 ' O ' ' A' ' 43' ' ' THR . 2.4 mp -70.28 -39.67 74.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.154 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -78.84 -21.33 47.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.336 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.9 t30 -135.24 70.56 1.43 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.801 0.334 . . . . 0.0 111.4 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.474 ' SD ' HG11 ' A' ' 97' ' ' VAL . 18.4 ptp -102.28 145.14 29.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.673 178.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.867 ' HG2' ' HD2' ' A' ' 52' ' ' PRO . 3.1 tttp -80.79 148.17 64.35 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.783 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.867 ' HD2' ' HG2' ' A' ' 51' ' ' LYS . 58.7 Cg_exo -39.03 -75.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.25 2.634 . . . . 0.0 114.173 -178.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.86 59.7 0.48 Allowed Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.001 -0.618 . . . . 0.0 113.261 -177.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -90.92 153.68 20.02 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.014 0.435 . . . . 0.0 111.918 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.2 mt -132.5 116.0 26.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.99 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.533 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 5.0 mp -126.72 152.13 47.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.119 0.485 . . . . 0.0 111.949 -178.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -113.92 129.53 56.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.402 177.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.569 HG12 HH22 ' A' ' 68' ' ' ARG . 2.2 t -114.12 128.77 70.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.165 0.507 . . . . 0.0 111.925 -177.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -122.87 101.17 7.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.448 178.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.542 HD13 ' HB2' ' A' ' 64' ' ' MET . 0.5 OUTLIER -149.64 -160.01 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.681 -179.437 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -145.17 35.26 1.09 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.704 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.494 ' H ' ' HA ' ' A' ' 63' ' ' PRO . 44.4 m-85 -105.74 -63.02 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.001 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.494 ' HA ' ' H ' ' A' ' 62' ' ' TYR . 85.7 Cg_endo -97.53 164.23 12.48 Favored 'Cis proline' 0 C--N 1.356 0.971 0 CA-C-N 119.507 0.86 . . . . 0.0 112.088 -1.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.542 ' HB2' HD13 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -68.48 -17.76 64.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.808 0.337 . . . . 0.0 111.147 179.815 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.579 ' HA ' ' HD3' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -60.44 -17.4 44.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.932 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.412 ' HG3' ' N ' ' A' ' 67' ' ' GLU . 2.9 pttp -62.51 -27.22 68.99 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.844 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.504 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.7 OUTLIER -94.34 -26.19 16.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.178 0.513 . . . . 0.0 109.863 178.107 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.579 ' HD3' ' HA ' ' A' ' 65' ' ' SER . 3.8 mpt_? -58.89 -47.57 84.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.193 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.705 HG21 ' HB3' ' A' ' 78' ' ' HIS . 3.8 mt -57.8 -55.32 46.2 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.834 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.677 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 83.8 Cg_exo -42.94 -51.47 5.42 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 122.73 2.286 . . . . 0.0 113.171 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.401 ' O ' ' HD3' ' A' ' 75' ' ' LYS . 2.0 mm-40 -62.41 -41.34 98.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.007 0.432 . . . . 0.0 110.978 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.799 HG21 ' HG3' ' A' ' 79' ' ' GLU . 2.9 m -59.72 -52.08 67.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.754 -179.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -58.67 -26.33 31.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.937 -178.863 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.6 -44.17 89.79 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 176.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.401 ' HD3' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -90.36 -77.28 0.41 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.429 176.898 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.52 -98.64 0.22 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.828 178.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.14 -84.54 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.151 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.705 ' HB3' HG21 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -146.36 146.91 30.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.976 0.417 . . . . 0.0 111.213 179.276 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.799 ' HG3' HG21 ' A' ' 72' ' ' THR . 0.5 OUTLIER -95.34 52.75 1.43 Allowed 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 177.737 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.584 HG11 ' HB2' ' A' ' 78' ' ' HIS . 1.4 p -98.71 118.77 45.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.208 -177.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.68 HD23 ' O ' ' A' ' 94' ' ' TYR . 1.1 pt? -133.65 -29.35 1.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.686 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.497 ' O ' HG13 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -152.81 144.78 23.71 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.979 179.074 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 82' ' ' GLU . 2.5 mp -144.5 126.44 9.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.566 178.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -153.06 174.67 13.89 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.905 0.384 . . . . 0.0 111.137 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.04 169.06 17.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.877 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.2 t -129.25 -52.68 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.215 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -126.1 -145.53 6.41 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.767 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.89 -77.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.606 2.204 . . . . 0.0 112.523 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.18 -6.85 27.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.937 0.399 . . . . 0.0 111.138 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -89.62 134.47 34.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.567 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -151.31 169.63 21.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.047 0.451 . . . . 0.0 111.265 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.5 ttpt -126.97 125.51 41.63 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.344 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.712 HG23 ' H ' ' A' ' 94' ' ' TYR . 4.1 mp -125.5 159.87 32.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.925 0.393 . . . . 0.0 110.836 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.712 ' H ' HG23 ' A' ' 93' ' ' ILE . 6.3 m-85 -118.2 133.55 55.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.579 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.641 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 12.9 mm -124.21 137.82 55.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.093 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.629 ' C ' ' HB3' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -144.91 109.78 5.05 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.375 -0.53 . . . . 0.0 112.052 -176.677 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.474 HG11 ' SD ' ' A' ' 50' ' ' MET . 4.1 t -65.54 116.19 4.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.304 178.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.082 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.8 t . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.768 0.318 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.57 -56.08 2.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.152 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.03 137.76 50.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.829 0.347 . . . . 0.0 111.356 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 54.9 m -123.89 126.87 47.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.522 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.5 tp -109.83 118.76 37.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.292 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -108.24 128.42 54.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.528 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.517 ' HB ' HG21 ' A' ' 60' ' ' ILE . 18.9 t -117.24 -23.45 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.357 -179.019 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.7 t . . . . . 0 N--CA 1.458 -0.053 0 CA-C-O 120.646 0.26 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.2 -43.78 71.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.859 0.361 . . . . 0.0 110.702 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.41 -32.76 74.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.412 178.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.509 ' HA ' HD22 ' A' ' 49' ' ' ASN . . . -59.32 -45.27 91.78 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.038 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -72.48 -19.47 61.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.772 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.41 -36.64 29.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.359 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.59 ' H ' HD21 ' A' ' 49' ' ' ASN . 0.1 OUTLIER -106.74 48.6 0.83 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.909 0.385 . . . . 0.0 111.606 -178.621 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.1 ptm -89.9 126.35 35.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.897 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.407 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -94.67 152.35 39.78 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.795 -179.86 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.407 ' HD2' ' HG3' ' A' ' 51' ' ' LYS . 61.0 Cg_exo -40.4 -67.61 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.175 2.583 . . . . 0.0 113.831 -178.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.32 57.87 0.51 Allowed Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.993 -0.622 . . . . 0.0 113.141 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.408 ' O ' HD13 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -91.25 150.29 21.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.983 0.421 . . . . 0.0 111.898 -179.71 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.508 HG22 ' HB2' ' A' ' 96' ' ' LYS . 0.6 OUTLIER -131.07 112.81 22.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.032 178.282 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 mt -119.78 154.51 34.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.176 0.513 . . . . 0.0 112.173 -177.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -119.75 125.86 49.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.472 177.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.489 HG13 ' NH1' ' A' ' 68' ' ' ARG . 1.1 t -114.96 138.22 45.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.176 0.512 . . . . 0.0 112.327 -177.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.456 ' C ' HG13 ' A' ' 60' ' ' ILE . 7.1 m0 -122.46 105.62 10.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.654 177.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.913 HG12 ' HB2' ' A' ' 64' ' ' MET . 0.1 OUTLIER -144.97 -176.97 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 CA-C-O 120.966 0.412 . . . . 0.0 111.505 -177.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.533 ' HB3' ' HA ' ' A' ' 90' ' ' GLU . 0.5 OUTLIER -138.4 25.9 2.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.869 179.396 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.718 ' H ' ' HA ' ' A' ' 63' ' ' PRO . 0.6 OUTLIER -106.19 -55.48 0.07 OUTLIER Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.597 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.718 ' HA ' ' H ' ' A' ' 62' ' ' TYR . 78.5 Cg_endo -95.61 177.36 9.94 Favored 'Cis proline' 0 C--N 1.355 0.897 0 C-N-CA 124.904 -0.873 . . . . 0.0 112.708 0.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.913 ' HB2' HG12 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -68.43 -25.7 65.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.228 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.448 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 14.4 p -61.3 -13.02 15.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.087 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.521 ' HG3' ' N ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -62.97 -31.93 73.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.886 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.556 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -94.2 -25.66 16.99 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.084 0.469 . . . . 0.0 110.241 178.758 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.489 ' NH1' HG13 ' A' ' 58' ' ' VAL . 18.5 mtt85 -62.17 -41.91 98.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.954 179.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.712 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 12.5 mt -56.7 -55.84 38.99 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.684 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.712 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 76.2 Cg_exo -49.31 -40.8 43.59 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.292 1.995 . . . . 0.0 112.703 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.86 -51.65 52.99 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.899 0.381 . . . . 0.0 111.219 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.51 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -59.53 -50.63 73.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.59 -178.799 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.428 HG13 ' O ' ' A' ' 70' ' ' PRO . 11.0 p -58.37 -28.12 34.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.895 -178.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.78 -42.46 89.03 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 176.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.6 -80.62 0.3 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.949 176.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.51 HD23 ' O ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -98.58 -106.65 0.19 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.363 177.2 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -132.73 -84.76 0.26 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.018 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.39 164.23 33.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.915 0.388 . . . . 0.0 111.309 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.695 ' O ' ' HA ' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -107.09 62.3 0.62 Allowed 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.397 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.4 p -98.14 120.88 48.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.427 -175.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.504 HD12 ' HB2' ' A' ' 82' ' ' GLU . 0.5 OUTLIER -133.68 -33.52 1.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.795 179.807 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.504 ' HB2' HD12 ' A' ' 81' ' ' LEU . 0.9 OUTLIER -151.77 145.16 24.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.014 0.435 . . . . 0.0 111.811 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.5 mp -142.23 123.51 12.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.288 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.548 ' HG3' ' HB3' ' A' ' 92' ' ' LYS . 5.1 pt-20 -156.55 -175.55 5.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.221 0.534 . . . . 0.0 111.349 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.464 ' HB3' ' HD1' ' A' ' 91' ' ' TRP . 3.6 pt-20 -133.24 166.39 22.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.639 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.8 p -131.27 -44.9 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.477 -179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -133.33 -151.83 6.68 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.673 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.412 ' HG2' ' H ' ' A' ' 89' ' ' SER . 38.3 Cg_endo -66.89 -74.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.547 2.164 . . . . 0.0 112.426 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.412 ' H ' ' HG2' ' A' ' 88' ' ' PRO . 24.7 p -95.65 -5.84 41.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.812 0.339 . . . . 0.0 111.157 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.533 ' HA ' ' HB3' ' A' ' 61' ' ' ASP . 4.5 pt-20 -93.03 140.94 28.95 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.558 179.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.464 ' HD1' ' HB3' ' A' ' 85' ' ' GLU . 6.1 m-90 -136.44 163.97 29.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.047 0.451 . . . . 0.0 111.335 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.548 ' HB3' ' HG3' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -120.23 117.0 26.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.077 178.99 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.4 mp -125.28 145.34 32.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.99 -178.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.415 ' HB2' ' CB ' ' A' ' 82' ' ' GLU . 29.1 m-85 -118.04 132.54 56.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.187 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.695 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -124.13 141.66 43.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.796 -177.945 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.589 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -151.21 130.05 12.44 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.239 -0.584 . . . . 0.0 112.287 -177.714 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.3 t -80.85 120.05 31.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.089 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.954 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 57.6 t . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.753 0.311 . . . . 0.0 111.12 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.3 m -106.36 -53.64 2.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.196 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.509 ' HB3' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -119.39 167.03 12.32 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.048 0.452 . . . . 0.0 111.466 -179.197 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.436 ' H ' ' HG3' ' A' ' 27' ' ' LYS . 87.8 m -134.09 121.99 22.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.648 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.662 HD22 HG13 ' A' ' 58' ' ' VAL . 5.1 tt -103.69 120.75 41.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.935 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -132.37 120.17 21.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.727 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.41 ' HB ' ' CG2' ' A' ' 60' ' ' ILE . 3.0 t -109.65 -4.66 10.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.246 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.613 ' HD3' ' HE1' ' A' ' 59' ' ' TRP . 0.7 OUTLIER . . . . . 0 CA--C 1.532 0.261 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.285 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.555 ' HA ' HD12 ' A' ' 29' ' ' LEU . 13.3 t . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.688 0.28 . . . . 0.0 110.791 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.549 ' N ' HG23 ' A' ' 43' ' ' THR . 0.7 OUTLIER -55.64 -41.63 73.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.676 179.503 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.68 -30.35 69.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.05 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.52 -43.98 80.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.25 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.812 HD11 ' HG2' ' A' ' 68' ' ' ARG . 2.3 mm? -71.4 -43.86 66.02 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.69 -179.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -81.35 -12.65 58.94 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -177.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.414 ' ND2' ' HE3' ' A' ' 51' ' ' LYS . 2.2 t30 -135.51 72.71 1.45 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.94 0.4 . . . . 0.0 111.139 -179.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.637 ' HE3' ' H ' ' A' ' 50' ' ' MET . 0.0 OUTLIER -108.53 138.49 44.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.866 179.832 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.628 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -96.09 153.29 39.16 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.7 179.708 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -52.94 -43.61 55.32 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.624 2.216 . . . . 0.0 113.198 -178.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.8 50.14 0.86 Allowed Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.532 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.671 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 20.0 mm-40 -91.27 129.0 37.31 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 117.358 0.579 . . . . 0.0 111.635 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 1.1 mp -135.59 89.46 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.779 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.509 HD23 ' HB3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -118.89 -177.98 3.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.252 0.549 . . . . 0.0 112.087 -176.695 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.523 ' C ' HG23 ' A' ' 58' ' ' VAL . 6.5 pt-20 -129.25 174.01 9.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.236 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.662 HG13 HD22 ' A' ' 29' ' ' LEU . 13.4 t -140.17 136.02 37.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.858 0.361 . . . . 0.0 111.303 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.613 ' HE1' ' HD3' ' A' ' 32' ' ' ARG . 57.9 t-105 -122.49 104.49 9.41 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.706 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.501 HD12 ' O ' ' A' ' 62' ' ' TYR . 0.8 OUTLIER -159.04 -177.8 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.084 0.469 . . . . 0.0 111.528 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 4.9 m-20 -99.89 -13.8 19.02 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.016 177.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.501 ' O ' HD12 ' A' ' 60' ' ' ILE . 1.8 m-85 -129.91 124.8 21.79 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.274 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.474 ' HD3' ' HE1' ' A' ' 91' ' ' TRP . 86.4 Cg_exo -47.54 104.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.643 2.229 . . . . 0.0 112.863 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.88 -19.27 65.81 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.116 0.484 . . . . 0.0 110.586 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.676 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 6.1 p -61.82 -10.09 8.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.625 179.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.7 ptmt -58.15 -37.96 75.68 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.58 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.548 ' O ' ' HG2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -91.74 -24.21 19.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.277 0.56 . . . . 0.0 109.967 178.259 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.812 ' HG2' HD11 ' A' ' 47' ' ' LEU . 33.2 mtt-85 -63.46 -39.69 95.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.756 179.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.457 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 12.2 mt -57.5 -56.96 28.64 Favored Pre-proline 0 CA--C 1.532 0.282 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.559 ' O ' HG13 ' A' ' 73' ' ' VAL . 9.8 Cg_endo -53.4 -34.58 71.84 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.138 1.892 . . . . 0.0 112.574 -178.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.56 ' HG3' ' HB3' ' A' ' 47' ' ' LEU . 65.1 mm-40 -72.92 -65.71 0.76 Allowed 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.042 0.448 . . . . 0.0 111.327 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.434 ' HB ' ' O ' ' A' ' 77' ' ' GLY . 0.2 OUTLIER -58.7 -24.91 62.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.353 -178.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.559 HG13 ' O ' ' A' ' 70' ' ' PRO . 3.4 p -76.07 -27.89 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-O 120.74 0.305 . . . . 0.0 110.474 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.97 -43.35 86.43 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 176.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.08 -77.89 0.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.117 176.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.18 -100.24 0.21 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.626 178.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.27 -85.62 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.71 178.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.496 ' CE1' ' HB2' ' A' ' 65' ' ' SER . 6.3 t-80 -147.05 172.7 13.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.924 0.392 . . . . 0.0 110.94 177.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.861 ' HB2' HG13 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -111.48 68.53 0.67 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.84 178.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -99.02 122.06 50.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.952 0.406 . . . . 0.0 112.025 -176.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.977 ' HB3' ' HG2' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -133.74 -40.97 0.86 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.036 178.563 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.511 ' C ' HG13 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -153.88 151.02 28.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.04 0.448 . . . . 0.0 112.116 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.511 HG13 ' C ' ' A' ' 82' ' ' GLU . 1.1 mp -141.54 142.14 29.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.159 178.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -156.63 176.05 13.24 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.027 0.442 . . . . 0.0 111.682 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -136.07 176.65 8.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.732 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.63 HG11 ' HA ' ' A' ' 91' ' ' TRP . 0.7 OUTLIER -144.34 -53.48 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.134 -178.298 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -123.92 -153.91 8.79 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.564 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.415 ' HB2' ' H ' ' A' ' 89' ' ' SER . 31.4 Cg_exo -58.97 -78.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.626 2.218 . . . . 0.0 112.311 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.415 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -100.05 -3.02 32.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.869 0.366 . . . . 0.0 111.111 -179.742 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 8.7 pt-20 -93.35 133.24 36.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.765 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.63 ' HA ' HG11 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -151.56 173.73 14.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.272 -179.902 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.55 ' HG3' ' HE3' ' A' ' 59' ' ' TRP . 3.3 mttm -122.33 143.43 49.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.365 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.63 151.27 31.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.919 0.39 . . . . 0.0 111.258 -179.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.454 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 14.4 m-85 -118.66 123.65 45.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.081 178.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.861 HG13 ' HB2' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -123.77 151.51 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.045 -177.959 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.977 ' HG2' ' HB3' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -148.83 97.74 2.76 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.926 -177.445 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.671 ' HB ' ' HB2' ' A' ' 54' ' ' GLU . 17.6 t -60.56 117.53 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.701 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.908 -179.905 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 68.9 t . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.828 0.347 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.7 m -99.84 -67.82 0.83 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.891 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -115.76 159.43 21.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.801 0.334 . . . . 0.0 110.842 179.636 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.6 m -135.65 124.77 24.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.096 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.3 tt -104.94 112.87 26.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.571 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -130.05 112.55 13.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.142 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.51 72.45 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.818 179.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.499 -179.301 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.45 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 14.6 t . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.792 0.329 . . . . 0.0 110.61 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.447 ' N ' HG23 ' A' ' 43' ' ' THR . 2.3 tptm -61.26 -39.54 90.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.397 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -32.67 72.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.762 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.63 -48.71 80.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.822 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.636 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 3.0 mt -62.02 -30.05 70.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.784 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.62 -25.63 45.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.164 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -132.43 69.62 1.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.058 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.499 ' SD ' ' HE2' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -84.6 147.47 26.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.792 179.835 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.783 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 0.8 OUTLIER -103.08 161.57 22.7 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.658 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -46.61 -72.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.988 2.458 . . . . 0.0 113.905 -177.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.28 59.99 0.45 Allowed Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.333 -177.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.783 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 26.3 mm-40 -87.34 139.19 30.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.896 0.379 . . . . 0.0 111.377 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.523 ' HA ' ' HB2' ' A' ' 96' ' ' LYS . 16.8 mt -135.25 121.03 30.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.682 178.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.482 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.5 mp -127.1 146.82 50.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.156 0.503 . . . . 0.0 112.076 -177.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -111.31 123.34 50.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.699 177.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.3 t -114.34 130.36 68.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.977 0.417 . . . . 0.0 111.758 -177.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.4 t90 -126.73 111.33 14.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.427 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.487 HD11 ' O ' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -158.14 -168.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 121.071 0.462 . . . . 0.0 111.796 -178.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.429 ' OD2' ' HB2' ' A' ' 89' ' ' SER . 0.4 OUTLIER -102.7 -11.42 18.41 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.9 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.487 ' O ' HD11 ' A' ' 60' ' ' ILE . 4.5 m-85 -133.59 139.75 34.71 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.909 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.445 ' HA ' HD13 ' A' ' 93' ' ' ILE . 16.9 Cg_exo -67.66 101.73 0.68 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.722 2.282 . . . . 0.0 112.615 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.24 -16.78 64.1 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.138 0.494 . . . . 0.0 110.524 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.73 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -59.36 -12.62 6.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.458 179.105 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.673 ' HE2' ' HG3' ' A' ' 67' ' ' GLU . 2.2 pttm -54.91 -39.29 68.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.989 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.673 ' HG3' ' HE2' ' A' ' 66' ' ' LYS . 4.9 mt-10 -91.48 -27.97 17.92 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.146 0.498 . . . . 0.0 110.067 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.73 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -62.94 -34.62 77.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.115 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.753 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 21.0 mt -60.85 -56.95 30.1 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.753 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 75.7 Cg_exo -51.09 -37.29 57.53 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.255 1.97 . . . . 0.0 112.666 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.636 ' HG3' ' HB3' ' A' ' 47' ' ' LEU . 17.4 mm-40 -67.35 -65.79 0.64 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.841 0.353 . . . . 0.0 111.481 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.429 HG21 HD13 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -54.52 -45.35 73.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.433 -178.909 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.456 HG11 ' O ' ' A' ' 70' ' ' PRO . 7.1 p -59.18 -29.1 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.209 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.9 tptt -58.5 -43.89 89.25 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 176.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.499 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 2.9 mtpp -90.07 -77.64 0.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.484 177.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.429 HD13 HG21 ' A' ' 72' ' ' THR . 0.0 OUTLIER -98.44 -97.6 0.22 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.947 178.783 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.24 -82.39 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.372 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.63 166.94 25.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.018 0.437 . . . . 0.0 111.524 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.884 ' HB2' HG13 ' A' ' 95' ' ' ILE . 3.9 mt-10 -106.58 56.55 0.65 Allowed 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.2 p -97.38 122.18 48.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.086 0.469 . . . . 0.0 111.186 -176.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.812 HD22 ' HD2' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -133.61 -38.27 0.92 Allowed 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.341 -179.336 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.526 ' O ' ' HB2' ' A' ' 94' ' ' TYR . 1.0 OUTLIER -153.8 126.27 8.07 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.725 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.58 137.48 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.093 178.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 92' ' ' LYS . 0.5 OUTLIER -158.54 173.69 16.23 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.908 0.385 . . . . 0.0 111.398 -179.798 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -133.78 168.1 19.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.613 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.0 t -129.55 -60.25 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.04 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -125.13 -150.83 7.87 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.492 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.14 -77.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.69 2.26 . . . . 0.0 112.297 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.429 ' HB2' ' OD2' ' A' ' 61' ' ' ASP . 0.8 OUTLIER -96.8 -2.45 44.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.004 -179.756 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.35 134.82 35.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.545 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -151.07 169.19 22.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.019 0.438 . . . . 0.0 111.259 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.494 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 0.9 OUTLIER -121.08 131.58 54.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.456 179.549 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.445 HD13 ' HA ' ' A' ' 63' ' ' PRO . 2.9 mt -125.48 144.24 36.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.979 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.545 ' HB3' ' HG ' ' A' ' 81' ' ' LEU . 2.8 m-85 -118.1 119.86 36.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.141 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.884 HG13 ' HB2' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -123.92 141.88 42.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.901 -178.205 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.812 ' HD2' HD22 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -151.04 130.06 12.58 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 120.107 -0.637 . . . . 0.0 112.391 -178.539 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.8 t -72.68 116.12 14.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.652 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.92 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.661 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 87.9 t . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.427 0.156 . . . . 0.0 111.178 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.535 ' HB ' HD23 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -99.77 -42.15 6.96 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.845 -179.389 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.649 ' O ' ' HB3' ' A' ' 56' ' ' LEU . 4.4 mmtt -131.68 159.4 38.48 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.375 0.607 . . . . 0.0 112.433 -178.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 99.3 m -135.26 124.23 24.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.629 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.72 HD23 HG12 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -101.69 121.98 43.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.084 -179.848 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -129.49 87.42 2.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.922 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.72 HG12 HD23 ' A' ' 29' ' ' LEU . 6.4 m -114.37 43.42 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.001 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 21.7 ttp85 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.665 -179.084 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.2 t . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.774 0.321 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.88 -40.55 89.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.622 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.3 tmm_? -67.1 -33.31 75.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.627 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.531 ' O ' ' HG3' ' A' ' 50' ' ' MET . . . -64.01 -54.18 38.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.848 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.483 ' O ' ' HE2' ' A' ' 50' ' ' MET . 53.2 mt -52.19 -35.32 48.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.339 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.99 -22.38 39.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.181 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -126.52 49.51 2.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.289 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.531 ' HG3' ' O ' ' A' ' 46' ' ' ALA . 60.6 mtm -83.19 128.65 34.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.053 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.527 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 4.3 mtpp -85.83 154.73 58.59 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.419 179.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.47 -43.08 42.48 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.589 2.192 . . . . 0.0 112.826 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.41 57.44 0.49 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.426 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.527 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 7.2 mm-40 -90.08 128.37 36.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.3 0.55 . . . . 0.0 111.305 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.692 ' H ' HD21 ' A' ' 56' ' ' LEU . 6.1 mt -135.93 66.89 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.814 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.692 HD21 ' H ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -118.71 -172.23 2.24 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -171.772 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.457 ' C ' HG22 ' A' ' 58' ' ' VAL . 3.1 pt-20 -140.47 171.35 14.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.555 -178.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.518 HG13 HD21 ' A' ' 29' ' ' LEU . 33.6 t -139.58 146.2 25.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.57 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.422 ' C ' HG13 ' A' ' 60' ' ' ILE . 6.8 t90 -122.98 109.74 14.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.014 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.444 HG13 HG11 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -151.7 -178.39 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.308 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -101.59 -2.95 29.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.496 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.82 139.44 26.52 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.612 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -62.13 89.85 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.498 2.132 . . . . 0.0 112.245 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -23.37 67.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.927 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.794 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.4 OUTLIER -55.86 -16.91 5.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.116 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.6 pttt -53.49 -37.32 62.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.274 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.463 ' O ' ' HG2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -94.21 -27.91 15.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.175 0.512 . . . . 0.0 110.093 178.517 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.794 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -64.77 -25.43 67.92 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.378 179.725 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.491 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 18.9 mt -73.42 -54.83 3.88 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 9.2 Cg_endo -53.99 -33.67 73.72 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.194 1.929 . . . . 0.0 112.366 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.53 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -69.45 -46.89 65.65 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.996 0.427 . . . . 0.0 110.767 179.169 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.454 ' O ' HD21 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -62.08 -47.82 82.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.041 -179.861 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.1 p -58.89 -27.53 35.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.841 -179.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 4.5 mmmt -58.71 -42.69 89.24 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 175.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.1 -81.49 0.29 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.986 176.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.495 ' HG ' ' HB2' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -98.56 -107.43 0.19 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.416 177.35 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -129.22 -82.53 0.31 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.079 -0.581 . . . . 0.0 111.939 178.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.03 161.47 40.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.92 0.391 . . . . 0.0 110.856 178.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.635 ' HB2' ' H ' ' A' ' 96' ' ' LYS . 0.5 OUTLIER -103.84 52.73 0.76 Allowed 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.127 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.6 p -98.97 122.18 50.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.872 -178.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.46 ' HG ' ' N ' ' A' ' 82' ' ' GLU . 0.4 OUTLIER -133.48 -35.0 1.02 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.063 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -153.69 153.46 32.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.025 0.441 . . . . 0.0 112.052 179.351 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 82' ' ' GLU . 3.6 mp -144.03 135.53 22.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.437 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -156.07 -179.66 8.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.067 0.461 . . . . 0.0 111.314 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -133.57 158.51 42.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.783 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 62.0 t -117.65 -59.26 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.261 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -127.08 -152.73 8.07 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.729 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -56.67 -75.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.678 2.252 . . . . 0.0 112.612 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.18 -5.62 29.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.907 0.384 . . . . 0.0 111.235 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -93.61 137.1 33.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.769 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.02 168.56 20.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.923 0.392 . . . . 0.0 111.121 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.3 tttm -126.14 136.9 53.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.623 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.581 HG23 ' N ' ' A' ' 94' ' ' TYR . 2.2 mp -125.99 157.69 35.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.937 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.581 ' N ' HG23 ' A' ' 93' ' ' ILE . 15.3 m-85 -118.21 135.02 54.51 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.014 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.634 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 10.9 mm -122.88 145.48 29.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.214 -176.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.635 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -143.68 106.04 4.41 Favored 'General case' 0 C--N 1.334 -0.085 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.738 -177.569 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.503 HG12 ' HB3' ' A' ' 50' ' ' MET . 23.7 t -75.79 131.11 35.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.642 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.495 ' HB2' ' HG ' ' A' ' 76' ' ' LEU . 3.5 mmmp? . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.152 -0.928 . . . . 0.0 110.908 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 26' ' ' THR . 20.1 t . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.856 0.36 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.447 ' N ' HG12 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -100.08 -53.52 3.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.966 179.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.25 160.54 30.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.016 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.537 HG22 ' O ' ' A' ' 57' ' ' GLU . 98.3 m -135.27 122.65 21.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.832 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.632 ' HB3' ' HB ' ' A' ' 58' ' ' VAL . 8.6 tt -99.15 103.35 15.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.948 0.404 . . . . 0.0 111.028 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.22 111.66 17.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.625 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.2 m -140.15 75.98 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.231 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.052 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.548 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 10.2 t . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.644 0.259 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.04 -50.46 69.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.695 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.39 -33.08 74.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.075 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.52 -42.29 91.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.037 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 43' ' ' THR . 2.8 mt -77.54 -45.69 24.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.677 -179.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -15.81 60.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.943 -177.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.71 63.06 1.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.938 0.399 . . . . 0.0 111.2 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 6.6 ptt? -109.25 136.48 48.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.868 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.46 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -92.27 147.44 34.58 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.671 179.491 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -42.47 -56.82 1.89 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.025 2.483 . . . . 0.0 113.476 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.24 56.0 0.58 Allowed Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.056 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.46 ' HG2' ' HB3' ' A' ' 51' ' ' LYS . 4.2 mm-40 -90.72 150.66 21.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.082 0.468 . . . . 0.0 111.78 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.8 mp -133.65 111.59 15.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.499 177.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.3 mp -119.3 168.38 10.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.456 0.646 . . . . 0.0 112.39 -176.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.537 ' O ' HG22 ' A' ' 28' ' ' THR . 4.3 tt0 -141.51 117.4 10.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.445 178.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.632 ' HB ' ' HB3' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -114.06 136.26 51.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.148 0.499 . . . . 0.0 112.076 -176.172 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.56 ' HZ3' HG12 ' A' ' 86' ' ' VAL . 2.7 t-105 -122.89 119.43 30.47 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.038 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.477 HD13 ' HA ' ' A' ' 63' ' ' PRO . 1.0 OUTLIER -158.88 -169.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.096 0.474 . . . . 0.0 111.528 -178.61 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' A' ' 89' ' ' SER . 85.7 m-20 -104.09 -9.18 18.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.973 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.49 110.99 4.96 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.301 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.477 ' HA ' HD13 ' A' ' 60' ' ' ILE . 84.6 Cg_exo -45.98 106.26 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.747 2.298 . . . . 0.0 112.752 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.52 -8.13 38.54 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.724 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.762 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 15.8 p -61.2 -12.82 14.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.661 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.02 -38.75 68.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.978 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.504 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -93.58 -27.49 16.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.18 0.514 . . . . 0.0 110.126 178.618 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.762 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 4.4 mtm-85 -64.09 -32.43 73.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.045 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.718 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 17.2 mt -62.54 -57.76 20.67 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.154 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.718 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 84.9 Cg_exo -48.13 -40.28 34.23 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.196 1.931 . . . . 0.0 112.442 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.0 -46.26 78.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.994 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.628 HG21 ' HG3' ' A' ' 79' ' ' GLU . 1.9 m -65.66 -37.96 87.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.749 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 70' ' ' PRO . 1.5 m -63.89 -29.35 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.465 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.52 -45.53 88.62 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 176.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.623 ' HG3' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -86.75 -80.97 0.23 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.658 177.218 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.623 HD22 ' HG3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -100.29 -95.16 0.26 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.962 0.41 . . . . 0.0 110.902 178.584 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.495 ' O ' ' HB ' ' A' ' 72' ' ' THR . . . -145.13 -82.22 0.05 OUTLIER Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.03 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.446 ' HB2' HG13 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -145.43 152.02 39.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.898 0.38 . . . . 0.0 111.002 179.212 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.628 ' HG3' HG21 ' A' ' 72' ' ' THR . 2.2 mt-10 -95.54 54.2 1.55 Allowed 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.943 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.446 HG13 ' HB2' ' A' ' 78' ' ' HIS . 1.2 p -98.92 116.14 41.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.903 -178.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.7 HD12 ' HB2' ' A' ' 96' ' ' LYS . 2.0 pt? -133.22 -31.23 1.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.119 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.508 ' O ' HD13 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -150.99 130.66 13.1 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.194 -0.603 . . . . 0.0 112.244 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.508 HD13 ' O ' ' A' ' 82' ' ' GLU . 1.8 mm -131.05 131.1 64.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.4 178.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -154.85 173.4 16.53 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.895 0.378 . . . . 0.0 111.263 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.92 172.18 13.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.775 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.56 HG12 ' HZ3' ' A' ' 59' ' ' TRP . 2.7 p -140.86 -50.42 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.189 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -123.55 -158.54 10.19 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.566 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.25 -66.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.602 2.201 . . . . 0.0 112.588 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.403 ' O ' ' HA ' ' A' ' 61' ' ' ASP . 80.2 p -100.26 -8.53 23.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.55 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.24 116.99 29.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.756 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.413 ' HE3' ' HD3' ' A' ' 63' ' ' PRO . 4.8 m0 -131.63 163.82 27.24 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.972 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.506 ' HG3' ' HE3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -125.81 123.06 37.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.301 179.103 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.596 HG21 ' N ' ' A' ' 94' ' ' TYR . 3.8 mp -125.54 150.95 31.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.976 0.417 . . . . 0.0 111.305 -178.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.596 ' N ' HG21 ' A' ' 93' ' ' ILE . 6.9 m-85 -118.2 134.22 55.21 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.987 178.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.613 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 13.6 mm -123.32 139.14 50.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.266 -178.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.7 ' HB2' HD12 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -143.41 122.92 13.19 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 120.182 -0.607 . . . . 0.0 112.518 -176.178 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.5 t -78.57 118.32 25.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.439 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.43 ' HA ' ' HZ2' ' A' ' 96' ' ' LYS . 2.8 tttt . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.999 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.965 ' HA ' HG22 ' A' ' 55' ' ' ILE . 52.8 t . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.852 0.358 . . . . 0.0 111.074 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.27 -48.96 4.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.197 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.543 ' HB3' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -120.6 129.83 53.91 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.83 0.348 . . . . 0.0 110.991 -179.998 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 99.8 m -118.58 121.16 39.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.847 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.604 HD13 HH22 ' A' ' 68' ' ' ARG . 6.9 tt -99.66 115.82 30.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.081 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -116.81 115.85 26.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.44 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.551 HG13 HG23 ' A' ' 60' ' ' ILE . 7.7 p -140.27 76.57 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.443 0.639 . . . . 0.0 111.163 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.015 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.4 t . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.716 0.293 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.29 -44.23 97.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.538 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.11 -38.56 78.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.865 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.24 -43.15 99.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.747 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.75 HD13 ' HE1' ' A' ' 50' ' ' MET . 0.1 OUTLIER -67.23 -33.56 75.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.96 179.741 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -81.13 -6.36 58.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.097 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -130.64 51.24 2.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.32 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.75 ' HE1' HD13 ' A' ' 47' ' ' LEU . 10.5 mtp -99.74 109.61 22.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.901 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.476 ' HB3' ' HG3' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -74.69 138.06 73.8 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.455 179.305 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_exo -42.57 -41.77 8.12 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.751 2.301 . . . . 0.0 112.907 -179.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.27 50.31 0.87 Allowed Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.932 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.525 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 9.3 mt-10 -90.89 151.02 21.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.465 0.65 . . . . 0.0 112.177 -178.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.967 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 3.1 mp -134.24 106.15 7.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.049 178.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.543 HD21 ' HB3' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -128.48 156.44 43.23 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -175.185 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -135.59 136.86 41.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.145 176.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.459 HG12 HD12 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -114.77 140.18 37.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.067 0.461 . . . . 0.0 112.059 -177.007 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -122.67 98.12 5.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.351 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.551 HG23 HG13 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -147.0 -173.06 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.461 -179.069 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.26 -16.39 14.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.951 178.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -123.18 126.73 25.86 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.55 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -56.52 93.68 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.588 2.192 . . . . 0.0 112.658 -179.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.54 -16.19 63.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.905 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.629 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 9.7 p -63.66 -10.47 19.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.856 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -61.28 -33.28 73.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.605 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.582 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -93.72 -28.59 15.86 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.355 0.598 . . . . 0.0 110.075 178.175 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.629 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 37.6 mtt-85 -61.51 -39.57 91.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.604 178.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.657 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 22.3 mt -55.83 -57.1 23.54 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.279 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.657 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 83.2 Cg_exo -45.63 -39.3 17.72 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.249 1.966 . . . . 0.0 112.385 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.449 ' OE1' HD23 ' A' ' 47' ' ' LEU . 2.3 mp0 -71.36 -61.08 1.9 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.49 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.514 ' HB ' ' O ' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -56.78 -31.3 64.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.54 -178.745 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.599 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 8.6 p -74.26 -26.53 20.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.67 0.271 . . . . 0.0 110.873 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.481 ' N ' HG13 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -58.33 -46.56 85.96 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 177.103 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.29 -73.9 0.49 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.211 177.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 72' ' ' THR . 0.1 OUTLIER -98.12 -106.92 0.19 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.322 177.842 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.599 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.67 -89.07 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.464 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 0.6 OUTLIER -147.81 145.76 28.88 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 178.223 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.695 ' O ' ' HA ' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -96.77 61.61 1.87 Allowed 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.129 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.464 ' CG2' ' HB2' ' A' ' 78' ' ' HIS . 0.2 OUTLIER -98.36 118.61 45.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.516 -177.221 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.821 HD22 ' HD3' ' A' ' 96' ' ' LYS . 0.5 OUTLIER -133.86 -28.11 1.42 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.038 179.722 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.31 139.77 18.69 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.348 -0.541 . . . . 0.0 112.371 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.412 HD12 HG13 ' A' ' 80' ' ' VAL . 3.9 mp -144.18 128.05 12.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.159 178.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -156.17 -176.36 5.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.188 0.518 . . . . 0.0 111.403 -178.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 91' ' ' TRP . 8.4 pt-20 -133.17 161.18 35.12 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.691 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -113.69 -55.41 4.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.232 -179.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -122.95 -139.98 5.61 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.738 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.42 -83.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.609 2.206 . . . . 0.0 112.418 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.9 p -98.8 -0.36 42.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.906 0.384 . . . . 0.0 111.009 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -93.29 122.2 35.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.641 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -135.38 165.54 25.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.042 0.449 . . . . 0.0 111.297 -179.737 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -121.25 141.52 50.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.38 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.4 HG22 ' N ' ' A' ' 94' ' ' TYR . 1.3 mp -125.64 152.28 32.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.125 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.529 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 19.3 m-85 -118.82 111.54 18.55 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.719 179.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.695 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -124.45 120.99 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.078 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.967 ' HG3' ' HA ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -133.36 106.74 7.68 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.963 -172.577 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.525 ' HB ' ' HB2' ' A' ' 54' ' ' GLU . 22.0 t -56.58 113.09 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.767 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.5 mmtm . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.972 -179.535 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.788 HG21 ' HB2' ' A' ' 57' ' ' GLU . 1.5 p . . . . . 0 CA--C 1.529 0.145 0 CA-C-O 120.938 0.399 . . . . 0.0 111.505 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.6 m -99.77 -58.82 1.84 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.477 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.652 ' HB2' HD13 ' A' ' 56' ' ' LEU . 4.2 mptt -100.71 158.11 16.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.362 178.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.763 HG21 ' HB3' ' A' ' 57' ' ' GLU . 28.6 m -135.88 118.26 15.72 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.829 0.347 . . . . 0.0 111.6 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.9 tt -102.25 113.09 26.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.126 177.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.417 ' HB3' ' HB3' ' A' ' 59' ' ' TRP . 2.7 p-10 -132.29 116.2 16.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.188 -178.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.6 64.23 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.131 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.061 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.688 0.28 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.86 -37.25 78.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.983 0.421 . . . . 0.0 110.288 179.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.12 -30.99 71.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.719 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.61 -49.89 75.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.087 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.654 HD12 ' HA ' ' A' ' 68' ' ' ARG . 3.2 mm? -59.59 -35.42 74.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.007 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -81.26 -23.26 38.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.293 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -121.95 52.18 1.29 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.959 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.77 146.84 25.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.018 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.711 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -98.82 153.64 37.77 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.545 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.711 ' HD2' ' HG3' ' A' ' 51' ' ' LYS . 53.6 Cg_exo -38.77 -84.2 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.145 2.563 . . . . 0.0 113.794 -178.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 97' ' ' VAL . . . -104.28 59.33 0.47 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.97 -0.634 . . . . 0.0 113.046 -178.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -90.89 158.41 16.79 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.076 0.465 . . . . 0.0 111.753 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.673 HD12 ' HG3' ' A' ' 96' ' ' LYS . 0.1 OUTLIER -130.57 121.75 51.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.108 179.263 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.652 HD13 ' HB2' ' A' ' 27' ' ' LYS . 4.7 mp -129.29 163.86 24.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.221 0.534 . . . . 0.0 111.59 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.788 ' HB2' HG21 ' A' ' 25' ' ' VAL . 48.4 tt0 -121.04 158.1 28.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.809 178.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.8 t -136.56 115.75 15.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.894 0.378 . . . . 0.0 111.089 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.417 ' HB3' ' HB3' ' A' ' 30' ' ' ASP . 6.5 t90 -122.08 104.94 9.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.492 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.433 HD11 ' O ' ' A' ' 62' ' ' TYR . 1.0 OUTLIER -158.29 -174.31 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.656 -178.477 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -99.01 -23.68 15.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.933 178.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.433 ' O ' HD11 ' A' ' 60' ' ' ILE . 42.9 m-85 -115.27 112.24 44.08 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.372 178.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -47.22 99.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.816 2.344 . . . . 0.0 113.119 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.26 -26.66 65.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.544 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.717 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -63.27 -13.7 41.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.762 179.714 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.557 ' HG3' ' N ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -58.65 -32.06 68.74 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.436 179.243 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.557 ' N ' ' HG3' ' A' ' 66' ' ' LYS . 0.3 OUTLIER -94.52 -26.44 16.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.898 178.019 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.717 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 9.1 mtt85 -60.81 -39.39 88.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.066 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.685 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 6.9 mt -62.14 -55.87 36.62 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.543 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.685 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 84.0 Cg_exo -46.34 -39.56 21.69 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.304 2.003 . . . . 0.0 112.511 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.6 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 0.9 OUTLIER -68.64 -51.93 36.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.957 179.42 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.575 ' O ' ' HG2' ' A' ' 75' ' ' LYS . 1.7 m -60.46 -40.12 90.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.982 -178.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.532 HG11 ' O ' ' A' ' 69' ' ' ILE . 12.9 m -64.92 -30.24 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.856 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.442 ' N ' HG23 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -58.25 -43.09 87.68 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.539 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.646 ' HG3' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -90.26 -78.17 0.38 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.784 177.707 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.646 HD23 ' HG3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -99.38 -97.46 0.23 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.98 0.419 . . . . 0.0 110.596 178.399 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.502 ' O ' ' HB ' ' A' ' 72' ' ' THR . . . -145.01 -86.56 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.735 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.427 ' HB2' HG21 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -146.71 153.97 40.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.823 0.345 . . . . 0.0 110.824 178.799 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.799 ' HB2' HG22 ' A' ' 95' ' ' ILE . 0.6 OUTLIER -101.35 63.72 0.99 Allowed 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.087 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.459 ' H ' HG23 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -99.22 127.36 52.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.336 -177.54 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.512 ' HG ' ' HB3' ' A' ' 94' ' ' TYR . 1.0 OUTLIER -132.98 -36.41 1.03 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.719 179.528 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.458 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 0.7 OUTLIER -154.15 151.96 29.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.076 0.465 . . . . 0.0 111.951 179.245 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 82' ' ' GLU . 2.6 mp -144.18 134.99 21.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.268 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -158.66 -179.22 7.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.092 0.473 . . . . 0.0 111.267 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -133.57 167.47 20.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.664 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.74 -59.01 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.215 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -124.87 -151.86 8.16 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.682 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -63.01 -75.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.741 2.294 . . . . 0.0 112.593 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.56 -4.08 34.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.245 -179.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -93.2 123.83 36.75 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.433 178.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 2.9 m-90 -129.8 167.82 17.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.021 0.438 . . . . 0.0 111.394 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -123.5 132.99 54.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.598 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.532 HG23 ' HG ' ' A' ' 65' ' ' SER . 2.4 mt -125.48 146.85 30.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.69 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.56 ' HE2' HG13 ' A' ' 25' ' ' VAL . 36.4 m-85 -118.09 124.23 47.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.098 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.799 HG22 ' HB2' ' A' ' 79' ' ' GLU . 28.5 mm -123.91 148.53 28.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.291 -176.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.673 ' HG3' HD12 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -150.78 106.13 3.36 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.107 -177.463 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.448 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 1.7 t -59.86 119.28 3.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.638 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.188 -0.91 . . . . 0.0 110.887 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.436 HG23 ' HE2' ' A' ' 94' ' ' TYR . 15.5 t . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.846 0.355 . . . . 0.0 111.237 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.74 -70.3 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.037 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -118.6 162.73 17.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.86 0.362 . . . . 0.0 111.223 -179.763 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 92.3 m -135.64 129.0 32.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.856 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.5 tt -111.35 118.1 34.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.001 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.81 110.95 16.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.919 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.61 70.77 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.397 0.618 . . . . 0.0 110.977 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 32' ' ' ARG . 3.8 ttp180 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.855 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.472 HG22 ' N ' ' A' ' 44' ' ' LYS . 15.3 t . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.875 0.369 . . . . 0.0 110.683 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.472 ' N ' HG22 ' A' ' 43' ' ' THR . 4.9 tptt -54.98 -45.47 75.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.509 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -33.58 76.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.013 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.94 -30.84 64.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.993 0.425 . . . . 0.0 110.791 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.3 mt -77.4 -57.2 3.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.301 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.16 -10.09 59.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.717 -178.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -131.23 67.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.855 0.359 . . . . 0.0 111.048 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.01 144.87 36.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.857 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.662 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 11.6 mttt -81.18 159.15 68.58 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.033 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.4 ' HB2' ' H ' ' A' ' 53' ' ' GLY . 100.0 Cg_exo -45.91 -75.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.939 2.426 . . . . 0.0 113.873 -178.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 97' ' ' VAL . . . -103.83 60.77 0.45 Allowed Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.144 -177.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.662 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 3.2 mm-40 -90.98 152.4 20.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.056 0.455 . . . . 0.0 111.72 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.416 HG21 ' HA ' ' A' ' 25' ' ' VAL . 3.5 mp -135.31 112.57 14.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.018 178.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.51 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.1 mp -126.27 151.69 47.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.228 0.537 . . . . 0.0 112.355 -177.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -113.31 124.64 52.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.376 176.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.0 t -114.32 134.31 57.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.136 0.493 . . . . 0.0 112.075 -177.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 13.7 t90 -123.0 106.76 11.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.325 178.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.03 -162.95 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.823 0.344 . . . . 0.0 111.267 -178.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -145.27 24.16 1.45 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.313 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.65 ' H ' ' HA ' ' A' ' 63' ' ' PRO . 29.3 m-85 -101.26 -56.14 0.13 Allowed Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 116.673 -0.239 . . . . 0.0 111.483 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.65 ' HA ' ' H ' ' A' ' 62' ' ' TYR . 76.7 Cg_endo -94.32 177.79 11.03 Favored 'Cis proline' 0 C--N 1.355 0.873 0 C-N-CA 124.796 -0.918 . . . . 0.0 112.294 -0.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -65.18 -21.45 66.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.755 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.628 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 30.4 t -63.6 -15.62 58.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.149 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.402 ' HG3' ' N ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -61.39 -34.13 74.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.978 -179.867 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.554 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -92.23 -23.43 19.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.225 0.536 . . . . 0.0 109.979 178.432 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.628 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 20.7 mtt-85 -63.41 -47.8 80.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.81 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.709 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 8.1 mt -51.04 -54.92 32.47 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.664 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.709 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 82.8 Cg_exo -48.64 -50.48 12.35 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.267 1.978 . . . . 0.0 112.959 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.44 -53.62 33.39 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.153 0.501 . . . . 0.0 111.637 -179.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.724 HG23 ' HA ' ' A' ' 78' ' ' HIS . 0.9 OUTLIER -56.41 -49.56 74.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.601 -178.245 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.631 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 18.2 m -64.75 -21.16 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 120.607 0.241 . . . . 0.0 111.198 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.35 -55.27 37.22 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.781 ' HG2' ' H ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -91.1 -61.28 1.7 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.942 177.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.781 ' H ' ' HG2' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -100.45 -109.09 0.21 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.042 0.448 . . . . 0.0 110.526 176.565 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.631 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -144.97 -87.63 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 178.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.724 ' HA ' HG23 ' A' ' 72' ' ' THR . 0.2 OUTLIER -148.14 150.6 34.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.642 0.258 . . . . 0.0 110.762 177.499 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.707 ' HB2' ' H ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -97.81 74.2 2.34 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.14 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.56 123.86 51.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.997 0.427 . . . . 0.0 111.831 -176.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.478 ' HG ' ' N ' ' A' ' 82' ' ' GLU . 0.6 OUTLIER -133.45 -35.59 1.01 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.669 179.076 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.628 ' HB3' ' HB2' ' A' ' 94' ' ' TYR . 0.3 OUTLIER -153.69 149.01 27.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.618 179.377 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 82' ' ' GLU . 2.2 mp -142.62 133.41 23.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.625 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.569 ' HG3' ' HB3' ' A' ' 92' ' ' LYS . 8.4 pt-20 -158.07 -177.46 6.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.078 0.466 . . . . 0.0 111.219 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -133.39 167.21 20.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.817 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.7 t -124.63 -66.95 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.205 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -124.34 -154.41 8.87 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.567 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.16 -71.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.632 2.221 . . . . 0.0 112.325 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.2 0.19 39.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.093 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.3 132.52 37.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.774 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 -138.92 159.62 41.7 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.929 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.569 ' HB3' ' HG3' ' A' ' 84' ' ' GLU . 24.5 ttmt -124.37 126.4 45.92 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.344 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.6 mp -125.33 149.87 30.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.967 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.628 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 8.6 m-85 -118.15 129.98 55.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.369 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.607 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -123.69 148.88 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.166 -178.068 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.707 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -150.83 104.73 3.2 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.582 -178.298 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.51 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 3.1 t -62.96 119.05 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.26 178.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.1 mttt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.058 -179.509 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.95 -15.47 1.52 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.782 0.325 . . . . 0.0 110.896 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.4 t -88.53 121.1 30.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.902 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -133.62 -40.53 0.87 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.937 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -134.61 -162.32 1.24 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.039 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -62.66 165.76 6.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.024 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 8.7 m80 -80.65 101.97 9.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.874 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.71 30.97 3.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.834 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.422 ' HB2' ' H ' ' A' ' 10' ' ' SER . 5.7 m80 -89.92 -81.93 0.28 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.783 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.422 ' H ' ' HB2' ' A' ' 9' ' ' HIS . 0.1 OUTLIER -86.53 68.18 10.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.0 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.61 -79.09 0.16 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.058 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.9 158.95 45.2 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.58 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.84 91.07 2.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.838 0.351 . . . . 0.0 110.888 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.3 m -86.65 123.83 70.28 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.165 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -83.69 21.36 1.06 Allowed 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.681 2.254 . . . . 0.0 112.442 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.2 mtp180 -83.31 28.16 0.55 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.286 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.92 97.5 0.16 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.311 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.83 -150.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.58 0.229 . . . . 0.0 110.964 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -55.03 -62.1 1.88 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.147 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.73 123.95 26.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.956 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.09 140.64 40.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.074 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -84.31 72.34 10.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.976 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -74.7 166.34 23.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.843 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.28 64.86 8.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.893 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.5 t -82.65 146.57 6.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.6 -65.21 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.078 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.411 ' HB2' HD13 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -118.11 169.77 9.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.097 -179.714 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.684 HG21 ' HB3' ' A' ' 57' ' ' GLU . 83.3 m -135.51 130.85 35.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.808 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.1 tp -106.37 113.08 26.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.845 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.68 123.33 42.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.888 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.4 47.62 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.079 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.502 ' HB2' ' H ' ' A' ' 33' ' ' GLY . 14.4 mtm180 -69.97 -100.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.752 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.502 ' H ' ' HB2' ' A' ' 32' ' ' ARG . . . -79.45 82.13 1.41 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.096 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -83.98 163.92 19.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.962 0.41 . . . . 0.0 111.385 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.14 -90.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.652 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.531 ' O ' ' HD2' ' A' ' 39' ' ' PRO . 0.5 OUTLIER -65.71 163.32 36.11 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.339 178.567 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.73 15.83 0.84 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.467 2.111 . . . . 0.0 112.68 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.636 ' HB ' ' HD3' ' A' ' 39' ' ' PRO . 11.7 t -65.74 -52.98 39.05 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.549 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.636 ' HD3' ' HB ' ' A' ' 38' ' ' VAL . 52.1 Cg_exo -54.42 -29.96 61.4 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.215 1.943 . . . . 0.0 112.2 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.461 ' O ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -63.45 -49.96 71.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.477 179.48 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.5 t -67.25 -20.98 27.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.88 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -66.31 -59.13 4.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.944 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 40' ' ' ASP . 7.2 t -56.03 -33.25 64.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.694 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.462 ' O ' ' HB3' ' A' ' 48' ' ' GLN . 5.3 mmtt -56.79 -41.89 78.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.514 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.62 -30.74 71.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.946 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.53 -54.34 47.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.967 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.782 ' HB3' ' HG2' ' A' ' 71' ' ' GLU . 0.4 OUTLIER -77.24 -37.31 53.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.768 -179.492 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.462 ' HB3' ' O ' ' A' ' 44' ' ' LYS . 1.4 tt0 -68.14 -31.18 70.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.396 -178.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -134.96 72.18 1.45 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.064 0.459 . . . . 0.0 110.932 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.18 140.73 31.53 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.846 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.508 ' HG2' ' HD2' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -94.17 151.48 39.61 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.778 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.508 ' HD2' ' HG2' ' A' ' 51' ' ' LYS . 50.0 Cg_exo -38.23 -86.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.366 2.71 . . . . 0.0 114.027 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.44 ' H ' ' HB2' ' A' ' 52' ' ' PRO . . . -103.89 59.05 0.5 Allowed Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.989 -0.624 . . . . 0.0 113.124 -177.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -90.7 156.42 18.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.104 0.478 . . . . 0.0 111.705 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.4 mp -135.05 117.75 22.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.992 178.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.411 HD13 ' HB2' ' A' ' 27' ' ' LYS . 4.6 mp -122.77 164.05 19.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.209 0.528 . . . . 0.0 111.753 -178.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.684 ' HB3' HG21 ' A' ' 28' ' ' THR . 37.2 tt0 -114.38 161.27 18.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.131 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 57' ' ' GLU . 22.1 t -142.7 113.92 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.808 0.337 . . . . 0.0 111.221 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.6 103.25 8.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.786 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -158.11 -166.19 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.029 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -103.04 -2.5 27.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.015 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -137.58 148.12 60.13 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.927 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.69 104.4 1.88 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.601 2.201 . . . . 0.0 112.624 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 8.4 tpp -68.1 -19.95 64.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.108 0.48 . . . . 0.0 110.617 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.808 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 3.6 p -58.85 -10.84 2.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.215 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.458 ' HG3' ' H ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -56.75 -44.69 81.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.789 0.328 . . . . 0.0 110.727 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.547 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 0.7 OUTLIER -86.64 -24.88 25.15 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.085 0.469 . . . . 0.0 110.055 178.398 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.808 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 1.0 OUTLIER -61.69 -41.34 97.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.233 179.565 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.739 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 12.9 mt -54.59 -56.67 24.54 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.739 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 76.1 Cg_exo -51.87 -36.96 65.38 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.288 1.992 . . . . 0.0 112.682 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.782 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 0.6 OUTLIER -71.92 -64.46 0.93 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.782 0.325 . . . . 0.0 111.66 -179.2 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.444 ' HG1' ' HG2' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -55.9 -30.6 61.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.555 -178.515 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.462 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 6.6 p -73.47 -28.89 26.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.905 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.4 tptp -58.57 -42.11 87.23 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.45 -77.51 0.4 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.226 177.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.559 HD12 ' HB2' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -98.79 -98.52 0.22 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.786 178.358 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.34 -79.71 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.249 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.68 157.32 43.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.803 0.335 . . . . 0.0 111.014 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.698 ' HB2' ' H ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -101.18 55.89 0.84 Allowed 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.135 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.6 p -98.31 123.49 50.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.269 -176.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.474 ' HG ' ' N ' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -133.31 -36.12 1.0 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.186 -179.687 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.53 ' HB3' ' HB2' ' A' ' 94' ' ' TYR . 0.5 OUTLIER -153.51 145.49 23.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.999 0.428 . . . . 0.0 111.826 -179.711 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.494 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 3.0 mp -142.44 136.11 27.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.414 178.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -157.47 179.04 9.63 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.038 0.447 . . . . 0.0 111.421 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -133.67 166.14 23.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.854 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.3 t -127.28 -64.4 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.133 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -124.83 -147.14 7.02 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.825 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -60.81 -77.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.757 2.305 . . . . 0.0 112.616 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.2 -1.74 35.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.419 -178.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.47 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 0.7 OUTLIER -93.26 120.26 33.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.746 179.442 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 7.0 m0 -130.46 166.08 21.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.904 0.383 . . . . 0.0 111.187 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -127.04 129.91 48.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.612 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.7 mp -125.79 149.52 30.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.296 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.53 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 9.3 m-85 -118.68 127.97 54.07 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.202 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.642 HG13 ' HB2' ' A' ' 79' ' ' GLU . 1.1 tp -124.49 149.81 28.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.519 -177.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.698 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -151.11 109.47 3.78 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 120.523 -0.471 . . . . 0.0 112.132 -178.455 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.413 ' H ' HG23 ' A' ' 97' ' ' VAL . 2.1 t -64.41 111.16 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.266 178.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.559 ' HB2' HD12 ' A' ' 76' ' ' LEU . 16.5 mmtt . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.097 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.136 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.0 t -128.57 -63.13 1.0 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.859 0.361 . . . . 0.0 110.887 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.53 -73.41 0.68 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.873 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -87.29 165.07 15.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.795 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -97.4 140.51 31.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.968 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -90.48 131.05 36.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.037 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.59 -173.46 2.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.855 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.21 -5.0 39.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.899 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -87.7 88.35 7.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.44 138.91 57.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.885 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 t -76.36 -79.54 0.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.979 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.9 136.36 20.54 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.468 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 22.7 tp -81.25 79.98 7.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.902 0.382 . . . . 0.0 110.979 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.479 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 13.2 t -83.52 -51.29 0.64 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.425 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 59.8 Cg_endo -72.25 102.12 1.33 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.124 1.883 . . . . 0.0 112.172 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.34 27.91 0.56 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.133 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.29 148.28 43.81 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.486 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.09 -151.59 0.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.592 0.234 . . . . 0.0 110.784 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -84.13 29.24 0.57 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.979 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.13 50.01 1.34 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.851 0.357 . . . . 0.0 110.94 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.88 157.4 25.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.926 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -89.05 70.94 8.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.814 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.402 ' HA ' HD12 ' A' ' 55' ' ' ILE . 5.5 p90 -93.46 47.32 1.24 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.898 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.434 ' O ' HD13 ' A' ' 55' ' ' ILE . 1.7 tm0? -83.29 126.83 33.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.942 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.649 HG21 HG22 ' A' ' 55' ' ' ILE . 87.5 t -61.33 126.44 19.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.105 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.17 -48.2 4.7 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.945 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -121.33 148.57 44.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.098 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.417 HG22 ' HB3' ' A' ' 57' ' ' GLU . 28.3 m -132.98 140.86 47.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.825 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.6 tp -112.03 110.98 21.58 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.905 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.512 ' HB3' ' HE1' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -104.86 113.34 26.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.741 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.61 HG23 HG22 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -131.09 61.6 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.274 -179.593 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.47 ' HB2' ' H ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -64.86 -88.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.332 179.19 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.47 ' H ' ' HB2' ' A' ' 32' ' ' ARG . . . -77.99 103.36 1.89 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.12 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -80.78 142.89 33.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.913 0.387 . . . . 0.0 111.346 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.95 -91.47 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.012 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.458 ' HB3' ' HD2' ' A' ' 37' ' ' PRO . 63.0 m -77.42 160.48 75.14 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.653 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 36' ' ' CYS . 60.9 Cg_endo -72.83 21.61 0.31 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.55 2.167 . . . . 0.0 112.736 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.628 ' HB ' ' HD3' ' A' ' 39' ' ' PRO . 19.3 t -60.54 -51.38 80.26 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.417 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.628 ' HD3' ' HB ' ' A' ' 38' ' ' VAL . 33.6 Cg_exo -59.88 -23.27 71.87 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.138 1.892 . . . . 0.0 112.234 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 37' ' ' PRO . 0.3 OUTLIER -65.22 -57.17 9.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.707 179.808 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.8 t -73.96 -24.01 19.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.926 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -66.53 -54.1 27.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.928 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.462 HG22 ' N ' ' A' ' 44' ' ' LYS . 14.3 t -59.99 -37.42 79.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.81 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.462 ' N ' HG22 ' A' ' 43' ' ' THR . 0.1 OUTLIER -54.05 -41.56 68.25 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.839 179.603 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 45' ' ' ARG . 3.5 tmm_? -67.95 -32.56 73.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.801 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.54 -49.38 77.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.207 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.811 ' HB3' ' HG2' ' A' ' 71' ' ' GLU . 2.5 mm? -58.67 -42.72 89.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.063 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -75.54 -15.5 60.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.036 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.19 61.68 0.77 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.92 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.483 ' HB3' HG23 ' A' ' 97' ' ' VAL . 10.1 mmt -108.32 146.76 32.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.859 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.624 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 2.2 mtpp -102.81 164.21 16.04 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.767 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.61 ' HD2' ' HB3' ' A' ' 51' ' ' LYS . 2.2 Cg_endo -46.2 -73.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.119 2.546 . . . . 0.0 113.398 -178.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.27 58.78 0.49 Allowed Glycine 0 C--N 1.329 0.192 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.278 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.624 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 3.8 mm-40 -90.34 151.35 21.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.09 0.472 . . . . 0.0 111.525 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.649 HG22 HG21 ' A' ' 25' ' ' VAL . 3.7 mp -134.75 113.51 16.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.815 178.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.558 HD13 ' C ' ' A' ' 55' ' ' ILE . 0.4 OUTLIER -118.71 145.35 45.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.164 0.506 . . . . 0.0 111.846 -176.825 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.449 ' C ' HG22 ' A' ' 58' ' ' VAL . 58.9 tt0 -111.07 135.49 51.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.987 177.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.449 HG22 ' C ' ' A' ' 57' ' ' GLU . 2.0 t -134.82 126.5 47.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.512 ' HE1' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -122.97 115.33 21.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.879 176.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.61 HG22 HG23 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -147.42 -170.52 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.303 -178.027 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.02 -11.71 16.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.419 178.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.4 ' O ' HD12 ' A' ' 60' ' ' ILE . 64.9 m-85 -129.76 143.92 50.95 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.55 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.88 93.73 0.39 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.532 2.155 . . . . 0.0 112.481 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.06 -16.33 63.98 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.042 0.448 . . . . 0.0 110.585 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.401 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -62.04 -15.58 45.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.793 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.506 ' HG3' ' N ' ' A' ' 67' ' ' GLU . 1.2 ptpp? -57.58 -32.88 67.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.772 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.506 ' N ' ' HG3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -94.54 -27.95 15.68 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.169 0.509 . . . . 0.0 110.401 178.737 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.619 ' HA ' HD11 ' A' ' 47' ' ' LEU . 54.3 mtt-85 -65.78 -32.68 74.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.175 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.489 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 26.6 mt -63.62 -55.33 35.31 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.493 ' HG2' ' O ' ' A' ' 67' ' ' GLU . 12.2 Cg_endo -56.97 -32.23 92.22 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.182 1.921 . . . . 0.0 112.566 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.811 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 0.4 OUTLIER -74.13 -60.83 2.09 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.873 0.368 . . . . 0.0 111.296 -179.818 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.468 HG22 ' OE1' ' A' ' 79' ' ' GLU . 0.2 OUTLIER -61.26 -25.0 66.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.314 -179.028 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.495 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 4.5 p -75.23 -28.95 21.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.274 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.46 -43.51 88.89 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.603 ' HG3' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -86.85 -78.18 0.3 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.164 176.7 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.603 HD23 ' HG3' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -98.73 -98.59 0.22 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.848 0.356 . . . . 0.0 110.659 177.947 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.28 -80.98 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.865 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -146.2 149.64 34.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.889 0.376 . . . . 0.0 110.922 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.623 ' HB2' ' H ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -97.87 58.93 1.42 Allowed 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.018 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.4 p -98.9 125.84 52.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.022 -177.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.565 HD12 ' HB2' ' A' ' 82' ' ' GLU . 0.6 OUTLIER -133.53 -35.79 0.99 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.043 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.565 ' HB2' HD12 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -153.52 144.61 22.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.985 0.421 . . . . 0.0 111.906 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 82' ' ' GLU . 3.5 mp -143.96 128.55 14.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.346 178.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -149.87 -178.25 6.36 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.239 0.542 . . . . 0.0 111.552 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.505 ' HB3' ' HD1' ' A' ' 91' ' ' TRP . 0.9 OUTLIER -133.2 163.67 28.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.616 -179.738 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 56.9 t -124.65 -73.76 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.427 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -122.73 -139.37 5.51 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.795 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.464 ' HB2' ' H ' ' A' ' 89' ' ' SER . 37.1 Cg_exo -60.82 -82.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.557 2.171 . . . . 0.0 112.5 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.464 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 59.9 p -100.15 1.51 42.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.249 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.413 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 1.2 pt-20 -93.15 119.51 32.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.747 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.505 ' HD1' ' HB3' ' A' ' 85' ' ' GLU . 4.4 m-90 -132.24 164.99 25.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.92 0.391 . . . . 0.0 111.112 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.96 140.71 51.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.795 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.1 mp -136.76 143.78 34.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.974 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.445 ' HB3' ' HG ' ' A' ' 81' ' ' LEU . 12.3 m-85 -118.54 127.56 53.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.379 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.603 HG22 ' HB2' ' A' ' 79' ' ' GLU . 32.8 mm -124.86 144.94 33.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.26 -177.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.623 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -152.12 111.2 3.86 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.157 -0.617 . . . . 0.0 112.156 -178.441 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.483 HG23 ' HB3' ' A' ' 50' ' ' MET . 2.2 t -63.69 121.39 12.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.56 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.2 tttp . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.006 -179.913 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.103 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.4 p -116.54 -25.78 7.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.783 0.325 . . . . 0.0 110.923 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -109.85 9.29 24.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.975 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -91.14 110.44 21.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.838 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -138.02 60.86 1.61 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -131.12 -171.69 2.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.009 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -66.11 147.5 53.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.867 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -75.63 175.92 8.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.704 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -104.73 3.41 31.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.941 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.8 p -69.16 95.56 0.76 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.938 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.0 m -86.01 -81.97 0.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.082 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -88.71 38.96 3.15 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.656 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.5 tp -96.68 80.89 3.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.894 0.378 . . . . 0.0 110.875 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.609 HG21 ' HA3' ' A' ' 17' ' ' GLY . 2.4 m -64.87 140.89 98.21 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.186 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 14' ' ' VAL . 31.7 Cg_exo -59.78 -59.39 0.41 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.691 2.261 . . . . 0.0 112.456 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -81.56 26.2 0.49 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.448 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.609 ' HA3' HG21 ' A' ' 14' ' ' VAL . . . -81.23 75.24 2.32 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.391 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.26 -89.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.667 0.27 . . . . 0.0 111.102 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.47 ' HB3' ' H ' ' A' ' 20' ' ' MET . 1.0 OUTLIER -139.97 -92.32 0.17 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.115 -179.719 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.47 ' H ' ' HB3' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -81.75 45.07 0.86 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.235 -179.786 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.97 102.95 8.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.999 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -88.07 30.5 0.85 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.13 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -101.88 92.68 4.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.667 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.03 61.85 7.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.186 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.3 t -77.46 136.25 24.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.436 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.51 -52.22 3.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.508 -178.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.88 149.89 41.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.905 0.384 . . . . 0.0 111.462 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 83.2 m -129.12 122.58 30.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.699 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 2.9 tt -109.23 125.37 52.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.081 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -130.79 123.39 29.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.726 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.449 ' HB ' HG23 ' A' ' 60' ' ' ILE . 8.4 t -118.45 64.3 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.128 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -63.27 -176.24 0.14 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.099 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.64 79.63 0.69 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.529 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.4 ' OE2' HG12 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -108.06 -156.22 0.58 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.599 0.238 . . . . 0.0 110.72 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.3 -88.2 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -178.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.4 p -53.31 144.29 31.24 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.405 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.21 30.4 0.47 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.627 2.218 . . . . 0.0 112.107 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.491 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 3.9 t -53.19 -51.79 71.95 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.351 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' A' ' 38' ' ' VAL . 42.7 Cg_endo -68.1 -19.98 44.51 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.134 1.89 . . . . 0.0 112.364 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.02 -58.6 3.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.751 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.1 t -66.86 -15.29 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.858 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -70.97 -50.57 33.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.869 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.484 HG22 ' SD ' ' A' ' 64' ' ' MET . 14.6 t -64.36 -32.13 73.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.832 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.483 ' N ' HG23 ' A' ' 43' ' ' THR . 0.3 OUTLIER -59.98 -46.95 87.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.968 0.413 . . . . 0.0 110.451 179.25 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.39 -31.65 72.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.878 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.25 -43.45 86.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.047 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.49 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 1.2 mp -58.77 -39.26 80.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.744 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.404 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 1.5 tt0 -81.2 -23.29 38.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.944 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -119.12 62.18 0.8 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.63 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.4 ptp -103.65 145.32 30.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.593 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.912 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 10.7 mttm -90.73 160.09 39.29 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.178 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -43.7 -70.78 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.098 2.532 . . . . 0.0 113.901 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.46 59.79 0.45 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.9 -0.667 . . . . 0.0 113.264 -178.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.912 ' HG3' ' HB2' ' A' ' 51' ' ' LYS . 7.2 mt-10 -90.89 151.41 21.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.02 0.438 . . . . 0.0 111.572 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.66 HG12 ' HG3' ' A' ' 96' ' ' LYS . 7.4 mt -135.66 103.7 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.114 178.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.9 mt -118.73 160.51 21.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.072 0.463 . . . . 0.0 111.659 -177.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -130.6 139.64 50.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.365 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.508 HG12 HG12 ' A' ' 60' ' ' ILE . 11.7 t -120.04 136.45 57.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.136 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -122.57 110.8 16.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.677 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.508 HG12 HG12 ' A' ' 58' ' ' VAL . 0.4 OUTLIER -158.66 -177.75 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.581 -179.428 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -97.68 2.38 49.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.72 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -139.22 149.63 61.58 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.566 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.76 95.64 1.08 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.488 2.125 . . . . 0.0 112.856 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.484 ' SD ' HG22 ' A' ' 43' ' ' THR . 0.0 OUTLIER -68.22 -15.43 63.57 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.172 0.51 . . . . 0.0 110.539 178.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.727 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 23.9 p -61.34 -12.2 12.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.719 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.3 pttm -56.36 -36.05 68.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.899 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.564 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.8 OUTLIER -94.25 -27.39 16.17 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.218 0.532 . . . . 0.0 110.018 178.209 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.727 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 4.7 mtt85 -61.91 -37.14 83.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.008 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.696 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 14.7 mt -62.15 -55.83 36.88 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.369 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.696 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 83.3 Cg_exo -47.19 -37.43 23.71 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.447 2.098 . . . . 0.0 112.717 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.49 ' HG3' ' HB3' ' A' ' 47' ' ' LEU . 15.7 mm-40 -70.86 -54.05 12.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.056 0.455 . . . . 0.0 111.106 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.617 HG23 ' HG2' ' A' ' 79' ' ' GLU . 0.6 OUTLIER -60.75 -38.23 84.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.771 -178.605 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.491 HG21 ' N ' ' A' ' 74' ' ' LYS . 20.2 m -67.5 -27.84 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-O 120.688 0.28 . . . . 0.0 110.84 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.491 ' N ' HG21 ' A' ' 73' ' ' VAL . 0.1 OUTLIER -58.04 -43.98 87.11 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.61 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.53 ' HG2' ' O ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -90.2 -78.36 0.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.483 176.85 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.406 ' H ' ' CG ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -99.57 -97.37 0.24 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.967 0.413 . . . . 0.0 110.954 178.469 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.555 ' O ' ' HB ' ' A' ' 72' ' ' THR . . . -144.89 -84.33 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.195 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.95 152.65 39.75 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 122.723 -0.281 . . . . 0.0 110.778 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.753 ' HB2' ' H ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -96.96 71.27 2.47 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.034 0.445 . . . . 0.0 109.849 179.609 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.6 t -98.58 122.04 49.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.575 -177.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.508 ' HG ' ' N ' ' A' ' 82' ' ' GLU . 0.5 OUTLIER -133.53 -37.85 0.93 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.174 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.508 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -153.56 141.98 20.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.003 0.43 . . . . 0.0 111.866 -179.701 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.449 HG13 ' C ' ' A' ' 82' ' ' GLU . 2.7 mt -143.53 129.93 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.222 178.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.414 ' OE2' ' HE2' ' A' ' 92' ' ' LYS . 4.8 pt-20 -156.78 179.77 8.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.184 0.516 . . . . 0.0 111.689 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -133.55 159.56 40.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.413 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.9 t -120.8 -66.97 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.398 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -122.84 -145.43 6.92 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.666 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.478 ' HB2' ' H ' ' A' ' 89' ' ' SER . 46.2 Cg_exo -56.44 -82.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.672 2.248 . . . . 0.0 112.509 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.478 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 61.8 p -100.07 -3.75 31.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.831 0.348 . . . . 0.0 111.151 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.425 ' OE2' ' HD2' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -86.05 117.72 25.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.669 179.743 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 2.9 m-90 -130.83 164.21 25.68 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.1 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.414 ' HE2' ' OE2' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -124.28 129.51 50.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.537 179.538 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -125.8 143.39 39.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.002 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.489 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 13.6 m-85 -118.95 129.59 55.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.675 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.59 HG21 ' HE ' ' A' ' 68' ' ' ARG . 1.0 OUTLIER -124.13 149.03 28.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.68 -179.051 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.753 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -150.85 109.97 3.93 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.289 -0.564 . . . . 0.0 112.161 -178.117 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.8 t -62.75 118.86 5.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.262 177.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.457 ' HG2' ' HD3' ' A' ' 96' ' ' LYS . 6.9 mtmt . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.986 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.164 0 N-CA-C 112.553 -0.219 . . . . 0.0 112.553 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.7 m -107.47 -3.27 19.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.794 0.33 . . . . 0.0 110.968 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.81 -55.47 4.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.958 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -106.84 120.15 41.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.911 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -127.64 137.22 52.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.935 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -65.74 126.69 29.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.033 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -124.22 -1.7 8.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.936 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.454 ' HA ' ' HB2' ' A' ' 11' ' ' SER . 7.9 m-70 -90.73 22.77 3.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.986 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 23.4 t60 -70.92 -72.8 0.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.0 m -86.16 -2.72 58.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.169 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.454 ' HB2' ' HA ' ' A' ' 8' ' ' HIS . 0.5 OUTLIER -75.07 -106.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.918 -179.707 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -89.63 171.71 38.26 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.603 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.32 76.37 3.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 0.0 110.828 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.7 t -85.78 114.61 57.8 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.85 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.48 122.44 10.12 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.425 2.084 . . . . 0.0 112.369 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -84.2 28.03 0.65 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.223 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.59 -76.59 0.62 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.39 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.27 27.54 0.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.616 0.246 . . . . 0.0 111.31 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.91 -150.15 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.858 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.2 -24.62 59.73 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.822 0.344 . . . . 0.0 111.058 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.18 108.6 1.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.978 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -91.03 45.01 1.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.004 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -88.16 42.43 1.06 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.893 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.63 80.41 1.66 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.118 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.466 HG11 ' O ' ' A' ' 55' ' ' ILE . 80.6 t -64.45 153.01 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.586 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -98.82 -66.0 0.93 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.964 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.466 ' CB ' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -105.53 148.24 27.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.892 0.377 . . . . 0.0 110.941 179.6 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.474 HG22 ' HG2' ' A' ' 57' ' ' GLU . 86.4 m -133.9 110.47 9.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.863 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.5 tt -100.15 100.87 11.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.87 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -119.46 99.89 6.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.575 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.484 HG22 ' HB3' ' A' ' 34' ' ' GLU . 7.1 p -132.9 70.06 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.457 0.646 . . . . 0.0 111.179 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.443 ' HB3' ' H ' ' A' ' 33' ' ' GLY . 0.8 OUTLIER -58.91 -88.61 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.794 179.476 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.443 ' H ' ' HB3' ' A' ' 32' ' ' ARG . . . -79.27 98.75 1.65 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.133 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.484 ' HB3' HG22 ' A' ' 31' ' ' VAL . 1.8 pm0 -106.62 177.59 4.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.95 0.405 . . . . 0.0 111.238 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.03 -90.48 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.854 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.485 ' O ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -60.03 157.22 32.67 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.672 179.124 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -72.91 23.86 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.739 2.293 . . . . 0.0 112.522 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.593 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 26.8 t -60.79 -50.99 82.67 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.537 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 38' ' ' VAL . 16.8 Cg_endo -57.26 -28.47 79.78 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.263 1.975 . . . . 0.0 112.182 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.8 -57.37 11.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.74 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.9 t -71.3 -15.88 18.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.888 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -66.79 -61.1 2.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.921 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.453 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 2.2 t -60.92 -34.64 75.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.019 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -56.23 -45.16 80.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.89 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.47 -33.09 75.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.707 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.65 -36.89 85.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.192 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.648 HD22 ' HG2' ' A' ' 68' ' ' ARG . 4.9 mt -65.55 -43.33 90.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.693 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -71.81 -26.57 62.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.481 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -117.26 57.08 0.81 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.998 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.3 ptm -96.01 150.06 20.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.831 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 5.6 mttt -104.24 156.35 35.91 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.872 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.05 -55.41 3.91 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.004 2.469 . . . . 0.0 113.277 -178.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.21 59.57 0.47 Allowed Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.844 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.831 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 3.6 mm-40 -90.8 146.39 23.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.041 0.448 . . . . 0.0 111.779 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.466 ' O ' HG11 ' A' ' 25' ' ' VAL . 5.3 mt -135.53 102.53 3.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.894 177.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.466 HD23 ' CB ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -119.89 143.86 47.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.04 0.447 . . . . 0.0 112.031 -177.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.474 ' HG2' HG22 ' A' ' 28' ' ' THR . 2.8 pt-20 -118.62 130.97 56.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.448 176.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.6 t -114.77 129.49 70.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.016 0.436 . . . . 0.0 111.906 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -122.44 106.39 11.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.349 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.402 ' HB ' ' H ' ' A' ' 61' ' ' ASP . 1.0 OUTLIER -158.29 -163.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.439 -178.874 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.402 ' H ' ' HB ' ' A' ' 60' ' ' ILE . 1.0 OUTLIER -109.41 -34.49 6.52 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.664 179.315 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.08 114.47 65.49 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.625 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.85 97.49 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.535 2.157 . . . . 0.0 112.429 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.9 mtt -68.3 -11.17 59.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.943 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.576 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.5 OUTLIER -61.57 -15.11 35.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.993 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -32.74 71.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.036 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.569 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 1.0 OUTLIER -94.22 -27.95 15.89 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.191 0.519 . . . . 0.0 110.365 178.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.648 ' HG2' HD22 ' A' ' 47' ' ' LEU . 14.3 mtt85 -62.88 -38.0 89.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.894 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.711 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 17.0 mt -59.37 -55.79 42.51 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.686 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.711 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 72.6 Cg_exo -50.21 -38.85 52.03 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.307 2.005 . . . . 0.0 112.781 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.555 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -68.56 -56.38 8.48 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.957 0.408 . . . . 0.0 111.518 -179.285 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.628 HG23 ' HG3' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -58.96 -45.58 90.17 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.269 -178.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.483 HG13 ' N ' ' A' ' 74' ' ' LYS . 8.2 p -58.69 -28.67 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.682 -0.236 . . . . 0.0 110.939 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.555 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 5.1 mmtt -58.42 -42.99 88.5 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 176.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.38 -82.84 0.21 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.872 176.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.466 HD21 ' O ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -98.59 -106.32 0.2 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.274 177.071 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -134.87 -83.15 0.18 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.104 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.07 170.71 16.59 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.78 0.324 . . . . 0.0 111.071 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.858 ' HB2' HG13 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -110.09 72.77 0.81 Allowed 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.39 117.51 43.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.491 -176.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.581 HD21 ' HB3' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -133.73 -40.69 0.86 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.092 179.715 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.58 ' HB3' ' HB2' ' A' ' 94' ' ' TYR . 0.3 OUTLIER -153.85 144.98 22.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.027 0.441 . . . . 0.0 111.924 -179.743 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.528 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 3.4 mp -144.04 130.65 16.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.275 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -149.78 178.57 8.76 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.042 0.448 . . . . 0.0 111.428 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.6 pm0 -133.35 159.07 41.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.663 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.6 t -124.28 -63.37 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.284 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -126.87 -144.7 6.1 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.654 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.455 ' HB2' ' H ' ' A' ' 89' ' ' SER . 37.3 Cg_exo -61.37 -82.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.601 2.201 . . . . 0.0 112.416 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.455 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 2.1 p -98.59 -1.33 41.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.025 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -92.93 116.28 28.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.511 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 4.2 m-90 -130.65 167.59 18.52 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.983 0.42 . . . . 0.0 111.37 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.7 128.52 49.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.29 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.419 HG21 ' N ' ' A' ' 94' ' ' TYR . 3.8 mp -125.67 146.15 31.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.172 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.58 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 24.8 m-85 -118.81 123.84 45.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.576 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.858 HG13 ' HB2' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -124.79 144.68 33.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.848 -179.112 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.626 ' C ' ' HB3' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -150.77 115.86 5.32 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.961 -178.793 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.0 t -65.69 125.67 23.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.359 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.8 tttp . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.004 -179.486 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 112.446 -0.261 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -124.76 -37.81 2.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.804 0.335 . . . . 0.0 110.997 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.5 m -139.15 -166.96 2.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.915 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.44 -21.76 20.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.896 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -70.84 110.7 5.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.782 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.23 132.13 49.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.968 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -108.69 -170.46 1.67 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.943 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -92.04 73.02 5.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.945 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -130.91 -88.61 0.48 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.837 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 55.4 m -86.23 -38.04 18.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.987 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.2 m -83.5 28.51 0.55 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.229 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.81 -146.08 6.11 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.515 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.555 HD13 ' H ' ' A' ' 14' ' ' VAL . 0.6 OUTLIER -76.79 -175.66 3.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.78 0.324 . . . . 0.0 110.979 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.555 ' H ' HD13 ' A' ' 13' ' ' LEU . 17.0 m -68.44 150.2 97.77 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.29 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -56.4 -34.45 94.47 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.619 2.213 . . . . 0.0 112.235 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -89.44 -150.24 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.909 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.593 ' HA3' ' HG2' ' A' ' 22' ' ' LYS . . . -76.25 130.2 10.65 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.467 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.63 -76.93 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.746 0.308 . . . . 0.0 110.94 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.435 ' HB3' ' H ' ' A' ' 20' ' ' MET . 7.7 m80 -104.9 -150.51 0.43 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.731 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.435 ' H ' ' HB3' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -74.46 -3.56 31.44 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.809 0.338 . . . . 0.0 111.004 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.18 51.94 2.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.059 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.593 ' HG2' ' HA3' ' A' ' 17' ' ' GLY . 4.3 mtmt -91.14 40.09 1.02 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.235 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -94.17 38.67 1.08 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.9 0.381 . . . . 0.0 111.033 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.28 73.38 10.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.788 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.7 t -82.85 145.52 8.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.985 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.4 m -99.61 -62.06 1.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.933 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -118.56 158.63 25.05 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.011 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.7 m -127.45 151.72 48.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.865 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.446 HD22 HG21 ' A' ' 31' ' ' VAL . 5.2 tt -131.52 121.04 23.8 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.25 119.0 31.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.532 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.656 HG22 ' HE3' ' A' ' 64' ' ' MET . 0.0 OUTLIER -124.33 19.67 4.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.553 -179.093 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.4 14.76 0.41 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.667 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 31' ' ' VAL . . . -81.89 -105.59 0.39 Allowed Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.652 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -87.49 -161.2 0.67 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.606 0.241 . . . . 0.0 110.809 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.09 -169.73 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.812 0.339 . . . . 0.0 111.291 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.81 ' HA ' ' HD2' ' A' ' 39' ' ' PRO . 19.5 m -55.36 159.75 4.19 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.049 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -92.69 20.18 35.03 Favored 'Cis proline' 0 C--N 1.35 0.608 0 C-N-CA 124.038 -1.234 . . . . 0.0 112.81 1.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.47 ' HB ' ' HD3' ' A' ' 39' ' ' PRO . 60.6 t -63.56 -53.36 52.15 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.65 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.81 ' HD2' ' HA ' ' A' ' 36' ' ' CYS . 64.1 Cg_endo -73.04 -17.28 25.05 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.207 1.938 . . . . 0.0 112.413 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -65.63 -58.34 5.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.3 t -74.05 -25.55 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.046 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -64.95 -49.34 70.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.053 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.0 t -67.52 -42.77 82.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.008 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.16 -43.04 73.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.949 0.404 . . . . 0.0 110.544 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.508 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 0.2 OUTLIER -64.09 -31.31 72.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.796 179.048 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.553 ' HB3' HH12 ' A' ' 68' ' ' ARG . . . -60.62 -48.7 80.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.335 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.613 HD11 ' HE2' ' A' ' 50' ' ' MET . 2.2 mm? -59.06 -42.65 90.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.051 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -81.14 9.79 6.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.443 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.508 ' HB2' ' O ' ' A' ' 45' ' ' ARG . 0.9 OUTLIER -135.07 32.97 3.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.785 0.326 . . . . 0.0 111.202 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.613 ' HE2' HD11 ' A' ' 47' ' ' LEU . 26.0 mtt -109.18 143.61 38.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.122 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.766 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 23.0 mttp -95.41 163.15 22.3 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 51' ' ' LYS . 74.1 Cg_exo -41.83 -69.03 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.01 2.473 . . . . 0.0 113.508 -178.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 97' ' ' VAL . . . -103.95 56.91 0.56 Allowed Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.023 -178.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.766 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 14.4 mm-40 -90.92 157.17 17.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.001 0.429 . . . . 0.0 111.815 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.532 ' C ' HD11 ' A' ' 56' ' ' LEU . 3.0 mp -135.04 110.31 12.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.973 178.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.532 HD11 ' C ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -118.74 148.22 43.03 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.164 0.506 . . . . 0.0 111.985 -177.243 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -111.69 135.31 52.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.863 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 t -125.78 144.22 36.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.114 0.483 . . . . 0.0 112.006 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.457 ' C ' HG13 ' A' ' 60' ' ' ILE . 18.4 t90 -131.04 107.93 9.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.235 178.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.511 HG22 HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -144.24 -166.64 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.009 -178.875 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -145.13 27.47 1.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.144 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.668 ' H ' ' HA ' ' A' ' 63' ' ' PRO . 1.2 m-85 -101.06 -56.34 0.13 Allowed Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.368 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.668 ' HA ' ' H ' ' A' ' 62' ' ' TYR . 72.1 Cg_endo -94.19 171.24 17.49 Favored 'Cis proline' 0 C--N 1.356 0.949 0 C-N-CA 124.912 -0.87 . . . . 0.0 112.374 -0.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.656 ' HE3' HG22 ' A' ' 31' ' ' VAL . 6.0 tpp -68.32 -26.35 65.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.356 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.639 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -59.71 -17.44 34.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.188 -179.405 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.7 pttp -59.73 -34.8 73.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.629 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.565 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 4.9 mt-10 -90.21 -22.55 21.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.169 0.509 . . . . 0.0 110.222 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.639 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 0.4 OUTLIER -62.03 -46.4 89.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.041 179.318 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.71 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 5.1 mt -54.52 -54.6 46.9 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.71 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 75.1 Cg_exo -51.36 -37.05 59.98 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.412 2.075 . . . . 0.0 112.61 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.555 ' HG3' ' HG ' ' A' ' 47' ' ' LEU . 4.8 tm-20 -71.24 -58.17 3.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.866 0.365 . . . . 0.0 111.525 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.443 HG23 HD12 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -58.89 -31.9 69.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.463 -178.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.532 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 8.6 p -73.52 -26.46 22.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.709 0.29 . . . . 0.0 110.731 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.432 ' N ' HG13 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -58.69 -46.53 87.08 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.042 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.738 ' HG3' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -88.7 -74.32 0.47 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.565 177.463 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.738 HD22 ' HG3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -98.21 -102.31 0.2 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.85 0.357 . . . . 0.0 110.482 178.19 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.532 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.27 -85.51 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.866 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.444 ' HB2' HG21 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -147.6 155.74 42.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.731 0.3 . . . . 0.0 111.076 178.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.691 ' HB2' ' H ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -103.87 69.24 0.95 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 177.396 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.444 HG21 ' HB2' ' A' ' 78' ' ' HIS . 0.2 OUTLIER -98.67 121.52 49.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.88 -175.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.599 HD21 ' HB3' ' A' ' 96' ' ' LYS . 1.5 pt? -139.71 -35.5 0.53 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.677 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.6 ' HB3' ' HB2' ' A' ' 94' ' ' TYR . 0.8 OUTLIER -153.01 142.55 21.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.19 0.519 . . . . 0.0 112.009 179.574 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.502 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 3.7 mp -144.19 135.87 22.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.263 178.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -157.79 179.87 8.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.073 0.463 . . . . 0.0 111.28 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -133.5 161.25 35.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.555 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.0 t -120.7 -62.83 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.318 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -125.37 -146.52 6.77 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.787 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -57.11 -83.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.768 2.312 . . . . 0.0 112.513 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.73 -3.09 46.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.876 0.37 . . . . 0.0 111.184 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -93.16 133.89 35.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.713 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.11 168.81 20.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.929 0.395 . . . . 0.0 111.09 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.3 mttt -120.74 128.11 52.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.534 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.407 HG21 ' N ' ' A' ' 94' ' ' TYR . 4.4 mp -125.28 145.11 33.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.885 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.6 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 13.0 m-85 -118.17 129.05 55.29 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.441 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.594 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -123.97 142.14 41.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.291 -179.697 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.691 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -144.04 110.57 5.56 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.755 -176.752 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.43 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 3.2 t -61.26 118.48 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.314 178.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.591 ' HE3' ' HD3' ' A' ' 96' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.937 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.19 0 N-CA-C 112.437 -0.265 . . . . 0.0 112.437 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 t -124.45 110.89 15.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.73 0.3 . . . . 0.0 110.921 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.8 m -75.32 106.31 6.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.01 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.97 -34.05 9.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.794 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -133.65 -175.91 3.98 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.772 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -70.65 -63.38 1.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.799 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -89.03 -169.06 2.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.881 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.5 p-80 -91.28 -167.89 1.92 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.844 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -92.16 70.4 5.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.815 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.7 t -75.24 -63.04 1.36 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.9 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.91 28.39 0.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.19 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.83 134.56 32.29 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.368 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.9 mt -79.21 122.75 26.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.915 0.388 . . . . 0.0 111.015 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.6 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 47.2 t -73.3 -49.97 6.59 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.649 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 20.9 Cg_endo -59.86 162.88 14.84 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.231 1.954 . . . . 0.0 112.217 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -61.15 -66.25 0.56 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.297 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -57.93 96.09 0.06 OUTLIER Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.68 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.82 -79.19 0.16 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.729 0.3 . . . . 0.0 111.061 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.99 -89.33 0.46 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.147 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.416 ' HB3' ' H ' ' A' ' 21' ' ' ALA . 74.4 mtm -69.39 -157.92 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.806 0.336 . . . . 0.0 111.179 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.416 ' H ' ' HB3' ' A' ' 20' ' ' MET . . . -61.97 -176.19 0.08 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.375 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -89.7 58.84 4.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.153 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -102.42 76.05 1.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.845 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -94.98 138.17 33.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.963 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.6 t -72.83 130.86 35.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.876 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.73 -56.62 2.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.134 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.432 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -113.4 139.53 48.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.085 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.3 m -133.85 117.47 16.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.802 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 11.7 tp -109.92 115.41 29.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.033 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.667 ' HB3' ' HB3' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -132.9 102.11 5.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.705 179.774 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.85 75.04 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.298 0.57 . . . . 0.0 111.19 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 32' ' ' ARG . 2.1 mtp180 -54.72 -87.62 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.001 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.8 98.76 0.71 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.36 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -96.0 162.9 13.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.893 0.377 . . . . 0.0 111.158 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.403 ' HB ' ' H ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -134.33 -90.88 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.957 179.494 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.56 ' O ' ' HD2' ' A' ' 39' ' ' PRO . 1.2 p -62.75 157.95 55.34 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.657 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -75.22 12.86 1.18 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.801 2.334 . . . . 0.0 112.621 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.524 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 46.4 t -62.07 -53.69 56.95 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.545 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.56 ' HD2' ' O ' ' A' ' 36' ' ' CYS . 29.9 Cg_endo -61.9 -24.25 76.85 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.137 1.891 . . . . 0.0 112.099 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.43 -46.74 87.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.539 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.416 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 4.5 t -69.85 -25.22 27.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.697 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -64.37 -55.38 21.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.824 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.428 ' O ' HD11 ' A' ' 47' ' ' LEU . 11.9 t -62.59 -26.56 68.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.678 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 0.7 OUTLIER -58.72 -43.45 90.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.316 178.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.24 -39.54 92.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.81 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.46 -31.39 65.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.967 0.413 . . . . 0.0 110.52 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.471 HD23 ' HB3' ' A' ' 67' ' ' GLU . 2.9 mp -77.62 -51.73 10.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.486 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -81.46 -3.34 52.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.195 -177.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -134.96 71.2 1.44 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.822 0.344 . . . . 0.0 110.915 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.674 ' HB3' HG22 ' A' ' 97' ' ' VAL . 11.9 mtm -106.62 137.79 43.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.013 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.807 ' HG2' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -92.56 150.73 40.34 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.301 178.817 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.807 ' HD2' ' HG2' ' A' ' 51' ' ' LYS . 56.1 Cg_exo -37.28 -70.19 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.249 2.633 . . . . 0.0 113.992 -178.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.53 60.74 0.42 Allowed Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.121 -178.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.474 ' HG2' ' HB3' ' A' ' 51' ' ' LYS . 4.5 mm-40 -90.53 147.54 23.3 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.089 0.471 . . . . 0.0 111.753 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.667 HG23 ' HB2' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -130.84 114.65 27.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.065 178.418 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.432 HD22 ' HB3' ' A' ' 27' ' ' LYS . 4.0 mt -119.56 151.35 38.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.314 0.578 . . . . 0.0 112.095 -177.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -124.25 121.4 34.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.582 177.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.462 HG11 HG12 ' A' ' 60' ' ' ILE . 4.5 t -114.31 139.3 40.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.069 0.461 . . . . 0.0 111.987 -177.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.667 ' HB3' ' HB3' ' A' ' 30' ' ' ASP . 6.3 t90 -133.33 107.23 7.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.372 178.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.462 HG12 HG11 ' A' ' 58' ' ' VAL . 0.9 OUTLIER -156.95 -166.77 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.278 -178.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -111.52 -2.2 15.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.934 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -131.08 126.65 21.69 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.841 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.91 98.63 0.1 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.477 2.118 . . . . 0.0 112.377 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.469 ' HB3' ' NH1' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -67.98 -17.6 64.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.021 0.439 . . . . 0.0 110.885 179.637 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.512 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 5.1 p -64.0 -11.15 26.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.897 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.7 pttt -60.05 -39.67 86.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.981 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.544 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 6.1 mt-10 -89.93 -26.24 20.52 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.25 0.548 . . . . 0.0 110.207 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.512 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 28.7 mtt85 -63.71 -43.06 97.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.993 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.715 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 24.1 mt -51.83 -55.63 28.51 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.695 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.715 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 53.1 Cg_exo -53.18 -40.74 76.27 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.189 1.926 . . . . 0.0 112.603 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -61.04 2.19 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.965 0.412 . . . . 0.0 111.534 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.745 HG21 ' HG3' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -57.14 -43.58 82.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.63 -178.546 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.529 HG13 ' N ' ' A' ' 74' ' ' LYS . 9.8 p -58.84 -30.04 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.784 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.529 ' N ' HG13 ' A' ' 73' ' ' VAL . 1.1 tppp? -58.65 -40.36 83.2 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.465 ' HB3' HD11 ' A' ' 76' ' ' LEU . 2.0 mtpt -87.97 -84.86 0.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.875 176.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.465 HD11 ' HB3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -98.46 -105.21 0.2 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.221 176.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -132.93 -83.64 0.23 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.083 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.417 ' HB2' HG23 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -146.96 168.79 20.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.869 0.366 . . . . 0.0 111.25 179.613 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.745 ' HG3' HG21 ' A' ' 72' ' ' THR . 0.1 OUTLIER -110.26 61.07 0.6 Allowed 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.702 178.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.417 HG23 ' HB2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -98.43 122.53 50.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.242 -177.533 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.456 ' HG ' ' N ' ' A' ' 82' ' ' GLU . 1.1 pp -133.64 -37.86 0.92 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.274 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.456 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -153.11 147.99 26.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.992 0.425 . . . . 0.0 111.9 -179.748 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.7 mp -144.15 132.96 18.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.331 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.436 ' HG3' ' HB3' ' A' ' 92' ' ' LYS . 15.0 pt-20 -154.59 175.93 13.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.01 0.433 . . . . 0.0 111.363 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.43 173.71 11.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.982 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.46 -48.41 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.063 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -128.27 -150.65 7.32 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.545 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.98 -74.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.561 2.174 . . . . 0.0 112.533 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.9 p -99.36 -5.44 29.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.921 0.391 . . . . 0.0 111.193 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.28 131.11 38.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.786 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -151.48 170.34 19.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.971 0.415 . . . . 0.0 111.259 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.436 ' HB3' ' HG3' ' A' ' 84' ' ' GLU . 5.3 tttt -120.67 132.87 55.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.461 179.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.502 HG21 ' N ' ' A' ' 94' ' ' TYR . 2.4 mp -125.64 149.81 30.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.105 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.502 ' N ' HG21 ' A' ' 93' ' ' ILE . 29.2 m-85 -118.57 125.29 49.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.486 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.712 HG21 ' HB2' ' A' ' 79' ' ' GLU . 16.1 mm -124.98 143.24 39.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.967 -177.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.678 ' C ' ' HB3' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -151.82 114.7 4.66 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 120.061 -0.656 . . . . 0.0 112.217 -178.797 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.674 HG22 ' HB3' ' A' ' 50' ' ' MET . 16.1 t -64.3 119.91 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.644 178.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.923 -179.777 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.33 116.21 30.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.827 0.346 . . . . 0.0 110.923 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.1 t -137.77 92.11 2.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.908 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -112.74 43.02 1.74 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.979 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -85.43 127.55 34.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.89 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -136.64 22.36 3.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.012 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.75 112.47 23.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.039 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -90.41 -31.67 16.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -113.97 59.46 0.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.885 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.63 138.85 56.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.932 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.6 t -63.8 -68.18 0.37 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.264 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.45 82.67 0.37 Allowed Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.77 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mt -67.96 -71.63 0.2 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.727 0.299 . . . . 0.0 111.032 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.46 ' HB ' ' HD3' ' A' ' 15' ' ' PRO . 33.8 t -58.93 -45.66 99.58 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.005 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.46 ' HD3' ' HB ' ' A' ' 14' ' ' VAL . 52.8 Cg_exo -56.2 -168.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.394 2.063 . . . . 0.0 112.698 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 43.4 mmt-85 -73.59 19.67 0.1 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.781 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 15' ' ' PRO . . . -81.18 -104.05 0.33 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.362 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.5 t -81.37 31.96 0.34 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.45 0.167 . . . . 0.0 111.192 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -42.94 -36.67 1.61 Allowed 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 111.744 0.275 . . . . 0.0 111.744 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.5 tmm? -62.86 96.53 0.09 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.812 0.339 . . . . 0.0 110.835 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.48 155.88 36.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.199 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.29 32.06 1.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.868 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -98.85 155.86 17.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -91.65 99.64 12.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.931 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 47.2 t -62.97 147.42 12.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.974 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -114.86 -60.2 1.92 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.416 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.27 159.18 23.1 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.03 0.443 . . . . 0.0 111.823 -178.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.5 m -135.77 108.16 7.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.554 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.663 HD21 HG22 ' A' ' 31' ' ' VAL . 5.5 tt -106.12 112.51 25.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.816 0.341 . . . . 0.0 111.126 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -133.29 107.74 8.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.457 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.663 HG22 HD21 ' A' ' 29' ' ' LEU . 2.0 t -137.93 72.87 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.505 -178.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.406 ' HB3' ' H ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -58.83 -88.43 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.707 179.074 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.406 ' H ' ' HB3' ' A' ' 32' ' ' ARG . . . -81.14 98.77 1.88 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.205 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -92.22 163.02 14.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.937 0.398 . . . . 0.0 111.253 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.415 ' HB ' ' H ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -135.03 -89.58 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.965 179.105 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.465 ' HB2' HG21 ' A' ' 38' ' ' VAL . 3.6 m -62.41 154.86 70.32 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.745 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -78.08 17.74 0.98 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.629 2.219 . . . . 0.0 112.625 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.685 ' HB ' ' HD3' ' A' ' 39' ' ' PRO . 34.6 t -65.82 -53.21 36.84 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.457 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.685 ' HD3' ' HB ' ' A' ' 38' ' ' VAL . 20.7 Cg_exo -66.04 -21.9 55.69 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.241 1.96 . . . . 0.0 112.205 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.03 -57.45 9.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.031 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.4 t -67.3 -26.66 36.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.106 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -63.29 -61.37 2.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.959 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.1 t -60.43 -27.55 67.58 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.805 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.99 -45.13 93.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.643 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.0 -32.36 74.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.777 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.71 -39.32 84.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.943 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.514 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 2.2 mt -68.92 -34.15 74.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.606 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -81.16 -12.46 59.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.021 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -135.24 70.94 1.43 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.261 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.554 ' HB3' HG22 ' A' ' 97' ' ' VAL . 0.8 OUTLIER -99.82 126.33 45.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.071 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.535 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 1.3 mtpm? -81.88 150.1 64.84 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.964 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.19 -25.46 80.84 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.536 2.157 . . . . 0.0 112.499 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.59 39.21 2.94 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.564 -0.827 . . . . 0.0 113.118 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.758 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 28.5 mt-10 -90.75 123.43 34.33 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 117.198 0.499 . . . . 0.0 111.905 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 0.7 OUTLIER -135.2 84.5 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.625 177.741 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.464 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -119.27 -179.79 3.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.278 0.561 . . . . 0.0 112.301 -176.862 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -136.76 145.82 45.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.295 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.517 HG11 HG13 ' A' ' 60' ' ' ILE . 4.7 t -119.72 134.29 63.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.824 0.345 . . . . 0.0 111.413 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 11.7 t90 -122.47 96.17 4.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.079 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.652 HD11 ' HB2' ' A' ' 64' ' ' MET . 0.5 OUTLIER -148.97 -160.06 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.646 179.053 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.468 ' HB3' ' O ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -131.0 37.53 3.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.461 -179.452 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.586 ' H ' ' HA ' ' A' ' 63' ' ' PRO . 86.1 m-85 -115.94 -60.81 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.119 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.648 ' HG3' HD11 ' A' ' 93' ' ' ILE . 63.7 Cg_endo -97.22 -168.34 1.56 Allowed 'Cis proline' 0 C--N 1.356 0.939 0 CA-C-N 119.449 0.839 . . . . 0.0 111.881 -1.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.652 ' HB2' HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -68.69 -27.65 66.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.825 0.345 . . . . 0.0 111.024 179.176 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.532 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.7 OUTLIER -58.73 -16.01 14.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.275 -178.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.5 ' HG3' ' N ' ' A' ' 67' ' ' GLU . 5.6 pttt -59.61 -34.32 72.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.024 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.523 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 1.4 mm-40 -93.97 -25.31 17.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.078 0.466 . . . . 0.0 110.352 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.532 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 6.2 mtt85 -62.97 -38.62 91.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.939 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.707 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 8.9 mt -60.04 -56.58 34.11 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.484 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.707 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 82.5 Cg_exo -46.51 -47.23 15.9 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.507 2.138 . . . . 0.0 112.805 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.514 ' HG3' ' HB3' ' A' ' 47' ' ' LEU . 64.5 mm-40 -60.97 -47.21 87.49 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.051 0.453 . . . . 0.0 110.944 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.771 HG21 ' HG3' ' A' ' 79' ' ' GLU . 1.9 m -59.53 -46.34 89.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.508 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.612 HG12 ' O ' ' A' ' 77' ' ' GLY . 1.3 m -58.87 -29.4 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 121.119 -0.232 . . . . 0.0 111.004 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.439 ' N ' HG21 ' A' ' 73' ' ' VAL . 1.0 OUTLIER -58.52 -41.51 85.61 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 176.864 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.64 -81.46 0.31 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.487 177.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.42 -96.21 0.24 Allowed 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.81 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.612 ' O ' HG12 ' A' ' 73' ' ' VAL . . . -144.07 -85.02 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.853 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.18 147.61 31.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.762 0.315 . . . . 0.0 110.912 178.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.771 ' HG3' HG21 ' A' ' 72' ' ' THR . 0.0 OUTLIER -95.36 55.72 1.77 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.422 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.7 p -99.22 127.21 52.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.291 -177.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.47 ' HG ' ' N ' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -133.29 -35.75 1.02 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.986 179.665 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.47 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 0.3 OUTLIER -153.91 148.7 26.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.064 0.459 . . . . 0.0 111.925 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.2 mp -141.75 140.8 30.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.454 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -158.04 178.92 9.67 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.033 0.444 . . . . 0.0 111.454 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -133.68 170.1 16.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.716 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.1 t -130.23 -56.54 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.287 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -128.52 -145.98 6.13 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.721 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.453 ' HB2' ' H ' ' A' ' 89' ' ' SER . 32.8 Cg_exo -58.4 -80.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.671 2.247 . . . . 0.0 112.547 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.468 ' O ' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -100.1 -2.7 33.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.785 0.326 . . . . 0.0 111.201 -179.399 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -91.86 133.4 35.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.787 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -148.59 168.76 21.95 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.032 0.444 . . . . 0.0 111.387 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -120.62 146.81 46.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.523 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.648 HD11 ' HG3' ' A' ' 63' ' ' PRO . 0.8 OUTLIER -129.98 159.3 42.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.244 -179.229 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -125.58 124.01 40.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.731 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.765 HG22 ' HB2' ' A' ' 79' ' ' GLU . 31.0 mm -123.95 148.97 27.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.448 -176.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.607 ' C ' ' HB3' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -150.64 99.03 2.7 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 120.404 -0.519 . . . . 0.0 111.659 -177.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.758 ' HB ' ' HB2' ' A' ' 54' ' ' GLU . 48.6 t -70.63 89.58 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.532 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.2 pttm . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.273 -0.87 . . . . 0.0 111.041 -179.861 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m -98.11 17.31 18.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.882 0.372 . . . . 0.0 110.841 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.8 m -88.75 138.69 31.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.992 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -126.53 -62.38 1.14 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.931 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -94.66 -0.64 54.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.996 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -78.38 -76.03 0.21 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.865 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -128.25 114.15 16.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -103.77 126.94 51.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.044 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.568 ' HD2' ' HA ' ' A' ' 16' ' ' ARG . 0.3 OUTLIER -70.91 102.9 2.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.764 179.744 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.5 t -67.15 -14.89 63.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.969 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.0 m -75.75 -153.22 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.805 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -89.18 -148.83 19.31 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.467 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -91.61 91.81 8.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.886 0.374 . . . . 0.0 110.74 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.777 ' N ' ' HA ' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -84.59 -41.45 0.7 Allowed Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 116.108 -0.497 . . . . 0.0 112.047 -179.82 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.777 ' HA ' ' N ' ' A' ' 14' ' ' VAL . 79.3 Cg_endo -102.09 -152.9 0.15 OUTLIER 'Cis proline' 0 C--N 1.358 1.047 0 CA-C-N 119.861 0.986 . . . . 0.0 112.793 1.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.568 ' HA ' ' HD2' ' A' ' 9' ' ' HIS . 0.0 OUTLIER -59.54 -4.61 0.66 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.096 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 19' ' ' HIS . . . -75.29 92.48 0.86 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.343 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.21 25.17 0.31 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.648 0.261 . . . . 0.0 111.428 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.405 ' H ' ' C ' ' A' ' 17' ' ' GLY . 8.0 m-70 -90.29 30.88 1.05 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.075 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 13.3 ptt? -81.03 -2.3 47.47 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.733 0.301 . . . . 0.0 111.01 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.58 166.96 17.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.025 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.22 77.95 5.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.924 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -72.63 80.68 1.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.847 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.0 66.27 7.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.028 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.1 t -76.31 138.5 20.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.988 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.85 -65.98 0.93 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.096 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -108.67 149.23 29.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.112 -179.717 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.0 m -135.09 117.15 15.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.766 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.8 tp -103.52 109.79 21.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.922 0.391 . . . . 0.0 111.036 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.404 ' HB3' ' HB3' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -125.02 115.3 20.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.507 179.61 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.409 ' C ' ' H ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -137.62 47.47 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.299 -179.445 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -75.01 15.52 0.39 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.708 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 31' ' ' VAL . . . -81.94 -80.21 0.93 Allowed Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.324 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.96 -165.52 1.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.646 0.26 . . . . 0.0 110.751 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.81 -173.99 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.894 0.378 . . . . 0.0 111.258 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.797 ' HA ' ' HD2' ' A' ' 39' ' ' PRO . 0.5 OUTLIER -58.38 158.86 13.23 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.812 179.727 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -93.09 25.19 23.17 Favored 'Cis proline' 0 C--N 1.35 0.62 0 C-N-CA 123.995 -1.252 . . . . 0.0 112.798 1.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.508 ' HB ' ' HD3' ' A' ' 39' ' ' PRO . 21.4 t -60.42 -52.57 72.02 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.565 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.797 ' HD2' ' HA ' ' A' ' 36' ' ' CYS . 73.5 Cg_endo -74.79 -16.84 20.56 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.162 1.908 . . . . 0.0 112.439 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.22 -52.54 39.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.094 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 17.1 t -72.66 -31.44 37.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.055 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -58.64 -60.81 3.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.061 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.468 HG21 ' O ' ' A' ' 39' ' ' PRO . 9.6 t -62.06 -36.88 82.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.028 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.25 -42.3 60.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.948 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.65 -33.95 73.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.743 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.25 -48.19 82.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.294 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.456 HD12 ' CE ' ' A' ' 50' ' ' MET . 1.1 mm? -61.24 -36.11 79.08 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.916 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -74.72 -9.61 58.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.073 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -134.98 49.83 2.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.037 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.733 ' HB2' HG21 ' A' ' 97' ' ' VAL . 16.1 ptp -88.48 146.64 25.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.875 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.564 ' HB3' ' HG3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -101.98 150.09 37.12 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.374 179.31 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.492 ' HD2' ' HG3' ' A' ' 51' ' ' LYS . 81.6 Cg_exo -31.19 -78.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.736 2.957 . . . . 0.0 114.137 -178.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.41 62.18 0.39 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.117 -178.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.564 ' HG3' ' HB3' ' A' ' 51' ' ' LYS . 8.6 mt-10 -89.21 150.49 22.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.027 0.441 . . . . 0.0 111.46 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.6 mp -135.64 106.55 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.687 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 1.2 mt -119.09 147.85 43.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.177 0.513 . . . . 0.0 112.194 -176.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -114.87 128.96 56.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.099 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.81 133.15 61.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.972 0.415 . . . . 0.0 111.529 -178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.527 ' HE1' HG22 ' A' ' 86' ' ' VAL . 13.7 t90 -122.57 109.36 14.21 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.815 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.486 HG12 ' HE3' ' A' ' 64' ' ' MET . 0.6 OUTLIER -156.9 -169.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.262 -179.536 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.589 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -109.24 -7.83 15.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.073 -179.598 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -126.25 122.42 24.05 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.606 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.05 92.48 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.572 2.181 . . . . 0.0 112.172 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.486 ' HE3' HG12 ' A' ' 60' ' ' ILE . 21.1 mtm -68.0 -15.58 63.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.606 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.49 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 2.4 p -63.92 -17.52 63.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.811 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.8 pttt -57.92 -32.12 67.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.841 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.55 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -94.12 -28.25 15.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.346 179.033 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.49 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 39.4 mtt180 -64.24 -39.56 94.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.207 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.679 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 12.5 mt -59.11 -54.77 53.12 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.509 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.679 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 80.6 Cg_exo -48.34 -44.06 30.46 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.307 2.005 . . . . 0.0 112.564 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.545 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 4.7 tt0 -69.11 -49.56 55.98 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.959 0.409 . . . . 0.0 111.433 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.536 HG23 ' HG3' ' A' ' 79' ' ' GLU . 6.6 m -58.74 -48.16 82.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.364 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.472 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 19.1 m -59.0 -28.81 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-O 120.504 0.193 . . . . 0.0 111.11 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.545 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.3 OUTLIER -58.02 -41.56 83.4 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.21 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.07 -80.55 0.31 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.176 176.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.85 -100.09 0.22 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.529 178.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.53 -86.56 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.835 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.466 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -146.67 152.56 39.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.751 0.31 . . . . 0.0 110.796 178.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.844 ' HB2' HG13 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -100.31 68.78 1.43 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.853 179.08 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.466 HG22 ' HB2' ' A' ' 78' ' ' HIS . 0.2 OUTLIER -98.96 124.01 51.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.724 -176.736 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.87 ' HB3' ' HG2' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -133.42 -37.51 0.95 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.933 179.05 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.56 ' HG3' ' N ' ' A' ' 83' ' ' ILE . 0.8 OUTLIER -154.05 146.34 23.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.946 0.403 . . . . 0.0 111.845 179.531 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.56 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 3.0 mt -141.55 135.31 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.35 178.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.621 ' HG3' ' HB3' ' A' ' 92' ' ' LYS . 6.2 pt-20 -158.05 -179.21 7.91 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.032 0.444 . . . . 0.0 111.321 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.22 162.59 31.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.814 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.527 HG22 ' HE1' ' A' ' 59' ' ' TRP . 60.3 t -123.21 -65.99 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.403 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -122.92 -153.14 8.71 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.743 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.41 ' HB2' ' H ' ' A' ' 89' ' ' SER . 52.8 Cg_exo -54.72 -75.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.7 2.267 . . . . 0.0 112.344 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.41 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 0.8 OUTLIER -99.58 -3.16 33.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.946 179.808 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.589 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 1.1 pm0 -93.56 138.15 32.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.809 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -151.53 171.05 18.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.993 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.621 ' HB3' ' HG3' ' A' ' 84' ' ' GLU . 2.3 ttpt -120.81 132.99 55.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.72 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.3 mp -125.43 144.95 33.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.84 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.466 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 10.5 m-85 -118.76 124.3 46.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.699 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.844 HG13 ' HB2' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -124.33 148.86 28.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.852 -178.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.87 ' HG2' ' HB3' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -150.93 108.54 3.65 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 120.239 -0.584 . . . . 0.0 112.506 -177.587 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.733 HG21 ' HB2' ' A' ' 50' ' ' MET . 5.0 t -58.15 119.54 3.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.587 178.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.84 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.99 -73.57 0.61 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.732 0.301 . . . . 0.0 111.007 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.2 p -140.07 -76.45 0.33 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.97 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -129.98 81.32 2.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.902 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.81 78.63 1.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.994 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -96.72 -66.5 0.9 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -128.19 140.98 51.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.906 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -106.34 151.54 24.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -98.91 42.22 1.11 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.11 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.1 t -77.52 104.73 8.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.84 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.29 -150.94 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.865 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.75 167.75 48.61 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.494 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.555 HD22 ' H ' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -70.87 153.18 42.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.824 0.345 . . . . 0.0 110.966 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.555 ' H ' HD22 ' A' ' 13' ' ' LEU . 2.6 t -70.78 130.52 88.51 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.832 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -56.43 -31.7 86.52 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.455 2.103 . . . . 0.0 112.316 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -84.68 29.24 0.62 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.185 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.89 -179.93 9.87 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.517 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.34 28.0 0.4 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.587 0.232 . . . . 0.0 111.213 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -50.78 -48.6 59.42 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.544 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.3 mtt -54.15 -55.46 27.63 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.721 0.295 . . . . 0.0 111.17 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.73 160.26 17.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.04 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.9 mttt -89.53 28.87 1.21 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.815 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -103.1 119.51 38.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.864 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -93.18 59.13 3.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.977 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.0 t -85.17 134.21 27.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.013 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.08 -61.87 1.31 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.154 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.1 tptt -113.34 139.98 48.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.887 0.375 . . . . 0.0 111.161 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.0 m -130.2 134.74 47.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.859 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.15 127.97 56.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.915 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -120.01 108.51 14.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.783 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.426 HG23 HG21 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -128.2 68.49 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.05 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 -54.73 -89.78 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.061 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.5 -153.69 4.22 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.254 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -110.66 144.79 39.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.846 0.355 . . . . 0.0 110.752 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.08 -158.1 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.04 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.646 ' O ' ' HD2' ' A' ' 39' ' ' PRO . 2.5 m -60.62 162.78 10.65 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.678 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -73.76 -6.56 18.83 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.599 2.2 . . . . 0.0 112.282 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.738 ' HB ' ' HD3' ' A' ' 39' ' ' PRO . 21.6 t -67.02 -56.5 13.36 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.72 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.738 ' HD3' ' HB ' ' A' ' 38' ' ' VAL . 51.7 Cg_exo -54.25 -31.19 65.44 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.12 1.88 . . . . 0.0 112.356 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.4 ' O ' HG22 ' A' ' 43' ' ' THR . 0.4 OUTLIER -62.41 -50.46 71.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 179.85 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.4 t -70.07 -23.64 25.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.95 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -66.71 -54.3 24.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.919 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.424 ' O ' ' HB2' ' A' ' 46' ' ' ALA . 4.1 t -59.07 -34.84 72.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.864 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.76 -36.57 76.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.893 0.378 . . . . 0.0 110.318 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -66.06 -31.34 72.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.439 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.424 ' HB2' ' O ' ' A' ' 43' ' ' THR . . . -58.62 -53.0 63.29 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.018 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.668 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 0.8 OUTLIER -58.65 -35.44 72.54 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.144 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.06 -9.83 59.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.249 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -133.52 69.23 1.48 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.948 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.555 ' HB3' HG22 ' A' ' 97' ' ' VAL . 41.9 mtm -109.02 147.86 31.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.997 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.534 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.4 OUTLIER -91.93 153.85 43.53 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.391 179.466 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.534 ' HD2' ' HG3' ' A' ' 51' ' ' LYS . 53.9 Cg_exo -38.48 -71.31 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.148 2.565 . . . . 0.0 113.962 -178.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.17 57.37 0.54 Allowed Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.913 -0.661 . . . . 0.0 113.415 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.502 ' HG3' ' HB3' ' A' ' 51' ' ' LYS . 11.0 mt-10 -91.41 156.1 17.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.134 0.493 . . . . 0.0 111.984 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.538 ' C ' HD12 ' A' ' 56' ' ' LEU . 3.5 mp -135.55 115.71 17.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.008 178.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.538 HD12 ' C ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -118.52 154.29 32.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.035 0.445 . . . . 0.0 111.692 -177.624 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -114.74 145.9 41.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.376 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.484 HG12 HG13 ' A' ' 60' ' ' ILE . 16.7 t -131.01 131.52 64.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.858 0.361 . . . . 0.0 111.527 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.406 ' CD1' ' HG2' ' A' ' 92' ' ' LYS . 52.8 m0 -122.59 107.25 11.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.422 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.484 HG13 HG12 ' A' ' 58' ' ' VAL . 1.0 OUTLIER -158.67 -172.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-O 121.046 0.451 . . . . 0.0 111.334 -179.213 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -99.67 -25.59 14.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.106 178.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -120.62 121.06 29.31 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.445 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -45.68 105.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.651 2.234 . . . . 0.0 112.561 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.481 ' HG3' ' NH1' ' A' ' 68' ' ' ARG . 3.0 tpt -65.64 -15.09 62.43 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.808 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.743 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 14.8 p -55.79 -13.38 1.72 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.846 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.459 ' HZ2' ' HG3' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -55.66 -42.96 75.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 179.309 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.541 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 1.7 mt-10 -87.16 -26.07 23.77 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.225 0.536 . . . . 0.0 110.132 178.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.743 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 0.2 OUTLIER -61.48 -41.98 98.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.088 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.709 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 18.9 mt -55.33 -56.0 33.6 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.804 -178.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.709 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 78.3 Cg_exo -49.0 -41.27 40.44 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.216 1.944 . . . . 0.0 112.491 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.668 ' HG3' ' HB3' ' A' ' 47' ' ' LEU . 7.4 mm-40 -68.49 -55.2 12.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.571 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.468 ' O ' HD21 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -57.57 -49.01 77.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.468 -178.834 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.449 HG11 ' N ' ' A' ' 74' ' ' LYS . 10.2 p -58.36 -28.32 35.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.139 -178.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 2.8 mmtt -58.67 -43.25 89.82 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 176.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.429 ' HE2' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -89.19 -80.81 0.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.118 176.686 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.468 HD21 ' O ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -99.02 -106.38 0.2 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.459 177.685 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -133.84 -80.92 0.16 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.365 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.482 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -146.14 165.6 28.67 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.775 0.322 . . . . 0.0 110.977 179.644 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.726 ' HB2' ' H ' ' A' ' 96' ' ' LYS . 0.1 OUTLIER -110.19 62.76 0.6 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.394 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.482 ' CG2' ' HB2' ' A' ' 78' ' ' HIS . 0.1 OUTLIER -98.77 123.05 51.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.69 -176.656 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.544 HD21 ' C ' ' A' ' 95' ' ' ILE . 0.8 OUTLIER -142.11 -36.42 0.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.223 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.471 ' HB3' ' HB2' ' A' ' 94' ' ' TYR . 2.3 tp10 -149.06 141.25 24.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.215 0.531 . . . . 0.0 112.348 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.8 mp -143.71 118.57 4.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.155 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -155.1 -176.05 5.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.164 0.507 . . . . 0.0 111.373 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -133.71 166.46 22.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.789 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.15 -47.74 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.17 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -123.39 -161.06 11.05 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.706 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.401 ' HB2' ' H ' ' A' ' 89' ' ' SER . 35.9 Cg_exo -58.1 -76.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.689 2.259 . . . . 0.0 112.424 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.401 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 0.8 OUTLIER -98.32 -2.48 39.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.101 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -93.34 119.84 32.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.402 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 14.4 m0 -120.79 167.66 12.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.03 0.443 . . . . 0.0 111.382 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.406 ' HG2' ' CD1' ' A' ' 59' ' ' TRP . 1.6 mttm -120.56 131.65 54.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.306 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -125.14 137.72 56.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.02 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.471 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 23.8 m-85 -118.27 123.44 45.42 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.384 178.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.661 HG13 ' HG3' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -123.95 142.53 40.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.251 -179.71 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.726 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -145.79 114.88 7.01 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.826 -176.844 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.555 HG22 ' HB3' ' A' ' 50' ' ' MET . 2.2 t -63.33 120.91 11.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.499 178.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 33.1 mttp . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.174 -0.917 . . . . 0.0 110.977 -179.631 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 112.522 -0.231 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 m -68.0 -50.28 56.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.736 0.303 . . . . 0.0 110.909 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.91 -68.15 0.65 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.952 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -136.51 35.29 2.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.856 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 64.1 m170 -80.48 -153.85 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.858 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -55.85 139.67 45.02 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.039 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -61.0 119.33 8.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.944 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -130.56 125.15 33.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.54 29.37 3.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.851 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.8 m -72.46 -32.43 66.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.893 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.05 28.57 0.7 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.289 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.9 138.13 48.2 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.586 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.25 76.72 4.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.912 0.387 . . . . 0.0 110.833 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.7 m -76.49 136.85 67.68 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.208 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.17 78.97 2.81 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.521 2.147 . . . . 0.0 112.063 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.6 ttt85 -84.97 -82.73 0.17 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.136 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.7 128.25 8.36 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.513 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.96 -53.96 45.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.597 0.237 . . . . 0.0 111.359 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -78.93 30.81 0.2 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.425 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.61 122.09 7.51 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.806 0.336 . . . . 0.0 111.135 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.56 102.91 11.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.941 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.7 51.06 2.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.961 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -89.06 33.09 0.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.877 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.65 66.77 8.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.967 0.413 . . . . 0.0 110.666 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 20.9 t -63.48 148.48 11.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.3 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.457 ' N ' HG11 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -118.52 -46.7 2.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.068 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.09 154.26 38.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.137 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 51.6 m -135.52 114.78 12.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.845 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 5.8 tt -102.96 117.01 33.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.709 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -132.77 115.83 15.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.113 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.51 65.79 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.828 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.427 ' HB3' ' H ' ' A' ' 33' ' ' GLY . 5.9 ttm180 -59.49 -92.86 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.091 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.427 ' H ' ' HB3' ' A' ' 32' ' ' ARG . . . -67.3 99.18 0.5 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.211 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.401 ' HB2' ' HG2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -108.18 158.68 17.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.936 0.398 . . . . 0.0 111.198 -179.675 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.4 -90.74 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.888 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.665 ' HB2' HG22 ' A' ' 38' ' ' VAL . 2.9 m -63.75 164.05 18.46 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.527 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -69.97 18.17 0.2 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.647 2.231 . . . . 0.0 112.825 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.665 HG22 ' HB2' ' A' ' 36' ' ' CYS . 49.0 t -57.23 -52.08 76.89 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.499 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.659 ' HD3' ' HB ' ' A' ' 38' ' ' VAL . 51.6 Cg_exo -55.33 -28.25 61.82 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.302 2.001 . . . . 0.0 112.449 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.99 -54.81 32.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.637 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.446 ' O ' HG12 ' A' ' 41' ' ' VAL . 1.0 OUTLIER -74.34 -21.14 17.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.412 178.8 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -65.38 -55.93 15.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.657 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.404 ' O ' HD13 ' A' ' 47' ' ' LEU . 7.6 t -61.37 -32.3 72.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.498 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -55.29 -38.96 69.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.493 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.87 -42.4 77.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.133 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.79 -38.47 78.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.1 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.404 HD13 ' O ' ' A' ' 43' ' ' THR . 2.2 mp -64.52 -44.55 90.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.956 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.35 -3.88 51.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -126.14 62.91 1.25 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.103 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.19 152.06 25.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.072 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.851 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -105.04 162.11 20.73 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.678 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.576 ' HD2' ' HB3' ' A' ' 51' ' ' LYS . 4.9 Cg_endo -47.47 -68.9 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.087 2.524 . . . . 0.0 113.451 -178.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.53 58.34 0.49 Allowed Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.442 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.851 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 13.1 mm-40 -90.63 143.29 26.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.032 0.444 . . . . 0.0 111.57 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 5.5 mt -135.81 96.27 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.198 178.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.91 175.12 5.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.285 0.564 . . . . 0.0 111.959 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -138.25 140.91 39.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.317 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.774 HG22 ' HE1' ' A' ' 64' ' ' MET . 2.8 t -114.12 135.72 52.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.991 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -121.75 107.84 12.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.69 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -157.97 -163.7 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.224 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -114.17 -5.88 13.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -125.84 132.57 24.36 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.803 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -58.36 91.2 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.61 2.207 . . . . 0.0 112.78 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.774 ' HE1' HG22 ' A' ' 58' ' ' VAL . 5.1 tmm? -68.53 -25.95 65.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.056 0.455 . . . . 0.0 110.449 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.633 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 67.5 m -64.05 -13.86 50.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.946 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.444 ' HG3' ' N ' ' A' ' 67' ' ' GLU . 2.1 pttp -57.69 -33.91 68.86 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.734 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.572 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -94.32 -27.13 16.27 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.186 0.517 . . . . 0.0 110.112 178.383 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.633 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -61.31 -34.34 75.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.942 179.126 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.709 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 11.3 mt -63.53 -56.75 23.84 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.342 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.709 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 83.4 Cg_exo -47.78 -32.39 16.89 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.307 2.004 . . . . 0.0 112.373 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.08 -58.26 3.73 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.061 0.457 . . . . 0.0 111.012 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.75 -30.0 68.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.557 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.587 HG12 ' HA ' ' A' ' 70' ' ' PRO . 5.7 p -72.72 -29.84 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.83 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.494 ' N ' HG11 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -58.68 -41.39 86.07 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -90.6 -78.67 0.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.446 177.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.48 -97.92 0.22 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.755 178.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.09 -82.4 0.05 OUTLIER Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.14 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.545 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -146.32 157.98 43.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.86 0.362 . . . . 0.0 111.234 179.449 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.683 ' HB2' ' H ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -104.72 63.4 0.72 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.491 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.545 HG22 ' HB2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -99.13 121.83 50.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.805 -176.863 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.727 ' HB3' ' HG2' ' A' ' 96' ' ' LYS . 2.2 pt? -139.79 -32.41 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.421 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.549 ' O ' HD12 ' A' ' 83' ' ' ILE . 0.4 OUTLIER -149.88 132.84 16.14 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -179.704 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.549 HD12 ' O ' ' A' ' 82' ' ' GLU . 1.0 OUTLIER -134.62 126.23 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.315 178.268 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -158.34 175.96 13.06 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.072 0.463 . . . . 0.0 111.554 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -134.51 178.04 7.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.738 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.5 p -138.73 -43.32 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.283 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -133.7 -148.4 5.85 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.726 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.07 -77.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.608 2.205 . . . . 0.0 112.346 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.8 p -97.89 -3.47 38.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.881 0.372 . . . . 0.0 110.886 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -93.23 130.8 38.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.766 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -147.45 168.95 20.57 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.971 0.415 . . . . 0.0 111.203 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.9 ttpt -126.38 127.45 45.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.448 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.6 mt -125.53 149.46 30.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.885 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.623 ' O ' HD22 ' A' ' 81' ' ' LEU . 6.8 m-85 -118.42 135.66 54.22 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.289 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.584 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -125.55 143.24 39.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.299 178.856 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.727 ' HG2' ' HB3' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -138.42 106.31 5.67 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 120.232 -0.587 . . . . 0.0 112.189 -177.514 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -64.43 118.97 7.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.424 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.918 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.82 151.28 35.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.751 0.31 . . . . 0.0 110.791 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.1 170.49 13.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.019 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -81.44 -7.02 59.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.146 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -117.76 169.19 9.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.9 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -125.11 -44.57 1.9 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.958 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 9.5 m170 -65.65 -68.49 0.36 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.022 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -111.43 178.05 4.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.965 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 62.1 m-70 -104.78 -22.01 13.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.931 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.0 m -73.71 114.04 11.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.916 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.31 28.81 0.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.333 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.54 -71.8 0.78 Allowed Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.503 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.439 ' HG ' ' H ' ' A' ' 14' ' ' VAL . 1.7 tp -85.42 161.06 19.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.851 0.358 . . . . 0.0 110.875 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.439 ' H ' ' HG ' ' A' ' 13' ' ' LEU . 28.1 m -64.51 143.27 98.56 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.056 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.31 106.91 2.15 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.451 2.101 . . . . 0.0 112.251 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -85.53 27.62 0.82 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.359 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.45 -89.51 0.59 Allowed Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.491 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.29 29.01 0.36 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.65 0.262 . . . . 0.0 111.078 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 28.2 t60 -53.54 -78.32 0.02 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.321 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.443 ' HB2' ' H ' ' A' ' 21' ' ' ALA . 23.8 mtp -81.16 -89.89 0.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.287 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.443 ' H ' ' HB2' ' A' ' 20' ' ' MET . . . -79.18 177.23 8.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.364 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.2 mttm -91.18 53.41 2.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.208 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -97.5 86.64 3.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.88 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -106.36 77.83 1.24 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.406 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.626 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 85.6 t -79.0 136.5 23.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.561 178.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.695 ' HB ' HD12 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -99.47 -37.37 9.22 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.846 -0.341 . . . . 0.0 111.82 -178.731 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.574 ' H ' ' CD1' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -145.52 162.23 37.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.407 0.622 . . . . 0.0 111.845 -178.723 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 83.1 m -136.17 125.99 25.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.715 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.517 HD23 ' HE3' ' A' ' 64' ' ' MET . 2.4 tt -107.64 120.38 42.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.575 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.32 112.44 8.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.861 0.362 . . . . 0.0 111.084 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.1 t -134.14 70.06 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.972 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.02 -87.32 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.45 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.41 -156.49 4.81 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.384 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.18 130.53 55.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.863 0.364 . . . . 0.0 110.687 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.6 m -135.53 -157.66 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.791 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.549 ' O ' ' HD2' ' A' ' 39' ' ' PRO . 10.1 m -55.12 160.71 3.01 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.607 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.01 15.26 1.17 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.379 2.053 . . . . 0.0 112.596 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.52 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 10.5 t -65.24 -53.25 41.35 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.371 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.549 ' HD2' ' O ' ' A' ' 36' ' ' CYS . 30.9 Cg_endo -63.38 -24.12 71.41 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.166 1.911 . . . . 0.0 112.197 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -61.05 -65.93 0.61 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.652 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.7 t -65.55 -18.64 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.465 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -65.2 -50.82 64.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.731 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.561 HG21 ' N ' ' A' ' 44' ' ' LYS . 1.4 t -63.82 -33.34 75.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.44 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.561 ' N ' HG21 ' A' ' 43' ' ' THR . 8.0 tptt -59.69 -40.23 87.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.151 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -67.75 -29.79 69.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.99 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.88 -56.06 26.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.017 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.674 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 1.7 mm? -61.3 -62.0 2.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.58 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -58.7 -32.77 69.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.492 . . . . 0.0 112.184 -177.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -124.97 66.05 1.12 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.842 0.353 . . . . 0.0 111.24 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.516 ' HG3' HG11 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -98.78 158.18 15.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.921 179.775 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.12 144.86 29.21 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.648 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -49.87 -46.75 26.27 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.885 2.39 . . . . 0.0 113.573 -178.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.0 56.31 0.54 Allowed Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.622 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -90.86 136.01 33.35 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 117.18 0.49 . . . . 0.0 111.614 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.626 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 2.6 mp -136.4 81.41 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.613 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.695 HD12 ' HB ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -117.19 176.26 5.22 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.349 -0.541 . . . . 0.0 112.246 -173.481 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.42 ' C ' HG22 ' A' ' 58' ' ' VAL . 5.3 pt-20 -132.04 162.52 30.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.811 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.42 HG22 ' C ' ' A' ' 57' ' ' GLU . 6.2 t -135.3 139.59 46.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.815 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 9.1 t-105 -127.77 104.53 7.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.745 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.507 HD11 ' O ' ' A' ' 62' ' ' TYR . 0.5 OUTLIER -158.29 -177.31 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.27 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -97.26 0.23 47.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.64 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.507 ' O ' HD11 ' A' ' 60' ' ' ILE . 1.4 t80 -136.93 130.16 17.48 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.642 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.46 100.46 0.57 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.42 2.08 . . . . 0.0 112.304 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.517 ' HE3' HD23 ' A' ' 29' ' ' LEU . 1.3 mtt -68.01 -13.04 61.87 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.753 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 14.4 p -59.14 -11.01 3.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.363 178.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -55.09 -46.44 75.48 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.11 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.542 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -87.23 -25.19 24.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.171 0.51 . . . . 0.0 110.209 178.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.753 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -62.41 -35.6 79.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.915 179.343 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.74 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 16.6 mt -60.39 -56.89 30.91 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.513 -179.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.74 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 67.0 Cg_exo -52.09 -32.15 47.91 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.283 1.988 . . . . 0.0 112.47 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.674 ' HG3' ' HB3' ' A' ' 47' ' ' LEU . 30.1 mm-40 -72.46 -63.69 1.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.884 0.373 . . . . 0.0 111.338 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.452 ' HB ' ' HA ' ' A' ' 78' ' ' HIS . 0.2 OUTLIER -57.42 -28.36 63.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.479 -178.791 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.587 HG13 ' HA ' ' A' ' 70' ' ' PRO . 5.8 p -74.19 -29.49 25.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.803 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.487 ' N ' HG12 ' A' ' 73' ' ' VAL . 0.4 OUTLIER -58.67 -41.43 86.1 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 176.873 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.409 ' HD3' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -90.47 -78.38 0.38 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.283 177.104 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.54 -96.75 0.22 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.743 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.29 -79.52 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.1 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.452 ' HA ' ' HB ' ' A' ' 72' ' ' THR . 0.1 OUTLIER -146.12 158.55 43.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.769 0.319 . . . . 0.0 110.863 179.262 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.657 ' HB2' ' H ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -103.49 56.67 0.74 Allowed 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.822 179.44 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.712 HG13 HD13 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -98.88 125.36 52.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.236 -177.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.663 HD12 ' HB2' ' A' ' 82' ' ' GLU . 1.1 pp -133.43 -36.9 0.97 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.015 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.663 ' HB2' HD12 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -153.38 143.67 22.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.97 0.414 . . . . 0.0 111.724 179.823 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.712 HD13 HG13 ' A' ' 80' ' ' VAL . 3.4 mp -143.19 137.52 26.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.336 178.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.406 ' HG3' ' HB3' ' A' ' 92' ' ' LYS . 2.5 pt-20 -152.6 176.53 11.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.016 0.436 . . . . 0.0 111.214 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -133.49 163.59 29.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.681 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.406 HG21 ' HA ' ' A' ' 91' ' ' TRP . 2.8 t -127.46 -66.58 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.321 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -123.0 -141.08 5.83 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.671 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.71 -84.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.7 2.267 . . . . 0.0 112.329 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 85.1 p -100.05 -1.16 37.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.011 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -91.68 128.05 37.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.822 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.406 ' HA ' HG21 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -150.16 171.13 17.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.253 -179.682 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.406 ' HB3' ' HG3' ' A' ' 84' ' ' GLU . 12.0 tttt -121.36 141.69 50.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.491 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.602 HG23 ' H ' ' A' ' 94' ' ' TYR . 0.8 OUTLIER -131.16 165.17 32.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.186 -179.542 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.602 ' H ' HG23 ' A' ' 93' ' ' ILE . 12.7 m-85 -132.88 126.17 31.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.001 178.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.619 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 18.7 mm -124.76 145.73 31.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.078 -177.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.657 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -150.54 120.1 6.96 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 119.759 -0.776 . . . . 0.0 112.924 -178.62 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.516 HG11 ' HG3' ' A' ' 50' ' ' MET . 22.7 t -73.57 128.48 36.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.242 178.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.8 tttm . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.929 -179.708 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 112.409 -0.277 . . . . 0.0 112.409 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -121.08 -41.52 2.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.746 0.308 . . . . 0.0 110.797 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.48 127.97 50.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.903 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -69.58 135.9 50.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.002 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -64.88 129.28 39.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.875 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -130.55 -84.4 0.53 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.005 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.7 -59.43 0.72 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.922 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 -62.67 110.41 1.71 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.986 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -82.59 -16.05 49.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.842 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 27.4 t -80.27 147.27 31.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.048 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.33 -80.73 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.032 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.0 -166.89 38.53 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.59 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.31 34.41 0.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.792 0.33 . . . . 0.0 110.909 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.427 ' H ' HG22 ' A' ' 14' ' ' VAL . 3.7 m -76.28 144.06 74.11 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.163 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.21 164.02 88.69 Favored 'Cis proline' 0 C--N 1.348 0.529 0 C-N-CA 123.754 -1.353 . . . . 0.0 112.139 0.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.496 ' HB3' ' H ' ' A' ' 17' ' ' GLY . 1.1 mpt_? -81.11 -150.55 0.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.824 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.496 ' H ' ' HB3' ' A' ' 16' ' ' ARG . . . -72.39 155.47 51.41 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.565 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.99 -75.67 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.805 0.336 . . . . 0.0 110.943 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.429 ' HB3' ' H ' ' A' ' 20' ' ' MET . 2.2 m-70 -90.53 -151.27 0.24 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.862 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.429 ' H ' ' HB3' ' A' ' 19' ' ' HIS . 12.3 mtm -70.12 -85.63 0.02 OUTLIER 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.755 0.312 . . . . 0.0 110.998 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.412 ' H ' ' HB2' ' A' ' 20' ' ' MET . . . -87.19 165.29 15.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.255 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -91.17 72.9 6.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.822 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -89.97 39.36 0.96 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.922 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.28 61.13 6.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.581 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.488 HG11 ' N ' ' A' ' 26' ' ' THR . 6.7 t -85.46 152.79 3.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.243 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.488 ' N ' HG11 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -99.29 -61.88 1.31 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.691 179.441 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.533 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 0.8 OUTLIER -115.56 157.83 23.53 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.801 179.117 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.0 m -135.49 125.72 26.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.066 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.0 tt -107.46 119.44 39.42 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.975 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -124.04 113.96 19.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.516 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.617 HG13 ' HB3' ' A' ' 39' ' ' PRO . 3.8 m -140.39 74.06 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.891 0.377 . . . . 0.0 111.543 -179.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -163.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.864 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.68 94.29 0.04 OUTLIER Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.44 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -103.18 -173.19 2.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.792 0.33 . . . . 0.0 111.012 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.0 t -104.64 -86.24 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.653 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.596 ' HB3' HG22 ' A' ' 38' ' ' VAL . 0.8 OUTLIER -52.35 155.67 3.42 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.172 -179.467 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.63 25.05 0.4 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.613 2.208 . . . . 0.0 112.439 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.601 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 50.2 t -59.5 -48.68 95.18 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.855 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.617 ' HB3' HG13 ' A' ' 31' ' ' VAL . 19.5 Cg_endo -60.11 -31.44 93.29 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.221 1.947 . . . . 0.0 112.457 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -64.04 -57.82 8.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.959 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.5 t -66.19 -19.65 26.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.066 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -65.97 -67.14 0.47 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.118 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.509 ' O ' HD11 ' A' ' 47' ' ' LEU . 8.4 t -60.2 -31.02 69.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.085 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.67 -44.3 77.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.665 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.56 -35.25 79.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.75 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.8 -36.4 84.2 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.997 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.509 HD11 ' O ' ' A' ' 43' ' ' THR . 2.4 mp -70.28 -39.67 74.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.154 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -78.84 -21.33 47.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.336 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.9 t30 -135.24 70.56 1.43 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.801 0.334 . . . . 0.0 111.4 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.474 ' SD ' HG11 ' A' ' 97' ' ' VAL . 18.4 ptp -102.28 145.14 29.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.673 178.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.867 ' HG2' ' HD2' ' A' ' 52' ' ' PRO . 3.1 tttp -80.79 148.17 64.35 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.783 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.867 ' HD2' ' HG2' ' A' ' 51' ' ' LYS . 58.7 Cg_exo -39.03 -75.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.25 2.634 . . . . 0.0 114.173 -178.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.86 59.7 0.48 Allowed Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.001 -0.618 . . . . 0.0 113.261 -177.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -90.92 153.68 20.02 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.014 0.435 . . . . 0.0 111.918 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.2 mt -132.5 116.0 26.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.99 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.533 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 5.0 mp -126.72 152.13 47.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.119 0.485 . . . . 0.0 111.949 -178.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -113.92 129.53 56.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.402 177.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.569 HG12 HH22 ' A' ' 68' ' ' ARG . 2.2 t -114.12 128.77 70.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.165 0.507 . . . . 0.0 111.925 -177.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -122.87 101.17 7.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.448 178.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.542 HD13 ' HB2' ' A' ' 64' ' ' MET . 0.5 OUTLIER -149.64 -160.01 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.681 -179.437 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -145.17 35.26 1.09 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.704 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.494 ' H ' ' HA ' ' A' ' 63' ' ' PRO . 44.4 m-85 -105.74 -63.02 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.001 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.494 ' HA ' ' H ' ' A' ' 62' ' ' TYR . 85.7 Cg_endo -97.53 164.23 12.48 Favored 'Cis proline' 0 C--N 1.356 0.971 0 CA-C-N 119.507 0.86 . . . . 0.0 112.088 -1.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.542 ' HB2' HD13 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -68.48 -17.76 64.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.808 0.337 . . . . 0.0 111.147 179.815 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.579 ' HA ' ' HD3' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -60.44 -17.4 44.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.932 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.412 ' HG3' ' N ' ' A' ' 67' ' ' GLU . 2.9 pttp -62.51 -27.22 68.99 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.844 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.504 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.7 OUTLIER -94.34 -26.19 16.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.178 0.513 . . . . 0.0 109.863 178.107 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.579 ' HD3' ' HA ' ' A' ' 65' ' ' SER . 3.8 mpt_? -58.89 -47.57 84.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.193 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.705 HG21 ' HB3' ' A' ' 78' ' ' HIS . 3.8 mt -57.8 -55.32 46.2 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.834 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.677 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 83.8 Cg_exo -42.94 -51.47 5.42 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 122.73 2.286 . . . . 0.0 113.171 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.401 ' O ' ' HD3' ' A' ' 75' ' ' LYS . 2.0 mm-40 -62.41 -41.34 98.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.007 0.432 . . . . 0.0 110.978 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.799 HG21 ' HG3' ' A' ' 79' ' ' GLU . 2.9 m -59.72 -52.08 67.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.754 -179.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -58.67 -26.33 31.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.937 -178.863 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.6 -44.17 89.79 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 176.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.401 ' HD3' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -90.36 -77.28 0.41 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.429 176.898 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.52 -98.64 0.22 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.828 178.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.14 -84.54 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.151 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.705 ' HB3' HG21 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -146.36 146.91 30.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.976 0.417 . . . . 0.0 111.213 179.276 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.799 ' HG3' HG21 ' A' ' 72' ' ' THR . 0.5 OUTLIER -95.34 52.75 1.43 Allowed 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 177.737 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.584 HG11 ' HB2' ' A' ' 78' ' ' HIS . 1.4 p -98.71 118.77 45.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.208 -177.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.68 HD23 ' O ' ' A' ' 94' ' ' TYR . 1.1 pt? -133.65 -29.35 1.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.686 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.497 ' O ' HG13 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -152.81 144.78 23.71 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.979 179.074 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 82' ' ' GLU . 2.5 mp -144.5 126.44 9.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.566 178.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -153.06 174.67 13.89 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.905 0.384 . . . . 0.0 111.137 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.04 169.06 17.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.877 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.2 t -129.25 -52.68 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.215 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -126.1 -145.53 6.41 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.767 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.89 -77.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.606 2.204 . . . . 0.0 112.523 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.18 -6.85 27.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.937 0.399 . . . . 0.0 111.138 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -89.62 134.47 34.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.567 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -151.31 169.63 21.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.047 0.451 . . . . 0.0 111.265 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.5 ttpt -126.97 125.51 41.63 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.344 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.712 HG23 ' H ' ' A' ' 94' ' ' TYR . 4.1 mp -125.5 159.87 32.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.925 0.393 . . . . 0.0 110.836 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.712 ' H ' HG23 ' A' ' 93' ' ' ILE . 6.3 m-85 -118.2 133.55 55.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.579 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.641 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 12.9 mm -124.21 137.82 55.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.093 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.629 ' C ' ' HB3' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -144.91 109.78 5.05 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.375 -0.53 . . . . 0.0 112.052 -176.677 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.474 HG11 ' SD ' ' A' ' 50' ' ' MET . 4.1 t -65.54 116.19 4.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.304 178.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.082 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.581 -0.208 . . . . 0.0 112.581 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 p -126.94 -77.15 0.58 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.745 0.307 . . . . 0.0 110.885 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.8 m -139.18 124.0 18.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -102.79 11.02 38.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.941 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -74.2 90.52 2.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.819 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -133.38 44.96 2.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.904 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -90.78 28.26 1.58 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.965 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -89.89 102.0 14.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.961 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -115.6 40.8 2.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.931 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.2 m -81.77 -166.69 1.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.894 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.16 27.06 0.58 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.192 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.84 92.63 1.63 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.482 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.561 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 4.3 mm? -70.5 -173.23 0.7 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.742 0.305 . . . . 0.0 110.77 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.498 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 58.8 t -58.99 -50.77 86.22 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.261 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.561 ' HD2' ' HB3' ' A' ' 13' ' ' LEU . 56.2 Cg_endo -70.22 148.74 62.76 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.092 1.861 . . . . 0.0 112.231 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -85.27 33.07 0.55 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.059 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -53.76 172.31 0.69 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.055 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.428 ' C ' ' H ' ' A' ' 20' ' ' MET . 15.9 p -80.6 35.42 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.455 0.169 . . . . 0.0 111.451 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -76.66 25.99 0.14 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.642 0.258 . . . . 0.0 111.446 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.471 ' HE3' ' H ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -81.11 -169.03 2.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.768 0.318 . . . . 0.0 111.034 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.471 ' H ' ' HE3' ' A' ' 20' ' ' MET . . . -68.67 -174.0 0.51 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.013 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.6 mttm -91.29 20.61 5.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.112 0.482 . . . . 0.0 110.904 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -103.74 41.44 1.28 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.986 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.5 77.71 1.3 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.091 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.8 t -61.24 135.69 25.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.772 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.57 -56.08 2.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.152 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.03 137.76 50.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.829 0.347 . . . . 0.0 111.356 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 54.9 m -123.89 126.87 47.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.522 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.578 HD12 ' HG2' ' A' ' 42' ' ' GLU . 10.5 tp -109.83 118.76 37.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.292 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -108.24 128.42 54.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.528 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.517 ' HB ' HG21 ' A' ' 60' ' ' ILE . 18.9 t -117.24 -23.45 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.357 -179.019 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.84 -10.39 0.75 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.13 -91.76 0.37 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.76 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -80.6 175.4 10.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.804 0.335 . . . . 0.0 110.961 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.14 -177.72 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.208 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.736 ' HA ' ' HD2' ' A' ' 39' ' ' PRO . 20.9 p -53.1 154.98 4.86 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.104 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -91.81 18.91 38.56 Favored 'Cis proline' 0 C--N 1.348 0.521 0 C-N-CA 123.863 -1.307 . . . . 0.0 112.785 1.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.684 ' HB ' ' HD3' ' A' ' 39' ' ' PRO . 24.9 t -59.49 -53.1 69.18 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.627 -179.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.736 ' HD2' ' HA ' ' A' ' 36' ' ' CYS . 24.5 Cg_exo -64.26 -22.55 66.63 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.284 1.989 . . . . 0.0 112.176 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.16 -64.68 0.85 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.132 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 17.2 t -70.07 -30.01 42.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.294 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.578 ' HG2' HD12 ' A' ' 29' ' ' LEU . 28.2 tt0 -61.69 -56.94 14.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.148 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.7 t -62.65 -41.36 99.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.005 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.2 -43.78 71.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.859 0.361 . . . . 0.0 110.702 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.41 -32.76 74.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.412 178.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.509 ' HA ' HD22 ' A' ' 49' ' ' ASN . . . -59.32 -45.27 91.78 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.038 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -72.48 -19.47 61.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.772 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.41 -36.64 29.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.359 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.59 ' H ' HD21 ' A' ' 49' ' ' ASN . 0.1 OUTLIER -106.74 48.6 0.83 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.909 0.385 . . . . 0.0 111.606 -178.621 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.1 ptm -89.9 126.35 35.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.897 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.407 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -94.67 152.35 39.78 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.795 -179.86 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.407 ' HD2' ' HG3' ' A' ' 51' ' ' LYS . 61.0 Cg_exo -40.4 -67.61 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.175 2.583 . . . . 0.0 113.831 -178.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.32 57.87 0.51 Allowed Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.993 -0.622 . . . . 0.0 113.141 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.408 ' O ' HD13 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -91.25 150.29 21.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.983 0.421 . . . . 0.0 111.898 -179.71 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.508 HG22 ' HB2' ' A' ' 96' ' ' LYS . 0.6 OUTLIER -131.07 112.81 22.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.032 178.282 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 mt -119.78 154.51 34.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.176 0.513 . . . . 0.0 112.173 -177.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -119.75 125.86 49.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.472 177.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.489 HG13 ' NH1' ' A' ' 68' ' ' ARG . 1.1 t -114.96 138.22 45.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.176 0.512 . . . . 0.0 112.327 -177.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.456 ' C ' HG13 ' A' ' 60' ' ' ILE . 7.1 m0 -122.46 105.62 10.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.654 177.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.913 HG12 ' HB2' ' A' ' 64' ' ' MET . 0.1 OUTLIER -144.97 -176.97 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 CA-C-O 120.966 0.412 . . . . 0.0 111.505 -177.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.533 ' HB3' ' HA ' ' A' ' 90' ' ' GLU . 0.5 OUTLIER -138.4 25.9 2.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.869 179.396 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.718 ' H ' ' HA ' ' A' ' 63' ' ' PRO . 0.6 OUTLIER -106.19 -55.48 0.07 OUTLIER Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.597 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.718 ' HA ' ' H ' ' A' ' 62' ' ' TYR . 78.5 Cg_endo -95.61 177.36 9.94 Favored 'Cis proline' 0 C--N 1.355 0.897 0 C-N-CA 124.904 -0.873 . . . . 0.0 112.708 0.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.913 ' HB2' HG12 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -68.43 -25.7 65.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.228 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.448 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 14.4 p -61.3 -13.02 15.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.087 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.521 ' HG3' ' N ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -62.97 -31.93 73.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.886 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.556 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -94.2 -25.66 16.99 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.084 0.469 . . . . 0.0 110.241 178.758 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.489 ' NH1' HG13 ' A' ' 58' ' ' VAL . 18.5 mtt85 -62.17 -41.91 98.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.954 179.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.712 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 12.5 mt -56.7 -55.84 38.99 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.684 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.712 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 76.2 Cg_exo -49.31 -40.8 43.59 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.292 1.995 . . . . 0.0 112.703 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.86 -51.65 52.99 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.899 0.381 . . . . 0.0 111.219 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.51 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -59.53 -50.63 73.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.59 -178.799 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.428 HG13 ' O ' ' A' ' 70' ' ' PRO . 11.0 p -58.37 -28.12 34.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.895 -178.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.78 -42.46 89.03 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 176.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.6 -80.62 0.3 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.949 176.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.51 HD23 ' O ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -98.58 -106.65 0.19 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.363 177.2 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -132.73 -84.76 0.26 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.018 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.39 164.23 33.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.915 0.388 . . . . 0.0 111.309 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.695 ' O ' ' HA ' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -107.09 62.3 0.62 Allowed 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.397 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.4 p -98.14 120.88 48.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.427 -175.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.504 HD12 ' HB2' ' A' ' 82' ' ' GLU . 0.5 OUTLIER -133.68 -33.52 1.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.795 179.807 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.504 ' HB2' HD12 ' A' ' 81' ' ' LEU . 0.9 OUTLIER -151.77 145.16 24.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.014 0.435 . . . . 0.0 111.811 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.5 mp -142.23 123.51 12.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.288 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.548 ' HG3' ' HB3' ' A' ' 92' ' ' LYS . 5.1 pt-20 -156.55 -175.55 5.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.221 0.534 . . . . 0.0 111.349 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.464 ' HB3' ' HD1' ' A' ' 91' ' ' TRP . 3.6 pt-20 -133.24 166.39 22.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.639 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.8 p -131.27 -44.9 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.477 -179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -133.33 -151.83 6.68 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.673 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.412 ' HG2' ' H ' ' A' ' 89' ' ' SER . 38.3 Cg_endo -66.89 -74.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.547 2.164 . . . . 0.0 112.426 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.412 ' H ' ' HG2' ' A' ' 88' ' ' PRO . 24.7 p -95.65 -5.84 41.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.812 0.339 . . . . 0.0 111.157 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.533 ' HA ' ' HB3' ' A' ' 61' ' ' ASP . 4.5 pt-20 -93.03 140.94 28.95 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.558 179.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.464 ' HD1' ' HB3' ' A' ' 85' ' ' GLU . 6.1 m-90 -136.44 163.97 29.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.047 0.451 . . . . 0.0 111.335 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.548 ' HB3' ' HG3' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -120.23 117.0 26.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.077 178.99 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.4 mp -125.28 145.34 32.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.99 -178.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.415 ' HB2' ' CB ' ' A' ' 82' ' ' GLU . 29.1 m-85 -118.04 132.54 56.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.187 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.695 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -124.13 141.66 43.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.796 -177.945 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.589 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -151.21 130.05 12.44 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.239 -0.584 . . . . 0.0 112.287 -177.714 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.3 t -80.85 120.05 31.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.089 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.954 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 112.449 -0.261 . . . . 0.0 112.449 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.1 t -77.31 156.72 31.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.768 0.318 . . . . 0.0 110.974 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.77 -3.34 25.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.985 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -79.06 106.99 11.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.029 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -120.38 -96.74 0.47 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.802 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.48 23.55 2.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.781 0.324 . . . . 0.0 111.022 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 40.1 m-70 -131.96 27.63 4.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.078 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -108.91 -168.99 1.41 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.976 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -63.81 141.75 58.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.905 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.59 144.05 44.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.873 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.86 -69.55 0.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.922 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.77 158.53 53.17 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.527 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -95.47 -94.09 0.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.669 0.271 . . . . 0.0 110.968 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.5 m -89.26 144.14 31.98 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.173 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -78.76 136.22 40.02 Favored 'Cis proline' 0 C--N 1.349 0.571 0 C-N-CA 123.462 -1.474 . . . . 0.0 112.398 -0.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.6 mtt180 -82.2 26.15 0.55 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.332 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.63 28.82 3.05 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.565 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 85.2 p -80.57 -150.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.722 0.296 . . . . 0.0 110.846 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -83.2 28.6 0.52 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.181 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.88 -148.79 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.913 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.91 129.43 41.51 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.127 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -89.43 76.22 7.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.955 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -72.72 125.62 27.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.98 151.6 35.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.03 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 57.6 t -85.02 145.41 8.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.12 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.3 m -106.36 -53.64 2.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.196 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.509 ' HB3' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -119.39 167.03 12.32 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.048 0.452 . . . . 0.0 111.466 -179.197 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.436 ' H ' ' HG3' ' A' ' 27' ' ' LYS . 87.8 m -134.09 121.99 22.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.648 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.662 HD22 HG13 ' A' ' 58' ' ' VAL . 5.1 tt -103.69 120.75 41.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.935 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -132.37 120.17 21.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.727 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.532 HG13 ' HB2' ' A' ' 39' ' ' PRO . 3.0 t -109.65 -4.66 10.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.246 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.613 ' HD3' ' HE1' ' A' ' 59' ' ' TRP . 0.7 OUTLIER -50.76 -18.57 0.75 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.285 -179.474 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.61 102.02 0.7 Allowed Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.551 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.87 23.55 0.54 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.686 0.279 . . . . 0.0 111.421 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -104.27 -133.36 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.95 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.446 ' C ' ' H ' ' A' ' 38' ' ' VAL . 99.2 m -50.83 155.15 2.09 Favored Pre-proline 0 C--O 1.232 0.136 0 CA-C-O 120.603 0.239 . . . . 0.0 111.127 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.95 26.64 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.633 2.222 . . . . 0.0 112.534 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.687 ' HB ' ' HD3' ' A' ' 39' ' ' PRO . 73.6 t -58.5 -51.47 81.57 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.341 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.687 ' HD3' ' HB ' ' A' ' 38' ' ' VAL . 19.7 Cg_exo -66.61 -20.49 53.36 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.335 2.024 . . . . 0.0 112.137 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -70.59 -51.12 30.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.983 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.1 t -74.39 -29.98 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.711 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -60.69 -53.36 58.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.829 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.555 ' HA ' HD12 ' A' ' 29' ' ' LEU . 13.3 t -64.14 -38.81 92.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.791 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.549 ' N ' HG23 ' A' ' 43' ' ' THR . 0.7 OUTLIER -55.64 -41.63 73.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.676 179.503 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.68 -30.35 69.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.05 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.52 -43.98 80.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.25 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.812 HD11 ' HG2' ' A' ' 68' ' ' ARG . 2.3 mm? -71.4 -43.86 66.02 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.69 -179.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -81.35 -12.65 58.94 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -177.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.414 ' ND2' ' HE3' ' A' ' 51' ' ' LYS . 2.2 t30 -135.51 72.71 1.45 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.94 0.4 . . . . 0.0 111.139 -179.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.637 ' HE3' ' H ' ' A' ' 50' ' ' MET . 0.0 OUTLIER -108.53 138.49 44.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.866 179.832 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.628 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -96.09 153.29 39.16 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.7 179.708 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -52.94 -43.61 55.32 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.624 2.216 . . . . 0.0 113.198 -178.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.8 50.14 0.86 Allowed Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.532 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.671 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 20.0 mm-40 -91.27 129.0 37.31 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 117.358 0.579 . . . . 0.0 111.635 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 1.1 mp -135.59 89.46 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.779 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.509 HD23 ' HB3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -118.89 -177.98 3.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.252 0.549 . . . . 0.0 112.087 -176.695 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.523 ' C ' HG23 ' A' ' 58' ' ' VAL . 6.5 pt-20 -129.25 174.01 9.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.236 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.662 HG13 HD22 ' A' ' 29' ' ' LEU . 13.4 t -140.17 136.02 37.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.858 0.361 . . . . 0.0 111.303 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.613 ' HE1' ' HD3' ' A' ' 32' ' ' ARG . 57.9 t-105 -122.49 104.49 9.41 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.706 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.501 HD12 ' O ' ' A' ' 62' ' ' TYR . 0.8 OUTLIER -159.04 -177.8 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.084 0.469 . . . . 0.0 111.528 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 4.9 m-20 -99.89 -13.8 19.02 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.016 177.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.501 ' O ' HD12 ' A' ' 60' ' ' ILE . 1.8 m-85 -129.91 124.8 21.79 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.274 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.474 ' HD3' ' HE1' ' A' ' 91' ' ' TRP . 86.4 Cg_exo -47.54 104.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.643 2.229 . . . . 0.0 112.863 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.88 -19.27 65.81 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.116 0.484 . . . . 0.0 110.586 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.676 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 6.1 p -61.82 -10.09 8.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.625 179.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.7 ptmt -58.15 -37.96 75.68 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.58 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.548 ' O ' ' HG2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -91.74 -24.21 19.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.277 0.56 . . . . 0.0 109.967 178.259 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.812 ' HG2' HD11 ' A' ' 47' ' ' LEU . 33.2 mtt-85 -63.46 -39.69 95.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.756 179.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.457 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 12.2 mt -57.5 -56.96 28.64 Favored Pre-proline 0 CA--C 1.532 0.282 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.559 ' O ' HG13 ' A' ' 73' ' ' VAL . 9.8 Cg_endo -53.4 -34.58 71.84 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.138 1.892 . . . . 0.0 112.574 -178.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.56 ' HG3' ' HB3' ' A' ' 47' ' ' LEU . 65.1 mm-40 -72.92 -65.71 0.76 Allowed 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.042 0.448 . . . . 0.0 111.327 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.434 ' HB ' ' O ' ' A' ' 77' ' ' GLY . 0.2 OUTLIER -58.7 -24.91 62.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.353 -178.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.559 HG13 ' O ' ' A' ' 70' ' ' PRO . 3.4 p -76.07 -27.89 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-O 120.74 0.305 . . . . 0.0 110.474 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.97 -43.35 86.43 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 176.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.08 -77.89 0.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.117 176.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.18 -100.24 0.21 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.626 178.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.27 -85.62 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.71 178.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.496 ' CE1' ' HB2' ' A' ' 65' ' ' SER . 6.3 t-80 -147.05 172.7 13.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.924 0.392 . . . . 0.0 110.94 177.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.861 ' HB2' HG13 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -111.48 68.53 0.67 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.84 178.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -99.02 122.06 50.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.952 0.406 . . . . 0.0 112.025 -176.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.977 ' HB3' ' HG2' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -133.74 -40.97 0.86 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.036 178.563 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.511 ' C ' HG13 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -153.88 151.02 28.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.04 0.448 . . . . 0.0 112.116 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.511 HG13 ' C ' ' A' ' 82' ' ' GLU . 1.1 mp -141.54 142.14 29.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.159 178.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -156.63 176.05 13.24 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.027 0.442 . . . . 0.0 111.682 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -136.07 176.65 8.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.732 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.63 HG11 ' HA ' ' A' ' 91' ' ' TRP . 0.7 OUTLIER -144.34 -53.48 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.134 -178.298 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -123.92 -153.91 8.79 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.564 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.415 ' HB2' ' H ' ' A' ' 89' ' ' SER . 31.4 Cg_exo -58.97 -78.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.626 2.218 . . . . 0.0 112.311 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.415 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -100.05 -3.02 32.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.869 0.366 . . . . 0.0 111.111 -179.742 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 8.7 pt-20 -93.35 133.24 36.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.765 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.63 ' HA ' HG11 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -151.56 173.73 14.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.272 -179.902 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.55 ' HG3' ' HE3' ' A' ' 59' ' ' TRP . 3.3 mttm -122.33 143.43 49.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.365 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.63 151.27 31.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.919 0.39 . . . . 0.0 111.258 -179.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.454 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 14.4 m-85 -118.66 123.65 45.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.081 178.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.861 HG13 ' HB2' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -123.77 151.51 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.045 -177.959 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.977 ' HG2' ' HB3' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -148.83 97.74 2.76 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.926 -177.445 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.671 ' HB ' ' HB2' ' A' ' 54' ' ' GLU . 17.6 t -60.56 117.53 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.701 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.908 -179.905 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.6 t -107.02 -69.07 0.85 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.807 0.336 . . . . 0.0 110.973 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -127.55 -0.14 6.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.903 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.42 37.94 1.41 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -66.04 169.0 7.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.963 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -65.22 146.64 54.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.924 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -71.75 139.18 48.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.095 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.711 ' HB3' ' HB2' ' A' ' 11' ' ' SER . 39.3 m80 -92.75 131.17 38.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.742 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -102.36 -80.9 0.5 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.131 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.02 -9.81 58.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.143 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.711 ' HB2' ' HB3' ' A' ' 8' ' ' HIS . 66.8 m -75.54 -77.64 0.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.88 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.23 93.61 0.79 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.779 -0.725 . . . . 0.0 112.404 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 mp -73.2 -76.18 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.683 0.278 . . . . 0.0 110.963 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.5 m -88.69 141.82 30.37 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.088 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -80.89 38.13 0.74 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.067 2.511 . . . . 0.0 112.258 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -77.62 -79.16 0.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.037 -179.649 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.54 85.61 0.84 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.445 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.4 -77.45 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.79 0.329 . . . . 0.0 110.981 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -83.86 -81.64 0.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.899 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.12 128.78 34.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.874 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.13 -169.64 1.92 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.333 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.12 -106.1 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.69 178.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -92.32 112.22 24.08 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.904 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -103.87 126.27 50.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.949 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 68.9 t -61.82 136.61 25.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.26 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.7 m -99.84 -67.82 0.83 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.891 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -115.76 159.43 21.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.801 0.334 . . . . 0.0 110.842 179.636 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.6 m -135.65 124.77 24.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.096 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.3 tt -104.94 112.87 26.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.571 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -130.05 112.55 13.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.142 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.51 72.45 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.818 179.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.446 ' HB3' ' H ' ' A' ' 33' ' ' GLY . 4.3 ttm180 -52.65 -90.14 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.499 -179.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.446 ' H ' ' HB3' ' A' ' 32' ' ' ARG . . . -75.46 -159.46 7.9 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.333 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.8 134.51 36.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.535 0.683 . . . . 0.0 112.286 -178.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.26 -176.88 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 114.691 -1.141 . . . . 0.0 111.178 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.592 ' O ' ' HD2' ' A' ' 39' ' ' PRO . 0.8 OUTLIER -67.52 163.22 49.71 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.365 178.885 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -73.03 11.52 0.89 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.72 2.28 . . . . 0.0 112.692 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.487 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 39.8 t -64.31 -54.85 35.23 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.671 -179.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.592 ' HD2' ' O ' ' A' ' 36' ' ' CYS . 28.8 Cg_endo -61.94 -21.24 71.93 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.321 2.014 . . . . 0.0 112.14 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -63.53 -62.67 1.52 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.646 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.1 t -71.76 -18.4 19.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.805 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -66.35 -57.44 7.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.886 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.45 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 14.6 t -60.43 -35.01 74.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.61 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.447 ' N ' HG23 ' A' ' 43' ' ' THR . 2.3 tptm -61.26 -39.54 90.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.397 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -32.67 72.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.762 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.63 -48.71 80.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.822 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.636 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 3.0 mt -62.02 -30.05 70.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.784 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.62 -25.63 45.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.164 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -132.43 69.62 1.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.058 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.499 ' SD ' ' HE2' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -84.6 147.47 26.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.792 179.835 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.783 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 0.8 OUTLIER -103.08 161.57 22.7 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.658 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -46.61 -72.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.988 2.458 . . . . 0.0 113.905 -177.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.28 59.99 0.45 Allowed Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.333 -177.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.783 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 26.3 mm-40 -87.34 139.19 30.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.896 0.379 . . . . 0.0 111.377 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.523 ' HA ' ' HB2' ' A' ' 96' ' ' LYS . 16.8 mt -135.25 121.03 30.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.682 178.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.482 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.5 mp -127.1 146.82 50.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.156 0.503 . . . . 0.0 112.076 -177.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -111.31 123.34 50.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.699 177.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.3 t -114.34 130.36 68.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.977 0.417 . . . . 0.0 111.758 -177.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.4 t90 -126.73 111.33 14.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.427 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.487 HD11 ' O ' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -158.14 -168.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 121.071 0.462 . . . . 0.0 111.796 -178.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.429 ' OD2' ' HB2' ' A' ' 89' ' ' SER . 0.4 OUTLIER -102.7 -11.42 18.41 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.9 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.487 ' O ' HD11 ' A' ' 60' ' ' ILE . 4.5 m-85 -133.59 139.75 34.71 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.909 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.445 ' HA ' HD13 ' A' ' 93' ' ' ILE . 16.9 Cg_exo -67.66 101.73 0.68 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.722 2.282 . . . . 0.0 112.615 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.24 -16.78 64.1 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.138 0.494 . . . . 0.0 110.524 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.73 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -59.36 -12.62 6.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.458 179.105 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.673 ' HE2' ' HG3' ' A' ' 67' ' ' GLU . 2.2 pttm -54.91 -39.29 68.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.989 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.673 ' HG3' ' HE2' ' A' ' 66' ' ' LYS . 4.9 mt-10 -91.48 -27.97 17.92 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.146 0.498 . . . . 0.0 110.067 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.73 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -62.94 -34.62 77.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.115 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.753 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 21.0 mt -60.85 -56.95 30.1 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.753 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 75.7 Cg_exo -51.09 -37.29 57.53 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.255 1.97 . . . . 0.0 112.666 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.636 ' HG3' ' HB3' ' A' ' 47' ' ' LEU . 17.4 mm-40 -67.35 -65.79 0.64 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.841 0.353 . . . . 0.0 111.481 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.429 HG21 HD13 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -54.52 -45.35 73.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.433 -178.909 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.456 HG11 ' O ' ' A' ' 70' ' ' PRO . 7.1 p -59.18 -29.1 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.209 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.9 tptt -58.5 -43.89 89.25 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 176.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.499 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 2.9 mtpp -90.07 -77.64 0.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.484 177.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.429 HD13 HG21 ' A' ' 72' ' ' THR . 0.0 OUTLIER -98.44 -97.6 0.22 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.947 178.783 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.24 -82.39 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.372 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.63 166.94 25.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.018 0.437 . . . . 0.0 111.524 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.884 ' HB2' HG13 ' A' ' 95' ' ' ILE . 3.9 mt-10 -106.58 56.55 0.65 Allowed 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.2 p -97.38 122.18 48.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.086 0.469 . . . . 0.0 111.186 -176.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.812 HD22 ' HD2' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -133.61 -38.27 0.92 Allowed 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.341 -179.336 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.526 ' O ' ' HB2' ' A' ' 94' ' ' TYR . 1.0 OUTLIER -153.8 126.27 8.07 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.725 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.58 137.48 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.093 178.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 92' ' ' LYS . 0.5 OUTLIER -158.54 173.69 16.23 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.908 0.385 . . . . 0.0 111.398 -179.798 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -133.78 168.1 19.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.613 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.0 t -129.55 -60.25 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.04 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -125.13 -150.83 7.87 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.492 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.14 -77.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.69 2.26 . . . . 0.0 112.297 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.429 ' HB2' ' OD2' ' A' ' 61' ' ' ASP . 0.8 OUTLIER -96.8 -2.45 44.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.004 -179.756 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.35 134.82 35.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.545 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -151.07 169.19 22.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.019 0.438 . . . . 0.0 111.259 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.494 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 0.9 OUTLIER -121.08 131.58 54.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.456 179.549 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.445 HD13 ' HA ' ' A' ' 63' ' ' PRO . 2.9 mt -125.48 144.24 36.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.979 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.545 ' HB3' ' HG ' ' A' ' 81' ' ' LEU . 2.8 m-85 -118.1 119.86 36.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.141 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.884 HG13 ' HB2' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -123.92 141.88 42.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.901 -178.205 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.812 ' HD2' HD22 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -151.04 130.06 12.58 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 120.107 -0.637 . . . . 0.0 112.391 -178.539 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.8 t -72.68 116.12 14.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.652 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.92 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.185 0 N-CA-C 112.536 -0.225 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.2 -18.71 14.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.829 0.347 . . . . 0.0 110.955 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.28 -25.72 11.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -91.87 107.55 19.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.994 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -105.25 130.01 53.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.7 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -107.92 -170.13 1.64 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.996 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -103.63 2.8 33.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.917 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -102.3 176.53 5.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -93.17 65.5 3.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.011 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.23 58.56 5.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.839 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.92 -77.2 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.97 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.72 147.94 47.47 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.515 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.26 115.75 28.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.778 0.323 . . . . 0.0 110.88 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.0 p -70.39 127.21 92.3 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -57.76 98.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.517 2.145 . . . . 0.0 112.284 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -85.26 29.41 0.66 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.103 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.14 -135.22 0.69 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.566 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.55 -150.98 0.05 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.63 0.253 . . . . 0.0 110.907 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -84.23 28.14 0.64 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.308 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -78.2 104.32 8.7 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.778 0.323 . . . . 0.0 110.853 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.73 170.76 14.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.078 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -83.27 71.56 10.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.705 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.21 48.39 1.04 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.948 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -102.74 75.59 1.43 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.661 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 87.9 t -77.11 140.49 17.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.178 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.535 ' HB ' HD23 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -99.77 -42.15 6.96 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.845 -179.389 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.649 ' O ' ' HB3' ' A' ' 56' ' ' LEU . 4.4 mmtt -131.68 159.4 38.48 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.375 0.607 . . . . 0.0 112.433 -178.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 99.3 m -135.26 124.23 24.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.629 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.72 HD23 HG12 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -101.69 121.98 43.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.084 -179.848 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -129.49 87.42 2.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.922 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.72 HG12 HD23 ' A' ' 29' ' ' LEU . 6.4 m -114.37 43.42 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.001 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 21.7 ttp85 -71.96 -73.39 0.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.665 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.57 -2.75 3.55 Favored Glycine 0 CA--C 1.519 0.309 0 CA-C-N 115.846 -0.615 . . . . 0.0 113.303 -178.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.535 ' OE1' ' HA ' ' A' ' 31' ' ' VAL . 2.0 mt-10 -80.48 -169.89 2.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.787 0.293 . . . . 0.0 110.851 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.729 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -104.11 -163.14 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.411 -178.484 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.592 ' O ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -81.72 -47.87 1.01 Allowed Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -178.402 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.729 ' HD2' ' HB ' ' A' ' 35' ' ' VAL . 56.6 Cg_endo -71.23 -15.25 31.74 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.099 1.866 . . . . 0.0 113.042 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.747 ' HB ' ' HD3' ' A' ' 39' ' ' PRO . 34.8 t -67.35 -56.15 13.47 Favored Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 111.656 0.243 . . . . 0.0 111.656 -179.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.747 ' HD3' ' HB ' ' A' ' 38' ' ' VAL . 16.8 Cg_exo -67.54 -21.86 45.55 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.201 1.934 . . . . 0.0 112.144 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -61.85 -56.11 22.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.93 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.2 t -70.68 -29.35 37.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.065 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.82 -63.57 1.13 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.025 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.2 t -58.35 -30.91 67.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.016 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.88 -40.55 89.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.622 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.3 tmm_? -67.1 -33.31 75.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.627 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.531 ' O ' ' HG3' ' A' ' 50' ' ' MET . . . -64.01 -54.18 38.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.848 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.483 ' O ' ' HE2' ' A' ' 50' ' ' MET . 53.2 mt -52.19 -35.32 48.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.339 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.99 -22.38 39.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.181 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -126.52 49.51 2.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.289 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.531 ' HG3' ' O ' ' A' ' 46' ' ' ALA . 60.6 mtm -83.19 128.65 34.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.053 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.527 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 4.3 mtpp -85.83 154.73 58.59 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.419 179.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.47 -43.08 42.48 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.589 2.192 . . . . 0.0 112.826 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.41 57.44 0.49 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.426 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.527 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 7.2 mm-40 -90.08 128.37 36.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.3 0.55 . . . . 0.0 111.305 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.692 ' H ' HD21 ' A' ' 56' ' ' LEU . 6.1 mt -135.93 66.89 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.814 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.692 HD21 ' H ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -118.71 -172.23 2.24 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -171.772 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.457 ' C ' HG22 ' A' ' 58' ' ' VAL . 3.1 pt-20 -140.47 171.35 14.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.555 -178.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.518 HG13 HD21 ' A' ' 29' ' ' LEU . 33.6 t -139.58 146.2 25.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.57 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.422 ' C ' HG13 ' A' ' 60' ' ' ILE . 6.8 t90 -122.98 109.74 14.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.014 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.444 HG13 HG11 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -151.7 -178.39 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.308 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -101.59 -2.95 29.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.496 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.82 139.44 26.52 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.612 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -62.13 89.85 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.498 2.132 . . . . 0.0 112.245 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -23.37 67.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.927 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.794 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.4 OUTLIER -55.86 -16.91 5.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.116 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.6 pttt -53.49 -37.32 62.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.274 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.463 ' O ' ' HG2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -94.21 -27.91 15.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.175 0.512 . . . . 0.0 110.093 178.517 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.794 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -64.77 -25.43 67.92 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.378 179.725 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.491 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 18.9 mt -73.42 -54.83 3.88 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 9.2 Cg_endo -53.99 -33.67 73.72 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.194 1.929 . . . . 0.0 112.366 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.53 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -69.45 -46.89 65.65 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.996 0.427 . . . . 0.0 110.767 179.169 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.454 ' O ' HD21 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -62.08 -47.82 82.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.041 -179.861 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.1 p -58.89 -27.53 35.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.841 -179.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 4.5 mmmt -58.71 -42.69 89.24 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 175.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.1 -81.49 0.29 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.986 176.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.495 ' HG ' ' HB2' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -98.56 -107.43 0.19 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.416 177.35 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -129.22 -82.53 0.31 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.079 -0.581 . . . . 0.0 111.939 178.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.03 161.47 40.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.92 0.391 . . . . 0.0 110.856 178.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.635 ' HB2' ' H ' ' A' ' 96' ' ' LYS . 0.5 OUTLIER -103.84 52.73 0.76 Allowed 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.127 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.6 p -98.97 122.18 50.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.872 -178.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.46 ' HG ' ' N ' ' A' ' 82' ' ' GLU . 0.4 OUTLIER -133.48 -35.0 1.02 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.063 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -153.69 153.46 32.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.025 0.441 . . . . 0.0 112.052 179.351 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 82' ' ' GLU . 3.6 mp -144.03 135.53 22.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.437 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -156.07 -179.66 8.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.067 0.461 . . . . 0.0 111.314 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -133.57 158.51 42.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.783 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 62.0 t -117.65 -59.26 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.261 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -127.08 -152.73 8.07 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.729 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -56.67 -75.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.678 2.252 . . . . 0.0 112.612 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.18 -5.62 29.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.907 0.384 . . . . 0.0 111.235 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -93.61 137.1 33.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.769 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.02 168.56 20.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.923 0.392 . . . . 0.0 111.121 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.3 tttm -126.14 136.9 53.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.623 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.581 HG23 ' N ' ' A' ' 94' ' ' TYR . 2.2 mp -125.99 157.69 35.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.937 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.581 ' N ' HG23 ' A' ' 93' ' ' ILE . 15.3 m-85 -118.21 135.02 54.51 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.014 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.634 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 10.9 mm -122.88 145.48 29.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.214 -176.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.635 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -143.68 106.04 4.41 Favored 'General case' 0 C--N 1.334 -0.085 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.738 -177.569 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.503 HG12 ' HB3' ' A' ' 50' ' ' MET . 23.7 t -75.79 131.11 35.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.642 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.495 ' HB2' ' HG ' ' A' ' 76' ' ' LEU . 3.5 mmmp? . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.152 -0.928 . . . . 0.0 110.908 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 112.454 -0.258 . . . . 0.0 112.454 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.33 108.02 8.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.783 0.325 . . . . 0.0 110.982 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.84 134.43 47.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -62.08 149.04 42.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -115.75 -52.69 2.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.02 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -120.27 174.89 6.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.936 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -97.6 178.07 5.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.781 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 -130.58 -83.94 0.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.105 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -132.59 160.45 36.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.053 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.6 m -70.93 110.44 5.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.755 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.4 m -65.31 -73.99 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.885 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -86.53 121.07 5.62 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.558 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.69 161.62 30.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.878 0.371 . . . . 0.0 111.004 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.712 HG13 ' HD3' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -89.31 -47.34 0.41 Allowed Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.337 179.388 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.712 ' HD3' HG13 ' A' ' 14' ' ' VAL . 24.0 Cg_exo -64.21 91.26 0.17 Allowed 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.257 1.971 . . . . 0.0 112.098 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.7 mmt85 -84.31 -152.03 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.787 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.18 110.65 3.47 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.508 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.24 -151.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.567 0.222 . . . . 0.0 110.763 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -89.16 -84.84 0.21 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.692 0.282 . . . . 0.0 110.871 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.25 175.69 10.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.965 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.54 79.67 9.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.976 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.2 mtmt -84.29 65.79 9.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.016 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -86.08 101.82 13.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.918 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.54 126.4 30.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.015 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 26' ' ' THR . 20.1 t -85.26 144.35 9.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.128 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.447 ' N ' HG12 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -100.08 -53.52 3.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.966 179.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.25 160.54 30.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.016 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.537 HG22 ' O ' ' A' ' 57' ' ' GLU . 98.3 m -135.27 122.65 21.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.832 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.632 ' HB3' ' HB ' ' A' ' 58' ' ' VAL . 8.6 tt -99.15 103.35 15.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.948 0.404 . . . . 0.0 111.028 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.22 111.66 17.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.625 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.2 m -140.15 75.98 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.231 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -157.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.052 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.1 81.65 0.13 Allowed Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.801 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -111.64 -161.5 0.76 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.698 0.285 . . . . 0.0 110.793 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 36' ' ' CYS . 0.9 OUTLIER -120.57 145.24 27.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.913 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.718 ' HA ' ' HD2' ' A' ' 39' ' ' PRO . 59.3 m -76.27 160.17 78.46 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.922 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.546 ' HA ' ' HB3' ' A' ' 36' ' ' CYS . 69.3 Cg_endo -93.41 32.11 11.21 Favored 'Cis proline' 0 C--N 1.351 0.666 0 C-N-CA 124.039 -1.234 . . . . 0.0 112.944 1.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.465 ' HB ' ' HD3' ' A' ' 39' ' ' PRO . 61.4 t -59.33 -51.64 80.01 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.572 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.718 ' HD2' ' HA ' ' A' ' 36' ' ' CYS . 66.3 Cg_endo -73.82 -18.85 21.55 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.131 1.888 . . . . 0.0 112.362 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.48 -61.04 1.92 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.068 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.8 t -64.57 -24.32 35.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.249 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -63.24 -74.05 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.074 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.548 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 10.2 t -57.18 -28.46 62.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.956 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.04 -50.46 69.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.695 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.39 -33.08 74.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.075 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.52 -42.29 91.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.037 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 43' ' ' THR . 2.8 mt -77.54 -45.69 24.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.677 -179.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -15.81 60.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.943 -177.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.71 63.06 1.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.938 0.399 . . . . 0.0 111.2 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 6.6 ptt? -109.25 136.48 48.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.868 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.46 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -92.27 147.44 34.58 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.671 179.491 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -42.47 -56.82 1.89 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.025 2.483 . . . . 0.0 113.476 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.24 56.0 0.58 Allowed Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.056 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.46 ' HG2' ' HB3' ' A' ' 51' ' ' LYS . 4.2 mm-40 -90.72 150.66 21.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.082 0.468 . . . . 0.0 111.78 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.8 mp -133.65 111.59 15.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.499 177.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.3 mp -119.3 168.38 10.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.456 0.646 . . . . 0.0 112.39 -176.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.537 ' O ' HG22 ' A' ' 28' ' ' THR . 4.3 tt0 -141.51 117.4 10.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.445 178.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.632 ' HB ' ' HB3' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -114.06 136.26 51.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.148 0.499 . . . . 0.0 112.076 -176.172 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.56 ' HZ3' HG12 ' A' ' 86' ' ' VAL . 2.7 t-105 -122.89 119.43 30.47 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.038 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.477 HD13 ' HA ' ' A' ' 63' ' ' PRO . 1.0 OUTLIER -158.88 -169.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.096 0.474 . . . . 0.0 111.528 -178.61 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' A' ' 89' ' ' SER . 85.7 m-20 -104.09 -9.18 18.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.973 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.49 110.99 4.96 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.301 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.477 ' HA ' HD13 ' A' ' 60' ' ' ILE . 84.6 Cg_exo -45.98 106.26 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.747 2.298 . . . . 0.0 112.752 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.52 -8.13 38.54 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.724 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.762 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 15.8 p -61.2 -12.82 14.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.661 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.02 -38.75 68.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.978 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.504 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -93.58 -27.49 16.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.18 0.514 . . . . 0.0 110.126 178.618 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.762 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 4.4 mtm-85 -64.09 -32.43 73.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.045 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.718 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 17.2 mt -62.54 -57.76 20.67 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.154 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.718 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 84.9 Cg_exo -48.13 -40.28 34.23 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.196 1.931 . . . . 0.0 112.442 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.0 -46.26 78.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.994 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.628 HG21 ' HG3' ' A' ' 79' ' ' GLU . 1.9 m -65.66 -37.96 87.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.749 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 70' ' ' PRO . 1.5 m -63.89 -29.35 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.465 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.52 -45.53 88.62 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 176.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.623 ' HG3' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -86.75 -80.97 0.23 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.658 177.218 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.623 HD22 ' HG3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -100.29 -95.16 0.26 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.962 0.41 . . . . 0.0 110.902 178.584 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.495 ' O ' ' HB ' ' A' ' 72' ' ' THR . . . -145.13 -82.22 0.05 OUTLIER Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.03 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.446 ' HB2' HG13 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -145.43 152.02 39.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.898 0.38 . . . . 0.0 111.002 179.212 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.628 ' HG3' HG21 ' A' ' 72' ' ' THR . 2.2 mt-10 -95.54 54.2 1.55 Allowed 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.943 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.446 HG13 ' HB2' ' A' ' 78' ' ' HIS . 1.2 p -98.92 116.14 41.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.903 -178.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.7 HD12 ' HB2' ' A' ' 96' ' ' LYS . 2.0 pt? -133.22 -31.23 1.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.119 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.508 ' O ' HD13 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -150.99 130.66 13.1 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.194 -0.603 . . . . 0.0 112.244 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.508 HD13 ' O ' ' A' ' 82' ' ' GLU . 1.8 mm -131.05 131.1 64.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.4 178.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -154.85 173.4 16.53 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.895 0.378 . . . . 0.0 111.263 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.92 172.18 13.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.775 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.56 HG12 ' HZ3' ' A' ' 59' ' ' TRP . 2.7 p -140.86 -50.42 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.189 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -123.55 -158.54 10.19 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.566 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.25 -66.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.602 2.201 . . . . 0.0 112.588 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.403 ' O ' ' HA ' ' A' ' 61' ' ' ASP . 80.2 p -100.26 -8.53 23.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.55 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.24 116.99 29.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.756 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.413 ' HE3' ' HD3' ' A' ' 63' ' ' PRO . 4.8 m0 -131.63 163.82 27.24 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.972 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.506 ' HG3' ' HE3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -125.81 123.06 37.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.301 179.103 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.596 HG21 ' N ' ' A' ' 94' ' ' TYR . 3.8 mp -125.54 150.95 31.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.976 0.417 . . . . 0.0 111.305 -178.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.596 ' N ' HG21 ' A' ' 93' ' ' ILE . 6.9 m-85 -118.2 134.22 55.21 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.987 178.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.613 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 13.6 mm -123.32 139.14 50.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.266 -178.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.7 ' HB2' HD12 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -143.41 122.92 13.19 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 120.182 -0.607 . . . . 0.0 112.518 -176.178 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.5 t -78.57 118.32 25.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.439 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.43 ' HA ' ' HZ2' ' A' ' 96' ' ' LYS . 2.8 tttt . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.999 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 112.546 -0.222 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.47 137.64 56.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.79 0.329 . . . . 0.0 110.952 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 p -109.77 157.18 19.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.984 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -65.55 123.46 19.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.938 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -133.33 10.65 4.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.908 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -126.59 105.6 8.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -78.34 -35.09 48.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.913 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -86.34 124.26 32.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.97 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -104.34 63.59 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.941 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.1 p -86.05 39.26 0.8 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.918 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 m -65.47 -70.93 0.21 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.018 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -67.83 109.57 2.98 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.593 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.5 130.46 37.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.764 0.316 . . . . 0.0 110.876 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.457 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 4.5 m -71.39 130.71 87.29 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.014 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 14' ' ' VAL . 9.9 Cg_endo -88.08 13.89 2.47 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.182 2.588 . . . . 0.0 112.133 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -82.88 27.29 0.55 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.344 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.52 162.69 51.99 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.431 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.01 26.59 0.42 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.578 0.228 . . . . 0.0 111.279 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -77.76 -78.49 0.13 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.766 0.317 . . . . 0.0 110.913 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.9 mmt -74.0 177.29 5.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.873 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.33 -175.32 5.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.982 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.55 45.48 1.2 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.875 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -88.84 35.2 0.78 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.93 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -99.41 117.28 33.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.876 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.965 ' HA ' HG22 ' A' ' 55' ' ' ILE . 52.8 t -81.58 143.79 11.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.074 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.27 -48.96 4.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.197 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.543 ' HB3' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -120.6 129.83 53.91 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.83 0.348 . . . . 0.0 110.991 -179.998 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 99.8 m -118.58 121.16 39.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.847 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.604 HD13 HH22 ' A' ' 68' ' ' ARG . 6.9 tt -99.66 115.82 30.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.081 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -116.81 115.85 26.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.44 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.551 HG13 HG23 ' A' ' 60' ' ' ILE . 7.7 p -140.27 76.57 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.443 0.639 . . . . 0.0 111.163 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.23 -163.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.015 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.29 88.71 0.05 OUTLIER Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.644 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -111.39 -159.78 0.69 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.609 0.242 . . . . 0.0 110.807 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.54 144.18 31.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.987 0.422 . . . . 0.0 111.708 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.719 ' HA ' ' HD2' ' A' ' 39' ' ' PRO . 1.6 p -81.27 162.43 58.98 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.608 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.422 ' HA ' ' HB2' ' A' ' 36' ' ' CYS . 65.2 Cg_endo -93.17 30.36 13.76 Favored 'Cis proline' 0 C--N 1.351 0.665 0 C-N-CA 124.195 -1.169 . . . . 0.0 112.652 1.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.562 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 40.4 t -55.83 -48.49 96.49 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.823 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.719 ' HD2' ' HA ' ' A' ' 36' ' ' CYS . 41.9 Cg_endo -66.94 -27.77 42.75 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.111 1.874 . . . . 0.0 112.343 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -60.24 -61.96 2.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.963 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.7 t -70.9 -18.67 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.041 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -62.47 -61.06 2.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.858 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.4 t -67.91 -23.02 65.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.844 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.29 -44.23 97.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.538 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.11 -38.56 78.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.865 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.24 -43.15 99.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.747 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.75 HD13 ' HE1' ' A' ' 50' ' ' MET . 0.1 OUTLIER -67.23 -33.56 75.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.96 179.741 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -81.13 -6.36 58.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.097 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -130.64 51.24 2.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.32 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.75 ' HE1' HD13 ' A' ' 47' ' ' LEU . 10.5 mtp -99.74 109.61 22.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.901 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.476 ' HB3' ' HG3' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -74.69 138.06 73.8 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.455 179.305 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_exo -42.57 -41.77 8.12 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.751 2.301 . . . . 0.0 112.907 -179.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.27 50.31 0.87 Allowed Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.932 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.525 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 9.3 mt-10 -90.89 151.02 21.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.465 0.65 . . . . 0.0 112.177 -178.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.967 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 3.1 mp -134.24 106.15 7.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.049 178.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.543 HD21 ' HB3' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -128.48 156.44 43.23 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -175.185 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -135.59 136.86 41.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.145 176.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.459 HG12 HD12 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -114.77 140.18 37.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.067 0.461 . . . . 0.0 112.059 -177.007 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -122.67 98.12 5.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.351 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.551 HG23 HG13 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -147.0 -173.06 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.461 -179.069 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.26 -16.39 14.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.951 178.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -123.18 126.73 25.86 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.55 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -56.52 93.68 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.588 2.192 . . . . 0.0 112.658 -179.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.54 -16.19 63.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.905 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.629 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 9.7 p -63.66 -10.47 19.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.856 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -61.28 -33.28 73.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.605 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.582 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -93.72 -28.59 15.86 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.355 0.598 . . . . 0.0 110.075 178.175 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.629 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 37.6 mtt-85 -61.51 -39.57 91.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.604 178.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.657 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 22.3 mt -55.83 -57.1 23.54 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.279 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.657 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 83.2 Cg_exo -45.63 -39.3 17.72 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.249 1.966 . . . . 0.0 112.385 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.449 ' OE1' HD23 ' A' ' 47' ' ' LEU . 2.3 mp0 -71.36 -61.08 1.9 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.49 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.514 ' HB ' ' O ' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -56.78 -31.3 64.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.54 -178.745 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.599 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 8.6 p -74.26 -26.53 20.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.67 0.271 . . . . 0.0 110.873 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.481 ' N ' HG13 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -58.33 -46.56 85.96 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 177.103 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.29 -73.9 0.49 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.211 177.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 72' ' ' THR . 0.1 OUTLIER -98.12 -106.92 0.19 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.322 177.842 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.599 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.67 -89.07 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.464 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 0.6 OUTLIER -147.81 145.76 28.88 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 178.223 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.695 ' O ' ' HA ' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -96.77 61.61 1.87 Allowed 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.129 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.464 ' CG2' ' HB2' ' A' ' 78' ' ' HIS . 0.2 OUTLIER -98.36 118.61 45.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.516 -177.221 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.821 HD22 ' HD3' ' A' ' 96' ' ' LYS . 0.5 OUTLIER -133.86 -28.11 1.42 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.038 179.722 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.31 139.77 18.69 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.348 -0.541 . . . . 0.0 112.371 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.412 HD12 HG13 ' A' ' 80' ' ' VAL . 3.9 mp -144.18 128.05 12.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.159 178.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -156.17 -176.36 5.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.188 0.518 . . . . 0.0 111.403 -178.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 91' ' ' TRP . 8.4 pt-20 -133.17 161.18 35.12 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.691 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -113.69 -55.41 4.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.232 -179.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -122.95 -139.98 5.61 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.738 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.42 -83.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.609 2.206 . . . . 0.0 112.418 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.9 p -98.8 -0.36 42.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.906 0.384 . . . . 0.0 111.009 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -93.29 122.2 35.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.641 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -135.38 165.54 25.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.042 0.449 . . . . 0.0 111.297 -179.737 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -121.25 141.52 50.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.38 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.4 HG22 ' N ' ' A' ' 94' ' ' TYR . 1.3 mp -125.64 152.28 32.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.125 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.529 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 19.3 m-85 -118.82 111.54 18.55 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.719 179.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.695 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -124.45 120.99 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.078 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.967 ' HG3' ' HA ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -133.36 106.74 7.68 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.963 -172.577 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.525 ' HB ' ' HB2' ' A' ' 54' ' ' GLU . 22.0 t -56.58 113.09 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.767 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.5 mmtm . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.972 -179.535 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.15 0 N-CA-C 112.567 -0.213 . . . . 0.0 112.567 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.91 171.41 8.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.793 0.33 . . . . 0.0 111.02 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.93 -54.05 0.65 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.932 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -110.78 57.39 0.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.775 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -111.57 86.09 2.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.023 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.14 43.08 2.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.905 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -82.16 68.49 8.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.843 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -135.81 25.1 3.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.89 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -75.08 -3.66 33.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.956 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.6 t -85.75 24.03 1.32 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.5 t -61.23 -67.28 0.42 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.064 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.53 -107.53 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.467 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.406 ' HA ' HD13 ' A' ' 13' ' ' LEU . 1.7 mm? -80.55 142.93 33.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.773 0.32 . . . . 0.0 110.881 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.406 ' O ' HG11 ' A' ' 14' ' ' VAL . 2.8 p -84.82 116.91 67.4 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.097 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.5 147.24 82.0 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.6 2.2 . . . . 0.0 112.083 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -90.22 -86.61 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.783 179.556 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.29 74.23 2.47 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.419 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.445 ' H ' ' HG ' ' A' ' 18' ' ' SER . 3.8 p -81.09 -80.36 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.748 0.309 . . . . 0.0 111.083 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.44 -74.89 0.14 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.002 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.22 137.17 42.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.992 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.3 178.94 4.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.091 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -90.33 75.62 6.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.824 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -83.55 -175.56 5.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.382 0.61 . . . . 0.0 111.304 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -93.16 -156.68 0.49 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.399 178.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.788 HG21 ' HB2' ' A' ' 57' ' ' GLU . 1.5 p -52.75 129.42 13.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.505 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.6 m -99.77 -58.82 1.84 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.477 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.652 ' HB2' HD13 ' A' ' 56' ' ' LEU . 4.2 mptt -100.71 158.11 16.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.362 178.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.763 HG21 ' HB3' ' A' ' 57' ' ' GLU . 28.6 m -135.88 118.26 15.72 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.829 0.347 . . . . 0.0 111.6 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.9 tt -102.25 113.09 26.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.126 177.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.417 ' HB3' ' HB3' ' A' ' 59' ' ' TRP . 2.7 p-10 -132.29 116.2 16.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.188 -178.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.432 HG13 ' HB3' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -131.6 64.23 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.131 179.661 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.45 ' HG3' ' H ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -50.46 -81.64 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.061 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.45 ' H ' ' HG3' ' A' ' 32' ' ' ARG . . . -72.79 100.49 1.01 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.102 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -80.63 139.44 36.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.983 0.421 . . . . 0.0 111.338 -179.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.0 t -129.89 -115.59 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.547 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.565 ' O ' ' HD2' ' A' ' 39' ' ' PRO . 1.1 m -57.74 164.7 2.88 Favored Pre-proline 0 CA--C 1.53 0.184 0 N-CA-C 110.566 -0.161 . . . . 0.0 110.566 179.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -73.55 17.52 0.45 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.286 1.991 . . . . 0.0 112.704 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.486 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 15.4 t -61.41 -53.95 57.33 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.381 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.565 ' HD2' ' O ' ' A' ' 36' ' ' CYS . 38.3 Cg_endo -66.08 -22.81 54.2 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.124 1.883 . . . . 0.0 112.049 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -59.36 -52.8 64.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.559 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.2 t -74.31 -19.32 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.782 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -66.58 -60.83 2.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.028 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.3 t -59.97 -40.33 88.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.851 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.86 -37.25 78.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.983 0.421 . . . . 0.0 110.288 179.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.12 -30.99 71.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.719 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.61 -49.89 75.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.087 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.654 HD12 ' HA ' ' A' ' 68' ' ' ARG . 3.2 mm? -59.59 -35.42 74.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.007 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -81.26 -23.26 38.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.293 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -121.95 52.18 1.29 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.959 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.77 146.84 25.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.018 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.711 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -98.82 153.64 37.77 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.545 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.711 ' HD2' ' HG3' ' A' ' 51' ' ' LYS . 53.6 Cg_exo -38.77 -84.2 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.145 2.563 . . . . 0.0 113.794 -178.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 97' ' ' VAL . . . -104.28 59.33 0.47 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.97 -0.634 . . . . 0.0 113.046 -178.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -90.89 158.41 16.79 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.076 0.465 . . . . 0.0 111.753 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.673 HD12 ' HG3' ' A' ' 96' ' ' LYS . 0.1 OUTLIER -130.57 121.75 51.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.108 179.263 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.652 HD13 ' HB2' ' A' ' 27' ' ' LYS . 4.7 mp -129.29 163.86 24.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.221 0.534 . . . . 0.0 111.59 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.788 ' HB2' HG21 ' A' ' 25' ' ' VAL . 48.4 tt0 -121.04 158.1 28.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.809 178.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.8 t -136.56 115.75 15.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.894 0.378 . . . . 0.0 111.089 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.417 ' HB3' ' HB3' ' A' ' 30' ' ' ASP . 6.5 t90 -122.08 104.94 9.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.492 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.433 HD11 ' O ' ' A' ' 62' ' ' TYR . 1.0 OUTLIER -158.29 -174.31 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.656 -178.477 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -99.01 -23.68 15.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.933 178.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.433 ' O ' HD11 ' A' ' 60' ' ' ILE . 42.9 m-85 -115.27 112.24 44.08 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.372 178.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -47.22 99.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.816 2.344 . . . . 0.0 113.119 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.26 -26.66 65.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.544 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.717 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -63.27 -13.7 41.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.762 179.714 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.557 ' HG3' ' N ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -58.65 -32.06 68.74 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.436 179.243 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.557 ' N ' ' HG3' ' A' ' 66' ' ' LYS . 0.3 OUTLIER -94.52 -26.44 16.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.898 178.019 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.717 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 9.1 mtt85 -60.81 -39.39 88.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.066 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.685 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 6.9 mt -62.14 -55.87 36.62 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.543 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.685 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 84.0 Cg_exo -46.34 -39.56 21.69 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.304 2.003 . . . . 0.0 112.511 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.6 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 0.9 OUTLIER -68.64 -51.93 36.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.957 179.42 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.575 ' O ' ' HG2' ' A' ' 75' ' ' LYS . 1.7 m -60.46 -40.12 90.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.982 -178.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.532 HG11 ' O ' ' A' ' 69' ' ' ILE . 12.9 m -64.92 -30.24 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.856 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.442 ' N ' HG23 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -58.25 -43.09 87.68 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.539 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.646 ' HG3' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -90.26 -78.17 0.38 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.784 177.707 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.646 HD23 ' HG3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -99.38 -97.46 0.23 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.98 0.419 . . . . 0.0 110.596 178.399 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.502 ' O ' ' HB ' ' A' ' 72' ' ' THR . . . -145.01 -86.56 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.735 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.427 ' HB2' HG21 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -146.71 153.97 40.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.823 0.345 . . . . 0.0 110.824 178.799 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.799 ' HB2' HG22 ' A' ' 95' ' ' ILE . 0.6 OUTLIER -101.35 63.72 0.99 Allowed 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.087 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.459 ' H ' HG23 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -99.22 127.36 52.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.336 -177.54 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.512 ' HG ' ' HB3' ' A' ' 94' ' ' TYR . 1.0 OUTLIER -132.98 -36.41 1.03 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.719 179.528 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.458 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 0.7 OUTLIER -154.15 151.96 29.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.076 0.465 . . . . 0.0 111.951 179.245 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 82' ' ' GLU . 2.6 mp -144.18 134.99 21.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.268 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -158.66 -179.22 7.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.092 0.473 . . . . 0.0 111.267 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -133.57 167.47 20.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.664 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.74 -59.01 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.215 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -124.87 -151.86 8.16 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.682 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -63.01 -75.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.741 2.294 . . . . 0.0 112.593 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.56 -4.08 34.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.245 -179.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -93.2 123.83 36.75 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.433 178.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 2.9 m-90 -129.8 167.82 17.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.021 0.438 . . . . 0.0 111.394 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -123.5 132.99 54.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.598 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.532 HG23 ' HG ' ' A' ' 65' ' ' SER . 2.4 mt -125.48 146.85 30.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.69 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.56 ' HE2' HG13 ' A' ' 25' ' ' VAL . 36.4 m-85 -118.09 124.23 47.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.098 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.799 HG22 ' HB2' ' A' ' 79' ' ' GLU . 28.5 mm -123.91 148.53 28.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.291 -176.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.673 ' HG3' HD12 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -150.78 106.13 3.36 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.107 -177.463 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.448 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 1.7 t -59.86 119.28 3.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.638 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.188 -0.91 . . . . 0.0 110.887 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 N-CA-C 112.439 -0.264 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.99 -178.81 7.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.775 0.322 . . . . 0.0 110.815 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.1 p -98.74 149.98 22.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.9 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 -70.41 -38.72 74.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.931 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -68.27 116.4 8.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.005 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.09 157.82 42.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.835 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -86.51 59.54 5.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.939 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -138.45 -169.57 2.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.907 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -119.27 94.65 4.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.06 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.1 t -81.81 104.55 12.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.697 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.409 ' HB3' ' H ' ' A' ' 12' ' ' GLY . 7.3 t -78.82 -86.25 0.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.118 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.409 ' H ' ' HB3' ' A' ' 11' ' ' SER . . . -89.09 102.69 2.91 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.744 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 15.0 tp -95.54 52.89 1.41 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.941 0.401 . . . . 0.0 110.602 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.8 m -85.15 137.58 37.21 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.167 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.88 -154.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.531 2.154 . . . . 0.0 112.296 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.61 -84.35 0.11 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.025 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.11 140.7 21.68 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.581 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.03 -72.04 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.753 0.311 . . . . 0.0 110.829 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -111.8 -149.93 0.45 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.801 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.89 -60.67 2.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.094 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.57 -176.94 2.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.128 0.49 . . . . 0.0 111.367 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.73 -102.31 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.675 178.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -92.12 155.34 18.11 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.0 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.69 65.98 7.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.793 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.436 HG23 ' HE2' ' A' ' 94' ' ' TYR . 15.5 t -80.98 144.73 10.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.237 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.74 -70.3 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.037 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -118.6 162.73 17.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.86 0.362 . . . . 0.0 111.223 -179.763 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 92.3 m -135.64 129.0 32.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.856 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.5 tt -111.35 118.1 34.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.001 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.81 110.95 16.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.919 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.61 70.77 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.397 0.618 . . . . 0.0 110.977 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.474 ' HB3' ' H ' ' A' ' 33' ' ' GLY . 3.8 ttp180 -69.29 -92.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.855 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.474 ' H ' ' HB3' ' A' ' 32' ' ' ARG . . . -76.11 88.16 0.88 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.407 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -85.1 164.4 18.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.87 0.367 . . . . 0.0 111.039 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.508 HG12 ' H ' ' A' ' 36' ' ' CYS . 0.7 OUTLIER -134.68 -89.5 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.79 -179.793 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.531 ' O ' ' HD2' ' A' ' 39' ' ' PRO . 0.5 OUTLIER -58.9 158.2 17.52 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.782 179.826 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.81 7.17 3.68 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.847 2.365 . . . . 0.0 112.491 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.499 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 39.7 t -63.43 -54.08 46.95 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.612 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.531 ' HD2' ' O ' ' A' ' 36' ' ' CYS . 32.8 Cg_endo -63.37 -21.68 71.49 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.285 1.99 . . . . 0.0 112.055 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -62.91 -55.24 27.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.701 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.5 t -72.29 -22.4 20.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.781 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -62.97 -58.4 7.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.832 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.472 HG22 ' N ' ' A' ' 44' ' ' LYS . 15.3 t -61.44 -31.61 71.56 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.683 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.472 ' N ' HG22 ' A' ' 43' ' ' THR . 4.9 tptt -54.98 -45.47 75.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.509 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -33.58 76.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.013 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.94 -30.84 64.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.993 0.425 . . . . 0.0 110.791 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.3 mt -77.4 -57.2 3.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.301 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.16 -10.09 59.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.717 -178.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -131.23 67.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.855 0.359 . . . . 0.0 111.048 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.01 144.87 36.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.857 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.662 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 11.6 mttt -81.18 159.15 68.58 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.033 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.4 ' HB2' ' H ' ' A' ' 53' ' ' GLY . 100.0 Cg_exo -45.91 -75.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.939 2.426 . . . . 0.0 113.873 -178.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 97' ' ' VAL . . . -103.83 60.77 0.45 Allowed Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.144 -177.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.662 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 3.2 mm-40 -90.98 152.4 20.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.056 0.455 . . . . 0.0 111.72 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.416 HG21 ' HA ' ' A' ' 25' ' ' VAL . 3.5 mp -135.31 112.57 14.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.018 178.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.51 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.1 mp -126.27 151.69 47.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.228 0.537 . . . . 0.0 112.355 -177.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -113.31 124.64 52.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.376 176.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.0 t -114.32 134.31 57.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.136 0.493 . . . . 0.0 112.075 -177.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 13.7 t90 -123.0 106.76 11.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.325 178.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.03 -162.95 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.823 0.344 . . . . 0.0 111.267 -178.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -145.27 24.16 1.45 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.313 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.65 ' H ' ' HA ' ' A' ' 63' ' ' PRO . 29.3 m-85 -101.26 -56.14 0.13 Allowed Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 116.673 -0.239 . . . . 0.0 111.483 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.65 ' HA ' ' H ' ' A' ' 62' ' ' TYR . 76.7 Cg_endo -94.32 177.79 11.03 Favored 'Cis proline' 0 C--N 1.355 0.873 0 C-N-CA 124.796 -0.918 . . . . 0.0 112.294 -0.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -65.18 -21.45 66.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.755 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.628 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 30.4 t -63.6 -15.62 58.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.149 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.402 ' HG3' ' N ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -61.39 -34.13 74.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.978 -179.867 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.554 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -92.23 -23.43 19.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.225 0.536 . . . . 0.0 109.979 178.432 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.628 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 20.7 mtt-85 -63.41 -47.8 80.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.81 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.709 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 8.1 mt -51.04 -54.92 32.47 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.664 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.709 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 82.8 Cg_exo -48.64 -50.48 12.35 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.267 1.978 . . . . 0.0 112.959 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.44 -53.62 33.39 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.153 0.501 . . . . 0.0 111.637 -179.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.724 HG23 ' HA ' ' A' ' 78' ' ' HIS . 0.9 OUTLIER -56.41 -49.56 74.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.601 -178.245 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.631 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 18.2 m -64.75 -21.16 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 120.607 0.241 . . . . 0.0 111.198 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.35 -55.27 37.22 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.781 ' HG2' ' H ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -91.1 -61.28 1.7 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.942 177.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.781 ' H ' ' HG2' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -100.45 -109.09 0.21 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.042 0.448 . . . . 0.0 110.526 176.565 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.631 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -144.97 -87.63 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 178.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.724 ' HA ' HG23 ' A' ' 72' ' ' THR . 0.2 OUTLIER -148.14 150.6 34.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.642 0.258 . . . . 0.0 110.762 177.499 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.707 ' HB2' ' H ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -97.81 74.2 2.34 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.14 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.56 123.86 51.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.997 0.427 . . . . 0.0 111.831 -176.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.478 ' HG ' ' N ' ' A' ' 82' ' ' GLU . 0.6 OUTLIER -133.45 -35.59 1.01 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.669 179.076 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.628 ' HB3' ' HB2' ' A' ' 94' ' ' TYR . 0.3 OUTLIER -153.69 149.01 27.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.618 179.377 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 82' ' ' GLU . 2.2 mp -142.62 133.41 23.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.625 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.569 ' HG3' ' HB3' ' A' ' 92' ' ' LYS . 8.4 pt-20 -158.07 -177.46 6.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.078 0.466 . . . . 0.0 111.219 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -133.39 167.21 20.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.817 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.7 t -124.63 -66.95 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.205 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -124.34 -154.41 8.87 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.567 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.16 -71.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.632 2.221 . . . . 0.0 112.325 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.2 0.19 39.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.093 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.3 132.52 37.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.774 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 -138.92 159.62 41.7 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.929 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.569 ' HB3' ' HG3' ' A' ' 84' ' ' GLU . 24.5 ttmt -124.37 126.4 45.92 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.344 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.6 mp -125.33 149.87 30.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.967 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.628 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 8.6 m-85 -118.15 129.98 55.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.369 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.607 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -123.69 148.88 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.166 -178.068 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.707 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -150.83 104.73 3.2 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.582 -178.298 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.51 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 3.1 t -62.96 119.05 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.26 178.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.1 mttt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.058 -179.509 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.5 t . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.787 0.327 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.438 HG21 ' OE1' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -99.6 -65.21 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.078 -179.568 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.11 169.77 9.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.097 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.755 HG23 ' HB3' ' A' ' 57' ' ' GLU . 83.3 m -135.51 130.85 35.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.808 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.1 tp -106.37 113.08 26.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.845 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.68 123.33 42.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.888 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.4 47.62 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.079 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.44 ' H ' ' HG3' ' A' ' 32' ' ' ARG . 14.4 mtm180 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.752 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.549 ' O ' HD22 ' A' ' 47' ' ' LEU . 7.2 t . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.799 0.333 . . . . 0.0 110.694 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 48' ' ' GLN . 5.3 mmtt -56.79 -41.89 78.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.514 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.62 -30.74 71.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.946 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 43' ' ' THR . . . -56.53 -54.34 47.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.967 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.793 ' HB3' ' HG2' ' A' ' 71' ' ' GLU . 0.4 OUTLIER -77.24 -37.31 53.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.768 -179.492 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.474 ' HB3' ' O ' ' A' ' 44' ' ' LYS . 1.4 tt0 -68.14 -31.18 70.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.396 -178.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -134.96 72.18 1.45 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.064 0.459 . . . . 0.0 110.932 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.18 140.73 31.53 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.846 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.538 ' HG2' ' HD2' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -94.17 151.48 39.61 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.778 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.538 ' HD2' ' HG2' ' A' ' 51' ' ' LYS . 50.0 Cg_exo -38.23 -86.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.366 2.71 . . . . 0.0 114.027 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.439 ' H ' ' HB2' ' A' ' 52' ' ' PRO . . . -103.89 59.05 0.5 Allowed Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.989 -0.624 . . . . 0.0 113.124 -177.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.438 ' OE1' HG21 ' A' ' 26' ' ' THR . 2.8 mm-40 -90.7 156.42 18.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.104 0.478 . . . . 0.0 111.705 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.442 HG23 ' HB2' ' A' ' 96' ' ' LYS . 3.4 mp -135.05 117.75 22.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.992 178.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.6 mp -122.77 164.05 19.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.209 0.528 . . . . 0.0 111.753 -178.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.755 ' HB3' HG23 ' A' ' 28' ' ' THR . 37.2 tt0 -114.38 161.27 18.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.131 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.1 t -142.7 113.92 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.808 0.337 . . . . 0.0 111.221 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.6 103.25 8.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.786 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -158.11 -166.19 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.029 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -103.04 -2.5 27.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.015 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -137.58 148.12 60.13 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.927 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.69 104.4 1.88 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.601 2.201 . . . . 0.0 112.624 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 8.4 tpp -68.1 -19.95 64.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.108 0.48 . . . . 0.0 110.617 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.819 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 3.6 p -58.85 -10.84 2.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.215 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.44 ' HG3' ' H ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -56.75 -44.69 81.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.789 0.328 . . . . 0.0 110.727 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.534 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 0.7 OUTLIER -86.64 -24.88 25.15 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.085 0.469 . . . . 0.0 110.055 178.398 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.819 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 1.0 OUTLIER -61.69 -41.34 97.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.233 179.565 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.745 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 12.9 mt -54.59 -56.67 24.54 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.745 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 76.1 Cg_exo -51.87 -36.96 65.38 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.288 1.992 . . . . 0.0 112.682 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.793 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 0.6 OUTLIER -71.92 -64.46 0.93 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.782 0.325 . . . . 0.0 111.66 -179.2 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.47 HG21 ' HG2' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -55.9 -30.6 61.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.555 -178.515 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 70' ' ' PRO . 6.6 p -73.47 -28.89 26.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.905 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.4 tptp -58.57 -42.11 87.23 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.45 -77.51 0.4 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.226 177.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.597 HD13 ' HB2' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -98.79 -98.52 0.22 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.786 178.358 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.34 -79.71 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.249 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.68 157.32 43.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.803 0.335 . . . . 0.0 111.014 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.7 ' HB2' ' H ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -101.18 55.89 0.84 Allowed 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.135 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.6 p -98.31 123.49 50.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.269 -176.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.489 ' HG ' ' N ' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -133.31 -36.12 1.0 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.186 -179.687 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.525 ' HB3' ' HB2' ' A' ' 94' ' ' TYR . 0.5 OUTLIER -153.51 145.49 23.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.999 0.428 . . . . 0.0 111.826 -179.711 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.502 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 3.0 mp -142.44 136.11 27.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.414 178.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -157.47 179.04 9.63 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.038 0.447 . . . . 0.0 111.421 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -133.67 166.14 23.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.854 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.3 t -127.28 -64.4 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.133 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -124.83 -147.14 7.02 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.825 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -60.81 -77.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.757 2.305 . . . . 0.0 112.616 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.2 -1.74 35.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.419 -178.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.458 ' HG2' ' H ' ' A' ' 90' ' ' GLU . 0.7 OUTLIER -93.26 120.26 33.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.746 179.442 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 7.0 m0 -130.46 166.08 21.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.904 0.383 . . . . 0.0 111.187 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -127.04 129.91 48.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.612 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.7 mp -125.79 149.52 30.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.296 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.525 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 9.3 m-85 -118.68 127.97 54.07 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.202 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.646 HG13 ' HB2' ' A' ' 79' ' ' GLU . 1.1 tp -124.49 149.81 28.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.519 -177.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.7 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -151.11 109.47 3.78 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 120.523 -0.471 . . . . 0.0 112.132 -178.455 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.404 ' H ' HG23 ' A' ' 97' ' ' VAL . 2.1 t -64.41 111.16 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.266 178.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.597 ' HB2' HD13 ' A' ' 76' ' ' LEU . 16.5 mmtt . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.097 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 87.5 t . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.766 0.317 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.17 -48.2 4.7 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.945 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -121.33 148.57 44.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.098 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.3 m -132.98 140.86 47.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.825 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.641 ' HB3' HG13 ' A' ' 58' ' ' VAL . 12.6 tp -112.03 110.98 21.58 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.905 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.52 ' HB3' ' HE1' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -104.86 113.34 26.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.741 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.09 61.6 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.274 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.495 ' H ' ' HG3' ' A' ' 32' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.332 179.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.3 t . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.665 0.269 . . . . 0.0 110.81 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.05 -41.56 68.25 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.839 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 45' ' ' ARG . 3.5 tmm_? -67.95 -32.56 73.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.801 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.54 -49.38 77.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.207 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.831 ' HB3' ' HG2' ' A' ' 71' ' ' GLU . 2.5 mm? -58.67 -42.72 89.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.063 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -75.54 -15.5 60.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.036 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 45' ' ' ARG . 0.6 OUTLIER -118.19 61.68 0.77 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.92 -179.871 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 10.1 mmt -108.32 146.76 32.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.859 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.654 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 2.2 mtpp -102.81 164.21 16.04 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.767 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.625 ' HD2' ' HB3' ' A' ' 51' ' ' LYS . 2.2 Cg_endo -46.2 -73.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.119 2.546 . . . . 0.0 113.398 -178.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.27 58.78 0.49 Allowed Glycine 0 C--N 1.329 0.192 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.278 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.654 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 3.8 mm-40 -90.34 151.35 21.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.09 0.472 . . . . 0.0 111.525 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.564 ' C ' HD13 ' A' ' 56' ' ' LEU . 3.7 mp -134.75 113.51 16.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.815 178.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.564 HD13 ' C ' ' A' ' 55' ' ' ILE . 0.4 OUTLIER -118.71 145.35 45.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.164 0.506 . . . . 0.0 111.846 -176.825 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -111.07 135.49 51.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.987 177.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.641 HG13 ' HB3' ' A' ' 29' ' ' LEU . 2.0 t -134.82 126.5 47.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.52 ' HE1' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -122.97 115.33 21.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.879 176.973 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.476 HG13 ' C ' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -147.42 -170.52 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.303 -178.027 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.02 -11.71 16.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.419 178.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.425 ' O ' HD13 ' A' ' 60' ' ' ILE . 64.9 m-85 -129.76 143.92 50.95 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.55 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.88 93.73 0.39 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.532 2.155 . . . . 0.0 112.481 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.06 -16.33 63.98 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.042 0.448 . . . . 0.0 110.585 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.406 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -62.04 -15.58 45.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.793 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.503 ' HG3' ' N ' ' A' ' 67' ' ' GLU . 1.2 ptpp? -57.58 -32.88 67.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.772 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.503 ' N ' ' HG3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -94.54 -27.95 15.68 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.169 0.509 . . . . 0.0 110.401 178.737 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.675 ' HG2' HD11 ' A' ' 47' ' ' LEU . 54.3 mtt-85 -65.78 -32.68 74.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.175 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.499 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 26.6 mt -63.62 -55.33 35.31 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.553 ' O ' HG12 ' A' ' 73' ' ' VAL . 12.2 Cg_endo -56.97 -32.23 92.22 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.182 1.921 . . . . 0.0 112.566 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.831 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 0.4 OUTLIER -74.13 -60.83 2.09 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.873 0.368 . . . . 0.0 111.296 -179.818 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.669 HG21 ' HG2' ' A' ' 79' ' ' GLU . 0.2 OUTLIER -61.26 -25.0 66.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.314 -179.028 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' ' 70' ' ' PRO . 4.5 p -75.23 -28.95 21.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.274 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.46 -43.51 88.89 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.463 ' CG ' ' H ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -86.85 -78.18 0.3 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.164 176.7 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.518 HD12 ' H ' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -98.73 -98.59 0.22 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.848 0.356 . . . . 0.0 110.659 177.947 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.518 ' H ' HD12 ' A' ' 76' ' ' LEU . . . -145.28 -80.98 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.865 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -146.2 149.64 34.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.889 0.376 . . . . 0.0 110.922 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.669 ' HG2' HG21 ' A' ' 72' ' ' THR . 0.0 OUTLIER -97.87 58.93 1.42 Allowed 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.018 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.568 HG23 HD11 ' A' ' 83' ' ' ILE . 1.4 p -98.9 125.84 52.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.022 -177.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.531 ' HG ' ' N ' ' A' ' 82' ' ' GLU . 0.6 OUTLIER -133.53 -35.79 0.99 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.043 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.531 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -153.52 144.61 22.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.985 0.421 . . . . 0.0 111.906 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.568 HD11 HG23 ' A' ' 80' ' ' VAL . 3.5 mp -143.96 128.55 14.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.346 178.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -149.87 -178.25 6.36 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.239 0.542 . . . . 0.0 111.552 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.519 ' HB3' ' HD1' ' A' ' 91' ' ' TRP . 0.9 OUTLIER -133.2 163.67 28.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.616 -179.738 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 56.9 t -124.65 -73.76 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.427 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -122.73 -139.37 5.51 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.795 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.408 ' HB2' ' H ' ' A' ' 89' ' ' SER . 37.1 Cg_exo -60.82 -82.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.557 2.171 . . . . 0.0 112.5 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.408 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 59.9 p -100.15 1.51 42.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.249 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.51 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 1.2 pt-20 -93.15 119.51 32.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.747 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.519 ' HD1' ' HB3' ' A' ' 85' ' ' GLU . 4.4 m-90 -132.24 164.99 25.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.92 0.391 . . . . 0.0 111.112 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.96 140.71 51.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.795 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.1 mp -136.76 143.78 34.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.974 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.463 ' HB3' ' HG ' ' A' ' 81' ' ' LEU . 12.3 m-85 -118.54 127.56 53.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.379 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.656 HG23 ' HB2' ' A' ' 79' ' ' GLU . 32.8 mm -124.86 144.94 33.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.26 -177.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.616 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -152.12 111.2 3.86 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.157 -0.617 . . . . 0.0 112.156 -178.441 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 t -63.69 121.39 12.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.56 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.2 tttp . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.006 -179.913 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.3 t . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.748 0.309 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.51 -52.22 3.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.508 -178.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.482 ' HB2' HD22 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -120.88 149.89 41.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.905 0.384 . . . . 0.0 111.462 -178.946 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 83.2 m -129.12 122.58 30.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.699 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 2.9 tt -109.23 125.37 52.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.081 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -130.79 123.39 29.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.726 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.523 ' HB ' HG21 ' A' ' 60' ' ' ILE . 8.4 t -118.45 64.3 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.128 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 32' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.099 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.602 ' O ' HD13 ' A' ' 47' ' ' LEU . 14.6 t . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.762 0.315 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.98 -46.95 87.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.968 0.413 . . . . 0.0 110.451 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.39 -31.65 72.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.878 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.25 -43.45 86.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.047 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.602 HD13 ' O ' ' A' ' 43' ' ' THR . 1.2 mp -58.77 -39.26 80.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.744 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.417 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 1.5 tt0 -81.2 -23.29 38.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.944 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -119.12 62.18 0.8 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.63 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.744 ' HB2' HG21 ' A' ' 97' ' ' VAL . 12.4 ptp -103.65 145.32 30.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.593 178.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.923 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 10.7 mttm -90.73 160.09 39.29 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.178 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 51' ' ' LYS . 86.3 Cg_exo -43.7 -70.78 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.098 2.532 . . . . 0.0 113.901 -178.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.46 59.79 0.45 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.9 -0.667 . . . . 0.0 113.264 -178.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.923 ' HG3' ' HB2' ' A' ' 51' ' ' LYS . 7.2 mt-10 -90.89 151.41 21.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.02 0.438 . . . . 0.0 111.572 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.683 HG12 ' HG3' ' A' ' 96' ' ' LYS . 7.4 mt -135.66 103.7 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.114 178.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.482 HD22 ' HB2' ' A' ' 27' ' ' LYS . 8.9 mt -118.73 160.51 21.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.072 0.463 . . . . 0.0 111.659 -177.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -130.6 139.64 50.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.365 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.514 HG12 HG12 ' A' ' 60' ' ' ILE . 11.7 t -120.04 136.45 57.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.136 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -122.57 110.8 16.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.677 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.607 HD11 ' HB2' ' A' ' 64' ' ' MET . 0.4 OUTLIER -158.66 -177.75 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.581 -179.428 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 89' ' ' SER . 19.0 m-20 -97.68 2.38 49.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.72 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -139.22 149.63 61.58 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.566 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.76 95.64 1.08 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.488 2.125 . . . . 0.0 112.856 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.607 ' HB2' HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -68.22 -15.43 63.57 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.172 0.51 . . . . 0.0 110.539 178.963 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.736 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 23.9 p -61.34 -12.2 12.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.719 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.3 pttm -56.36 -36.05 68.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.899 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.565 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.8 OUTLIER -94.25 -27.39 16.17 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.218 0.532 . . . . 0.0 110.018 178.209 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.736 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 4.7 mtt85 -61.91 -37.14 83.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.008 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.713 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 14.7 mt -62.15 -55.83 36.88 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.369 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.713 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 83.3 Cg_exo -47.19 -37.43 23.71 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.447 2.098 . . . . 0.0 112.717 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.509 ' HG3' ' HB3' ' A' ' 47' ' ' LEU . 15.7 mm-40 -70.86 -54.05 12.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.056 0.455 . . . . 0.0 111.106 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.597 ' HB ' ' O ' ' A' ' 77' ' ' GLY . 0.6 OUTLIER -60.75 -38.23 84.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.771 -178.605 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 69' ' ' ILE . 20.2 m -67.5 -27.84 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-O 120.688 0.28 . . . . 0.0 110.84 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.04 -43.98 87.11 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.547 ' HG2' ' O ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -90.2 -78.36 0.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.483 176.85 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.57 -97.37 0.24 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.967 0.413 . . . . 0.0 110.954 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.597 ' O ' ' HB ' ' A' ' 72' ' ' THR . . . -144.89 -84.33 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.195 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.95 152.65 39.75 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 122.723 -0.281 . . . . 0.0 110.778 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.772 ' HB2' ' H ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -96.96 71.27 2.47 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.034 0.445 . . . . 0.0 109.849 179.609 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.473 ' CG1' HD11 ' A' ' 83' ' ' ILE . 1.6 t -98.58 122.04 49.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.575 -177.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.522 ' HG ' ' N ' ' A' ' 82' ' ' GLU . 0.5 OUTLIER -133.53 -37.85 0.93 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.174 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.522 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -153.56 141.98 20.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.003 0.43 . . . . 0.0 111.866 -179.701 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.473 HD11 ' CG1' ' A' ' 80' ' ' VAL . 2.7 mt -143.53 129.93 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.222 178.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.426 ' OE2' ' HE2' ' A' ' 92' ' ' LYS . 4.8 pt-20 -156.78 179.77 8.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.184 0.516 . . . . 0.0 111.689 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -133.55 159.56 40.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.413 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.9 t -120.8 -66.97 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.398 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -122.84 -145.43 6.92 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.666 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.428 ' HD2' ' OE2' ' A' ' 90' ' ' GLU . 46.2 Cg_exo -56.44 -82.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.672 2.248 . . . . 0.0 112.509 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 61' ' ' ASP . 61.8 p -100.07 -3.75 31.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.831 0.348 . . . . 0.0 111.151 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.489 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -86.05 117.72 25.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.669 179.743 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 2.9 m-90 -130.83 164.21 25.68 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.1 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.426 ' HE2' ' OE2' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -124.28 129.51 50.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.537 179.538 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -125.8 143.39 39.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.002 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.507 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 13.6 m-85 -118.95 129.59 55.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.675 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.643 HG21 ' HE ' ' A' ' 68' ' ' ARG . 1.0 OUTLIER -124.13 149.03 28.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.68 -179.051 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.772 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -150.85 109.97 3.93 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.289 -0.564 . . . . 0.0 112.161 -178.117 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.744 HG21 ' HB2' ' A' ' 50' ' ' MET . 10.8 t -62.75 118.86 5.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.262 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.487 ' HG2' ' HD3' ' A' ' 96' ' ' LYS . 6.9 mtmt . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.986 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 80.6 t . . . . . 0 CA--C 1.529 0.143 0 CA-C-O 120.624 0.25 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -98.82 -66.0 0.93 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.964 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -105.53 148.24 27.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.892 0.377 . . . . 0.0 110.941 179.6 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.607 HG23 ' HG2' ' A' ' 57' ' ' GLU . 86.4 m -133.9 110.47 9.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.863 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.5 tt -100.15 100.87 11.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.87 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -119.46 99.89 6.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.575 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 31' ' ' VAL . 7.1 p -132.9 70.06 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.457 0.646 . . . . 0.0 111.179 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.794 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.464 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 2.2 t . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.687 0.279 . . . . 0.0 111.019 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -56.23 -45.16 80.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.89 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.47 -33.09 75.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.707 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.65 -36.89 85.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.192 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 43' ' ' THR . 4.9 mt -65.55 -43.33 90.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.693 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -71.81 -26.57 62.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.481 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -117.26 57.08 0.81 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.998 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.3 ptm -96.01 150.06 20.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.855 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 5.6 mttt -104.24 156.35 35.91 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.872 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.05 -55.41 3.91 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.004 2.469 . . . . 0.0 113.277 -178.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.21 59.57 0.47 Allowed Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.844 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.855 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 3.6 mm-40 -90.8 146.39 23.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.041 0.448 . . . . 0.0 111.779 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.3 mt -135.53 102.53 3.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.894 177.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.428 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -119.89 143.86 47.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.04 0.447 . . . . 0.0 112.031 -177.635 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.607 ' HG2' HG23 ' A' ' 28' ' ' THR . 2.8 pt-20 -118.62 130.97 56.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.448 176.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.429 HG21 HH12 ' A' ' 68' ' ' ARG . 2.6 t -114.77 129.49 70.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.016 0.436 . . . . 0.0 111.906 -177.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.488 ' HE1' HG21 ' A' ' 86' ' ' VAL . 1.4 t90 -122.44 106.39 11.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.349 178.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.501 HD13 ' O ' ' A' ' 62' ' ' TYR . 1.0 OUTLIER -158.29 -163.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.439 -178.874 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -109.41 -34.49 6.52 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.664 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.501 ' O ' HD13 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -102.08 114.47 65.49 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.625 179.545 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.85 97.49 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.535 2.157 . . . . 0.0 112.429 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.9 mtt -68.3 -11.17 59.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.943 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.595 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.5 OUTLIER -61.57 -15.11 35.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.993 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -32.74 71.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.036 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.581 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 1.0 OUTLIER -94.22 -27.95 15.89 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.191 0.519 . . . . 0.0 110.365 178.883 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.595 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 14.3 mtt85 -62.88 -38.0 89.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.894 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.725 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 17.0 mt -59.37 -55.79 42.51 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.686 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 72.6 Cg_exo -50.21 -38.85 52.03 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.307 2.005 . . . . 0.0 112.781 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.561 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -68.56 -56.38 8.48 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.957 0.408 . . . . 0.0 111.518 -179.285 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.722 HG21 ' HG3' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -58.96 -45.58 90.17 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.269 -178.978 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 70' ' ' PRO . 8.2 p -58.69 -28.67 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.682 -0.236 . . . . 0.0 110.939 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.561 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 5.1 mmtt -58.42 -42.99 88.5 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 176.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.549 ' HB3' HD13 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -87.38 -82.84 0.21 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.872 176.22 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.795 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -98.59 -106.32 0.2 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.274 177.071 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.486 ' H ' HD23 ' A' ' 76' ' ' LEU . . . -134.87 -83.15 0.18 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.104 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.07 170.71 16.59 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.78 0.324 . . . . 0.0 111.071 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.885 ' HB2' HG13 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -110.09 72.77 0.81 Allowed 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.964 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.39 117.51 43.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.491 -176.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.55 ' HG ' ' N ' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -133.73 -40.69 0.86 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.092 179.715 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.585 ' HB3' ' HB2' ' A' ' 94' ' ' TYR . 0.3 OUTLIER -153.85 144.98 22.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.027 0.441 . . . . 0.0 111.924 -179.743 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.537 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 3.4 mp -144.04 130.65 16.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.275 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -149.78 178.57 8.76 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.042 0.448 . . . . 0.0 111.428 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.6 pm0 -133.35 159.07 41.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.663 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.488 HG21 ' HE1' ' A' ' 59' ' ' TRP . 4.6 t -124.28 -63.37 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.284 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -126.87 -144.7 6.1 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.654 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.429 ' HB2' ' H ' ' A' ' 89' ' ' SER . 37.3 Cg_exo -61.37 -82.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.601 2.201 . . . . 0.0 112.416 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.429 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 2.1 p -98.59 -1.33 41.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.025 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -92.93 116.28 28.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.511 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 4.2 m-90 -130.65 167.59 18.52 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.983 0.42 . . . . 0.0 111.37 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.7 128.52 49.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.29 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.8 mp -125.67 146.15 31.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.172 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.585 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 24.8 m-85 -118.81 123.84 45.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.576 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.885 HG13 ' HB2' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -124.79 144.68 33.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.848 -179.112 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.66 ' H ' ' HB3' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -150.77 115.86 5.32 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.961 -178.793 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.416 ' HA ' ' HG2' ' A' ' 79' ' ' GLU . 15.0 t -65.69 125.67 23.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.359 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.8 tttp . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.004 -179.486 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.7 t . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.826 0.346 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.4 m -99.61 -62.06 1.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.933 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -118.56 158.63 25.05 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.011 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.7 m -127.45 151.72 48.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.865 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.2 tt -131.52 121.04 23.8 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.25 119.0 31.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.532 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.686 HG23 HG23 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -124.33 19.67 4.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.553 -179.093 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.667 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.405 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 15.0 t . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.668 0.27 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.16 -43.04 73.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.949 0.404 . . . . 0.0 110.544 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.511 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 0.2 OUTLIER -64.09 -31.31 72.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.796 179.048 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.461 ' HB3' HH12 ' A' ' 68' ' ' ARG . . . -60.62 -48.7 80.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.335 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.564 ' HG ' ' HG3' ' A' ' 71' ' ' GLU . 2.2 mm? -59.06 -42.65 90.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.051 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -81.14 9.79 6.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.443 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.511 ' HB2' ' O ' ' A' ' 45' ' ' ARG . 0.9 OUTLIER -135.07 32.97 3.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.785 0.326 . . . . 0.0 111.202 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.838 ' HB3' HG21 ' A' ' 97' ' ' VAL . 26.0 mtt -109.18 143.61 38.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.122 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.779 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 23.0 mttp -95.41 163.15 22.3 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 51' ' ' LYS . 74.1 Cg_exo -41.83 -69.03 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.01 2.473 . . . . 0.0 113.508 -178.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 97' ' ' VAL . . . -103.95 56.91 0.56 Allowed Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.023 -178.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.779 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 14.4 mm-40 -90.92 157.17 17.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.001 0.429 . . . . 0.0 111.815 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.53 HG13 ' HG3' ' A' ' 96' ' ' LYS . 3.0 mp -135.04 110.31 12.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.973 178.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.528 HD13 ' C ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -118.74 148.22 43.03 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.164 0.506 . . . . 0.0 111.985 -177.243 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -111.69 135.31 52.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.863 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 t -125.78 144.22 36.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.114 0.483 . . . . 0.0 112.006 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.451 ' C ' HG13 ' A' ' 60' ' ' ILE . 18.4 t90 -131.04 107.93 9.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.235 178.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.686 HG23 HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -144.24 -166.64 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.009 -178.875 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -145.13 27.47 1.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.144 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.73 ' H ' ' HA ' ' A' ' 63' ' ' PRO . 1.2 m-85 -101.06 -56.34 0.13 Allowed Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.368 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.73 ' HA ' ' H ' ' A' ' 62' ' ' TYR . 72.1 Cg_endo -94.19 171.24 17.49 Favored 'Cis proline' 0 C--N 1.356 0.949 0 C-N-CA 124.912 -0.87 . . . . 0.0 112.374 -0.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.654 ' H ' HD13 ' A' ' 60' ' ' ILE . 6.0 tpp -68.32 -26.35 65.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.356 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.654 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -59.71 -17.44 34.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.188 -179.405 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.7 pttp -59.73 -34.8 73.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.629 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.571 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 4.9 mt-10 -90.21 -22.55 21.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.169 0.509 . . . . 0.0 110.222 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.654 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 0.4 OUTLIER -62.03 -46.4 89.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.041 179.318 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.723 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 5.1 mt -54.52 -54.6 46.9 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.723 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 75.1 Cg_exo -51.36 -37.05 59.98 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.412 2.075 . . . . 0.0 112.61 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.564 ' HG3' ' HG ' ' A' ' 47' ' ' LEU . 4.8 tm-20 -71.24 -58.17 3.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.866 0.365 . . . . 0.0 111.525 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.763 HG21 ' HG2' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -58.89 -31.9 69.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.463 -178.815 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.529 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 8.6 p -73.52 -26.46 22.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.709 0.29 . . . . 0.0 110.731 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.69 -46.53 87.08 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.441 ' HG2' ' H ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -88.7 -74.32 0.47 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.565 177.463 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.505 HD11 HG22 ' A' ' 72' ' ' THR . 0.0 OUTLIER -98.21 -102.31 0.2 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.85 0.357 . . . . 0.0 110.482 178.19 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.27 -85.51 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.866 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.534 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -147.6 155.74 42.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.731 0.3 . . . . 0.0 111.076 178.792 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.763 ' HG2' HG21 ' A' ' 72' ' ' THR . 0.0 OUTLIER -103.87 69.24 0.95 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 177.396 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.535 HG12 HD11 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -98.67 121.52 49.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.88 -175.894 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.759 HD22 ' HB3' ' A' ' 96' ' ' LYS . 1.5 pt? -139.71 -35.5 0.53 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.677 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.613 ' HB3' ' HB2' ' A' ' 94' ' ' TYR . 0.8 OUTLIER -153.01 142.55 21.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.19 0.519 . . . . 0.0 112.009 179.574 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.535 HD11 HG12 ' A' ' 80' ' ' VAL . 3.7 mp -144.19 135.87 22.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.263 178.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -157.79 179.87 8.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.073 0.463 . . . . 0.0 111.28 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -133.5 161.25 35.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.555 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.0 t -120.7 -62.83 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.318 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.453 ' H ' ' HG3' ' A' ' 90' ' ' GLU . . . -125.37 -146.52 6.77 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.787 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.425 ' HB2' ' H ' ' A' ' 89' ' ' SER . 43.2 Cg_exo -57.11 -83.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.768 2.312 . . . . 0.0 112.513 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.425 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -95.73 -3.09 46.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.876 0.37 . . . . 0.0 111.184 -179.376 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.453 ' HG3' ' H ' ' A' ' 87' ' ' GLY . 5.5 pt-20 -93.16 133.89 35.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.713 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.11 168.81 20.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.929 0.395 . . . . 0.0 111.09 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.3 mttt -120.74 128.11 52.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.534 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.4 mp -125.28 145.11 33.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.885 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.613 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 13.0 m-85 -118.17 129.05 55.29 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.441 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.607 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -123.97 142.14 41.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.291 -179.697 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.759 ' HB3' HD22 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -144.04 110.57 5.56 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.755 -176.752 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.838 HG21 ' HB3' ' A' ' 50' ' ' MET . 3.2 t -61.26 118.48 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.314 178.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.59 ' HE3' ' HD3' ' A' ' 96' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.937 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.6 t . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.79 0.328 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.73 -56.62 2.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.134 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.467 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -113.4 139.53 48.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.085 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.3 m -133.85 117.47 16.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.802 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 11.7 tp -109.92 115.41 29.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.033 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.702 ' HB3' ' HB3' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -132.9 102.11 5.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.705 179.774 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 31' ' ' VAL . 7.2 p -140.85 75.04 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.298 0.57 . . . . 0.0 111.19 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.441 HH11 ' HD3' ' A' ' 32' ' ' ARG . 2.1 mtp180 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.001 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.455 ' O ' HD13 ' A' ' 47' ' ' LEU . 11.9 t . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.766 0.317 . . . . 0.0 110.678 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.72 -43.45 90.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.316 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -65.24 -39.54 92.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.81 178.919 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.46 -31.39 65.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.967 0.413 . . . . 0.0 110.52 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 43' ' ' THR . 2.9 mp -77.62 -51.73 10.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.486 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -81.46 -3.34 52.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.195 -177.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -134.96 71.2 1.44 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.822 0.344 . . . . 0.0 110.915 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.788 ' HB3' HG21 ' A' ' 97' ' ' VAL . 11.9 mtm -106.62 137.79 43.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.013 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.834 ' HG2' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -92.56 150.73 40.34 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.301 178.817 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.834 ' HD2' ' HG2' ' A' ' 51' ' ' LYS . 56.1 Cg_exo -37.28 -70.19 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.249 2.633 . . . . 0.0 113.992 -178.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.53 60.74 0.42 Allowed Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.121 -178.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.511 ' HG2' ' HB3' ' A' ' 51' ' ' LYS . 4.5 mm-40 -90.53 147.54 23.3 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.089 0.471 . . . . 0.0 111.753 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.516 HG23 ' HB2' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -130.84 114.65 27.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.065 178.418 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.467 HD22 ' HB3' ' A' ' 27' ' ' LYS . 4.0 mt -119.56 151.35 38.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.314 0.578 . . . . 0.0 112.095 -177.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -124.25 121.4 34.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.582 177.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.526 HG12 HG12 ' A' ' 60' ' ' ILE . 4.5 t -114.31 139.3 40.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.069 0.461 . . . . 0.0 111.987 -177.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.702 ' HB3' ' HB3' ' A' ' 30' ' ' ASP . 6.3 t90 -133.33 107.23 7.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.372 178.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.526 HG12 HG12 ' A' ' 58' ' ' VAL . 0.9 OUTLIER -156.95 -166.77 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.278 -178.814 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -111.52 -2.2 15.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.934 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.452 ' O ' HD12 ' A' ' 60' ' ' ILE . 3.3 m-85 -131.08 126.65 21.69 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.841 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 62' ' ' TYR . 31.8 Cg_exo -58.91 98.63 0.1 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.477 2.118 . . . . 0.0 112.377 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.484 ' HB3' ' NH1' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -67.98 -17.6 64.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.021 0.439 . . . . 0.0 110.885 179.637 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.516 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 5.1 p -64.0 -11.15 26.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.897 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.7 pttt -60.05 -39.67 86.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.981 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.554 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 6.1 mt-10 -89.93 -26.24 20.52 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.25 0.548 . . . . 0.0 110.207 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.516 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 28.7 mtt85 -63.71 -43.06 97.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.993 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.724 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 24.1 mt -51.83 -55.63 28.51 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.695 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.724 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 53.1 Cg_exo -53.18 -40.74 76.27 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.189 1.926 . . . . 0.0 112.603 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -61.04 2.19 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.965 0.412 . . . . 0.0 111.534 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.874 HG21 ' HG3' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -57.14 -43.58 82.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.63 -178.546 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 70' ' ' PRO . 9.8 p -58.84 -30.04 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.784 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -58.65 -40.36 83.2 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.679 ' HB3' HD13 ' A' ' 76' ' ' LEU . 2.0 mtpt -87.97 -84.86 0.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.875 176.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.815 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -98.46 -105.21 0.2 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.221 176.833 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.492 ' H ' HD23 ' A' ' 76' ' ' LEU . . . -132.93 -83.64 0.23 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.083 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.481 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -146.96 168.79 20.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.869 0.366 . . . . 0.0 111.25 179.613 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.95 ' HB2' HG23 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -110.26 61.07 0.6 Allowed 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.702 178.942 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.546 HG12 HD11 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -98.43 122.53 50.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.242 -177.533 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.505 HD12 ' HB2' ' A' ' 82' ' ' GLU . 1.1 pp -133.64 -37.86 0.92 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.274 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.505 ' HB2' HD12 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -153.11 147.99 26.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.992 0.425 . . . . 0.0 111.9 -179.748 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.546 HD11 HG12 ' A' ' 80' ' ' VAL . 3.7 mp -144.15 132.96 18.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.331 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.464 ' HG3' ' HB3' ' A' ' 92' ' ' LYS . 15.0 pt-20 -154.59 175.93 13.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.01 0.433 . . . . 0.0 111.363 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.43 173.71 11.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.982 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.46 -48.41 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.063 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -128.27 -150.65 7.32 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.545 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.98 -74.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.561 2.174 . . . . 0.0 112.533 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.9 p -99.36 -5.44 29.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.921 0.391 . . . . 0.0 111.193 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.413 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -93.28 131.11 38.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.786 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -151.48 170.34 19.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.971 0.415 . . . . 0.0 111.259 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.464 ' HB3' ' HG3' ' A' ' 84' ' ' GLU . 5.3 tttt -120.67 132.87 55.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.461 179.11 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.4 mp -125.64 149.81 30.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.105 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -118.57 125.29 49.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.486 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.95 HG23 ' HB2' ' A' ' 79' ' ' GLU . 16.1 mm -124.98 143.24 39.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.967 -177.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.694 ' C ' ' HB3' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -151.82 114.7 4.66 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 120.061 -0.656 . . . . 0.0 112.217 -178.797 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.788 HG21 ' HB3' ' A' ' 50' ' ' MET . 16.1 t -64.3 119.91 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.644 178.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.923 -179.777 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 47.2 t . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.654 0.264 . . . . 0.0 110.974 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -114.86 -60.2 1.92 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.416 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.27 159.18 23.1 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.03 0.443 . . . . 0.0 111.823 -178.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.5 m -135.77 108.16 7.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.554 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.5 tt -106.12 112.51 25.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.816 0.341 . . . . 0.0 111.126 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -133.29 107.74 8.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.457 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.0 t -137.93 72.87 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.505 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.707 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.458 -0.073 0 CA-C-O 120.794 0.33 . . . . 0.0 110.805 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.99 -45.13 93.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.643 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.0 -32.36 74.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.777 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.71 -39.32 84.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.943 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.553 HD22 ' HG2' ' A' ' 68' ' ' ARG . 2.2 mt -68.92 -34.15 74.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.606 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -81.16 -12.46 59.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.021 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -135.24 70.94 1.43 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.261 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.755 ' HB3' HG21 ' A' ' 97' ' ' VAL . 0.8 OUTLIER -99.82 126.33 45.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.071 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.559 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 1.3 mtpm? -81.88 150.1 64.84 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.964 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.19 -25.46 80.84 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.536 2.157 . . . . 0.0 112.499 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.59 39.21 2.94 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.564 -0.827 . . . . 0.0 113.118 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.772 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 28.5 mt-10 -90.75 123.43 34.33 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 117.198 0.499 . . . . 0.0 111.905 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.505 HD13 ' O ' ' A' ' 54' ' ' GLU . 0.7 OUTLIER -135.2 84.5 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.625 177.741 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.498 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -119.27 -179.79 3.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.278 0.561 . . . . 0.0 112.301 -176.862 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -136.76 145.82 45.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.295 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.699 HG11 ' HB2' ' A' ' 64' ' ' MET . 4.7 t -119.72 134.29 63.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.824 0.345 . . . . 0.0 111.413 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.527 ' HE1' HG21 ' A' ' 86' ' ' VAL . 11.7 t90 -122.47 96.17 4.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.079 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.547 HG13 HG12 ' A' ' 58' ' ' VAL . 0.5 OUTLIER -148.97 -160.06 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.646 179.053 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.476 ' HB3' ' O ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -131.0 37.53 3.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.461 -179.452 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.643 ' H ' ' HA ' ' A' ' 63' ' ' PRO . 86.1 m-85 -115.94 -60.81 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.119 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.643 ' HA ' ' H ' ' A' ' 62' ' ' TYR . 63.7 Cg_endo -97.22 -168.34 1.56 Allowed 'Cis proline' 0 C--N 1.356 0.939 0 CA-C-N 119.449 0.839 . . . . 0.0 111.881 -1.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.699 ' HB2' HG11 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -68.69 -27.65 66.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.825 0.345 . . . . 0.0 111.024 179.176 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.54 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.7 OUTLIER -58.73 -16.01 14.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.275 -178.966 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.51 ' HG3' ' N ' ' A' ' 67' ' ' GLU . 5.6 pttt -59.61 -34.32 72.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.024 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.531 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 1.4 mm-40 -93.97 -25.31 17.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.078 0.466 . . . . 0.0 110.352 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.553 ' HG2' HD22 ' A' ' 47' ' ' LEU . 6.2 mtt85 -62.97 -38.62 91.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.939 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.727 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 8.9 mt -60.04 -56.58 34.11 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.484 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.727 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 82.5 Cg_exo -46.51 -47.23 15.9 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.507 2.138 . . . . 0.0 112.805 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.534 ' HG3' ' HB3' ' A' ' 47' ' ' LEU . 64.5 mm-40 -60.97 -47.21 87.49 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.051 0.453 . . . . 0.0 110.944 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.566 ' HB ' ' O ' ' A' ' 77' ' ' GLY . 1.9 m -59.53 -46.34 89.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.508 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.703 HG13 ' O ' ' A' ' 69' ' ' ILE . 1.3 m -58.87 -29.4 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 121.119 -0.232 . . . . 0.0 111.004 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.52 -41.51 85.61 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 176.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.64 -81.46 0.31 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.487 177.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.42 -96.21 0.24 Allowed 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.81 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.566 ' O ' ' HB ' ' A' ' 72' ' ' THR . . . -144.07 -85.02 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.853 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.414 ' HB3' HG23 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -146.18 147.61 31.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.762 0.315 . . . . 0.0 110.912 178.844 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.877 ' HB2' HG23 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -95.36 55.72 1.77 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.422 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.7 p -99.22 127.21 52.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.291 -177.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.485 ' HG ' ' N ' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -133.29 -35.75 1.02 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.986 179.665 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.485 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 0.3 OUTLIER -153.91 148.7 26.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.064 0.459 . . . . 0.0 111.925 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.2 mp -141.75 140.8 30.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.454 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.41 ' OE2' ' HD2' ' A' ' 92' ' ' LYS . 11.4 pt-20 -158.04 178.92 9.67 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.033 0.444 . . . . 0.0 111.454 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -133.68 170.1 16.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.716 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.527 HG21 ' HE1' ' A' ' 59' ' ' TRP . 25.1 t -130.23 -56.54 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.287 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.45 ' H ' ' HG3' ' A' ' 90' ' ' GLU . . . -128.52 -145.98 6.13 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.721 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -58.4 -80.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.671 2.247 . . . . 0.0 112.547 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.476 ' O ' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -100.1 -2.7 33.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.785 0.326 . . . . 0.0 111.201 -179.399 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.45 ' HG3' ' H ' ' A' ' 87' ' ' GLY . 5.3 pt-20 -91.86 133.4 35.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.787 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -148.59 168.76 21.95 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.032 0.444 . . . . 0.0 111.387 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.41 ' HD2' ' OE2' ' A' ' 84' ' ' GLU . 2.2 tttt -120.62 146.81 46.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.523 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -129.98 159.3 42.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.244 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -125.58 124.01 40.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.731 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.877 HG23 ' HB2' ' A' ' 79' ' ' GLU . 31.0 mm -123.95 148.97 27.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.448 -176.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.627 ' C ' ' HB3' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -150.64 99.03 2.7 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 120.404 -0.519 . . . . 0.0 111.659 -177.981 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.772 ' HB ' ' HB2' ' A' ' 54' ' ' GLU . 48.6 t -70.63 89.58 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.532 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.2 pttm . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.273 -0.87 . . . . 0.0 111.041 -179.861 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.1 t . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.833 0.349 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.85 -65.98 0.93 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.096 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -108.67 149.23 29.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.112 -179.717 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.0 m -135.09 117.15 15.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.766 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.8 tp -103.52 109.79 21.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.922 0.391 . . . . 0.0 111.036 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.443 ' HB3' ' HB3' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -125.02 115.3 20.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.507 179.61 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.62 47.47 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.299 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.708 -179.887 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.47 ' O ' HD22 ' A' ' 47' ' ' LEU . 9.6 t . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.611 0.244 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.25 -42.3 60.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.948 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.65 -33.95 73.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.743 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.25 -48.19 82.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.294 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.54 HD21 ' HG2' ' A' ' 68' ' ' ARG . 1.1 mm? -61.24 -36.11 79.08 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.916 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -74.72 -9.61 58.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.073 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -134.98 49.83 2.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.037 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.607 ' HB2' HG21 ' A' ' 97' ' ' VAL . 16.1 ptp -88.48 146.64 25.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.875 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.579 ' HB3' ' HG3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -101.98 150.09 37.12 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.374 179.31 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.529 ' HD2' ' HG3' ' A' ' 51' ' ' LYS . 81.6 Cg_exo -31.19 -78.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.736 2.957 . . . . 0.0 114.137 -178.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.441 ' H ' ' HB2' ' A' ' 52' ' ' PRO . . . -104.41 62.18 0.39 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.117 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.579 ' HG3' ' HB3' ' A' ' 51' ' ' LYS . 8.6 mt-10 -89.21 150.49 22.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.027 0.441 . . . . 0.0 111.46 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.41 HG23 ' HB3' ' A' ' 96' ' ' LYS . 2.6 mp -135.64 106.55 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.687 177.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.401 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 1.2 mt -119.09 147.85 43.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.177 0.513 . . . . 0.0 112.194 -176.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -114.87 128.96 56.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.099 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.607 HG21 ' NH1' ' A' ' 68' ' ' ARG . 2.3 t -114.81 133.15 61.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.972 0.415 . . . . 0.0 111.529 -178.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.736 ' HE1' HG21 ' A' ' 86' ' ' VAL . 13.7 t90 -122.57 109.36 14.21 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.815 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.56 HD13 ' O ' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -156.9 -169.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.262 -179.536 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.609 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -109.24 -7.83 15.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.073 -179.598 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.56 ' O ' HD13 ' A' ' 60' ' ' ILE . 0.9 OUTLIER -126.25 122.42 24.05 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.606 179.74 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.05 92.48 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.572 2.181 . . . . 0.0 112.172 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 21.1 mtm -68.0 -15.58 63.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.606 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.495 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 2.4 p -63.92 -17.52 63.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.811 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.8 pttt -57.92 -32.12 67.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.841 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.555 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -94.12 -28.25 15.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.346 179.033 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.607 ' NH1' HG21 ' A' ' 58' ' ' VAL . 39.4 mtt180 -64.24 -39.56 94.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.207 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.7 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 12.5 mt -59.11 -54.77 53.12 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.509 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.7 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 80.6 Cg_exo -48.34 -44.06 30.46 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.307 2.005 . . . . 0.0 112.564 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.543 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 4.7 tt0 -69.11 -49.56 55.98 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.959 0.409 . . . . 0.0 111.433 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.465 ' HB ' ' O ' ' A' ' 77' ' ' GLY . 6.6 m -58.74 -48.16 82.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.364 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 69' ' ' ILE . 19.1 m -59.0 -28.81 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-O 120.504 0.193 . . . . 0.0 111.11 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.543 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.3 OUTLIER -58.02 -41.56 83.4 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.21 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.07 -80.55 0.31 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.176 176.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.85 -100.09 0.22 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.529 178.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.53 -86.56 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.835 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.415 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -146.67 152.56 39.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.751 0.31 . . . . 0.0 110.796 178.668 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.882 ' HB2' HG13 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -100.31 68.78 1.43 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.853 179.08 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.415 HG22 ' HB2' ' A' ' 78' ' ' HIS . 0.2 OUTLIER -98.96 124.01 51.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.724 -176.736 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.892 ' HB3' ' HG2' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -133.42 -37.51 0.95 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.933 179.05 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.561 ' HG3' ' N ' ' A' ' 83' ' ' ILE . 0.8 OUTLIER -154.05 146.34 23.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.946 0.403 . . . . 0.0 111.845 179.531 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.561 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 3.0 mt -141.55 135.31 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.35 178.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.649 ' HG3' ' HB3' ' A' ' 92' ' ' LYS . 6.2 pt-20 -158.05 -179.21 7.91 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.032 0.444 . . . . 0.0 111.321 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.22 162.59 31.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.814 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.736 HG21 ' HE1' ' A' ' 59' ' ' TRP . 60.3 t -123.21 -65.99 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.403 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -122.92 -153.14 8.71 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.743 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.72 -75.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.7 2.267 . . . . 0.0 112.344 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -99.58 -3.16 33.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.946 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.609 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 1.1 pm0 -93.56 138.15 32.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.809 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -151.53 171.05 18.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.993 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.649 ' HB3' ' HG3' ' A' ' 84' ' ' GLU . 2.3 ttpt -120.81 132.99 55.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.72 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.3 mp -125.43 144.95 33.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.84 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.468 ' HB3' ' HG ' ' A' ' 81' ' ' LEU . 10.5 m-85 -118.76 124.3 46.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.699 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.882 HG13 ' HB2' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -124.33 148.86 28.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.852 -178.972 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.892 ' HG2' ' HB3' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -150.93 108.54 3.65 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 120.239 -0.584 . . . . 0.0 112.506 -177.587 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.607 HG21 ' HB2' ' A' ' 50' ' ' MET . 5.0 t -58.15 119.54 3.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.587 178.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.84 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.0 t . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.76 0.315 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.08 -61.87 1.31 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.154 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.1 tptt -113.34 139.98 48.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.887 0.375 . . . . 0.0 111.161 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.404 HG23 ' HB3' ' A' ' 57' ' ' GLU . 71.0 m -130.2 134.74 47.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.859 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.609 HD23 HG22 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -113.15 127.97 56.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.915 179.726 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -120.01 108.51 14.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.783 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.609 HG22 HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -128.2 68.49 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.05 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.061 179.956 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.547 ' O ' HD22 ' A' ' 47' ' ' LEU . 4.1 t . . . . . 0 C--O 1.23 0.04 0 CA-C-O 120.685 0.279 . . . . 0.0 110.864 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.76 -36.57 76.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.893 0.378 . . . . 0.0 110.318 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -66.06 -31.34 72.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.439 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 43' ' ' THR . . . -58.62 -53.0 63.29 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.018 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.688 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 0.8 OUTLIER -58.65 -35.44 72.54 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.144 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.06 -9.83 59.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.249 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -133.52 69.23 1.48 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.948 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.803 ' HB3' HG21 ' A' ' 97' ' ' VAL . 41.9 mtm -109.02 147.86 31.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.997 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.584 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.4 OUTLIER -91.93 153.85 43.53 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.391 179.466 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.584 ' HD2' ' HG3' ' A' ' 51' ' ' LYS . 53.9 Cg_exo -38.48 -71.31 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.148 2.565 . . . . 0.0 113.962 -178.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.17 57.37 0.54 Allowed Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.913 -0.661 . . . . 0.0 113.415 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.515 ' HG3' ' HB3' ' A' ' 51' ' ' LYS . 11.0 mt-10 -91.41 156.1 17.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.134 0.493 . . . . 0.0 111.984 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.542 ' C ' HD13 ' A' ' 56' ' ' LEU . 3.5 mp -135.55 115.71 17.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.008 178.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.542 HD13 ' C ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -118.52 154.29 32.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.035 0.445 . . . . 0.0 111.692 -177.624 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.404 ' HB3' HG23 ' A' ' 28' ' ' THR . 51.1 tt0 -114.74 145.9 41.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.376 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.543 HG12 HG13 ' A' ' 60' ' ' ILE . 16.7 t -131.01 131.52 64.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.858 0.361 . . . . 0.0 111.527 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.416 ' CD1' ' HG2' ' A' ' 92' ' ' LYS . 52.8 m0 -122.59 107.25 11.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.422 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.543 HG13 HG12 ' A' ' 58' ' ' VAL . 1.0 OUTLIER -158.67 -172.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-O 121.046 0.451 . . . . 0.0 111.334 -179.213 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -99.67 -25.59 14.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.106 178.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.474 ' O ' HD13 ' A' ' 60' ' ' ILE . 93.0 m-85 -120.62 121.06 29.31 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.445 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -45.68 105.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.651 2.234 . . . . 0.0 112.561 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.499 ' HG3' ' NH1' ' A' ' 68' ' ' ARG . 3.0 tpt -65.64 -15.09 62.43 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.808 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.755 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 14.8 p -55.79 -13.38 1.72 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.846 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.66 -42.96 75.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.549 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 1.7 mt-10 -87.16 -26.07 23.77 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.225 0.536 . . . . 0.0 110.132 178.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.755 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 0.2 OUTLIER -61.48 -41.98 98.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.088 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.723 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 18.9 mt -55.33 -56.0 33.6 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.804 -178.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.723 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 78.3 Cg_exo -49.0 -41.27 40.44 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.216 1.944 . . . . 0.0 112.491 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.688 ' HG3' ' HB3' ' A' ' 47' ' ' LEU . 7.4 mm-40 -68.49 -55.2 12.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.571 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.76 HG21 ' HG2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -57.57 -49.01 77.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.468 -178.834 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.2 p -58.36 -28.32 35.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.139 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.553 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 2.8 mmtt -58.67 -43.25 89.82 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 176.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.51 ' HB3' HD13 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -89.19 -80.81 0.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.118 176.686 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.781 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -99.02 -106.38 0.2 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.459 177.685 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.479 ' H ' HD23 ' A' ' 76' ' ' LEU . . . -133.84 -80.92 0.16 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.365 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.491 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -146.14 165.6 28.67 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.775 0.322 . . . . 0.0 110.977 179.644 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.76 ' HG2' HG21 ' A' ' 72' ' ' THR . 0.1 OUTLIER -110.19 62.76 0.6 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.394 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.491 HG22 ' HB2' ' A' ' 78' ' ' HIS . 0.1 OUTLIER -98.77 123.05 51.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.69 -176.656 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.772 HD22 ' HB3' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -142.11 -36.42 0.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.223 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.482 ' HB3' ' HB2' ' A' ' 94' ' ' TYR . 2.3 tp10 -149.06 141.25 24.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.215 0.531 . . . . 0.0 112.348 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.469 HD11 HG12 ' A' ' 80' ' ' VAL . 3.8 mp -143.71 118.57 4.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.155 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -155.1 -176.05 5.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.164 0.507 . . . . 0.0 111.373 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -133.71 166.46 22.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.789 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.15 -47.74 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.17 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -123.39 -161.06 11.05 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.706 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.1 -76.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.689 2.259 . . . . 0.0 112.424 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -98.32 -2.48 39.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.101 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -93.34 119.84 32.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.402 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 14.4 m0 -120.79 167.66 12.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.03 0.443 . . . . 0.0 111.382 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.416 ' HG2' ' CD1' ' A' ' 59' ' ' TRP . 1.6 mttm -120.56 131.65 54.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.306 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -125.14 137.72 56.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.02 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.482 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 23.8 m-85 -118.27 123.44 45.42 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.384 178.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.681 HG13 ' HG3' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -123.95 142.53 40.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.251 -179.71 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.772 ' HB3' HD22 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -145.79 114.88 7.01 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.826 -176.844 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.803 HG21 ' HB3' ' A' ' 50' ' ' MET . 2.2 t -63.33 120.91 11.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.499 178.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 33.1 mttp . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.174 -0.917 . . . . 0.0 110.977 -179.631 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 20.9 t . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.813 0.34 . . . . 0.0 111.3 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.52 -46.7 2.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.068 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.09 154.26 38.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.137 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 51.6 m -135.52 114.78 12.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.845 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 5.8 tt -102.96 117.01 33.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.709 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -132.77 115.83 15.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.113 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.459 HG23 ' CG2' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -123.51 65.79 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.828 179.726 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.9 ttm180 . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.091 -179.934 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.464 ' O ' HD13 ' A' ' 47' ' ' LEU . 7.6 t . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.772 0.32 . . . . 0.0 110.498 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -55.29 -38.96 69.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.493 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.87 -42.4 77.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.133 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.79 -38.47 78.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.1 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.464 HD13 ' O ' ' A' ' 43' ' ' THR . 2.2 mp -64.52 -44.55 90.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.956 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.35 -3.88 51.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -126.14 62.91 1.25 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.103 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.19 152.06 25.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.072 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.861 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -105.04 162.11 20.73 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.678 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.587 ' HD2' ' HB3' ' A' ' 51' ' ' LYS . 4.9 Cg_endo -47.47 -68.9 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.087 2.524 . . . . 0.0 113.451 -178.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.53 58.34 0.49 Allowed Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.442 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.861 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 13.1 mm-40 -90.63 143.29 26.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.032 0.444 . . . . 0.0 111.57 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 5.5 mt -135.81 96.27 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.198 178.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.91 175.12 5.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.285 0.564 . . . . 0.0 111.959 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -138.25 140.91 39.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.317 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 2.8 t -114.12 135.72 52.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.991 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -121.75 107.84 12.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.69 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.643 HD13 ' O ' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -157.97 -163.7 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.224 -179.199 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -114.17 -5.88 13.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.643 ' O ' HD13 ' A' ' 60' ' ' ILE . 6.8 m-85 -125.84 132.57 24.36 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.803 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -58.36 91.2 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.61 2.207 . . . . 0.0 112.78 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 5.1 tmm? -68.53 -25.95 65.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.056 0.455 . . . . 0.0 110.449 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.637 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 67.5 m -64.05 -13.86 50.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.946 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.453 ' HG3' ' N ' ' A' ' 67' ' ' GLU . 2.1 pttp -57.69 -33.91 68.86 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.734 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.577 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -94.32 -27.13 16.27 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.186 0.517 . . . . 0.0 110.112 178.383 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.637 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -61.31 -34.34 75.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.942 179.126 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.733 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 11.3 mt -63.53 -56.75 23.84 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.342 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.733 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 83.4 Cg_exo -47.78 -32.39 16.89 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.307 2.004 . . . . 0.0 112.373 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.08 -58.26 3.73 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.061 0.457 . . . . 0.0 111.012 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.587 HG21 ' HG2' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -59.75 -30.0 68.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.557 -178.954 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.579 HG12 ' O ' ' A' ' 70' ' ' PRO . 5.7 p -72.72 -29.84 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.83 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.68 -41.39 86.07 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -90.6 -78.67 0.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.446 177.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.431 HD11 HG22 ' A' ' 72' ' ' THR . 0.0 OUTLIER -98.48 -97.92 0.22 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.755 178.53 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.09 -82.4 0.05 OUTLIER Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.14 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.681 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -146.32 157.98 43.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.86 0.362 . . . . 0.0 111.234 179.449 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.706 ' HB2' ' H ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -104.72 63.4 0.72 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.491 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.681 HG22 ' HB2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -99.13 121.83 50.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.805 -176.863 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.744 ' HB3' ' HG2' ' A' ' 96' ' ' LYS . 2.2 pt? -139.79 -32.41 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.421 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.559 ' O ' HD13 ' A' ' 83' ' ' ILE . 0.4 OUTLIER -149.88 132.84 16.14 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -179.704 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.663 HD11 HG12 ' A' ' 80' ' ' VAL . 1.0 OUTLIER -134.62 126.23 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.315 178.268 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -158.34 175.96 13.06 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.072 0.463 . . . . 0.0 111.554 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -134.51 178.04 7.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.738 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.5 p -138.73 -43.32 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.283 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -133.7 -148.4 5.85 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.726 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.07 -77.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.608 2.205 . . . . 0.0 112.346 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.8 p -97.89 -3.47 38.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.881 0.372 . . . . 0.0 110.886 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.418 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 4.4 pt-20 -93.23 130.8 38.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.766 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -147.45 168.95 20.57 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.971 0.415 . . . . 0.0 111.203 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.406 ' HG2' ' HE1' ' A' ' 94' ' ' TYR . 20.9 ttpt -126.38 127.45 45.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.448 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.6 mt -125.53 149.46 30.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.885 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.467 ' HB2' ' CB ' ' A' ' 82' ' ' GLU . 6.8 m-85 -118.42 135.66 54.22 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.289 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.598 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -125.55 143.24 39.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.299 178.856 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.744 ' HG2' ' HB3' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -138.42 106.31 5.67 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 120.232 -0.587 . . . . 0.0 112.189 -177.514 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.416 ' H ' HG23 ' A' ' 97' ' ' VAL . 2.4 t -64.43 118.97 7.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.424 178.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.918 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.629 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 85.6 t . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.512 0.196 . . . . 0.0 110.561 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.678 ' HB ' HD11 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -99.47 -37.37 9.22 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.846 -0.341 . . . . 0.0 111.82 -178.731 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.583 ' H ' ' CD1' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -145.52 162.23 37.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.407 0.622 . . . . 0.0 111.845 -178.723 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 83.1 m -136.17 125.99 25.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.715 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 tt -107.64 120.38 42.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.575 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.32 112.44 8.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.861 0.362 . . . . 0.0 111.084 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.1 t -134.14 70.06 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.972 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.332 -0.18 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.45 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.403 ' O ' HD22 ' A' ' 47' ' ' LEU . 1.4 t . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.719 0.295 . . . . 0.0 110.44 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -59.69 -40.23 87.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.151 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -67.75 -29.79 69.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.99 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.88 -56.06 26.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.017 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.671 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 1.7 mm? -61.3 -62.0 2.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.58 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -58.7 -32.77 69.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.492 . . . . 0.0 112.184 -177.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -124.97 66.05 1.12 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.842 0.353 . . . . 0.0 111.24 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.507 ' HB2' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -98.78 158.18 15.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.921 179.775 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -100.12 144.86 29.21 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.648 179.538 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -49.87 -46.75 26.27 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.885 2.39 . . . . 0.0 113.573 -178.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.0 56.31 0.54 Allowed Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.622 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 11.7 mm-40 -90.86 136.01 33.35 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 117.18 0.49 . . . . 0.0 111.614 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.629 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 2.6 mp -136.4 81.41 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.613 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.678 HD11 ' HB ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -117.19 176.26 5.22 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.349 -0.541 . . . . 0.0 112.246 -173.481 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -132.04 162.52 30.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.811 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.481 HG12 HG12 ' A' ' 60' ' ' ILE . 6.2 t -135.3 139.59 46.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.815 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 9.1 t-105 -127.77 104.53 7.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.745 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.481 HG12 HG12 ' A' ' 58' ' ' VAL . 0.5 OUTLIER -158.29 -177.31 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.27 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -97.26 0.23 47.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.64 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -136.93 130.16 17.48 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.642 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.46 100.46 0.57 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.42 2.08 . . . . 0.0 112.304 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.408 ' O ' ' HD3' ' A' ' 68' ' ' ARG . 1.3 mtt -68.01 -13.04 61.87 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.773 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 14.4 p -59.14 -11.01 3.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.363 178.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -55.09 -46.44 75.48 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.11 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.548 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -87.23 -25.19 24.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.171 0.51 . . . . 0.0 110.209 178.955 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.773 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -62.41 -35.6 79.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.915 179.343 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.758 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 16.6 mt -60.39 -56.89 30.91 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.513 -179.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.758 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 67.0 Cg_exo -52.09 -32.15 47.91 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.283 1.988 . . . . 0.0 112.47 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.671 ' HG3' ' HB3' ' A' ' 47' ' ' LEU . 30.1 mm-40 -72.46 -63.69 1.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.884 0.373 . . . . 0.0 111.338 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.467 HG22 HD11 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -57.42 -28.36 63.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.479 -178.791 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.521 HG12 ' O ' ' A' ' 70' ' ' PRO . 5.8 p -74.19 -29.49 25.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.803 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.67 -41.43 86.1 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 176.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.433 ' HD3' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -90.47 -78.38 0.38 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.283 177.104 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.467 HD11 HG22 ' A' ' 72' ' ' THR . 0.0 OUTLIER -98.54 -96.75 0.22 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.743 178.515 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.29 -79.52 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.1 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.522 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -146.12 158.55 43.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.769 0.319 . . . . 0.0 110.863 179.262 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.77 ' HB2' HG23 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -103.49 56.67 0.74 Allowed 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.822 179.44 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.651 HG12 HD11 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -98.88 125.36 52.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.236 -177.996 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.522 ' HG ' ' HB3' ' A' ' 94' ' ' TYR . 1.1 pp -133.43 -36.9 0.97 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.015 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.485 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -153.38 143.67 22.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.97 0.414 . . . . 0.0 111.724 179.823 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.651 HD11 HG12 ' A' ' 80' ' ' VAL . 3.4 mp -143.19 137.52 26.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.336 178.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.429 ' HG3' ' HB3' ' A' ' 92' ' ' LYS . 2.5 pt-20 -152.6 176.53 11.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.016 0.436 . . . . 0.0 111.214 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -133.49 163.59 29.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.681 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.58 HG23 ' HA ' ' A' ' 91' ' ' TRP . 2.8 t -127.46 -66.58 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.321 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -123.0 -141.08 5.83 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.671 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.459 ' HB2' ' H ' ' A' ' 89' ' ' SER . 31.4 Cg_exo -58.71 -84.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.7 2.267 . . . . 0.0 112.329 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.459 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 85.1 p -100.05 -1.16 37.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.011 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -91.68 128.05 37.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.822 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.58 ' HA ' HG23 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -150.16 171.13 17.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.253 -179.682 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.429 ' HB3' ' HG3' ' A' ' 84' ' ' GLU . 12.0 tttt -121.36 141.69 50.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.491 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.426 HG22 ' H ' ' A' ' 94' ' ' TYR . 0.8 OUTLIER -131.16 165.17 32.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.186 -179.542 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.522 ' HB3' ' HG ' ' A' ' 81' ' ' LEU . 12.7 m-85 -132.88 126.17 31.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.001 178.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.77 HG23 ' HB2' ' A' ' 79' ' ' GLU . 18.7 mm -124.76 145.73 31.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.078 -177.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.662 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -150.54 120.1 6.96 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 119.759 -0.776 . . . . 0.0 112.924 -178.62 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.512 HG22 ' OE1' ' A' ' 79' ' ' GLU . 22.7 t -73.57 128.48 36.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.242 178.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.8 tttm . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.929 -179.708 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.7 t . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.772 0.32 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.29 -61.88 1.31 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.691 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 0.8 OUTLIER -115.56 157.83 23.53 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.801 179.117 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.0 m -135.49 125.72 26.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.066 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.0 tt -107.46 119.44 39.42 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.975 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -124.04 113.96 19.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.516 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.446 ' O ' HG23 ' A' ' 60' ' ' ILE . 3.8 m -140.39 74.06 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.891 0.377 . . . . 0.0 111.543 -179.177 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.864 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.535 ' O ' HD13 ' A' ' 47' ' ' LEU . 8.4 t . . . . . 0 CA--C 1.526 0.053 0 CA-C-O 120.704 0.288 . . . . 0.0 111.085 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.67 -44.3 77.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.665 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.56 -35.25 79.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.75 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.8 -36.4 84.2 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.997 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.535 HD13 ' O ' ' A' ' 43' ' ' THR . 2.4 mp -70.28 -39.67 74.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.154 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -78.84 -21.33 47.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.336 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.9 t30 -135.24 70.56 1.43 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.801 0.334 . . . . 0.0 111.4 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.658 ' HB2' HG21 ' A' ' 97' ' ' VAL . 18.4 ptp -102.28 145.14 29.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.673 178.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.891 ' HG2' ' HD2' ' A' ' 52' ' ' PRO . 3.1 tttp -80.79 148.17 64.35 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.783 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.891 ' HD2' ' HG2' ' A' ' 51' ' ' LYS . 58.7 Cg_exo -39.03 -75.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.25 2.634 . . . . 0.0 114.173 -178.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.86 59.7 0.48 Allowed Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.001 -0.618 . . . . 0.0 113.261 -177.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.406 ' HG2' ' HB3' ' A' ' 51' ' ' LYS . 1.8 mm-40 -90.92 153.68 20.02 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.014 0.435 . . . . 0.0 111.918 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.2 mt -132.5 116.0 26.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.99 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.536 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 5.0 mp -126.72 152.13 47.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.119 0.485 . . . . 0.0 111.949 -178.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -113.92 129.53 56.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.402 177.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.81 HG11 HH12 ' A' ' 68' ' ' ARG . 2.2 t -114.12 128.77 70.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.165 0.507 . . . . 0.0 111.925 -177.061 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -122.87 101.17 7.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.448 178.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.733 HD12 ' HB2' ' A' ' 64' ' ' MET . 0.5 OUTLIER -149.64 -160.01 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.681 -179.437 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.478 ' H ' HG22 ' A' ' 60' ' ' ILE . 10.1 p-10 -145.17 35.26 1.09 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.704 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.556 ' H ' ' HA ' ' A' ' 63' ' ' PRO . 44.4 m-85 -105.74 -63.02 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.001 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.556 ' HA ' ' H ' ' A' ' 62' ' ' TYR . 85.7 Cg_endo -97.53 164.23 12.48 Favored 'Cis proline' 0 C--N 1.356 0.971 0 CA-C-N 119.507 0.86 . . . . 0.0 112.088 -1.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.733 ' HB2' HD12 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -68.48 -17.76 64.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.808 0.337 . . . . 0.0 111.147 179.815 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.577 ' HA ' ' HD3' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -60.44 -17.4 44.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.932 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 63' ' ' PRO . 2.9 pttp -62.51 -27.22 68.99 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.844 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.507 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.7 OUTLIER -94.34 -26.19 16.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.178 0.513 . . . . 0.0 109.863 178.107 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.81 HH12 HG11 ' A' ' 58' ' ' VAL . 3.8 mpt_? -58.89 -47.57 84.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.193 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.732 HG23 ' HB3' ' A' ' 78' ' ' HIS . 3.8 mt -57.8 -55.32 46.2 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.834 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.693 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 83.8 Cg_exo -42.94 -51.47 5.42 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 122.73 2.286 . . . . 0.0 113.171 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.415 ' O ' ' HD3' ' A' ' 75' ' ' LYS . 2.0 mm-40 -62.41 -41.34 98.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.007 0.432 . . . . 0.0 110.978 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.542 HG21 ' HG3' ' A' ' 79' ' ' GLU . 2.9 m -59.72 -52.08 67.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.754 -179.086 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -58.67 -26.33 31.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.937 -178.863 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.6 -44.17 89.79 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 176.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.415 ' HD3' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -90.36 -77.28 0.41 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.429 176.898 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.75 HD13 ' HB2' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -98.52 -98.64 0.22 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.828 178.978 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.14 -84.54 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.151 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.732 ' HB3' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -146.36 146.91 30.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.976 0.417 . . . . 0.0 111.213 179.276 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.916 ' HB2' HG23 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -95.34 52.75 1.43 Allowed 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 177.737 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.529 HG12 ' HB2' ' A' ' 78' ' ' HIS . 1.4 p -98.71 118.77 45.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.208 -177.185 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.785 HD22 ' HB3' ' A' ' 96' ' ' LYS . 1.1 pt? -133.65 -29.35 1.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.686 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.505 ' O ' HG13 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -152.81 144.78 23.71 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.979 179.074 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 82' ' ' GLU . 2.5 mp -144.5 126.44 9.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.566 178.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 92' ' ' LYS . 9.3 pt-20 -153.06 174.67 13.89 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.905 0.384 . . . . 0.0 111.137 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.04 169.06 17.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.877 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.2 t -129.25 -52.68 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.215 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -126.1 -145.53 6.41 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.767 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.89 -77.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.606 2.204 . . . . 0.0 112.523 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.18 -6.85 27.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.937 0.399 . . . . 0.0 111.138 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -89.62 134.47 34.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.567 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -151.31 169.63 21.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.047 0.451 . . . . 0.0 111.265 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 10.5 ttpt -126.97 125.51 41.63 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.344 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.5 HG22 ' N ' ' A' ' 94' ' ' TYR . 4.1 mp -125.5 159.87 32.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.925 0.393 . . . . 0.0 110.836 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.5 ' N ' HG22 ' A' ' 93' ' ' ILE . 6.3 m-85 -118.2 133.55 55.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.579 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.916 HG23 ' HB2' ' A' ' 79' ' ' GLU . 12.9 mm -124.21 137.82 55.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.093 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.785 ' HB3' HD22 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -144.91 109.78 5.05 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.375 -0.53 . . . . 0.0 112.052 -176.677 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.658 HG21 ' HB2' ' A' ' 50' ' ' MET . 4.1 t -65.54 116.19 4.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.304 178.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.75 ' HB2' HD13 ' A' ' 76' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.082 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.8 t . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.768 0.318 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.57 -56.08 2.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.152 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.03 137.76 50.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.829 0.347 . . . . 0.0 111.356 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 54.9 m -123.89 126.87 47.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.522 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.5 tp -109.83 118.76 37.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.292 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -108.24 128.42 54.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.528 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.793 ' HB ' HG23 ' A' ' 60' ' ' ILE . 18.9 t -117.24 -23.45 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.357 -179.019 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.439 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 6.7 t . . . . . 0 N--CA 1.458 -0.053 0 CA-C-O 120.646 0.26 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.2 -43.78 71.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.859 0.361 . . . . 0.0 110.702 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.41 -32.76 74.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.412 178.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 43' ' ' THR . . . -59.32 -45.27 91.78 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.038 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.408 HD22 ' O ' ' A' ' 43' ' ' THR . 1.8 mm? -72.48 -19.47 61.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.772 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.41 -36.64 29.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.359 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -106.74 48.6 0.83 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.909 0.385 . . . . 0.0 111.606 -178.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.1 ptm -89.9 126.35 35.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.897 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.461 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -94.67 152.35 39.78 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.795 -179.86 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.461 ' HD2' ' HG3' ' A' ' 51' ' ' LYS . 61.0 Cg_exo -40.4 -67.61 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.175 2.583 . . . . 0.0 113.831 -178.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.32 57.87 0.51 Allowed Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.993 -0.622 . . . . 0.0 113.141 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.446 ' O ' HD13 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -91.25 150.29 21.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.983 0.421 . . . . 0.0 111.898 -179.71 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.573 HD13 ' HG3' ' A' ' 96' ' ' LYS . 0.6 OUTLIER -131.07 112.81 22.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.032 178.282 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 mt -119.78 154.51 34.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.176 0.513 . . . . 0.0 112.173 -177.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -119.75 125.86 49.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.472 177.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.1 t -114.96 138.22 45.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.176 0.512 . . . . 0.0 112.327 -177.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.455 ' C ' HG13 ' A' ' 60' ' ' ILE . 7.1 m0 -122.46 105.62 10.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.654 177.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.924 HG12 ' HB2' ' A' ' 64' ' ' MET . 0.1 OUTLIER -144.97 -176.97 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 CA-C-O 120.966 0.412 . . . . 0.0 111.505 -177.98 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.563 ' HB3' ' HA ' ' A' ' 90' ' ' GLU . 0.5 OUTLIER -138.4 25.9 2.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.869 179.396 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.795 ' H ' ' HA ' ' A' ' 63' ' ' PRO . 0.6 OUTLIER -106.19 -55.48 0.07 OUTLIER Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.597 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.795 ' HA ' ' H ' ' A' ' 62' ' ' TYR . 78.5 Cg_endo -95.61 177.36 9.94 Favored 'Cis proline' 0 C--N 1.355 0.897 0 C-N-CA 124.904 -0.873 . . . . 0.0 112.708 0.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.924 ' HB2' HG12 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -68.43 -25.7 65.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.228 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.457 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 14.4 p -61.3 -13.02 15.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.087 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.514 ' HG3' ' N ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -62.97 -31.93 73.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.886 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.562 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -94.2 -25.66 16.99 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.084 0.469 . . . . 0.0 110.241 178.758 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.457 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 18.5 mtt85 -62.17 -41.91 98.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.954 179.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.731 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 12.5 mt -56.7 -55.84 38.99 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.684 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.731 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 76.2 Cg_exo -49.31 -40.8 43.59 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.292 1.995 . . . . 0.0 112.703 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.86 -51.65 52.99 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.899 0.381 . . . . 0.0 111.219 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.835 HG21 ' HG2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -59.53 -50.63 73.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.59 -178.799 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.0 p -58.37 -28.12 34.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.895 -178.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.78 -42.46 89.03 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 176.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.6 -80.62 0.3 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.949 176.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.757 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -98.58 -106.65 0.19 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.363 177.2 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.488 ' H ' HD23 ' A' ' 76' ' ' LEU . . . -132.73 -84.76 0.26 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.018 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.39 164.23 33.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.915 0.388 . . . . 0.0 111.309 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.835 ' HG2' HG21 ' A' ' 72' ' ' THR . 0.0 OUTLIER -107.09 62.3 0.62 Allowed 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.397 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.478 HG23 HD11 ' A' ' 83' ' ' ILE . 1.4 p -98.14 120.88 48.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.427 -175.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.575 HD21 ' HB3' ' A' ' 94' ' ' TYR . 0.5 OUTLIER -133.68 -33.52 1.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.795 179.807 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.468 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -151.77 145.16 24.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.014 0.435 . . . . 0.0 111.811 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.478 HD11 HG23 ' A' ' 80' ' ' VAL . 3.5 mp -142.23 123.51 12.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.288 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.574 ' HG3' ' HB3' ' A' ' 92' ' ' LYS . 5.1 pt-20 -156.55 -175.55 5.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.221 0.534 . . . . 0.0 111.349 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.486 ' HB3' ' HD1' ' A' ' 91' ' ' TRP . 3.6 pt-20 -133.24 166.39 22.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.639 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.406 HG13 ' N ' ' A' ' 87' ' ' GLY . 4.8 p -131.27 -44.9 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.477 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.406 ' N ' HG13 ' A' ' 86' ' ' VAL . . . -133.33 -151.83 6.68 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.673 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.89 -74.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.547 2.164 . . . . 0.0 112.426 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.7 p -95.65 -5.84 41.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.812 0.339 . . . . 0.0 111.157 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.563 ' HA ' ' HB3' ' A' ' 61' ' ' ASP . 4.5 pt-20 -93.03 140.94 28.95 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.558 179.091 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.486 ' HD1' ' HB3' ' A' ' 85' ' ' GLU . 6.1 m-90 -136.44 163.97 29.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.047 0.451 . . . . 0.0 111.335 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.574 ' HB3' ' HG3' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -120.23 117.0 26.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.077 178.99 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.4 mp -125.28 145.34 32.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.99 -178.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.575 ' HB3' HD21 ' A' ' 81' ' ' LEU . 29.1 m-85 -118.04 132.54 56.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.187 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.711 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -124.13 141.66 43.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.796 -177.945 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.585 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -151.21 130.05 12.44 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.239 -0.584 . . . . 0.0 112.287 -177.714 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.433 HG22 ' OE1' ' A' ' 79' ' ' GLU . 2.3 t -80.85 120.05 31.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.089 177.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.954 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.695 HG13 ' HA ' ' A' ' 56' ' ' LEU . 57.6 t . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.753 0.311 . . . . 0.0 111.12 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.3 m -106.36 -53.64 2.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.196 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.456 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -119.39 167.03 12.32 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.048 0.452 . . . . 0.0 111.466 -179.197 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.418 ' H ' ' HG3' ' A' ' 27' ' ' LYS . 87.8 m -134.09 121.99 22.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.648 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.476 HD22 HG13 ' A' ' 58' ' ' VAL . 5.1 tt -103.69 120.75 41.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.935 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -132.37 120.17 21.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.727 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.418 ' HB ' ' CG2' ' A' ' 60' ' ' ILE . 3.0 t -109.65 -4.66 10.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.246 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.645 ' HD3' ' HE1' ' A' ' 59' ' ' TRP . 0.7 OUTLIER . . . . . 0 CA--C 1.532 0.261 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.285 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.445 ' CB ' HD11 ' A' ' 29' ' ' LEU . 13.3 t . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.688 0.28 . . . . 0.0 110.791 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.64 -41.63 73.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.676 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.68 -30.35 69.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.05 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.52 -43.98 80.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.25 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.817 HD11 ' HG2' ' A' ' 68' ' ' ARG . 2.3 mm? -71.4 -43.86 66.02 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.69 -179.143 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -81.35 -12.65 58.94 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -177.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -135.51 72.71 1.45 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.94 0.4 . . . . 0.0 111.139 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.67 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -108.53 138.49 44.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.866 179.832 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.656 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -96.09 153.29 39.16 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.7 179.708 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -52.94 -43.61 55.32 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.624 2.216 . . . . 0.0 113.198 -178.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.8 50.14 0.86 Allowed Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.532 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.684 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 20.0 mm-40 -91.27 129.0 37.31 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 117.358 0.579 . . . . 0.0 111.635 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 1.1 mp -135.59 89.46 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.779 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.695 ' HA ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -118.89 -177.98 3.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.252 0.549 . . . . 0.0 112.087 -176.695 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -129.25 174.01 9.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.236 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.569 HG12 HG13 ' A' ' 60' ' ' ILE . 13.4 t -140.17 136.02 37.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.858 0.361 . . . . 0.0 111.303 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.645 ' HE1' ' HD3' ' A' ' 32' ' ' ARG . 57.9 t-105 -122.49 104.49 9.41 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.706 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.569 HG13 HG12 ' A' ' 58' ' ' VAL . 0.8 OUTLIER -159.04 -177.8 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.084 0.469 . . . . 0.0 111.528 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 4.9 m-20 -99.89 -13.8 19.02 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.016 177.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.466 ' O ' HD13 ' A' ' 60' ' ' ILE . 1.8 m-85 -129.91 124.8 21.79 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.274 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.482 ' HD3' ' HE1' ' A' ' 91' ' ' TRP . 86.4 Cg_exo -47.54 104.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.643 2.229 . . . . 0.0 112.863 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.425 ' CE ' HD21 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -64.88 -19.27 65.81 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.116 0.484 . . . . 0.0 110.586 179.3 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.681 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 6.1 p -61.82 -10.09 8.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.625 179.18 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.7 ptmt -58.15 -37.96 75.68 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.58 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.552 ' O ' ' HG2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -91.74 -24.21 19.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.277 0.56 . . . . 0.0 109.967 178.259 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.817 ' HG2' HD11 ' A' ' 47' ' ' LEU . 33.2 mtt-85 -63.46 -39.69 95.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.756 179.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.464 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 12.2 mt -57.5 -56.96 28.64 Favored Pre-proline 0 CA--C 1.532 0.282 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.552 ' HG2' ' O ' ' A' ' 67' ' ' GLU . 9.8 Cg_endo -53.4 -34.58 71.84 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.138 1.892 . . . . 0.0 112.574 -178.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.556 ' HG3' ' HB3' ' A' ' 47' ' ' LEU . 65.1 mm-40 -72.92 -65.71 0.76 Allowed 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.042 0.448 . . . . 0.0 111.327 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.636 HG21 ' HG3' ' A' ' 79' ' ' GLU . 0.2 OUTLIER -58.7 -24.91 62.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.353 -178.992 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.534 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 3.4 p -76.07 -27.89 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-O 120.74 0.305 . . . . 0.0 110.474 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.97 -43.35 86.43 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 176.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.08 -77.89 0.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.117 176.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.421 HD11 HG22 ' A' ' 72' ' ' THR . 0.0 OUTLIER -98.18 -100.24 0.21 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.626 178.216 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.27 -85.62 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.71 178.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.597 ' CE1' HD11 ' A' ' 95' ' ' ILE . 6.3 t-80 -147.05 172.7 13.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.924 0.392 . . . . 0.0 110.94 177.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.885 ' HB2' HG13 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -111.48 68.53 0.67 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.84 178.988 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.565 HG22 ' ND1' ' A' ' 78' ' ' HIS . 0.1 OUTLIER -99.02 122.06 50.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.952 0.406 . . . . 0.0 112.025 -176.64 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.999 ' HB3' ' HG2' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -133.74 -40.97 0.86 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.036 178.563 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.567 ' HB2' HD12 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -153.88 151.02 28.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.04 0.448 . . . . 0.0 112.116 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.512 HG13 ' C ' ' A' ' 82' ' ' GLU . 1.1 mp -141.54 142.14 29.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.159 178.432 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -156.63 176.05 13.24 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.027 0.442 . . . . 0.0 111.682 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -136.07 176.65 8.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.732 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.578 HG12 ' HA ' ' A' ' 91' ' ' TRP . 0.7 OUTLIER -144.34 -53.48 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.134 -178.298 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.405 ' H ' HG13 ' A' ' 86' ' ' VAL . . . -123.92 -153.91 8.79 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.564 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.97 -78.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.626 2.218 . . . . 0.0 112.311 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.05 -3.02 32.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.869 0.366 . . . . 0.0 111.111 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 8.7 pt-20 -93.35 133.24 36.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.765 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.578 ' HA ' HG12 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -151.56 173.73 14.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.272 -179.902 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.551 ' HG3' ' HE3' ' A' ' 59' ' ' TRP . 3.3 mttm -122.33 143.43 49.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.365 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.63 151.27 31.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.919 0.39 . . . . 0.0 111.258 -179.196 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.464 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 14.4 m-85 -118.66 123.65 45.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.081 178.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.885 HG13 ' HB2' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -123.77 151.51 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.045 -177.959 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.999 ' HG2' ' HB3' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -148.83 97.74 2.76 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.926 -177.445 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.684 ' HB ' ' HB2' ' A' ' 54' ' ' GLU . 17.6 t -60.56 117.53 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.701 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.908 -179.905 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 68.9 t . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.828 0.347 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.7 m -99.84 -67.82 0.83 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.891 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -115.76 159.43 21.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.801 0.334 . . . . 0.0 110.842 179.636 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.6 m -135.65 124.77 24.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.096 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.3 tt -104.94 112.87 26.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.571 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -130.05 112.55 13.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.142 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.554 HG23 ' CG2' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -135.51 72.45 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.818 179.13 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.499 -179.301 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.481 HG21 ' SD ' ' A' ' 64' ' ' MET . 14.6 t . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.792 0.329 . . . . 0.0 110.61 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.3 tptm -61.26 -39.54 90.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.397 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -32.67 72.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.762 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.63 -48.71 80.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.822 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.638 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 3.0 mt -62.02 -30.05 70.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.784 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.62 -25.63 45.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.164 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -132.43 69.62 1.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.058 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.636 ' HB3' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -84.6 147.47 26.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.792 179.835 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.795 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 0.8 OUTLIER -103.08 161.57 22.7 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.658 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -46.61 -72.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.988 2.458 . . . . 0.0 113.905 -177.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.28 59.99 0.45 Allowed Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.333 -177.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.795 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 26.3 mm-40 -87.34 139.19 30.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.896 0.379 . . . . 0.0 111.377 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.557 ' HA ' ' HB2' ' A' ' 96' ' ' LYS . 16.8 mt -135.25 121.03 30.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.682 178.105 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.486 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.5 mp -127.1 146.82 50.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.156 0.503 . . . . 0.0 112.076 -177.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -111.31 123.34 50.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.699 177.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.41 HG12 HG12 ' A' ' 60' ' ' ILE . 8.3 t -114.34 130.36 68.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.977 0.417 . . . . 0.0 111.758 -177.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.587 ' HE1' HG21 ' A' ' 86' ' ' VAL . 2.4 t90 -126.73 111.33 14.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.427 179.181 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.554 ' CG2' HG23 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -158.14 -168.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 121.071 0.462 . . . . 0.0 111.796 -178.953 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.45 ' OD2' ' HB2' ' A' ' 89' ' ' SER . 0.4 OUTLIER -102.7 -11.42 18.41 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.9 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.469 ' O ' HD12 ' A' ' 60' ' ' ILE . 4.5 m-85 -133.59 139.75 34.71 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.909 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.41 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 16.9 Cg_exo -67.66 101.73 0.68 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.722 2.282 . . . . 0.0 112.615 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.481 ' SD ' HG21 ' A' ' 43' ' ' THR . 0.0 OUTLIER -68.24 -16.78 64.1 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.138 0.494 . . . . 0.0 110.524 178.954 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.75 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -59.36 -12.62 6.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.458 179.105 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.71 ' HE2' ' HG3' ' A' ' 67' ' ' GLU . 2.2 pttm -54.91 -39.29 68.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.989 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.71 ' HG3' ' HE2' ' A' ' 66' ' ' LYS . 4.9 mt-10 -91.48 -27.97 17.92 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.146 0.498 . . . . 0.0 110.067 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.75 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -62.94 -34.62 77.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.115 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.768 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 21.0 mt -60.85 -56.95 30.1 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.768 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 75.7 Cg_exo -51.09 -37.29 57.53 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.255 1.97 . . . . 0.0 112.666 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.638 ' HG3' ' HB3' ' A' ' 47' ' ' LEU . 17.4 mm-40 -67.35 -65.79 0.64 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.841 0.353 . . . . 0.0 111.481 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.543 HG21 ' HG3' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -54.52 -45.35 73.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.433 -178.909 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.439 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 7.1 p -59.18 -29.1 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.209 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.9 tptt -58.5 -43.89 89.25 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 176.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.499 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 2.9 mtpp -90.07 -77.64 0.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.484 177.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.43 ' HG ' ' H ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -98.44 -97.6 0.22 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.947 178.783 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.24 -82.39 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.372 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.63 166.94 25.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.018 0.437 . . . . 0.0 111.524 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.926 ' HB2' HG13 ' A' ' 95' ' ' ILE . 3.9 mt-10 -106.58 56.55 0.65 Allowed 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.2 p -97.38 122.18 48.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.086 0.469 . . . . 0.0 111.186 -176.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.631 HD22 ' HB3' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -133.61 -38.27 0.92 Allowed 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.341 -179.336 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.543 ' O ' ' HB2' ' A' ' 94' ' ' TYR . 1.0 OUTLIER -153.8 126.27 8.07 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.725 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.425 HD13 ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -118.58 137.48 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.093 178.929 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 92' ' ' LYS . 0.5 OUTLIER -158.54 173.69 16.23 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.908 0.385 . . . . 0.0 111.398 -179.798 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -133.78 168.1 19.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.613 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.587 HG21 ' HE1' ' A' ' 59' ' ' TRP . 48.0 t -129.55 -60.25 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.04 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -125.13 -150.83 7.87 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.492 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.14 -77.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.69 2.26 . . . . 0.0 112.297 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.45 ' HB2' ' OD2' ' A' ' 61' ' ' ASP . 0.8 OUTLIER -96.8 -2.45 44.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.004 -179.756 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.35 134.82 35.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.545 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.409 ' HZ2' ' HD3' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -151.07 169.19 22.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.019 0.438 . . . . 0.0 111.259 -179.767 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.499 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 0.9 OUTLIER -121.08 131.58 54.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.456 179.549 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.9 mt -125.48 144.24 36.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.979 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.563 ' HB3' ' HG ' ' A' ' 81' ' ' LEU . 2.8 m-85 -118.1 119.86 36.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.141 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.926 HG13 ' HB2' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -123.92 141.88 42.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.901 -178.205 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.631 ' HB3' HD22 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -151.04 130.06 12.58 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 120.107 -0.637 . . . . 0.0 112.391 -178.539 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.636 HG21 ' HB3' ' A' ' 50' ' ' MET . 10.8 t -72.68 116.12 14.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.652 178.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.92 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.862 HG13 ' HA ' ' A' ' 56' ' ' LEU . 87.9 t . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.427 0.156 . . . . 0.0 111.178 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.423 ' H ' HD23 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -99.77 -42.15 6.96 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.845 -179.389 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.817 ' H ' HD22 ' A' ' 56' ' ' LEU . 4.4 mmtt -131.68 159.4 38.48 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.375 0.607 . . . . 0.0 112.433 -178.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 99.3 m -135.26 124.23 24.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.629 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.556 HD22 HG13 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -101.69 121.98 43.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.084 -179.848 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -129.49 87.42 2.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.922 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.79 HG23 HG23 ' A' ' 60' ' ' ILE . 6.4 m -114.37 43.42 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.001 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 21.7 ttp85 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.665 -179.084 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.2 t . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.774 0.321 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.88 -40.55 89.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.622 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.3 tmm_? -67.1 -33.31 75.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.627 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.548 ' O ' ' HG3' ' A' ' 50' ' ' MET . . . -64.01 -54.18 38.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.848 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.497 HD21 ' CD ' ' A' ' 68' ' ' ARG . 53.2 mt -52.19 -35.32 48.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.339 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.99 -22.38 39.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.181 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -126.52 49.51 2.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.289 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.786 ' HB3' HG11 ' A' ' 97' ' ' VAL . 60.6 mtm -83.19 128.65 34.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.053 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.531 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 4.3 mtpp -85.83 154.73 58.59 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.419 179.07 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.47 -43.08 42.48 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.589 2.192 . . . . 0.0 112.826 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.41 57.44 0.49 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.426 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.531 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 7.2 mm-40 -90.08 128.37 36.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.3 0.55 . . . . 0.0 111.305 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.668 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 6.1 mt -135.93 66.89 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.814 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.862 ' HA ' HG13 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -118.71 -172.23 2.24 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -171.772 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -140.47 171.35 14.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.555 -178.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.556 HG13 HD22 ' A' ' 29' ' ' LEU . 33.6 t -139.58 146.2 25.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.57 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.419 ' C ' HG13 ' A' ' 60' ' ' ILE . 6.8 t90 -122.98 109.74 14.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.014 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.79 HG23 HG23 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -151.7 -178.39 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.308 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -101.59 -2.95 29.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.496 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.598 ' O ' HD13 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -137.82 139.44 26.52 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.612 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -62.13 89.85 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.498 2.132 . . . . 0.0 112.245 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -23.37 67.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.927 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.812 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.4 OUTLIER -55.86 -16.91 5.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.116 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.6 pttt -53.49 -37.32 62.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.274 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -94.21 -27.91 15.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.175 0.512 . . . . 0.0 110.093 178.517 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.812 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -64.77 -25.43 67.92 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.378 179.725 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.502 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 18.9 mt -73.42 -54.83 3.88 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 9.2 Cg_endo -53.99 -33.67 73.72 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.194 1.929 . . . . 0.0 112.366 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.531 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -69.45 -46.89 65.65 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.996 0.427 . . . . 0.0 110.767 179.169 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.613 ' O ' HD22 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -62.08 -47.82 82.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.041 -179.861 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 70' ' ' PRO . 7.1 p -58.89 -27.53 35.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.841 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.531 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 4.5 mmmt -58.71 -42.69 89.24 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 175.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.443 ' HB3' HD13 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -90.1 -81.49 0.29 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.986 176.421 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.782 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -98.56 -107.43 0.19 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.416 177.35 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.444 ' H ' HD23 ' A' ' 76' ' ' LEU . . . -129.22 -82.53 0.31 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.079 -0.581 . . . . 0.0 111.939 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.03 161.47 40.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.92 0.391 . . . . 0.0 110.856 178.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.829 ' HB2' HG23 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -103.84 52.73 0.76 Allowed 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.127 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.6 p -98.97 122.18 50.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.872 -178.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.475 ' HG ' ' N ' ' A' ' 82' ' ' GLU . 0.4 OUTLIER -133.48 -35.0 1.02 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.063 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -153.69 153.46 32.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.025 0.441 . . . . 0.0 112.052 179.351 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 82' ' ' GLU . 3.6 mp -144.03 135.53 22.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.437 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -156.07 -179.66 8.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.067 0.461 . . . . 0.0 111.314 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -133.57 158.51 42.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.783 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 62.0 t -117.65 -59.26 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.261 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -127.08 -152.73 8.07 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.729 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -56.67 -75.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.678 2.252 . . . . 0.0 112.612 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.18 -5.62 29.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.907 0.384 . . . . 0.0 111.235 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.468 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 4.3 pt-20 -93.61 137.1 33.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.769 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.02 168.56 20.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.923 0.392 . . . . 0.0 111.121 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.3 tttm -126.14 136.9 53.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.623 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.422 HG22 ' N ' ' A' ' 94' ' ' TYR . 2.2 mp -125.99 157.69 35.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.937 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.492 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 15.3 m-85 -118.21 135.02 54.51 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.014 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.829 HG23 ' HB2' ' A' ' 79' ' ' GLU . 10.9 mm -122.88 145.48 29.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.214 -176.078 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.663 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -143.68 106.04 4.41 Favored 'General case' 0 C--N 1.334 -0.085 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.738 -177.569 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.786 HG11 ' HB3' ' A' ' 50' ' ' MET . 23.7 t -75.79 131.11 35.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.642 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.509 ' HB2' ' HG ' ' A' ' 76' ' ' LEU . 3.5 mmmp? . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.152 -0.928 . . . . 0.0 110.908 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.1 t . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.856 0.36 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.08 -53.52 3.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.966 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.4 ' HB3' ' HG ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -126.25 160.54 30.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.016 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 57' ' ' GLU . 98.3 m -135.27 122.65 21.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.832 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.662 ' HB3' ' HB ' ' A' ' 58' ' ' VAL . 8.6 tt -99.15 103.35 15.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.948 0.404 . . . . 0.0 111.028 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.22 111.66 17.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.625 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.4 HG23 ' CG2' ' A' ' 60' ' ' ILE . 1.2 m -140.15 75.98 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.231 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.052 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.562 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 10.2 t . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.644 0.259 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.04 -50.46 69.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.695 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.39 -33.08 74.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.075 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.52 -42.29 91.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.037 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 43' ' ' THR . 2.8 mt -77.54 -45.69 24.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.677 -179.239 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -15.81 60.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.943 -177.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.71 63.06 1.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.938 0.399 . . . . 0.0 111.2 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.416 ' HB2' HG21 ' A' ' 97' ' ' VAL . 6.6 ptt? -109.25 136.48 48.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.868 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.489 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -92.27 147.44 34.58 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.671 179.491 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -42.47 -56.82 1.89 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.025 2.483 . . . . 0.0 113.476 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.24 56.0 0.58 Allowed Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.056 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.489 ' HG2' ' HB3' ' A' ' 51' ' ' LYS . 4.2 mm-40 -90.72 150.66 21.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.082 0.468 . . . . 0.0 111.78 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.8 mp -133.65 111.59 15.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.499 177.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.4 ' HG ' ' HB3' ' A' ' 27' ' ' LYS . 4.3 mp -119.3 168.38 10.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.456 0.646 . . . . 0.0 112.39 -176.314 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.511 ' O ' HG23 ' A' ' 28' ' ' THR . 4.3 tt0 -141.51 117.4 10.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.445 178.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.662 ' HB ' ' HB3' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -114.06 136.26 51.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.148 0.499 . . . . 0.0 112.076 -176.172 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.524 ' HE3' ' HG3' ' A' ' 92' ' ' LYS . 2.7 t-105 -122.89 119.43 30.47 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.038 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.524 HD13 ' C ' ' A' ' 62' ' ' TYR . 1.0 OUTLIER -158.88 -169.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.096 0.474 . . . . 0.0 111.528 -178.61 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.419 ' HA ' ' O ' ' A' ' 89' ' ' SER . 85.7 m-20 -104.09 -9.18 18.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.973 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.524 ' C ' HD13 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -144.49 110.99 4.96 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.301 179.494 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.417 ' HD3' ' HE3' ' A' ' 91' ' ' TRP . 84.6 Cg_exo -45.98 106.26 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.747 2.298 . . . . 0.0 112.752 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.52 -8.13 38.54 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.724 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.777 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 15.8 p -61.2 -12.82 14.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.661 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.02 -38.75 68.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.978 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.509 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -93.58 -27.49 16.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.18 0.514 . . . . 0.0 110.126 178.618 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.777 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 4.4 mtm-85 -64.09 -32.43 73.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.045 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.774 ' O ' HG13 ' A' ' 73' ' ' VAL . 17.2 mt -62.54 -57.76 20.67 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.154 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.737 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 84.9 Cg_exo -48.13 -40.28 34.23 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.196 1.931 . . . . 0.0 112.442 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.0 -46.26 78.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.994 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.62 ' O ' ' HG2' ' A' ' 75' ' ' LYS . 1.9 m -65.66 -37.96 87.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.749 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.774 HG13 ' O ' ' A' ' 69' ' ' ILE . 1.5 m -63.89 -29.35 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.465 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.52 -45.53 88.62 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 176.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.62 ' HG2' ' O ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -86.75 -80.97 0.23 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.658 177.218 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.619 HD13 ' HB3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -100.29 -95.16 0.26 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.962 0.41 . . . . 0.0 110.902 178.584 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.53 ' O ' ' HB ' ' A' ' 72' ' ' THR . . . -145.13 -82.22 0.05 OUTLIER Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.03 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.43 152.02 39.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.898 0.38 . . . . 0.0 111.002 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.931 ' HB2' HG23 ' A' ' 95' ' ' ILE . 2.2 mt-10 -95.54 54.2 1.55 Allowed 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.943 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.519 HG23 HD11 ' A' ' 83' ' ' ILE . 1.2 p -98.92 116.14 41.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.903 -178.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.619 HD23 ' H ' ' A' ' 81' ' ' LEU . 2.0 pt? -133.22 -31.23 1.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.119 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.528 ' O ' HD13 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -150.99 130.66 13.1 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.194 -0.603 . . . . 0.0 112.244 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.528 HD13 ' O ' ' A' ' 82' ' ' GLU . 1.8 mm -131.05 131.1 64.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.4 178.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -154.85 173.4 16.53 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.895 0.378 . . . . 0.0 111.263 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.92 172.18 13.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.775 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.43 HG13 ' N ' ' A' ' 87' ' ' GLY . 2.7 p -140.86 -50.42 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.189 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.43 ' N ' HG13 ' A' ' 86' ' ' VAL . . . -123.55 -158.54 10.19 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.566 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.25 -66.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.602 2.201 . . . . 0.0 112.588 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 61' ' ' ASP . 80.2 p -100.26 -8.53 23.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.55 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.45 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -93.24 116.99 29.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.756 179.737 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.417 ' HE3' ' HD3' ' A' ' 63' ' ' PRO . 4.8 m0 -131.63 163.82 27.24 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.972 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.524 ' HG3' ' HE3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -125.81 123.06 37.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.301 179.103 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.8 mp -125.54 150.95 31.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.976 0.417 . . . . 0.0 111.305 -178.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.505 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 6.9 m-85 -118.2 134.22 55.21 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.987 178.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.931 HG23 ' HB2' ' A' ' 79' ' ' GLU . 13.6 mm -123.32 139.14 50.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.266 -178.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.576 ' H ' ' HB3' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -143.41 122.92 13.19 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 120.182 -0.607 . . . . 0.0 112.518 -176.178 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.422 ' HB ' ' H ' ' A' ' 54' ' ' GLU . 6.5 t -78.57 118.32 25.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.439 177.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.619 ' HB3' HD13 ' A' ' 76' ' ' LEU . 2.8 tttt . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.999 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.543 ' HA ' HG22 ' A' ' 55' ' ' ILE . 52.8 t . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.852 0.358 . . . . 0.0 111.074 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.404 ' OG1' ' HB ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -99.27 -48.96 4.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.197 -179.284 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.478 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -120.6 129.83 53.91 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.83 0.348 . . . . 0.0 110.991 -179.998 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 99.8 m -118.58 121.16 39.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.847 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.677 HD13 HH22 ' A' ' 68' ' ' ARG . 6.9 tt -99.66 115.82 30.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.081 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -116.81 115.85 26.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.44 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.564 HG13 HG23 ' A' ' 60' ' ' ILE . 7.7 p -140.27 76.57 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.443 0.639 . . . . 0.0 111.163 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.015 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.4 t . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.716 0.293 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.29 -44.23 97.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.538 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.11 -38.56 78.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.865 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.24 -43.15 99.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.747 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.653 HD11 ' HG2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -67.23 -33.56 75.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.96 179.741 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -81.13 -6.36 58.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.097 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -130.64 51.24 2.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.32 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.453 ' HB3' HG21 ' A' ' 97' ' ' VAL . 10.5 mtp -99.74 109.61 22.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.901 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.507 ' HB3' ' HG3' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -74.69 138.06 73.8 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.455 179.305 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_exo -42.57 -41.77 8.12 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.751 2.301 . . . . 0.0 112.907 -179.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.27 50.31 0.87 Allowed Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.932 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.546 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 9.3 mt-10 -90.89 151.02 21.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.465 0.65 . . . . 0.0 112.177 -178.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.984 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 3.1 mp -134.24 106.15 7.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.049 178.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.478 HD22 ' HB3' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -128.48 156.44 43.23 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -175.185 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -135.59 136.86 41.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.145 176.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.606 HG13 ' HB3' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -114.77 140.18 37.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.067 0.461 . . . . 0.0 112.059 -177.007 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -122.67 98.12 5.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.351 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.564 HG23 HG13 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -147.0 -173.06 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.461 -179.069 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.404 ' H ' HG22 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -109.26 -16.39 14.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.951 178.023 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -123.18 126.73 25.86 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.55 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -56.52 93.68 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.588 2.192 . . . . 0.0 112.658 -179.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.54 -16.19 63.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.905 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.633 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 9.7 p -63.66 -10.47 19.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.856 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -61.28 -33.28 73.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.605 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.587 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -93.72 -28.59 15.86 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.355 0.598 . . . . 0.0 110.075 178.175 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.677 HH22 HD13 ' A' ' 29' ' ' LEU . 37.6 mtt-85 -61.51 -39.57 91.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.604 178.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.674 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 22.3 mt -55.83 -57.1 23.54 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.279 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.674 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 83.2 Cg_exo -45.63 -39.3 17.72 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.249 1.966 . . . . 0.0 112.385 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.437 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 2.3 mp0 -71.36 -61.08 1.9 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.49 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.527 ' HB ' ' O ' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -56.78 -31.3 64.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.54 -178.745 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.605 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 8.6 p -74.26 -26.53 20.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.67 0.271 . . . . 0.0 110.873 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.33 -46.56 85.96 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 177.103 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.29 -73.9 0.49 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.211 177.19 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.423 HD11 HG22 ' A' ' 72' ' ' THR . 0.1 OUTLIER -98.12 -106.92 0.19 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.322 177.842 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.605 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.67 -89.07 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.458 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 0.6 OUTLIER -147.81 145.76 28.88 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 178.223 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.704 ' O ' ' HA ' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -96.77 61.61 1.87 Allowed 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.129 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.651 HG12 HD11 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -98.36 118.61 45.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.516 -177.221 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 1.012 HD21 ' HD3' ' A' ' 96' ' ' LYS . 0.5 OUTLIER -133.86 -28.11 1.42 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.038 179.722 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.31 139.77 18.69 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.348 -0.541 . . . . 0.0 112.371 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.651 HD11 HG12 ' A' ' 80' ' ' VAL . 3.9 mp -144.18 128.05 12.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.159 178.241 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -156.17 -176.36 5.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.188 0.518 . . . . 0.0 111.403 -178.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 91' ' ' TRP . 8.4 pt-20 -133.17 161.18 35.12 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.691 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -113.69 -55.41 4.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.232 -179.14 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -122.95 -139.98 5.61 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.738 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.42 -83.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.609 2.206 . . . . 0.0 112.418 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.9 p -98.8 -0.36 42.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.906 0.384 . . . . 0.0 111.009 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -93.29 122.2 35.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.641 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -135.38 165.54 25.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.042 0.449 . . . . 0.0 111.297 -179.737 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -121.25 141.52 50.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.38 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.3 mp -125.64 152.28 32.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.125 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.51 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 19.3 m-85 -118.82 111.54 18.55 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.719 179.103 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.704 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -124.45 120.99 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.078 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 1.012 ' HD3' HD21 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -133.36 106.74 7.68 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.963 -172.577 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.546 ' HB ' ' HB2' ' A' ' 54' ' ' GLU . 22.0 t -56.58 113.09 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.767 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.5 mmtm . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.972 -179.535 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.737 HG21 ' HB2' ' A' ' 57' ' ' GLU . 1.5 p . . . . . 0 CA--C 1.529 0.145 0 CA-C-O 120.938 0.399 . . . . 0.0 111.505 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.6 m -99.77 -58.82 1.84 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.477 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 4.2 mptt -100.71 158.11 16.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.362 178.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.781 HG23 ' HB3' ' A' ' 57' ' ' GLU . 28.6 m -135.88 118.26 15.72 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.829 0.347 . . . . 0.0 111.6 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.9 tt -102.25 113.09 26.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.126 177.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.463 ' HB3' ' HB3' ' A' ' 59' ' ' TRP . 2.7 p-10 -132.29 116.2 16.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.188 -178.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.499 ' H ' HG23 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -131.6 64.23 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.131 179.661 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.061 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.688 0.28 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.86 -37.25 78.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.983 0.421 . . . . 0.0 110.288 179.051 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.12 -30.99 71.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.719 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.61 -49.89 75.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.087 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.617 ' HB3' ' HG2' ' A' ' 71' ' ' GLU . 3.2 mm? -59.59 -35.42 74.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.007 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -81.26 -23.26 38.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.293 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -121.95 52.18 1.29 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.959 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.77 146.84 25.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.018 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.757 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -98.82 153.64 37.77 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.545 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.757 ' HD2' ' HG3' ' A' ' 51' ' ' LYS . 53.6 Cg_exo -38.77 -84.2 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.145 2.563 . . . . 0.0 113.794 -178.556 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 97' ' ' VAL . . . -104.28 59.33 0.47 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.97 -0.634 . . . . 0.0 113.046 -178.345 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -90.89 158.41 16.79 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.076 0.465 . . . . 0.0 111.753 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.523 HG23 ' HB2' ' A' ' 96' ' ' LYS . 0.1 OUTLIER -130.57 121.75 51.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.108 179.263 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.7 mp -129.29 163.86 24.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.221 0.534 . . . . 0.0 111.59 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.781 ' HB3' HG23 ' A' ' 28' ' ' THR . 48.4 tt0 -121.04 158.1 28.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.809 178.153 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.8 t -136.56 115.75 15.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.894 0.378 . . . . 0.0 111.089 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.521 ' HE1' HG21 ' A' ' 86' ' ' VAL . 6.5 t90 -122.08 104.94 9.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.492 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.499 HG23 ' H ' ' A' ' 31' ' ' VAL . 1.0 OUTLIER -158.29 -174.31 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.656 -178.477 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -99.01 -23.68 15.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.933 178.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.48 ' O ' HD13 ' A' ' 60' ' ' ILE . 42.9 m-85 -115.27 112.24 44.08 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.372 178.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -47.22 99.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.816 2.344 . . . . 0.0 113.119 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.26 -26.66 65.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.544 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.735 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -63.27 -13.7 41.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.762 179.714 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.549 ' HG3' ' N ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -58.65 -32.06 68.74 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.436 179.243 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.549 ' N ' ' HG3' ' A' ' 66' ' ' LYS . 0.3 OUTLIER -94.52 -26.44 16.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.898 178.019 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.735 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 9.1 mtt85 -60.81 -39.39 88.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.066 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.697 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 6.9 mt -62.14 -55.87 36.62 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.543 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.697 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 84.0 Cg_exo -46.34 -39.56 21.69 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.304 2.003 . . . . 0.0 112.511 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.617 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 0.9 OUTLIER -68.64 -51.93 36.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.957 179.42 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.633 HG21 ' HG3' ' A' ' 79' ' ' GLU . 1.7 m -60.46 -40.12 90.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.982 -178.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 70' ' ' PRO . 12.9 m -64.92 -30.24 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.856 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.25 -43.09 87.68 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -90.26 -78.17 0.38 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.784 177.707 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.42 ' H ' ' CG ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -99.38 -97.46 0.23 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.98 0.419 . . . . 0.0 110.596 178.399 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.536 ' O ' ' HB ' ' A' ' 72' ' ' THR . . . -145.01 -86.56 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.735 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.555 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -146.71 153.97 40.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.823 0.345 . . . . 0.0 110.824 178.799 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.931 ' HB2' HG23 ' A' ' 95' ' ' ILE . 0.6 OUTLIER -101.35 63.72 0.99 Allowed 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.087 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.555 HG22 ' HB2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -99.22 127.36 52.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.336 -177.54 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.526 ' HG ' ' HB3' ' A' ' 94' ' ' TYR . 1.0 OUTLIER -132.98 -36.41 1.03 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.719 179.528 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.473 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 0.7 OUTLIER -154.15 151.96 29.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.076 0.465 . . . . 0.0 111.951 179.245 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 82' ' ' GLU . 2.6 mp -144.18 134.99 21.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.268 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -158.66 -179.22 7.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.092 0.473 . . . . 0.0 111.267 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -133.57 167.47 20.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.664 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.521 HG21 ' HE1' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -129.74 -59.01 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.215 -179.654 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -124.87 -151.86 8.16 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.682 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -63.01 -75.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.741 2.294 . . . . 0.0 112.593 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.56 -4.08 34.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.245 -179.077 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.409 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 3.3 pt-20 -93.2 123.83 36.75 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.433 178.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 2.9 m-90 -129.8 167.82 17.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.021 0.438 . . . . 0.0 111.394 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -123.5 132.99 54.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.598 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.4 mt -125.48 146.85 30.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.69 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.526 ' HB3' ' HG ' ' A' ' 81' ' ' LEU . 36.4 m-85 -118.09 124.23 47.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.098 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.931 HG23 ' HB2' ' A' ' 79' ' ' GLU . 28.5 mm -123.91 148.53 28.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.291 -176.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.678 ' C ' ' HB3' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -150.78 106.13 3.36 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.107 -177.463 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.447 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 1.7 t -59.86 119.28 3.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.638 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.188 -0.91 . . . . 0.0 110.887 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.5 t . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.846 0.355 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.74 -70.3 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.037 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -118.6 162.73 17.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.86 0.362 . . . . 0.0 111.223 -179.763 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 92.3 m -135.64 129.0 32.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.856 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.5 tt -111.35 118.1 34.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.001 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.81 110.95 16.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.919 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 31' ' ' VAL . 7.1 p -137.61 70.77 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.397 0.618 . . . . 0.0 110.977 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 32' ' ' ARG . 3.8 ttp180 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.855 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.875 0.369 . . . . 0.0 110.683 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.9 tptt -54.98 -45.47 75.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.509 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -33.58 76.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.013 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.94 -30.84 64.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.993 0.425 . . . . 0.0 110.791 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.641 HD22 ' HG2' ' A' ' 68' ' ' ARG . 1.3 mt -77.4 -57.2 3.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.301 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.16 -10.09 59.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.717 -178.304 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -131.23 67.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.855 0.359 . . . . 0.0 111.048 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.48 ' HB2' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -109.01 144.87 36.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.857 179.699 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.693 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 11.6 mttt -81.18 159.15 68.58 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.033 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 100.0 Cg_exo -45.91 -75.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.939 2.426 . . . . 0.0 113.873 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 97' ' ' VAL . . . -103.83 60.77 0.45 Allowed Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.144 -177.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.693 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 3.2 mm-40 -90.98 152.4 20.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.056 0.455 . . . . 0.0 111.72 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.5 mp -135.31 112.57 14.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.018 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.1 mp -126.27 151.69 47.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.228 0.537 . . . . 0.0 112.355 -177.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -113.31 124.64 52.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.376 176.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.0 t -114.32 134.31 57.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.136 0.493 . . . . 0.0 112.075 -177.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.52 ' NE1' HG21 ' A' ' 86' ' ' VAL . 13.7 t90 -123.0 106.76 11.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.325 178.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.617 HD13 ' H ' ' A' ' 64' ' ' MET . 0.1 OUTLIER -144.03 -162.95 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.823 0.344 . . . . 0.0 111.267 -178.659 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -145.27 24.16 1.45 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.313 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.737 ' H ' ' HA ' ' A' ' 63' ' ' PRO . 29.3 m-85 -101.26 -56.14 0.13 Allowed Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 116.673 -0.239 . . . . 0.0 111.483 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.737 ' HA ' ' H ' ' A' ' 62' ' ' TYR . 76.7 Cg_endo -94.32 177.79 11.03 Favored 'Cis proline' 0 C--N 1.355 0.873 0 C-N-CA 124.796 -0.918 . . . . 0.0 112.294 -0.315 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.617 ' H ' HD13 ' A' ' 60' ' ' ILE . 14.2 tmm? -65.18 -21.45 66.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.755 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.641 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 30.4 t -63.6 -15.62 58.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.149 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.39 -34.13 74.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.978 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.556 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -92.23 -23.43 19.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.225 0.536 . . . . 0.0 109.979 178.432 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.641 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 20.7 mtt-85 -63.41 -47.8 80.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.81 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.723 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 8.1 mt -51.04 -54.92 32.47 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.664 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.723 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 82.8 Cg_exo -48.64 -50.48 12.35 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.267 1.978 . . . . 0.0 112.959 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.44 -53.62 33.39 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.153 0.501 . . . . 0.0 111.637 -179.156 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.55 ' HB ' ' O ' ' A' ' 77' ' ' GLY . 0.9 OUTLIER -56.41 -49.56 74.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.601 -178.245 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.631 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 18.2 m -64.75 -21.16 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 120.607 0.241 . . . . 0.0 111.198 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.35 -55.27 37.22 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.858 ' HG2' ' H ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -91.1 -61.28 1.7 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.942 177.963 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.858 ' H ' ' HG2' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -100.45 -109.09 0.21 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.042 0.448 . . . . 0.0 110.526 176.565 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.631 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -144.97 -87.63 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 178.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.468 ' HA ' HG21 ' A' ' 72' ' ' THR . 0.2 OUTLIER -148.14 150.6 34.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.642 0.258 . . . . 0.0 110.762 177.499 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.73 ' HB2' ' H ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -97.81 74.2 2.34 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.14 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.56 123.86 51.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.997 0.427 . . . . 0.0 111.831 -176.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.491 ' HG ' ' N ' ' A' ' 82' ' ' GLU . 0.6 OUTLIER -133.45 -35.59 1.01 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.669 179.076 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.642 ' HB3' ' HB2' ' A' ' 94' ' ' TYR . 0.3 OUTLIER -153.69 149.01 27.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.618 179.377 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 82' ' ' GLU . 2.2 mp -142.62 133.41 23.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.625 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.607 ' HG3' ' HB3' ' A' ' 92' ' ' LYS . 8.4 pt-20 -158.07 -177.46 6.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.078 0.466 . . . . 0.0 111.219 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -133.39 167.21 20.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.817 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.52 HG21 ' NE1' ' A' ' 59' ' ' TRP . 40.7 t -124.63 -66.95 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.205 -179.271 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -124.34 -154.41 8.87 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.567 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.16 -71.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.632 2.221 . . . . 0.0 112.325 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.2 0.19 39.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.093 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.428 ' HG2' ' H ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -93.3 132.52 37.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.774 179.639 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 -138.92 159.62 41.7 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.929 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.607 ' HB3' ' HG3' ' A' ' 84' ' ' GLU . 24.5 ttmt -124.37 126.4 45.92 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.344 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.6 mp -125.33 149.87 30.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.967 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.642 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 8.6 m-85 -118.15 129.98 55.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.369 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.617 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -123.69 148.88 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.166 -178.068 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.73 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -150.83 104.73 3.2 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.582 -178.298 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.507 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 3.1 t -62.96 119.05 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.26 178.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.1 mttt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.058 -179.509 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.95 -15.47 1.52 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.782 0.325 . . . . 0.0 110.896 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.4 t -88.53 121.1 30.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.902 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -133.62 -40.53 0.87 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.937 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -134.61 -162.32 1.24 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.039 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -62.66 165.76 6.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.024 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 8.7 m80 -80.65 101.97 9.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.874 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.71 30.97 3.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.834 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.7 m80 -89.92 -81.93 0.28 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.783 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.53 68.18 10.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.0 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.61 -79.09 0.16 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.058 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.9 158.95 45.2 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.58 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.84 91.07 2.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.838 0.351 . . . . 0.0 110.888 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.3 m -86.65 123.83 70.28 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.165 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -83.69 21.36 1.06 Allowed 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.681 2.254 . . . . 0.0 112.442 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.411 ' HD2' HH11 ' A' ' 16' ' ' ARG . 1.2 mtp180 -83.31 28.16 0.55 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.286 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.92 97.5 0.16 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.311 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.481 ' HB3' ' H ' ' A' ' 19' ' ' HIS . 0.6 OUTLIER -73.83 -150.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.58 0.229 . . . . 0.0 110.964 -179.585 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.481 ' H ' ' HB3' ' A' ' 18' ' ' SER . 1.5 m-70 -55.03 -62.1 1.88 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.147 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.73 123.95 26.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.956 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.09 140.64 40.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.074 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -84.31 72.34 10.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.976 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -74.7 166.34 23.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.843 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.28 64.86 8.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.893 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.5 t -82.65 146.57 6.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.438 HG21 ' OE1' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -99.6 -65.21 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.078 -179.568 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.11 169.77 9.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.097 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.755 HG23 ' HB3' ' A' ' 57' ' ' GLU . 83.3 m -135.51 130.85 35.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.808 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.1 tp -106.37 113.08 26.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.845 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.68 123.33 42.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.888 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.4 47.62 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.079 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.464 ' HB2' ' H ' ' A' ' 33' ' ' GLY . 14.4 mtm180 -69.97 -100.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.752 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.464 ' H ' ' HB2' ' A' ' 32' ' ' ARG . . . -79.45 82.13 1.41 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.096 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -83.98 163.92 19.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.962 0.41 . . . . 0.0 111.385 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.14 -90.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.652 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.559 ' O ' ' HD2' ' A' ' 39' ' ' PRO . 0.5 OUTLIER -65.71 163.32 36.11 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.339 178.567 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.73 15.83 0.84 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.467 2.111 . . . . 0.0 112.68 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.651 ' HB ' ' HD3' ' A' ' 39' ' ' PRO . 11.7 t -65.74 -52.98 39.05 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.549 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.651 ' HD3' ' HB ' ' A' ' 38' ' ' VAL . 52.1 Cg_exo -54.42 -29.96 61.4 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.215 1.943 . . . . 0.0 112.2 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.425 ' O ' HG22 ' A' ' 43' ' ' THR . 0.1 OUTLIER -63.45 -49.96 71.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.477 179.48 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.5 t -67.25 -20.98 27.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.88 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -66.31 -59.13 4.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.944 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.549 ' O ' HD22 ' A' ' 47' ' ' LEU . 7.2 t -56.03 -33.25 64.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.694 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 48' ' ' GLN . 5.3 mmtt -56.79 -41.89 78.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.514 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.62 -30.74 71.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.946 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 43' ' ' THR . . . -56.53 -54.34 47.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.967 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.793 ' HB3' ' HG2' ' A' ' 71' ' ' GLU . 0.4 OUTLIER -77.24 -37.31 53.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.768 -179.492 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.474 ' HB3' ' O ' ' A' ' 44' ' ' LYS . 1.4 tt0 -68.14 -31.18 70.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.396 -178.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -134.96 72.18 1.45 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.064 0.459 . . . . 0.0 110.932 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.18 140.73 31.53 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.846 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.538 ' HG2' ' HD2' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -94.17 151.48 39.61 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.778 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.538 ' HD2' ' HG2' ' A' ' 51' ' ' LYS . 50.0 Cg_exo -38.23 -86.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.366 2.71 . . . . 0.0 114.027 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.439 ' H ' ' HB2' ' A' ' 52' ' ' PRO . . . -103.89 59.05 0.5 Allowed Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.989 -0.624 . . . . 0.0 113.124 -177.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.438 ' OE1' HG21 ' A' ' 26' ' ' THR . 2.8 mm-40 -90.7 156.42 18.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.104 0.478 . . . . 0.0 111.705 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.442 HG23 ' HB2' ' A' ' 96' ' ' LYS . 3.4 mp -135.05 117.75 22.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.992 178.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.6 mp -122.77 164.05 19.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.209 0.528 . . . . 0.0 111.753 -178.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.755 ' HB3' HG23 ' A' ' 28' ' ' THR . 37.2 tt0 -114.38 161.27 18.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.131 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.1 t -142.7 113.92 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.808 0.337 . . . . 0.0 111.221 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.6 103.25 8.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.786 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -158.11 -166.19 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.029 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -103.04 -2.5 27.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.015 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -137.58 148.12 60.13 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.927 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.69 104.4 1.88 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.601 2.201 . . . . 0.0 112.624 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 8.4 tpp -68.1 -19.95 64.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.108 0.48 . . . . 0.0 110.617 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.819 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 3.6 p -58.85 -10.84 2.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.215 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.44 ' HG3' ' H ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -56.75 -44.69 81.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.789 0.328 . . . . 0.0 110.727 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.534 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 0.7 OUTLIER -86.64 -24.88 25.15 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.085 0.469 . . . . 0.0 110.055 178.398 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.819 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 1.0 OUTLIER -61.69 -41.34 97.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.233 179.565 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.745 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 12.9 mt -54.59 -56.67 24.54 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.745 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 76.1 Cg_exo -51.87 -36.96 65.38 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.288 1.992 . . . . 0.0 112.682 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.793 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 0.6 OUTLIER -71.92 -64.46 0.93 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.782 0.325 . . . . 0.0 111.66 -179.2 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.47 HG21 ' HG2' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -55.9 -30.6 61.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.555 -178.515 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 70' ' ' PRO . 6.6 p -73.47 -28.89 26.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.905 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.4 tptp -58.57 -42.11 87.23 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.45 -77.51 0.4 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.226 177.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.597 HD13 ' HB2' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -98.79 -98.52 0.22 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.786 178.358 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.34 -79.71 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.249 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.68 157.32 43.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.803 0.335 . . . . 0.0 111.014 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.7 ' HB2' ' H ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -101.18 55.89 0.84 Allowed 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.135 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.6 p -98.31 123.49 50.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.269 -176.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.489 ' HG ' ' N ' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -133.31 -36.12 1.0 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.186 -179.687 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.525 ' HB3' ' HB2' ' A' ' 94' ' ' TYR . 0.5 OUTLIER -153.51 145.49 23.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.999 0.428 . . . . 0.0 111.826 -179.711 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.502 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 3.0 mp -142.44 136.11 27.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.414 178.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -157.47 179.04 9.63 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.038 0.447 . . . . 0.0 111.421 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -133.67 166.14 23.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.854 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.3 t -127.28 -64.4 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.133 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -124.83 -147.14 7.02 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.825 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -60.81 -77.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.757 2.305 . . . . 0.0 112.616 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.2 -1.74 35.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.419 -178.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.458 ' HG2' ' H ' ' A' ' 90' ' ' GLU . 0.7 OUTLIER -93.26 120.26 33.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.746 179.442 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 7.0 m0 -130.46 166.08 21.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.904 0.383 . . . . 0.0 111.187 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -127.04 129.91 48.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.612 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.7 mp -125.79 149.52 30.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.296 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.525 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 9.3 m-85 -118.68 127.97 54.07 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.202 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.646 HG13 ' HB2' ' A' ' 79' ' ' GLU . 1.1 tp -124.49 149.81 28.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.519 -177.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.7 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -151.11 109.47 3.78 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 120.523 -0.471 . . . . 0.0 112.132 -178.455 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.404 ' H ' HG23 ' A' ' 97' ' ' VAL . 2.1 t -64.41 111.16 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.266 178.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.597 ' HB2' HD13 ' A' ' 76' ' ' LEU . 16.5 mmtt . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.097 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.136 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.0 t -128.57 -63.13 1.0 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.859 0.361 . . . . 0.0 110.887 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.53 -73.41 0.68 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.873 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -87.29 165.07 15.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.795 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -97.4 140.51 31.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.968 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -90.48 131.05 36.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.037 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.59 -173.46 2.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.855 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.21 -5.0 39.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.899 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -87.7 88.35 7.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.44 138.91 57.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.885 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 t -76.36 -79.54 0.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.979 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.9 136.36 20.54 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.468 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 22.7 tp -81.25 79.98 7.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.902 0.382 . . . . 0.0 110.979 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.492 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 13.2 t -83.52 -51.29 0.64 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.425 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 59.8 Cg_endo -72.25 102.12 1.33 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.124 1.883 . . . . 0.0 112.172 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.34 27.91 0.56 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.133 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.29 148.28 43.81 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.486 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.09 -151.59 0.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.592 0.234 . . . . 0.0 110.784 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -84.13 29.24 0.57 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.979 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.13 50.01 1.34 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.851 0.357 . . . . 0.0 110.94 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.88 157.4 25.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.926 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -89.05 70.94 8.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.814 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -93.46 47.32 1.24 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.898 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -83.29 126.83 33.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.942 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 87.5 t -61.33 126.44 19.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.105 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.17 -48.2 4.7 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.945 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -121.33 148.57 44.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.098 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.3 m -132.98 140.86 47.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.825 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.641 ' HB3' HG13 ' A' ' 58' ' ' VAL . 12.6 tp -112.03 110.98 21.58 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.905 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.52 ' HB3' ' HE1' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -104.86 113.34 26.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.741 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.09 61.6 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.274 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.495 ' H ' ' HG3' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -64.86 -88.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.332 179.19 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.401 ' H ' ' HB2' ' A' ' 32' ' ' ARG . . . -77.99 103.36 1.89 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.12 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -80.78 142.89 33.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.913 0.387 . . . . 0.0 111.346 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.95 -91.47 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.012 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.568 ' HB2' HG23 ' A' ' 38' ' ' VAL . 63.0 m -77.42 160.48 75.14 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.653 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 36' ' ' CYS . 60.9 Cg_endo -72.83 21.61 0.31 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.55 2.167 . . . . 0.0 112.736 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.633 ' HB ' ' HD3' ' A' ' 39' ' ' PRO . 19.3 t -60.54 -51.38 80.26 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.417 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.633 ' HD3' ' HB ' ' A' ' 38' ' ' VAL . 33.6 Cg_exo -59.88 -23.27 71.87 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.138 1.892 . . . . 0.0 112.234 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 37' ' ' PRO . 0.3 OUTLIER -65.22 -57.17 9.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.707 179.808 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.8 t -73.96 -24.01 19.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.926 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -66.53 -54.1 27.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.928 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.3 t -59.99 -37.42 79.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.81 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.05 -41.56 68.25 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.839 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 45' ' ' ARG . 3.5 tmm_? -67.95 -32.56 73.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.801 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.54 -49.38 77.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.207 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.831 ' HB3' ' HG2' ' A' ' 71' ' ' GLU . 2.5 mm? -58.67 -42.72 89.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.063 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -75.54 -15.5 60.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.036 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 45' ' ' ARG . 0.6 OUTLIER -118.19 61.68 0.77 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.92 -179.871 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 10.1 mmt -108.32 146.76 32.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.859 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.654 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 2.2 mtpp -102.81 164.21 16.04 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.767 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.625 ' HD2' ' HB3' ' A' ' 51' ' ' LYS . 2.2 Cg_endo -46.2 -73.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.119 2.546 . . . . 0.0 113.398 -178.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.27 58.78 0.49 Allowed Glycine 0 C--N 1.329 0.192 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.278 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.654 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 3.8 mm-40 -90.34 151.35 21.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.09 0.472 . . . . 0.0 111.525 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.564 ' C ' HD13 ' A' ' 56' ' ' LEU . 3.7 mp -134.75 113.51 16.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.815 178.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.564 HD13 ' C ' ' A' ' 55' ' ' ILE . 0.4 OUTLIER -118.71 145.35 45.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.164 0.506 . . . . 0.0 111.846 -176.825 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -111.07 135.49 51.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.987 177.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.641 HG13 ' HB3' ' A' ' 29' ' ' LEU . 2.0 t -134.82 126.5 47.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.52 ' HE1' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -122.97 115.33 21.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.879 176.973 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.476 HG13 ' C ' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -147.42 -170.52 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.303 -178.027 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.02 -11.71 16.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.419 178.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.425 ' O ' HD13 ' A' ' 60' ' ' ILE . 64.9 m-85 -129.76 143.92 50.95 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.55 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.88 93.73 0.39 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.532 2.155 . . . . 0.0 112.481 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.06 -16.33 63.98 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.042 0.448 . . . . 0.0 110.585 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.406 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -62.04 -15.58 45.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.793 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.503 ' HG3' ' N ' ' A' ' 67' ' ' GLU . 1.2 ptpp? -57.58 -32.88 67.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.772 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.503 ' N ' ' HG3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -94.54 -27.95 15.68 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.169 0.509 . . . . 0.0 110.401 178.737 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.675 ' HG2' HD11 ' A' ' 47' ' ' LEU . 54.3 mtt-85 -65.78 -32.68 74.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.175 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.499 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 26.6 mt -63.62 -55.33 35.31 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.553 ' O ' HG12 ' A' ' 73' ' ' VAL . 12.2 Cg_endo -56.97 -32.23 92.22 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.182 1.921 . . . . 0.0 112.566 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.831 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 0.4 OUTLIER -74.13 -60.83 2.09 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.873 0.368 . . . . 0.0 111.296 -179.818 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.669 HG21 ' HG2' ' A' ' 79' ' ' GLU . 0.2 OUTLIER -61.26 -25.0 66.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.314 -179.028 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' ' 70' ' ' PRO . 4.5 p -75.23 -28.95 21.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.274 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.46 -43.51 88.89 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.463 ' CG ' ' H ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -86.85 -78.18 0.3 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.164 176.7 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.518 HD12 ' H ' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -98.73 -98.59 0.22 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.848 0.356 . . . . 0.0 110.659 177.947 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.518 ' H ' HD12 ' A' ' 76' ' ' LEU . . . -145.28 -80.98 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.865 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -146.2 149.64 34.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.889 0.376 . . . . 0.0 110.922 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.669 ' HG2' HG21 ' A' ' 72' ' ' THR . 0.0 OUTLIER -97.87 58.93 1.42 Allowed 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.018 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.568 HG23 HD11 ' A' ' 83' ' ' ILE . 1.4 p -98.9 125.84 52.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.022 -177.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.531 ' HG ' ' N ' ' A' ' 82' ' ' GLU . 0.6 OUTLIER -133.53 -35.79 0.99 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.043 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.531 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -153.52 144.61 22.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.985 0.421 . . . . 0.0 111.906 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.568 HD11 HG23 ' A' ' 80' ' ' VAL . 3.5 mp -143.96 128.55 14.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.346 178.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -149.87 -178.25 6.36 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.239 0.542 . . . . 0.0 111.552 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.519 ' HB3' ' HD1' ' A' ' 91' ' ' TRP . 0.9 OUTLIER -133.2 163.67 28.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.616 -179.738 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 56.9 t -124.65 -73.76 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.427 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -122.73 -139.37 5.51 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.795 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.408 ' HB2' ' H ' ' A' ' 89' ' ' SER . 37.1 Cg_exo -60.82 -82.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.557 2.171 . . . . 0.0 112.5 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.408 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 59.9 p -100.15 1.51 42.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.249 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.51 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 1.2 pt-20 -93.15 119.51 32.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.747 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.519 ' HD1' ' HB3' ' A' ' 85' ' ' GLU . 4.4 m-90 -132.24 164.99 25.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.92 0.391 . . . . 0.0 111.112 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.96 140.71 51.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.795 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.1 mp -136.76 143.78 34.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.974 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.463 ' HB3' ' HG ' ' A' ' 81' ' ' LEU . 12.3 m-85 -118.54 127.56 53.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.379 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.656 HG23 ' HB2' ' A' ' 79' ' ' GLU . 32.8 mm -124.86 144.94 33.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.26 -177.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.616 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -152.12 111.2 3.86 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.157 -0.617 . . . . 0.0 112.156 -178.441 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 t -63.69 121.39 12.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.56 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.2 tttp . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.006 -179.913 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.103 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.4 p -116.54 -25.78 7.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.783 0.325 . . . . 0.0 110.923 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -109.85 9.29 24.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.975 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -91.14 110.44 21.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.838 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -138.02 60.86 1.61 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -131.12 -171.69 2.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.009 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -66.11 147.5 53.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.867 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -75.63 175.92 8.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.704 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -104.73 3.41 31.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.941 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.8 p -69.16 95.56 0.76 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.938 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.0 m -86.01 -81.97 0.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.082 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -88.71 38.96 3.15 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.656 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.5 tp -96.68 80.89 3.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.894 0.378 . . . . 0.0 110.875 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.566 HG23 ' HA3' ' A' ' 17' ' ' GLY . 2.4 m -64.87 140.89 98.21 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.186 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 14' ' ' VAL . 31.7 Cg_exo -59.78 -59.39 0.41 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.691 2.261 . . . . 0.0 112.456 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -81.56 26.2 0.49 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.448 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.566 ' HA3' HG23 ' A' ' 14' ' ' VAL . . . -81.23 75.24 2.32 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.391 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.26 -89.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.667 0.27 . . . . 0.0 111.102 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.401 ' HB3' ' H ' ' A' ' 20' ' ' MET . 1.0 OUTLIER -139.97 -92.32 0.17 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.115 -179.719 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.401 ' H ' ' HB3' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -81.75 45.07 0.86 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.235 -179.786 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.97 102.95 8.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.999 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -88.07 30.5 0.85 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.13 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -101.88 92.68 4.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.667 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.03 61.85 7.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.186 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.3 t -77.46 136.25 24.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.436 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.51 -52.22 3.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.508 -178.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.482 ' HB2' HD22 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -120.88 149.89 41.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.905 0.384 . . . . 0.0 111.462 -178.946 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 83.2 m -129.12 122.58 30.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.699 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 2.9 tt -109.23 125.37 52.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.081 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -130.79 123.39 29.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.726 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.79 HG22 ' HB2' ' A' ' 39' ' ' PRO . 8.4 t -118.45 64.3 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.128 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -63.27 -176.24 0.14 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.099 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.64 79.63 0.69 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.529 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.06 -156.22 0.58 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.599 0.238 . . . . 0.0 110.72 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.3 -88.2 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -178.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.4 p -53.31 144.29 31.24 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.405 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.21 30.4 0.47 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.627 2.218 . . . . 0.0 112.107 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.504 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 3.9 t -53.19 -51.79 71.95 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.351 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.79 ' HB2' HG22 ' A' ' 31' ' ' VAL . 42.7 Cg_endo -68.1 -19.98 44.51 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.134 1.89 . . . . 0.0 112.364 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.548 ' O ' HG22 ' A' ' 43' ' ' THR . 0.1 OUTLIER -70.02 -58.6 3.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.751 179.761 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.1 t -66.86 -15.29 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.858 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -70.97 -50.57 33.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.869 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.602 ' O ' HD13 ' A' ' 47' ' ' LEU . 14.6 t -64.36 -32.13 73.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.832 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.98 -46.95 87.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.968 0.413 . . . . 0.0 110.451 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.39 -31.65 72.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.878 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.25 -43.45 86.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.047 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.602 HD13 ' O ' ' A' ' 43' ' ' THR . 1.2 mp -58.77 -39.26 80.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.744 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.417 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 1.5 tt0 -81.2 -23.29 38.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.944 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -119.12 62.18 0.8 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.63 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.744 ' HB2' HG21 ' A' ' 97' ' ' VAL . 12.4 ptp -103.65 145.32 30.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.593 178.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.923 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 10.7 mttm -90.73 160.09 39.29 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.178 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 51' ' ' LYS . 86.3 Cg_exo -43.7 -70.78 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.098 2.532 . . . . 0.0 113.901 -178.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.46 59.79 0.45 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.9 -0.667 . . . . 0.0 113.264 -178.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.923 ' HG3' ' HB2' ' A' ' 51' ' ' LYS . 7.2 mt-10 -90.89 151.41 21.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.02 0.438 . . . . 0.0 111.572 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.683 HG12 ' HG3' ' A' ' 96' ' ' LYS . 7.4 mt -135.66 103.7 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.114 178.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.482 HD22 ' HB2' ' A' ' 27' ' ' LYS . 8.9 mt -118.73 160.51 21.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.072 0.463 . . . . 0.0 111.659 -177.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -130.6 139.64 50.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.365 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.514 HG12 HG12 ' A' ' 60' ' ' ILE . 11.7 t -120.04 136.45 57.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.136 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -122.57 110.8 16.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.677 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.607 HD11 ' HB2' ' A' ' 64' ' ' MET . 0.4 OUTLIER -158.66 -177.75 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.581 -179.428 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 89' ' ' SER . 19.0 m-20 -97.68 2.38 49.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.72 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -139.22 149.63 61.58 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.566 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.76 95.64 1.08 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.488 2.125 . . . . 0.0 112.856 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.607 ' HB2' HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -68.22 -15.43 63.57 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.172 0.51 . . . . 0.0 110.539 178.963 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.736 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 23.9 p -61.34 -12.2 12.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.719 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.3 pttm -56.36 -36.05 68.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.899 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.565 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.8 OUTLIER -94.25 -27.39 16.17 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.218 0.532 . . . . 0.0 110.018 178.209 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.736 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 4.7 mtt85 -61.91 -37.14 83.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.008 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.713 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 14.7 mt -62.15 -55.83 36.88 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.369 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.713 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 83.3 Cg_exo -47.19 -37.43 23.71 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.447 2.098 . . . . 0.0 112.717 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.509 ' HG3' ' HB3' ' A' ' 47' ' ' LEU . 15.7 mm-40 -70.86 -54.05 12.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.056 0.455 . . . . 0.0 111.106 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.597 ' HB ' ' O ' ' A' ' 77' ' ' GLY . 0.6 OUTLIER -60.75 -38.23 84.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.771 -178.605 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 69' ' ' ILE . 20.2 m -67.5 -27.84 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-O 120.688 0.28 . . . . 0.0 110.84 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.04 -43.98 87.11 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.547 ' HG2' ' O ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -90.2 -78.36 0.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.483 176.85 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.57 -97.37 0.24 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.967 0.413 . . . . 0.0 110.954 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.597 ' O ' ' HB ' ' A' ' 72' ' ' THR . . . -144.89 -84.33 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.195 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.95 152.65 39.75 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 122.723 -0.281 . . . . 0.0 110.778 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.772 ' HB2' ' H ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -96.96 71.27 2.47 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.034 0.445 . . . . 0.0 109.849 179.609 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.473 ' CG1' HD11 ' A' ' 83' ' ' ILE . 1.6 t -98.58 122.04 49.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.575 -177.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.522 ' HG ' ' N ' ' A' ' 82' ' ' GLU . 0.5 OUTLIER -133.53 -37.85 0.93 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.174 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.522 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -153.56 141.98 20.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.003 0.43 . . . . 0.0 111.866 -179.701 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.473 HD11 ' CG1' ' A' ' 80' ' ' VAL . 2.7 mt -143.53 129.93 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.222 178.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.426 ' OE2' ' HE2' ' A' ' 92' ' ' LYS . 4.8 pt-20 -156.78 179.77 8.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.184 0.516 . . . . 0.0 111.689 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -133.55 159.56 40.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.413 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.9 t -120.8 -66.97 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.398 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -122.84 -145.43 6.92 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.666 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.428 ' HD2' ' OE2' ' A' ' 90' ' ' GLU . 46.2 Cg_exo -56.44 -82.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.672 2.248 . . . . 0.0 112.509 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 61' ' ' ASP . 61.8 p -100.07 -3.75 31.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.831 0.348 . . . . 0.0 111.151 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.489 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -86.05 117.72 25.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.669 179.743 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 2.9 m-90 -130.83 164.21 25.68 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.1 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.426 ' HE2' ' OE2' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -124.28 129.51 50.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.537 179.538 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -125.8 143.39 39.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.002 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.507 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 13.6 m-85 -118.95 129.59 55.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.675 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.643 HG21 ' HE ' ' A' ' 68' ' ' ARG . 1.0 OUTLIER -124.13 149.03 28.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.68 -179.051 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.772 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -150.85 109.97 3.93 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.289 -0.564 . . . . 0.0 112.161 -178.117 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.744 HG21 ' HB2' ' A' ' 50' ' ' MET . 10.8 t -62.75 118.86 5.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.262 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.487 ' HG2' ' HD3' ' A' ' 96' ' ' LYS . 6.9 mtmt . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.986 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.164 0 N-CA-C 112.553 -0.219 . . . . 0.0 112.553 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.7 m -107.47 -3.27 19.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.794 0.33 . . . . 0.0 110.968 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.81 -55.47 4.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.958 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -106.84 120.15 41.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.911 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -127.64 137.22 52.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.935 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -65.74 126.69 29.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.033 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -124.22 -1.7 8.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.936 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.485 ' HA ' ' HB2' ' A' ' 11' ' ' SER . 7.9 m-70 -90.73 22.77 3.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.986 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 23.4 t60 -70.92 -72.8 0.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.0 m -86.16 -2.72 58.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.169 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.485 ' HB2' ' HA ' ' A' ' 8' ' ' HIS . 0.5 OUTLIER -75.07 -106.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.918 -179.707 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -89.63 171.71 38.26 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.603 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.32 76.37 3.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 0.0 110.828 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.7 t -85.78 114.61 57.8 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.85 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.48 122.44 10.12 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.425 2.084 . . . . 0.0 112.369 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -84.2 28.03 0.65 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.223 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.59 -76.59 0.62 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.39 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.27 27.54 0.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.616 0.246 . . . . 0.0 111.31 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.91 -150.15 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.858 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.2 -24.62 59.73 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.822 0.344 . . . . 0.0 111.058 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.18 108.6 1.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.978 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -91.03 45.01 1.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.004 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -88.16 42.43 1.06 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.893 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.63 80.41 1.66 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.118 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 80.6 t -64.45 153.01 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.586 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -98.82 -66.0 0.93 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.964 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -105.53 148.24 27.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.892 0.377 . . . . 0.0 110.941 179.6 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.607 HG23 ' HG2' ' A' ' 57' ' ' GLU . 86.4 m -133.9 110.47 9.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.863 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.5 tt -100.15 100.87 11.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.87 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -119.46 99.89 6.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.575 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.522 HG22 ' HB3' ' A' ' 34' ' ' GLU . 7.1 p -132.9 70.06 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.457 0.646 . . . . 0.0 111.179 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.91 -88.61 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.794 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.27 98.75 1.65 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.133 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.522 ' HB3' HG22 ' A' ' 31' ' ' VAL . 1.8 pm0 -106.62 177.59 4.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.95 0.405 . . . . 0.0 111.238 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.03 -90.48 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.854 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.751 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -60.03 157.22 32.67 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.672 179.124 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -72.91 23.86 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.739 2.293 . . . . 0.0 112.522 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.751 HG23 ' HB3' ' A' ' 36' ' ' CYS . 26.8 t -60.79 -50.99 82.67 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.537 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 38' ' ' VAL . 16.8 Cg_endo -57.26 -28.47 79.78 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.263 1.975 . . . . 0.0 112.182 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.8 -57.37 11.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.74 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.9 t -71.3 -15.88 18.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.888 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -66.79 -61.1 2.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.921 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.464 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 2.2 t -60.92 -34.64 75.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.019 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -56.23 -45.16 80.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.89 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.47 -33.09 75.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.707 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.65 -36.89 85.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.192 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 43' ' ' THR . 4.9 mt -65.55 -43.33 90.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.693 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -71.81 -26.57 62.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.481 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -117.26 57.08 0.81 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.998 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.3 ptm -96.01 150.06 20.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.855 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 5.6 mttt -104.24 156.35 35.91 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.872 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.05 -55.41 3.91 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.004 2.469 . . . . 0.0 113.277 -178.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.21 59.57 0.47 Allowed Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.844 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.855 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 3.6 mm-40 -90.8 146.39 23.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.041 0.448 . . . . 0.0 111.779 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.3 mt -135.53 102.53 3.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.894 177.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.428 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -119.89 143.86 47.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.04 0.447 . . . . 0.0 112.031 -177.635 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.607 ' HG2' HG23 ' A' ' 28' ' ' THR . 2.8 pt-20 -118.62 130.97 56.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.448 176.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.429 HG21 HH12 ' A' ' 68' ' ' ARG . 2.6 t -114.77 129.49 70.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.016 0.436 . . . . 0.0 111.906 -177.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.488 ' HE1' HG21 ' A' ' 86' ' ' VAL . 1.4 t90 -122.44 106.39 11.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.349 178.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.501 HD13 ' O ' ' A' ' 62' ' ' TYR . 1.0 OUTLIER -158.29 -163.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.439 -178.874 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -109.41 -34.49 6.52 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.664 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.501 ' O ' HD13 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -102.08 114.47 65.49 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.625 179.545 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.85 97.49 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.535 2.157 . . . . 0.0 112.429 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.9 mtt -68.3 -11.17 59.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.943 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.595 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.5 OUTLIER -61.57 -15.11 35.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.993 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -32.74 71.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.036 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.581 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 1.0 OUTLIER -94.22 -27.95 15.89 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.191 0.519 . . . . 0.0 110.365 178.883 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.595 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 14.3 mtt85 -62.88 -38.0 89.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.894 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.725 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 17.0 mt -59.37 -55.79 42.51 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.686 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 72.6 Cg_exo -50.21 -38.85 52.03 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.307 2.005 . . . . 0.0 112.781 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.561 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -68.56 -56.38 8.48 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.957 0.408 . . . . 0.0 111.518 -179.285 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.722 HG21 ' HG3' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -58.96 -45.58 90.17 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.269 -178.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 70' ' ' PRO . 8.2 p -58.69 -28.67 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.682 -0.236 . . . . 0.0 110.939 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.561 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 5.1 mmtt -58.42 -42.99 88.5 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 176.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.549 ' HB3' HD13 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -87.38 -82.84 0.21 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.872 176.22 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.795 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -98.59 -106.32 0.2 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.274 177.071 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.486 ' H ' HD23 ' A' ' 76' ' ' LEU . . . -134.87 -83.15 0.18 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.104 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.07 170.71 16.59 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.78 0.324 . . . . 0.0 111.071 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.885 ' HB2' HG13 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -110.09 72.77 0.81 Allowed 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.39 117.51 43.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.491 -176.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.55 ' HG ' ' N ' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -133.73 -40.69 0.86 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.092 179.715 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.585 ' HB3' ' HB2' ' A' ' 94' ' ' TYR . 0.3 OUTLIER -153.85 144.98 22.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.027 0.441 . . . . 0.0 111.924 -179.743 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.537 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 3.4 mp -144.04 130.65 16.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.275 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -149.78 178.57 8.76 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.042 0.448 . . . . 0.0 111.428 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.6 pm0 -133.35 159.07 41.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.663 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.488 HG21 ' HE1' ' A' ' 59' ' ' TRP . 4.6 t -124.28 -63.37 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.284 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -126.87 -144.7 6.1 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.654 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.429 ' HB2' ' H ' ' A' ' 89' ' ' SER . 37.3 Cg_exo -61.37 -82.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.601 2.201 . . . . 0.0 112.416 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.429 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 2.1 p -98.59 -1.33 41.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.025 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -92.93 116.28 28.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.511 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 4.2 m-90 -130.65 167.59 18.52 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.983 0.42 . . . . 0.0 111.37 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.7 128.52 49.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.29 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.8 mp -125.67 146.15 31.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.172 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.585 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 24.8 m-85 -118.81 123.84 45.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.576 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.885 HG13 ' HB2' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -124.79 144.68 33.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.848 -179.112 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.66 ' H ' ' HB3' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -150.77 115.86 5.32 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.961 -178.793 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.416 ' HA ' ' HG2' ' A' ' 79' ' ' GLU . 15.0 t -65.69 125.67 23.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.359 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.8 tttp . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.004 -179.486 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 112.446 -0.261 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -124.76 -37.81 2.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.804 0.335 . . . . 0.0 110.997 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.5 m -139.15 -166.96 2.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.915 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.44 -21.76 20.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.896 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -70.84 110.7 5.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.782 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.23 132.13 49.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.968 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -108.69 -170.46 1.67 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.943 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -92.04 73.02 5.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.945 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -130.91 -88.61 0.48 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.837 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 55.4 m -86.23 -38.04 18.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.987 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.2 m -83.5 28.51 0.55 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.229 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.81 -146.08 6.11 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.515 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.79 -175.66 3.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.78 0.324 . . . . 0.0 110.979 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.0 m -68.44 150.2 97.77 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.29 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -56.4 -34.45 94.47 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.619 2.213 . . . . 0.0 112.235 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.466 ' HB3' ' H ' ' A' ' 17' ' ' GLY . 5.0 mtt180 -89.44 -150.24 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.909 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.609 ' HA3' ' HG2' ' A' ' 22' ' ' LYS . . . -76.25 130.2 10.65 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.467 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.63 -76.93 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.746 0.308 . . . . 0.0 110.94 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.516 ' HB3' ' H ' ' A' ' 20' ' ' MET . 7.7 m80 -104.9 -150.51 0.43 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.731 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.516 ' H ' ' HB3' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -74.46 -3.56 31.44 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.809 0.338 . . . . 0.0 111.004 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.18 51.94 2.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.059 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.609 ' HG2' ' HA3' ' A' ' 17' ' ' GLY . 4.3 mtmt -91.14 40.09 1.02 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.235 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -94.17 38.67 1.08 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.9 0.381 . . . . 0.0 111.033 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.28 73.38 10.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.788 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.7 t -82.85 145.52 8.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.985 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.4 m -99.61 -62.06 1.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.933 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -118.56 158.63 25.05 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.011 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.7 m -127.45 151.72 48.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.865 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.2 tt -131.52 121.04 23.8 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.25 119.0 31.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.532 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.686 HG23 HG23 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -124.33 19.67 4.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.553 -179.093 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.4 14.76 0.41 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.667 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.89 -105.59 0.39 Allowed Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.652 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.435 ' CD ' HG21 ' A' ' 38' ' ' VAL . 5.2 pt-20 -87.49 -161.2 0.67 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.606 0.241 . . . . 0.0 110.809 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.09 -169.73 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.812 0.339 . . . . 0.0 111.291 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.814 ' HA ' ' HD2' ' A' ' 39' ' ' PRO . 19.5 m -55.36 159.75 4.19 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.049 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -92.69 20.18 35.03 Favored 'Cis proline' 0 C--N 1.35 0.608 0 C-N-CA 124.038 -1.234 . . . . 0.0 112.81 1.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.498 ' HB ' ' HD3' ' A' ' 39' ' ' PRO . 60.6 t -63.56 -53.36 52.15 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.65 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.814 ' HD2' ' HA ' ' A' ' 36' ' ' CYS . 64.1 Cg_endo -73.04 -17.28 25.05 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.207 1.938 . . . . 0.0 112.413 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -65.63 -58.34 5.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.3 t -74.05 -25.55 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.046 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -64.95 -49.34 70.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.053 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.405 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 15.0 t -67.52 -42.77 82.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.008 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.16 -43.04 73.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.949 0.404 . . . . 0.0 110.544 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.511 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 0.2 OUTLIER -64.09 -31.31 72.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.796 179.048 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.461 ' HB3' HH12 ' A' ' 68' ' ' ARG . . . -60.62 -48.7 80.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.335 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.564 ' HG ' ' HG3' ' A' ' 71' ' ' GLU . 2.2 mm? -59.06 -42.65 90.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.051 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -81.14 9.79 6.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.443 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.511 ' HB2' ' O ' ' A' ' 45' ' ' ARG . 0.9 OUTLIER -135.07 32.97 3.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.785 0.326 . . . . 0.0 111.202 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.838 ' HB3' HG21 ' A' ' 97' ' ' VAL . 26.0 mtt -109.18 143.61 38.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.122 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.779 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 23.0 mttp -95.41 163.15 22.3 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 51' ' ' LYS . 74.1 Cg_exo -41.83 -69.03 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.01 2.473 . . . . 0.0 113.508 -178.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 97' ' ' VAL . . . -103.95 56.91 0.56 Allowed Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.023 -178.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.779 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 14.4 mm-40 -90.92 157.17 17.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.001 0.429 . . . . 0.0 111.815 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.53 HG13 ' HG3' ' A' ' 96' ' ' LYS . 3.0 mp -135.04 110.31 12.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.973 178.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.528 HD13 ' C ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -118.74 148.22 43.03 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.164 0.506 . . . . 0.0 111.985 -177.243 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -111.69 135.31 52.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.863 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 t -125.78 144.22 36.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.114 0.483 . . . . 0.0 112.006 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.451 ' C ' HG13 ' A' ' 60' ' ' ILE . 18.4 t90 -131.04 107.93 9.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.235 178.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.686 HG23 HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -144.24 -166.64 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.009 -178.875 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -145.13 27.47 1.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.144 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.73 ' H ' ' HA ' ' A' ' 63' ' ' PRO . 1.2 m-85 -101.06 -56.34 0.13 Allowed Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.368 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.73 ' HA ' ' H ' ' A' ' 62' ' ' TYR . 72.1 Cg_endo -94.19 171.24 17.49 Favored 'Cis proline' 0 C--N 1.356 0.949 0 C-N-CA 124.912 -0.87 . . . . 0.0 112.374 -0.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.654 ' H ' HD13 ' A' ' 60' ' ' ILE . 6.0 tpp -68.32 -26.35 65.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.356 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.654 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -59.71 -17.44 34.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.188 -179.405 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.7 pttp -59.73 -34.8 73.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.629 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.571 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 4.9 mt-10 -90.21 -22.55 21.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.169 0.509 . . . . 0.0 110.222 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.654 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 0.4 OUTLIER -62.03 -46.4 89.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.041 179.318 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.723 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 5.1 mt -54.52 -54.6 46.9 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.723 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 75.1 Cg_exo -51.36 -37.05 59.98 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.412 2.075 . . . . 0.0 112.61 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.564 ' HG3' ' HG ' ' A' ' 47' ' ' LEU . 4.8 tm-20 -71.24 -58.17 3.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.866 0.365 . . . . 0.0 111.525 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.763 HG21 ' HG2' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -58.89 -31.9 69.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.463 -178.815 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.529 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 8.6 p -73.52 -26.46 22.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.709 0.29 . . . . 0.0 110.731 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.69 -46.53 87.08 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.441 ' HG2' ' H ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -88.7 -74.32 0.47 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.565 177.463 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.505 HD11 HG22 ' A' ' 72' ' ' THR . 0.0 OUTLIER -98.21 -102.31 0.2 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.85 0.357 . . . . 0.0 110.482 178.19 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.27 -85.51 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.866 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.534 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -147.6 155.74 42.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.731 0.3 . . . . 0.0 111.076 178.792 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.763 ' HG2' HG21 ' A' ' 72' ' ' THR . 0.0 OUTLIER -103.87 69.24 0.95 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 177.396 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.535 HG12 HD11 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -98.67 121.52 49.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.88 -175.894 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.759 HD22 ' HB3' ' A' ' 96' ' ' LYS . 1.5 pt? -139.71 -35.5 0.53 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.677 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.613 ' HB3' ' HB2' ' A' ' 94' ' ' TYR . 0.8 OUTLIER -153.01 142.55 21.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.19 0.519 . . . . 0.0 112.009 179.574 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.535 HD11 HG12 ' A' ' 80' ' ' VAL . 3.7 mp -144.19 135.87 22.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.263 178.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -157.79 179.87 8.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.073 0.463 . . . . 0.0 111.28 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -133.5 161.25 35.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.555 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.0 t -120.7 -62.83 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.318 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.453 ' H ' ' HG3' ' A' ' 90' ' ' GLU . . . -125.37 -146.52 6.77 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.787 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.425 ' HB2' ' H ' ' A' ' 89' ' ' SER . 43.2 Cg_exo -57.11 -83.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.768 2.312 . . . . 0.0 112.513 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.425 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -95.73 -3.09 46.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.876 0.37 . . . . 0.0 111.184 -179.376 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.453 ' HG3' ' H ' ' A' ' 87' ' ' GLY . 5.5 pt-20 -93.16 133.89 35.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.713 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.11 168.81 20.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.929 0.395 . . . . 0.0 111.09 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.3 mttt -120.74 128.11 52.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.534 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.4 mp -125.28 145.11 33.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.885 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.613 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 13.0 m-85 -118.17 129.05 55.29 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.441 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.607 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -123.97 142.14 41.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.291 -179.697 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.759 ' HB3' HD22 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -144.04 110.57 5.56 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.755 -176.752 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.838 HG21 ' HB3' ' A' ' 50' ' ' MET . 3.2 t -61.26 118.48 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.314 178.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.59 ' HE3' ' HD3' ' A' ' 96' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.937 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.19 0 N-CA-C 112.437 -0.265 . . . . 0.0 112.437 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 t -124.45 110.89 15.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.73 0.3 . . . . 0.0 110.921 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.8 m -75.32 106.31 6.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.01 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.97 -34.05 9.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.794 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -133.65 -175.91 3.98 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.772 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -70.65 -63.38 1.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.799 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -89.03 -169.06 2.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.881 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.5 p-80 -91.28 -167.89 1.92 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.844 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -92.16 70.4 5.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.815 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.7 t -75.24 -63.04 1.36 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.9 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.91 28.39 0.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.19 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.83 134.56 32.29 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.368 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.585 HD13 ' HA ' ' A' ' 18' ' ' SER . 8.9 mt -79.21 122.75 26.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.915 0.388 . . . . 0.0 111.015 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.61 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 47.2 t -73.3 -49.97 6.59 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.649 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 20.9 Cg_endo -59.86 162.88 14.84 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.231 1.954 . . . . 0.0 112.217 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -61.15 -66.25 0.56 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.297 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -57.93 96.09 0.06 OUTLIER Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.68 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.585 ' HA ' HD13 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -80.82 -79.19 0.16 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.729 0.3 . . . . 0.0 111.061 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.99 -89.33 0.46 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.147 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 74.4 mtm -69.39 -157.92 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.806 0.336 . . . . 0.0 111.179 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.97 -176.19 0.08 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.375 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -89.7 58.84 4.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.153 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -102.42 76.05 1.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.845 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -94.98 138.17 33.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.963 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.6 t -72.83 130.86 35.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.876 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.73 -56.62 2.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.134 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.467 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -113.4 139.53 48.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.085 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.3 m -133.85 117.47 16.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.802 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 11.7 tp -109.92 115.41 29.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.033 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.702 ' HB3' ' HB3' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -132.9 102.11 5.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.705 179.774 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 31' ' ' VAL . 7.2 p -140.85 75.04 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.298 0.57 . . . . 0.0 111.19 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.441 HH11 ' HD3' ' A' ' 32' ' ' ARG . 2.1 mtp180 -54.72 -87.62 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.001 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.8 98.76 0.71 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.36 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -96.0 162.9 13.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.893 0.377 . . . . 0.0 111.158 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.33 -90.88 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.957 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.565 ' O ' ' HD2' ' A' ' 39' ' ' PRO . 1.2 p -62.75 157.95 55.34 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.657 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -75.22 12.86 1.18 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.801 2.334 . . . . 0.0 112.621 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.532 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 46.4 t -62.07 -53.69 56.95 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.545 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.565 ' HD2' ' O ' ' A' ' 36' ' ' CYS . 29.9 Cg_endo -61.9 -24.25 76.85 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.137 1.891 . . . . 0.0 112.099 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.43 -46.74 87.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.539 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.425 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 4.5 t -69.85 -25.22 27.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.697 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -64.37 -55.38 21.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.824 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.455 ' O ' HD13 ' A' ' 47' ' ' LEU . 11.9 t -62.59 -26.56 68.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.678 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 0.7 OUTLIER -58.72 -43.45 90.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.316 178.964 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -65.24 -39.54 92.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.81 178.919 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.46 -31.39 65.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.967 0.413 . . . . 0.0 110.52 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 43' ' ' THR . 2.9 mp -77.62 -51.73 10.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.486 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -81.46 -3.34 52.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.195 -177.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -134.96 71.2 1.44 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.822 0.344 . . . . 0.0 110.915 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.788 ' HB3' HG21 ' A' ' 97' ' ' VAL . 11.9 mtm -106.62 137.79 43.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.013 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.834 ' HG2' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -92.56 150.73 40.34 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.301 178.817 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.834 ' HD2' ' HG2' ' A' ' 51' ' ' LYS . 56.1 Cg_exo -37.28 -70.19 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.249 2.633 . . . . 0.0 113.992 -178.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.53 60.74 0.42 Allowed Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.121 -178.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.511 ' HG2' ' HB3' ' A' ' 51' ' ' LYS . 4.5 mm-40 -90.53 147.54 23.3 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.089 0.471 . . . . 0.0 111.753 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.516 HG23 ' HB2' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -130.84 114.65 27.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.065 178.418 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.467 HD22 ' HB3' ' A' ' 27' ' ' LYS . 4.0 mt -119.56 151.35 38.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.314 0.578 . . . . 0.0 112.095 -177.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -124.25 121.4 34.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.582 177.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.526 HG12 HG12 ' A' ' 60' ' ' ILE . 4.5 t -114.31 139.3 40.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.069 0.461 . . . . 0.0 111.987 -177.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.702 ' HB3' ' HB3' ' A' ' 30' ' ' ASP . 6.3 t90 -133.33 107.23 7.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.372 178.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.526 HG12 HG12 ' A' ' 58' ' ' VAL . 0.9 OUTLIER -156.95 -166.77 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.278 -178.814 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -111.52 -2.2 15.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.934 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.452 ' O ' HD12 ' A' ' 60' ' ' ILE . 3.3 m-85 -131.08 126.65 21.69 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.841 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 62' ' ' TYR . 31.8 Cg_exo -58.91 98.63 0.1 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.477 2.118 . . . . 0.0 112.377 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.484 ' HB3' ' NH1' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -67.98 -17.6 64.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.021 0.439 . . . . 0.0 110.885 179.637 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.516 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 5.1 p -64.0 -11.15 26.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.897 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.7 pttt -60.05 -39.67 86.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.981 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.554 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 6.1 mt-10 -89.93 -26.24 20.52 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.25 0.548 . . . . 0.0 110.207 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.516 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 28.7 mtt85 -63.71 -43.06 97.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.993 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.724 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 24.1 mt -51.83 -55.63 28.51 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.695 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.724 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 53.1 Cg_exo -53.18 -40.74 76.27 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.189 1.926 . . . . 0.0 112.603 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -61.04 2.19 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.965 0.412 . . . . 0.0 111.534 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.874 HG21 ' HG3' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -57.14 -43.58 82.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.63 -178.546 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 70' ' ' PRO . 9.8 p -58.84 -30.04 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.784 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -58.65 -40.36 83.2 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.679 ' HB3' HD13 ' A' ' 76' ' ' LEU . 2.0 mtpt -87.97 -84.86 0.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.875 176.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.815 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -98.46 -105.21 0.2 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.221 176.833 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.492 ' H ' HD23 ' A' ' 76' ' ' LEU . . . -132.93 -83.64 0.23 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.083 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.481 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -146.96 168.79 20.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.869 0.366 . . . . 0.0 111.25 179.613 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.95 ' HB2' HG23 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -110.26 61.07 0.6 Allowed 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.702 178.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.546 HG12 HD11 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -98.43 122.53 50.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.242 -177.533 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.505 HD12 ' HB2' ' A' ' 82' ' ' GLU . 1.1 pp -133.64 -37.86 0.92 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.274 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.505 ' HB2' HD12 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -153.11 147.99 26.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.992 0.425 . . . . 0.0 111.9 -179.748 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.546 HD11 HG12 ' A' ' 80' ' ' VAL . 3.7 mp -144.15 132.96 18.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.331 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.464 ' HG3' ' HB3' ' A' ' 92' ' ' LYS . 15.0 pt-20 -154.59 175.93 13.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.01 0.433 . . . . 0.0 111.363 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.43 173.71 11.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.982 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.46 -48.41 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.063 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -128.27 -150.65 7.32 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.545 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.98 -74.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.561 2.174 . . . . 0.0 112.533 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.9 p -99.36 -5.44 29.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.921 0.391 . . . . 0.0 111.193 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.413 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -93.28 131.11 38.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.786 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -151.48 170.34 19.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.971 0.415 . . . . 0.0 111.259 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.464 ' HB3' ' HG3' ' A' ' 84' ' ' GLU . 5.3 tttt -120.67 132.87 55.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.461 179.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.4 mp -125.64 149.81 30.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.105 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -118.57 125.29 49.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.486 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.95 HG23 ' HB2' ' A' ' 79' ' ' GLU . 16.1 mm -124.98 143.24 39.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.967 -177.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.694 ' C ' ' HB3' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -151.82 114.7 4.66 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 120.061 -0.656 . . . . 0.0 112.217 -178.797 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.788 HG21 ' HB3' ' A' ' 50' ' ' MET . 16.1 t -64.3 119.91 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.644 178.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.923 -179.777 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.33 116.21 30.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.827 0.346 . . . . 0.0 110.923 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.1 t -137.77 92.11 2.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.908 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -112.74 43.02 1.74 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.979 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -85.43 127.55 34.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.89 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -136.64 22.36 3.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.012 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.75 112.47 23.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.039 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -90.41 -31.67 16.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -113.97 59.46 0.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.885 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.63 138.85 56.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.932 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.6 t -63.8 -68.18 0.37 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.264 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.45 82.67 0.37 Allowed Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.77 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mt -67.96 -71.63 0.2 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.727 0.299 . . . . 0.0 111.032 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.465 ' HB ' ' HD3' ' A' ' 15' ' ' PRO . 33.8 t -58.93 -45.66 99.58 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.005 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.465 ' HD3' ' HB ' ' A' ' 14' ' ' VAL . 52.8 Cg_exo -56.2 -168.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.394 2.063 . . . . 0.0 112.698 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 43.4 mmt-85 -73.59 19.67 0.1 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.781 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 15' ' ' PRO . . . -81.18 -104.05 0.33 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.362 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.5 t -81.37 31.96 0.34 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.45 0.167 . . . . 0.0 111.192 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -42.94 -36.67 1.61 Allowed 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 111.744 0.275 . . . . 0.0 111.744 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.5 tmm? -62.86 96.53 0.09 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.812 0.339 . . . . 0.0 110.835 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.48 155.88 36.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.199 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.406 ' HG3' ' H ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -91.29 32.06 1.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.868 179.778 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -98.85 155.86 17.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -91.65 99.64 12.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.931 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 47.2 t -62.97 147.42 12.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.974 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -114.86 -60.2 1.92 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.416 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.27 159.18 23.1 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.03 0.443 . . . . 0.0 111.823 -178.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.5 m -135.77 108.16 7.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.554 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.5 tt -106.12 112.51 25.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.816 0.341 . . . . 0.0 111.126 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -133.29 107.74 8.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.457 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.0 t -137.93 72.87 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.505 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.462 ' HB3' ' H ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -58.83 -88.43 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.707 179.074 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.462 ' H ' ' HB3' ' A' ' 32' ' ' ARG . . . -81.14 98.77 1.88 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.205 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -92.22 163.02 14.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.937 0.398 . . . . 0.0 111.253 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.03 -89.58 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.965 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.6 m -62.41 154.86 70.32 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.745 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -78.08 17.74 0.98 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.629 2.219 . . . . 0.0 112.625 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.693 ' HB ' ' HD3' ' A' ' 39' ' ' PRO . 34.6 t -65.82 -53.21 36.84 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.457 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.693 ' HD3' ' HB ' ' A' ' 38' ' ' VAL . 20.7 Cg_exo -66.04 -21.9 55.69 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.241 1.96 . . . . 0.0 112.205 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.03 -57.45 9.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.031 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.4 t -67.3 -26.66 36.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.106 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -63.29 -61.37 2.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.959 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.4 HG22 ' O ' ' A' ' 39' ' ' PRO . 9.1 t -60.43 -27.55 67.58 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.805 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.99 -45.13 93.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.643 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.0 -32.36 74.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.777 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.71 -39.32 84.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.943 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.553 HD22 ' HG2' ' A' ' 68' ' ' ARG . 2.2 mt -68.92 -34.15 74.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.606 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -81.16 -12.46 59.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.021 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -135.24 70.94 1.43 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.261 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.755 ' HB3' HG21 ' A' ' 97' ' ' VAL . 0.8 OUTLIER -99.82 126.33 45.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.071 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.559 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 1.3 mtpm? -81.88 150.1 64.84 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.964 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.19 -25.46 80.84 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.536 2.157 . . . . 0.0 112.499 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.59 39.21 2.94 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.564 -0.827 . . . . 0.0 113.118 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.772 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 28.5 mt-10 -90.75 123.43 34.33 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 117.198 0.499 . . . . 0.0 111.905 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.505 HD13 ' O ' ' A' ' 54' ' ' GLU . 0.7 OUTLIER -135.2 84.5 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.625 177.741 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.498 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -119.27 -179.79 3.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.278 0.561 . . . . 0.0 112.301 -176.862 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -136.76 145.82 45.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.295 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.699 HG11 ' HB2' ' A' ' 64' ' ' MET . 4.7 t -119.72 134.29 63.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.824 0.345 . . . . 0.0 111.413 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.527 ' HE1' HG21 ' A' ' 86' ' ' VAL . 11.7 t90 -122.47 96.17 4.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.079 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.547 HG13 HG12 ' A' ' 58' ' ' VAL . 0.5 OUTLIER -148.97 -160.06 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.646 179.053 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.476 ' HB3' ' O ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -131.0 37.53 3.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.461 -179.452 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.643 ' H ' ' HA ' ' A' ' 63' ' ' PRO . 86.1 m-85 -115.94 -60.81 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.119 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.643 ' HA ' ' H ' ' A' ' 62' ' ' TYR . 63.7 Cg_endo -97.22 -168.34 1.56 Allowed 'Cis proline' 0 C--N 1.356 0.939 0 CA-C-N 119.449 0.839 . . . . 0.0 111.881 -1.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.699 ' HB2' HG11 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -68.69 -27.65 66.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.825 0.345 . . . . 0.0 111.024 179.176 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.54 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.7 OUTLIER -58.73 -16.01 14.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.275 -178.966 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.51 ' HG3' ' N ' ' A' ' 67' ' ' GLU . 5.6 pttt -59.61 -34.32 72.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.024 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.531 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 1.4 mm-40 -93.97 -25.31 17.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.078 0.466 . . . . 0.0 110.352 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.553 ' HG2' HD22 ' A' ' 47' ' ' LEU . 6.2 mtt85 -62.97 -38.62 91.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.939 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.727 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 8.9 mt -60.04 -56.58 34.11 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.484 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.727 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 82.5 Cg_exo -46.51 -47.23 15.9 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.507 2.138 . . . . 0.0 112.805 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.534 ' HG3' ' HB3' ' A' ' 47' ' ' LEU . 64.5 mm-40 -60.97 -47.21 87.49 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.051 0.453 . . . . 0.0 110.944 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.566 ' HB ' ' O ' ' A' ' 77' ' ' GLY . 1.9 m -59.53 -46.34 89.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.508 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.703 HG13 ' O ' ' A' ' 69' ' ' ILE . 1.3 m -58.87 -29.4 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 121.119 -0.232 . . . . 0.0 111.004 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.52 -41.51 85.61 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 176.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.64 -81.46 0.31 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.487 177.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.42 -96.21 0.24 Allowed 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.81 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.566 ' O ' ' HB ' ' A' ' 72' ' ' THR . . . -144.07 -85.02 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.853 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.414 ' HB3' HG23 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -146.18 147.61 31.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.762 0.315 . . . . 0.0 110.912 178.844 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.877 ' HB2' HG23 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -95.36 55.72 1.77 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.422 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.7 p -99.22 127.21 52.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.291 -177.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.485 ' HG ' ' N ' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -133.29 -35.75 1.02 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.986 179.665 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.485 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 0.3 OUTLIER -153.91 148.7 26.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.064 0.459 . . . . 0.0 111.925 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.2 mp -141.75 140.8 30.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.454 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.41 ' OE2' ' HD2' ' A' ' 92' ' ' LYS . 11.4 pt-20 -158.04 178.92 9.67 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.033 0.444 . . . . 0.0 111.454 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -133.68 170.1 16.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.716 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.527 HG21 ' HE1' ' A' ' 59' ' ' TRP . 25.1 t -130.23 -56.54 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.287 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.45 ' H ' ' HG3' ' A' ' 90' ' ' GLU . . . -128.52 -145.98 6.13 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.721 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -58.4 -80.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.671 2.247 . . . . 0.0 112.547 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.476 ' O ' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -100.1 -2.7 33.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.785 0.326 . . . . 0.0 111.201 -179.399 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.45 ' HG3' ' H ' ' A' ' 87' ' ' GLY . 5.3 pt-20 -91.86 133.4 35.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.787 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -148.59 168.76 21.95 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.032 0.444 . . . . 0.0 111.387 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.41 ' HD2' ' OE2' ' A' ' 84' ' ' GLU . 2.2 tttt -120.62 146.81 46.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.523 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -129.98 159.3 42.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.244 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -125.58 124.01 40.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.731 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.877 HG23 ' HB2' ' A' ' 79' ' ' GLU . 31.0 mm -123.95 148.97 27.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.448 -176.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.627 ' C ' ' HB3' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -150.64 99.03 2.7 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 120.404 -0.519 . . . . 0.0 111.659 -177.981 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.772 ' HB ' ' HB2' ' A' ' 54' ' ' GLU . 48.6 t -70.63 89.58 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.532 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.2 pttm . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.273 -0.87 . . . . 0.0 111.041 -179.861 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m -98.11 17.31 18.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.882 0.372 . . . . 0.0 110.841 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.8 m -88.75 138.69 31.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.992 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -126.53 -62.38 1.14 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.931 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.7 p-80 -94.66 -0.64 54.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.996 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -78.38 -76.03 0.21 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.865 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -128.25 114.15 16.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -103.77 126.94 51.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.044 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.91 102.9 2.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.764 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.5 t -67.15 -14.89 63.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.969 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.409 ' HB3' ' H ' ' A' ' 12' ' ' GLY . 31.0 m -75.75 -153.22 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.805 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.409 ' H ' ' HB3' ' A' ' 11' ' ' SER . . . -89.18 -148.83 19.31 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.467 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 13' ' ' LEU . 4.3 mm? -91.61 91.81 8.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.886 0.374 . . . . 0.0 110.74 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.775 ' N ' ' HA ' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -84.59 -41.45 0.7 Allowed Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 116.108 -0.497 . . . . 0.0 112.047 -179.82 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.775 ' HA ' ' N ' ' A' ' 14' ' ' VAL . 79.3 Cg_endo -102.09 -152.9 0.15 OUTLIER 'Cis proline' 0 C--N 1.358 1.047 0 CA-C-N 119.861 0.986 . . . . 0.0 112.793 1.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.404 ' H ' ' HB2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -59.54 -4.61 0.66 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.096 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.29 92.48 0.86 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.343 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.21 25.17 0.31 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.648 0.261 . . . . 0.0 111.428 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -90.29 30.88 1.05 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.075 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 13.3 ptt? -81.03 -2.3 47.47 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.733 0.301 . . . . 0.0 111.01 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.58 166.96 17.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.025 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.22 77.95 5.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.924 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -72.63 80.68 1.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.847 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.0 66.27 7.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.028 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.1 t -76.31 138.5 20.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.988 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.85 -65.98 0.93 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.096 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -108.67 149.23 29.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.112 -179.717 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.0 m -135.09 117.15 15.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.766 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.603 HD21 ' HG2' ' A' ' 42' ' ' GLU . 12.8 tp -103.52 109.79 21.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.922 0.391 . . . . 0.0 111.036 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.443 ' HB3' ' HB3' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -125.02 115.3 20.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.507 179.61 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.62 47.47 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.299 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -75.01 15.52 0.39 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.708 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.94 -80.21 0.93 Allowed Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.324 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.597 ' HG3' HG21 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -82.96 -165.52 1.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.646 0.26 . . . . 0.0 110.751 179.567 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.81 -173.99 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.894 0.378 . . . . 0.0 111.258 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.809 ' HA ' ' HD2' ' A' ' 39' ' ' PRO . 0.5 OUTLIER -58.38 158.86 13.23 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.812 179.727 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -93.09 25.19 23.17 Favored 'Cis proline' 0 C--N 1.35 0.62 0 C-N-CA 123.995 -1.252 . . . . 0.0 112.798 1.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.597 HG21 ' HG3' ' A' ' 34' ' ' GLU . 21.4 t -60.42 -52.57 72.02 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.565 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.809 ' HD2' ' HA ' ' A' ' 36' ' ' CYS . 73.5 Cg_endo -74.79 -16.84 20.56 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.162 1.908 . . . . 0.0 112.439 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.22 -52.54 39.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.094 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 17.1 t -72.66 -31.44 37.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.055 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.603 ' HG2' HD21 ' A' ' 29' ' ' LEU . 4.9 tt0 -58.64 -60.81 3.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.061 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.47 ' O ' HD22 ' A' ' 47' ' ' LEU . 9.6 t -62.06 -36.88 82.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.028 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.25 -42.3 60.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.948 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.65 -33.95 73.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.743 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.25 -48.19 82.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.294 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.54 HD21 ' HG2' ' A' ' 68' ' ' ARG . 1.1 mm? -61.24 -36.11 79.08 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.916 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -74.72 -9.61 58.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.073 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -134.98 49.83 2.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.037 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.607 ' HB2' HG21 ' A' ' 97' ' ' VAL . 16.1 ptp -88.48 146.64 25.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.875 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.579 ' HB3' ' HG3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -101.98 150.09 37.12 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.374 179.31 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.529 ' HD2' ' HG3' ' A' ' 51' ' ' LYS . 81.6 Cg_exo -31.19 -78.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.736 2.957 . . . . 0.0 114.137 -178.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.441 ' H ' ' HB2' ' A' ' 52' ' ' PRO . . . -104.41 62.18 0.39 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.117 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.579 ' HG3' ' HB3' ' A' ' 51' ' ' LYS . 8.6 mt-10 -89.21 150.49 22.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.027 0.441 . . . . 0.0 111.46 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.41 HG23 ' HB3' ' A' ' 96' ' ' LYS . 2.6 mp -135.64 106.55 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.687 177.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.401 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 1.2 mt -119.09 147.85 43.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.177 0.513 . . . . 0.0 112.194 -176.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -114.87 128.96 56.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.099 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.607 HG21 ' NH1' ' A' ' 68' ' ' ARG . 2.3 t -114.81 133.15 61.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.972 0.415 . . . . 0.0 111.529 -178.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.736 ' HE1' HG21 ' A' ' 86' ' ' VAL . 13.7 t90 -122.57 109.36 14.21 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.815 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.56 HD13 ' O ' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -156.9 -169.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.262 -179.536 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.609 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -109.24 -7.83 15.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.073 -179.598 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.56 ' O ' HD13 ' A' ' 60' ' ' ILE . 0.9 OUTLIER -126.25 122.42 24.05 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.606 179.74 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.05 92.48 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.572 2.181 . . . . 0.0 112.172 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 21.1 mtm -68.0 -15.58 63.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.606 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.495 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 2.4 p -63.92 -17.52 63.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.811 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.8 pttt -57.92 -32.12 67.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.841 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.555 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -94.12 -28.25 15.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.346 179.033 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.607 ' NH1' HG21 ' A' ' 58' ' ' VAL . 39.4 mtt180 -64.24 -39.56 94.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.207 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.7 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 12.5 mt -59.11 -54.77 53.12 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.509 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.7 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 80.6 Cg_exo -48.34 -44.06 30.46 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.307 2.005 . . . . 0.0 112.564 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.543 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 4.7 tt0 -69.11 -49.56 55.98 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.959 0.409 . . . . 0.0 111.433 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.465 ' HB ' ' O ' ' A' ' 77' ' ' GLY . 6.6 m -58.74 -48.16 82.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.364 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 69' ' ' ILE . 19.1 m -59.0 -28.81 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-O 120.504 0.193 . . . . 0.0 111.11 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.543 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.3 OUTLIER -58.02 -41.56 83.4 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.21 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.07 -80.55 0.31 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.176 176.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.85 -100.09 0.22 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.529 178.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.53 -86.56 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.835 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.415 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -146.67 152.56 39.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.751 0.31 . . . . 0.0 110.796 178.668 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.882 ' HB2' HG13 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -100.31 68.78 1.43 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.853 179.08 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.415 HG22 ' HB2' ' A' ' 78' ' ' HIS . 0.2 OUTLIER -98.96 124.01 51.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.724 -176.736 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.892 ' HB3' ' HG2' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -133.42 -37.51 0.95 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.933 179.05 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.561 ' HG3' ' N ' ' A' ' 83' ' ' ILE . 0.8 OUTLIER -154.05 146.34 23.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.946 0.403 . . . . 0.0 111.845 179.531 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.561 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 3.0 mt -141.55 135.31 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.35 178.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.649 ' HG3' ' HB3' ' A' ' 92' ' ' LYS . 6.2 pt-20 -158.05 -179.21 7.91 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.032 0.444 . . . . 0.0 111.321 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.22 162.59 31.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.814 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.736 HG21 ' HE1' ' A' ' 59' ' ' TRP . 60.3 t -123.21 -65.99 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.403 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -122.92 -153.14 8.71 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.743 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.72 -75.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.7 2.267 . . . . 0.0 112.344 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -99.58 -3.16 33.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.946 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.609 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 1.1 pm0 -93.56 138.15 32.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.809 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -151.53 171.05 18.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.993 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.649 ' HB3' ' HG3' ' A' ' 84' ' ' GLU . 2.3 ttpt -120.81 132.99 55.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.72 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.3 mp -125.43 144.95 33.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.84 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.468 ' HB3' ' HG ' ' A' ' 81' ' ' LEU . 10.5 m-85 -118.76 124.3 46.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.699 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.882 HG13 ' HB2' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -124.33 148.86 28.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.852 -178.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.892 ' HG2' ' HB3' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -150.93 108.54 3.65 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 120.239 -0.584 . . . . 0.0 112.506 -177.587 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.607 HG21 ' HB2' ' A' ' 50' ' ' MET . 5.0 t -58.15 119.54 3.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.587 178.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.84 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.99 -73.57 0.61 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.732 0.301 . . . . 0.0 111.007 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.2 p -140.07 -76.45 0.33 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.97 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -129.98 81.32 2.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.902 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.81 78.63 1.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.994 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -96.72 -66.5 0.9 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -128.19 140.98 51.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.906 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -106.34 151.54 24.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -98.91 42.22 1.11 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.11 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.1 t -77.52 104.73 8.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.84 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.29 -150.94 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.865 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.75 167.75 48.61 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.494 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.6 HD23 ' H ' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -70.87 153.18 42.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.824 0.345 . . . . 0.0 110.966 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.6 ' H ' HD23 ' A' ' 13' ' ' LEU . 2.6 t -70.78 130.52 88.51 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.832 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -56.43 -31.7 86.52 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.455 2.103 . . . . 0.0 112.316 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -84.68 29.24 0.62 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.185 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.89 -179.93 9.87 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.517 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.34 28.0 0.4 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.587 0.232 . . . . 0.0 111.213 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -50.78 -48.6 59.42 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.544 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.3 mtt -54.15 -55.46 27.63 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.721 0.295 . . . . 0.0 111.17 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.73 160.26 17.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.04 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.9 mttt -89.53 28.87 1.21 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.815 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -103.1 119.51 38.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.864 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.4 ' O ' HD13 ' A' ' 55' ' ' ILE . 3.0 mt-30 -93.18 59.13 3.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.977 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.0 t -85.17 134.21 27.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.013 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.08 -61.87 1.31 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.154 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.1 tptt -113.34 139.98 48.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.887 0.375 . . . . 0.0 111.161 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.404 HG23 ' HB3' ' A' ' 57' ' ' GLU . 71.0 m -130.2 134.74 47.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.859 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.609 HD23 HG22 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -113.15 127.97 56.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.915 179.726 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -120.01 108.51 14.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.783 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.609 HG22 HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -128.2 68.49 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.05 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 -54.73 -89.78 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.061 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.5 -153.69 4.22 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.254 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -110.66 144.79 39.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.846 0.355 . . . . 0.0 110.752 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.08 -158.1 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.04 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.655 ' O ' ' HD2' ' A' ' 39' ' ' PRO . 2.5 m -60.62 162.78 10.65 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.678 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -73.76 -6.56 18.83 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.599 2.2 . . . . 0.0 112.282 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.759 ' HB ' ' HD3' ' A' ' 39' ' ' PRO . 21.6 t -67.02 -56.5 13.36 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.72 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.759 ' HD3' ' HB ' ' A' ' 38' ' ' VAL . 51.7 Cg_exo -54.25 -31.19 65.44 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.12 1.88 . . . . 0.0 112.356 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.435 ' O ' HG22 ' A' ' 43' ' ' THR . 0.4 OUTLIER -62.41 -50.46 71.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 179.85 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.4 t -70.07 -23.64 25.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.95 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -66.71 -54.3 24.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.919 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.547 ' O ' HD22 ' A' ' 47' ' ' LEU . 4.1 t -59.07 -34.84 72.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.864 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.76 -36.57 76.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.893 0.378 . . . . 0.0 110.318 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -66.06 -31.34 72.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.439 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 43' ' ' THR . . . -58.62 -53.0 63.29 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.018 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.688 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 0.8 OUTLIER -58.65 -35.44 72.54 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.144 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.06 -9.83 59.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.249 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -133.52 69.23 1.48 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.948 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.803 ' HB3' HG21 ' A' ' 97' ' ' VAL . 41.9 mtm -109.02 147.86 31.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.997 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.584 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.4 OUTLIER -91.93 153.85 43.53 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.391 179.466 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.584 ' HD2' ' HG3' ' A' ' 51' ' ' LYS . 53.9 Cg_exo -38.48 -71.31 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.148 2.565 . . . . 0.0 113.962 -178.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.17 57.37 0.54 Allowed Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.913 -0.661 . . . . 0.0 113.415 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.515 ' HG3' ' HB3' ' A' ' 51' ' ' LYS . 11.0 mt-10 -91.41 156.1 17.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.134 0.493 . . . . 0.0 111.984 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.542 ' C ' HD13 ' A' ' 56' ' ' LEU . 3.5 mp -135.55 115.71 17.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.008 178.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.542 HD13 ' C ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -118.52 154.29 32.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.035 0.445 . . . . 0.0 111.692 -177.624 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.404 ' HB3' HG23 ' A' ' 28' ' ' THR . 51.1 tt0 -114.74 145.9 41.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.376 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.543 HG12 HG13 ' A' ' 60' ' ' ILE . 16.7 t -131.01 131.52 64.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.858 0.361 . . . . 0.0 111.527 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.416 ' CD1' ' HG2' ' A' ' 92' ' ' LYS . 52.8 m0 -122.59 107.25 11.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.422 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.543 HG13 HG12 ' A' ' 58' ' ' VAL . 1.0 OUTLIER -158.67 -172.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-O 121.046 0.451 . . . . 0.0 111.334 -179.213 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -99.67 -25.59 14.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.106 178.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.474 ' O ' HD13 ' A' ' 60' ' ' ILE . 93.0 m-85 -120.62 121.06 29.31 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.445 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -45.68 105.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.651 2.234 . . . . 0.0 112.561 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.499 ' HG3' ' NH1' ' A' ' 68' ' ' ARG . 3.0 tpt -65.64 -15.09 62.43 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.808 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.755 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 14.8 p -55.79 -13.38 1.72 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.846 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.66 -42.96 75.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.549 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 1.7 mt-10 -87.16 -26.07 23.77 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.225 0.536 . . . . 0.0 110.132 178.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.755 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 0.2 OUTLIER -61.48 -41.98 98.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.088 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.723 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 18.9 mt -55.33 -56.0 33.6 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.804 -178.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.723 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 78.3 Cg_exo -49.0 -41.27 40.44 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.216 1.944 . . . . 0.0 112.491 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.688 ' HG3' ' HB3' ' A' ' 47' ' ' LEU . 7.4 mm-40 -68.49 -55.2 12.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.571 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.76 HG21 ' HG2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -57.57 -49.01 77.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.468 -178.834 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.2 p -58.36 -28.32 35.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.139 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.553 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 2.8 mmtt -58.67 -43.25 89.82 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 176.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.51 ' HB3' HD13 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -89.19 -80.81 0.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.118 176.686 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.781 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -99.02 -106.38 0.2 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.459 177.685 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.479 ' H ' HD23 ' A' ' 76' ' ' LEU . . . -133.84 -80.92 0.16 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.365 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.491 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -146.14 165.6 28.67 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.775 0.322 . . . . 0.0 110.977 179.644 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.76 ' HG2' HG21 ' A' ' 72' ' ' THR . 0.1 OUTLIER -110.19 62.76 0.6 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.394 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.491 HG22 ' HB2' ' A' ' 78' ' ' HIS . 0.1 OUTLIER -98.77 123.05 51.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.69 -176.656 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.772 HD22 ' HB3' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -142.11 -36.42 0.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.223 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.482 ' HB3' ' HB2' ' A' ' 94' ' ' TYR . 2.3 tp10 -149.06 141.25 24.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.215 0.531 . . . . 0.0 112.348 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.469 HD11 HG12 ' A' ' 80' ' ' VAL . 3.8 mp -143.71 118.57 4.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.155 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -155.1 -176.05 5.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.164 0.507 . . . . 0.0 111.373 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -133.71 166.46 22.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.789 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.15 -47.74 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.17 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -123.39 -161.06 11.05 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.706 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.1 -76.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.689 2.259 . . . . 0.0 112.424 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -98.32 -2.48 39.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.101 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -93.34 119.84 32.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.402 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 14.4 m0 -120.79 167.66 12.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.03 0.443 . . . . 0.0 111.382 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.416 ' HG2' ' CD1' ' A' ' 59' ' ' TRP . 1.6 mttm -120.56 131.65 54.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.306 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -125.14 137.72 56.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.02 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.482 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 23.8 m-85 -118.27 123.44 45.42 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.384 178.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.681 HG13 ' HG3' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -123.95 142.53 40.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.251 -179.71 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.772 ' HB3' HD22 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -145.79 114.88 7.01 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.826 -176.844 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.803 HG21 ' HB3' ' A' ' 50' ' ' MET . 2.2 t -63.33 120.91 11.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.499 178.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 33.1 mttp . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.174 -0.917 . . . . 0.0 110.977 -179.631 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 112.522 -0.231 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 m -68.0 -50.28 56.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.736 0.303 . . . . 0.0 110.909 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.91 -68.15 0.65 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.952 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -136.51 35.29 2.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.856 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 64.1 m170 -80.48 -153.85 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.858 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -55.85 139.67 45.02 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.039 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -61.0 119.33 8.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.944 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -130.56 125.15 33.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.54 29.37 3.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.851 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.8 m -72.46 -32.43 66.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.893 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.05 28.57 0.7 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.289 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.9 138.13 48.2 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.586 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.25 76.72 4.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.912 0.387 . . . . 0.0 110.833 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.7 m -76.49 136.85 67.68 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.208 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.17 78.97 2.81 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.521 2.147 . . . . 0.0 112.063 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.6 ttt85 -84.97 -82.73 0.17 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.136 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.7 128.25 8.36 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.513 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.96 -53.96 45.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.597 0.237 . . . . 0.0 111.359 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -78.93 30.81 0.2 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.425 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.61 122.09 7.51 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.806 0.336 . . . . 0.0 111.135 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.56 102.91 11.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.941 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.7 51.06 2.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.961 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -89.06 33.09 0.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.877 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.65 66.77 8.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.967 0.413 . . . . 0.0 110.666 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 20.9 t -63.48 148.48 11.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.3 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.52 -46.7 2.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.068 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.09 154.26 38.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.137 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 51.6 m -135.52 114.78 12.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.845 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 5.8 tt -102.96 117.01 33.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.709 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -132.77 115.83 15.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.113 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.459 HG23 ' CG2' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -123.51 65.79 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.828 179.726 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.497 ' HB3' ' H ' ' A' ' 33' ' ' GLY . 5.9 ttm180 -59.49 -92.86 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.091 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.497 ' H ' ' HB3' ' A' ' 32' ' ' ARG . . . -67.3 99.18 0.5 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.211 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.437 ' HB2' ' HG2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -108.18 158.68 17.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.936 0.398 . . . . 0.0 111.198 -179.675 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.4 -90.74 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.888 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.663 ' HB2' HG23 ' A' ' 38' ' ' VAL . 2.9 m -63.75 164.05 18.46 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.527 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -69.97 18.17 0.2 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.647 2.231 . . . . 0.0 112.825 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.673 ' HB ' ' HD3' ' A' ' 39' ' ' PRO . 49.0 t -57.23 -52.08 76.89 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.499 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.673 ' HD3' ' HB ' ' A' ' 38' ' ' VAL . 51.6 Cg_exo -55.33 -28.25 61.82 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.302 2.001 . . . . 0.0 112.449 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.99 -54.81 32.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.637 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.34 -21.14 17.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.412 178.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.412 ' HB3' ' HA ' ' A' ' 39' ' ' PRO . 19.1 tt0 -65.38 -55.93 15.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.657 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.464 ' O ' HD13 ' A' ' 47' ' ' LEU . 7.6 t -61.37 -32.3 72.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.498 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -55.29 -38.96 69.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.493 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.87 -42.4 77.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.133 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.79 -38.47 78.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.1 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.464 HD13 ' O ' ' A' ' 43' ' ' THR . 2.2 mp -64.52 -44.55 90.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.956 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.35 -3.88 51.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -126.14 62.91 1.25 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.103 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.19 152.06 25.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.072 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.861 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -105.04 162.11 20.73 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.678 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.587 ' HD2' ' HB3' ' A' ' 51' ' ' LYS . 4.9 Cg_endo -47.47 -68.9 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.087 2.524 . . . . 0.0 113.451 -178.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.53 58.34 0.49 Allowed Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.442 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.861 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 13.1 mm-40 -90.63 143.29 26.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.032 0.444 . . . . 0.0 111.57 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 5.5 mt -135.81 96.27 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.198 178.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.91 175.12 5.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.285 0.564 . . . . 0.0 111.959 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -138.25 140.91 39.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.317 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 2.8 t -114.12 135.72 52.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.991 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -121.75 107.84 12.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.69 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.643 HD13 ' O ' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -157.97 -163.7 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.224 -179.199 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -114.17 -5.88 13.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.643 ' O ' HD13 ' A' ' 60' ' ' ILE . 6.8 m-85 -125.84 132.57 24.36 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.803 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -58.36 91.2 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.61 2.207 . . . . 0.0 112.78 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 5.1 tmm? -68.53 -25.95 65.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.056 0.455 . . . . 0.0 110.449 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.637 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 67.5 m -64.05 -13.86 50.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.946 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.453 ' HG3' ' N ' ' A' ' 67' ' ' GLU . 2.1 pttp -57.69 -33.91 68.86 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.734 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.577 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -94.32 -27.13 16.27 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.186 0.517 . . . . 0.0 110.112 178.383 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.637 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -61.31 -34.34 75.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.942 179.126 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.733 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 11.3 mt -63.53 -56.75 23.84 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.342 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.733 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 83.4 Cg_exo -47.78 -32.39 16.89 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.307 2.004 . . . . 0.0 112.373 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.08 -58.26 3.73 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.061 0.457 . . . . 0.0 111.012 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.587 HG21 ' HG2' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -59.75 -30.0 68.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.557 -178.954 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.579 HG12 ' O ' ' A' ' 70' ' ' PRO . 5.7 p -72.72 -29.84 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.83 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.68 -41.39 86.07 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -90.6 -78.67 0.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.446 177.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.431 HD11 HG22 ' A' ' 72' ' ' THR . 0.0 OUTLIER -98.48 -97.92 0.22 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.755 178.53 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.09 -82.4 0.05 OUTLIER Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.14 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.681 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -146.32 157.98 43.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.86 0.362 . . . . 0.0 111.234 179.449 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.706 ' HB2' ' H ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -104.72 63.4 0.72 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.491 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.681 HG22 ' HB2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -99.13 121.83 50.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.805 -176.863 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.744 ' HB3' ' HG2' ' A' ' 96' ' ' LYS . 2.2 pt? -139.79 -32.41 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.421 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.559 ' O ' HD13 ' A' ' 83' ' ' ILE . 0.4 OUTLIER -149.88 132.84 16.14 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -179.704 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.663 HD11 HG12 ' A' ' 80' ' ' VAL . 1.0 OUTLIER -134.62 126.23 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.315 178.268 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -158.34 175.96 13.06 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.072 0.463 . . . . 0.0 111.554 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -134.51 178.04 7.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.738 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.5 p -138.73 -43.32 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.283 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -133.7 -148.4 5.85 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.726 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.07 -77.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.608 2.205 . . . . 0.0 112.346 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.8 p -97.89 -3.47 38.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.881 0.372 . . . . 0.0 110.886 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.418 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 4.4 pt-20 -93.23 130.8 38.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.766 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -147.45 168.95 20.57 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.971 0.415 . . . . 0.0 111.203 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.406 ' HG2' ' HE1' ' A' ' 94' ' ' TYR . 20.9 ttpt -126.38 127.45 45.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.448 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.6 mt -125.53 149.46 30.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.885 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.467 ' HB2' ' CB ' ' A' ' 82' ' ' GLU . 6.8 m-85 -118.42 135.66 54.22 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.289 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.598 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -125.55 143.24 39.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.299 178.856 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.744 ' HG2' ' HB3' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -138.42 106.31 5.67 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 120.232 -0.587 . . . . 0.0 112.189 -177.514 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.416 ' H ' HG23 ' A' ' 97' ' ' VAL . 2.4 t -64.43 118.97 7.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.424 178.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.918 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.82 151.28 35.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.751 0.31 . . . . 0.0 110.791 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.1 170.49 13.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.019 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -81.44 -7.02 59.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.146 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -117.76 169.19 9.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.9 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -125.11 -44.57 1.9 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.958 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 9.5 m170 -65.65 -68.49 0.36 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.022 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -111.43 178.05 4.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.965 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 62.1 m-70 -104.78 -22.01 13.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.931 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.0 m -73.71 114.04 11.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.916 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.31 28.81 0.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.333 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.54 -71.8 0.78 Allowed Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.503 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.436 ' HG ' ' H ' ' A' ' 14' ' ' VAL . 1.7 tp -85.42 161.06 19.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.851 0.358 . . . . 0.0 110.875 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.436 ' H ' ' HG ' ' A' ' 13' ' ' LEU . 28.1 m -64.51 143.27 98.56 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.056 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.31 106.91 2.15 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.451 2.101 . . . . 0.0 112.251 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -85.53 27.62 0.82 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.359 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.45 -89.51 0.59 Allowed Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.491 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.29 29.01 0.36 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.65 0.262 . . . . 0.0 111.078 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 28.2 t60 -53.54 -78.32 0.02 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.321 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.8 mtp -81.16 -89.89 0.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.287 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.18 177.23 8.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.364 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.2 mttm -91.18 53.41 2.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.208 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -97.5 86.64 3.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.88 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -106.36 77.83 1.24 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.406 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.629 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 85.6 t -79.0 136.5 23.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.561 178.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.678 ' HB ' HD11 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -99.47 -37.37 9.22 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.846 -0.341 . . . . 0.0 111.82 -178.731 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.583 ' H ' ' CD1' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -145.52 162.23 37.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.407 0.622 . . . . 0.0 111.845 -178.723 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 83.1 m -136.17 125.99 25.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.715 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 tt -107.64 120.38 42.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.575 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.32 112.44 8.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.861 0.362 . . . . 0.0 111.084 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.1 t -134.14 70.06 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.972 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.02 -87.32 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.45 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.41 -156.49 4.81 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.384 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.18 130.53 55.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.863 0.364 . . . . 0.0 110.687 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.6 m -135.53 -157.66 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.791 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.556 ' O ' ' HD2' ' A' ' 39' ' ' PRO . 10.1 m -55.12 160.71 3.01 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.607 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.01 15.26 1.17 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.379 2.053 . . . . 0.0 112.596 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.529 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 10.5 t -65.24 -53.25 41.35 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.371 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.556 ' HD2' ' O ' ' A' ' 36' ' ' CYS . 30.9 Cg_endo -63.38 -24.12 71.41 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.166 1.911 . . . . 0.0 112.197 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.416 ' O ' HG22 ' A' ' 43' ' ' THR . 4.0 t70 -61.05 -65.93 0.61 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.652 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.7 t -65.55 -18.64 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.465 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -65.2 -50.82 64.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.731 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 40' ' ' ASP . 1.4 t -63.82 -33.34 75.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.44 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -59.69 -40.23 87.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.151 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -67.75 -29.79 69.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.99 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.88 -56.06 26.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.017 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.671 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 1.7 mm? -61.3 -62.0 2.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.58 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -58.7 -32.77 69.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.492 . . . . 0.0 112.184 -177.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -124.97 66.05 1.12 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.842 0.353 . . . . 0.0 111.24 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.507 ' HB2' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -98.78 158.18 15.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.921 179.775 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -100.12 144.86 29.21 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.648 179.538 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -49.87 -46.75 26.27 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.885 2.39 . . . . 0.0 113.573 -178.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.0 56.31 0.54 Allowed Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.622 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 11.7 mm-40 -90.86 136.01 33.35 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 117.18 0.49 . . . . 0.0 111.614 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.629 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 2.6 mp -136.4 81.41 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.613 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.678 HD11 ' HB ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -117.19 176.26 5.22 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.349 -0.541 . . . . 0.0 112.246 -173.481 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -132.04 162.52 30.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.811 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.481 HG12 HG12 ' A' ' 60' ' ' ILE . 6.2 t -135.3 139.59 46.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.815 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 9.1 t-105 -127.77 104.53 7.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.745 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.481 HG12 HG12 ' A' ' 58' ' ' VAL . 0.5 OUTLIER -158.29 -177.31 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.27 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -97.26 0.23 47.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.64 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -136.93 130.16 17.48 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.642 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.46 100.46 0.57 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.42 2.08 . . . . 0.0 112.304 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.408 ' O ' ' HD3' ' A' ' 68' ' ' ARG . 1.3 mtt -68.01 -13.04 61.87 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.773 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 14.4 p -59.14 -11.01 3.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.363 178.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -55.09 -46.44 75.48 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.11 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.548 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -87.23 -25.19 24.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.171 0.51 . . . . 0.0 110.209 178.955 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.773 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -62.41 -35.6 79.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.915 179.343 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.758 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 16.6 mt -60.39 -56.89 30.91 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.513 -179.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.758 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 67.0 Cg_exo -52.09 -32.15 47.91 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.283 1.988 . . . . 0.0 112.47 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.671 ' HG3' ' HB3' ' A' ' 47' ' ' LEU . 30.1 mm-40 -72.46 -63.69 1.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.884 0.373 . . . . 0.0 111.338 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.467 HG22 HD11 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -57.42 -28.36 63.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.479 -178.791 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.521 HG12 ' O ' ' A' ' 70' ' ' PRO . 5.8 p -74.19 -29.49 25.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.803 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.67 -41.43 86.1 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 176.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.433 ' HD3' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -90.47 -78.38 0.38 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.283 177.104 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.467 HD11 HG22 ' A' ' 72' ' ' THR . 0.0 OUTLIER -98.54 -96.75 0.22 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.743 178.515 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.29 -79.52 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.1 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.522 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -146.12 158.55 43.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.769 0.319 . . . . 0.0 110.863 179.262 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.77 ' HB2' HG23 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -103.49 56.67 0.74 Allowed 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.822 179.44 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.651 HG12 HD11 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -98.88 125.36 52.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.236 -177.996 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.522 ' HG ' ' HB3' ' A' ' 94' ' ' TYR . 1.1 pp -133.43 -36.9 0.97 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.015 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.485 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -153.38 143.67 22.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.97 0.414 . . . . 0.0 111.724 179.823 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.651 HD11 HG12 ' A' ' 80' ' ' VAL . 3.4 mp -143.19 137.52 26.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.336 178.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.429 ' HG3' ' HB3' ' A' ' 92' ' ' LYS . 2.5 pt-20 -152.6 176.53 11.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.016 0.436 . . . . 0.0 111.214 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -133.49 163.59 29.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.681 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.58 HG23 ' HA ' ' A' ' 91' ' ' TRP . 2.8 t -127.46 -66.58 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.321 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -123.0 -141.08 5.83 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.671 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.459 ' HB2' ' H ' ' A' ' 89' ' ' SER . 31.4 Cg_exo -58.71 -84.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.7 2.267 . . . . 0.0 112.329 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.459 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 85.1 p -100.05 -1.16 37.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.011 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -91.68 128.05 37.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.822 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.58 ' HA ' HG23 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -150.16 171.13 17.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.253 -179.682 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.429 ' HB3' ' HG3' ' A' ' 84' ' ' GLU . 12.0 tttt -121.36 141.69 50.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.491 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.426 HG22 ' H ' ' A' ' 94' ' ' TYR . 0.8 OUTLIER -131.16 165.17 32.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.186 -179.542 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.522 ' HB3' ' HG ' ' A' ' 81' ' ' LEU . 12.7 m-85 -132.88 126.17 31.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.001 178.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.77 HG23 ' HB2' ' A' ' 79' ' ' GLU . 18.7 mm -124.76 145.73 31.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.078 -177.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.662 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -150.54 120.1 6.96 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 119.759 -0.776 . . . . 0.0 112.924 -178.62 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.512 HG22 ' OE1' ' A' ' 79' ' ' GLU . 22.7 t -73.57 128.48 36.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.242 178.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.8 tttm . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.929 -179.708 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 112.409 -0.277 . . . . 0.0 112.409 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -121.08 -41.52 2.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.746 0.308 . . . . 0.0 110.797 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.48 127.97 50.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.903 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -69.58 135.9 50.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.002 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -64.88 129.28 39.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.875 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -130.55 -84.4 0.53 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.005 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.7 -59.43 0.72 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.922 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 -62.67 110.41 1.71 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.986 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -82.59 -16.05 49.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.842 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 27.4 t -80.27 147.27 31.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.048 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.33 -80.73 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.032 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.0 -166.89 38.53 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.59 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.31 34.41 0.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.792 0.33 . . . . 0.0 110.909 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.41 ' H ' HG22 ' A' ' 14' ' ' VAL . 3.7 m -76.28 144.06 74.11 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.163 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.21 164.02 88.69 Favored 'Cis proline' 0 C--N 1.348 0.529 0 C-N-CA 123.754 -1.353 . . . . 0.0 112.139 0.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.488 ' HB3' ' H ' ' A' ' 17' ' ' GLY . 1.1 mpt_? -81.11 -150.55 0.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.824 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.488 ' H ' ' HB3' ' A' ' 16' ' ' ARG . . . -72.39 155.47 51.41 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.565 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.99 -75.67 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.805 0.336 . . . . 0.0 110.943 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.488 ' HB3' ' H ' ' A' ' 20' ' ' MET . 2.2 m-70 -90.53 -151.27 0.24 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.862 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.488 ' H ' ' HB3' ' A' ' 19' ' ' HIS . 12.3 mtm -70.12 -85.63 0.02 OUTLIER 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.755 0.312 . . . . 0.0 110.998 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.19 165.29 15.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.255 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -91.17 72.9 6.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.822 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -89.97 39.36 0.96 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.922 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 8.4 mp0 -84.28 61.13 6.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.581 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.7 t -85.46 152.79 3.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.243 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.29 -61.88 1.31 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.691 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 0.8 OUTLIER -115.56 157.83 23.53 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.801 179.117 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.0 m -135.49 125.72 26.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.066 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.0 tt -107.46 119.44 39.42 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.975 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -124.04 113.96 19.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.516 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.446 ' O ' HG23 ' A' ' 60' ' ' ILE . 3.8 m -140.39 74.06 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.891 0.377 . . . . 0.0 111.543 -179.177 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -163.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.864 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.68 94.29 0.04 OUTLIER Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.44 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -103.18 -173.19 2.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.792 0.33 . . . . 0.0 111.012 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.418 ' HB ' ' H ' ' A' ' 36' ' ' CYS . 2.0 t -104.64 -86.24 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.653 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.692 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.8 OUTLIER -52.35 155.67 3.42 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.172 -179.467 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.63 25.05 0.4 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.613 2.208 . . . . 0.0 112.439 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.692 HG23 ' HB3' ' A' ' 36' ' ' CYS . 50.2 t -59.5 -48.68 95.18 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.855 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 38' ' ' VAL . 19.5 Cg_endo -60.11 -31.44 93.29 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.221 1.947 . . . . 0.0 112.457 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -64.04 -57.82 8.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.959 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.5 t -66.19 -19.65 26.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.066 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -65.97 -67.14 0.47 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.118 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.535 ' O ' HD13 ' A' ' 47' ' ' LEU . 8.4 t -60.2 -31.02 69.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.085 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.67 -44.3 77.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.665 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.56 -35.25 79.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.75 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.8 -36.4 84.2 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.997 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.535 HD13 ' O ' ' A' ' 43' ' ' THR . 2.4 mp -70.28 -39.67 74.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.154 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -78.84 -21.33 47.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.336 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.9 t30 -135.24 70.56 1.43 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.801 0.334 . . . . 0.0 111.4 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.658 ' HB2' HG21 ' A' ' 97' ' ' VAL . 18.4 ptp -102.28 145.14 29.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.673 178.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.891 ' HG2' ' HD2' ' A' ' 52' ' ' PRO . 3.1 tttp -80.79 148.17 64.35 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.783 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.891 ' HD2' ' HG2' ' A' ' 51' ' ' LYS . 58.7 Cg_exo -39.03 -75.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.25 2.634 . . . . 0.0 114.173 -178.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.86 59.7 0.48 Allowed Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.001 -0.618 . . . . 0.0 113.261 -177.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.406 ' HG2' ' HB3' ' A' ' 51' ' ' LYS . 1.8 mm-40 -90.92 153.68 20.02 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.014 0.435 . . . . 0.0 111.918 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.2 mt -132.5 116.0 26.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.99 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.536 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 5.0 mp -126.72 152.13 47.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.119 0.485 . . . . 0.0 111.949 -178.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -113.92 129.53 56.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.402 177.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.81 HG11 HH12 ' A' ' 68' ' ' ARG . 2.2 t -114.12 128.77 70.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.165 0.507 . . . . 0.0 111.925 -177.061 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -122.87 101.17 7.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.448 178.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.733 HD12 ' HB2' ' A' ' 64' ' ' MET . 0.5 OUTLIER -149.64 -160.01 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.681 -179.437 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.478 ' H ' HG22 ' A' ' 60' ' ' ILE . 10.1 p-10 -145.17 35.26 1.09 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.704 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.556 ' H ' ' HA ' ' A' ' 63' ' ' PRO . 44.4 m-85 -105.74 -63.02 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.001 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.556 ' HA ' ' H ' ' A' ' 62' ' ' TYR . 85.7 Cg_endo -97.53 164.23 12.48 Favored 'Cis proline' 0 C--N 1.356 0.971 0 CA-C-N 119.507 0.86 . . . . 0.0 112.088 -1.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.733 ' HB2' HD12 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -68.48 -17.76 64.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.808 0.337 . . . . 0.0 111.147 179.815 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.577 ' HA ' ' HD3' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -60.44 -17.4 44.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.932 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 63' ' ' PRO . 2.9 pttp -62.51 -27.22 68.99 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.844 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.507 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.7 OUTLIER -94.34 -26.19 16.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.178 0.513 . . . . 0.0 109.863 178.107 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.81 HH12 HG11 ' A' ' 58' ' ' VAL . 3.8 mpt_? -58.89 -47.57 84.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.193 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.732 HG23 ' HB3' ' A' ' 78' ' ' HIS . 3.8 mt -57.8 -55.32 46.2 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.834 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.693 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 83.8 Cg_exo -42.94 -51.47 5.42 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 122.73 2.286 . . . . 0.0 113.171 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.415 ' O ' ' HD3' ' A' ' 75' ' ' LYS . 2.0 mm-40 -62.41 -41.34 98.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.007 0.432 . . . . 0.0 110.978 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.542 HG21 ' HG3' ' A' ' 79' ' ' GLU . 2.9 m -59.72 -52.08 67.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.754 -179.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -58.67 -26.33 31.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.937 -178.863 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.6 -44.17 89.79 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 176.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.415 ' HD3' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -90.36 -77.28 0.41 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.429 176.898 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.75 HD13 ' HB2' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -98.52 -98.64 0.22 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.828 178.978 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.14 -84.54 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.151 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.732 ' HB3' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -146.36 146.91 30.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.976 0.417 . . . . 0.0 111.213 179.276 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.916 ' HB2' HG23 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -95.34 52.75 1.43 Allowed 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 177.737 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.529 HG12 ' HB2' ' A' ' 78' ' ' HIS . 1.4 p -98.71 118.77 45.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.208 -177.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.785 HD22 ' HB3' ' A' ' 96' ' ' LYS . 1.1 pt? -133.65 -29.35 1.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.686 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.505 ' O ' HG13 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -152.81 144.78 23.71 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.979 179.074 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 82' ' ' GLU . 2.5 mp -144.5 126.44 9.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.566 178.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 92' ' ' LYS . 9.3 pt-20 -153.06 174.67 13.89 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.905 0.384 . . . . 0.0 111.137 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.04 169.06 17.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.877 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.2 t -129.25 -52.68 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.215 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -126.1 -145.53 6.41 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.767 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.89 -77.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.606 2.204 . . . . 0.0 112.523 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.18 -6.85 27.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.937 0.399 . . . . 0.0 111.138 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -89.62 134.47 34.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.567 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -151.31 169.63 21.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.047 0.451 . . . . 0.0 111.265 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 10.5 ttpt -126.97 125.51 41.63 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.344 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.5 HG22 ' N ' ' A' ' 94' ' ' TYR . 4.1 mp -125.5 159.87 32.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.925 0.393 . . . . 0.0 110.836 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.5 ' N ' HG22 ' A' ' 93' ' ' ILE . 6.3 m-85 -118.2 133.55 55.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.579 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.916 HG23 ' HB2' ' A' ' 79' ' ' GLU . 12.9 mm -124.21 137.82 55.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.093 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.785 ' HB3' HD22 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -144.91 109.78 5.05 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.375 -0.53 . . . . 0.0 112.052 -176.677 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.658 HG21 ' HB2' ' A' ' 50' ' ' MET . 4.1 t -65.54 116.19 4.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.304 178.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.75 ' HB2' HD13 ' A' ' 76' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.082 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.581 -0.208 . . . . 0.0 112.581 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 p -126.94 -77.15 0.58 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.745 0.307 . . . . 0.0 110.885 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.8 m -139.18 124.0 18.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -102.79 11.02 38.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.941 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -74.2 90.52 2.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.819 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -133.38 44.96 2.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.904 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -90.78 28.26 1.58 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.965 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -89.89 102.0 14.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.961 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -115.6 40.8 2.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.931 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.2 m -81.77 -166.69 1.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.894 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.16 27.06 0.58 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.192 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.84 92.63 1.63 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.482 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.584 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 4.3 mm? -70.5 -173.23 0.7 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.742 0.305 . . . . 0.0 110.77 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.508 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 58.8 t -58.99 -50.77 86.22 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.261 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.584 ' HD2' ' HB3' ' A' ' 13' ' ' LEU . 56.2 Cg_endo -70.22 148.74 62.76 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.092 1.861 . . . . 0.0 112.231 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -85.27 33.07 0.55 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.059 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -53.76 172.31 0.69 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.055 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.405 ' C ' ' H ' ' A' ' 20' ' ' MET . 15.9 p -80.6 35.42 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.455 0.169 . . . . 0.0 111.451 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -76.66 25.99 0.14 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.642 0.258 . . . . 0.0 111.446 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.405 ' H ' ' C ' ' A' ' 18' ' ' SER . 0.0 OUTLIER -81.11 -169.03 2.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.768 0.318 . . . . 0.0 111.034 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.67 -174.0 0.51 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.013 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.6 mttm -91.29 20.61 5.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.112 0.482 . . . . 0.0 110.904 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -103.74 41.44 1.28 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.986 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.5 77.71 1.3 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.091 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.8 t -61.24 135.69 25.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.772 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.57 -56.08 2.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.152 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.03 137.76 50.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.829 0.347 . . . . 0.0 111.356 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 54.9 m -123.89 126.87 47.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.522 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.685 HD11 ' HG2' ' A' ' 42' ' ' GLU . 10.5 tp -109.83 118.76 37.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.292 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -108.24 128.42 54.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.528 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.793 ' HB ' HG23 ' A' ' 60' ' ' ILE . 18.9 t -117.24 -23.45 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.357 -179.019 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.84 -10.39 0.75 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.13 -91.76 0.37 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.76 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -80.6 175.4 10.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.804 0.335 . . . . 0.0 110.961 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.14 -177.72 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.208 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.766 ' HA ' ' HD2' ' A' ' 39' ' ' PRO . 20.9 p -53.1 154.98 4.86 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.104 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -91.81 18.91 38.56 Favored 'Cis proline' 0 C--N 1.348 0.521 0 C-N-CA 123.863 -1.307 . . . . 0.0 112.785 1.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.68 ' HB ' ' HD3' ' A' ' 39' ' ' PRO . 24.9 t -59.49 -53.1 69.18 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.627 -179.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.766 ' HD2' ' HA ' ' A' ' 36' ' ' CYS . 24.5 Cg_exo -64.26 -22.55 66.63 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.284 1.989 . . . . 0.0 112.176 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.16 -64.68 0.85 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.132 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 17.2 t -70.07 -30.01 42.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.294 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.685 ' HG2' HD11 ' A' ' 29' ' ' LEU . 28.2 tt0 -61.69 -56.94 14.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.148 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.439 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 6.7 t -62.65 -41.36 99.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.005 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.2 -43.78 71.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.859 0.361 . . . . 0.0 110.702 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.41 -32.76 74.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.412 178.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 43' ' ' THR . . . -59.32 -45.27 91.78 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.038 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.408 HD22 ' O ' ' A' ' 43' ' ' THR . 1.8 mm? -72.48 -19.47 61.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.772 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.41 -36.64 29.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.359 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -106.74 48.6 0.83 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.909 0.385 . . . . 0.0 111.606 -178.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.1 ptm -89.9 126.35 35.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.897 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.461 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -94.67 152.35 39.78 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.795 -179.86 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.461 ' HD2' ' HG3' ' A' ' 51' ' ' LYS . 61.0 Cg_exo -40.4 -67.61 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.175 2.583 . . . . 0.0 113.831 -178.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.32 57.87 0.51 Allowed Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.993 -0.622 . . . . 0.0 113.141 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.446 ' O ' HD13 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -91.25 150.29 21.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.983 0.421 . . . . 0.0 111.898 -179.71 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.573 HD13 ' HG3' ' A' ' 96' ' ' LYS . 0.6 OUTLIER -131.07 112.81 22.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.032 178.282 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 mt -119.78 154.51 34.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.176 0.513 . . . . 0.0 112.173 -177.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -119.75 125.86 49.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.472 177.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.1 t -114.96 138.22 45.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.176 0.512 . . . . 0.0 112.327 -177.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.455 ' C ' HG13 ' A' ' 60' ' ' ILE . 7.1 m0 -122.46 105.62 10.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.654 177.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.924 HG12 ' HB2' ' A' ' 64' ' ' MET . 0.1 OUTLIER -144.97 -176.97 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 CA-C-O 120.966 0.412 . . . . 0.0 111.505 -177.98 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.563 ' HB3' ' HA ' ' A' ' 90' ' ' GLU . 0.5 OUTLIER -138.4 25.9 2.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.869 179.396 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.795 ' H ' ' HA ' ' A' ' 63' ' ' PRO . 0.6 OUTLIER -106.19 -55.48 0.07 OUTLIER Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.597 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.795 ' HA ' ' H ' ' A' ' 62' ' ' TYR . 78.5 Cg_endo -95.61 177.36 9.94 Favored 'Cis proline' 0 C--N 1.355 0.897 0 C-N-CA 124.904 -0.873 . . . . 0.0 112.708 0.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.924 ' HB2' HG12 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -68.43 -25.7 65.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.228 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.457 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 14.4 p -61.3 -13.02 15.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.087 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.514 ' HG3' ' N ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -62.97 -31.93 73.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.886 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.562 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -94.2 -25.66 16.99 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.084 0.469 . . . . 0.0 110.241 178.758 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.457 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 18.5 mtt85 -62.17 -41.91 98.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.954 179.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.731 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 12.5 mt -56.7 -55.84 38.99 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.684 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.731 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 76.2 Cg_exo -49.31 -40.8 43.59 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.292 1.995 . . . . 0.0 112.703 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.86 -51.65 52.99 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.899 0.381 . . . . 0.0 111.219 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.835 HG21 ' HG2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -59.53 -50.63 73.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.59 -178.799 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.0 p -58.37 -28.12 34.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.895 -178.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.78 -42.46 89.03 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 176.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.6 -80.62 0.3 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.949 176.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.757 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -98.58 -106.65 0.19 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.363 177.2 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.488 ' H ' HD23 ' A' ' 76' ' ' LEU . . . -132.73 -84.76 0.26 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.018 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.39 164.23 33.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.915 0.388 . . . . 0.0 111.309 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.835 ' HG2' HG21 ' A' ' 72' ' ' THR . 0.0 OUTLIER -107.09 62.3 0.62 Allowed 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.397 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.478 HG23 HD11 ' A' ' 83' ' ' ILE . 1.4 p -98.14 120.88 48.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.427 -175.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.575 HD21 ' HB3' ' A' ' 94' ' ' TYR . 0.5 OUTLIER -133.68 -33.52 1.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.795 179.807 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.468 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -151.77 145.16 24.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.014 0.435 . . . . 0.0 111.811 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.478 HD11 HG23 ' A' ' 80' ' ' VAL . 3.5 mp -142.23 123.51 12.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.288 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.574 ' HG3' ' HB3' ' A' ' 92' ' ' LYS . 5.1 pt-20 -156.55 -175.55 5.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.221 0.534 . . . . 0.0 111.349 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.486 ' HB3' ' HD1' ' A' ' 91' ' ' TRP . 3.6 pt-20 -133.24 166.39 22.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.639 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.406 HG13 ' N ' ' A' ' 87' ' ' GLY . 4.8 p -131.27 -44.9 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.477 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.406 ' N ' HG13 ' A' ' 86' ' ' VAL . . . -133.33 -151.83 6.68 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.673 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.89 -74.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.547 2.164 . . . . 0.0 112.426 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.7 p -95.65 -5.84 41.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.812 0.339 . . . . 0.0 111.157 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.563 ' HA ' ' HB3' ' A' ' 61' ' ' ASP . 4.5 pt-20 -93.03 140.94 28.95 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.558 179.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.486 ' HD1' ' HB3' ' A' ' 85' ' ' GLU . 6.1 m-90 -136.44 163.97 29.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.047 0.451 . . . . 0.0 111.335 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.574 ' HB3' ' HG3' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -120.23 117.0 26.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.077 178.99 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.4 mp -125.28 145.34 32.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.99 -178.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.575 ' HB3' HD21 ' A' ' 81' ' ' LEU . 29.1 m-85 -118.04 132.54 56.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.187 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.711 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -124.13 141.66 43.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.796 -177.945 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.585 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -151.21 130.05 12.44 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.239 -0.584 . . . . 0.0 112.287 -177.714 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.433 HG22 ' OE1' ' A' ' 79' ' ' GLU . 2.3 t -80.85 120.05 31.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.089 177.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.954 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 112.449 -0.261 . . . . 0.0 112.449 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.1 t -77.31 156.72 31.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.768 0.318 . . . . 0.0 110.974 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.77 -3.34 25.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.985 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -79.06 106.99 11.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.029 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -120.38 -96.74 0.47 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.802 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.48 23.55 2.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.781 0.324 . . . . 0.0 111.022 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 40.1 m-70 -131.96 27.63 4.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.078 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -108.91 -168.99 1.41 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.976 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -63.81 141.75 58.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.905 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.59 144.05 44.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.873 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.86 -69.55 0.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.922 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.77 158.53 53.17 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.527 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -95.47 -94.09 0.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.669 0.271 . . . . 0.0 110.968 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.5 m -89.26 144.14 31.98 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.173 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -78.76 136.22 40.02 Favored 'Cis proline' 0 C--N 1.349 0.571 0 C-N-CA 123.462 -1.474 . . . . 0.0 112.398 -0.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.6 mtt180 -82.2 26.15 0.55 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.332 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.63 28.82 3.05 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.565 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 85.2 p -80.57 -150.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.722 0.296 . . . . 0.0 110.846 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -83.2 28.6 0.52 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.181 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.88 -148.79 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.913 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.91 129.43 41.51 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.127 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -89.43 76.22 7.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.955 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -72.72 125.62 27.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.98 151.6 35.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.03 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.695 HG13 ' HA ' ' A' ' 56' ' ' LEU . 57.6 t -85.02 145.41 8.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.12 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.3 m -106.36 -53.64 2.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.196 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.456 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -119.39 167.03 12.32 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.048 0.452 . . . . 0.0 111.466 -179.197 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.418 ' H ' ' HG3' ' A' ' 27' ' ' LYS . 87.8 m -134.09 121.99 22.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.648 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.476 HD22 HG13 ' A' ' 58' ' ' VAL . 5.1 tt -103.69 120.75 41.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.935 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -132.37 120.17 21.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.727 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.427 ' HA ' ' HB3' ' A' ' 39' ' ' PRO . 3.0 t -109.65 -4.66 10.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.246 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.645 ' HD3' ' HE1' ' A' ' 59' ' ' TRP . 0.7 OUTLIER -50.76 -18.57 0.75 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.285 -179.474 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.61 102.02 0.7 Allowed Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.551 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.87 23.55 0.54 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.686 0.279 . . . . 0.0 111.421 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -104.27 -133.36 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.95 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.405 ' C ' ' H ' ' A' ' 38' ' ' VAL . 99.2 m -50.83 155.15 2.09 Favored Pre-proline 0 C--O 1.232 0.136 0 CA-C-O 120.603 0.239 . . . . 0.0 111.127 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.95 26.64 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.633 2.222 . . . . 0.0 112.534 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.691 ' HB ' ' HD3' ' A' ' 39' ' ' PRO . 73.6 t -58.5 -51.47 81.57 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.341 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.691 ' HD3' ' HB ' ' A' ' 38' ' ' VAL . 19.7 Cg_exo -66.61 -20.49 53.36 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.335 2.024 . . . . 0.0 112.137 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -70.59 -51.12 30.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.983 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.1 t -74.39 -29.98 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.711 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -60.69 -53.36 58.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.829 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.445 ' CB ' HD11 ' A' ' 29' ' ' LEU . 13.3 t -64.14 -38.81 92.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.791 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.64 -41.63 73.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.676 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.68 -30.35 69.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.05 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.52 -43.98 80.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.25 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.817 HD11 ' HG2' ' A' ' 68' ' ' ARG . 2.3 mm? -71.4 -43.86 66.02 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.69 -179.143 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -81.35 -12.65 58.94 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -177.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -135.51 72.71 1.45 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.94 0.4 . . . . 0.0 111.139 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.67 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -108.53 138.49 44.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.866 179.832 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.656 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -96.09 153.29 39.16 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.7 179.708 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -52.94 -43.61 55.32 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.624 2.216 . . . . 0.0 113.198 -178.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.8 50.14 0.86 Allowed Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.532 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.684 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 20.0 mm-40 -91.27 129.0 37.31 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 117.358 0.579 . . . . 0.0 111.635 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 1.1 mp -135.59 89.46 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.779 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.695 ' HA ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -118.89 -177.98 3.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.252 0.549 . . . . 0.0 112.087 -176.695 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -129.25 174.01 9.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.236 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.569 HG12 HG13 ' A' ' 60' ' ' ILE . 13.4 t -140.17 136.02 37.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.858 0.361 . . . . 0.0 111.303 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.645 ' HE1' ' HD3' ' A' ' 32' ' ' ARG . 57.9 t-105 -122.49 104.49 9.41 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.706 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.569 HG13 HG12 ' A' ' 58' ' ' VAL . 0.8 OUTLIER -159.04 -177.8 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.084 0.469 . . . . 0.0 111.528 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 4.9 m-20 -99.89 -13.8 19.02 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.016 177.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.466 ' O ' HD13 ' A' ' 60' ' ' ILE . 1.8 m-85 -129.91 124.8 21.79 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.274 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.482 ' HD3' ' HE1' ' A' ' 91' ' ' TRP . 86.4 Cg_exo -47.54 104.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.643 2.229 . . . . 0.0 112.863 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.425 ' CE ' HD21 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -64.88 -19.27 65.81 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.116 0.484 . . . . 0.0 110.586 179.3 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.681 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 6.1 p -61.82 -10.09 8.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.625 179.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.7 ptmt -58.15 -37.96 75.68 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.58 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.552 ' O ' ' HG2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -91.74 -24.21 19.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.277 0.56 . . . . 0.0 109.967 178.259 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.817 ' HG2' HD11 ' A' ' 47' ' ' LEU . 33.2 mtt-85 -63.46 -39.69 95.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.756 179.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.464 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 12.2 mt -57.5 -56.96 28.64 Favored Pre-proline 0 CA--C 1.532 0.282 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.552 ' HG2' ' O ' ' A' ' 67' ' ' GLU . 9.8 Cg_endo -53.4 -34.58 71.84 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.138 1.892 . . . . 0.0 112.574 -178.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.556 ' HG3' ' HB3' ' A' ' 47' ' ' LEU . 65.1 mm-40 -72.92 -65.71 0.76 Allowed 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.042 0.448 . . . . 0.0 111.327 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.636 HG21 ' HG3' ' A' ' 79' ' ' GLU . 0.2 OUTLIER -58.7 -24.91 62.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.353 -178.992 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.534 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 3.4 p -76.07 -27.89 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-O 120.74 0.305 . . . . 0.0 110.474 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.97 -43.35 86.43 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 176.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.08 -77.89 0.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.117 176.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.421 HD11 HG22 ' A' ' 72' ' ' THR . 0.0 OUTLIER -98.18 -100.24 0.21 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.626 178.216 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.27 -85.62 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.71 178.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.597 ' CE1' HD11 ' A' ' 95' ' ' ILE . 6.3 t-80 -147.05 172.7 13.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.924 0.392 . . . . 0.0 110.94 177.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.885 ' HB2' HG13 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -111.48 68.53 0.67 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.84 178.988 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.565 HG22 ' ND1' ' A' ' 78' ' ' HIS . 0.1 OUTLIER -99.02 122.06 50.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.952 0.406 . . . . 0.0 112.025 -176.64 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.999 ' HB3' ' HG2' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -133.74 -40.97 0.86 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.036 178.563 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.567 ' HB2' HD12 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -153.88 151.02 28.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.04 0.448 . . . . 0.0 112.116 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.512 HG13 ' C ' ' A' ' 82' ' ' GLU . 1.1 mp -141.54 142.14 29.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.159 178.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -156.63 176.05 13.24 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.027 0.442 . . . . 0.0 111.682 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -136.07 176.65 8.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.732 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.578 HG12 ' HA ' ' A' ' 91' ' ' TRP . 0.7 OUTLIER -144.34 -53.48 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.134 -178.298 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.405 ' H ' HG13 ' A' ' 86' ' ' VAL . . . -123.92 -153.91 8.79 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.564 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.97 -78.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.626 2.218 . . . . 0.0 112.311 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.05 -3.02 32.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.869 0.366 . . . . 0.0 111.111 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 8.7 pt-20 -93.35 133.24 36.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.765 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.578 ' HA ' HG12 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -151.56 173.73 14.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.272 -179.902 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.551 ' HG3' ' HE3' ' A' ' 59' ' ' TRP . 3.3 mttm -122.33 143.43 49.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.365 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.63 151.27 31.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.919 0.39 . . . . 0.0 111.258 -179.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.464 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 14.4 m-85 -118.66 123.65 45.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.081 178.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.885 HG13 ' HB2' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -123.77 151.51 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.045 -177.959 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.999 ' HG2' ' HB3' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -148.83 97.74 2.76 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.926 -177.445 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.684 ' HB ' ' HB2' ' A' ' 54' ' ' GLU . 17.6 t -60.56 117.53 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.701 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.908 -179.905 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.6 t -107.02 -69.07 0.85 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.807 0.336 . . . . 0.0 110.973 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -127.55 -0.14 6.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.903 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.42 37.94 1.41 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -66.04 169.0 7.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.963 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -65.22 146.64 54.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.924 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -71.75 139.18 48.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.095 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.733 ' HB3' ' HB2' ' A' ' 11' ' ' SER . 39.3 m80 -92.75 131.17 38.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.742 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -102.36 -80.9 0.5 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.131 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.02 -9.81 58.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.143 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.733 ' HB2' ' HB3' ' A' ' 8' ' ' HIS . 66.8 m -75.54 -77.64 0.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.88 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.23 93.61 0.79 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.779 -0.725 . . . . 0.0 112.404 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 mp -73.2 -76.18 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.683 0.278 . . . . 0.0 110.963 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.5 m -88.69 141.82 30.37 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.088 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -80.89 38.13 0.74 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.067 2.511 . . . . 0.0 112.258 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -77.62 -79.16 0.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.037 -179.649 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.54 85.61 0.84 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.445 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.4 -77.45 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.79 0.329 . . . . 0.0 110.981 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -83.86 -81.64 0.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.899 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.12 128.78 34.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.874 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.13 -169.64 1.92 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.333 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.46 ' HB2' ' H ' ' A' ' 23' ' ' TYR . 1.0 OUTLIER -68.12 -106.1 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.69 178.59 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.46 ' H ' ' HB2' ' A' ' 22' ' ' LYS . 28.5 m-85 -92.32 112.22 24.08 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.904 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -103.87 126.27 50.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.949 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 68.9 t -61.82 136.61 25.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.26 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.7 m -99.84 -67.82 0.83 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.891 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -115.76 159.43 21.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.801 0.334 . . . . 0.0 110.842 179.636 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.6 m -135.65 124.77 24.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.096 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.3 tt -104.94 112.87 26.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.571 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -130.05 112.55 13.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.142 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.725 HG12 HG21 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -135.51 72.45 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.818 179.13 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.437 ' HB3' ' H ' ' A' ' 33' ' ' GLY . 4.3 ttm180 -52.65 -90.14 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.499 -179.301 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.437 ' H ' ' HB3' ' A' ' 32' ' ' ARG . . . -75.46 -159.46 7.9 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.333 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.8 134.51 36.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.535 0.683 . . . . 0.0 112.286 -178.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.725 HG21 HG12 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -136.26 -176.88 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 114.691 -1.141 . . . . 0.0 111.178 179.538 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.601 ' O ' ' HD2' ' A' ' 39' ' ' PRO . 0.8 OUTLIER -67.52 163.22 49.71 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.365 178.885 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -73.03 11.52 0.89 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.72 2.28 . . . . 0.0 112.692 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.493 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 39.8 t -64.31 -54.85 35.23 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.671 -179.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.601 ' HD2' ' O ' ' A' ' 36' ' ' CYS . 28.8 Cg_endo -61.94 -21.24 71.93 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.321 2.014 . . . . 0.0 112.14 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -63.53 -62.67 1.52 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.646 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.1 t -71.76 -18.4 19.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.805 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -66.35 -57.44 7.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.886 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.481 HG21 ' SD ' ' A' ' 64' ' ' MET . 14.6 t -60.43 -35.01 74.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.61 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.3 tptm -61.26 -39.54 90.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.397 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -32.67 72.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.762 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.63 -48.71 80.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.822 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.638 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 3.0 mt -62.02 -30.05 70.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.784 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.62 -25.63 45.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.164 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -132.43 69.62 1.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.058 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.636 ' HB3' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -84.6 147.47 26.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.792 179.835 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.795 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 0.8 OUTLIER -103.08 161.57 22.7 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.658 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -46.61 -72.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.988 2.458 . . . . 0.0 113.905 -177.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.28 59.99 0.45 Allowed Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.333 -177.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.795 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 26.3 mm-40 -87.34 139.19 30.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.896 0.379 . . . . 0.0 111.377 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.557 ' HA ' ' HB2' ' A' ' 96' ' ' LYS . 16.8 mt -135.25 121.03 30.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.682 178.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.486 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.5 mp -127.1 146.82 50.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.156 0.503 . . . . 0.0 112.076 -177.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -111.31 123.34 50.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.699 177.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.41 HG12 HG12 ' A' ' 60' ' ' ILE . 8.3 t -114.34 130.36 68.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.977 0.417 . . . . 0.0 111.758 -177.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.587 ' HE1' HG21 ' A' ' 86' ' ' VAL . 2.4 t90 -126.73 111.33 14.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.427 179.181 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.554 ' CG2' HG23 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -158.14 -168.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 121.071 0.462 . . . . 0.0 111.796 -178.953 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.45 ' OD2' ' HB2' ' A' ' 89' ' ' SER . 0.4 OUTLIER -102.7 -11.42 18.41 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.9 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.469 ' O ' HD12 ' A' ' 60' ' ' ILE . 4.5 m-85 -133.59 139.75 34.71 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.909 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.41 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 16.9 Cg_exo -67.66 101.73 0.68 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.722 2.282 . . . . 0.0 112.615 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.481 ' SD ' HG21 ' A' ' 43' ' ' THR . 0.0 OUTLIER -68.24 -16.78 64.1 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.138 0.494 . . . . 0.0 110.524 178.954 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.75 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -59.36 -12.62 6.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.458 179.105 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.71 ' HE2' ' HG3' ' A' ' 67' ' ' GLU . 2.2 pttm -54.91 -39.29 68.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.989 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.71 ' HG3' ' HE2' ' A' ' 66' ' ' LYS . 4.9 mt-10 -91.48 -27.97 17.92 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.146 0.498 . . . . 0.0 110.067 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.75 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -62.94 -34.62 77.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.115 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.768 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 21.0 mt -60.85 -56.95 30.1 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.768 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 75.7 Cg_exo -51.09 -37.29 57.53 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.255 1.97 . . . . 0.0 112.666 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.638 ' HG3' ' HB3' ' A' ' 47' ' ' LEU . 17.4 mm-40 -67.35 -65.79 0.64 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.841 0.353 . . . . 0.0 111.481 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.543 HG21 ' HG3' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -54.52 -45.35 73.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.433 -178.909 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.439 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 7.1 p -59.18 -29.1 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.209 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.9 tptt -58.5 -43.89 89.25 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 176.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.499 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 2.9 mtpp -90.07 -77.64 0.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.484 177.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.43 ' HG ' ' H ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -98.44 -97.6 0.22 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.947 178.783 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.24 -82.39 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.372 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.63 166.94 25.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.018 0.437 . . . . 0.0 111.524 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.926 ' HB2' HG13 ' A' ' 95' ' ' ILE . 3.9 mt-10 -106.58 56.55 0.65 Allowed 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.2 p -97.38 122.18 48.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.086 0.469 . . . . 0.0 111.186 -176.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.631 HD22 ' HB3' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -133.61 -38.27 0.92 Allowed 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.341 -179.336 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.543 ' O ' ' HB2' ' A' ' 94' ' ' TYR . 1.0 OUTLIER -153.8 126.27 8.07 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.725 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.425 HD13 ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -118.58 137.48 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.093 178.929 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 92' ' ' LYS . 0.5 OUTLIER -158.54 173.69 16.23 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.908 0.385 . . . . 0.0 111.398 -179.798 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -133.78 168.1 19.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.613 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.587 HG21 ' HE1' ' A' ' 59' ' ' TRP . 48.0 t -129.55 -60.25 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.04 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -125.13 -150.83 7.87 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.492 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.14 -77.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.69 2.26 . . . . 0.0 112.297 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.45 ' HB2' ' OD2' ' A' ' 61' ' ' ASP . 0.8 OUTLIER -96.8 -2.45 44.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.004 -179.756 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.35 134.82 35.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.545 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.409 ' HZ2' ' HD3' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -151.07 169.19 22.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.019 0.438 . . . . 0.0 111.259 -179.767 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.499 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 0.9 OUTLIER -121.08 131.58 54.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.456 179.549 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.9 mt -125.48 144.24 36.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.979 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.563 ' HB3' ' HG ' ' A' ' 81' ' ' LEU . 2.8 m-85 -118.1 119.86 36.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.141 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.926 HG13 ' HB2' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -123.92 141.88 42.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.901 -178.205 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.631 ' HB3' HD22 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -151.04 130.06 12.58 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 120.107 -0.637 . . . . 0.0 112.391 -178.539 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.636 HG21 ' HB3' ' A' ' 50' ' ' MET . 10.8 t -72.68 116.12 14.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.652 178.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.92 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.185 0 N-CA-C 112.536 -0.225 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.2 -18.71 14.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.829 0.347 . . . . 0.0 110.955 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.28 -25.72 11.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -91.87 107.55 19.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.994 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -105.25 130.01 53.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.7 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -107.92 -170.13 1.64 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.996 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -103.63 2.8 33.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.917 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -102.3 176.53 5.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -93.17 65.5 3.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.011 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.23 58.56 5.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.839 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.92 -77.2 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.97 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.72 147.94 47.47 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.515 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.26 115.75 28.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.778 0.323 . . . . 0.0 110.88 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.0 p -70.39 127.21 92.3 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -57.76 98.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.517 2.145 . . . . 0.0 112.284 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -85.26 29.41 0.66 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.103 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.14 -135.22 0.69 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.566 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.55 -150.98 0.05 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.63 0.253 . . . . 0.0 110.907 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -84.23 28.14 0.64 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.308 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -78.2 104.32 8.7 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.778 0.323 . . . . 0.0 110.853 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.73 170.76 14.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.078 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -83.27 71.56 10.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.705 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.21 48.39 1.04 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.948 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -102.74 75.59 1.43 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.862 HG13 ' HA ' ' A' ' 56' ' ' LEU . 87.9 t -77.11 140.49 17.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.178 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.423 ' H ' HD23 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -99.77 -42.15 6.96 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.845 -179.389 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.817 ' H ' HD22 ' A' ' 56' ' ' LEU . 4.4 mmtt -131.68 159.4 38.48 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.375 0.607 . . . . 0.0 112.433 -178.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 99.3 m -135.26 124.23 24.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.629 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.556 HD22 HG13 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -101.69 121.98 43.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.084 -179.848 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -129.49 87.42 2.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.922 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.79 HG23 HG23 ' A' ' 60' ' ' ILE . 6.4 m -114.37 43.42 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.001 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 21.7 ttp85 -71.96 -73.39 0.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.665 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.57 -2.75 3.55 Favored Glycine 0 CA--C 1.519 0.309 0 CA-C-N 115.846 -0.615 . . . . 0.0 113.303 -178.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.618 ' OE2' HG12 ' A' ' 31' ' ' VAL . 2.0 mt-10 -80.48 -169.89 2.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.787 0.293 . . . . 0.0 110.851 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.748 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -104.11 -163.14 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.411 -178.484 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.602 ' O ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -81.72 -47.87 1.01 Allowed Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -178.402 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.748 ' HD2' ' HB ' ' A' ' 35' ' ' VAL . 56.6 Cg_endo -71.23 -15.25 31.74 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.099 1.866 . . . . 0.0 113.042 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.742 ' HB ' ' HD3' ' A' ' 39' ' ' PRO . 34.8 t -67.35 -56.15 13.47 Favored Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 111.656 0.243 . . . . 0.0 111.656 -179.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.742 ' HD3' ' HB ' ' A' ' 38' ' ' VAL . 16.8 Cg_exo -67.54 -21.86 45.55 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.201 1.934 . . . . 0.0 112.144 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -61.85 -56.11 22.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.93 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.2 t -70.68 -29.35 37.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.065 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.432 ' HG2' HD11 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -63.82 -63.57 1.13 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.025 -179.756 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.532 HG22 ' O ' ' A' ' 39' ' ' PRO . 14.2 t -58.35 -30.91 67.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.016 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.88 -40.55 89.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.622 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.3 tmm_? -67.1 -33.31 75.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.627 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.548 ' O ' ' HG3' ' A' ' 50' ' ' MET . . . -64.01 -54.18 38.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.848 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.497 HD21 ' CD ' ' A' ' 68' ' ' ARG . 53.2 mt -52.19 -35.32 48.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.339 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.99 -22.38 39.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.181 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -126.52 49.51 2.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.289 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.786 ' HB3' HG11 ' A' ' 97' ' ' VAL . 60.6 mtm -83.19 128.65 34.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.053 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.531 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 4.3 mtpp -85.83 154.73 58.59 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.419 179.07 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.47 -43.08 42.48 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.589 2.192 . . . . 0.0 112.826 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.41 57.44 0.49 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.426 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.531 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 7.2 mm-40 -90.08 128.37 36.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.3 0.55 . . . . 0.0 111.305 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.668 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 6.1 mt -135.93 66.89 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.814 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.862 ' HA ' HG13 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -118.71 -172.23 2.24 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -171.772 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -140.47 171.35 14.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.555 -178.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.556 HG13 HD22 ' A' ' 29' ' ' LEU . 33.6 t -139.58 146.2 25.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.57 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.419 ' C ' HG13 ' A' ' 60' ' ' ILE . 6.8 t90 -122.98 109.74 14.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.014 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.79 HG23 HG23 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -151.7 -178.39 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.308 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -101.59 -2.95 29.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.496 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.598 ' O ' HD13 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -137.82 139.44 26.52 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.612 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -62.13 89.85 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.498 2.132 . . . . 0.0 112.245 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -23.37 67.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.927 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.812 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.4 OUTLIER -55.86 -16.91 5.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.116 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.6 pttt -53.49 -37.32 62.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.274 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -94.21 -27.91 15.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.175 0.512 . . . . 0.0 110.093 178.517 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.812 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -64.77 -25.43 67.92 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.378 179.725 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.502 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 18.9 mt -73.42 -54.83 3.88 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 9.2 Cg_endo -53.99 -33.67 73.72 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.194 1.929 . . . . 0.0 112.366 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.531 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -69.45 -46.89 65.65 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.996 0.427 . . . . 0.0 110.767 179.169 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.613 ' O ' HD22 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -62.08 -47.82 82.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.041 -179.861 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 70' ' ' PRO . 7.1 p -58.89 -27.53 35.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.841 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.531 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 4.5 mmmt -58.71 -42.69 89.24 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 175.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.443 ' HB3' HD13 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -90.1 -81.49 0.29 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.986 176.421 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.782 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -98.56 -107.43 0.19 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.416 177.35 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.444 ' H ' HD23 ' A' ' 76' ' ' LEU . . . -129.22 -82.53 0.31 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.079 -0.581 . . . . 0.0 111.939 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.03 161.47 40.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.92 0.391 . . . . 0.0 110.856 178.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.829 ' HB2' HG23 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -103.84 52.73 0.76 Allowed 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.127 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.6 p -98.97 122.18 50.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.872 -178.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.475 ' HG ' ' N ' ' A' ' 82' ' ' GLU . 0.4 OUTLIER -133.48 -35.0 1.02 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.063 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -153.69 153.46 32.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.025 0.441 . . . . 0.0 112.052 179.351 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 82' ' ' GLU . 3.6 mp -144.03 135.53 22.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.437 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -156.07 -179.66 8.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.067 0.461 . . . . 0.0 111.314 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -133.57 158.51 42.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.783 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 62.0 t -117.65 -59.26 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.261 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -127.08 -152.73 8.07 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.729 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -56.67 -75.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.678 2.252 . . . . 0.0 112.612 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.18 -5.62 29.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.907 0.384 . . . . 0.0 111.235 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.468 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 4.3 pt-20 -93.61 137.1 33.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.769 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.02 168.56 20.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.923 0.392 . . . . 0.0 111.121 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.3 tttm -126.14 136.9 53.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.623 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.422 HG22 ' N ' ' A' ' 94' ' ' TYR . 2.2 mp -125.99 157.69 35.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.937 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.492 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 15.3 m-85 -118.21 135.02 54.51 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.014 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.829 HG23 ' HB2' ' A' ' 79' ' ' GLU . 10.9 mm -122.88 145.48 29.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.214 -176.078 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.663 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -143.68 106.04 4.41 Favored 'General case' 0 C--N 1.334 -0.085 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.738 -177.569 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.786 HG11 ' HB3' ' A' ' 50' ' ' MET . 23.7 t -75.79 131.11 35.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.642 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.509 ' HB2' ' HG ' ' A' ' 76' ' ' LEU . 3.5 mmmp? . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.152 -0.928 . . . . 0.0 110.908 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 112.454 -0.258 . . . . 0.0 112.454 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.33 108.02 8.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.783 0.325 . . . . 0.0 110.982 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.84 134.43 47.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -62.08 149.04 42.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -115.75 -52.69 2.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.02 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -120.27 174.89 6.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.936 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -97.6 178.07 5.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.781 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 -130.58 -83.94 0.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.105 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -132.59 160.45 36.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.053 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.6 m -70.93 110.44 5.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.755 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.4 m -65.31 -73.99 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.885 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -86.53 121.07 5.62 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.558 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.69 161.62 30.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.878 0.371 . . . . 0.0 111.004 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.861 HG13 ' HD3' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -89.31 -47.34 0.41 Allowed Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.337 179.388 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.861 ' HD3' HG13 ' A' ' 14' ' ' VAL . 24.0 Cg_exo -64.21 91.26 0.17 Allowed 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.257 1.971 . . . . 0.0 112.098 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.7 mmt85 -84.31 -152.03 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.787 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.18 110.65 3.47 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.508 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.24 -151.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.567 0.222 . . . . 0.0 110.763 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -89.16 -84.84 0.21 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.692 0.282 . . . . 0.0 110.871 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.25 175.69 10.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.965 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.54 79.67 9.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.976 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.2 mtmt -84.29 65.79 9.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.016 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -86.08 101.82 13.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.918 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.54 126.4 30.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.015 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.1 t -85.26 144.35 9.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.128 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.08 -53.52 3.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.966 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.4 ' HB3' ' HG ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -126.25 160.54 30.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.016 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 57' ' ' GLU . 98.3 m -135.27 122.65 21.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.832 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.662 ' HB3' ' HB ' ' A' ' 58' ' ' VAL . 8.6 tt -99.15 103.35 15.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.948 0.404 . . . . 0.0 111.028 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.22 111.66 17.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.625 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.4 HG23 ' CG2' ' A' ' 60' ' ' ILE . 1.2 m -140.15 75.98 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.231 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -157.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.052 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.1 81.65 0.13 Allowed Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.801 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.409 ' HG3' ' HD3' ' A' ' 39' ' ' PRO . 5.1 pt-20 -111.64 -161.5 0.76 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.698 0.285 . . . . 0.0 110.793 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -120.57 145.24 27.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.913 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.744 ' HA ' ' HD2' ' A' ' 39' ' ' PRO . 59.3 m -76.27 160.17 78.46 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.922 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.517 ' HA ' ' HB3' ' A' ' 36' ' ' CYS . 69.3 Cg_endo -93.41 32.11 11.21 Favored 'Cis proline' 0 C--N 1.351 0.666 0 C-N-CA 124.039 -1.234 . . . . 0.0 112.944 1.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.492 ' HB ' ' HD3' ' A' ' 39' ' ' PRO . 61.4 t -59.33 -51.64 80.01 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.572 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.744 ' HD2' ' HA ' ' A' ' 36' ' ' CYS . 66.3 Cg_endo -73.82 -18.85 21.55 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.131 1.888 . . . . 0.0 112.362 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.48 -61.04 1.92 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.068 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 37' ' ' PRO . 3.8 t -64.57 -24.32 35.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.249 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -63.24 -74.05 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.074 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.562 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 10.2 t -57.18 -28.46 62.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.956 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.04 -50.46 69.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.695 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.39 -33.08 74.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.075 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.52 -42.29 91.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.037 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 43' ' ' THR . 2.8 mt -77.54 -45.69 24.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.677 -179.239 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -15.81 60.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.943 -177.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.71 63.06 1.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.938 0.399 . . . . 0.0 111.2 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.416 ' HB2' HG21 ' A' ' 97' ' ' VAL . 6.6 ptt? -109.25 136.48 48.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.868 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.489 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -92.27 147.44 34.58 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.671 179.491 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -42.47 -56.82 1.89 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.025 2.483 . . . . 0.0 113.476 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.24 56.0 0.58 Allowed Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.056 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.489 ' HG2' ' HB3' ' A' ' 51' ' ' LYS . 4.2 mm-40 -90.72 150.66 21.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.082 0.468 . . . . 0.0 111.78 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.8 mp -133.65 111.59 15.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.499 177.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.4 ' HG ' ' HB3' ' A' ' 27' ' ' LYS . 4.3 mp -119.3 168.38 10.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.456 0.646 . . . . 0.0 112.39 -176.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.511 ' O ' HG23 ' A' ' 28' ' ' THR . 4.3 tt0 -141.51 117.4 10.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.445 178.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.662 ' HB ' ' HB3' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -114.06 136.26 51.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.148 0.499 . . . . 0.0 112.076 -176.172 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.524 ' HE3' ' HG3' ' A' ' 92' ' ' LYS . 2.7 t-105 -122.89 119.43 30.47 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.038 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.524 HD13 ' C ' ' A' ' 62' ' ' TYR . 1.0 OUTLIER -158.88 -169.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.096 0.474 . . . . 0.0 111.528 -178.61 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.419 ' HA ' ' O ' ' A' ' 89' ' ' SER . 85.7 m-20 -104.09 -9.18 18.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.973 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.524 ' C ' HD13 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -144.49 110.99 4.96 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.301 179.494 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.417 ' HD3' ' HE3' ' A' ' 91' ' ' TRP . 84.6 Cg_exo -45.98 106.26 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.747 2.298 . . . . 0.0 112.752 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.52 -8.13 38.54 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.724 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.777 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 15.8 p -61.2 -12.82 14.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.661 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.02 -38.75 68.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.978 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.509 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -93.58 -27.49 16.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.18 0.514 . . . . 0.0 110.126 178.618 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.777 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 4.4 mtm-85 -64.09 -32.43 73.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.045 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.774 ' O ' HG13 ' A' ' 73' ' ' VAL . 17.2 mt -62.54 -57.76 20.67 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.154 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.737 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 84.9 Cg_exo -48.13 -40.28 34.23 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.196 1.931 . . . . 0.0 112.442 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.0 -46.26 78.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.994 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.62 ' O ' ' HG2' ' A' ' 75' ' ' LYS . 1.9 m -65.66 -37.96 87.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.749 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.774 HG13 ' O ' ' A' ' 69' ' ' ILE . 1.5 m -63.89 -29.35 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.465 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.52 -45.53 88.62 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 176.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.62 ' HG2' ' O ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -86.75 -80.97 0.23 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.658 177.218 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.619 HD13 ' HB3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -100.29 -95.16 0.26 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.962 0.41 . . . . 0.0 110.902 178.584 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.53 ' O ' ' HB ' ' A' ' 72' ' ' THR . . . -145.13 -82.22 0.05 OUTLIER Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.03 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.43 152.02 39.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.898 0.38 . . . . 0.0 111.002 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.931 ' HB2' HG23 ' A' ' 95' ' ' ILE . 2.2 mt-10 -95.54 54.2 1.55 Allowed 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.943 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.519 HG23 HD11 ' A' ' 83' ' ' ILE . 1.2 p -98.92 116.14 41.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.903 -178.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.619 HD23 ' H ' ' A' ' 81' ' ' LEU . 2.0 pt? -133.22 -31.23 1.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.119 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.528 ' O ' HD13 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -150.99 130.66 13.1 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.194 -0.603 . . . . 0.0 112.244 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.528 HD13 ' O ' ' A' ' 82' ' ' GLU . 1.8 mm -131.05 131.1 64.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.4 178.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -154.85 173.4 16.53 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.895 0.378 . . . . 0.0 111.263 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.92 172.18 13.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.775 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.43 HG13 ' N ' ' A' ' 87' ' ' GLY . 2.7 p -140.86 -50.42 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.189 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.43 ' N ' HG13 ' A' ' 86' ' ' VAL . . . -123.55 -158.54 10.19 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.566 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.25 -66.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.602 2.201 . . . . 0.0 112.588 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 61' ' ' ASP . 80.2 p -100.26 -8.53 23.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.55 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.45 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -93.24 116.99 29.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.756 179.737 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.417 ' HE3' ' HD3' ' A' ' 63' ' ' PRO . 4.8 m0 -131.63 163.82 27.24 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.972 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.524 ' HG3' ' HE3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -125.81 123.06 37.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.301 179.103 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.8 mp -125.54 150.95 31.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.976 0.417 . . . . 0.0 111.305 -178.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.505 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 6.9 m-85 -118.2 134.22 55.21 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.987 178.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.931 HG23 ' HB2' ' A' ' 79' ' ' GLU . 13.6 mm -123.32 139.14 50.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.266 -178.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.576 ' H ' ' HB3' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -143.41 122.92 13.19 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 120.182 -0.607 . . . . 0.0 112.518 -176.178 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.422 ' HB ' ' H ' ' A' ' 54' ' ' GLU . 6.5 t -78.57 118.32 25.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.439 177.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.619 ' HB3' HD13 ' A' ' 76' ' ' LEU . 2.8 tttt . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.999 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 112.546 -0.222 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.47 137.64 56.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.79 0.329 . . . . 0.0 110.952 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 p -109.77 157.18 19.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.984 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -65.55 123.46 19.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.938 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -133.33 10.65 4.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.908 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -126.59 105.6 8.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -78.34 -35.09 48.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.913 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -86.34 124.26 32.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.97 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -104.34 63.59 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.941 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.1 p -86.05 39.26 0.8 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.918 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 m -65.47 -70.93 0.21 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.018 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -67.83 109.57 2.98 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.593 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.5 130.46 37.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.764 0.316 . . . . 0.0 110.876 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.463 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 4.5 m -71.39 130.71 87.29 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.014 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 14' ' ' VAL . 9.9 Cg_endo -88.08 13.89 2.47 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.182 2.588 . . . . 0.0 112.133 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -82.88 27.29 0.55 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.344 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.52 162.69 51.99 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.431 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.01 26.59 0.42 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.578 0.228 . . . . 0.0 111.279 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -77.76 -78.49 0.13 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.766 0.317 . . . . 0.0 110.913 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.9 mmt -74.0 177.29 5.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.873 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.33 -175.32 5.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.982 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.55 45.48 1.2 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.875 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -88.84 35.2 0.78 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.93 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -99.41 117.28 33.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.876 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.543 ' HA ' HG22 ' A' ' 55' ' ' ILE . 52.8 t -81.58 143.79 11.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.074 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.404 ' OG1' ' HB ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -99.27 -48.96 4.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.197 -179.284 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.478 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -120.6 129.83 53.91 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.83 0.348 . . . . 0.0 110.991 -179.998 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 99.8 m -118.58 121.16 39.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.847 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.677 HD13 HH22 ' A' ' 68' ' ' ARG . 6.9 tt -99.66 115.82 30.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.081 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -116.81 115.85 26.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.44 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.564 HG13 HG23 ' A' ' 60' ' ' ILE . 7.7 p -140.27 76.57 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.443 0.639 . . . . 0.0 111.163 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.23 -163.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.015 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.29 88.71 0.05 OUTLIER Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.644 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -111.39 -159.78 0.69 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.609 0.242 . . . . 0.0 110.807 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.54 144.18 31.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.987 0.422 . . . . 0.0 111.708 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.753 ' HA ' ' HD2' ' A' ' 39' ' ' PRO . 1.6 p -81.27 162.43 58.98 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.608 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.401 ' HA ' ' HB2' ' A' ' 36' ' ' CYS . 65.2 Cg_endo -93.17 30.36 13.76 Favored 'Cis proline' 0 C--N 1.351 0.665 0 C-N-CA 124.195 -1.169 . . . . 0.0 112.652 1.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.573 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 40.4 t -55.83 -48.49 96.49 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.823 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.753 ' HD2' ' HA ' ' A' ' 36' ' ' CYS . 41.9 Cg_endo -66.94 -27.77 42.75 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.111 1.874 . . . . 0.0 112.343 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -60.24 -61.96 2.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.963 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.7 t -70.9 -18.67 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.041 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 38' ' ' VAL . 23.3 tt0 -62.47 -61.06 2.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.858 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.4 t -67.91 -23.02 65.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.844 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.29 -44.23 97.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.538 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.11 -38.56 78.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.865 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.24 -43.15 99.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.747 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.653 HD11 ' HG2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -67.23 -33.56 75.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.96 179.741 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -81.13 -6.36 58.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.097 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -130.64 51.24 2.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.32 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.453 ' HB3' HG21 ' A' ' 97' ' ' VAL . 10.5 mtp -99.74 109.61 22.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.901 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.507 ' HB3' ' HG3' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -74.69 138.06 73.8 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.455 179.305 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_exo -42.57 -41.77 8.12 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.751 2.301 . . . . 0.0 112.907 -179.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.27 50.31 0.87 Allowed Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.932 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.546 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 9.3 mt-10 -90.89 151.02 21.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.465 0.65 . . . . 0.0 112.177 -178.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.984 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 3.1 mp -134.24 106.15 7.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.049 178.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.478 HD22 ' HB3' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -128.48 156.44 43.23 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -175.185 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -135.59 136.86 41.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.145 176.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.606 HG13 ' HB3' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -114.77 140.18 37.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.067 0.461 . . . . 0.0 112.059 -177.007 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -122.67 98.12 5.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.351 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.564 HG23 HG13 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -147.0 -173.06 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.461 -179.069 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.404 ' H ' HG22 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -109.26 -16.39 14.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.951 178.023 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -123.18 126.73 25.86 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.55 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -56.52 93.68 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.588 2.192 . . . . 0.0 112.658 -179.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.54 -16.19 63.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.905 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.633 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 9.7 p -63.66 -10.47 19.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.856 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -61.28 -33.28 73.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.605 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.587 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -93.72 -28.59 15.86 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.355 0.598 . . . . 0.0 110.075 178.175 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.677 HH22 HD13 ' A' ' 29' ' ' LEU . 37.6 mtt-85 -61.51 -39.57 91.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.604 178.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.674 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 22.3 mt -55.83 -57.1 23.54 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.279 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.674 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 83.2 Cg_exo -45.63 -39.3 17.72 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.249 1.966 . . . . 0.0 112.385 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.437 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 2.3 mp0 -71.36 -61.08 1.9 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.49 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.527 ' HB ' ' O ' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -56.78 -31.3 64.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.54 -178.745 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.605 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 8.6 p -74.26 -26.53 20.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.67 0.271 . . . . 0.0 110.873 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.33 -46.56 85.96 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 177.103 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.29 -73.9 0.49 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.211 177.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.423 HD11 HG22 ' A' ' 72' ' ' THR . 0.1 OUTLIER -98.12 -106.92 0.19 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.322 177.842 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.605 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.67 -89.07 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.458 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 0.6 OUTLIER -147.81 145.76 28.88 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 178.223 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.704 ' O ' ' HA ' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -96.77 61.61 1.87 Allowed 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.129 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.651 HG12 HD11 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -98.36 118.61 45.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.516 -177.221 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 1.012 HD21 ' HD3' ' A' ' 96' ' ' LYS . 0.5 OUTLIER -133.86 -28.11 1.42 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.038 179.722 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.31 139.77 18.69 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.348 -0.541 . . . . 0.0 112.371 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.651 HD11 HG12 ' A' ' 80' ' ' VAL . 3.9 mp -144.18 128.05 12.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.159 178.241 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -156.17 -176.36 5.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.188 0.518 . . . . 0.0 111.403 -178.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 91' ' ' TRP . 8.4 pt-20 -133.17 161.18 35.12 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.691 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -113.69 -55.41 4.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.232 -179.14 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -122.95 -139.98 5.61 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.738 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.42 -83.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.609 2.206 . . . . 0.0 112.418 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.9 p -98.8 -0.36 42.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.906 0.384 . . . . 0.0 111.009 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -93.29 122.2 35.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.641 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -135.38 165.54 25.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.042 0.449 . . . . 0.0 111.297 -179.737 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -121.25 141.52 50.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.38 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.3 mp -125.64 152.28 32.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.125 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.51 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 19.3 m-85 -118.82 111.54 18.55 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.719 179.103 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.704 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -124.45 120.99 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.078 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 1.012 ' HD3' HD21 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -133.36 106.74 7.68 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.963 -172.577 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.546 ' HB ' ' HB2' ' A' ' 54' ' ' GLU . 22.0 t -56.58 113.09 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.767 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.5 mmtm . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.972 -179.535 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.15 0 N-CA-C 112.567 -0.213 . . . . 0.0 112.567 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.91 171.41 8.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.793 0.33 . . . . 0.0 111.02 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.93 -54.05 0.65 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.932 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -110.78 57.39 0.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.775 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -111.57 86.09 2.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.023 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.14 43.08 2.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.905 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.16 68.49 8.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.843 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -135.81 25.1 3.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.89 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -75.08 -3.66 33.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.956 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.6 t -85.75 24.03 1.32 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.5 t -61.23 -67.28 0.42 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.064 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.53 -107.53 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.467 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -80.55 142.93 33.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.773 0.32 . . . . 0.0 110.881 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.416 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 2.8 p -84.82 116.91 67.4 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.097 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 14' ' ' VAL . 17.3 Cg_exo -66.5 147.24 82.0 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.6 2.2 . . . . 0.0 112.083 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.444 HH11 ' HD2' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -90.22 -86.61 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.783 179.556 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.29 74.23 2.47 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.419 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.8 p -81.09 -80.36 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.748 0.309 . . . . 0.0 111.083 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.44 -74.89 0.14 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.002 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.22 137.17 42.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.992 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.3 178.94 4.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.091 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -90.33 75.62 6.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.824 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -83.55 -175.56 5.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.382 0.61 . . . . 0.0 111.304 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -93.16 -156.68 0.49 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.399 178.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.737 HG21 ' HB2' ' A' ' 57' ' ' GLU . 1.5 p -52.75 129.42 13.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.505 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.6 m -99.77 -58.82 1.84 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.477 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 4.2 mptt -100.71 158.11 16.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.362 178.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.781 HG23 ' HB3' ' A' ' 57' ' ' GLU . 28.6 m -135.88 118.26 15.72 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.829 0.347 . . . . 0.0 111.6 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.9 tt -102.25 113.09 26.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.126 177.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.463 ' HB3' ' HB3' ' A' ' 59' ' ' TRP . 2.7 p-10 -132.29 116.2 16.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.188 -178.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.499 ' H ' HG23 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -131.6 64.23 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.131 179.661 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.412 ' HG3' ' H ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -50.46 -81.64 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.061 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.412 ' H ' ' HG3' ' A' ' 32' ' ' ARG . . . -72.79 100.49 1.01 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.102 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -80.63 139.44 36.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.983 0.421 . . . . 0.0 111.338 -179.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.0 t -129.89 -115.59 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.547 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.578 ' O ' ' HD2' ' A' ' 39' ' ' PRO . 1.1 m -57.74 164.7 2.88 Favored Pre-proline 0 CA--C 1.53 0.184 0 N-CA-C 110.566 -0.161 . . . . 0.0 110.566 179.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' A' ' 40' ' ' ASP . 63.9 Cg_endo -73.55 17.52 0.45 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.286 1.991 . . . . 0.0 112.704 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.508 HG23 ' HB3' ' A' ' 36' ' ' CYS . 15.4 t -61.41 -53.95 57.33 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.381 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.578 ' HD2' ' O ' ' A' ' 36' ' ' CYS . 38.3 Cg_endo -66.08 -22.81 54.2 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.124 1.883 . . . . 0.0 112.049 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 37' ' ' PRO . 1.9 m-20 -59.36 -52.8 64.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.559 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.2 t -74.31 -19.32 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.782 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -66.58 -60.83 2.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.028 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.3 t -59.97 -40.33 88.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.851 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.86 -37.25 78.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.983 0.421 . . . . 0.0 110.288 179.051 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.12 -30.99 71.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.719 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.61 -49.89 75.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.087 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.617 ' HB3' ' HG2' ' A' ' 71' ' ' GLU . 3.2 mm? -59.59 -35.42 74.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.007 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -81.26 -23.26 38.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.293 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -121.95 52.18 1.29 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.959 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.77 146.84 25.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.018 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.757 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -98.82 153.64 37.77 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.545 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.757 ' HD2' ' HG3' ' A' ' 51' ' ' LYS . 53.6 Cg_exo -38.77 -84.2 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.145 2.563 . . . . 0.0 113.794 -178.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 97' ' ' VAL . . . -104.28 59.33 0.47 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.97 -0.634 . . . . 0.0 113.046 -178.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -90.89 158.41 16.79 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.076 0.465 . . . . 0.0 111.753 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.523 HG23 ' HB2' ' A' ' 96' ' ' LYS . 0.1 OUTLIER -130.57 121.75 51.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.108 179.263 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.7 mp -129.29 163.86 24.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.221 0.534 . . . . 0.0 111.59 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.781 ' HB3' HG23 ' A' ' 28' ' ' THR . 48.4 tt0 -121.04 158.1 28.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.809 178.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.8 t -136.56 115.75 15.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.894 0.378 . . . . 0.0 111.089 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.521 ' HE1' HG21 ' A' ' 86' ' ' VAL . 6.5 t90 -122.08 104.94 9.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.492 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.499 HG23 ' H ' ' A' ' 31' ' ' VAL . 1.0 OUTLIER -158.29 -174.31 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.656 -178.477 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -99.01 -23.68 15.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.933 178.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.48 ' O ' HD13 ' A' ' 60' ' ' ILE . 42.9 m-85 -115.27 112.24 44.08 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.372 178.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -47.22 99.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.816 2.344 . . . . 0.0 113.119 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.26 -26.66 65.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.544 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.735 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -63.27 -13.7 41.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.762 179.714 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.549 ' HG3' ' N ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -58.65 -32.06 68.74 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.436 179.243 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.549 ' N ' ' HG3' ' A' ' 66' ' ' LYS . 0.3 OUTLIER -94.52 -26.44 16.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.898 178.019 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.735 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 9.1 mtt85 -60.81 -39.39 88.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.066 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.697 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 6.9 mt -62.14 -55.87 36.62 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.543 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.697 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 84.0 Cg_exo -46.34 -39.56 21.69 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.304 2.003 . . . . 0.0 112.511 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.617 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 0.9 OUTLIER -68.64 -51.93 36.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.957 179.42 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.633 HG21 ' HG3' ' A' ' 79' ' ' GLU . 1.7 m -60.46 -40.12 90.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.982 -178.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 70' ' ' PRO . 12.9 m -64.92 -30.24 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.856 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.25 -43.09 87.68 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -90.26 -78.17 0.38 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.784 177.707 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.42 ' H ' ' CG ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -99.38 -97.46 0.23 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.98 0.419 . . . . 0.0 110.596 178.399 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.536 ' O ' ' HB ' ' A' ' 72' ' ' THR . . . -145.01 -86.56 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.735 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.555 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -146.71 153.97 40.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.823 0.345 . . . . 0.0 110.824 178.799 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.931 ' HB2' HG23 ' A' ' 95' ' ' ILE . 0.6 OUTLIER -101.35 63.72 0.99 Allowed 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.087 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.555 HG22 ' HB2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -99.22 127.36 52.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.336 -177.54 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.526 ' HG ' ' HB3' ' A' ' 94' ' ' TYR . 1.0 OUTLIER -132.98 -36.41 1.03 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.719 179.528 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.473 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 0.7 OUTLIER -154.15 151.96 29.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.076 0.465 . . . . 0.0 111.951 179.245 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 82' ' ' GLU . 2.6 mp -144.18 134.99 21.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.268 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -158.66 -179.22 7.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.092 0.473 . . . . 0.0 111.267 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -133.57 167.47 20.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.664 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.521 HG21 ' HE1' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -129.74 -59.01 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.215 -179.654 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -124.87 -151.86 8.16 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.682 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -63.01 -75.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.741 2.294 . . . . 0.0 112.593 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.56 -4.08 34.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.245 -179.077 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.409 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 3.3 pt-20 -93.2 123.83 36.75 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.433 178.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 2.9 m-90 -129.8 167.82 17.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.021 0.438 . . . . 0.0 111.394 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -123.5 132.99 54.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.598 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.4 mt -125.48 146.85 30.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.69 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.526 ' HB3' ' HG ' ' A' ' 81' ' ' LEU . 36.4 m-85 -118.09 124.23 47.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.098 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.931 HG23 ' HB2' ' A' ' 79' ' ' GLU . 28.5 mm -123.91 148.53 28.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.291 -176.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.678 ' C ' ' HB3' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -150.78 106.13 3.36 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.107 -177.463 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.447 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 1.7 t -59.86 119.28 3.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.638 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.188 -0.91 . . . . 0.0 110.887 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 N-CA-C 112.439 -0.264 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.99 -178.81 7.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.775 0.322 . . . . 0.0 110.815 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.1 p -98.74 149.98 22.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.9 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 -70.41 -38.72 74.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.931 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -68.27 116.4 8.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.005 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.09 157.82 42.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.835 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -86.51 59.54 5.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.939 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -138.45 -169.57 2.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.907 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -119.27 94.65 4.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.06 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.1 t -81.81 104.55 12.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.697 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.3 t -78.82 -86.25 0.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.118 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -89.09 102.69 2.91 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.744 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 15.0 tp -95.54 52.89 1.41 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.941 0.401 . . . . 0.0 110.602 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.8 m -85.15 137.58 37.21 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.167 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.88 -154.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.531 2.154 . . . . 0.0 112.296 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.61 -84.35 0.11 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.025 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.11 140.7 21.68 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.581 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.03 -72.04 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.753 0.311 . . . . 0.0 110.829 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -111.8 -149.93 0.45 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.801 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.89 -60.67 2.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.094 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.57 -176.94 2.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.128 0.49 . . . . 0.0 111.367 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.73 -102.31 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.675 178.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -92.12 155.34 18.11 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.0 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.69 65.98 7.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.793 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.5 t -80.98 144.73 10.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.237 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.74 -70.3 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.037 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -118.6 162.73 17.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.86 0.362 . . . . 0.0 111.223 -179.763 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 92.3 m -135.64 129.0 32.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.856 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.5 tt -111.35 118.1 34.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.001 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.81 110.95 16.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.919 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 31' ' ' VAL . 7.1 p -137.61 70.77 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.397 0.618 . . . . 0.0 110.977 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 32' ' ' ARG . 3.8 ttp180 -69.29 -92.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.855 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.401 ' H ' ' HB3' ' A' ' 32' ' ' ARG . . . -76.11 88.16 0.88 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.407 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -85.1 164.4 18.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.87 0.367 . . . . 0.0 111.039 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.699 HG22 ' N ' ' A' ' 36' ' ' CYS . 0.7 OUTLIER -134.68 -89.5 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.79 -179.793 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.699 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.5 OUTLIER -58.9 158.2 17.52 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.782 179.826 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.81 7.17 3.68 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.847 2.365 . . . . 0.0 112.491 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.505 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 39.7 t -63.43 -54.08 46.95 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.612 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.537 ' HD2' ' O ' ' A' ' 36' ' ' CYS . 32.8 Cg_endo -63.37 -21.68 71.49 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.285 1.99 . . . . 0.0 112.055 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -62.91 -55.24 27.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.701 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.5 t -72.29 -22.4 20.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.781 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -62.97 -58.4 7.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.832 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.3 t -61.44 -31.61 71.56 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.683 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.9 tptt -54.98 -45.47 75.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.509 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -33.58 76.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.013 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.94 -30.84 64.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.993 0.425 . . . . 0.0 110.791 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.641 HD22 ' HG2' ' A' ' 68' ' ' ARG . 1.3 mt -77.4 -57.2 3.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.301 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.16 -10.09 59.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.717 -178.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -131.23 67.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.855 0.359 . . . . 0.0 111.048 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.48 ' HB2' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -109.01 144.87 36.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.857 179.699 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.693 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 11.6 mttt -81.18 159.15 68.58 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.033 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 100.0 Cg_exo -45.91 -75.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.939 2.426 . . . . 0.0 113.873 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 97' ' ' VAL . . . -103.83 60.77 0.45 Allowed Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.144 -177.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.693 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 3.2 mm-40 -90.98 152.4 20.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.056 0.455 . . . . 0.0 111.72 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.5 mp -135.31 112.57 14.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.018 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.1 mp -126.27 151.69 47.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.228 0.537 . . . . 0.0 112.355 -177.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -113.31 124.64 52.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.376 176.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.0 t -114.32 134.31 57.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.136 0.493 . . . . 0.0 112.075 -177.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.52 ' NE1' HG21 ' A' ' 86' ' ' VAL . 13.7 t90 -123.0 106.76 11.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.325 178.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.617 HD13 ' H ' ' A' ' 64' ' ' MET . 0.1 OUTLIER -144.03 -162.95 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.823 0.344 . . . . 0.0 111.267 -178.659 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -145.27 24.16 1.45 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.313 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.737 ' H ' ' HA ' ' A' ' 63' ' ' PRO . 29.3 m-85 -101.26 -56.14 0.13 Allowed Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 116.673 -0.239 . . . . 0.0 111.483 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.737 ' HA ' ' H ' ' A' ' 62' ' ' TYR . 76.7 Cg_endo -94.32 177.79 11.03 Favored 'Cis proline' 0 C--N 1.355 0.873 0 C-N-CA 124.796 -0.918 . . . . 0.0 112.294 -0.315 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.617 ' H ' HD13 ' A' ' 60' ' ' ILE . 14.2 tmm? -65.18 -21.45 66.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.755 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.641 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 30.4 t -63.6 -15.62 58.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.149 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.39 -34.13 74.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.978 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.556 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -92.23 -23.43 19.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.225 0.536 . . . . 0.0 109.979 178.432 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.641 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 20.7 mtt-85 -63.41 -47.8 80.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.81 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.723 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 8.1 mt -51.04 -54.92 32.47 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.664 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.723 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 82.8 Cg_exo -48.64 -50.48 12.35 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.267 1.978 . . . . 0.0 112.959 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.44 -53.62 33.39 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.153 0.501 . . . . 0.0 111.637 -179.156 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.55 ' HB ' ' O ' ' A' ' 77' ' ' GLY . 0.9 OUTLIER -56.41 -49.56 74.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.601 -178.245 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.631 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 18.2 m -64.75 -21.16 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 120.607 0.241 . . . . 0.0 111.198 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.35 -55.27 37.22 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.858 ' HG2' ' H ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -91.1 -61.28 1.7 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.942 177.963 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.858 ' H ' ' HG2' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -100.45 -109.09 0.21 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.042 0.448 . . . . 0.0 110.526 176.565 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.631 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -144.97 -87.63 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 178.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.468 ' HA ' HG21 ' A' ' 72' ' ' THR . 0.2 OUTLIER -148.14 150.6 34.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.642 0.258 . . . . 0.0 110.762 177.499 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.73 ' HB2' ' H ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -97.81 74.2 2.34 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.14 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.56 123.86 51.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.997 0.427 . . . . 0.0 111.831 -176.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.491 ' HG ' ' N ' ' A' ' 82' ' ' GLU . 0.6 OUTLIER -133.45 -35.59 1.01 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.669 179.076 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.642 ' HB3' ' HB2' ' A' ' 94' ' ' TYR . 0.3 OUTLIER -153.69 149.01 27.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.618 179.377 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 82' ' ' GLU . 2.2 mp -142.62 133.41 23.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.625 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.607 ' HG3' ' HB3' ' A' ' 92' ' ' LYS . 8.4 pt-20 -158.07 -177.46 6.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.078 0.466 . . . . 0.0 111.219 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -133.39 167.21 20.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.817 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.52 HG21 ' NE1' ' A' ' 59' ' ' TRP . 40.7 t -124.63 -66.95 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.205 -179.271 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -124.34 -154.41 8.87 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.567 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.16 -71.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.632 2.221 . . . . 0.0 112.325 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.2 0.19 39.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.093 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.428 ' HG2' ' H ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -93.3 132.52 37.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.774 179.639 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 -138.92 159.62 41.7 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.929 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.607 ' HB3' ' HG3' ' A' ' 84' ' ' GLU . 24.5 ttmt -124.37 126.4 45.92 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.344 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.6 mp -125.33 149.87 30.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.967 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.642 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 8.6 m-85 -118.15 129.98 55.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.369 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.617 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -123.69 148.88 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.166 -178.068 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.73 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -150.83 104.73 3.2 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.582 -178.298 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.507 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 3.1 t -62.96 119.05 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.26 178.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.1 mttt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.058 -179.509 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.5 t . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.787 0.327 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.438 HG21 ' OE1' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -99.6 -65.21 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.078 -179.568 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.11 169.77 9.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.097 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.755 HG23 ' HB3' ' A' ' 57' ' ' GLU . 83.3 m -135.51 130.85 35.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.808 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.1 tp -106.37 113.08 26.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.845 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.68 123.33 42.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.888 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.4 47.62 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.079 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.44 ' H ' ' HG3' ' A' ' 32' ' ' ARG . 14.4 mtm180 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.752 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.549 ' O ' HD22 ' A' ' 47' ' ' LEU . 7.2 t . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.799 0.333 . . . . 0.0 110.694 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 48' ' ' GLN . 5.3 mmtt -56.79 -41.89 78.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.514 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.62 -30.74 71.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.946 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 43' ' ' THR . . . -56.53 -54.34 47.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.967 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.793 ' HB3' ' HG2' ' A' ' 71' ' ' GLU . 0.4 OUTLIER -77.24 -37.31 53.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.768 -179.492 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.474 ' HB3' ' O ' ' A' ' 44' ' ' LYS . 1.4 tt0 -68.14 -31.18 70.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.396 -178.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -134.96 72.18 1.45 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.064 0.459 . . . . 0.0 110.932 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.18 140.73 31.53 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.846 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.538 ' HG2' ' HD2' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -94.17 151.48 39.61 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.778 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.538 ' HD2' ' HG2' ' A' ' 51' ' ' LYS . 50.0 Cg_exo -38.23 -86.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.366 2.71 . . . . 0.0 114.027 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.439 ' H ' ' HB2' ' A' ' 52' ' ' PRO . . . -103.89 59.05 0.5 Allowed Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.989 -0.624 . . . . 0.0 113.124 -177.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.438 ' OE1' HG21 ' A' ' 26' ' ' THR . 2.8 mm-40 -90.7 156.42 18.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.104 0.478 . . . . 0.0 111.705 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.442 HG23 ' HB2' ' A' ' 96' ' ' LYS . 3.4 mp -135.05 117.75 22.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.992 178.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.6 mp -122.77 164.05 19.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.209 0.528 . . . . 0.0 111.753 -178.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.755 ' HB3' HG23 ' A' ' 28' ' ' THR . 37.2 tt0 -114.38 161.27 18.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.131 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.1 t -142.7 113.92 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.808 0.337 . . . . 0.0 111.221 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.6 103.25 8.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.786 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -158.11 -166.19 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.029 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -103.04 -2.5 27.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.015 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -137.58 148.12 60.13 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.927 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.69 104.4 1.88 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.601 2.201 . . . . 0.0 112.624 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 8.4 tpp -68.1 -19.95 64.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.108 0.48 . . . . 0.0 110.617 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.819 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 3.6 p -58.85 -10.84 2.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.215 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.44 ' HG3' ' H ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -56.75 -44.69 81.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.789 0.328 . . . . 0.0 110.727 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.534 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 0.7 OUTLIER -86.64 -24.88 25.15 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.085 0.469 . . . . 0.0 110.055 178.398 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.819 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 1.0 OUTLIER -61.69 -41.34 97.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.233 179.565 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.745 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 12.9 mt -54.59 -56.67 24.54 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.745 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 76.1 Cg_exo -51.87 -36.96 65.38 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.288 1.992 . . . . 0.0 112.682 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.793 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 0.6 OUTLIER -71.92 -64.46 0.93 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.782 0.325 . . . . 0.0 111.66 -179.2 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.47 HG21 ' HG2' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -55.9 -30.6 61.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.555 -178.515 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 70' ' ' PRO . 6.6 p -73.47 -28.89 26.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.905 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.4 tptp -58.57 -42.11 87.23 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.45 -77.51 0.4 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.226 177.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.597 HD13 ' HB2' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -98.79 -98.52 0.22 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.786 178.358 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.34 -79.71 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.249 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.68 157.32 43.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.803 0.335 . . . . 0.0 111.014 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.7 ' HB2' ' H ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -101.18 55.89 0.84 Allowed 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.135 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.6 p -98.31 123.49 50.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.269 -176.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.489 ' HG ' ' N ' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -133.31 -36.12 1.0 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.186 -179.687 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.525 ' HB3' ' HB2' ' A' ' 94' ' ' TYR . 0.5 OUTLIER -153.51 145.49 23.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.999 0.428 . . . . 0.0 111.826 -179.711 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.502 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 3.0 mp -142.44 136.11 27.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.414 178.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -157.47 179.04 9.63 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.038 0.447 . . . . 0.0 111.421 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -133.67 166.14 23.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.854 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.3 t -127.28 -64.4 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.133 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -124.83 -147.14 7.02 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.825 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -60.81 -77.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.757 2.305 . . . . 0.0 112.616 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.2 -1.74 35.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.419 -178.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.458 ' HG2' ' H ' ' A' ' 90' ' ' GLU . 0.7 OUTLIER -93.26 120.26 33.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.746 179.442 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 7.0 m0 -130.46 166.08 21.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.904 0.383 . . . . 0.0 111.187 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -127.04 129.91 48.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.612 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.7 mp -125.79 149.52 30.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.296 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.525 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 9.3 m-85 -118.68 127.97 54.07 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.202 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.646 HG13 ' HB2' ' A' ' 79' ' ' GLU . 1.1 tp -124.49 149.81 28.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.519 -177.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.7 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -151.11 109.47 3.78 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 120.523 -0.471 . . . . 0.0 112.132 -178.455 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.404 ' H ' HG23 ' A' ' 97' ' ' VAL . 2.1 t -64.41 111.16 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.266 178.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.597 ' HB2' HD13 ' A' ' 76' ' ' LEU . 16.5 mmtt . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.097 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 87.5 t . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.766 0.317 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.17 -48.2 4.7 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.945 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -121.33 148.57 44.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.098 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.3 m -132.98 140.86 47.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.825 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.641 ' HB3' HG13 ' A' ' 58' ' ' VAL . 12.6 tp -112.03 110.98 21.58 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.905 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.52 ' HB3' ' HE1' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -104.86 113.34 26.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.741 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.09 61.6 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.274 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.495 ' H ' ' HG3' ' A' ' 32' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.332 179.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.3 t . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.665 0.269 . . . . 0.0 110.81 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.05 -41.56 68.25 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.839 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 45' ' ' ARG . 3.5 tmm_? -67.95 -32.56 73.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.801 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.54 -49.38 77.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.207 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.831 ' HB3' ' HG2' ' A' ' 71' ' ' GLU . 2.5 mm? -58.67 -42.72 89.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.063 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -75.54 -15.5 60.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.036 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 45' ' ' ARG . 0.6 OUTLIER -118.19 61.68 0.77 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.92 -179.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 10.1 mmt -108.32 146.76 32.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.859 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.654 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 2.2 mtpp -102.81 164.21 16.04 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.767 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.625 ' HD2' ' HB3' ' A' ' 51' ' ' LYS . 2.2 Cg_endo -46.2 -73.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.119 2.546 . . . . 0.0 113.398 -178.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.27 58.78 0.49 Allowed Glycine 0 C--N 1.329 0.192 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.278 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.654 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 3.8 mm-40 -90.34 151.35 21.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.09 0.472 . . . . 0.0 111.525 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.564 ' C ' HD13 ' A' ' 56' ' ' LEU . 3.7 mp -134.75 113.51 16.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.815 178.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.564 HD13 ' C ' ' A' ' 55' ' ' ILE . 0.4 OUTLIER -118.71 145.35 45.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.164 0.506 . . . . 0.0 111.846 -176.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -111.07 135.49 51.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.987 177.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.641 HG13 ' HB3' ' A' ' 29' ' ' LEU . 2.0 t -134.82 126.5 47.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.52 ' HE1' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -122.97 115.33 21.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.879 176.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.476 HG13 ' C ' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -147.42 -170.52 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.303 -178.027 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.02 -11.71 16.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.419 178.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.425 ' O ' HD13 ' A' ' 60' ' ' ILE . 64.9 m-85 -129.76 143.92 50.95 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.55 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.88 93.73 0.39 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.532 2.155 . . . . 0.0 112.481 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.06 -16.33 63.98 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.042 0.448 . . . . 0.0 110.585 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.406 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -62.04 -15.58 45.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.793 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.503 ' HG3' ' N ' ' A' ' 67' ' ' GLU . 1.2 ptpp? -57.58 -32.88 67.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.772 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.503 ' N ' ' HG3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -94.54 -27.95 15.68 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.169 0.509 . . . . 0.0 110.401 178.737 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.675 ' HG2' HD11 ' A' ' 47' ' ' LEU . 54.3 mtt-85 -65.78 -32.68 74.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.175 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.499 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 26.6 mt -63.62 -55.33 35.31 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.553 ' O ' HG12 ' A' ' 73' ' ' VAL . 12.2 Cg_endo -56.97 -32.23 92.22 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.182 1.921 . . . . 0.0 112.566 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.831 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 0.4 OUTLIER -74.13 -60.83 2.09 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.873 0.368 . . . . 0.0 111.296 -179.818 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.669 HG21 ' HG2' ' A' ' 79' ' ' GLU . 0.2 OUTLIER -61.26 -25.0 66.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.314 -179.028 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' ' 70' ' ' PRO . 4.5 p -75.23 -28.95 21.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.274 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.46 -43.51 88.89 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.463 ' CG ' ' H ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -86.85 -78.18 0.3 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.164 176.7 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.518 HD12 ' H ' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -98.73 -98.59 0.22 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.848 0.356 . . . . 0.0 110.659 177.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.518 ' H ' HD12 ' A' ' 76' ' ' LEU . . . -145.28 -80.98 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.865 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -146.2 149.64 34.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.889 0.376 . . . . 0.0 110.922 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.669 ' HG2' HG21 ' A' ' 72' ' ' THR . 0.0 OUTLIER -97.87 58.93 1.42 Allowed 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.018 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.568 HG23 HD11 ' A' ' 83' ' ' ILE . 1.4 p -98.9 125.84 52.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.022 -177.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.531 ' HG ' ' N ' ' A' ' 82' ' ' GLU . 0.6 OUTLIER -133.53 -35.79 0.99 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.043 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.531 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -153.52 144.61 22.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.985 0.421 . . . . 0.0 111.906 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.568 HD11 HG23 ' A' ' 80' ' ' VAL . 3.5 mp -143.96 128.55 14.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.346 178.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -149.87 -178.25 6.36 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.239 0.542 . . . . 0.0 111.552 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.519 ' HB3' ' HD1' ' A' ' 91' ' ' TRP . 0.9 OUTLIER -133.2 163.67 28.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.616 -179.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 56.9 t -124.65 -73.76 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.427 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -122.73 -139.37 5.51 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.795 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.408 ' HB2' ' H ' ' A' ' 89' ' ' SER . 37.1 Cg_exo -60.82 -82.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.557 2.171 . . . . 0.0 112.5 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.408 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 59.9 p -100.15 1.51 42.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.249 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.51 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 1.2 pt-20 -93.15 119.51 32.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.747 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.519 ' HD1' ' HB3' ' A' ' 85' ' ' GLU . 4.4 m-90 -132.24 164.99 25.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.92 0.391 . . . . 0.0 111.112 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.96 140.71 51.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.795 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.1 mp -136.76 143.78 34.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.974 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.463 ' HB3' ' HG ' ' A' ' 81' ' ' LEU . 12.3 m-85 -118.54 127.56 53.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.379 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.656 HG23 ' HB2' ' A' ' 79' ' ' GLU . 32.8 mm -124.86 144.94 33.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.26 -177.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.616 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -152.12 111.2 3.86 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.157 -0.617 . . . . 0.0 112.156 -178.441 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 t -63.69 121.39 12.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.56 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.2 tttp . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.006 -179.913 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.3 t . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.748 0.309 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.51 -52.22 3.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.508 -178.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.482 ' HB2' HD22 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -120.88 149.89 41.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.905 0.384 . . . . 0.0 111.462 -178.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 83.2 m -129.12 122.58 30.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.699 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 2.9 tt -109.23 125.37 52.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.081 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -130.79 123.39 29.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.726 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.523 ' HB ' HG21 ' A' ' 60' ' ' ILE . 8.4 t -118.45 64.3 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.128 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 32' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.099 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.602 ' O ' HD13 ' A' ' 47' ' ' LEU . 14.6 t . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.762 0.315 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.98 -46.95 87.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.968 0.413 . . . . 0.0 110.451 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.39 -31.65 72.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.878 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.25 -43.45 86.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.047 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.602 HD13 ' O ' ' A' ' 43' ' ' THR . 1.2 mp -58.77 -39.26 80.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.744 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.417 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 1.5 tt0 -81.2 -23.29 38.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.944 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -119.12 62.18 0.8 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.63 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.744 ' HB2' HG21 ' A' ' 97' ' ' VAL . 12.4 ptp -103.65 145.32 30.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.593 178.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.923 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 10.7 mttm -90.73 160.09 39.29 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.178 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 51' ' ' LYS . 86.3 Cg_exo -43.7 -70.78 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.098 2.532 . . . . 0.0 113.901 -178.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.46 59.79 0.45 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.9 -0.667 . . . . 0.0 113.264 -178.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.923 ' HG3' ' HB2' ' A' ' 51' ' ' LYS . 7.2 mt-10 -90.89 151.41 21.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.02 0.438 . . . . 0.0 111.572 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.683 HG12 ' HG3' ' A' ' 96' ' ' LYS . 7.4 mt -135.66 103.7 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.114 178.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.482 HD22 ' HB2' ' A' ' 27' ' ' LYS . 8.9 mt -118.73 160.51 21.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.072 0.463 . . . . 0.0 111.659 -177.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -130.6 139.64 50.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.365 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.514 HG12 HG12 ' A' ' 60' ' ' ILE . 11.7 t -120.04 136.45 57.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.136 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -122.57 110.8 16.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.677 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.607 HD11 ' HB2' ' A' ' 64' ' ' MET . 0.4 OUTLIER -158.66 -177.75 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.581 -179.428 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 89' ' ' SER . 19.0 m-20 -97.68 2.38 49.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.72 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -139.22 149.63 61.58 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.566 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.76 95.64 1.08 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.488 2.125 . . . . 0.0 112.856 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.607 ' HB2' HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -68.22 -15.43 63.57 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.172 0.51 . . . . 0.0 110.539 178.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.736 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 23.9 p -61.34 -12.2 12.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.719 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.3 pttm -56.36 -36.05 68.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.899 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.565 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.8 OUTLIER -94.25 -27.39 16.17 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.218 0.532 . . . . 0.0 110.018 178.209 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.736 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 4.7 mtt85 -61.91 -37.14 83.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.008 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.713 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 14.7 mt -62.15 -55.83 36.88 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.369 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.713 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 83.3 Cg_exo -47.19 -37.43 23.71 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.447 2.098 . . . . 0.0 112.717 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.509 ' HG3' ' HB3' ' A' ' 47' ' ' LEU . 15.7 mm-40 -70.86 -54.05 12.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.056 0.455 . . . . 0.0 111.106 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.597 ' HB ' ' O ' ' A' ' 77' ' ' GLY . 0.6 OUTLIER -60.75 -38.23 84.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.771 -178.605 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 69' ' ' ILE . 20.2 m -67.5 -27.84 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-O 120.688 0.28 . . . . 0.0 110.84 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.04 -43.98 87.11 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.547 ' HG2' ' O ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -90.2 -78.36 0.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.483 176.85 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.57 -97.37 0.24 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.967 0.413 . . . . 0.0 110.954 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.597 ' O ' ' HB ' ' A' ' 72' ' ' THR . . . -144.89 -84.33 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.195 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.95 152.65 39.75 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 122.723 -0.281 . . . . 0.0 110.778 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.772 ' HB2' ' H ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -96.96 71.27 2.47 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.034 0.445 . . . . 0.0 109.849 179.609 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.473 ' CG1' HD11 ' A' ' 83' ' ' ILE . 1.6 t -98.58 122.04 49.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.575 -177.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.522 ' HG ' ' N ' ' A' ' 82' ' ' GLU . 0.5 OUTLIER -133.53 -37.85 0.93 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.174 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.522 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -153.56 141.98 20.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.003 0.43 . . . . 0.0 111.866 -179.701 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.473 HD11 ' CG1' ' A' ' 80' ' ' VAL . 2.7 mt -143.53 129.93 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.222 178.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.426 ' OE2' ' HE2' ' A' ' 92' ' ' LYS . 4.8 pt-20 -156.78 179.77 8.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.184 0.516 . . . . 0.0 111.689 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -133.55 159.56 40.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.413 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.9 t -120.8 -66.97 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.398 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -122.84 -145.43 6.92 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.666 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.428 ' HD2' ' OE2' ' A' ' 90' ' ' GLU . 46.2 Cg_exo -56.44 -82.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.672 2.248 . . . . 0.0 112.509 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 61' ' ' ASP . 61.8 p -100.07 -3.75 31.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.831 0.348 . . . . 0.0 111.151 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.489 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -86.05 117.72 25.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.669 179.743 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 2.9 m-90 -130.83 164.21 25.68 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.1 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.426 ' HE2' ' OE2' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -124.28 129.51 50.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.537 179.538 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -125.8 143.39 39.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.002 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.507 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 13.6 m-85 -118.95 129.59 55.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.675 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.643 HG21 ' HE ' ' A' ' 68' ' ' ARG . 1.0 OUTLIER -124.13 149.03 28.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.68 -179.051 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.772 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -150.85 109.97 3.93 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.289 -0.564 . . . . 0.0 112.161 -178.117 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.744 HG21 ' HB2' ' A' ' 50' ' ' MET . 10.8 t -62.75 118.86 5.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.262 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.487 ' HG2' ' HD3' ' A' ' 96' ' ' LYS . 6.9 mtmt . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.986 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 80.6 t . . . . . 0 CA--C 1.529 0.143 0 CA-C-O 120.624 0.25 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -98.82 -66.0 0.93 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.964 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -105.53 148.24 27.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.892 0.377 . . . . 0.0 110.941 179.6 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.607 HG23 ' HG2' ' A' ' 57' ' ' GLU . 86.4 m -133.9 110.47 9.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.863 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.5 tt -100.15 100.87 11.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.87 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -119.46 99.89 6.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.575 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.486 ' O ' HG13 ' A' ' 31' ' ' VAL . 7.1 p -132.9 70.06 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.457 0.646 . . . . 0.0 111.179 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.794 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.464 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 2.2 t . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.687 0.279 . . . . 0.0 111.019 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -56.23 -45.16 80.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.89 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.47 -33.09 75.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.707 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.65 -36.89 85.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.192 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 43' ' ' THR . 4.9 mt -65.55 -43.33 90.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.693 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -71.81 -26.57 62.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.481 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -117.26 57.08 0.81 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.998 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.3 ptm -96.01 150.06 20.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.855 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 5.6 mttt -104.24 156.35 35.91 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.872 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.05 -55.41 3.91 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.004 2.469 . . . . 0.0 113.277 -178.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.21 59.57 0.47 Allowed Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.844 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.855 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 3.6 mm-40 -90.8 146.39 23.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.041 0.448 . . . . 0.0 111.779 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.3 mt -135.53 102.53 3.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.894 177.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.428 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -119.89 143.86 47.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.04 0.447 . . . . 0.0 112.031 -177.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.607 ' HG2' HG23 ' A' ' 28' ' ' THR . 2.8 pt-20 -118.62 130.97 56.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.448 176.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.429 HG21 HH12 ' A' ' 68' ' ' ARG . 2.6 t -114.77 129.49 70.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.016 0.436 . . . . 0.0 111.906 -177.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.488 ' HE1' HG21 ' A' ' 86' ' ' VAL . 1.4 t90 -122.44 106.39 11.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.349 178.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.501 HD13 ' O ' ' A' ' 62' ' ' TYR . 1.0 OUTLIER -158.29 -163.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.439 -178.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -109.41 -34.49 6.52 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.664 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.501 ' O ' HD13 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -102.08 114.47 65.49 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.625 179.545 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.85 97.49 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.535 2.157 . . . . 0.0 112.429 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.9 mtt -68.3 -11.17 59.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.943 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.595 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.5 OUTLIER -61.57 -15.11 35.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.993 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -32.74 71.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.036 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.581 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 1.0 OUTLIER -94.22 -27.95 15.89 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.191 0.519 . . . . 0.0 110.365 178.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.595 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 14.3 mtt85 -62.88 -38.0 89.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.894 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.725 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 17.0 mt -59.37 -55.79 42.51 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.686 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 72.6 Cg_exo -50.21 -38.85 52.03 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.307 2.005 . . . . 0.0 112.781 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.561 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -68.56 -56.38 8.48 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.957 0.408 . . . . 0.0 111.518 -179.285 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.722 HG21 ' HG3' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -58.96 -45.58 90.17 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.269 -178.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 70' ' ' PRO . 8.2 p -58.69 -28.67 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.682 -0.236 . . . . 0.0 110.939 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.561 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 5.1 mmtt -58.42 -42.99 88.5 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 176.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.549 ' HB3' HD13 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -87.38 -82.84 0.21 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.872 176.22 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.795 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -98.59 -106.32 0.2 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.274 177.071 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.486 ' H ' HD23 ' A' ' 76' ' ' LEU . . . -134.87 -83.15 0.18 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.104 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.07 170.71 16.59 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.78 0.324 . . . . 0.0 111.071 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.885 ' HB2' HG13 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -110.09 72.77 0.81 Allowed 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.39 117.51 43.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.491 -176.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.55 ' HG ' ' N ' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -133.73 -40.69 0.86 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.092 179.715 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.585 ' HB3' ' HB2' ' A' ' 94' ' ' TYR . 0.3 OUTLIER -153.85 144.98 22.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.027 0.441 . . . . 0.0 111.924 -179.743 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.537 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 3.4 mp -144.04 130.65 16.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.275 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -149.78 178.57 8.76 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.042 0.448 . . . . 0.0 111.428 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.6 pm0 -133.35 159.07 41.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.663 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.488 HG21 ' HE1' ' A' ' 59' ' ' TRP . 4.6 t -124.28 -63.37 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.284 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -126.87 -144.7 6.1 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.654 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.429 ' HB2' ' H ' ' A' ' 89' ' ' SER . 37.3 Cg_exo -61.37 -82.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.601 2.201 . . . . 0.0 112.416 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.429 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 2.1 p -98.59 -1.33 41.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.025 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -92.93 116.28 28.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.511 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 4.2 m-90 -130.65 167.59 18.52 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.983 0.42 . . . . 0.0 111.37 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.7 128.52 49.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.29 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.8 mp -125.67 146.15 31.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.172 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.585 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 24.8 m-85 -118.81 123.84 45.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.576 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.885 HG13 ' HB2' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -124.79 144.68 33.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.848 -179.112 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.66 ' H ' ' HB3' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -150.77 115.86 5.32 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.961 -178.793 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.416 ' HA ' ' HG2' ' A' ' 79' ' ' GLU . 15.0 t -65.69 125.67 23.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.359 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.8 tttp . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.004 -179.486 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.7 t . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.826 0.346 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.4 m -99.61 -62.06 1.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.933 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -118.56 158.63 25.05 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.011 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.7 m -127.45 151.72 48.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.865 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.2 tt -131.52 121.04 23.8 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.25 119.0 31.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.532 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.686 HG23 HG23 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -124.33 19.67 4.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.553 -179.093 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.667 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.405 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 15.0 t . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.668 0.27 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.16 -43.04 73.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.949 0.404 . . . . 0.0 110.544 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.511 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 0.2 OUTLIER -64.09 -31.31 72.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.796 179.048 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.461 ' HB3' HH12 ' A' ' 68' ' ' ARG . . . -60.62 -48.7 80.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.335 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.564 ' HG ' ' HG3' ' A' ' 71' ' ' GLU . 2.2 mm? -59.06 -42.65 90.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.051 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -81.14 9.79 6.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.443 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.511 ' HB2' ' O ' ' A' ' 45' ' ' ARG . 0.9 OUTLIER -135.07 32.97 3.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.785 0.326 . . . . 0.0 111.202 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.838 ' HB3' HG21 ' A' ' 97' ' ' VAL . 26.0 mtt -109.18 143.61 38.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.122 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.779 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 23.0 mttp -95.41 163.15 22.3 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 51' ' ' LYS . 74.1 Cg_exo -41.83 -69.03 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.01 2.473 . . . . 0.0 113.508 -178.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 97' ' ' VAL . . . -103.95 56.91 0.56 Allowed Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.023 -178.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.779 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 14.4 mm-40 -90.92 157.17 17.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.001 0.429 . . . . 0.0 111.815 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.53 HG13 ' HG3' ' A' ' 96' ' ' LYS . 3.0 mp -135.04 110.31 12.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.973 178.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.528 HD13 ' C ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -118.74 148.22 43.03 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.164 0.506 . . . . 0.0 111.985 -177.243 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -111.69 135.31 52.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.863 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 t -125.78 144.22 36.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.114 0.483 . . . . 0.0 112.006 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.451 ' C ' HG13 ' A' ' 60' ' ' ILE . 18.4 t90 -131.04 107.93 9.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.235 178.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.686 HG23 HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -144.24 -166.64 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.009 -178.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -145.13 27.47 1.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.144 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.73 ' H ' ' HA ' ' A' ' 63' ' ' PRO . 1.2 m-85 -101.06 -56.34 0.13 Allowed Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.368 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.73 ' HA ' ' H ' ' A' ' 62' ' ' TYR . 72.1 Cg_endo -94.19 171.24 17.49 Favored 'Cis proline' 0 C--N 1.356 0.949 0 C-N-CA 124.912 -0.87 . . . . 0.0 112.374 -0.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.654 ' H ' HD13 ' A' ' 60' ' ' ILE . 6.0 tpp -68.32 -26.35 65.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.356 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.654 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -59.71 -17.44 34.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.188 -179.405 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.7 pttp -59.73 -34.8 73.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.629 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.571 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 4.9 mt-10 -90.21 -22.55 21.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.169 0.509 . . . . 0.0 110.222 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.654 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 0.4 OUTLIER -62.03 -46.4 89.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.041 179.318 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.723 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 5.1 mt -54.52 -54.6 46.9 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.723 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 75.1 Cg_exo -51.36 -37.05 59.98 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.412 2.075 . . . . 0.0 112.61 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.564 ' HG3' ' HG ' ' A' ' 47' ' ' LEU . 4.8 tm-20 -71.24 -58.17 3.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.866 0.365 . . . . 0.0 111.525 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.763 HG21 ' HG2' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -58.89 -31.9 69.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.463 -178.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.529 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 8.6 p -73.52 -26.46 22.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.709 0.29 . . . . 0.0 110.731 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.69 -46.53 87.08 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.441 ' HG2' ' H ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -88.7 -74.32 0.47 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.565 177.463 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.505 HD11 HG22 ' A' ' 72' ' ' THR . 0.0 OUTLIER -98.21 -102.31 0.2 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.85 0.357 . . . . 0.0 110.482 178.19 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.27 -85.51 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.866 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.534 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -147.6 155.74 42.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.731 0.3 . . . . 0.0 111.076 178.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.763 ' HG2' HG21 ' A' ' 72' ' ' THR . 0.0 OUTLIER -103.87 69.24 0.95 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 177.396 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.535 HG12 HD11 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -98.67 121.52 49.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.88 -175.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.759 HD22 ' HB3' ' A' ' 96' ' ' LYS . 1.5 pt? -139.71 -35.5 0.53 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.677 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.613 ' HB3' ' HB2' ' A' ' 94' ' ' TYR . 0.8 OUTLIER -153.01 142.55 21.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.19 0.519 . . . . 0.0 112.009 179.574 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.535 HD11 HG12 ' A' ' 80' ' ' VAL . 3.7 mp -144.19 135.87 22.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.263 178.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -157.79 179.87 8.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.073 0.463 . . . . 0.0 111.28 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -133.5 161.25 35.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.555 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.0 t -120.7 -62.83 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.318 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.453 ' H ' ' HG3' ' A' ' 90' ' ' GLU . . . -125.37 -146.52 6.77 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.787 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.425 ' HB2' ' H ' ' A' ' 89' ' ' SER . 43.2 Cg_exo -57.11 -83.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.768 2.312 . . . . 0.0 112.513 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.425 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -95.73 -3.09 46.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.876 0.37 . . . . 0.0 111.184 -179.376 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.453 ' HG3' ' H ' ' A' ' 87' ' ' GLY . 5.5 pt-20 -93.16 133.89 35.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.713 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.11 168.81 20.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.929 0.395 . . . . 0.0 111.09 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.3 mttt -120.74 128.11 52.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.534 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.4 mp -125.28 145.11 33.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.885 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.613 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 13.0 m-85 -118.17 129.05 55.29 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.441 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.607 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -123.97 142.14 41.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.291 -179.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.759 ' HB3' HD22 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -144.04 110.57 5.56 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.755 -176.752 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.838 HG21 ' HB3' ' A' ' 50' ' ' MET . 3.2 t -61.26 118.48 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.314 178.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.59 ' HE3' ' HD3' ' A' ' 96' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.937 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.6 t . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.79 0.328 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.73 -56.62 2.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.134 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.467 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -113.4 139.53 48.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.085 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.3 m -133.85 117.47 16.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.802 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 11.7 tp -109.92 115.41 29.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.033 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.702 ' HB3' ' HB3' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -132.9 102.11 5.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.705 179.774 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.506 ' O ' HG13 ' A' ' 31' ' ' VAL . 7.2 p -140.85 75.04 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.298 0.57 . . . . 0.0 111.19 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.441 HH11 ' HD3' ' A' ' 32' ' ' ARG . 2.1 mtp180 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.001 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.455 ' O ' HD13 ' A' ' 47' ' ' LEU . 11.9 t . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.766 0.317 . . . . 0.0 110.678 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.72 -43.45 90.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.316 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -65.24 -39.54 92.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.81 178.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.46 -31.39 65.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.967 0.413 . . . . 0.0 110.52 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 43' ' ' THR . 2.9 mp -77.62 -51.73 10.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.486 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -81.46 -3.34 52.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.195 -177.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -134.96 71.2 1.44 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.822 0.344 . . . . 0.0 110.915 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.788 ' HB3' HG21 ' A' ' 97' ' ' VAL . 11.9 mtm -106.62 137.79 43.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.013 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.834 ' HG2' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -92.56 150.73 40.34 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.301 178.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.834 ' HD2' ' HG2' ' A' ' 51' ' ' LYS . 56.1 Cg_exo -37.28 -70.19 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.249 2.633 . . . . 0.0 113.992 -178.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.53 60.74 0.42 Allowed Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.121 -178.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.511 ' HG2' ' HB3' ' A' ' 51' ' ' LYS . 4.5 mm-40 -90.53 147.54 23.3 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.089 0.471 . . . . 0.0 111.753 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.516 HG23 ' HB2' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -130.84 114.65 27.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.065 178.418 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.467 HD22 ' HB3' ' A' ' 27' ' ' LYS . 4.0 mt -119.56 151.35 38.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.314 0.578 . . . . 0.0 112.095 -177.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -124.25 121.4 34.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.582 177.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.526 HG12 HG12 ' A' ' 60' ' ' ILE . 4.5 t -114.31 139.3 40.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.069 0.461 . . . . 0.0 111.987 -177.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.702 ' HB3' ' HB3' ' A' ' 30' ' ' ASP . 6.3 t90 -133.33 107.23 7.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.372 178.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.526 HG12 HG12 ' A' ' 58' ' ' VAL . 0.9 OUTLIER -156.95 -166.77 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.278 -178.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -111.52 -2.2 15.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.934 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.452 ' O ' HD12 ' A' ' 60' ' ' ILE . 3.3 m-85 -131.08 126.65 21.69 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.841 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 62' ' ' TYR . 31.8 Cg_exo -58.91 98.63 0.1 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.477 2.118 . . . . 0.0 112.377 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.484 ' HB3' ' NH1' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -67.98 -17.6 64.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.021 0.439 . . . . 0.0 110.885 179.637 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.516 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 5.1 p -64.0 -11.15 26.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.897 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.7 pttt -60.05 -39.67 86.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.981 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.554 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 6.1 mt-10 -89.93 -26.24 20.52 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.25 0.548 . . . . 0.0 110.207 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.516 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 28.7 mtt85 -63.71 -43.06 97.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.993 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.724 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 24.1 mt -51.83 -55.63 28.51 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.695 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.724 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 53.1 Cg_exo -53.18 -40.74 76.27 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.189 1.926 . . . . 0.0 112.603 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -61.04 2.19 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.965 0.412 . . . . 0.0 111.534 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.874 HG21 ' HG3' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -57.14 -43.58 82.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.63 -178.546 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 70' ' ' PRO . 9.8 p -58.84 -30.04 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.784 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -58.65 -40.36 83.2 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.679 ' HB3' HD13 ' A' ' 76' ' ' LEU . 2.0 mtpt -87.97 -84.86 0.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.875 176.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.815 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -98.46 -105.21 0.2 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.221 176.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.492 ' H ' HD23 ' A' ' 76' ' ' LEU . . . -132.93 -83.64 0.23 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.083 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.481 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -146.96 168.79 20.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.869 0.366 . . . . 0.0 111.25 179.613 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.95 ' HB2' HG23 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -110.26 61.07 0.6 Allowed 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.702 178.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.546 HG12 HD11 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -98.43 122.53 50.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.242 -177.533 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.505 HD12 ' HB2' ' A' ' 82' ' ' GLU . 1.1 pp -133.64 -37.86 0.92 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.274 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.505 ' HB2' HD12 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -153.11 147.99 26.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.992 0.425 . . . . 0.0 111.9 -179.748 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.546 HD11 HG12 ' A' ' 80' ' ' VAL . 3.7 mp -144.15 132.96 18.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.331 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.464 ' HG3' ' HB3' ' A' ' 92' ' ' LYS . 15.0 pt-20 -154.59 175.93 13.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.01 0.433 . . . . 0.0 111.363 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.43 173.71 11.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.982 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.46 -48.41 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.063 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -128.27 -150.65 7.32 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.545 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.98 -74.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.561 2.174 . . . . 0.0 112.533 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.9 p -99.36 -5.44 29.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.921 0.391 . . . . 0.0 111.193 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.413 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -93.28 131.11 38.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.786 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -151.48 170.34 19.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.971 0.415 . . . . 0.0 111.259 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.464 ' HB3' ' HG3' ' A' ' 84' ' ' GLU . 5.3 tttt -120.67 132.87 55.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.461 179.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.4 mp -125.64 149.81 30.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.105 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -118.57 125.29 49.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.486 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.95 HG23 ' HB2' ' A' ' 79' ' ' GLU . 16.1 mm -124.98 143.24 39.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.967 -177.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.694 ' C ' ' HB3' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -151.82 114.7 4.66 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 120.061 -0.656 . . . . 0.0 112.217 -178.797 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.788 HG21 ' HB3' ' A' ' 50' ' ' MET . 16.1 t -64.3 119.91 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.644 178.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.923 -179.777 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 47.2 t . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.654 0.264 . . . . 0.0 110.974 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -114.86 -60.2 1.92 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.416 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.27 159.18 23.1 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.03 0.443 . . . . 0.0 111.823 -178.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.5 m -135.77 108.16 7.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.554 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.5 tt -106.12 112.51 25.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.816 0.341 . . . . 0.0 111.126 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -133.29 107.74 8.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.457 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.0 t -137.93 72.87 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.505 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.707 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.458 -0.073 0 CA-C-O 120.794 0.33 . . . . 0.0 110.805 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.99 -45.13 93.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.643 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.0 -32.36 74.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.777 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.71 -39.32 84.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.943 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.553 HD22 ' HG2' ' A' ' 68' ' ' ARG . 2.2 mt -68.92 -34.15 74.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.606 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -81.16 -12.46 59.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.021 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -135.24 70.94 1.43 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.261 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.755 ' HB3' HG21 ' A' ' 97' ' ' VAL . 0.8 OUTLIER -99.82 126.33 45.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.071 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.559 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 1.3 mtpm? -81.88 150.1 64.84 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.964 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.19 -25.46 80.84 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.536 2.157 . . . . 0.0 112.499 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.59 39.21 2.94 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.564 -0.827 . . . . 0.0 113.118 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.772 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 28.5 mt-10 -90.75 123.43 34.33 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 117.198 0.499 . . . . 0.0 111.905 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.505 HD13 ' O ' ' A' ' 54' ' ' GLU . 0.7 OUTLIER -135.2 84.5 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.625 177.741 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.498 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -119.27 -179.79 3.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.278 0.561 . . . . 0.0 112.301 -176.862 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -136.76 145.82 45.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.295 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.699 HG11 ' HB2' ' A' ' 64' ' ' MET . 4.7 t -119.72 134.29 63.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.824 0.345 . . . . 0.0 111.413 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.527 ' HE1' HG21 ' A' ' 86' ' ' VAL . 11.7 t90 -122.47 96.17 4.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.079 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.547 HG13 HG12 ' A' ' 58' ' ' VAL . 0.5 OUTLIER -148.97 -160.06 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.646 179.053 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.476 ' HB3' ' O ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -131.0 37.53 3.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.461 -179.452 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.643 ' H ' ' HA ' ' A' ' 63' ' ' PRO . 86.1 m-85 -115.94 -60.81 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.119 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.643 ' HA ' ' H ' ' A' ' 62' ' ' TYR . 63.7 Cg_endo -97.22 -168.34 1.56 Allowed 'Cis proline' 0 C--N 1.356 0.939 0 CA-C-N 119.449 0.839 . . . . 0.0 111.881 -1.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.699 ' HB2' HG11 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -68.69 -27.65 66.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.825 0.345 . . . . 0.0 111.024 179.176 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.54 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.7 OUTLIER -58.73 -16.01 14.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.275 -178.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.51 ' HG3' ' N ' ' A' ' 67' ' ' GLU . 5.6 pttt -59.61 -34.32 72.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.024 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.531 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 1.4 mm-40 -93.97 -25.31 17.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.078 0.466 . . . . 0.0 110.352 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.553 ' HG2' HD22 ' A' ' 47' ' ' LEU . 6.2 mtt85 -62.97 -38.62 91.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.939 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.727 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 8.9 mt -60.04 -56.58 34.11 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.484 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.727 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 82.5 Cg_exo -46.51 -47.23 15.9 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.507 2.138 . . . . 0.0 112.805 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.534 ' HG3' ' HB3' ' A' ' 47' ' ' LEU . 64.5 mm-40 -60.97 -47.21 87.49 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.051 0.453 . . . . 0.0 110.944 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.566 ' HB ' ' O ' ' A' ' 77' ' ' GLY . 1.9 m -59.53 -46.34 89.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.508 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.703 HG13 ' O ' ' A' ' 69' ' ' ILE . 1.3 m -58.87 -29.4 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 121.119 -0.232 . . . . 0.0 111.004 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.52 -41.51 85.61 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 176.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.64 -81.46 0.31 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.487 177.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.42 -96.21 0.24 Allowed 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.81 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.566 ' O ' ' HB ' ' A' ' 72' ' ' THR . . . -144.07 -85.02 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.853 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.414 ' HB3' HG23 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -146.18 147.61 31.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.762 0.315 . . . . 0.0 110.912 178.844 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.877 ' HB2' HG23 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -95.36 55.72 1.77 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.422 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.7 p -99.22 127.21 52.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.291 -177.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.485 ' HG ' ' N ' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -133.29 -35.75 1.02 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.986 179.665 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.485 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 0.3 OUTLIER -153.91 148.7 26.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.064 0.459 . . . . 0.0 111.925 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.2 mp -141.75 140.8 30.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.454 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.41 ' OE2' ' HD2' ' A' ' 92' ' ' LYS . 11.4 pt-20 -158.04 178.92 9.67 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.033 0.444 . . . . 0.0 111.454 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -133.68 170.1 16.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.716 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.527 HG21 ' HE1' ' A' ' 59' ' ' TRP . 25.1 t -130.23 -56.54 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.287 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.45 ' H ' ' HG3' ' A' ' 90' ' ' GLU . . . -128.52 -145.98 6.13 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.721 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -58.4 -80.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.671 2.247 . . . . 0.0 112.547 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.476 ' O ' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -100.1 -2.7 33.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.785 0.326 . . . . 0.0 111.201 -179.399 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.45 ' HG3' ' H ' ' A' ' 87' ' ' GLY . 5.3 pt-20 -91.86 133.4 35.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.787 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -148.59 168.76 21.95 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.032 0.444 . . . . 0.0 111.387 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.41 ' HD2' ' OE2' ' A' ' 84' ' ' GLU . 2.2 tttt -120.62 146.81 46.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.523 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -129.98 159.3 42.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.244 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -125.58 124.01 40.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.731 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.877 HG23 ' HB2' ' A' ' 79' ' ' GLU . 31.0 mm -123.95 148.97 27.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.448 -176.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.627 ' C ' ' HB3' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -150.64 99.03 2.7 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 120.404 -0.519 . . . . 0.0 111.659 -177.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.772 ' HB ' ' HB2' ' A' ' 54' ' ' GLU . 48.6 t -70.63 89.58 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.532 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.2 pttm . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.273 -0.87 . . . . 0.0 111.041 -179.861 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.1 t . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.833 0.349 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.85 -65.98 0.93 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.096 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -108.67 149.23 29.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.112 -179.717 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.0 m -135.09 117.15 15.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.766 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.8 tp -103.52 109.79 21.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.922 0.391 . . . . 0.0 111.036 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.443 ' HB3' ' HB3' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -125.02 115.3 20.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.507 179.61 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.62 47.47 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.299 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.708 -179.887 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.47 ' O ' HD22 ' A' ' 47' ' ' LEU . 9.6 t . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.611 0.244 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.25 -42.3 60.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.948 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.65 -33.95 73.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.743 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.25 -48.19 82.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.294 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.54 HD21 ' HG2' ' A' ' 68' ' ' ARG . 1.1 mm? -61.24 -36.11 79.08 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.916 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -74.72 -9.61 58.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.073 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -134.98 49.83 2.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.037 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.607 ' HB2' HG21 ' A' ' 97' ' ' VAL . 16.1 ptp -88.48 146.64 25.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.875 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.579 ' HB3' ' HG3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -101.98 150.09 37.12 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.374 179.31 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.529 ' HD2' ' HG3' ' A' ' 51' ' ' LYS . 81.6 Cg_exo -31.19 -78.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.736 2.957 . . . . 0.0 114.137 -178.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.441 ' H ' ' HB2' ' A' ' 52' ' ' PRO . . . -104.41 62.18 0.39 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.117 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.579 ' HG3' ' HB3' ' A' ' 51' ' ' LYS . 8.6 mt-10 -89.21 150.49 22.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.027 0.441 . . . . 0.0 111.46 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.41 HG23 ' HB3' ' A' ' 96' ' ' LYS . 2.6 mp -135.64 106.55 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.687 177.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.401 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 1.2 mt -119.09 147.85 43.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.177 0.513 . . . . 0.0 112.194 -176.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -114.87 128.96 56.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.099 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.607 HG21 ' NH1' ' A' ' 68' ' ' ARG . 2.3 t -114.81 133.15 61.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.972 0.415 . . . . 0.0 111.529 -178.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.736 ' HE1' HG21 ' A' ' 86' ' ' VAL . 13.7 t90 -122.57 109.36 14.21 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.815 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.56 HD13 ' O ' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -156.9 -169.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.262 -179.536 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.609 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -109.24 -7.83 15.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.073 -179.598 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.56 ' O ' HD13 ' A' ' 60' ' ' ILE . 0.9 OUTLIER -126.25 122.42 24.05 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.606 179.74 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.05 92.48 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.572 2.181 . . . . 0.0 112.172 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 21.1 mtm -68.0 -15.58 63.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.606 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.495 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 2.4 p -63.92 -17.52 63.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.811 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.8 pttt -57.92 -32.12 67.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.841 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.555 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -94.12 -28.25 15.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.346 179.033 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.607 ' NH1' HG21 ' A' ' 58' ' ' VAL . 39.4 mtt180 -64.24 -39.56 94.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.207 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.7 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 12.5 mt -59.11 -54.77 53.12 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.509 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.7 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 80.6 Cg_exo -48.34 -44.06 30.46 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.307 2.005 . . . . 0.0 112.564 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.543 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 4.7 tt0 -69.11 -49.56 55.98 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.959 0.409 . . . . 0.0 111.433 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.465 ' HB ' ' O ' ' A' ' 77' ' ' GLY . 6.6 m -58.74 -48.16 82.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.364 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 69' ' ' ILE . 19.1 m -59.0 -28.81 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-O 120.504 0.193 . . . . 0.0 111.11 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.543 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.3 OUTLIER -58.02 -41.56 83.4 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.21 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.07 -80.55 0.31 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.176 176.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.85 -100.09 0.22 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.529 178.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.53 -86.56 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.835 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.415 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -146.67 152.56 39.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.751 0.31 . . . . 0.0 110.796 178.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.882 ' HB2' HG13 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -100.31 68.78 1.43 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.853 179.08 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.415 HG22 ' HB2' ' A' ' 78' ' ' HIS . 0.2 OUTLIER -98.96 124.01 51.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.724 -176.736 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.892 ' HB3' ' HG2' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -133.42 -37.51 0.95 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.933 179.05 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.561 ' HG3' ' N ' ' A' ' 83' ' ' ILE . 0.8 OUTLIER -154.05 146.34 23.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.946 0.403 . . . . 0.0 111.845 179.531 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.561 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 3.0 mt -141.55 135.31 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.35 178.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.649 ' HG3' ' HB3' ' A' ' 92' ' ' LYS . 6.2 pt-20 -158.05 -179.21 7.91 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.032 0.444 . . . . 0.0 111.321 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.22 162.59 31.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.814 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.736 HG21 ' HE1' ' A' ' 59' ' ' TRP . 60.3 t -123.21 -65.99 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.403 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -122.92 -153.14 8.71 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.743 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.72 -75.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.7 2.267 . . . . 0.0 112.344 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -99.58 -3.16 33.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.946 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.609 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 1.1 pm0 -93.56 138.15 32.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.809 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -151.53 171.05 18.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.993 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.649 ' HB3' ' HG3' ' A' ' 84' ' ' GLU . 2.3 ttpt -120.81 132.99 55.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.72 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.3 mp -125.43 144.95 33.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.84 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.468 ' HB3' ' HG ' ' A' ' 81' ' ' LEU . 10.5 m-85 -118.76 124.3 46.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.699 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.882 HG13 ' HB2' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -124.33 148.86 28.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.852 -178.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.892 ' HG2' ' HB3' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -150.93 108.54 3.65 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 120.239 -0.584 . . . . 0.0 112.506 -177.587 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.607 HG21 ' HB2' ' A' ' 50' ' ' MET . 5.0 t -58.15 119.54 3.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.587 178.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.84 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.0 t . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.76 0.315 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.08 -61.87 1.31 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.154 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.1 tptt -113.34 139.98 48.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.887 0.375 . . . . 0.0 111.161 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.404 HG23 ' HB3' ' A' ' 57' ' ' GLU . 71.0 m -130.2 134.74 47.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.859 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.609 HD23 HG22 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -113.15 127.97 56.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.915 179.726 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -120.01 108.51 14.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.783 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.609 HG22 HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -128.2 68.49 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.05 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.061 179.956 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.547 ' O ' HD22 ' A' ' 47' ' ' LEU . 4.1 t . . . . . 0 C--O 1.23 0.04 0 CA-C-O 120.685 0.279 . . . . 0.0 110.864 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.76 -36.57 76.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.893 0.378 . . . . 0.0 110.318 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -66.06 -31.34 72.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.439 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 43' ' ' THR . . . -58.62 -53.0 63.29 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.018 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.688 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 0.8 OUTLIER -58.65 -35.44 72.54 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.144 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.06 -9.83 59.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.249 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -133.52 69.23 1.48 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.948 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.803 ' HB3' HG21 ' A' ' 97' ' ' VAL . 41.9 mtm -109.02 147.86 31.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.997 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.584 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.4 OUTLIER -91.93 153.85 43.53 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.391 179.466 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.584 ' HD2' ' HG3' ' A' ' 51' ' ' LYS . 53.9 Cg_exo -38.48 -71.31 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.148 2.565 . . . . 0.0 113.962 -178.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.17 57.37 0.54 Allowed Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.913 -0.661 . . . . 0.0 113.415 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.515 ' HG3' ' HB3' ' A' ' 51' ' ' LYS . 11.0 mt-10 -91.41 156.1 17.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.134 0.493 . . . . 0.0 111.984 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.542 ' C ' HD13 ' A' ' 56' ' ' LEU . 3.5 mp -135.55 115.71 17.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.008 178.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.542 HD13 ' C ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -118.52 154.29 32.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.035 0.445 . . . . 0.0 111.692 -177.624 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.404 ' HB3' HG23 ' A' ' 28' ' ' THR . 51.1 tt0 -114.74 145.9 41.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.376 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.543 HG12 HG13 ' A' ' 60' ' ' ILE . 16.7 t -131.01 131.52 64.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.858 0.361 . . . . 0.0 111.527 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.416 ' CD1' ' HG2' ' A' ' 92' ' ' LYS . 52.8 m0 -122.59 107.25 11.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.422 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.543 HG13 HG12 ' A' ' 58' ' ' VAL . 1.0 OUTLIER -158.67 -172.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-O 121.046 0.451 . . . . 0.0 111.334 -179.213 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -99.67 -25.59 14.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.106 178.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.474 ' O ' HD13 ' A' ' 60' ' ' ILE . 93.0 m-85 -120.62 121.06 29.31 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.445 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -45.68 105.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.651 2.234 . . . . 0.0 112.561 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.499 ' HG3' ' NH1' ' A' ' 68' ' ' ARG . 3.0 tpt -65.64 -15.09 62.43 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.808 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.755 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 14.8 p -55.79 -13.38 1.72 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.846 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.66 -42.96 75.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.549 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 1.7 mt-10 -87.16 -26.07 23.77 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.225 0.536 . . . . 0.0 110.132 178.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.755 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 0.2 OUTLIER -61.48 -41.98 98.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.088 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.723 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 18.9 mt -55.33 -56.0 33.6 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.804 -178.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.723 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 78.3 Cg_exo -49.0 -41.27 40.44 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.216 1.944 . . . . 0.0 112.491 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.688 ' HG3' ' HB3' ' A' ' 47' ' ' LEU . 7.4 mm-40 -68.49 -55.2 12.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.571 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.76 HG21 ' HG2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -57.57 -49.01 77.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.468 -178.834 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.2 p -58.36 -28.32 35.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.139 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.553 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 2.8 mmtt -58.67 -43.25 89.82 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 176.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.51 ' HB3' HD13 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -89.19 -80.81 0.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.118 176.686 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.781 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -99.02 -106.38 0.2 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.459 177.685 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.479 ' H ' HD23 ' A' ' 76' ' ' LEU . . . -133.84 -80.92 0.16 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.365 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.491 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -146.14 165.6 28.67 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.775 0.322 . . . . 0.0 110.977 179.644 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.76 ' HG2' HG21 ' A' ' 72' ' ' THR . 0.1 OUTLIER -110.19 62.76 0.6 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.394 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.491 HG22 ' HB2' ' A' ' 78' ' ' HIS . 0.1 OUTLIER -98.77 123.05 51.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.69 -176.656 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.772 HD22 ' HB3' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -142.11 -36.42 0.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.223 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.482 ' HB3' ' HB2' ' A' ' 94' ' ' TYR . 2.3 tp10 -149.06 141.25 24.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.215 0.531 . . . . 0.0 112.348 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.469 HD11 HG12 ' A' ' 80' ' ' VAL . 3.8 mp -143.71 118.57 4.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.155 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -155.1 -176.05 5.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.164 0.507 . . . . 0.0 111.373 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -133.71 166.46 22.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.789 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.15 -47.74 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.17 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -123.39 -161.06 11.05 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.706 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.1 -76.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.689 2.259 . . . . 0.0 112.424 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -98.32 -2.48 39.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.101 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -93.34 119.84 32.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.402 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 14.4 m0 -120.79 167.66 12.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.03 0.443 . . . . 0.0 111.382 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.416 ' HG2' ' CD1' ' A' ' 59' ' ' TRP . 1.6 mttm -120.56 131.65 54.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.306 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -125.14 137.72 56.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.02 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.482 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 23.8 m-85 -118.27 123.44 45.42 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.384 178.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.681 HG13 ' HG3' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -123.95 142.53 40.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.251 -179.71 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.772 ' HB3' HD22 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -145.79 114.88 7.01 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.826 -176.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.803 HG21 ' HB3' ' A' ' 50' ' ' MET . 2.2 t -63.33 120.91 11.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.499 178.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 33.1 mttp . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.174 -0.917 . . . . 0.0 110.977 -179.631 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 20.9 t . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.813 0.34 . . . . 0.0 111.3 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.52 -46.7 2.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.068 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.09 154.26 38.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.137 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 51.6 m -135.52 114.78 12.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.845 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 5.8 tt -102.96 117.01 33.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.709 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -132.77 115.83 15.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.113 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.459 HG23 ' CG2' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -123.51 65.79 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.828 179.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.9 ttm180 . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.091 -179.934 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.464 ' O ' HD13 ' A' ' 47' ' ' LEU . 7.6 t . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.772 0.32 . . . . 0.0 110.498 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -55.29 -38.96 69.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.493 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.87 -42.4 77.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.133 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.79 -38.47 78.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.1 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.464 HD13 ' O ' ' A' ' 43' ' ' THR . 2.2 mp -64.52 -44.55 90.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.956 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.35 -3.88 51.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -126.14 62.91 1.25 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.103 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.19 152.06 25.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.072 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.861 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -105.04 162.11 20.73 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.678 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.587 ' HD2' ' HB3' ' A' ' 51' ' ' LYS . 4.9 Cg_endo -47.47 -68.9 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.087 2.524 . . . . 0.0 113.451 -178.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.53 58.34 0.49 Allowed Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.442 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.861 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 13.1 mm-40 -90.63 143.29 26.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.032 0.444 . . . . 0.0 111.57 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 5.5 mt -135.81 96.27 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.198 178.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.91 175.12 5.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.285 0.564 . . . . 0.0 111.959 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -138.25 140.91 39.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.317 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 2.8 t -114.12 135.72 52.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.991 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -121.75 107.84 12.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.69 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.643 HD13 ' O ' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -157.97 -163.7 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.224 -179.199 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -114.17 -5.88 13.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.643 ' O ' HD13 ' A' ' 60' ' ' ILE . 6.8 m-85 -125.84 132.57 24.36 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.803 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -58.36 91.2 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.61 2.207 . . . . 0.0 112.78 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 5.1 tmm? -68.53 -25.95 65.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.056 0.455 . . . . 0.0 110.449 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.637 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 67.5 m -64.05 -13.86 50.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.946 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.453 ' HG3' ' N ' ' A' ' 67' ' ' GLU . 2.1 pttp -57.69 -33.91 68.86 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.734 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.577 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -94.32 -27.13 16.27 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.186 0.517 . . . . 0.0 110.112 178.383 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.637 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -61.31 -34.34 75.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.942 179.126 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.733 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 11.3 mt -63.53 -56.75 23.84 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.342 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.733 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 83.4 Cg_exo -47.78 -32.39 16.89 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.307 2.004 . . . . 0.0 112.373 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.08 -58.26 3.73 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.061 0.457 . . . . 0.0 111.012 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.587 HG21 ' HG2' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -59.75 -30.0 68.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.557 -178.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.579 HG12 ' O ' ' A' ' 70' ' ' PRO . 5.7 p -72.72 -29.84 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.83 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.68 -41.39 86.07 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -90.6 -78.67 0.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.446 177.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.431 HD11 HG22 ' A' ' 72' ' ' THR . 0.0 OUTLIER -98.48 -97.92 0.22 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.755 178.53 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.09 -82.4 0.05 OUTLIER Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.14 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.681 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -146.32 157.98 43.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.86 0.362 . . . . 0.0 111.234 179.449 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.706 ' HB2' ' H ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -104.72 63.4 0.72 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.491 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.681 HG22 ' HB2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -99.13 121.83 50.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.805 -176.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.744 ' HB3' ' HG2' ' A' ' 96' ' ' LYS . 2.2 pt? -139.79 -32.41 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.421 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.559 ' O ' HD13 ' A' ' 83' ' ' ILE . 0.4 OUTLIER -149.88 132.84 16.14 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -179.704 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.663 HD11 HG12 ' A' ' 80' ' ' VAL . 1.0 OUTLIER -134.62 126.23 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.315 178.268 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -158.34 175.96 13.06 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.072 0.463 . . . . 0.0 111.554 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -134.51 178.04 7.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.738 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.5 p -138.73 -43.32 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.283 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -133.7 -148.4 5.85 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.726 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.07 -77.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.608 2.205 . . . . 0.0 112.346 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.8 p -97.89 -3.47 38.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.881 0.372 . . . . 0.0 110.886 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.418 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 4.4 pt-20 -93.23 130.8 38.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.766 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -147.45 168.95 20.57 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.971 0.415 . . . . 0.0 111.203 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.406 ' HG2' ' HE1' ' A' ' 94' ' ' TYR . 20.9 ttpt -126.38 127.45 45.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.448 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.6 mt -125.53 149.46 30.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.885 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.467 ' HB2' ' CB ' ' A' ' 82' ' ' GLU . 6.8 m-85 -118.42 135.66 54.22 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.289 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.598 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -125.55 143.24 39.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.299 178.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.744 ' HG2' ' HB3' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -138.42 106.31 5.67 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 120.232 -0.587 . . . . 0.0 112.189 -177.514 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.416 ' H ' HG23 ' A' ' 97' ' ' VAL . 2.4 t -64.43 118.97 7.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.424 178.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.918 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.629 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 85.6 t . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.512 0.196 . . . . 0.0 110.561 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.678 ' HB ' HD11 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -99.47 -37.37 9.22 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.846 -0.341 . . . . 0.0 111.82 -178.731 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.583 ' H ' ' CD1' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -145.52 162.23 37.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.407 0.622 . . . . 0.0 111.845 -178.723 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 83.1 m -136.17 125.99 25.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.715 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 tt -107.64 120.38 42.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.575 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.32 112.44 8.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.861 0.362 . . . . 0.0 111.084 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.1 t -134.14 70.06 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.972 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.332 -0.18 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.45 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.403 ' O ' HD22 ' A' ' 47' ' ' LEU . 1.4 t . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.719 0.295 . . . . 0.0 110.44 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -59.69 -40.23 87.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.151 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -67.75 -29.79 69.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.99 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.88 -56.06 26.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.017 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.671 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 1.7 mm? -61.3 -62.0 2.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.58 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -58.7 -32.77 69.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.492 . . . . 0.0 112.184 -177.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -124.97 66.05 1.12 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.842 0.353 . . . . 0.0 111.24 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.507 ' HB2' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -98.78 158.18 15.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.921 179.775 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -100.12 144.86 29.21 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.648 179.538 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -49.87 -46.75 26.27 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.885 2.39 . . . . 0.0 113.573 -178.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.0 56.31 0.54 Allowed Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.622 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 11.7 mm-40 -90.86 136.01 33.35 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 117.18 0.49 . . . . 0.0 111.614 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.629 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 2.6 mp -136.4 81.41 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.613 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.678 HD11 ' HB ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -117.19 176.26 5.22 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.349 -0.541 . . . . 0.0 112.246 -173.481 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -132.04 162.52 30.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.811 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.481 HG12 HG12 ' A' ' 60' ' ' ILE . 6.2 t -135.3 139.59 46.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.815 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 9.1 t-105 -127.77 104.53 7.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.745 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.481 HG12 HG12 ' A' ' 58' ' ' VAL . 0.5 OUTLIER -158.29 -177.31 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.27 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -97.26 0.23 47.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.64 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -136.93 130.16 17.48 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.642 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.46 100.46 0.57 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.42 2.08 . . . . 0.0 112.304 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.408 ' O ' ' HD3' ' A' ' 68' ' ' ARG . 1.3 mtt -68.01 -13.04 61.87 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.773 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 14.4 p -59.14 -11.01 3.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.363 178.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -55.09 -46.44 75.48 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.11 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.548 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -87.23 -25.19 24.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.171 0.51 . . . . 0.0 110.209 178.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.773 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -62.41 -35.6 79.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.915 179.343 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.758 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 16.6 mt -60.39 -56.89 30.91 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.513 -179.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.758 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 67.0 Cg_exo -52.09 -32.15 47.91 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.283 1.988 . . . . 0.0 112.47 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.671 ' HG3' ' HB3' ' A' ' 47' ' ' LEU . 30.1 mm-40 -72.46 -63.69 1.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.884 0.373 . . . . 0.0 111.338 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.467 HG22 HD11 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -57.42 -28.36 63.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.479 -178.791 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.521 HG12 ' O ' ' A' ' 70' ' ' PRO . 5.8 p -74.19 -29.49 25.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.803 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.67 -41.43 86.1 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 176.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.433 ' HD3' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -90.47 -78.38 0.38 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.283 177.104 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.467 HD11 HG22 ' A' ' 72' ' ' THR . 0.0 OUTLIER -98.54 -96.75 0.22 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.743 178.515 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.29 -79.52 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.1 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.522 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -146.12 158.55 43.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.769 0.319 . . . . 0.0 110.863 179.262 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.77 ' HB2' HG23 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -103.49 56.67 0.74 Allowed 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.822 179.44 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.651 HG12 HD11 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -98.88 125.36 52.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.236 -177.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.522 ' HG ' ' HB3' ' A' ' 94' ' ' TYR . 1.1 pp -133.43 -36.9 0.97 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.015 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.485 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -153.38 143.67 22.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.97 0.414 . . . . 0.0 111.724 179.823 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.651 HD11 HG12 ' A' ' 80' ' ' VAL . 3.4 mp -143.19 137.52 26.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.336 178.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.429 ' HG3' ' HB3' ' A' ' 92' ' ' LYS . 2.5 pt-20 -152.6 176.53 11.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.016 0.436 . . . . 0.0 111.214 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -133.49 163.59 29.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.681 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.58 HG23 ' HA ' ' A' ' 91' ' ' TRP . 2.8 t -127.46 -66.58 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.321 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -123.0 -141.08 5.83 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.671 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.459 ' HB2' ' H ' ' A' ' 89' ' ' SER . 31.4 Cg_exo -58.71 -84.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.7 2.267 . . . . 0.0 112.329 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.459 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 85.1 p -100.05 -1.16 37.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.011 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -91.68 128.05 37.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.822 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.58 ' HA ' HG23 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -150.16 171.13 17.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.253 -179.682 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.429 ' HB3' ' HG3' ' A' ' 84' ' ' GLU . 12.0 tttt -121.36 141.69 50.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.491 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.426 HG22 ' H ' ' A' ' 94' ' ' TYR . 0.8 OUTLIER -131.16 165.17 32.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.186 -179.542 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.522 ' HB3' ' HG ' ' A' ' 81' ' ' LEU . 12.7 m-85 -132.88 126.17 31.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.001 178.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.77 HG23 ' HB2' ' A' ' 79' ' ' GLU . 18.7 mm -124.76 145.73 31.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.078 -177.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.662 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -150.54 120.1 6.96 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 119.759 -0.776 . . . . 0.0 112.924 -178.62 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.512 HG22 ' OE1' ' A' ' 79' ' ' GLU . 22.7 t -73.57 128.48 36.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.242 178.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.8 tttm . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.929 -179.708 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.7 t . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.772 0.32 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.29 -61.88 1.31 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.691 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 0.8 OUTLIER -115.56 157.83 23.53 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.801 179.117 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.0 m -135.49 125.72 26.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.066 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.0 tt -107.46 119.44 39.42 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.975 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -124.04 113.96 19.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.516 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.446 ' O ' HG23 ' A' ' 60' ' ' ILE . 3.8 m -140.39 74.06 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.891 0.377 . . . . 0.0 111.543 -179.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.864 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.535 ' O ' HD13 ' A' ' 47' ' ' LEU . 8.4 t . . . . . 0 CA--C 1.526 0.053 0 CA-C-O 120.704 0.288 . . . . 0.0 111.085 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.67 -44.3 77.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.665 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.56 -35.25 79.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.75 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.8 -36.4 84.2 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.997 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.535 HD13 ' O ' ' A' ' 43' ' ' THR . 2.4 mp -70.28 -39.67 74.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.154 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -78.84 -21.33 47.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.336 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.9 t30 -135.24 70.56 1.43 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.801 0.334 . . . . 0.0 111.4 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.658 ' HB2' HG21 ' A' ' 97' ' ' VAL . 18.4 ptp -102.28 145.14 29.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.673 178.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.891 ' HG2' ' HD2' ' A' ' 52' ' ' PRO . 3.1 tttp -80.79 148.17 64.35 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.783 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.891 ' HD2' ' HG2' ' A' ' 51' ' ' LYS . 58.7 Cg_exo -39.03 -75.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.25 2.634 . . . . 0.0 114.173 -178.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.86 59.7 0.48 Allowed Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.001 -0.618 . . . . 0.0 113.261 -177.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.406 ' HG2' ' HB3' ' A' ' 51' ' ' LYS . 1.8 mm-40 -90.92 153.68 20.02 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.014 0.435 . . . . 0.0 111.918 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.2 mt -132.5 116.0 26.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.99 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.536 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 5.0 mp -126.72 152.13 47.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.119 0.485 . . . . 0.0 111.949 -178.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -113.92 129.53 56.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.402 177.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.81 HG11 HH12 ' A' ' 68' ' ' ARG . 2.2 t -114.12 128.77 70.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.165 0.507 . . . . 0.0 111.925 -177.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -122.87 101.17 7.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.448 178.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.733 HD12 ' HB2' ' A' ' 64' ' ' MET . 0.5 OUTLIER -149.64 -160.01 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.681 -179.437 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.478 ' H ' HG22 ' A' ' 60' ' ' ILE . 10.1 p-10 -145.17 35.26 1.09 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.704 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.556 ' H ' ' HA ' ' A' ' 63' ' ' PRO . 44.4 m-85 -105.74 -63.02 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.001 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.556 ' HA ' ' H ' ' A' ' 62' ' ' TYR . 85.7 Cg_endo -97.53 164.23 12.48 Favored 'Cis proline' 0 C--N 1.356 0.971 0 CA-C-N 119.507 0.86 . . . . 0.0 112.088 -1.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.733 ' HB2' HD12 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -68.48 -17.76 64.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.808 0.337 . . . . 0.0 111.147 179.815 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.577 ' HA ' ' HD3' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -60.44 -17.4 44.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.932 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 63' ' ' PRO . 2.9 pttp -62.51 -27.22 68.99 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.844 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.507 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.7 OUTLIER -94.34 -26.19 16.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.178 0.513 . . . . 0.0 109.863 178.107 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.81 HH12 HG11 ' A' ' 58' ' ' VAL . 3.8 mpt_? -58.89 -47.57 84.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.193 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.732 HG23 ' HB3' ' A' ' 78' ' ' HIS . 3.8 mt -57.8 -55.32 46.2 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.834 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.693 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 83.8 Cg_exo -42.94 -51.47 5.42 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 122.73 2.286 . . . . 0.0 113.171 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.415 ' O ' ' HD3' ' A' ' 75' ' ' LYS . 2.0 mm-40 -62.41 -41.34 98.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.007 0.432 . . . . 0.0 110.978 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.542 HG21 ' HG3' ' A' ' 79' ' ' GLU . 2.9 m -59.72 -52.08 67.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.754 -179.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -58.67 -26.33 31.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.937 -178.863 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.6 -44.17 89.79 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 176.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.415 ' HD3' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -90.36 -77.28 0.41 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.429 176.898 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.75 HD13 ' HB2' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -98.52 -98.64 0.22 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.828 178.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.14 -84.54 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.151 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.732 ' HB3' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -146.36 146.91 30.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.976 0.417 . . . . 0.0 111.213 179.276 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.916 ' HB2' HG23 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -95.34 52.75 1.43 Allowed 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 177.737 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.529 HG12 ' HB2' ' A' ' 78' ' ' HIS . 1.4 p -98.71 118.77 45.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.208 -177.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.785 HD22 ' HB3' ' A' ' 96' ' ' LYS . 1.1 pt? -133.65 -29.35 1.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.686 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.505 ' O ' HG13 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -152.81 144.78 23.71 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.979 179.074 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 82' ' ' GLU . 2.5 mp -144.5 126.44 9.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.566 178.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 92' ' ' LYS . 9.3 pt-20 -153.06 174.67 13.89 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.905 0.384 . . . . 0.0 111.137 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.04 169.06 17.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.877 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.2 t -129.25 -52.68 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.215 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -126.1 -145.53 6.41 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.767 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.89 -77.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.606 2.204 . . . . 0.0 112.523 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.18 -6.85 27.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.937 0.399 . . . . 0.0 111.138 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -89.62 134.47 34.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.567 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -151.31 169.63 21.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.047 0.451 . . . . 0.0 111.265 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 10.5 ttpt -126.97 125.51 41.63 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.344 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.5 HG22 ' N ' ' A' ' 94' ' ' TYR . 4.1 mp -125.5 159.87 32.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.925 0.393 . . . . 0.0 110.836 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.5 ' N ' HG22 ' A' ' 93' ' ' ILE . 6.3 m-85 -118.2 133.55 55.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.579 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.916 HG23 ' HB2' ' A' ' 79' ' ' GLU . 12.9 mm -124.21 137.82 55.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.093 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.785 ' HB3' HD22 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -144.91 109.78 5.05 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.375 -0.53 . . . . 0.0 112.052 -176.677 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.658 HG21 ' HB2' ' A' ' 50' ' ' MET . 4.1 t -65.54 116.19 4.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.304 178.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.75 ' HB2' HD13 ' A' ' 76' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.082 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.8 t . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.768 0.318 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.57 -56.08 2.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.152 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.03 137.76 50.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.829 0.347 . . . . 0.0 111.356 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 54.9 m -123.89 126.87 47.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.522 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.5 tp -109.83 118.76 37.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.292 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -108.24 128.42 54.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.528 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.793 ' HB ' HG23 ' A' ' 60' ' ' ILE . 18.9 t -117.24 -23.45 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.357 -179.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.439 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 6.7 t . . . . . 0 N--CA 1.458 -0.053 0 CA-C-O 120.646 0.26 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.2 -43.78 71.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.859 0.361 . . . . 0.0 110.702 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.41 -32.76 74.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.412 178.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.566 ' HA ' HD21 ' A' ' 49' ' ' ASN . . . -59.32 -45.27 91.78 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.038 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.408 HD22 ' O ' ' A' ' 43' ' ' THR . 1.8 mm? -72.48 -19.47 61.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.772 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.41 -36.64 29.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.359 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.705 HD22 ' H ' ' A' ' 49' ' ' ASN . 0.1 OUTLIER -106.74 48.6 0.83 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.909 0.385 . . . . 0.0 111.606 -178.621 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.1 ptm -89.9 126.35 35.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.897 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.461 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -94.67 152.35 39.78 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.795 -179.86 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.461 ' HD2' ' HG3' ' A' ' 51' ' ' LYS . 61.0 Cg_exo -40.4 -67.61 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.175 2.583 . . . . 0.0 113.831 -178.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.32 57.87 0.51 Allowed Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.993 -0.622 . . . . 0.0 113.141 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.446 ' O ' HD13 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -91.25 150.29 21.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.983 0.421 . . . . 0.0 111.898 -179.71 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.573 HD13 ' HG3' ' A' ' 96' ' ' LYS . 0.6 OUTLIER -131.07 112.81 22.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.032 178.282 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 mt -119.78 154.51 34.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.176 0.513 . . . . 0.0 112.173 -177.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -119.75 125.86 49.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.472 177.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.1 t -114.96 138.22 45.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.176 0.512 . . . . 0.0 112.327 -177.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.455 ' C ' HG13 ' A' ' 60' ' ' ILE . 7.1 m0 -122.46 105.62 10.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.654 177.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.924 HG12 ' HB2' ' A' ' 64' ' ' MET . 0.1 OUTLIER -144.97 -176.97 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 CA-C-O 120.966 0.412 . . . . 0.0 111.505 -177.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.563 ' HB3' ' HA ' ' A' ' 90' ' ' GLU . 0.5 OUTLIER -138.4 25.9 2.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.869 179.396 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.795 ' H ' ' HA ' ' A' ' 63' ' ' PRO . 0.6 OUTLIER -106.19 -55.48 0.07 OUTLIER Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.597 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.795 ' HA ' ' H ' ' A' ' 62' ' ' TYR . 78.5 Cg_endo -95.61 177.36 9.94 Favored 'Cis proline' 0 C--N 1.355 0.897 0 C-N-CA 124.904 -0.873 . . . . 0.0 112.708 0.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.924 ' HB2' HG12 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -68.43 -25.7 65.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.228 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.457 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 14.4 p -61.3 -13.02 15.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.087 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.514 ' HG3' ' N ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -62.97 -31.93 73.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.886 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.562 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -94.2 -25.66 16.99 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.084 0.469 . . . . 0.0 110.241 178.758 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.457 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 18.5 mtt85 -62.17 -41.91 98.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.954 179.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.731 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 12.5 mt -56.7 -55.84 38.99 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.684 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.731 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 76.2 Cg_exo -49.31 -40.8 43.59 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.292 1.995 . . . . 0.0 112.703 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.86 -51.65 52.99 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.899 0.381 . . . . 0.0 111.219 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.835 HG21 ' HG2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -59.53 -50.63 73.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.59 -178.799 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.0 p -58.37 -28.12 34.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.895 -178.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.78 -42.46 89.03 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 176.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.6 -80.62 0.3 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.949 176.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.757 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -98.58 -106.65 0.19 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.363 177.2 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.488 ' H ' HD23 ' A' ' 76' ' ' LEU . . . -132.73 -84.76 0.26 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.018 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.39 164.23 33.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.915 0.388 . . . . 0.0 111.309 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.835 ' HG2' HG21 ' A' ' 72' ' ' THR . 0.0 OUTLIER -107.09 62.3 0.62 Allowed 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.397 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.478 HG23 HD11 ' A' ' 83' ' ' ILE . 1.4 p -98.14 120.88 48.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.427 -175.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.575 HD21 ' HB3' ' A' ' 94' ' ' TYR . 0.5 OUTLIER -133.68 -33.52 1.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.795 179.807 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.468 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -151.77 145.16 24.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.014 0.435 . . . . 0.0 111.811 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.478 HD11 HG23 ' A' ' 80' ' ' VAL . 3.5 mp -142.23 123.51 12.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.288 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.574 ' HG3' ' HB3' ' A' ' 92' ' ' LYS . 5.1 pt-20 -156.55 -175.55 5.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.221 0.534 . . . . 0.0 111.349 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.486 ' HB3' ' HD1' ' A' ' 91' ' ' TRP . 3.6 pt-20 -133.24 166.39 22.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.639 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.406 HG13 ' N ' ' A' ' 87' ' ' GLY . 4.8 p -131.27 -44.9 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.477 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.406 ' N ' HG13 ' A' ' 86' ' ' VAL . . . -133.33 -151.83 6.68 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.673 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.89 -74.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.547 2.164 . . . . 0.0 112.426 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.7 p -95.65 -5.84 41.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.812 0.339 . . . . 0.0 111.157 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.563 ' HA ' ' HB3' ' A' ' 61' ' ' ASP . 4.5 pt-20 -93.03 140.94 28.95 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.558 179.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.486 ' HD1' ' HB3' ' A' ' 85' ' ' GLU . 6.1 m-90 -136.44 163.97 29.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.047 0.451 . . . . 0.0 111.335 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.574 ' HB3' ' HG3' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -120.23 117.0 26.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.077 178.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.4 mp -125.28 145.34 32.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.99 -178.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.575 ' HB3' HD21 ' A' ' 81' ' ' LEU . 29.1 m-85 -118.04 132.54 56.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.187 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.711 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -124.13 141.66 43.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.796 -177.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.585 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -151.21 130.05 12.44 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.239 -0.584 . . . . 0.0 112.287 -177.714 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.433 HG22 ' OE1' ' A' ' 79' ' ' GLU . 2.3 t -80.85 120.05 31.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.089 177.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.954 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.695 HG13 ' HA ' ' A' ' 56' ' ' LEU . 57.6 t . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.753 0.311 . . . . 0.0 111.12 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.3 m -106.36 -53.64 2.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.196 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.456 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -119.39 167.03 12.32 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.048 0.452 . . . . 0.0 111.466 -179.197 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.418 ' H ' ' HG3' ' A' ' 27' ' ' LYS . 87.8 m -134.09 121.99 22.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.648 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.476 HD22 HG13 ' A' ' 58' ' ' VAL . 5.1 tt -103.69 120.75 41.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.935 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -132.37 120.17 21.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.727 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.418 ' HB ' ' CG2' ' A' ' 60' ' ' ILE . 3.0 t -109.65 -4.66 10.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.246 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.645 ' HD3' ' HE1' ' A' ' 59' ' ' TRP . 0.7 OUTLIER . . . . . 0 CA--C 1.532 0.261 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.285 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.445 ' CB ' HD11 ' A' ' 29' ' ' LEU . 13.3 t . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.688 0.28 . . . . 0.0 110.791 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.64 -41.63 73.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.676 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.68 -30.35 69.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.05 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.52 -43.98 80.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.25 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.817 HD11 ' HG2' ' A' ' 68' ' ' ARG . 2.3 mm? -71.4 -43.86 66.02 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.69 -179.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -81.35 -12.65 58.94 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -177.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.412 ' ND2' ' HE3' ' A' ' 51' ' ' LYS . 2.2 t30 -135.51 72.71 1.45 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.94 0.4 . . . . 0.0 111.139 -179.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.67 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -108.53 138.49 44.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.866 179.832 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.656 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -96.09 153.29 39.16 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.7 179.708 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -52.94 -43.61 55.32 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.624 2.216 . . . . 0.0 113.198 -178.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.8 50.14 0.86 Allowed Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.532 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.684 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 20.0 mm-40 -91.27 129.0 37.31 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 117.358 0.579 . . . . 0.0 111.635 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 1.1 mp -135.59 89.46 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.779 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.695 ' HA ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -118.89 -177.98 3.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.252 0.549 . . . . 0.0 112.087 -176.695 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -129.25 174.01 9.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.236 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.569 HG12 HG13 ' A' ' 60' ' ' ILE . 13.4 t -140.17 136.02 37.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.858 0.361 . . . . 0.0 111.303 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.645 ' HE1' ' HD3' ' A' ' 32' ' ' ARG . 57.9 t-105 -122.49 104.49 9.41 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.706 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.569 HG13 HG12 ' A' ' 58' ' ' VAL . 0.8 OUTLIER -159.04 -177.8 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.084 0.469 . . . . 0.0 111.528 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 4.9 m-20 -99.89 -13.8 19.02 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.016 177.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.466 ' O ' HD13 ' A' ' 60' ' ' ILE . 1.8 m-85 -129.91 124.8 21.79 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.274 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.482 ' HD3' ' HE1' ' A' ' 91' ' ' TRP . 86.4 Cg_exo -47.54 104.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.643 2.229 . . . . 0.0 112.863 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.425 ' CE ' HD21 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -64.88 -19.27 65.81 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.116 0.484 . . . . 0.0 110.586 179.3 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.681 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 6.1 p -61.82 -10.09 8.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.625 179.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.7 ptmt -58.15 -37.96 75.68 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.58 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.552 ' O ' ' HG2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -91.74 -24.21 19.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.277 0.56 . . . . 0.0 109.967 178.259 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.817 ' HG2' HD11 ' A' ' 47' ' ' LEU . 33.2 mtt-85 -63.46 -39.69 95.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.756 179.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.464 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 12.2 mt -57.5 -56.96 28.64 Favored Pre-proline 0 CA--C 1.532 0.282 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.552 ' HG2' ' O ' ' A' ' 67' ' ' GLU . 9.8 Cg_endo -53.4 -34.58 71.84 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.138 1.892 . . . . 0.0 112.574 -178.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.556 ' HG3' ' HB3' ' A' ' 47' ' ' LEU . 65.1 mm-40 -72.92 -65.71 0.76 Allowed 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.042 0.448 . . . . 0.0 111.327 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.636 HG21 ' HG3' ' A' ' 79' ' ' GLU . 0.2 OUTLIER -58.7 -24.91 62.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.353 -178.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.534 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 3.4 p -76.07 -27.89 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-O 120.74 0.305 . . . . 0.0 110.474 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.97 -43.35 86.43 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 176.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.08 -77.89 0.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.117 176.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.421 HD11 HG22 ' A' ' 72' ' ' THR . 0.0 OUTLIER -98.18 -100.24 0.21 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.626 178.216 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.27 -85.62 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.71 178.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.597 ' CE1' HD11 ' A' ' 95' ' ' ILE . 6.3 t-80 -147.05 172.7 13.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.924 0.392 . . . . 0.0 110.94 177.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.885 ' HB2' HG13 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -111.48 68.53 0.67 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.84 178.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.565 HG22 ' ND1' ' A' ' 78' ' ' HIS . 0.1 OUTLIER -99.02 122.06 50.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.952 0.406 . . . . 0.0 112.025 -176.64 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.999 ' HB3' ' HG2' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -133.74 -40.97 0.86 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.036 178.563 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.567 ' HB2' HD12 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -153.88 151.02 28.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.04 0.448 . . . . 0.0 112.116 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.512 HG13 ' C ' ' A' ' 82' ' ' GLU . 1.1 mp -141.54 142.14 29.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.159 178.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -156.63 176.05 13.24 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.027 0.442 . . . . 0.0 111.682 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -136.07 176.65 8.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.732 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.578 HG12 ' HA ' ' A' ' 91' ' ' TRP . 0.7 OUTLIER -144.34 -53.48 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.134 -178.298 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.405 ' H ' HG13 ' A' ' 86' ' ' VAL . . . -123.92 -153.91 8.79 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.564 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.97 -78.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.626 2.218 . . . . 0.0 112.311 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.05 -3.02 32.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.869 0.366 . . . . 0.0 111.111 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 8.7 pt-20 -93.35 133.24 36.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.765 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.578 ' HA ' HG12 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -151.56 173.73 14.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.272 -179.902 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.551 ' HG3' ' HE3' ' A' ' 59' ' ' TRP . 3.3 mttm -122.33 143.43 49.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.365 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.63 151.27 31.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.919 0.39 . . . . 0.0 111.258 -179.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.464 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 14.4 m-85 -118.66 123.65 45.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.081 178.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.885 HG13 ' HB2' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -123.77 151.51 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.045 -177.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.999 ' HG2' ' HB3' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -148.83 97.74 2.76 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.926 -177.445 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.684 ' HB ' ' HB2' ' A' ' 54' ' ' GLU . 17.6 t -60.56 117.53 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.701 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.908 -179.905 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 68.9 t . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.828 0.347 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.7 m -99.84 -67.82 0.83 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.891 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -115.76 159.43 21.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.801 0.334 . . . . 0.0 110.842 179.636 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.6 m -135.65 124.77 24.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.096 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.3 tt -104.94 112.87 26.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.571 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -130.05 112.55 13.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.142 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.554 HG23 ' CG2' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -135.51 72.45 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.818 179.13 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.499 -179.301 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.481 HG21 ' SD ' ' A' ' 64' ' ' MET . 14.6 t . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.792 0.329 . . . . 0.0 110.61 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.3 tptm -61.26 -39.54 90.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.397 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -32.67 72.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.762 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.63 -48.71 80.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.822 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.638 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 3.0 mt -62.02 -30.05 70.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.784 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.62 -25.63 45.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.164 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -132.43 69.62 1.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.058 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.636 ' HB3' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -84.6 147.47 26.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.792 179.835 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.795 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 0.8 OUTLIER -103.08 161.57 22.7 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.658 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -46.61 -72.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.988 2.458 . . . . 0.0 113.905 -177.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.28 59.99 0.45 Allowed Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.333 -177.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.795 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 26.3 mm-40 -87.34 139.19 30.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.896 0.379 . . . . 0.0 111.377 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.557 ' HA ' ' HB2' ' A' ' 96' ' ' LYS . 16.8 mt -135.25 121.03 30.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.682 178.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.486 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.5 mp -127.1 146.82 50.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.156 0.503 . . . . 0.0 112.076 -177.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -111.31 123.34 50.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.699 177.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.41 HG12 HG12 ' A' ' 60' ' ' ILE . 8.3 t -114.34 130.36 68.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.977 0.417 . . . . 0.0 111.758 -177.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.587 ' HE1' HG21 ' A' ' 86' ' ' VAL . 2.4 t90 -126.73 111.33 14.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.427 179.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.554 ' CG2' HG23 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -158.14 -168.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 121.071 0.462 . . . . 0.0 111.796 -178.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.45 ' OD2' ' HB2' ' A' ' 89' ' ' SER . 0.4 OUTLIER -102.7 -11.42 18.41 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.9 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.469 ' O ' HD12 ' A' ' 60' ' ' ILE . 4.5 m-85 -133.59 139.75 34.71 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.909 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.41 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 16.9 Cg_exo -67.66 101.73 0.68 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.722 2.282 . . . . 0.0 112.615 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.481 ' SD ' HG21 ' A' ' 43' ' ' THR . 0.0 OUTLIER -68.24 -16.78 64.1 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.138 0.494 . . . . 0.0 110.524 178.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.75 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -59.36 -12.62 6.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.458 179.105 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.71 ' HE2' ' HG3' ' A' ' 67' ' ' GLU . 2.2 pttm -54.91 -39.29 68.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.989 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.71 ' HG3' ' HE2' ' A' ' 66' ' ' LYS . 4.9 mt-10 -91.48 -27.97 17.92 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.146 0.498 . . . . 0.0 110.067 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.75 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -62.94 -34.62 77.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.115 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.768 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 21.0 mt -60.85 -56.95 30.1 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.768 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 75.7 Cg_exo -51.09 -37.29 57.53 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.255 1.97 . . . . 0.0 112.666 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.638 ' HG3' ' HB3' ' A' ' 47' ' ' LEU . 17.4 mm-40 -67.35 -65.79 0.64 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.841 0.353 . . . . 0.0 111.481 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.543 HG21 ' HG3' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -54.52 -45.35 73.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.433 -178.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.439 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 7.1 p -59.18 -29.1 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.209 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.9 tptt -58.5 -43.89 89.25 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 176.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.499 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 2.9 mtpp -90.07 -77.64 0.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.484 177.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.43 ' H ' ' HG ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -98.44 -97.6 0.22 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.947 178.783 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.24 -82.39 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.372 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.63 166.94 25.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.018 0.437 . . . . 0.0 111.524 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.926 ' HB2' HG13 ' A' ' 95' ' ' ILE . 3.9 mt-10 -106.58 56.55 0.65 Allowed 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.2 p -97.38 122.18 48.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.086 0.469 . . . . 0.0 111.186 -176.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.631 HD22 ' HB3' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -133.61 -38.27 0.92 Allowed 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.341 -179.336 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.543 ' O ' ' HB2' ' A' ' 94' ' ' TYR . 1.0 OUTLIER -153.8 126.27 8.07 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.725 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.425 HD13 ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -118.58 137.48 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.093 178.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 92' ' ' LYS . 0.5 OUTLIER -158.54 173.69 16.23 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.908 0.385 . . . . 0.0 111.398 -179.798 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -133.78 168.1 19.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.613 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.587 HG21 ' HE1' ' A' ' 59' ' ' TRP . 48.0 t -129.55 -60.25 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.04 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -125.13 -150.83 7.87 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.492 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.14 -77.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.69 2.26 . . . . 0.0 112.297 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.45 ' HB2' ' OD2' ' A' ' 61' ' ' ASP . 0.8 OUTLIER -96.8 -2.45 44.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.004 -179.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.35 134.82 35.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.545 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.409 ' HZ2' ' HD3' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -151.07 169.19 22.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.019 0.438 . . . . 0.0 111.259 -179.767 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.499 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 0.9 OUTLIER -121.08 131.58 54.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.456 179.549 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.9 mt -125.48 144.24 36.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.979 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.563 ' HB3' ' HG ' ' A' ' 81' ' ' LEU . 2.8 m-85 -118.1 119.86 36.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.141 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.926 HG13 ' HB2' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -123.92 141.88 42.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.901 -178.205 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.631 ' HB3' HD22 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -151.04 130.06 12.58 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 120.107 -0.637 . . . . 0.0 112.391 -178.539 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.636 HG21 ' HB3' ' A' ' 50' ' ' MET . 10.8 t -72.68 116.12 14.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.652 178.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.92 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.862 HG13 ' HA ' ' A' ' 56' ' ' LEU . 87.9 t . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.427 0.156 . . . . 0.0 111.178 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.423 ' H ' HD23 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -99.77 -42.15 6.96 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.845 -179.389 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.817 ' H ' HD22 ' A' ' 56' ' ' LEU . 4.4 mmtt -131.68 159.4 38.48 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.375 0.607 . . . . 0.0 112.433 -178.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 99.3 m -135.26 124.23 24.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.629 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.556 HD22 HG13 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -101.69 121.98 43.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.084 -179.848 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -129.49 87.42 2.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.922 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.79 HG23 HG23 ' A' ' 60' ' ' ILE . 6.4 m -114.37 43.42 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.001 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 21.7 ttp85 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.665 -179.084 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.2 t . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.774 0.321 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.88 -40.55 89.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.622 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.3 tmm_? -67.1 -33.31 75.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.627 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.548 ' O ' ' HG3' ' A' ' 50' ' ' MET . . . -64.01 -54.18 38.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.848 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.497 HD21 ' CD ' ' A' ' 68' ' ' ARG . 53.2 mt -52.19 -35.32 48.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.339 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.99 -22.38 39.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.181 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -126.52 49.51 2.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.289 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.786 ' HB3' HG11 ' A' ' 97' ' ' VAL . 60.6 mtm -83.19 128.65 34.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.053 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.531 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 4.3 mtpp -85.83 154.73 58.59 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.419 179.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.47 -43.08 42.48 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.589 2.192 . . . . 0.0 112.826 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.41 57.44 0.49 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.426 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.531 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 7.2 mm-40 -90.08 128.37 36.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.3 0.55 . . . . 0.0 111.305 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.668 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 6.1 mt -135.93 66.89 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.814 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.862 ' HA ' HG13 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -118.71 -172.23 2.24 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -171.772 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -140.47 171.35 14.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.555 -178.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.556 HG13 HD22 ' A' ' 29' ' ' LEU . 33.6 t -139.58 146.2 25.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.57 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.419 ' C ' HG13 ' A' ' 60' ' ' ILE . 6.8 t90 -122.98 109.74 14.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.014 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.79 HG23 HG23 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -151.7 -178.39 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.308 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -101.59 -2.95 29.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.496 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.598 ' O ' HD13 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -137.82 139.44 26.52 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.612 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -62.13 89.85 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.498 2.132 . . . . 0.0 112.245 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -23.37 67.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.927 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.812 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.4 OUTLIER -55.86 -16.91 5.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.116 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.6 pttt -53.49 -37.32 62.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.274 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -94.21 -27.91 15.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.175 0.512 . . . . 0.0 110.093 178.517 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.812 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -64.77 -25.43 67.92 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.378 179.725 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.502 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 18.9 mt -73.42 -54.83 3.88 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 9.2 Cg_endo -53.99 -33.67 73.72 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.194 1.929 . . . . 0.0 112.366 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.531 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -69.45 -46.89 65.65 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.996 0.427 . . . . 0.0 110.767 179.169 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.613 ' O ' HD22 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -62.08 -47.82 82.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.041 -179.861 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 70' ' ' PRO . 7.1 p -58.89 -27.53 35.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.841 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.531 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 4.5 mmmt -58.71 -42.69 89.24 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 175.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.443 ' HB3' HD13 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -90.1 -81.49 0.29 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.986 176.421 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.782 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -98.56 -107.43 0.19 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.416 177.35 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.444 ' H ' HD23 ' A' ' 76' ' ' LEU . . . -129.22 -82.53 0.31 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.079 -0.581 . . . . 0.0 111.939 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.03 161.47 40.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.92 0.391 . . . . 0.0 110.856 178.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.829 ' HB2' HG23 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -103.84 52.73 0.76 Allowed 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.127 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.6 p -98.97 122.18 50.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.872 -178.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.475 ' HG ' ' N ' ' A' ' 82' ' ' GLU . 0.4 OUTLIER -133.48 -35.0 1.02 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.063 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -153.69 153.46 32.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.025 0.441 . . . . 0.0 112.052 179.351 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 82' ' ' GLU . 3.6 mp -144.03 135.53 22.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.437 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -156.07 -179.66 8.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.067 0.461 . . . . 0.0 111.314 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -133.57 158.51 42.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.783 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 62.0 t -117.65 -59.26 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.261 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -127.08 -152.73 8.07 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.729 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -56.67 -75.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.678 2.252 . . . . 0.0 112.612 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.18 -5.62 29.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.907 0.384 . . . . 0.0 111.235 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.468 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 4.3 pt-20 -93.61 137.1 33.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.769 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.02 168.56 20.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.923 0.392 . . . . 0.0 111.121 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.3 tttm -126.14 136.9 53.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.623 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.422 HG22 ' N ' ' A' ' 94' ' ' TYR . 2.2 mp -125.99 157.69 35.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.937 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.492 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 15.3 m-85 -118.21 135.02 54.51 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.014 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.829 HG23 ' HB2' ' A' ' 79' ' ' GLU . 10.9 mm -122.88 145.48 29.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.214 -176.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.663 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -143.68 106.04 4.41 Favored 'General case' 0 C--N 1.334 -0.085 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.738 -177.569 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.786 HG11 ' HB3' ' A' ' 50' ' ' MET . 23.7 t -75.79 131.11 35.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.642 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.509 ' HB2' ' HG ' ' A' ' 76' ' ' LEU . 3.5 mmmp? . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.152 -0.928 . . . . 0.0 110.908 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.1 t . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.856 0.36 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.08 -53.52 3.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.966 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.4 ' HB3' ' HG ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -126.25 160.54 30.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.016 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 57' ' ' GLU . 98.3 m -135.27 122.65 21.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.832 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.662 ' HB3' ' HB ' ' A' ' 58' ' ' VAL . 8.6 tt -99.15 103.35 15.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.948 0.404 . . . . 0.0 111.028 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.22 111.66 17.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.625 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.4 HG23 ' CG2' ' A' ' 60' ' ' ILE . 1.2 m -140.15 75.98 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.231 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.052 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.562 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 10.2 t . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.644 0.259 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.04 -50.46 69.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.695 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.39 -33.08 74.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.075 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.52 -42.29 91.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.037 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 43' ' ' THR . 2.8 mt -77.54 -45.69 24.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.677 -179.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -15.81 60.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.943 -177.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.71 63.06 1.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.938 0.399 . . . . 0.0 111.2 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.416 ' HB2' HG21 ' A' ' 97' ' ' VAL . 6.6 ptt? -109.25 136.48 48.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.868 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.489 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -92.27 147.44 34.58 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.671 179.491 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -42.47 -56.82 1.89 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.025 2.483 . . . . 0.0 113.476 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.24 56.0 0.58 Allowed Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.056 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.489 ' HG2' ' HB3' ' A' ' 51' ' ' LYS . 4.2 mm-40 -90.72 150.66 21.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.082 0.468 . . . . 0.0 111.78 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.8 mp -133.65 111.59 15.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.499 177.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.4 ' HG ' ' HB3' ' A' ' 27' ' ' LYS . 4.3 mp -119.3 168.38 10.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.456 0.646 . . . . 0.0 112.39 -176.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.511 ' O ' HG23 ' A' ' 28' ' ' THR . 4.3 tt0 -141.51 117.4 10.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.445 178.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.662 ' HB ' ' HB3' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -114.06 136.26 51.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.148 0.499 . . . . 0.0 112.076 -176.172 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.524 ' HE3' ' HG3' ' A' ' 92' ' ' LYS . 2.7 t-105 -122.89 119.43 30.47 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.038 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.524 HD13 ' C ' ' A' ' 62' ' ' TYR . 1.0 OUTLIER -158.88 -169.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.096 0.474 . . . . 0.0 111.528 -178.61 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.419 ' HA ' ' O ' ' A' ' 89' ' ' SER . 85.7 m-20 -104.09 -9.18 18.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.973 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.524 ' C ' HD13 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -144.49 110.99 4.96 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.301 179.494 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.417 ' HD3' ' HE3' ' A' ' 91' ' ' TRP . 84.6 Cg_exo -45.98 106.26 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.747 2.298 . . . . 0.0 112.752 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.52 -8.13 38.54 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.724 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.777 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 15.8 p -61.2 -12.82 14.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.661 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.02 -38.75 68.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.978 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.509 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -93.58 -27.49 16.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.18 0.514 . . . . 0.0 110.126 178.618 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.777 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 4.4 mtm-85 -64.09 -32.43 73.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.045 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.774 ' O ' HG13 ' A' ' 73' ' ' VAL . 17.2 mt -62.54 -57.76 20.67 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.154 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.737 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 84.9 Cg_exo -48.13 -40.28 34.23 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.196 1.931 . . . . 0.0 112.442 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.0 -46.26 78.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.994 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.62 ' O ' ' HG2' ' A' ' 75' ' ' LYS . 1.9 m -65.66 -37.96 87.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.749 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.774 HG13 ' O ' ' A' ' 69' ' ' ILE . 1.5 m -63.89 -29.35 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.465 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.52 -45.53 88.62 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 176.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.62 ' HG2' ' O ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -86.75 -80.97 0.23 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.658 177.218 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.619 HD13 ' HB3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -100.29 -95.16 0.26 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.962 0.41 . . . . 0.0 110.902 178.584 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.53 ' O ' ' HB ' ' A' ' 72' ' ' THR . . . -145.13 -82.22 0.05 OUTLIER Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.03 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.43 152.02 39.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.898 0.38 . . . . 0.0 111.002 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.931 ' HB2' HG23 ' A' ' 95' ' ' ILE . 2.2 mt-10 -95.54 54.2 1.55 Allowed 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.943 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.519 HG23 HD11 ' A' ' 83' ' ' ILE . 1.2 p -98.92 116.14 41.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.903 -178.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.619 ' H ' HD23 ' A' ' 81' ' ' LEU . 2.0 pt? -133.22 -31.23 1.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.119 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.528 ' O ' HD13 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -150.99 130.66 13.1 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.194 -0.603 . . . . 0.0 112.244 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.528 HD13 ' O ' ' A' ' 82' ' ' GLU . 1.8 mm -131.05 131.1 64.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.4 178.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -154.85 173.4 16.53 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.895 0.378 . . . . 0.0 111.263 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.92 172.18 13.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.775 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.43 HG13 ' N ' ' A' ' 87' ' ' GLY . 2.7 p -140.86 -50.42 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.189 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.43 ' N ' HG13 ' A' ' 86' ' ' VAL . . . -123.55 -158.54 10.19 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.566 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.25 -66.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.602 2.201 . . . . 0.0 112.588 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 61' ' ' ASP . 80.2 p -100.26 -8.53 23.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.55 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.45 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -93.24 116.99 29.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.756 179.737 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.417 ' HE3' ' HD3' ' A' ' 63' ' ' PRO . 4.8 m0 -131.63 163.82 27.24 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.972 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.524 ' HG3' ' HE3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -125.81 123.06 37.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.301 179.103 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.8 mp -125.54 150.95 31.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.976 0.417 . . . . 0.0 111.305 -178.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.505 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 6.9 m-85 -118.2 134.22 55.21 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.987 178.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.931 HG23 ' HB2' ' A' ' 79' ' ' GLU . 13.6 mm -123.32 139.14 50.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.266 -178.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.576 ' H ' ' HB3' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -143.41 122.92 13.19 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 120.182 -0.607 . . . . 0.0 112.518 -176.178 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.422 ' HB ' ' H ' ' A' ' 54' ' ' GLU . 6.5 t -78.57 118.32 25.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.439 177.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.619 ' HB3' HD13 ' A' ' 76' ' ' LEU . 2.8 tttt . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.999 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.543 ' HA ' HG22 ' A' ' 55' ' ' ILE . 52.8 t . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.852 0.358 . . . . 0.0 111.074 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.404 ' OG1' ' HB ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -99.27 -48.96 4.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.197 -179.284 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.478 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -120.6 129.83 53.91 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.83 0.348 . . . . 0.0 110.991 -179.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 99.8 m -118.58 121.16 39.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.847 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.677 HD13 HH22 ' A' ' 68' ' ' ARG . 6.9 tt -99.66 115.82 30.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.081 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -116.81 115.85 26.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.44 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.564 HG13 HG23 ' A' ' 60' ' ' ILE . 7.7 p -140.27 76.57 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.443 0.639 . . . . 0.0 111.163 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.015 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.4 t . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.716 0.293 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.29 -44.23 97.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.538 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.11 -38.56 78.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.865 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.24 -43.15 99.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.747 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.653 HD11 ' HG2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -67.23 -33.56 75.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.96 179.741 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -81.13 -6.36 58.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.097 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -130.64 51.24 2.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.32 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.453 ' HB3' HG21 ' A' ' 97' ' ' VAL . 10.5 mtp -99.74 109.61 22.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.901 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.507 ' HB3' ' HG3' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -74.69 138.06 73.8 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.455 179.305 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_exo -42.57 -41.77 8.12 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.751 2.301 . . . . 0.0 112.907 -179.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.27 50.31 0.87 Allowed Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.932 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.546 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 9.3 mt-10 -90.89 151.02 21.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.465 0.65 . . . . 0.0 112.177 -178.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.984 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 3.1 mp -134.24 106.15 7.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.049 178.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.478 HD22 ' HB3' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -128.48 156.44 43.23 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -175.185 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -135.59 136.86 41.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.145 176.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.606 HG13 ' HB3' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -114.77 140.18 37.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.067 0.461 . . . . 0.0 112.059 -177.007 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -122.67 98.12 5.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.351 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.564 HG23 HG13 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -147.0 -173.06 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.461 -179.069 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.404 ' H ' HG22 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -109.26 -16.39 14.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.951 178.023 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -123.18 126.73 25.86 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.55 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -56.52 93.68 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.588 2.192 . . . . 0.0 112.658 -179.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.54 -16.19 63.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.905 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.633 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 9.7 p -63.66 -10.47 19.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.856 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -61.28 -33.28 73.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.605 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.587 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -93.72 -28.59 15.86 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.355 0.598 . . . . 0.0 110.075 178.175 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.677 HH22 HD13 ' A' ' 29' ' ' LEU . 37.6 mtt-85 -61.51 -39.57 91.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.604 178.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.674 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 22.3 mt -55.83 -57.1 23.54 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.279 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.674 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 83.2 Cg_exo -45.63 -39.3 17.72 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.249 1.966 . . . . 0.0 112.385 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.437 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 2.3 mp0 -71.36 -61.08 1.9 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.49 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.527 ' HB ' ' O ' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -56.78 -31.3 64.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.54 -178.745 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.605 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 8.6 p -74.26 -26.53 20.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.67 0.271 . . . . 0.0 110.873 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.33 -46.56 85.96 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 177.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.29 -73.9 0.49 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.211 177.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.423 HD11 HG22 ' A' ' 72' ' ' THR . 0.1 OUTLIER -98.12 -106.92 0.19 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.322 177.842 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.605 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.67 -89.07 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.458 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 0.6 OUTLIER -147.81 145.76 28.88 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 178.223 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.704 ' O ' ' HA ' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -96.77 61.61 1.87 Allowed 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.129 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.651 HG12 HD11 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -98.36 118.61 45.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.516 -177.221 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 1.012 HD21 ' HD3' ' A' ' 96' ' ' LYS . 0.5 OUTLIER -133.86 -28.11 1.42 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.038 179.722 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.31 139.77 18.69 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.348 -0.541 . . . . 0.0 112.371 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.651 HD11 HG12 ' A' ' 80' ' ' VAL . 3.9 mp -144.18 128.05 12.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.159 178.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -156.17 -176.36 5.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.188 0.518 . . . . 0.0 111.403 -178.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 91' ' ' TRP . 8.4 pt-20 -133.17 161.18 35.12 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.691 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -113.69 -55.41 4.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.232 -179.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -122.95 -139.98 5.61 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.738 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.42 -83.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.609 2.206 . . . . 0.0 112.418 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.9 p -98.8 -0.36 42.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.906 0.384 . . . . 0.0 111.009 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -93.29 122.2 35.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.641 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -135.38 165.54 25.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.042 0.449 . . . . 0.0 111.297 -179.737 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -121.25 141.52 50.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.38 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.3 mp -125.64 152.28 32.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.125 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.51 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 19.3 m-85 -118.82 111.54 18.55 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.719 179.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.704 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -124.45 120.99 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.078 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 1.012 ' HD3' HD21 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -133.36 106.74 7.68 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.963 -172.577 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.546 ' HB ' ' HB2' ' A' ' 54' ' ' GLU . 22.0 t -56.58 113.09 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.767 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.5 mmtm . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.972 -179.535 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.737 HG21 ' HB2' ' A' ' 57' ' ' GLU . 1.5 p . . . . . 0 CA--C 1.529 0.145 0 CA-C-O 120.938 0.399 . . . . 0.0 111.505 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.6 m -99.77 -58.82 1.84 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.477 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 4.2 mptt -100.71 158.11 16.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.362 178.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.781 HG23 ' HB3' ' A' ' 57' ' ' GLU . 28.6 m -135.88 118.26 15.72 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.829 0.347 . . . . 0.0 111.6 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.9 tt -102.25 113.09 26.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.126 177.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.463 ' HB3' ' HB3' ' A' ' 59' ' ' TRP . 2.7 p-10 -132.29 116.2 16.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.188 -178.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.499 ' H ' HG23 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -131.6 64.23 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.131 179.661 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.061 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.688 0.28 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.86 -37.25 78.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.983 0.421 . . . . 0.0 110.288 179.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.12 -30.99 71.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.719 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.61 -49.89 75.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.087 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.617 ' HB3' ' HG2' ' A' ' 71' ' ' GLU . 3.2 mm? -59.59 -35.42 74.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.007 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -81.26 -23.26 38.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.293 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -121.95 52.18 1.29 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.959 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.77 146.84 25.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.018 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.757 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -98.82 153.64 37.77 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.545 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.757 ' HD2' ' HG3' ' A' ' 51' ' ' LYS . 53.6 Cg_exo -38.77 -84.2 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.145 2.563 . . . . 0.0 113.794 -178.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 97' ' ' VAL . . . -104.28 59.33 0.47 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.97 -0.634 . . . . 0.0 113.046 -178.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -90.89 158.41 16.79 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.076 0.465 . . . . 0.0 111.753 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.523 HG23 ' HB2' ' A' ' 96' ' ' LYS . 0.1 OUTLIER -130.57 121.75 51.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.108 179.263 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.7 mp -129.29 163.86 24.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.221 0.534 . . . . 0.0 111.59 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.781 ' HB3' HG23 ' A' ' 28' ' ' THR . 48.4 tt0 -121.04 158.1 28.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.809 178.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.8 t -136.56 115.75 15.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.894 0.378 . . . . 0.0 111.089 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.521 ' HE1' HG21 ' A' ' 86' ' ' VAL . 6.5 t90 -122.08 104.94 9.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.492 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.499 HG23 ' H ' ' A' ' 31' ' ' VAL . 1.0 OUTLIER -158.29 -174.31 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.656 -178.477 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -99.01 -23.68 15.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.933 178.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.48 ' O ' HD13 ' A' ' 60' ' ' ILE . 42.9 m-85 -115.27 112.24 44.08 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.372 178.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -47.22 99.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.816 2.344 . . . . 0.0 113.119 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.26 -26.66 65.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.544 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.735 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -63.27 -13.7 41.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.762 179.714 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.549 ' HG3' ' N ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -58.65 -32.06 68.74 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.436 179.243 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.549 ' N ' ' HG3' ' A' ' 66' ' ' LYS . 0.3 OUTLIER -94.52 -26.44 16.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.898 178.019 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.735 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 9.1 mtt85 -60.81 -39.39 88.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.066 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.697 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 6.9 mt -62.14 -55.87 36.62 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.543 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.697 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 84.0 Cg_exo -46.34 -39.56 21.69 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.304 2.003 . . . . 0.0 112.511 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.617 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 0.9 OUTLIER -68.64 -51.93 36.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.957 179.42 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.633 HG21 ' HG3' ' A' ' 79' ' ' GLU . 1.7 m -60.46 -40.12 90.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.982 -178.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 70' ' ' PRO . 12.9 m -64.92 -30.24 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.856 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.25 -43.09 87.68 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -90.26 -78.17 0.38 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.784 177.707 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.42 ' H ' ' CG ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -99.38 -97.46 0.23 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.98 0.419 . . . . 0.0 110.596 178.399 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.536 ' O ' ' HB ' ' A' ' 72' ' ' THR . . . -145.01 -86.56 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.735 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.555 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -146.71 153.97 40.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.823 0.345 . . . . 0.0 110.824 178.799 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.931 ' HB2' HG23 ' A' ' 95' ' ' ILE . 0.6 OUTLIER -101.35 63.72 0.99 Allowed 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.087 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.555 HG22 ' HB2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -99.22 127.36 52.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.336 -177.54 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.526 ' HG ' ' HB3' ' A' ' 94' ' ' TYR . 1.0 OUTLIER -132.98 -36.41 1.03 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.719 179.528 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.473 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 0.7 OUTLIER -154.15 151.96 29.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.076 0.465 . . . . 0.0 111.951 179.245 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 82' ' ' GLU . 2.6 mp -144.18 134.99 21.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.268 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -158.66 -179.22 7.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.092 0.473 . . . . 0.0 111.267 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -133.57 167.47 20.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.664 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.521 HG21 ' HE1' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -129.74 -59.01 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.215 -179.654 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -124.87 -151.86 8.16 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.682 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -63.01 -75.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.741 2.294 . . . . 0.0 112.593 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.56 -4.08 34.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.245 -179.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.409 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 3.3 pt-20 -93.2 123.83 36.75 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.433 178.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 2.9 m-90 -129.8 167.82 17.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.021 0.438 . . . . 0.0 111.394 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -123.5 132.99 54.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.598 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.4 mt -125.48 146.85 30.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.69 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.526 ' HB3' ' HG ' ' A' ' 81' ' ' LEU . 36.4 m-85 -118.09 124.23 47.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.098 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.931 HG23 ' HB2' ' A' ' 79' ' ' GLU . 28.5 mm -123.91 148.53 28.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.291 -176.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.678 ' C ' ' HB3' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -150.78 106.13 3.36 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.107 -177.463 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.447 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 1.7 t -59.86 119.28 3.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.638 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.188 -0.91 . . . . 0.0 110.887 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.5 t . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.846 0.355 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.74 -70.3 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.037 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -118.6 162.73 17.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.86 0.362 . . . . 0.0 111.223 -179.763 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 92.3 m -135.64 129.0 32.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.856 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.5 tt -111.35 118.1 34.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.001 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.81 110.95 16.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.919 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.493 ' O ' HG13 ' A' ' 31' ' ' VAL . 7.1 p -137.61 70.77 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.397 0.618 . . . . 0.0 110.977 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 32' ' ' ARG . 3.8 ttp180 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.855 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.875 0.369 . . . . 0.0 110.683 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.9 tptt -54.98 -45.47 75.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.509 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -33.58 76.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.013 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.94 -30.84 64.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.993 0.425 . . . . 0.0 110.791 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.641 HD22 ' HG2' ' A' ' 68' ' ' ARG . 1.3 mt -77.4 -57.2 3.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.301 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.16 -10.09 59.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.717 -178.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -131.23 67.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.855 0.359 . . . . 0.0 111.048 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.48 ' HB2' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -109.01 144.87 36.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.857 179.699 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.693 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 11.6 mttt -81.18 159.15 68.58 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.033 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 100.0 Cg_exo -45.91 -75.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.939 2.426 . . . . 0.0 113.873 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 97' ' ' VAL . . . -103.83 60.77 0.45 Allowed Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.144 -177.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.693 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 3.2 mm-40 -90.98 152.4 20.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.056 0.455 . . . . 0.0 111.72 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.5 mp -135.31 112.57 14.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.018 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.1 mp -126.27 151.69 47.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.228 0.537 . . . . 0.0 112.355 -177.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -113.31 124.64 52.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.376 176.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.0 t -114.32 134.31 57.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.136 0.493 . . . . 0.0 112.075 -177.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.52 ' NE1' HG21 ' A' ' 86' ' ' VAL . 13.7 t90 -123.0 106.76 11.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.325 178.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.617 HD13 ' H ' ' A' ' 64' ' ' MET . 0.1 OUTLIER -144.03 -162.95 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.823 0.344 . . . . 0.0 111.267 -178.659 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -145.27 24.16 1.45 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.313 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.737 ' H ' ' HA ' ' A' ' 63' ' ' PRO . 29.3 m-85 -101.26 -56.14 0.13 Allowed Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 116.673 -0.239 . . . . 0.0 111.483 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.737 ' HA ' ' H ' ' A' ' 62' ' ' TYR . 76.7 Cg_endo -94.32 177.79 11.03 Favored 'Cis proline' 0 C--N 1.355 0.873 0 C-N-CA 124.796 -0.918 . . . . 0.0 112.294 -0.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.617 ' H ' HD13 ' A' ' 60' ' ' ILE . 14.2 tmm? -65.18 -21.45 66.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.755 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.641 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 30.4 t -63.6 -15.62 58.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.149 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.39 -34.13 74.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.978 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.556 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -92.23 -23.43 19.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.225 0.536 . . . . 0.0 109.979 178.432 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.641 ' HG2' HD22 ' A' ' 47' ' ' LEU . 20.7 mtt-85 -63.41 -47.8 80.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.81 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.723 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 8.1 mt -51.04 -54.92 32.47 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.664 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.723 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 82.8 Cg_exo -48.64 -50.48 12.35 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.267 1.978 . . . . 0.0 112.959 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.44 -53.62 33.39 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.153 0.501 . . . . 0.0 111.637 -179.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.55 ' HB ' ' O ' ' A' ' 77' ' ' GLY . 0.9 OUTLIER -56.41 -49.56 74.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.601 -178.245 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.631 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 18.2 m -64.75 -21.16 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 120.607 0.241 . . . . 0.0 111.198 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.35 -55.27 37.22 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.858 ' HG2' ' H ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -91.1 -61.28 1.7 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.942 177.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.858 ' H ' ' HG2' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -100.45 -109.09 0.21 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.042 0.448 . . . . 0.0 110.526 176.565 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.631 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -144.97 -87.63 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 178.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.468 ' HA ' HG21 ' A' ' 72' ' ' THR . 0.2 OUTLIER -148.14 150.6 34.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.642 0.258 . . . . 0.0 110.762 177.499 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.73 ' HB2' ' H ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -97.81 74.2 2.34 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.14 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.56 123.86 51.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.997 0.427 . . . . 0.0 111.831 -176.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.491 ' HG ' ' N ' ' A' ' 82' ' ' GLU . 0.6 OUTLIER -133.45 -35.59 1.01 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.669 179.076 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.642 ' HB3' ' HB2' ' A' ' 94' ' ' TYR . 0.3 OUTLIER -153.69 149.01 27.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.618 179.377 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 82' ' ' GLU . 2.2 mp -142.62 133.41 23.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.625 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.607 ' HG3' ' HB3' ' A' ' 92' ' ' LYS . 8.4 pt-20 -158.07 -177.46 6.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.078 0.466 . . . . 0.0 111.219 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -133.39 167.21 20.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.817 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.52 HG21 ' NE1' ' A' ' 59' ' ' TRP . 40.7 t -124.63 -66.95 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.205 -179.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -124.34 -154.41 8.87 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.567 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.16 -71.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.632 2.221 . . . . 0.0 112.325 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.2 0.19 39.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.093 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.428 ' HG2' ' H ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -93.3 132.52 37.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.774 179.639 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 -138.92 159.62 41.7 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.929 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.607 ' HB3' ' HG3' ' A' ' 84' ' ' GLU . 24.5 ttmt -124.37 126.4 45.92 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.344 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.6 mp -125.33 149.87 30.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.967 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.642 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 8.6 m-85 -118.15 129.98 55.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.369 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.617 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -123.69 148.88 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.166 -178.068 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.73 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -150.83 104.73 3.2 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.582 -178.298 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.507 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 3.1 t -62.96 119.05 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.26 178.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.1 mttt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.058 -179.509 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.95 -15.47 1.52 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.782 0.325 . . . . 0.0 110.896 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.4 t -88.53 121.1 30.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.902 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -133.62 -40.53 0.87 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.937 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -134.61 -162.32 1.24 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.039 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -62.66 165.76 6.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.024 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 8.7 m80 -80.65 101.97 9.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.874 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.71 30.97 3.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.834 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.7 m80 -89.92 -81.93 0.28 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.783 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.53 68.18 10.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.0 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.61 -79.09 0.16 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.058 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.9 158.95 45.2 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.58 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.84 91.07 2.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.838 0.351 . . . . 0.0 110.888 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.3 m -86.65 123.83 70.28 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.165 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -83.69 21.36 1.06 Allowed 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.681 2.254 . . . . 0.0 112.442 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.411 ' HD2' HH11 ' A' ' 16' ' ' ARG . 1.2 mtp180 -83.31 28.16 0.55 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.286 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.92 97.5 0.16 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.311 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.481 ' HB3' ' H ' ' A' ' 19' ' ' HIS . 0.6 OUTLIER -73.83 -150.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.58 0.229 . . . . 0.0 110.964 -179.585 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.481 ' H ' ' HB3' ' A' ' 18' ' ' SER . 1.5 m-70 -55.03 -62.1 1.88 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.147 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.73 123.95 26.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.956 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.09 140.64 40.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.074 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -84.31 72.34 10.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.976 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -74.7 166.34 23.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.843 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.28 64.86 8.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.893 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.5 t -82.65 146.57 6.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.438 HG21 ' OE1' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -99.6 -65.21 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.078 -179.568 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.11 169.77 9.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.097 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.755 HG23 ' HB3' ' A' ' 57' ' ' GLU . 83.3 m -135.51 130.85 35.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.808 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.1 tp -106.37 113.08 26.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.845 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.68 123.33 42.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.888 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.4 47.62 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.079 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.464 ' HB2' ' H ' ' A' ' 33' ' ' GLY . 14.4 mtm180 -69.97 -100.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.752 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.464 ' H ' ' HB2' ' A' ' 32' ' ' ARG . . . -79.45 82.13 1.41 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.096 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -83.98 163.92 19.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.962 0.41 . . . . 0.0 111.385 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.14 -90.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.652 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.559 ' O ' ' HD2' ' A' ' 39' ' ' PRO . 0.5 OUTLIER -65.71 163.32 36.11 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.339 178.567 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.73 15.83 0.84 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.467 2.111 . . . . 0.0 112.68 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.651 ' HB ' ' HD3' ' A' ' 39' ' ' PRO . 11.7 t -65.74 -52.98 39.05 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.549 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.651 ' HD3' ' HB ' ' A' ' 38' ' ' VAL . 52.1 Cg_exo -54.42 -29.96 61.4 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.215 1.943 . . . . 0.0 112.2 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.425 ' O ' HG22 ' A' ' 43' ' ' THR . 0.1 OUTLIER -63.45 -49.96 71.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.477 179.48 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.5 t -67.25 -20.98 27.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.88 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -66.31 -59.13 4.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.944 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.549 ' O ' HD22 ' A' ' 47' ' ' LEU . 7.2 t -56.03 -33.25 64.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.694 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 48' ' ' GLN . 5.3 mmtt -56.79 -41.89 78.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.514 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.62 -30.74 71.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.946 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 43' ' ' THR . . . -56.53 -54.34 47.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.967 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.793 ' HB3' ' HG2' ' A' ' 71' ' ' GLU . 0.4 OUTLIER -77.24 -37.31 53.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.768 -179.492 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.474 ' HB3' ' O ' ' A' ' 44' ' ' LYS . 1.4 tt0 -68.14 -31.18 70.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.396 -178.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -134.96 72.18 1.45 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.064 0.459 . . . . 0.0 110.932 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.18 140.73 31.53 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.846 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.538 ' HG2' ' HD2' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -94.17 151.48 39.61 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.778 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.538 ' HD2' ' HG2' ' A' ' 51' ' ' LYS . 50.0 Cg_exo -38.23 -86.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.366 2.71 . . . . 0.0 114.027 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.439 ' H ' ' HB2' ' A' ' 52' ' ' PRO . . . -103.89 59.05 0.5 Allowed Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.989 -0.624 . . . . 0.0 113.124 -177.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.438 ' OE1' HG21 ' A' ' 26' ' ' THR . 2.8 mm-40 -90.7 156.42 18.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.104 0.478 . . . . 0.0 111.705 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.442 HG23 ' HB2' ' A' ' 96' ' ' LYS . 3.4 mp -135.05 117.75 22.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.992 178.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.6 mp -122.77 164.05 19.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.209 0.528 . . . . 0.0 111.753 -178.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.755 ' HB3' HG23 ' A' ' 28' ' ' THR . 37.2 tt0 -114.38 161.27 18.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.131 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.1 t -142.7 113.92 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.808 0.337 . . . . 0.0 111.221 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.6 103.25 8.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.786 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -158.11 -166.19 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.029 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -103.04 -2.5 27.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.015 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -137.58 148.12 60.13 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.927 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.69 104.4 1.88 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.601 2.201 . . . . 0.0 112.624 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 8.4 tpp -68.1 -19.95 64.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.108 0.48 . . . . 0.0 110.617 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.819 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 3.6 p -58.85 -10.84 2.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.215 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.44 ' HG3' ' H ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -56.75 -44.69 81.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.789 0.328 . . . . 0.0 110.727 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.534 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 0.7 OUTLIER -86.64 -24.88 25.15 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.085 0.469 . . . . 0.0 110.055 178.398 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.819 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 1.0 OUTLIER -61.69 -41.34 97.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.233 179.565 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.745 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 12.9 mt -54.59 -56.67 24.54 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.745 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 76.1 Cg_exo -51.87 -36.96 65.38 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.288 1.992 . . . . 0.0 112.682 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.793 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 0.6 OUTLIER -71.92 -64.46 0.93 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.782 0.325 . . . . 0.0 111.66 -179.2 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.47 HG21 ' HG2' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -55.9 -30.6 61.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.555 -178.515 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 70' ' ' PRO . 6.6 p -73.47 -28.89 26.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.905 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.4 tptp -58.57 -42.11 87.23 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.45 -77.51 0.4 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.226 177.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.597 HD13 ' HB2' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -98.79 -98.52 0.22 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.786 178.358 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.34 -79.71 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.249 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.68 157.32 43.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.803 0.335 . . . . 0.0 111.014 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.7 ' HB2' ' H ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -101.18 55.89 0.84 Allowed 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.135 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.6 p -98.31 123.49 50.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.269 -176.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.489 ' HG ' ' N ' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -133.31 -36.12 1.0 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.186 -179.687 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.525 ' HB3' ' HB2' ' A' ' 94' ' ' TYR . 0.5 OUTLIER -153.51 145.49 23.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.999 0.428 . . . . 0.0 111.826 -179.711 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.502 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 3.0 mp -142.44 136.11 27.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.414 178.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -157.47 179.04 9.63 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.038 0.447 . . . . 0.0 111.421 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -133.67 166.14 23.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.854 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.3 t -127.28 -64.4 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.133 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -124.83 -147.14 7.02 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.825 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -60.81 -77.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.757 2.305 . . . . 0.0 112.616 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.2 -1.74 35.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.419 -178.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.458 ' HG2' ' H ' ' A' ' 90' ' ' GLU . 0.7 OUTLIER -93.26 120.26 33.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.746 179.442 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 7.0 m0 -130.46 166.08 21.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.904 0.383 . . . . 0.0 111.187 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -127.04 129.91 48.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.612 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.7 mp -125.79 149.52 30.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.296 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.525 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 9.3 m-85 -118.68 127.97 54.07 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.202 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.646 HG13 ' HB2' ' A' ' 79' ' ' GLU . 1.1 tp -124.49 149.81 28.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.519 -177.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.7 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -151.11 109.47 3.78 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 120.523 -0.471 . . . . 0.0 112.132 -178.455 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.404 ' H ' HG23 ' A' ' 97' ' ' VAL . 2.1 t -64.41 111.16 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.266 178.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.597 ' HB2' HD13 ' A' ' 76' ' ' LEU . 16.5 mmtt . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.097 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.136 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.0 t -128.57 -63.13 1.0 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.859 0.361 . . . . 0.0 110.887 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.53 -73.41 0.68 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.873 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -87.29 165.07 15.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.795 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -97.4 140.51 31.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.968 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -90.48 131.05 36.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.037 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.59 -173.46 2.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.855 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.21 -5.0 39.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.899 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -87.7 88.35 7.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.44 138.91 57.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.885 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 t -76.36 -79.54 0.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.979 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.9 136.36 20.54 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.468 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 22.7 tp -81.25 79.98 7.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.902 0.382 . . . . 0.0 110.979 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.492 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 13.2 t -83.52 -51.29 0.64 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.425 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 59.8 Cg_endo -72.25 102.12 1.33 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.124 1.883 . . . . 0.0 112.172 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.34 27.91 0.56 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.133 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.29 148.28 43.81 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.486 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.09 -151.59 0.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.592 0.234 . . . . 0.0 110.784 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -84.13 29.24 0.57 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.979 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.13 50.01 1.34 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.851 0.357 . . . . 0.0 110.94 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.88 157.4 25.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.926 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -89.05 70.94 8.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.814 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -93.46 47.32 1.24 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.898 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -83.29 126.83 33.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.942 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 87.5 t -61.33 126.44 19.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.105 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.17 -48.2 4.7 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.945 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -121.33 148.57 44.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.098 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.3 m -132.98 140.86 47.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.825 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.641 ' HB3' HG13 ' A' ' 58' ' ' VAL . 12.6 tp -112.03 110.98 21.58 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.905 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.52 ' HB3' ' HE1' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -104.86 113.34 26.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.741 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.09 61.6 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.274 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.495 ' H ' ' HG3' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -64.86 -88.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.332 179.19 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.401 ' H ' ' HB2' ' A' ' 32' ' ' ARG . . . -77.99 103.36 1.89 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.12 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -80.78 142.89 33.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.913 0.387 . . . . 0.0 111.346 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.95 -91.47 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.012 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.568 ' HB2' HG23 ' A' ' 38' ' ' VAL . 63.0 m -77.42 160.48 75.14 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.653 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 36' ' ' CYS . 60.9 Cg_endo -72.83 21.61 0.31 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.55 2.167 . . . . 0.0 112.736 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.633 ' HB ' ' HD3' ' A' ' 39' ' ' PRO . 19.3 t -60.54 -51.38 80.26 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.417 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.633 ' HD3' ' HB ' ' A' ' 38' ' ' VAL . 33.6 Cg_exo -59.88 -23.27 71.87 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.138 1.892 . . . . 0.0 112.234 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 37' ' ' PRO . 0.3 OUTLIER -65.22 -57.17 9.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.707 179.808 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.8 t -73.96 -24.01 19.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.926 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -66.53 -54.1 27.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.928 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.3 t -59.99 -37.42 79.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.81 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.05 -41.56 68.25 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.839 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 45' ' ' ARG . 3.5 tmm_? -67.95 -32.56 73.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.801 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.54 -49.38 77.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.207 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.831 ' HB3' ' HG2' ' A' ' 71' ' ' GLU . 2.5 mm? -58.67 -42.72 89.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.063 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -75.54 -15.5 60.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.036 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 45' ' ' ARG . 0.6 OUTLIER -118.19 61.68 0.77 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.92 -179.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 10.1 mmt -108.32 146.76 32.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.859 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.654 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 2.2 mtpp -102.81 164.21 16.04 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.767 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.625 ' HD2' ' HB3' ' A' ' 51' ' ' LYS . 2.2 Cg_endo -46.2 -73.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.119 2.546 . . . . 0.0 113.398 -178.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.27 58.78 0.49 Allowed Glycine 0 C--N 1.329 0.192 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.278 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.654 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 3.8 mm-40 -90.34 151.35 21.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.09 0.472 . . . . 0.0 111.525 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.564 ' C ' HD13 ' A' ' 56' ' ' LEU . 3.7 mp -134.75 113.51 16.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.815 178.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.564 HD13 ' C ' ' A' ' 55' ' ' ILE . 0.4 OUTLIER -118.71 145.35 45.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.164 0.506 . . . . 0.0 111.846 -176.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -111.07 135.49 51.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.987 177.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.641 HG13 ' HB3' ' A' ' 29' ' ' LEU . 2.0 t -134.82 126.5 47.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.52 ' HE1' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -122.97 115.33 21.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.879 176.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.476 HG13 ' C ' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -147.42 -170.52 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.303 -178.027 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.02 -11.71 16.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.419 178.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.425 ' O ' HD13 ' A' ' 60' ' ' ILE . 64.9 m-85 -129.76 143.92 50.95 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.55 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.88 93.73 0.39 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.532 2.155 . . . . 0.0 112.481 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.06 -16.33 63.98 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.042 0.448 . . . . 0.0 110.585 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.406 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -62.04 -15.58 45.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.793 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.503 ' HG3' ' N ' ' A' ' 67' ' ' GLU . 1.2 ptpp? -57.58 -32.88 67.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.772 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.503 ' N ' ' HG3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -94.54 -27.95 15.68 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.169 0.509 . . . . 0.0 110.401 178.737 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.675 ' HG2' HD11 ' A' ' 47' ' ' LEU . 54.3 mtt-85 -65.78 -32.68 74.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.175 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.499 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 26.6 mt -63.62 -55.33 35.31 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.553 ' O ' HG12 ' A' ' 73' ' ' VAL . 12.2 Cg_endo -56.97 -32.23 92.22 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.182 1.921 . . . . 0.0 112.566 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.831 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 0.4 OUTLIER -74.13 -60.83 2.09 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.873 0.368 . . . . 0.0 111.296 -179.818 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.669 HG21 ' HG2' ' A' ' 79' ' ' GLU . 0.2 OUTLIER -61.26 -25.0 66.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.314 -179.028 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' ' 70' ' ' PRO . 4.5 p -75.23 -28.95 21.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.274 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.46 -43.51 88.89 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.463 ' CG ' ' H ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -86.85 -78.18 0.3 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.164 176.7 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.518 HD12 ' H ' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -98.73 -98.59 0.22 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.848 0.356 . . . . 0.0 110.659 177.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.518 ' H ' HD12 ' A' ' 76' ' ' LEU . . . -145.28 -80.98 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.865 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -146.2 149.64 34.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.889 0.376 . . . . 0.0 110.922 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.669 ' HG2' HG21 ' A' ' 72' ' ' THR . 0.0 OUTLIER -97.87 58.93 1.42 Allowed 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.018 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.568 HG23 HD11 ' A' ' 83' ' ' ILE . 1.4 p -98.9 125.84 52.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.022 -177.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.531 ' HG ' ' N ' ' A' ' 82' ' ' GLU . 0.6 OUTLIER -133.53 -35.79 0.99 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.043 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.531 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -153.52 144.61 22.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.985 0.421 . . . . 0.0 111.906 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.568 HD11 HG23 ' A' ' 80' ' ' VAL . 3.5 mp -143.96 128.55 14.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.346 178.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -149.87 -178.25 6.36 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.239 0.542 . . . . 0.0 111.552 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.519 ' HB3' ' HD1' ' A' ' 91' ' ' TRP . 0.9 OUTLIER -133.2 163.67 28.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.616 -179.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 56.9 t -124.65 -73.76 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.427 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -122.73 -139.37 5.51 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.795 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.408 ' HB2' ' H ' ' A' ' 89' ' ' SER . 37.1 Cg_exo -60.82 -82.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.557 2.171 . . . . 0.0 112.5 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.408 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 59.9 p -100.15 1.51 42.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.249 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.51 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 1.2 pt-20 -93.15 119.51 32.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.747 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.519 ' HD1' ' HB3' ' A' ' 85' ' ' GLU . 4.4 m-90 -132.24 164.99 25.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.92 0.391 . . . . 0.0 111.112 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.96 140.71 51.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.795 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.1 mp -136.76 143.78 34.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.974 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.463 ' HB3' ' HG ' ' A' ' 81' ' ' LEU . 12.3 m-85 -118.54 127.56 53.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.379 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.656 HG23 ' HB2' ' A' ' 79' ' ' GLU . 32.8 mm -124.86 144.94 33.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.26 -177.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.616 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -152.12 111.2 3.86 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.157 -0.617 . . . . 0.0 112.156 -178.441 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 t -63.69 121.39 12.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.56 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.2 tttp . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.006 -179.913 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.103 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.4 p -116.54 -25.78 7.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.783 0.325 . . . . 0.0 110.923 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -109.85 9.29 24.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.975 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -91.14 110.44 21.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.838 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -138.02 60.86 1.61 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -131.12 -171.69 2.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.009 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -66.11 147.5 53.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.867 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -75.63 175.92 8.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.704 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -104.73 3.41 31.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.941 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.8 p -69.16 95.56 0.76 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.938 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.0 m -86.01 -81.97 0.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.082 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -88.71 38.96 3.15 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.656 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.5 tp -96.68 80.89 3.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.894 0.378 . . . . 0.0 110.875 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.566 HG23 ' HA3' ' A' ' 17' ' ' GLY . 2.4 m -64.87 140.89 98.21 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.186 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 14' ' ' VAL . 31.7 Cg_exo -59.78 -59.39 0.41 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.691 2.261 . . . . 0.0 112.456 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -81.56 26.2 0.49 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.448 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.566 ' HA3' HG23 ' A' ' 14' ' ' VAL . . . -81.23 75.24 2.32 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.391 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.26 -89.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.667 0.27 . . . . 0.0 111.102 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.401 ' HB3' ' H ' ' A' ' 20' ' ' MET . 1.0 OUTLIER -139.97 -92.32 0.17 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.115 -179.719 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.401 ' H ' ' HB3' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -81.75 45.07 0.86 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.235 -179.786 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.97 102.95 8.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.999 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -88.07 30.5 0.85 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.13 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -101.88 92.68 4.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.667 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.03 61.85 7.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.186 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.3 t -77.46 136.25 24.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.436 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.51 -52.22 3.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.508 -178.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.482 ' HB2' HD22 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -120.88 149.89 41.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.905 0.384 . . . . 0.0 111.462 -178.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 83.2 m -129.12 122.58 30.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.699 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 2.9 tt -109.23 125.37 52.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.081 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -130.79 123.39 29.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.726 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.79 HG22 ' HB2' ' A' ' 39' ' ' PRO . 8.4 t -118.45 64.3 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.128 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -63.27 -176.24 0.14 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.099 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.64 79.63 0.69 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.529 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.06 -156.22 0.58 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.599 0.238 . . . . 0.0 110.72 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.3 -88.2 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -178.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.4 p -53.31 144.29 31.24 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.405 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.21 30.4 0.47 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.627 2.218 . . . . 0.0 112.107 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.504 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 3.9 t -53.19 -51.79 71.95 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.351 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.79 ' HB2' HG22 ' A' ' 31' ' ' VAL . 42.7 Cg_endo -68.1 -19.98 44.51 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.134 1.89 . . . . 0.0 112.364 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.548 ' O ' HG22 ' A' ' 43' ' ' THR . 0.1 OUTLIER -70.02 -58.6 3.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.751 179.761 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.1 t -66.86 -15.29 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.858 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -70.97 -50.57 33.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.869 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.602 ' O ' HD13 ' A' ' 47' ' ' LEU . 14.6 t -64.36 -32.13 73.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.832 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.98 -46.95 87.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.968 0.413 . . . . 0.0 110.451 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.39 -31.65 72.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.878 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.25 -43.45 86.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.047 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.602 HD13 ' O ' ' A' ' 43' ' ' THR . 1.2 mp -58.77 -39.26 80.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.744 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.417 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 1.5 tt0 -81.2 -23.29 38.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.944 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -119.12 62.18 0.8 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.63 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.744 ' HB2' HG21 ' A' ' 97' ' ' VAL . 12.4 ptp -103.65 145.32 30.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.593 178.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.923 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 10.7 mttm -90.73 160.09 39.29 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.178 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 51' ' ' LYS . 86.3 Cg_exo -43.7 -70.78 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.098 2.532 . . . . 0.0 113.901 -178.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.46 59.79 0.45 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.9 -0.667 . . . . 0.0 113.264 -178.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.923 ' HG3' ' HB2' ' A' ' 51' ' ' LYS . 7.2 mt-10 -90.89 151.41 21.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.02 0.438 . . . . 0.0 111.572 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.683 HG12 ' HG3' ' A' ' 96' ' ' LYS . 7.4 mt -135.66 103.7 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.114 178.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.482 HD22 ' HB2' ' A' ' 27' ' ' LYS . 8.9 mt -118.73 160.51 21.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.072 0.463 . . . . 0.0 111.659 -177.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -130.6 139.64 50.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.365 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.514 HG12 HG12 ' A' ' 60' ' ' ILE . 11.7 t -120.04 136.45 57.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.136 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -122.57 110.8 16.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.677 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.607 HD11 ' HB2' ' A' ' 64' ' ' MET . 0.4 OUTLIER -158.66 -177.75 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.581 -179.428 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 89' ' ' SER . 19.0 m-20 -97.68 2.38 49.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.72 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -139.22 149.63 61.58 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.566 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.76 95.64 1.08 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.488 2.125 . . . . 0.0 112.856 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.607 ' HB2' HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -68.22 -15.43 63.57 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.172 0.51 . . . . 0.0 110.539 178.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.736 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 23.9 p -61.34 -12.2 12.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.719 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.3 pttm -56.36 -36.05 68.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.899 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.565 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.8 OUTLIER -94.25 -27.39 16.17 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.218 0.532 . . . . 0.0 110.018 178.209 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.736 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 4.7 mtt85 -61.91 -37.14 83.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.008 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.713 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 14.7 mt -62.15 -55.83 36.88 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.369 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.713 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 83.3 Cg_exo -47.19 -37.43 23.71 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.447 2.098 . . . . 0.0 112.717 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.509 ' HG3' ' HB3' ' A' ' 47' ' ' LEU . 15.7 mm-40 -70.86 -54.05 12.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.056 0.455 . . . . 0.0 111.106 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.597 ' HB ' ' O ' ' A' ' 77' ' ' GLY . 0.6 OUTLIER -60.75 -38.23 84.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.771 -178.605 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 69' ' ' ILE . 20.2 m -67.5 -27.84 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-O 120.688 0.28 . . . . 0.0 110.84 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.04 -43.98 87.11 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.547 ' HG2' ' O ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -90.2 -78.36 0.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.483 176.85 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.57 -97.37 0.24 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.967 0.413 . . . . 0.0 110.954 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.597 ' O ' ' HB ' ' A' ' 72' ' ' THR . . . -144.89 -84.33 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.195 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.95 152.65 39.75 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 122.723 -0.281 . . . . 0.0 110.778 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.772 ' HB2' ' H ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -96.96 71.27 2.47 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.034 0.445 . . . . 0.0 109.849 179.609 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.473 ' CG1' HD11 ' A' ' 83' ' ' ILE . 1.6 t -98.58 122.04 49.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.575 -177.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.522 ' HG ' ' N ' ' A' ' 82' ' ' GLU . 0.5 OUTLIER -133.53 -37.85 0.93 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.174 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.522 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -153.56 141.98 20.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.003 0.43 . . . . 0.0 111.866 -179.701 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.473 HD11 ' CG1' ' A' ' 80' ' ' VAL . 2.7 mt -143.53 129.93 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.222 178.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.426 ' OE2' ' HE2' ' A' ' 92' ' ' LYS . 4.8 pt-20 -156.78 179.77 8.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.184 0.516 . . . . 0.0 111.689 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -133.55 159.56 40.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.413 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.9 t -120.8 -66.97 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.398 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -122.84 -145.43 6.92 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.666 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.428 ' HD2' ' OE2' ' A' ' 90' ' ' GLU . 46.2 Cg_exo -56.44 -82.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.672 2.248 . . . . 0.0 112.509 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 61' ' ' ASP . 61.8 p -100.07 -3.75 31.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.831 0.348 . . . . 0.0 111.151 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.489 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -86.05 117.72 25.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.669 179.743 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 2.9 m-90 -130.83 164.21 25.68 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.1 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.426 ' HE2' ' OE2' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -124.28 129.51 50.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.537 179.538 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -125.8 143.39 39.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.002 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.507 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 13.6 m-85 -118.95 129.59 55.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.675 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.643 HG21 ' HE ' ' A' ' 68' ' ' ARG . 1.0 OUTLIER -124.13 149.03 28.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.68 -179.051 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.772 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -150.85 109.97 3.93 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.289 -0.564 . . . . 0.0 112.161 -178.117 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.744 HG21 ' HB2' ' A' ' 50' ' ' MET . 10.8 t -62.75 118.86 5.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.262 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.487 ' HG2' ' HD3' ' A' ' 96' ' ' LYS . 6.9 mtmt . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.986 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.164 0 N-CA-C 112.553 -0.219 . . . . 0.0 112.553 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.7 m -107.47 -3.27 19.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.794 0.33 . . . . 0.0 110.968 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.81 -55.47 4.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.958 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -106.84 120.15 41.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.911 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -127.64 137.22 52.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.935 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -65.74 126.69 29.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.033 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -124.22 -1.7 8.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.936 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.485 ' HA ' ' HB2' ' A' ' 11' ' ' SER . 7.9 m-70 -90.73 22.77 3.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.986 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 23.4 t60 -70.92 -72.8 0.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.0 m -86.16 -2.72 58.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.169 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.485 ' HB2' ' HA ' ' A' ' 8' ' ' HIS . 0.5 OUTLIER -75.07 -106.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.918 -179.707 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -89.63 171.71 38.26 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.603 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.32 76.37 3.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 0.0 110.828 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.7 t -85.78 114.61 57.8 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.85 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.48 122.44 10.12 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.425 2.084 . . . . 0.0 112.369 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -84.2 28.03 0.65 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.223 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.59 -76.59 0.62 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.39 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.27 27.54 0.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.616 0.246 . . . . 0.0 111.31 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.91 -150.15 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.858 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.2 -24.62 59.73 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.822 0.344 . . . . 0.0 111.058 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.18 108.6 1.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.978 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -91.03 45.01 1.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.004 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -88.16 42.43 1.06 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.893 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.63 80.41 1.66 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.118 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 80.6 t -64.45 153.01 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.586 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -98.82 -66.0 0.93 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.964 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -105.53 148.24 27.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.892 0.377 . . . . 0.0 110.941 179.6 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.607 HG23 ' HG2' ' A' ' 57' ' ' GLU . 86.4 m -133.9 110.47 9.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.863 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.5 tt -100.15 100.87 11.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.87 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -119.46 99.89 6.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.575 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.522 HG22 ' HB3' ' A' ' 34' ' ' GLU . 7.1 p -132.9 70.06 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.457 0.646 . . . . 0.0 111.179 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.91 -88.61 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.794 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.27 98.75 1.65 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.133 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.522 ' HB3' HG22 ' A' ' 31' ' ' VAL . 1.8 pm0 -106.62 177.59 4.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.95 0.405 . . . . 0.0 111.238 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.03 -90.48 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.854 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.751 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -60.03 157.22 32.67 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.672 179.124 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -72.91 23.86 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.739 2.293 . . . . 0.0 112.522 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.751 HG23 ' HB3' ' A' ' 36' ' ' CYS . 26.8 t -60.79 -50.99 82.67 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.537 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 38' ' ' VAL . 16.8 Cg_endo -57.26 -28.47 79.78 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.263 1.975 . . . . 0.0 112.182 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.8 -57.37 11.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.74 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.9 t -71.3 -15.88 18.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.888 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -66.79 -61.1 2.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.921 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.464 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 2.2 t -60.92 -34.64 75.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.019 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -56.23 -45.16 80.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.89 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.47 -33.09 75.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.707 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.65 -36.89 85.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.192 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 43' ' ' THR . 4.9 mt -65.55 -43.33 90.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.693 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -71.81 -26.57 62.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.481 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -117.26 57.08 0.81 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.998 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.3 ptm -96.01 150.06 20.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.855 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 5.6 mttt -104.24 156.35 35.91 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.872 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.05 -55.41 3.91 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.004 2.469 . . . . 0.0 113.277 -178.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.21 59.57 0.47 Allowed Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.844 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.855 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 3.6 mm-40 -90.8 146.39 23.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.041 0.448 . . . . 0.0 111.779 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.3 mt -135.53 102.53 3.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.894 177.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.428 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -119.89 143.86 47.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.04 0.447 . . . . 0.0 112.031 -177.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.607 ' HG2' HG23 ' A' ' 28' ' ' THR . 2.8 pt-20 -118.62 130.97 56.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.448 176.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.429 HG21 HH12 ' A' ' 68' ' ' ARG . 2.6 t -114.77 129.49 70.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.016 0.436 . . . . 0.0 111.906 -177.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.488 ' HE1' HG21 ' A' ' 86' ' ' VAL . 1.4 t90 -122.44 106.39 11.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.349 178.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.501 HD13 ' O ' ' A' ' 62' ' ' TYR . 1.0 OUTLIER -158.29 -163.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.439 -178.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -109.41 -34.49 6.52 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.664 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.501 ' O ' HD13 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -102.08 114.47 65.49 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.625 179.545 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.85 97.49 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.535 2.157 . . . . 0.0 112.429 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 35.9 mtt -68.3 -11.17 59.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.943 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.595 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.5 OUTLIER -61.57 -15.11 35.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.993 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -32.74 71.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.036 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.581 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 1.0 OUTLIER -94.22 -27.95 15.89 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.191 0.519 . . . . 0.0 110.365 178.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.595 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 14.3 mtt85 -62.88 -38.0 89.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.894 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.725 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 17.0 mt -59.37 -55.79 42.51 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.686 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 72.6 Cg_exo -50.21 -38.85 52.03 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.307 2.005 . . . . 0.0 112.781 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.561 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -68.56 -56.38 8.48 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.957 0.408 . . . . 0.0 111.518 -179.285 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.722 HG21 ' HG3' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -58.96 -45.58 90.17 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.269 -178.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 70' ' ' PRO . 8.2 p -58.69 -28.67 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.682 -0.236 . . . . 0.0 110.939 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.561 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 5.1 mmtt -58.42 -42.99 88.5 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 176.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.549 ' HB3' HD13 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -87.38 -82.84 0.21 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.872 176.22 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.795 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -98.59 -106.32 0.2 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.274 177.071 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.486 ' H ' HD23 ' A' ' 76' ' ' LEU . . . -134.87 -83.15 0.18 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.104 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.07 170.71 16.59 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.78 0.324 . . . . 0.0 111.071 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.885 ' HB2' HG13 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -110.09 72.77 0.81 Allowed 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.39 117.51 43.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.491 -176.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.55 ' HG ' ' N ' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -133.73 -40.69 0.86 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.092 179.715 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.585 ' HB3' ' HB2' ' A' ' 94' ' ' TYR . 0.3 OUTLIER -153.85 144.98 22.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.027 0.441 . . . . 0.0 111.924 -179.743 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.537 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 3.4 mp -144.04 130.65 16.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.275 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -149.78 178.57 8.76 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.042 0.448 . . . . 0.0 111.428 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.6 pm0 -133.35 159.07 41.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.663 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.488 HG21 ' HE1' ' A' ' 59' ' ' TRP . 4.6 t -124.28 -63.37 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.284 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -126.87 -144.7 6.1 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.654 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.429 ' HB2' ' H ' ' A' ' 89' ' ' SER . 37.3 Cg_exo -61.37 -82.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.601 2.201 . . . . 0.0 112.416 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.429 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 2.1 p -98.59 -1.33 41.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.025 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -92.93 116.28 28.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.511 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 4.2 m-90 -130.65 167.59 18.52 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.983 0.42 . . . . 0.0 111.37 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.7 128.52 49.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.29 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.8 mp -125.67 146.15 31.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.172 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.585 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 24.8 m-85 -118.81 123.84 45.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.576 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.885 HG13 ' HB2' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -124.79 144.68 33.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.848 -179.112 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.66 ' H ' ' HB3' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -150.77 115.86 5.32 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.961 -178.793 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.416 ' HA ' ' HG2' ' A' ' 79' ' ' GLU . 15.0 t -65.69 125.67 23.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.359 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.8 tttp . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.004 -179.486 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 112.446 -0.261 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -124.76 -37.81 2.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.804 0.335 . . . . 0.0 110.997 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.5 m -139.15 -166.96 2.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.915 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.44 -21.76 20.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.896 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -70.84 110.7 5.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.782 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.23 132.13 49.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.968 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -108.69 -170.46 1.67 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.943 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -92.04 73.02 5.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.945 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -130.91 -88.61 0.48 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.837 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 55.4 m -86.23 -38.04 18.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.987 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.2 m -83.5 28.51 0.55 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.229 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.81 -146.08 6.11 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.515 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.79 -175.66 3.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.78 0.324 . . . . 0.0 110.979 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.0 m -68.44 150.2 97.77 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.29 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -56.4 -34.45 94.47 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.619 2.213 . . . . 0.0 112.235 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.466 ' HB3' ' H ' ' A' ' 17' ' ' GLY . 5.0 mtt180 -89.44 -150.24 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.909 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.609 ' HA3' ' HG2' ' A' ' 22' ' ' LYS . . . -76.25 130.2 10.65 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.467 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.63 -76.93 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.746 0.308 . . . . 0.0 110.94 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.516 ' HB3' ' H ' ' A' ' 20' ' ' MET . 7.7 m80 -104.9 -150.51 0.43 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.731 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.516 ' H ' ' HB3' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -74.46 -3.56 31.44 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.809 0.338 . . . . 0.0 111.004 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.18 51.94 2.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.059 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.609 ' HG2' ' HA3' ' A' ' 17' ' ' GLY . 4.3 mtmt -91.14 40.09 1.02 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.235 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -94.17 38.67 1.08 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.9 0.381 . . . . 0.0 111.033 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.28 73.38 10.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.788 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.7 t -82.85 145.52 8.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.985 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.4 m -99.61 -62.06 1.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.933 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -118.56 158.63 25.05 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.011 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.7 m -127.45 151.72 48.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.865 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.2 tt -131.52 121.04 23.8 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.25 119.0 31.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.532 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.686 HG23 HG23 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -124.33 19.67 4.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.553 -179.093 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.4 14.76 0.41 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.667 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.89 -105.59 0.39 Allowed Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.652 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.435 ' CD ' HG21 ' A' ' 38' ' ' VAL . 5.2 pt-20 -87.49 -161.2 0.67 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.606 0.241 . . . . 0.0 110.809 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.09 -169.73 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.812 0.339 . . . . 0.0 111.291 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.814 ' HA ' ' HD2' ' A' ' 39' ' ' PRO . 19.5 m -55.36 159.75 4.19 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.049 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -92.69 20.18 35.03 Favored 'Cis proline' 0 C--N 1.35 0.608 0 C-N-CA 124.038 -1.234 . . . . 0.0 112.81 1.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.498 ' HB ' ' HD3' ' A' ' 39' ' ' PRO . 60.6 t -63.56 -53.36 52.15 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.65 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.814 ' HD2' ' HA ' ' A' ' 36' ' ' CYS . 64.1 Cg_endo -73.04 -17.28 25.05 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.207 1.938 . . . . 0.0 112.413 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -65.63 -58.34 5.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.3 t -74.05 -25.55 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.046 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -64.95 -49.34 70.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.053 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.405 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 15.0 t -67.52 -42.77 82.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.008 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.16 -43.04 73.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.949 0.404 . . . . 0.0 110.544 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.511 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 0.2 OUTLIER -64.09 -31.31 72.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.796 179.048 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.461 ' HB3' HH12 ' A' ' 68' ' ' ARG . . . -60.62 -48.7 80.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.335 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.564 ' HG ' ' HG3' ' A' ' 71' ' ' GLU . 2.2 mm? -59.06 -42.65 90.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.051 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -81.14 9.79 6.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.443 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.511 ' HB2' ' O ' ' A' ' 45' ' ' ARG . 0.9 OUTLIER -135.07 32.97 3.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.785 0.326 . . . . 0.0 111.202 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.838 ' HB3' HG21 ' A' ' 97' ' ' VAL . 26.0 mtt -109.18 143.61 38.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.122 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.779 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 23.0 mttp -95.41 163.15 22.3 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 51' ' ' LYS . 74.1 Cg_exo -41.83 -69.03 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.01 2.473 . . . . 0.0 113.508 -178.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 97' ' ' VAL . . . -103.95 56.91 0.56 Allowed Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.023 -178.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.779 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 14.4 mm-40 -90.92 157.17 17.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.001 0.429 . . . . 0.0 111.815 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.53 HG13 ' HG3' ' A' ' 96' ' ' LYS . 3.0 mp -135.04 110.31 12.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.973 178.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.528 HD13 ' C ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -118.74 148.22 43.03 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.164 0.506 . . . . 0.0 111.985 -177.243 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -111.69 135.31 52.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.863 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 t -125.78 144.22 36.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.114 0.483 . . . . 0.0 112.006 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.451 ' C ' HG13 ' A' ' 60' ' ' ILE . 18.4 t90 -131.04 107.93 9.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.235 178.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.686 HG23 HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -144.24 -166.64 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.009 -178.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -145.13 27.47 1.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.144 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.73 ' H ' ' HA ' ' A' ' 63' ' ' PRO . 1.2 m-85 -101.06 -56.34 0.13 Allowed Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.368 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.73 ' HA ' ' H ' ' A' ' 62' ' ' TYR . 72.1 Cg_endo -94.19 171.24 17.49 Favored 'Cis proline' 0 C--N 1.356 0.949 0 C-N-CA 124.912 -0.87 . . . . 0.0 112.374 -0.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.654 ' H ' HD13 ' A' ' 60' ' ' ILE . 6.0 tpp -68.32 -26.35 65.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.356 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.654 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -59.71 -17.44 34.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.188 -179.405 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.7 pttp -59.73 -34.8 73.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.629 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.571 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 4.9 mt-10 -90.21 -22.55 21.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.169 0.509 . . . . 0.0 110.222 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.654 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 0.4 OUTLIER -62.03 -46.4 89.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.041 179.318 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.723 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 5.1 mt -54.52 -54.6 46.9 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.723 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 75.1 Cg_exo -51.36 -37.05 59.98 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.412 2.075 . . . . 0.0 112.61 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.564 ' HG3' ' HG ' ' A' ' 47' ' ' LEU . 4.8 tm-20 -71.24 -58.17 3.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.866 0.365 . . . . 0.0 111.525 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.763 HG21 ' HG2' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -58.89 -31.9 69.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.463 -178.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.529 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 8.6 p -73.52 -26.46 22.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.709 0.29 . . . . 0.0 110.731 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.69 -46.53 87.08 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.441 ' HG2' ' H ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -88.7 -74.32 0.47 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.565 177.463 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.505 HD11 HG22 ' A' ' 72' ' ' THR . 0.0 OUTLIER -98.21 -102.31 0.2 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.85 0.357 . . . . 0.0 110.482 178.19 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.27 -85.51 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.866 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.534 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -147.6 155.74 42.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.731 0.3 . . . . 0.0 111.076 178.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.763 ' HG2' HG21 ' A' ' 72' ' ' THR . 0.0 OUTLIER -103.87 69.24 0.95 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 177.396 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.535 HG12 HD11 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -98.67 121.52 49.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.88 -175.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.759 HD22 ' HB3' ' A' ' 96' ' ' LYS . 1.5 pt? -139.71 -35.5 0.53 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.677 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.613 ' HB3' ' HB2' ' A' ' 94' ' ' TYR . 0.8 OUTLIER -153.01 142.55 21.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.19 0.519 . . . . 0.0 112.009 179.574 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.535 HD11 HG12 ' A' ' 80' ' ' VAL . 3.7 mp -144.19 135.87 22.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.263 178.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -157.79 179.87 8.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.073 0.463 . . . . 0.0 111.28 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -133.5 161.25 35.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.555 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.0 t -120.7 -62.83 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.318 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.453 ' H ' ' HG3' ' A' ' 90' ' ' GLU . . . -125.37 -146.52 6.77 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.787 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.425 ' HB2' ' H ' ' A' ' 89' ' ' SER . 43.2 Cg_exo -57.11 -83.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.768 2.312 . . . . 0.0 112.513 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.425 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -95.73 -3.09 46.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.876 0.37 . . . . 0.0 111.184 -179.376 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.453 ' HG3' ' H ' ' A' ' 87' ' ' GLY . 5.5 pt-20 -93.16 133.89 35.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.713 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.11 168.81 20.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.929 0.395 . . . . 0.0 111.09 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.3 mttt -120.74 128.11 52.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.534 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.4 mp -125.28 145.11 33.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.885 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.613 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 13.0 m-85 -118.17 129.05 55.29 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.441 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.607 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -123.97 142.14 41.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.291 -179.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.759 ' HB3' HD22 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -144.04 110.57 5.56 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.755 -176.752 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.838 HG21 ' HB3' ' A' ' 50' ' ' MET . 3.2 t -61.26 118.48 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.314 178.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.59 ' HE3' ' HD3' ' A' ' 96' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.937 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.19 0 N-CA-C 112.437 -0.265 . . . . 0.0 112.437 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 t -124.45 110.89 15.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.73 0.3 . . . . 0.0 110.921 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.8 m -75.32 106.31 6.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.01 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.97 -34.05 9.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.794 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -133.65 -175.91 3.98 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.772 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -70.65 -63.38 1.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.799 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -89.03 -169.06 2.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.881 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.5 p-80 -91.28 -167.89 1.92 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.844 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -92.16 70.4 5.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.815 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.7 t -75.24 -63.04 1.36 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.9 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.91 28.39 0.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.19 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.83 134.56 32.29 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.368 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.585 HD13 ' HA ' ' A' ' 18' ' ' SER . 8.9 mt -79.21 122.75 26.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.915 0.388 . . . . 0.0 111.015 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.61 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 47.2 t -73.3 -49.97 6.59 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.649 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 20.9 Cg_endo -59.86 162.88 14.84 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.231 1.954 . . . . 0.0 112.217 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -61.15 -66.25 0.56 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.297 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -57.93 96.09 0.06 OUTLIER Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.68 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.585 ' HA ' HD13 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -80.82 -79.19 0.16 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.729 0.3 . . . . 0.0 111.061 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.99 -89.33 0.46 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.147 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 74.4 mtm -69.39 -157.92 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.806 0.336 . . . . 0.0 111.179 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.97 -176.19 0.08 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.375 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -89.7 58.84 4.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.153 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -102.42 76.05 1.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.845 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -94.98 138.17 33.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.963 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.6 t -72.83 130.86 35.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.876 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.73 -56.62 2.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.134 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.467 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -113.4 139.53 48.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.085 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.3 m -133.85 117.47 16.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.802 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 11.7 tp -109.92 115.41 29.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.033 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.702 ' HB3' ' HB3' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -132.9 102.11 5.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.705 179.774 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.506 ' O ' HG13 ' A' ' 31' ' ' VAL . 7.2 p -140.85 75.04 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.298 0.57 . . . . 0.0 111.19 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.441 HH11 ' HD3' ' A' ' 32' ' ' ARG . 2.1 mtp180 -54.72 -87.62 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.001 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.8 98.76 0.71 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.36 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -96.0 162.9 13.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.893 0.377 . . . . 0.0 111.158 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.33 -90.88 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.957 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.565 ' O ' ' HD2' ' A' ' 39' ' ' PRO . 1.2 p -62.75 157.95 55.34 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.657 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -75.22 12.86 1.18 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.801 2.334 . . . . 0.0 112.621 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.532 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 46.4 t -62.07 -53.69 56.95 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.545 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.565 ' HD2' ' O ' ' A' ' 36' ' ' CYS . 29.9 Cg_endo -61.9 -24.25 76.85 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.137 1.891 . . . . 0.0 112.099 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.43 -46.74 87.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.539 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.425 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 4.5 t -69.85 -25.22 27.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.697 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -64.37 -55.38 21.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.824 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.455 ' O ' HD13 ' A' ' 47' ' ' LEU . 11.9 t -62.59 -26.56 68.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.678 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 0.7 OUTLIER -58.72 -43.45 90.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.316 178.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -65.24 -39.54 92.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.81 178.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.46 -31.39 65.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.967 0.413 . . . . 0.0 110.52 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 43' ' ' THR . 2.9 mp -77.62 -51.73 10.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.486 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -81.46 -3.34 52.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.195 -177.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -134.96 71.2 1.44 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.822 0.344 . . . . 0.0 110.915 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.788 ' HB3' HG21 ' A' ' 97' ' ' VAL . 11.9 mtm -106.62 137.79 43.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.013 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.834 ' HG2' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -92.56 150.73 40.34 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.301 178.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.834 ' HD2' ' HG2' ' A' ' 51' ' ' LYS . 56.1 Cg_exo -37.28 -70.19 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.249 2.633 . . . . 0.0 113.992 -178.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.53 60.74 0.42 Allowed Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.121 -178.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.511 ' HG2' ' HB3' ' A' ' 51' ' ' LYS . 4.5 mm-40 -90.53 147.54 23.3 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.089 0.471 . . . . 0.0 111.753 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.516 HG23 ' HB2' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -130.84 114.65 27.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.065 178.418 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.467 HD22 ' HB3' ' A' ' 27' ' ' LYS . 4.0 mt -119.56 151.35 38.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.314 0.578 . . . . 0.0 112.095 -177.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -124.25 121.4 34.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.582 177.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.526 HG12 HG12 ' A' ' 60' ' ' ILE . 4.5 t -114.31 139.3 40.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.069 0.461 . . . . 0.0 111.987 -177.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.702 ' HB3' ' HB3' ' A' ' 30' ' ' ASP . 6.3 t90 -133.33 107.23 7.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.372 178.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.526 HG12 HG12 ' A' ' 58' ' ' VAL . 0.9 OUTLIER -156.95 -166.77 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.278 -178.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -111.52 -2.2 15.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.934 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.452 ' O ' HD12 ' A' ' 60' ' ' ILE . 3.3 m-85 -131.08 126.65 21.69 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.841 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 62' ' ' TYR . 31.8 Cg_exo -58.91 98.63 0.1 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.477 2.118 . . . . 0.0 112.377 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.484 ' HB3' ' NH1' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -67.98 -17.6 64.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.021 0.439 . . . . 0.0 110.885 179.637 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.516 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 5.1 p -64.0 -11.15 26.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.897 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.7 pttt -60.05 -39.67 86.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.981 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.554 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 6.1 mt-10 -89.93 -26.24 20.52 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.25 0.548 . . . . 0.0 110.207 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.516 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 28.7 mtt85 -63.71 -43.06 97.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.993 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.724 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 24.1 mt -51.83 -55.63 28.51 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.695 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.724 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 53.1 Cg_exo -53.18 -40.74 76.27 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.189 1.926 . . . . 0.0 112.603 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -61.04 2.19 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.965 0.412 . . . . 0.0 111.534 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.874 HG21 ' HG3' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -57.14 -43.58 82.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.63 -178.546 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 70' ' ' PRO . 9.8 p -58.84 -30.04 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.784 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -58.65 -40.36 83.2 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.679 ' HB3' HD13 ' A' ' 76' ' ' LEU . 2.0 mtpt -87.97 -84.86 0.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.875 176.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.815 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -98.46 -105.21 0.2 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.221 176.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.492 ' H ' HD23 ' A' ' 76' ' ' LEU . . . -132.93 -83.64 0.23 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.083 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.481 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -146.96 168.79 20.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.869 0.366 . . . . 0.0 111.25 179.613 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.95 ' HB2' HG23 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -110.26 61.07 0.6 Allowed 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.702 178.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.546 HG12 HD11 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -98.43 122.53 50.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.242 -177.533 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.505 HD12 ' HB2' ' A' ' 82' ' ' GLU . 1.1 pp -133.64 -37.86 0.92 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.274 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.505 ' HB2' HD12 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -153.11 147.99 26.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.992 0.425 . . . . 0.0 111.9 -179.748 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.546 HD11 HG12 ' A' ' 80' ' ' VAL . 3.7 mp -144.15 132.96 18.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.331 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.464 ' HG3' ' HB3' ' A' ' 92' ' ' LYS . 15.0 pt-20 -154.59 175.93 13.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.01 0.433 . . . . 0.0 111.363 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.43 173.71 11.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.982 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.46 -48.41 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.063 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -128.27 -150.65 7.32 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.545 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.98 -74.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.561 2.174 . . . . 0.0 112.533 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.9 p -99.36 -5.44 29.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.921 0.391 . . . . 0.0 111.193 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.413 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -93.28 131.11 38.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.786 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -151.48 170.34 19.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.971 0.415 . . . . 0.0 111.259 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.464 ' HB3' ' HG3' ' A' ' 84' ' ' GLU . 5.3 tttt -120.67 132.87 55.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.461 179.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.4 mp -125.64 149.81 30.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.105 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -118.57 125.29 49.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.486 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.95 HG23 ' HB2' ' A' ' 79' ' ' GLU . 16.1 mm -124.98 143.24 39.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.967 -177.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.694 ' C ' ' HB3' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -151.82 114.7 4.66 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 120.061 -0.656 . . . . 0.0 112.217 -178.797 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.788 HG21 ' HB3' ' A' ' 50' ' ' MET . 16.1 t -64.3 119.91 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.644 178.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.923 -179.777 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.33 116.21 30.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.827 0.346 . . . . 0.0 110.923 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.1 t -137.77 92.11 2.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.908 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -112.74 43.02 1.74 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.979 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -85.43 127.55 34.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.89 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -136.64 22.36 3.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.012 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.75 112.47 23.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.039 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -90.41 -31.67 16.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -113.97 59.46 0.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.885 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.63 138.85 56.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.932 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.6 t -63.8 -68.18 0.37 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.264 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.45 82.67 0.37 Allowed Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.77 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mt -67.96 -71.63 0.2 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.727 0.299 . . . . 0.0 111.032 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.465 ' HB ' ' HD3' ' A' ' 15' ' ' PRO . 33.8 t -58.93 -45.66 99.58 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.005 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.465 ' HD3' ' HB ' ' A' ' 14' ' ' VAL . 52.8 Cg_exo -56.2 -168.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.394 2.063 . . . . 0.0 112.698 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 43.4 mmt-85 -73.59 19.67 0.1 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.781 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 15' ' ' PRO . . . -81.18 -104.05 0.33 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.362 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.5 t -81.37 31.96 0.34 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.45 0.167 . . . . 0.0 111.192 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -42.94 -36.67 1.61 Allowed 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 111.744 0.275 . . . . 0.0 111.744 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.5 tmm? -62.86 96.53 0.09 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.812 0.339 . . . . 0.0 110.835 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.48 155.88 36.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.199 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.406 ' HG3' ' H ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -91.29 32.06 1.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.868 179.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -98.85 155.86 17.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -91.65 99.64 12.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.931 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 47.2 t -62.97 147.42 12.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.974 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -114.86 -60.2 1.92 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.416 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.27 159.18 23.1 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.03 0.443 . . . . 0.0 111.823 -178.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.5 m -135.77 108.16 7.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.554 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.5 tt -106.12 112.51 25.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.816 0.341 . . . . 0.0 111.126 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -133.29 107.74 8.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.457 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.0 t -137.93 72.87 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.505 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.462 ' HB3' ' H ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -58.83 -88.43 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.707 179.074 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.462 ' H ' ' HB3' ' A' ' 32' ' ' ARG . . . -81.14 98.77 1.88 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.205 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -92.22 163.02 14.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.937 0.398 . . . . 0.0 111.253 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.03 -89.58 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.965 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.6 m -62.41 154.86 70.32 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.745 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -78.08 17.74 0.98 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.629 2.219 . . . . 0.0 112.625 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.693 ' HB ' ' HD3' ' A' ' 39' ' ' PRO . 34.6 t -65.82 -53.21 36.84 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.457 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.693 ' HD3' ' HB ' ' A' ' 38' ' ' VAL . 20.7 Cg_exo -66.04 -21.9 55.69 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.241 1.96 . . . . 0.0 112.205 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.03 -57.45 9.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.031 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.4 t -67.3 -26.66 36.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.106 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -63.29 -61.37 2.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.959 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.4 HG22 ' O ' ' A' ' 39' ' ' PRO . 9.1 t -60.43 -27.55 67.58 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.805 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.99 -45.13 93.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.643 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.0 -32.36 74.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.777 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.71 -39.32 84.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.943 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.553 HD22 ' HG2' ' A' ' 68' ' ' ARG . 2.2 mt -68.92 -34.15 74.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.606 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -81.16 -12.46 59.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.021 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -135.24 70.94 1.43 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.261 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.755 ' HB3' HG21 ' A' ' 97' ' ' VAL . 0.8 OUTLIER -99.82 126.33 45.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.071 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.559 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 1.3 mtpm? -81.88 150.1 64.84 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.964 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.19 -25.46 80.84 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.536 2.157 . . . . 0.0 112.499 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.59 39.21 2.94 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.564 -0.827 . . . . 0.0 113.118 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.772 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 28.5 mt-10 -90.75 123.43 34.33 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 117.198 0.499 . . . . 0.0 111.905 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.505 HD13 ' O ' ' A' ' 54' ' ' GLU . 0.7 OUTLIER -135.2 84.5 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.625 177.741 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.498 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -119.27 -179.79 3.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.278 0.561 . . . . 0.0 112.301 -176.862 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -136.76 145.82 45.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.295 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.699 HG11 ' HB2' ' A' ' 64' ' ' MET . 4.7 t -119.72 134.29 63.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.824 0.345 . . . . 0.0 111.413 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.527 ' HE1' HG21 ' A' ' 86' ' ' VAL . 11.7 t90 -122.47 96.17 4.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.079 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.547 HG13 HG12 ' A' ' 58' ' ' VAL . 0.5 OUTLIER -148.97 -160.06 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.646 179.053 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.476 ' HB3' ' O ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -131.0 37.53 3.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.461 -179.452 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.643 ' H ' ' HA ' ' A' ' 63' ' ' PRO . 86.1 m-85 -115.94 -60.81 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.119 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.643 ' HA ' ' H ' ' A' ' 62' ' ' TYR . 63.7 Cg_endo -97.22 -168.34 1.56 Allowed 'Cis proline' 0 C--N 1.356 0.939 0 CA-C-N 119.449 0.839 . . . . 0.0 111.881 -1.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.699 ' HB2' HG11 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -68.69 -27.65 66.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.825 0.345 . . . . 0.0 111.024 179.176 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.54 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.7 OUTLIER -58.73 -16.01 14.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.275 -178.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.51 ' HG3' ' N ' ' A' ' 67' ' ' GLU . 5.6 pttt -59.61 -34.32 72.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.024 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.531 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 1.4 mm-40 -93.97 -25.31 17.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.078 0.466 . . . . 0.0 110.352 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.553 ' HG2' HD22 ' A' ' 47' ' ' LEU . 6.2 mtt85 -62.97 -38.62 91.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.939 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.727 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 8.9 mt -60.04 -56.58 34.11 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.484 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.727 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 82.5 Cg_exo -46.51 -47.23 15.9 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.507 2.138 . . . . 0.0 112.805 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.534 ' HG3' ' HB3' ' A' ' 47' ' ' LEU . 64.5 mm-40 -60.97 -47.21 87.49 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.051 0.453 . . . . 0.0 110.944 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.566 ' HB ' ' O ' ' A' ' 77' ' ' GLY . 1.9 m -59.53 -46.34 89.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.508 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.703 HG13 ' O ' ' A' ' 69' ' ' ILE . 1.3 m -58.87 -29.4 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 121.119 -0.232 . . . . 0.0 111.004 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.52 -41.51 85.61 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 176.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.64 -81.46 0.31 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.487 177.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.42 -96.21 0.24 Allowed 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.81 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.566 ' O ' ' HB ' ' A' ' 72' ' ' THR . . . -144.07 -85.02 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.853 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.414 ' HB3' HG23 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -146.18 147.61 31.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.762 0.315 . . . . 0.0 110.912 178.844 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.877 ' HB2' HG23 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -95.36 55.72 1.77 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.422 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.7 p -99.22 127.21 52.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.291 -177.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.485 ' HG ' ' N ' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -133.29 -35.75 1.02 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.986 179.665 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.485 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 0.3 OUTLIER -153.91 148.7 26.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.064 0.459 . . . . 0.0 111.925 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.2 mp -141.75 140.8 30.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.454 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.41 ' OE2' ' HD2' ' A' ' 92' ' ' LYS . 11.4 pt-20 -158.04 178.92 9.67 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.033 0.444 . . . . 0.0 111.454 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -133.68 170.1 16.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.716 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.527 HG21 ' HE1' ' A' ' 59' ' ' TRP . 25.1 t -130.23 -56.54 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.287 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.45 ' H ' ' HG3' ' A' ' 90' ' ' GLU . . . -128.52 -145.98 6.13 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.721 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -58.4 -80.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.671 2.247 . . . . 0.0 112.547 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.476 ' O ' ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -100.1 -2.7 33.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.785 0.326 . . . . 0.0 111.201 -179.399 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.45 ' HG3' ' H ' ' A' ' 87' ' ' GLY . 5.3 pt-20 -91.86 133.4 35.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.787 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -148.59 168.76 21.95 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.032 0.444 . . . . 0.0 111.387 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.41 ' HD2' ' OE2' ' A' ' 84' ' ' GLU . 2.2 tttt -120.62 146.81 46.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.523 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -129.98 159.3 42.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.244 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -125.58 124.01 40.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.731 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.877 HG23 ' HB2' ' A' ' 79' ' ' GLU . 31.0 mm -123.95 148.97 27.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.448 -176.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.627 ' C ' ' HB3' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -150.64 99.03 2.7 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 120.404 -0.519 . . . . 0.0 111.659 -177.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.772 ' HB ' ' HB2' ' A' ' 54' ' ' GLU . 48.6 t -70.63 89.58 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.532 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.2 pttm . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.273 -0.87 . . . . 0.0 111.041 -179.861 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m -98.11 17.31 18.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.882 0.372 . . . . 0.0 110.841 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.8 m -88.75 138.69 31.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.992 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -126.53 -62.38 1.14 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.931 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -94.66 -0.64 54.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.996 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -78.38 -76.03 0.21 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.865 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -128.25 114.15 16.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -103.77 126.94 51.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.044 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.58 ' HD2' ' HA ' ' A' ' 16' ' ' ARG . 0.3 OUTLIER -70.91 102.9 2.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.764 179.744 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.5 t -67.15 -14.89 63.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.969 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.409 ' HB3' ' H ' ' A' ' 12' ' ' GLY . 31.0 m -75.75 -153.22 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.805 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.409 ' H ' ' HB3' ' A' ' 11' ' ' SER . . . -89.18 -148.83 19.31 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.467 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 13' ' ' LEU . 4.3 mm? -91.61 91.81 8.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.886 0.374 . . . . 0.0 110.74 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.775 ' N ' ' HA ' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -84.59 -41.45 0.7 Allowed Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 116.108 -0.497 . . . . 0.0 112.047 -179.82 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.775 ' HA ' ' N ' ' A' ' 14' ' ' VAL . 79.3 Cg_endo -102.09 -152.9 0.15 OUTLIER 'Cis proline' 0 C--N 1.358 1.047 0 CA-C-N 119.861 0.986 . . . . 0.0 112.793 1.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.58 ' HA ' ' HD2' ' A' ' 9' ' ' HIS . 0.0 OUTLIER -59.54 -4.61 0.66 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.096 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.29 92.48 0.86 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.343 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.21 25.17 0.31 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.648 0.261 . . . . 0.0 111.428 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -90.29 30.88 1.05 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.075 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 13.3 ptt? -81.03 -2.3 47.47 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.733 0.301 . . . . 0.0 111.01 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.58 166.96 17.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.025 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.22 77.95 5.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.924 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -72.63 80.68 1.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.847 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.0 66.27 7.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.028 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.1 t -76.31 138.5 20.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.988 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.85 -65.98 0.93 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.096 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -108.67 149.23 29.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.112 -179.717 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.0 m -135.09 117.15 15.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.766 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.603 HD21 ' HG2' ' A' ' 42' ' ' GLU . 12.8 tp -103.52 109.79 21.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.922 0.391 . . . . 0.0 111.036 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.443 ' HB3' ' HB3' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -125.02 115.3 20.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.507 179.61 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.62 47.47 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.299 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -75.01 15.52 0.39 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.708 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.94 -80.21 0.93 Allowed Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.324 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.597 ' HG3' HG21 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -82.96 -165.52 1.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.646 0.26 . . . . 0.0 110.751 179.567 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.81 -173.99 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.894 0.378 . . . . 0.0 111.258 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.809 ' HA ' ' HD2' ' A' ' 39' ' ' PRO . 0.5 OUTLIER -58.38 158.86 13.23 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.812 179.727 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -93.09 25.19 23.17 Favored 'Cis proline' 0 C--N 1.35 0.62 0 C-N-CA 123.995 -1.252 . . . . 0.0 112.798 1.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.597 HG21 ' HG3' ' A' ' 34' ' ' GLU . 21.4 t -60.42 -52.57 72.02 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.565 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.809 ' HD2' ' HA ' ' A' ' 36' ' ' CYS . 73.5 Cg_endo -74.79 -16.84 20.56 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.162 1.908 . . . . 0.0 112.439 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.22 -52.54 39.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.094 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 17.1 t -72.66 -31.44 37.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.055 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.603 ' HG2' HD21 ' A' ' 29' ' ' LEU . 4.9 tt0 -58.64 -60.81 3.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.061 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.47 ' O ' HD22 ' A' ' 47' ' ' LEU . 9.6 t -62.06 -36.88 82.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.028 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.25 -42.3 60.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.948 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.65 -33.95 73.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.743 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.25 -48.19 82.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.294 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.54 HD21 ' HG2' ' A' ' 68' ' ' ARG . 1.1 mm? -61.24 -36.11 79.08 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.916 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -74.72 -9.61 58.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.073 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -134.98 49.83 2.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.037 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.607 ' HB2' HG21 ' A' ' 97' ' ' VAL . 16.1 ptp -88.48 146.64 25.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.875 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.579 ' HB3' ' HG3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -101.98 150.09 37.12 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.374 179.31 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.529 ' HD2' ' HG3' ' A' ' 51' ' ' LYS . 81.6 Cg_exo -31.19 -78.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.736 2.957 . . . . 0.0 114.137 -178.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.441 ' H ' ' HB2' ' A' ' 52' ' ' PRO . . . -104.41 62.18 0.39 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.117 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.579 ' HG3' ' HB3' ' A' ' 51' ' ' LYS . 8.6 mt-10 -89.21 150.49 22.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.027 0.441 . . . . 0.0 111.46 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.41 HG23 ' HB3' ' A' ' 96' ' ' LYS . 2.6 mp -135.64 106.55 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.687 177.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.401 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 1.2 mt -119.09 147.85 43.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.177 0.513 . . . . 0.0 112.194 -176.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -114.87 128.96 56.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.099 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.607 HG21 ' NH1' ' A' ' 68' ' ' ARG . 2.3 t -114.81 133.15 61.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.972 0.415 . . . . 0.0 111.529 -178.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.736 ' HE1' HG21 ' A' ' 86' ' ' VAL . 13.7 t90 -122.57 109.36 14.21 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.815 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.56 HD13 ' O ' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -156.9 -169.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.262 -179.536 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.609 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -109.24 -7.83 15.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.073 -179.598 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.56 ' O ' HD13 ' A' ' 60' ' ' ILE . 0.9 OUTLIER -126.25 122.42 24.05 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.606 179.74 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.05 92.48 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.572 2.181 . . . . 0.0 112.172 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 21.1 mtm -68.0 -15.58 63.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.606 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.495 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 2.4 p -63.92 -17.52 63.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.811 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.8 pttt -57.92 -32.12 67.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.841 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.555 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -94.12 -28.25 15.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.346 179.033 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.607 ' NH1' HG21 ' A' ' 58' ' ' VAL . 39.4 mtt180 -64.24 -39.56 94.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.207 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.7 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 12.5 mt -59.11 -54.77 53.12 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.509 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.7 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 80.6 Cg_exo -48.34 -44.06 30.46 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.307 2.005 . . . . 0.0 112.564 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.543 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 4.7 tt0 -69.11 -49.56 55.98 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.959 0.409 . . . . 0.0 111.433 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.465 ' HB ' ' O ' ' A' ' 77' ' ' GLY . 6.6 m -58.74 -48.16 82.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.364 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 69' ' ' ILE . 19.1 m -59.0 -28.81 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-O 120.504 0.193 . . . . 0.0 111.11 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.543 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.3 OUTLIER -58.02 -41.56 83.4 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.21 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.07 -80.55 0.31 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.176 176.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.85 -100.09 0.22 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.529 178.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.53 -86.56 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.835 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.415 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -146.67 152.56 39.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.751 0.31 . . . . 0.0 110.796 178.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.882 ' HB2' HG13 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -100.31 68.78 1.43 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.853 179.08 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.415 HG22 ' HB2' ' A' ' 78' ' ' HIS . 0.2 OUTLIER -98.96 124.01 51.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.724 -176.736 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.892 ' HB3' ' HG2' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -133.42 -37.51 0.95 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.933 179.05 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.561 ' HG3' ' N ' ' A' ' 83' ' ' ILE . 0.8 OUTLIER -154.05 146.34 23.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.946 0.403 . . . . 0.0 111.845 179.531 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.561 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 3.0 mt -141.55 135.31 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.35 178.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.649 ' HG3' ' HB3' ' A' ' 92' ' ' LYS . 6.2 pt-20 -158.05 -179.21 7.91 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.032 0.444 . . . . 0.0 111.321 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.22 162.59 31.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.814 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.736 HG21 ' HE1' ' A' ' 59' ' ' TRP . 60.3 t -123.21 -65.99 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.403 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -122.92 -153.14 8.71 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.743 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.72 -75.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.7 2.267 . . . . 0.0 112.344 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -99.58 -3.16 33.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.946 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.609 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 1.1 pm0 -93.56 138.15 32.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.809 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -151.53 171.05 18.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.993 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.649 ' HB3' ' HG3' ' A' ' 84' ' ' GLU . 2.3 ttpt -120.81 132.99 55.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.72 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.3 mp -125.43 144.95 33.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.84 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.468 ' HB3' ' HG ' ' A' ' 81' ' ' LEU . 10.5 m-85 -118.76 124.3 46.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.699 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.882 HG13 ' HB2' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -124.33 148.86 28.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.852 -178.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.892 ' HG2' ' HB3' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -150.93 108.54 3.65 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 120.239 -0.584 . . . . 0.0 112.506 -177.587 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.607 HG21 ' HB2' ' A' ' 50' ' ' MET . 5.0 t -58.15 119.54 3.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.587 178.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.84 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.99 -73.57 0.61 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.732 0.301 . . . . 0.0 111.007 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.2 p -140.07 -76.45 0.33 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.97 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -129.98 81.32 2.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.902 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.81 78.63 1.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.994 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -96.72 -66.5 0.9 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -128.19 140.98 51.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.906 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -106.34 151.54 24.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -98.91 42.22 1.11 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.11 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.1 t -77.52 104.73 8.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.84 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.29 -150.94 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.865 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.75 167.75 48.61 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.494 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.6 HD23 ' H ' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -70.87 153.18 42.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.824 0.345 . . . . 0.0 110.966 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.6 ' H ' HD23 ' A' ' 13' ' ' LEU . 2.6 t -70.78 130.52 88.51 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.832 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -56.43 -31.7 86.52 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.455 2.103 . . . . 0.0 112.316 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -84.68 29.24 0.62 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.185 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.89 -179.93 9.87 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.517 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.34 28.0 0.4 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.587 0.232 . . . . 0.0 111.213 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -50.78 -48.6 59.42 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.544 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.3 mtt -54.15 -55.46 27.63 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.721 0.295 . . . . 0.0 111.17 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.73 160.26 17.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.04 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.9 mttt -89.53 28.87 1.21 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.815 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -103.1 119.51 38.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.864 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.4 ' O ' HD13 ' A' ' 55' ' ' ILE . 3.0 mt-30 -93.18 59.13 3.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.977 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.0 t -85.17 134.21 27.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.013 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.08 -61.87 1.31 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.154 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.1 tptt -113.34 139.98 48.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.887 0.375 . . . . 0.0 111.161 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.404 HG23 ' HB3' ' A' ' 57' ' ' GLU . 71.0 m -130.2 134.74 47.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.859 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.609 HD23 HG22 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -113.15 127.97 56.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.915 179.726 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -120.01 108.51 14.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.783 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.609 HG22 HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -128.2 68.49 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.05 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 -54.73 -89.78 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.061 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.5 -153.69 4.22 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.254 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -110.66 144.79 39.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.846 0.355 . . . . 0.0 110.752 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.08 -158.1 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.04 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.655 ' O ' ' HD2' ' A' ' 39' ' ' PRO . 2.5 m -60.62 162.78 10.65 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.678 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -73.76 -6.56 18.83 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.599 2.2 . . . . 0.0 112.282 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.759 ' HB ' ' HD3' ' A' ' 39' ' ' PRO . 21.6 t -67.02 -56.5 13.36 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.72 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.759 ' HD3' ' HB ' ' A' ' 38' ' ' VAL . 51.7 Cg_exo -54.25 -31.19 65.44 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.12 1.88 . . . . 0.0 112.356 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.435 ' O ' HG22 ' A' ' 43' ' ' THR . 0.4 OUTLIER -62.41 -50.46 71.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 179.85 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.4 t -70.07 -23.64 25.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.95 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -66.71 -54.3 24.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.919 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.547 ' O ' HD22 ' A' ' 47' ' ' LEU . 4.1 t -59.07 -34.84 72.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.864 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.76 -36.57 76.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.893 0.378 . . . . 0.0 110.318 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -66.06 -31.34 72.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.439 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 43' ' ' THR . . . -58.62 -53.0 63.29 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.018 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.688 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 0.8 OUTLIER -58.65 -35.44 72.54 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.144 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.06 -9.83 59.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.249 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -133.52 69.23 1.48 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.948 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.803 ' HB3' HG21 ' A' ' 97' ' ' VAL . 41.9 mtm -109.02 147.86 31.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.997 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.584 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.4 OUTLIER -91.93 153.85 43.53 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.391 179.466 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.584 ' HD2' ' HG3' ' A' ' 51' ' ' LYS . 53.9 Cg_exo -38.48 -71.31 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.148 2.565 . . . . 0.0 113.962 -178.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.17 57.37 0.54 Allowed Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.913 -0.661 . . . . 0.0 113.415 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.515 ' HG3' ' HB3' ' A' ' 51' ' ' LYS . 11.0 mt-10 -91.41 156.1 17.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.134 0.493 . . . . 0.0 111.984 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.542 ' C ' HD13 ' A' ' 56' ' ' LEU . 3.5 mp -135.55 115.71 17.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.008 178.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.542 HD13 ' C ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -118.52 154.29 32.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.035 0.445 . . . . 0.0 111.692 -177.624 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.404 ' HB3' HG23 ' A' ' 28' ' ' THR . 51.1 tt0 -114.74 145.9 41.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.376 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.543 HG12 HG13 ' A' ' 60' ' ' ILE . 16.7 t -131.01 131.52 64.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.858 0.361 . . . . 0.0 111.527 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.416 ' CD1' ' HG2' ' A' ' 92' ' ' LYS . 52.8 m0 -122.59 107.25 11.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.422 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.543 HG13 HG12 ' A' ' 58' ' ' VAL . 1.0 OUTLIER -158.67 -172.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-O 121.046 0.451 . . . . 0.0 111.334 -179.213 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -99.67 -25.59 14.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.106 178.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.474 ' O ' HD13 ' A' ' 60' ' ' ILE . 93.0 m-85 -120.62 121.06 29.31 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.445 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -45.68 105.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.651 2.234 . . . . 0.0 112.561 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.499 ' HG3' ' NH1' ' A' ' 68' ' ' ARG . 3.0 tpt -65.64 -15.09 62.43 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.808 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.755 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 14.8 p -55.79 -13.38 1.72 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.846 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.66 -42.96 75.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.549 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 1.7 mt-10 -87.16 -26.07 23.77 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.225 0.536 . . . . 0.0 110.132 178.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.755 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 0.2 OUTLIER -61.48 -41.98 98.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.088 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.723 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 18.9 mt -55.33 -56.0 33.6 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.804 -178.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.723 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 78.3 Cg_exo -49.0 -41.27 40.44 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.216 1.944 . . . . 0.0 112.491 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.688 ' HG3' ' HB3' ' A' ' 47' ' ' LEU . 7.4 mm-40 -68.49 -55.2 12.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.571 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.76 HG21 ' HG2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -57.57 -49.01 77.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.468 -178.834 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.2 p -58.36 -28.32 35.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.139 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.553 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 2.8 mmtt -58.67 -43.25 89.82 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 176.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.51 ' HB3' HD13 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -89.19 -80.81 0.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.118 176.686 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.781 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -99.02 -106.38 0.2 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.459 177.685 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.479 ' H ' HD23 ' A' ' 76' ' ' LEU . . . -133.84 -80.92 0.16 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.365 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.491 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -146.14 165.6 28.67 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.775 0.322 . . . . 0.0 110.977 179.644 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.76 ' HG2' HG21 ' A' ' 72' ' ' THR . 0.1 OUTLIER -110.19 62.76 0.6 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.394 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.491 HG22 ' HB2' ' A' ' 78' ' ' HIS . 0.1 OUTLIER -98.77 123.05 51.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.69 -176.656 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.772 HD22 ' HB3' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -142.11 -36.42 0.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.223 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.482 ' HB3' ' HB2' ' A' ' 94' ' ' TYR . 2.3 tp10 -149.06 141.25 24.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.215 0.531 . . . . 0.0 112.348 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.469 HD11 HG12 ' A' ' 80' ' ' VAL . 3.8 mp -143.71 118.57 4.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.155 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -155.1 -176.05 5.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.164 0.507 . . . . 0.0 111.373 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -133.71 166.46 22.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.789 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.15 -47.74 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.17 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -123.39 -161.06 11.05 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.706 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.1 -76.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.689 2.259 . . . . 0.0 112.424 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -98.32 -2.48 39.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.101 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -93.34 119.84 32.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.402 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 14.4 m0 -120.79 167.66 12.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.03 0.443 . . . . 0.0 111.382 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.416 ' HG2' ' CD1' ' A' ' 59' ' ' TRP . 1.6 mttm -120.56 131.65 54.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.306 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -125.14 137.72 56.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.02 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.482 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 23.8 m-85 -118.27 123.44 45.42 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.384 178.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.681 HG13 ' HG3' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -123.95 142.53 40.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.251 -179.71 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.772 ' HB3' HD22 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -145.79 114.88 7.01 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.826 -176.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.803 HG21 ' HB3' ' A' ' 50' ' ' MET . 2.2 t -63.33 120.91 11.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.499 178.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 33.1 mttp . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.174 -0.917 . . . . 0.0 110.977 -179.631 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 112.522 -0.231 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 m -68.0 -50.28 56.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.736 0.303 . . . . 0.0 110.909 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.91 -68.15 0.65 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.952 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -136.51 35.29 2.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.856 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 64.1 m170 -80.48 -153.85 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.858 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -55.85 139.67 45.02 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.039 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -61.0 119.33 8.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.944 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -130.56 125.15 33.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.54 29.37 3.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.851 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.8 m -72.46 -32.43 66.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.893 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.05 28.57 0.7 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.289 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.9 138.13 48.2 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.586 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.25 76.72 4.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.912 0.387 . . . . 0.0 110.833 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.7 m -76.49 136.85 67.68 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.208 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.17 78.97 2.81 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.521 2.147 . . . . 0.0 112.063 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.6 ttt85 -84.97 -82.73 0.17 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.136 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.7 128.25 8.36 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.513 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.96 -53.96 45.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.597 0.237 . . . . 0.0 111.359 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -78.93 30.81 0.2 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.425 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.61 122.09 7.51 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.806 0.336 . . . . 0.0 111.135 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.56 102.91 11.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.941 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.7 51.06 2.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.961 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -89.06 33.09 0.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.877 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.65 66.77 8.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.967 0.413 . . . . 0.0 110.666 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 20.9 t -63.48 148.48 11.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.3 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.52 -46.7 2.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.068 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.09 154.26 38.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.137 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 51.6 m -135.52 114.78 12.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.845 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 5.8 tt -102.96 117.01 33.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.709 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -132.77 115.83 15.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.113 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.459 HG23 ' CG2' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -123.51 65.79 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.828 179.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.497 ' HB3' ' H ' ' A' ' 33' ' ' GLY . 5.9 ttm180 -59.49 -92.86 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.091 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.497 ' H ' ' HB3' ' A' ' 32' ' ' ARG . . . -67.3 99.18 0.5 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.211 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.437 ' HB2' ' HG2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -108.18 158.68 17.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.936 0.398 . . . . 0.0 111.198 -179.675 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.4 -90.74 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.888 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.663 ' HB2' HG23 ' A' ' 38' ' ' VAL . 2.9 m -63.75 164.05 18.46 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.527 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -69.97 18.17 0.2 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.647 2.231 . . . . 0.0 112.825 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.673 ' HB ' ' HD3' ' A' ' 39' ' ' PRO . 49.0 t -57.23 -52.08 76.89 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.499 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.673 ' HD3' ' HB ' ' A' ' 38' ' ' VAL . 51.6 Cg_exo -55.33 -28.25 61.82 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.302 2.001 . . . . 0.0 112.449 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.99 -54.81 32.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.637 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.34 -21.14 17.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.412 178.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.412 ' HB3' ' HA ' ' A' ' 39' ' ' PRO . 19.1 tt0 -65.38 -55.93 15.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.657 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.464 ' O ' HD13 ' A' ' 47' ' ' LEU . 7.6 t -61.37 -32.3 72.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.498 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -55.29 -38.96 69.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.493 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.87 -42.4 77.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.133 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.79 -38.47 78.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.1 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.464 HD13 ' O ' ' A' ' 43' ' ' THR . 2.2 mp -64.52 -44.55 90.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.956 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.35 -3.88 51.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -126.14 62.91 1.25 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.103 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.19 152.06 25.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.072 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.861 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -105.04 162.11 20.73 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.678 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.587 ' HD2' ' HB3' ' A' ' 51' ' ' LYS . 4.9 Cg_endo -47.47 -68.9 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.087 2.524 . . . . 0.0 113.451 -178.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.53 58.34 0.49 Allowed Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.442 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.861 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 13.1 mm-40 -90.63 143.29 26.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.032 0.444 . . . . 0.0 111.57 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 5.5 mt -135.81 96.27 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.198 178.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.91 175.12 5.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.285 0.564 . . . . 0.0 111.959 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -138.25 140.91 39.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.317 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 2.8 t -114.12 135.72 52.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.991 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -121.75 107.84 12.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.69 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.643 HD13 ' O ' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -157.97 -163.7 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.224 -179.199 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -114.17 -5.88 13.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.643 ' O ' HD13 ' A' ' 60' ' ' ILE . 6.8 m-85 -125.84 132.57 24.36 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.803 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -58.36 91.2 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.61 2.207 . . . . 0.0 112.78 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 5.1 tmm? -68.53 -25.95 65.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.056 0.455 . . . . 0.0 110.449 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.637 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 67.5 m -64.05 -13.86 50.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.946 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.453 ' HG3' ' N ' ' A' ' 67' ' ' GLU . 2.1 pttp -57.69 -33.91 68.86 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.734 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.577 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -94.32 -27.13 16.27 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.186 0.517 . . . . 0.0 110.112 178.383 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.637 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -61.31 -34.34 75.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.942 179.126 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.733 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 11.3 mt -63.53 -56.75 23.84 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.342 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.733 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 83.4 Cg_exo -47.78 -32.39 16.89 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.307 2.004 . . . . 0.0 112.373 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.08 -58.26 3.73 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.061 0.457 . . . . 0.0 111.012 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.587 HG21 ' HG2' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -59.75 -30.0 68.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.557 -178.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.579 HG12 ' O ' ' A' ' 70' ' ' PRO . 5.7 p -72.72 -29.84 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.83 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.68 -41.39 86.07 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -90.6 -78.67 0.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.446 177.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.431 HD11 HG22 ' A' ' 72' ' ' THR . 0.0 OUTLIER -98.48 -97.92 0.22 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.755 178.53 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.09 -82.4 0.05 OUTLIER Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.14 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.681 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -146.32 157.98 43.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.86 0.362 . . . . 0.0 111.234 179.449 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.706 ' HB2' ' H ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -104.72 63.4 0.72 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.491 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.681 HG22 ' HB2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -99.13 121.83 50.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.805 -176.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.744 ' HB3' ' HG2' ' A' ' 96' ' ' LYS . 2.2 pt? -139.79 -32.41 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.421 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.559 ' O ' HD13 ' A' ' 83' ' ' ILE . 0.4 OUTLIER -149.88 132.84 16.14 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -179.704 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.663 HD11 HG12 ' A' ' 80' ' ' VAL . 1.0 OUTLIER -134.62 126.23 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.315 178.268 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -158.34 175.96 13.06 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.072 0.463 . . . . 0.0 111.554 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -134.51 178.04 7.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.738 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.5 p -138.73 -43.32 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.283 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -133.7 -148.4 5.85 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.726 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.07 -77.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.608 2.205 . . . . 0.0 112.346 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.8 p -97.89 -3.47 38.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.881 0.372 . . . . 0.0 110.886 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.418 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 4.4 pt-20 -93.23 130.8 38.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.766 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -147.45 168.95 20.57 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.971 0.415 . . . . 0.0 111.203 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.406 ' HG2' ' HE1' ' A' ' 94' ' ' TYR . 20.9 ttpt -126.38 127.45 45.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.448 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.6 mt -125.53 149.46 30.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.885 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.467 ' HB2' ' CB ' ' A' ' 82' ' ' GLU . 6.8 m-85 -118.42 135.66 54.22 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.289 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.598 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -125.55 143.24 39.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.299 178.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.744 ' HG2' ' HB3' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -138.42 106.31 5.67 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 120.232 -0.587 . . . . 0.0 112.189 -177.514 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.416 ' H ' HG23 ' A' ' 97' ' ' VAL . 2.4 t -64.43 118.97 7.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.424 178.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.918 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.82 151.28 35.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.751 0.31 . . . . 0.0 110.791 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.1 170.49 13.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.019 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -81.44 -7.02 59.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.146 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -117.76 169.19 9.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.9 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -125.11 -44.57 1.9 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.958 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 9.5 m170 -65.65 -68.49 0.36 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.022 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -111.43 178.05 4.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.965 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 62.1 m-70 -104.78 -22.01 13.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.931 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.0 m -73.71 114.04 11.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.916 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.31 28.81 0.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.333 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.54 -71.8 0.78 Allowed Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.503 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.436 ' HG ' ' H ' ' A' ' 14' ' ' VAL . 1.7 tp -85.42 161.06 19.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.851 0.358 . . . . 0.0 110.875 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.436 ' H ' ' HG ' ' A' ' 13' ' ' LEU . 28.1 m -64.51 143.27 98.56 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.056 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.31 106.91 2.15 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.451 2.101 . . . . 0.0 112.251 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -85.53 27.62 0.82 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.359 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.45 -89.51 0.59 Allowed Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.491 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.29 29.01 0.36 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.65 0.262 . . . . 0.0 111.078 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 28.2 t60 -53.54 -78.32 0.02 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.321 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.8 mtp -81.16 -89.89 0.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.287 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.18 177.23 8.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.364 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.2 mttm -91.18 53.41 2.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.208 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -97.5 86.64 3.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.88 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -106.36 77.83 1.24 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.406 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.629 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 85.6 t -79.0 136.5 23.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.561 178.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.678 ' HB ' HD11 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -99.47 -37.37 9.22 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.846 -0.341 . . . . 0.0 111.82 -178.731 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.583 ' H ' ' CD1' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -145.52 162.23 37.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.407 0.622 . . . . 0.0 111.845 -178.723 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 83.1 m -136.17 125.99 25.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.715 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 tt -107.64 120.38 42.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.575 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.32 112.44 8.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.861 0.362 . . . . 0.0 111.084 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.1 t -134.14 70.06 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.972 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.02 -87.32 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.45 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.41 -156.49 4.81 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.384 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.18 130.53 55.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.863 0.364 . . . . 0.0 110.687 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.6 m -135.53 -157.66 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.791 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.556 ' O ' ' HD2' ' A' ' 39' ' ' PRO . 10.1 m -55.12 160.71 3.01 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.607 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.01 15.26 1.17 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.379 2.053 . . . . 0.0 112.596 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.529 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 10.5 t -65.24 -53.25 41.35 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.371 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.556 ' HD2' ' O ' ' A' ' 36' ' ' CYS . 30.9 Cg_endo -63.38 -24.12 71.41 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.166 1.911 . . . . 0.0 112.197 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.416 ' O ' HG22 ' A' ' 43' ' ' THR . 4.0 t70 -61.05 -65.93 0.61 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.652 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.7 t -65.55 -18.64 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.465 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -65.2 -50.82 64.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.731 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 40' ' ' ASP . 1.4 t -63.82 -33.34 75.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.44 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -59.69 -40.23 87.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.151 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -67.75 -29.79 69.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.99 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.88 -56.06 26.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.017 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.671 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 1.7 mm? -61.3 -62.0 2.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.58 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -58.7 -32.77 69.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.492 . . . . 0.0 112.184 -177.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -124.97 66.05 1.12 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.842 0.353 . . . . 0.0 111.24 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.507 ' HB2' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -98.78 158.18 15.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.921 179.775 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -100.12 144.86 29.21 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.648 179.538 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -49.87 -46.75 26.27 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.885 2.39 . . . . 0.0 113.573 -178.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.0 56.31 0.54 Allowed Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.622 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 11.7 mm-40 -90.86 136.01 33.35 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 117.18 0.49 . . . . 0.0 111.614 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.629 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 2.6 mp -136.4 81.41 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.613 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.678 HD11 ' HB ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -117.19 176.26 5.22 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.349 -0.541 . . . . 0.0 112.246 -173.481 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -132.04 162.52 30.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.811 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.481 HG12 HG12 ' A' ' 60' ' ' ILE . 6.2 t -135.3 139.59 46.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.815 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 9.1 t-105 -127.77 104.53 7.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.745 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.481 HG12 HG12 ' A' ' 58' ' ' VAL . 0.5 OUTLIER -158.29 -177.31 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.27 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -97.26 0.23 47.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.64 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -136.93 130.16 17.48 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.642 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.46 100.46 0.57 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.42 2.08 . . . . 0.0 112.304 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.408 ' O ' ' HD3' ' A' ' 68' ' ' ARG . 1.3 mtt -68.01 -13.04 61.87 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.773 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 14.4 p -59.14 -11.01 3.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.363 178.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -55.09 -46.44 75.48 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.11 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.548 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -87.23 -25.19 24.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.171 0.51 . . . . 0.0 110.209 178.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.773 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -62.41 -35.6 79.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.915 179.343 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.758 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 16.6 mt -60.39 -56.89 30.91 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.513 -179.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.758 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 67.0 Cg_exo -52.09 -32.15 47.91 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.283 1.988 . . . . 0.0 112.47 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.671 ' HG3' ' HB3' ' A' ' 47' ' ' LEU . 30.1 mm-40 -72.46 -63.69 1.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.884 0.373 . . . . 0.0 111.338 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.467 HG22 HD11 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -57.42 -28.36 63.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.479 -178.791 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.521 HG12 ' O ' ' A' ' 70' ' ' PRO . 5.8 p -74.19 -29.49 25.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.803 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.67 -41.43 86.1 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 176.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.433 ' HD3' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -90.47 -78.38 0.38 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.283 177.104 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.467 HD11 HG22 ' A' ' 72' ' ' THR . 0.0 OUTLIER -98.54 -96.75 0.22 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.743 178.515 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.29 -79.52 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.1 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.522 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -146.12 158.55 43.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.769 0.319 . . . . 0.0 110.863 179.262 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.77 ' HB2' HG23 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -103.49 56.67 0.74 Allowed 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.822 179.44 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.651 HG12 HD11 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -98.88 125.36 52.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.236 -177.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.522 ' HG ' ' HB3' ' A' ' 94' ' ' TYR . 1.1 pp -133.43 -36.9 0.97 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.015 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.485 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -153.38 143.67 22.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.97 0.414 . . . . 0.0 111.724 179.823 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.651 HD11 HG12 ' A' ' 80' ' ' VAL . 3.4 mp -143.19 137.52 26.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.336 178.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.429 ' HG3' ' HB3' ' A' ' 92' ' ' LYS . 2.5 pt-20 -152.6 176.53 11.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.016 0.436 . . . . 0.0 111.214 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -133.49 163.59 29.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.681 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.58 HG23 ' HA ' ' A' ' 91' ' ' TRP . 2.8 t -127.46 -66.58 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.321 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -123.0 -141.08 5.83 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.671 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.459 ' HB2' ' H ' ' A' ' 89' ' ' SER . 31.4 Cg_exo -58.71 -84.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.7 2.267 . . . . 0.0 112.329 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.459 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 85.1 p -100.05 -1.16 37.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.011 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -91.68 128.05 37.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.822 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.58 ' HA ' HG23 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -150.16 171.13 17.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.253 -179.682 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.429 ' HB3' ' HG3' ' A' ' 84' ' ' GLU . 12.0 tttt -121.36 141.69 50.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.491 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.426 HG22 ' H ' ' A' ' 94' ' ' TYR . 0.8 OUTLIER -131.16 165.17 32.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.186 -179.542 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.522 ' HB3' ' HG ' ' A' ' 81' ' ' LEU . 12.7 m-85 -132.88 126.17 31.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.001 178.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.77 HG23 ' HB2' ' A' ' 79' ' ' GLU . 18.7 mm -124.76 145.73 31.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.078 -177.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.662 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -150.54 120.1 6.96 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 119.759 -0.776 . . . . 0.0 112.924 -178.62 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.512 HG22 ' OE1' ' A' ' 79' ' ' GLU . 22.7 t -73.57 128.48 36.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.242 178.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.8 tttm . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.929 -179.708 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 112.409 -0.277 . . . . 0.0 112.409 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -121.08 -41.52 2.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.746 0.308 . . . . 0.0 110.797 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.48 127.97 50.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.903 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -69.58 135.9 50.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.002 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -64.88 129.28 39.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.875 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -130.55 -84.4 0.53 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.005 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.7 -59.43 0.72 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.922 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 -62.67 110.41 1.71 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.986 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -82.59 -16.05 49.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.842 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 27.4 t -80.27 147.27 31.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.048 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.33 -80.73 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.032 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.0 -166.89 38.53 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.59 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.31 34.41 0.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.792 0.33 . . . . 0.0 110.909 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.41 ' H ' HG22 ' A' ' 14' ' ' VAL . 3.7 m -76.28 144.06 74.11 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.163 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.21 164.02 88.69 Favored 'Cis proline' 0 C--N 1.348 0.529 0 C-N-CA 123.754 -1.353 . . . . 0.0 112.139 0.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.488 ' HB3' ' H ' ' A' ' 17' ' ' GLY . 1.1 mpt_? -81.11 -150.55 0.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.824 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.488 ' H ' ' HB3' ' A' ' 16' ' ' ARG . . . -72.39 155.47 51.41 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.565 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.99 -75.67 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.805 0.336 . . . . 0.0 110.943 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.488 ' HB3' ' H ' ' A' ' 20' ' ' MET . 2.2 m-70 -90.53 -151.27 0.24 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.862 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.488 ' H ' ' HB3' ' A' ' 19' ' ' HIS . 12.3 mtm -70.12 -85.63 0.02 OUTLIER 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.755 0.312 . . . . 0.0 110.998 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.19 165.29 15.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.255 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -91.17 72.9 6.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.822 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -89.97 39.36 0.96 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.922 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.28 61.13 6.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.581 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.7 t -85.46 152.79 3.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.243 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.29 -61.88 1.31 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.691 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 0.8 OUTLIER -115.56 157.83 23.53 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.801 179.117 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.0 m -135.49 125.72 26.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.066 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.0 tt -107.46 119.44 39.42 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.975 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -124.04 113.96 19.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.516 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.446 ' O ' HG23 ' A' ' 60' ' ' ILE . 3.8 m -140.39 74.06 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.891 0.377 . . . . 0.0 111.543 -179.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -163.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.864 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.68 94.29 0.04 OUTLIER Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.44 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -103.18 -173.19 2.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.792 0.33 . . . . 0.0 111.012 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.418 ' HB ' ' H ' ' A' ' 36' ' ' CYS . 2.0 t -104.64 -86.24 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.653 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.692 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.8 OUTLIER -52.35 155.67 3.42 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.172 -179.467 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.63 25.05 0.4 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.613 2.208 . . . . 0.0 112.439 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.692 HG23 ' HB3' ' A' ' 36' ' ' CYS . 50.2 t -59.5 -48.68 95.18 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.855 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 38' ' ' VAL . 19.5 Cg_endo -60.11 -31.44 93.29 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.221 1.947 . . . . 0.0 112.457 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -64.04 -57.82 8.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.959 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.5 t -66.19 -19.65 26.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.066 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -65.97 -67.14 0.47 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.118 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.535 ' O ' HD13 ' A' ' 47' ' ' LEU . 8.4 t -60.2 -31.02 69.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.085 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.67 -44.3 77.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.665 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.56 -35.25 79.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.75 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.8 -36.4 84.2 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.997 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.535 HD13 ' O ' ' A' ' 43' ' ' THR . 2.4 mp -70.28 -39.67 74.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.154 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -78.84 -21.33 47.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.336 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.9 t30 -135.24 70.56 1.43 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.801 0.334 . . . . 0.0 111.4 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.658 ' HB2' HG21 ' A' ' 97' ' ' VAL . 18.4 ptp -102.28 145.14 29.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.673 178.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.891 ' HG2' ' HD2' ' A' ' 52' ' ' PRO . 3.1 tttp -80.79 148.17 64.35 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.783 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.891 ' HD2' ' HG2' ' A' ' 51' ' ' LYS . 58.7 Cg_exo -39.03 -75.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.25 2.634 . . . . 0.0 114.173 -178.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.86 59.7 0.48 Allowed Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.001 -0.618 . . . . 0.0 113.261 -177.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.406 ' HG2' ' HB3' ' A' ' 51' ' ' LYS . 1.8 mm-40 -90.92 153.68 20.02 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.014 0.435 . . . . 0.0 111.918 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.2 mt -132.5 116.0 26.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.99 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.536 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 5.0 mp -126.72 152.13 47.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.119 0.485 . . . . 0.0 111.949 -178.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -113.92 129.53 56.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.402 177.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.81 HG11 HH12 ' A' ' 68' ' ' ARG . 2.2 t -114.12 128.77 70.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.165 0.507 . . . . 0.0 111.925 -177.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -122.87 101.17 7.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.448 178.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.733 HD12 ' HB2' ' A' ' 64' ' ' MET . 0.5 OUTLIER -149.64 -160.01 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.681 -179.437 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.478 ' H ' HG22 ' A' ' 60' ' ' ILE . 10.1 p-10 -145.17 35.26 1.09 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.704 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.556 ' H ' ' HA ' ' A' ' 63' ' ' PRO . 44.4 m-85 -105.74 -63.02 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.001 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.556 ' HA ' ' H ' ' A' ' 62' ' ' TYR . 85.7 Cg_endo -97.53 164.23 12.48 Favored 'Cis proline' 0 C--N 1.356 0.971 0 CA-C-N 119.507 0.86 . . . . 0.0 112.088 -1.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.733 ' HB2' HD12 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -68.48 -17.76 64.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.808 0.337 . . . . 0.0 111.147 179.815 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.577 ' HA ' ' HD3' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -60.44 -17.4 44.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.932 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 63' ' ' PRO . 2.9 pttp -62.51 -27.22 68.99 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.844 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.507 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.7 OUTLIER -94.34 -26.19 16.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.178 0.513 . . . . 0.0 109.863 178.107 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.81 HH12 HG11 ' A' ' 58' ' ' VAL . 3.8 mpt_? -58.89 -47.57 84.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.193 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.732 HG23 ' HB3' ' A' ' 78' ' ' HIS . 3.8 mt -57.8 -55.32 46.2 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.834 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.693 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 83.8 Cg_exo -42.94 -51.47 5.42 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 122.73 2.286 . . . . 0.0 113.171 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.415 ' O ' ' HD3' ' A' ' 75' ' ' LYS . 2.0 mm-40 -62.41 -41.34 98.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.007 0.432 . . . . 0.0 110.978 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.542 HG21 ' HG3' ' A' ' 79' ' ' GLU . 2.9 m -59.72 -52.08 67.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.754 -179.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -58.67 -26.33 31.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.937 -178.863 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.6 -44.17 89.79 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 176.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.415 ' HD3' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -90.36 -77.28 0.41 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.429 176.898 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.75 HD13 ' HB2' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -98.52 -98.64 0.22 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.828 178.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.14 -84.54 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.151 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.732 ' HB3' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -146.36 146.91 30.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.976 0.417 . . . . 0.0 111.213 179.276 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.916 ' HB2' HG23 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -95.34 52.75 1.43 Allowed 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 177.737 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.529 HG12 ' HB2' ' A' ' 78' ' ' HIS . 1.4 p -98.71 118.77 45.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.208 -177.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.785 HD22 ' HB3' ' A' ' 96' ' ' LYS . 1.1 pt? -133.65 -29.35 1.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.686 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.505 ' O ' HG13 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -152.81 144.78 23.71 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.979 179.074 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 82' ' ' GLU . 2.5 mp -144.5 126.44 9.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.566 178.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 92' ' ' LYS . 9.3 pt-20 -153.06 174.67 13.89 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.905 0.384 . . . . 0.0 111.137 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.04 169.06 17.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.877 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.2 t -129.25 -52.68 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.215 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -126.1 -145.53 6.41 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.767 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.89 -77.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.606 2.204 . . . . 0.0 112.523 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.18 -6.85 27.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.937 0.399 . . . . 0.0 111.138 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -89.62 134.47 34.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.567 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -151.31 169.63 21.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.047 0.451 . . . . 0.0 111.265 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 10.5 ttpt -126.97 125.51 41.63 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.344 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.5 HG22 ' N ' ' A' ' 94' ' ' TYR . 4.1 mp -125.5 159.87 32.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.925 0.393 . . . . 0.0 110.836 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.5 ' N ' HG22 ' A' ' 93' ' ' ILE . 6.3 m-85 -118.2 133.55 55.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.579 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.916 HG23 ' HB2' ' A' ' 79' ' ' GLU . 12.9 mm -124.21 137.82 55.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.093 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.785 ' HB3' HD22 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -144.91 109.78 5.05 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.375 -0.53 . . . . 0.0 112.052 -176.677 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.658 HG21 ' HB2' ' A' ' 50' ' ' MET . 4.1 t -65.54 116.19 4.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.304 178.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.75 ' HB2' HD13 ' A' ' 76' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.082 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.581 -0.208 . . . . 0.0 112.581 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 p -126.94 -77.15 0.58 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.745 0.307 . . . . 0.0 110.885 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.8 m -139.18 124.0 18.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -102.79 11.02 38.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.941 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -74.2 90.52 2.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.819 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -133.38 44.96 2.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.904 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -90.78 28.26 1.58 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.965 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -89.89 102.0 14.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.961 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -115.6 40.8 2.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.931 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.2 m -81.77 -166.69 1.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.894 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.16 27.06 0.58 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.192 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.84 92.63 1.63 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.482 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.584 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 4.3 mm? -70.5 -173.23 0.7 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.742 0.305 . . . . 0.0 110.77 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.508 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 58.8 t -58.99 -50.77 86.22 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.261 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.584 ' HD2' ' HB3' ' A' ' 13' ' ' LEU . 56.2 Cg_endo -70.22 148.74 62.76 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.092 1.861 . . . . 0.0 112.231 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -85.27 33.07 0.55 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.059 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -53.76 172.31 0.69 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.055 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.405 ' C ' ' H ' ' A' ' 20' ' ' MET . 15.9 p -80.6 35.42 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.455 0.169 . . . . 0.0 111.451 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -76.66 25.99 0.14 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.642 0.258 . . . . 0.0 111.446 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.405 ' H ' ' C ' ' A' ' 18' ' ' SER . 0.0 OUTLIER -81.11 -169.03 2.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.768 0.318 . . . . 0.0 111.034 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.67 -174.0 0.51 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.013 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.6 mttm -91.29 20.61 5.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.112 0.482 . . . . 0.0 110.904 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -103.74 41.44 1.28 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.986 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.5 77.71 1.3 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.091 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.8 t -61.24 135.69 25.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.772 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.57 -56.08 2.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.152 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.03 137.76 50.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.829 0.347 . . . . 0.0 111.356 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 54.9 m -123.89 126.87 47.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.522 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.685 HD11 ' HG2' ' A' ' 42' ' ' GLU . 10.5 tp -109.83 118.76 37.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.292 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -108.24 128.42 54.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.528 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.793 ' HB ' HG23 ' A' ' 60' ' ' ILE . 18.9 t -117.24 -23.45 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.357 -179.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.84 -10.39 0.75 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.13 -91.76 0.37 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.76 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -80.6 175.4 10.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.804 0.335 . . . . 0.0 110.961 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.14 -177.72 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.208 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.766 ' HA ' ' HD2' ' A' ' 39' ' ' PRO . 20.9 p -53.1 154.98 4.86 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.104 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -91.81 18.91 38.56 Favored 'Cis proline' 0 C--N 1.348 0.521 0 C-N-CA 123.863 -1.307 . . . . 0.0 112.785 1.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.68 ' HB ' ' HD3' ' A' ' 39' ' ' PRO . 24.9 t -59.49 -53.1 69.18 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.627 -179.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.766 ' HD2' ' HA ' ' A' ' 36' ' ' CYS . 24.5 Cg_exo -64.26 -22.55 66.63 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.284 1.989 . . . . 0.0 112.176 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.16 -64.68 0.85 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.132 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 17.2 t -70.07 -30.01 42.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.294 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.685 ' HG2' HD11 ' A' ' 29' ' ' LEU . 28.2 tt0 -61.69 -56.94 14.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.148 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.439 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 6.7 t -62.65 -41.36 99.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.005 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.2 -43.78 71.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.859 0.361 . . . . 0.0 110.702 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.41 -32.76 74.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.412 178.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.566 ' HA ' HD21 ' A' ' 49' ' ' ASN . . . -59.32 -45.27 91.78 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.038 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.408 HD22 ' O ' ' A' ' 43' ' ' THR . 1.8 mm? -72.48 -19.47 61.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.772 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.41 -36.64 29.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.359 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.705 HD22 ' H ' ' A' ' 49' ' ' ASN . 0.1 OUTLIER -106.74 48.6 0.83 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.909 0.385 . . . . 0.0 111.606 -178.621 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.1 ptm -89.9 126.35 35.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.897 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.461 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -94.67 152.35 39.78 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.795 -179.86 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.461 ' HD2' ' HG3' ' A' ' 51' ' ' LYS . 61.0 Cg_exo -40.4 -67.61 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.175 2.583 . . . . 0.0 113.831 -178.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.32 57.87 0.51 Allowed Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.993 -0.622 . . . . 0.0 113.141 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.446 ' O ' HD13 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -91.25 150.29 21.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.983 0.421 . . . . 0.0 111.898 -179.71 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.573 HD13 ' HG3' ' A' ' 96' ' ' LYS . 0.6 OUTLIER -131.07 112.81 22.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.032 178.282 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 mt -119.78 154.51 34.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.176 0.513 . . . . 0.0 112.173 -177.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -119.75 125.86 49.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.472 177.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.1 t -114.96 138.22 45.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.176 0.512 . . . . 0.0 112.327 -177.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.455 ' C ' HG13 ' A' ' 60' ' ' ILE . 7.1 m0 -122.46 105.62 10.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.654 177.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.924 HG12 ' HB2' ' A' ' 64' ' ' MET . 0.1 OUTLIER -144.97 -176.97 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 CA-C-O 120.966 0.412 . . . . 0.0 111.505 -177.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.563 ' HB3' ' HA ' ' A' ' 90' ' ' GLU . 0.5 OUTLIER -138.4 25.9 2.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.869 179.396 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.795 ' H ' ' HA ' ' A' ' 63' ' ' PRO . 0.6 OUTLIER -106.19 -55.48 0.07 OUTLIER Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.597 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.795 ' HA ' ' H ' ' A' ' 62' ' ' TYR . 78.5 Cg_endo -95.61 177.36 9.94 Favored 'Cis proline' 0 C--N 1.355 0.897 0 C-N-CA 124.904 -0.873 . . . . 0.0 112.708 0.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.924 ' HB2' HG12 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -68.43 -25.7 65.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.228 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.457 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 14.4 p -61.3 -13.02 15.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.087 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.514 ' HG3' ' N ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -62.97 -31.93 73.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.886 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.562 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -94.2 -25.66 16.99 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.084 0.469 . . . . 0.0 110.241 178.758 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.457 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 18.5 mtt85 -62.17 -41.91 98.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.954 179.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.731 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 12.5 mt -56.7 -55.84 38.99 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.684 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.731 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 76.2 Cg_exo -49.31 -40.8 43.59 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.292 1.995 . . . . 0.0 112.703 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.86 -51.65 52.99 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.899 0.381 . . . . 0.0 111.219 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.835 HG21 ' HG2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -59.53 -50.63 73.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.59 -178.799 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.0 p -58.37 -28.12 34.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.895 -178.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.78 -42.46 89.03 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 176.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.6 -80.62 0.3 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.949 176.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.757 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -98.58 -106.65 0.19 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.363 177.2 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.488 ' H ' HD23 ' A' ' 76' ' ' LEU . . . -132.73 -84.76 0.26 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.018 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.39 164.23 33.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.915 0.388 . . . . 0.0 111.309 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.835 ' HG2' HG21 ' A' ' 72' ' ' THR . 0.0 OUTLIER -107.09 62.3 0.62 Allowed 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.397 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.478 HG23 HD11 ' A' ' 83' ' ' ILE . 1.4 p -98.14 120.88 48.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.427 -175.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.575 HD21 ' HB3' ' A' ' 94' ' ' TYR . 0.5 OUTLIER -133.68 -33.52 1.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.795 179.807 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.468 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -151.77 145.16 24.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.014 0.435 . . . . 0.0 111.811 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.478 HD11 HG23 ' A' ' 80' ' ' VAL . 3.5 mp -142.23 123.51 12.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.288 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.574 ' HG3' ' HB3' ' A' ' 92' ' ' LYS . 5.1 pt-20 -156.55 -175.55 5.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.221 0.534 . . . . 0.0 111.349 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.486 ' HB3' ' HD1' ' A' ' 91' ' ' TRP . 3.6 pt-20 -133.24 166.39 22.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.639 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.406 HG13 ' N ' ' A' ' 87' ' ' GLY . 4.8 p -131.27 -44.9 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.477 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.406 ' N ' HG13 ' A' ' 86' ' ' VAL . . . -133.33 -151.83 6.68 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.673 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.89 -74.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.547 2.164 . . . . 0.0 112.426 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.7 p -95.65 -5.84 41.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.812 0.339 . . . . 0.0 111.157 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.563 ' HA ' ' HB3' ' A' ' 61' ' ' ASP . 4.5 pt-20 -93.03 140.94 28.95 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.558 179.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.486 ' HD1' ' HB3' ' A' ' 85' ' ' GLU . 6.1 m-90 -136.44 163.97 29.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.047 0.451 . . . . 0.0 111.335 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.574 ' HB3' ' HG3' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -120.23 117.0 26.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.077 178.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.4 mp -125.28 145.34 32.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.99 -178.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.575 ' HB3' HD21 ' A' ' 81' ' ' LEU . 29.1 m-85 -118.04 132.54 56.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.187 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.711 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -124.13 141.66 43.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.796 -177.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.585 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -151.21 130.05 12.44 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.239 -0.584 . . . . 0.0 112.287 -177.714 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.433 HG22 ' OE1' ' A' ' 79' ' ' GLU . 2.3 t -80.85 120.05 31.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.089 177.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.954 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 112.449 -0.261 . . . . 0.0 112.449 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.1 t -77.31 156.72 31.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.768 0.318 . . . . 0.0 110.974 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.77 -3.34 25.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.985 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -79.06 106.99 11.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.029 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -120.38 -96.74 0.47 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.802 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.48 23.55 2.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.781 0.324 . . . . 0.0 111.022 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 40.1 m-70 -131.96 27.63 4.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.078 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -108.91 -168.99 1.41 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.976 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -63.81 141.75 58.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.905 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.59 144.05 44.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.873 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.86 -69.55 0.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.922 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.77 158.53 53.17 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.527 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -95.47 -94.09 0.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.669 0.271 . . . . 0.0 110.968 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.5 m -89.26 144.14 31.98 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.173 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -78.76 136.22 40.02 Favored 'Cis proline' 0 C--N 1.349 0.571 0 C-N-CA 123.462 -1.474 . . . . 0.0 112.398 -0.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.6 mtt180 -82.2 26.15 0.55 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.332 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.63 28.82 3.05 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.565 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 85.2 p -80.57 -150.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.722 0.296 . . . . 0.0 110.846 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -83.2 28.6 0.52 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.181 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.88 -148.79 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.913 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.91 129.43 41.51 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.127 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -89.43 76.22 7.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.955 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -72.72 125.62 27.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.98 151.6 35.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.03 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.695 HG13 ' HA ' ' A' ' 56' ' ' LEU . 57.6 t -85.02 145.41 8.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.12 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.3 m -106.36 -53.64 2.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.196 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.456 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -119.39 167.03 12.32 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.048 0.452 . . . . 0.0 111.466 -179.197 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.418 ' H ' ' HG3' ' A' ' 27' ' ' LYS . 87.8 m -134.09 121.99 22.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.648 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.476 HD22 HG13 ' A' ' 58' ' ' VAL . 5.1 tt -103.69 120.75 41.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.935 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -132.37 120.17 21.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.727 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.427 ' HA ' ' HB3' ' A' ' 39' ' ' PRO . 3.0 t -109.65 -4.66 10.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.246 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.645 ' HD3' ' HE1' ' A' ' 59' ' ' TRP . 0.7 OUTLIER -50.76 -18.57 0.75 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.285 -179.474 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.61 102.02 0.7 Allowed Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.551 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.87 23.55 0.54 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.686 0.279 . . . . 0.0 111.421 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -104.27 -133.36 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.95 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.405 ' C ' ' H ' ' A' ' 38' ' ' VAL . 99.2 m -50.83 155.15 2.09 Favored Pre-proline 0 C--O 1.232 0.136 0 CA-C-O 120.603 0.239 . . . . 0.0 111.127 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.95 26.64 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.633 2.222 . . . . 0.0 112.534 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.691 ' HB ' ' HD3' ' A' ' 39' ' ' PRO . 73.6 t -58.5 -51.47 81.57 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.341 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.691 ' HD3' ' HB ' ' A' ' 38' ' ' VAL . 19.7 Cg_exo -66.61 -20.49 53.36 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.335 2.024 . . . . 0.0 112.137 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -70.59 -51.12 30.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.983 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.1 t -74.39 -29.98 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.711 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -60.69 -53.36 58.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.829 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.445 ' CB ' HD11 ' A' ' 29' ' ' LEU . 13.3 t -64.14 -38.81 92.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.791 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.64 -41.63 73.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.676 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.68 -30.35 69.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.05 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.52 -43.98 80.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.25 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.817 HD11 ' HG2' ' A' ' 68' ' ' ARG . 2.3 mm? -71.4 -43.86 66.02 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.69 -179.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -81.35 -12.65 58.94 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -177.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.412 ' ND2' ' HE3' ' A' ' 51' ' ' LYS . 2.2 t30 -135.51 72.71 1.45 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.94 0.4 . . . . 0.0 111.139 -179.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.67 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -108.53 138.49 44.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.866 179.832 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.656 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -96.09 153.29 39.16 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.7 179.708 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -52.94 -43.61 55.32 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.624 2.216 . . . . 0.0 113.198 -178.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.8 50.14 0.86 Allowed Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.532 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.684 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 20.0 mm-40 -91.27 129.0 37.31 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 117.358 0.579 . . . . 0.0 111.635 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 1.1 mp -135.59 89.46 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.779 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.695 ' HA ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -118.89 -177.98 3.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.252 0.549 . . . . 0.0 112.087 -176.695 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -129.25 174.01 9.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.236 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.569 HG12 HG13 ' A' ' 60' ' ' ILE . 13.4 t -140.17 136.02 37.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.858 0.361 . . . . 0.0 111.303 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.645 ' HE1' ' HD3' ' A' ' 32' ' ' ARG . 57.9 t-105 -122.49 104.49 9.41 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.706 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.569 HG13 HG12 ' A' ' 58' ' ' VAL . 0.8 OUTLIER -159.04 -177.8 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.084 0.469 . . . . 0.0 111.528 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 4.9 m-20 -99.89 -13.8 19.02 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.016 177.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.466 ' O ' HD13 ' A' ' 60' ' ' ILE . 1.8 m-85 -129.91 124.8 21.79 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.274 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.482 ' HD3' ' HE1' ' A' ' 91' ' ' TRP . 86.4 Cg_exo -47.54 104.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.643 2.229 . . . . 0.0 112.863 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.425 ' CE ' HD21 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -64.88 -19.27 65.81 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.116 0.484 . . . . 0.0 110.586 179.3 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.681 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 6.1 p -61.82 -10.09 8.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.625 179.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.7 ptmt -58.15 -37.96 75.68 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.58 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.552 ' O ' ' HG2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -91.74 -24.21 19.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.277 0.56 . . . . 0.0 109.967 178.259 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.817 ' HG2' HD11 ' A' ' 47' ' ' LEU . 33.2 mtt-85 -63.46 -39.69 95.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.756 179.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.464 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 12.2 mt -57.5 -56.96 28.64 Favored Pre-proline 0 CA--C 1.532 0.282 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.552 ' HG2' ' O ' ' A' ' 67' ' ' GLU . 9.8 Cg_endo -53.4 -34.58 71.84 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.138 1.892 . . . . 0.0 112.574 -178.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.556 ' HG3' ' HB3' ' A' ' 47' ' ' LEU . 65.1 mm-40 -72.92 -65.71 0.76 Allowed 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.042 0.448 . . . . 0.0 111.327 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.636 HG21 ' HG3' ' A' ' 79' ' ' GLU . 0.2 OUTLIER -58.7 -24.91 62.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.353 -178.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.534 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 3.4 p -76.07 -27.89 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-O 120.74 0.305 . . . . 0.0 110.474 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.97 -43.35 86.43 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 176.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.08 -77.89 0.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.117 176.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.421 HD11 HG22 ' A' ' 72' ' ' THR . 0.0 OUTLIER -98.18 -100.24 0.21 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.626 178.216 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.27 -85.62 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.71 178.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.597 ' CE1' HD11 ' A' ' 95' ' ' ILE . 6.3 t-80 -147.05 172.7 13.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.924 0.392 . . . . 0.0 110.94 177.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.885 ' HB2' HG13 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -111.48 68.53 0.67 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.84 178.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.565 HG22 ' ND1' ' A' ' 78' ' ' HIS . 0.1 OUTLIER -99.02 122.06 50.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.952 0.406 . . . . 0.0 112.025 -176.64 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.999 ' HB3' ' HG2' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -133.74 -40.97 0.86 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.036 178.563 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.567 ' HB2' HD12 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -153.88 151.02 28.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.04 0.448 . . . . 0.0 112.116 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.512 HG13 ' C ' ' A' ' 82' ' ' GLU . 1.1 mp -141.54 142.14 29.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.159 178.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -156.63 176.05 13.24 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.027 0.442 . . . . 0.0 111.682 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -136.07 176.65 8.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.732 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.578 HG12 ' HA ' ' A' ' 91' ' ' TRP . 0.7 OUTLIER -144.34 -53.48 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.134 -178.298 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.405 ' H ' HG13 ' A' ' 86' ' ' VAL . . . -123.92 -153.91 8.79 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.564 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.97 -78.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.626 2.218 . . . . 0.0 112.311 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.05 -3.02 32.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.869 0.366 . . . . 0.0 111.111 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 8.7 pt-20 -93.35 133.24 36.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.765 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.578 ' HA ' HG12 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -151.56 173.73 14.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.272 -179.902 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.551 ' HG3' ' HE3' ' A' ' 59' ' ' TRP . 3.3 mttm -122.33 143.43 49.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.365 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.63 151.27 31.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.919 0.39 . . . . 0.0 111.258 -179.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.464 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 14.4 m-85 -118.66 123.65 45.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.081 178.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.885 HG13 ' HB2' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -123.77 151.51 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.045 -177.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.999 ' HG2' ' HB3' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -148.83 97.74 2.76 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.926 -177.445 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.684 ' HB ' ' HB2' ' A' ' 54' ' ' GLU . 17.6 t -60.56 117.53 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.701 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.908 -179.905 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.6 t -107.02 -69.07 0.85 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.807 0.336 . . . . 0.0 110.973 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -127.55 -0.14 6.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.903 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.42 37.94 1.41 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -66.04 169.0 7.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.963 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -65.22 146.64 54.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.924 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -71.75 139.18 48.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.095 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.733 ' HB3' ' HB2' ' A' ' 11' ' ' SER . 39.3 m80 -92.75 131.17 38.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.742 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -102.36 -80.9 0.5 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.131 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.02 -9.81 58.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.143 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.733 ' HB2' ' HB3' ' A' ' 8' ' ' HIS . 66.8 m -75.54 -77.64 0.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.88 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.23 93.61 0.79 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.779 -0.725 . . . . 0.0 112.404 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 mp -73.2 -76.18 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.683 0.278 . . . . 0.0 110.963 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.5 m -88.69 141.82 30.37 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.088 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -80.89 38.13 0.74 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.067 2.511 . . . . 0.0 112.258 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -77.62 -79.16 0.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.037 -179.649 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.54 85.61 0.84 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.445 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.4 -77.45 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.79 0.329 . . . . 0.0 110.981 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -83.86 -81.64 0.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.899 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.12 128.78 34.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.874 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.13 -169.64 1.92 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.333 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.46 ' HB2' ' H ' ' A' ' 23' ' ' TYR . 1.0 OUTLIER -68.12 -106.1 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.69 178.59 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.46 ' H ' ' HB2' ' A' ' 22' ' ' LYS . 28.5 m-85 -92.32 112.22 24.08 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.904 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -103.87 126.27 50.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.949 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 68.9 t -61.82 136.61 25.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.26 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.7 m -99.84 -67.82 0.83 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.891 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -115.76 159.43 21.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.801 0.334 . . . . 0.0 110.842 179.636 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.6 m -135.65 124.77 24.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.096 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.3 tt -104.94 112.87 26.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.571 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -130.05 112.55 13.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.142 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.725 HG12 HG21 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -135.51 72.45 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.818 179.13 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.437 ' HB3' ' H ' ' A' ' 33' ' ' GLY . 4.3 ttm180 -52.65 -90.14 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.499 -179.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.437 ' H ' ' HB3' ' A' ' 32' ' ' ARG . . . -75.46 -159.46 7.9 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.333 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.8 134.51 36.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.535 0.683 . . . . 0.0 112.286 -178.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.725 HG21 HG12 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -136.26 -176.88 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 114.691 -1.141 . . . . 0.0 111.178 179.538 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.601 ' O ' ' HD2' ' A' ' 39' ' ' PRO . 0.8 OUTLIER -67.52 163.22 49.71 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.365 178.885 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -73.03 11.52 0.89 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.72 2.28 . . . . 0.0 112.692 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.493 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 39.8 t -64.31 -54.85 35.23 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.671 -179.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.601 ' HD2' ' O ' ' A' ' 36' ' ' CYS . 28.8 Cg_endo -61.94 -21.24 71.93 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.321 2.014 . . . . 0.0 112.14 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -63.53 -62.67 1.52 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.646 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.1 t -71.76 -18.4 19.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.805 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -66.35 -57.44 7.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.886 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.481 HG21 ' SD ' ' A' ' 64' ' ' MET . 14.6 t -60.43 -35.01 74.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.61 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.3 tptm -61.26 -39.54 90.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.397 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -32.67 72.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.762 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.63 -48.71 80.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.822 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.638 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 3.0 mt -62.02 -30.05 70.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.784 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.62 -25.63 45.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.164 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -132.43 69.62 1.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.058 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.636 ' HB3' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -84.6 147.47 26.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.792 179.835 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.795 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 0.8 OUTLIER -103.08 161.57 22.7 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.658 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -46.61 -72.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.988 2.458 . . . . 0.0 113.905 -177.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.28 59.99 0.45 Allowed Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.333 -177.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.795 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 26.3 mm-40 -87.34 139.19 30.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.896 0.379 . . . . 0.0 111.377 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.557 ' HA ' ' HB2' ' A' ' 96' ' ' LYS . 16.8 mt -135.25 121.03 30.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.682 178.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.486 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.5 mp -127.1 146.82 50.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.156 0.503 . . . . 0.0 112.076 -177.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -111.31 123.34 50.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.699 177.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.41 HG12 HG12 ' A' ' 60' ' ' ILE . 8.3 t -114.34 130.36 68.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.977 0.417 . . . . 0.0 111.758 -177.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.587 ' HE1' HG21 ' A' ' 86' ' ' VAL . 2.4 t90 -126.73 111.33 14.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.427 179.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.554 ' CG2' HG23 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -158.14 -168.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 121.071 0.462 . . . . 0.0 111.796 -178.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.45 ' OD2' ' HB2' ' A' ' 89' ' ' SER . 0.4 OUTLIER -102.7 -11.42 18.41 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.9 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.469 ' O ' HD12 ' A' ' 60' ' ' ILE . 4.5 m-85 -133.59 139.75 34.71 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.909 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.41 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 16.9 Cg_exo -67.66 101.73 0.68 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.722 2.282 . . . . 0.0 112.615 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.481 ' SD ' HG21 ' A' ' 43' ' ' THR . 0.0 OUTLIER -68.24 -16.78 64.1 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.138 0.494 . . . . 0.0 110.524 178.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.75 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -59.36 -12.62 6.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.458 179.105 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.71 ' HE2' ' HG3' ' A' ' 67' ' ' GLU . 2.2 pttm -54.91 -39.29 68.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.989 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.71 ' HG3' ' HE2' ' A' ' 66' ' ' LYS . 4.9 mt-10 -91.48 -27.97 17.92 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.146 0.498 . . . . 0.0 110.067 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.75 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -62.94 -34.62 77.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.115 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.768 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 21.0 mt -60.85 -56.95 30.1 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.768 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 75.7 Cg_exo -51.09 -37.29 57.53 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.255 1.97 . . . . 0.0 112.666 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.638 ' HG3' ' HB3' ' A' ' 47' ' ' LEU . 17.4 mm-40 -67.35 -65.79 0.64 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.841 0.353 . . . . 0.0 111.481 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.543 HG21 ' HG3' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -54.52 -45.35 73.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.433 -178.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.439 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 7.1 p -59.18 -29.1 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.209 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.9 tptt -58.5 -43.89 89.25 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 176.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.499 ' HE2' ' SD ' ' A' ' 50' ' ' MET . 2.9 mtpp -90.07 -77.64 0.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.484 177.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.43 ' H ' ' HG ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -98.44 -97.6 0.22 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.947 178.783 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.24 -82.39 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.372 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.63 166.94 25.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.018 0.437 . . . . 0.0 111.524 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.926 ' HB2' HG13 ' A' ' 95' ' ' ILE . 3.9 mt-10 -106.58 56.55 0.65 Allowed 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.2 p -97.38 122.18 48.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.086 0.469 . . . . 0.0 111.186 -176.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.631 HD22 ' HB3' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -133.61 -38.27 0.92 Allowed 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.341 -179.336 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.543 ' O ' ' HB2' ' A' ' 94' ' ' TYR . 1.0 OUTLIER -153.8 126.27 8.07 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.725 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.425 HD13 ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -118.58 137.48 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.093 178.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 92' ' ' LYS . 0.5 OUTLIER -158.54 173.69 16.23 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.908 0.385 . . . . 0.0 111.398 -179.798 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -133.78 168.1 19.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.613 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.587 HG21 ' HE1' ' A' ' 59' ' ' TRP . 48.0 t -129.55 -60.25 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.04 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -125.13 -150.83 7.87 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.492 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.14 -77.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.69 2.26 . . . . 0.0 112.297 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.45 ' HB2' ' OD2' ' A' ' 61' ' ' ASP . 0.8 OUTLIER -96.8 -2.45 44.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.004 -179.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.35 134.82 35.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.545 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.409 ' HZ2' ' HD3' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -151.07 169.19 22.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.019 0.438 . . . . 0.0 111.259 -179.767 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.499 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 0.9 OUTLIER -121.08 131.58 54.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.456 179.549 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.9 mt -125.48 144.24 36.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.979 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.563 ' HB3' ' HG ' ' A' ' 81' ' ' LEU . 2.8 m-85 -118.1 119.86 36.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.141 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.926 HG13 ' HB2' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -123.92 141.88 42.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.901 -178.205 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.631 ' HB3' HD22 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -151.04 130.06 12.58 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 120.107 -0.637 . . . . 0.0 112.391 -178.539 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.636 HG21 ' HB3' ' A' ' 50' ' ' MET . 10.8 t -72.68 116.12 14.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.652 178.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.92 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.185 0 N-CA-C 112.536 -0.225 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.2 -18.71 14.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.829 0.347 . . . . 0.0 110.955 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.28 -25.72 11.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -91.87 107.55 19.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.994 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -105.25 130.01 53.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.7 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -107.92 -170.13 1.64 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.996 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -103.63 2.8 33.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.917 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -102.3 176.53 5.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -93.17 65.5 3.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.011 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.23 58.56 5.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.839 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.92 -77.2 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.97 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.72 147.94 47.47 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.515 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.26 115.75 28.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.778 0.323 . . . . 0.0 110.88 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.0 p -70.39 127.21 92.3 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -57.76 98.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.517 2.145 . . . . 0.0 112.284 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -85.26 29.41 0.66 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.103 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.14 -135.22 0.69 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.566 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.55 -150.98 0.05 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.63 0.253 . . . . 0.0 110.907 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -84.23 28.14 0.64 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.308 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -78.2 104.32 8.7 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.778 0.323 . . . . 0.0 110.853 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.73 170.76 14.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.078 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -83.27 71.56 10.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.705 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.21 48.39 1.04 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.948 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -102.74 75.59 1.43 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.862 HG13 ' HA ' ' A' ' 56' ' ' LEU . 87.9 t -77.11 140.49 17.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.178 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.423 ' H ' HD23 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -99.77 -42.15 6.96 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.845 -179.389 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.817 ' H ' HD22 ' A' ' 56' ' ' LEU . 4.4 mmtt -131.68 159.4 38.48 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.375 0.607 . . . . 0.0 112.433 -178.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 99.3 m -135.26 124.23 24.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.629 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.556 HD22 HG13 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -101.69 121.98 43.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.084 -179.848 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -129.49 87.42 2.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.922 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.79 HG23 HG23 ' A' ' 60' ' ' ILE . 6.4 m -114.37 43.42 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.001 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 21.7 ttp85 -71.96 -73.39 0.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.665 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.57 -2.75 3.55 Favored Glycine 0 CA--C 1.519 0.309 0 CA-C-N 115.846 -0.615 . . . . 0.0 113.303 -178.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.618 ' OE2' HG12 ' A' ' 31' ' ' VAL . 2.0 mt-10 -80.48 -169.89 2.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.787 0.293 . . . . 0.0 110.851 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.748 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -104.11 -163.14 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.411 -178.484 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.602 ' O ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -81.72 -47.87 1.01 Allowed Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -178.402 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.748 ' HD2' ' HB ' ' A' ' 35' ' ' VAL . 56.6 Cg_endo -71.23 -15.25 31.74 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.099 1.866 . . . . 0.0 113.042 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.742 ' HB ' ' HD3' ' A' ' 39' ' ' PRO . 34.8 t -67.35 -56.15 13.47 Favored Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 111.656 0.243 . . . . 0.0 111.656 -179.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.742 ' HD3' ' HB ' ' A' ' 38' ' ' VAL . 16.8 Cg_exo -67.54 -21.86 45.55 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.201 1.934 . . . . 0.0 112.144 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -61.85 -56.11 22.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.93 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.2 t -70.68 -29.35 37.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.065 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.432 ' HG2' HD11 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -63.82 -63.57 1.13 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.025 -179.756 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.532 HG22 ' O ' ' A' ' 39' ' ' PRO . 14.2 t -58.35 -30.91 67.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.016 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.88 -40.55 89.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.622 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.3 tmm_? -67.1 -33.31 75.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.627 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.548 ' O ' ' HG3' ' A' ' 50' ' ' MET . . . -64.01 -54.18 38.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.848 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.497 HD21 ' CD ' ' A' ' 68' ' ' ARG . 53.2 mt -52.19 -35.32 48.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.339 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.99 -22.38 39.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.181 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -126.52 49.51 2.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.289 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.786 ' HB3' HG11 ' A' ' 97' ' ' VAL . 60.6 mtm -83.19 128.65 34.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.053 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.531 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 4.3 mtpp -85.83 154.73 58.59 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.419 179.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.47 -43.08 42.48 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.589 2.192 . . . . 0.0 112.826 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.41 57.44 0.49 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.426 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.531 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 7.2 mm-40 -90.08 128.37 36.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.3 0.55 . . . . 0.0 111.305 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.668 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 6.1 mt -135.93 66.89 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.814 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.862 ' HA ' HG13 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -118.71 -172.23 2.24 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -171.772 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -140.47 171.35 14.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.555 -178.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.556 HG13 HD22 ' A' ' 29' ' ' LEU . 33.6 t -139.58 146.2 25.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.57 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.419 ' C ' HG13 ' A' ' 60' ' ' ILE . 6.8 t90 -122.98 109.74 14.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.014 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.79 HG23 HG23 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -151.7 -178.39 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.308 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -101.59 -2.95 29.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.496 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.598 ' O ' HD13 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -137.82 139.44 26.52 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.612 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -62.13 89.85 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.498 2.132 . . . . 0.0 112.245 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -23.37 67.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.927 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.812 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.4 OUTLIER -55.86 -16.91 5.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.116 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.6 pttt -53.49 -37.32 62.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.274 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -94.21 -27.91 15.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.175 0.512 . . . . 0.0 110.093 178.517 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.812 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -64.77 -25.43 67.92 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.378 179.725 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.502 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 18.9 mt -73.42 -54.83 3.88 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 9.2 Cg_endo -53.99 -33.67 73.72 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.194 1.929 . . . . 0.0 112.366 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.531 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -69.45 -46.89 65.65 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.996 0.427 . . . . 0.0 110.767 179.169 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.613 ' O ' HD22 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -62.08 -47.82 82.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.041 -179.861 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 70' ' ' PRO . 7.1 p -58.89 -27.53 35.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.841 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.531 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 4.5 mmmt -58.71 -42.69 89.24 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 175.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.443 ' HB3' HD13 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -90.1 -81.49 0.29 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.986 176.421 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.782 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -98.56 -107.43 0.19 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.416 177.35 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.444 ' H ' HD23 ' A' ' 76' ' ' LEU . . . -129.22 -82.53 0.31 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.079 -0.581 . . . . 0.0 111.939 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.03 161.47 40.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.92 0.391 . . . . 0.0 110.856 178.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.829 ' HB2' HG23 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -103.84 52.73 0.76 Allowed 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.127 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.6 p -98.97 122.18 50.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.872 -178.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.475 ' HG ' ' N ' ' A' ' 82' ' ' GLU . 0.4 OUTLIER -133.48 -35.0 1.02 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.063 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -153.69 153.46 32.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.025 0.441 . . . . 0.0 112.052 179.351 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 82' ' ' GLU . 3.6 mp -144.03 135.53 22.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.437 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -156.07 -179.66 8.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.067 0.461 . . . . 0.0 111.314 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -133.57 158.51 42.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.783 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 62.0 t -117.65 -59.26 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.261 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -127.08 -152.73 8.07 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.729 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -56.67 -75.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.678 2.252 . . . . 0.0 112.612 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.18 -5.62 29.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.907 0.384 . . . . 0.0 111.235 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.468 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 4.3 pt-20 -93.61 137.1 33.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.769 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.02 168.56 20.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.923 0.392 . . . . 0.0 111.121 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.3 tttm -126.14 136.9 53.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.623 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.422 HG22 ' N ' ' A' ' 94' ' ' TYR . 2.2 mp -125.99 157.69 35.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.937 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.492 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 15.3 m-85 -118.21 135.02 54.51 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.014 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.829 HG23 ' HB2' ' A' ' 79' ' ' GLU . 10.9 mm -122.88 145.48 29.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.214 -176.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.663 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -143.68 106.04 4.41 Favored 'General case' 0 C--N 1.334 -0.085 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.738 -177.569 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.786 HG11 ' HB3' ' A' ' 50' ' ' MET . 23.7 t -75.79 131.11 35.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.642 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.509 ' HB2' ' HG ' ' A' ' 76' ' ' LEU . 3.5 mmmp? . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.152 -0.928 . . . . 0.0 110.908 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 112.454 -0.258 . . . . 0.0 112.454 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.33 108.02 8.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.783 0.325 . . . . 0.0 110.982 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.84 134.43 47.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -62.08 149.04 42.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -115.75 -52.69 2.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.02 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -120.27 174.89 6.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.936 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -97.6 178.07 5.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.781 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 -130.58 -83.94 0.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.105 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -132.59 160.45 36.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.053 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.6 m -70.93 110.44 5.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.755 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.4 m -65.31 -73.99 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.885 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -86.53 121.07 5.62 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.558 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.69 161.62 30.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.878 0.371 . . . . 0.0 111.004 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.861 HG13 ' HD3' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -89.31 -47.34 0.41 Allowed Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.337 179.388 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.861 ' HD3' HG13 ' A' ' 14' ' ' VAL . 24.0 Cg_exo -64.21 91.26 0.17 Allowed 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.257 1.971 . . . . 0.0 112.098 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.7 mmt85 -84.31 -152.03 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.787 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.18 110.65 3.47 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.508 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.24 -151.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.567 0.222 . . . . 0.0 110.763 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -89.16 -84.84 0.21 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.692 0.282 . . . . 0.0 110.871 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.25 175.69 10.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.965 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.54 79.67 9.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.976 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.2 mtmt -84.29 65.79 9.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.016 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -86.08 101.82 13.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.918 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.54 126.4 30.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.015 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.1 t -85.26 144.35 9.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.128 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.08 -53.52 3.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.966 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.4 ' HB3' ' HG ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -126.25 160.54 30.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.016 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 57' ' ' GLU . 98.3 m -135.27 122.65 21.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.832 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.662 ' HB3' ' HB ' ' A' ' 58' ' ' VAL . 8.6 tt -99.15 103.35 15.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.948 0.404 . . . . 0.0 111.028 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.22 111.66 17.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.625 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.4 HG23 ' CG2' ' A' ' 60' ' ' ILE . 1.2 m -140.15 75.98 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.231 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -157.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.052 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.1 81.65 0.13 Allowed Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.801 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.409 ' HG3' ' HD3' ' A' ' 39' ' ' PRO . 5.1 pt-20 -111.64 -161.5 0.76 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.698 0.285 . . . . 0.0 110.793 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -120.57 145.24 27.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.913 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.744 ' HA ' ' HD2' ' A' ' 39' ' ' PRO . 59.3 m -76.27 160.17 78.46 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.922 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.517 ' HA ' ' HB3' ' A' ' 36' ' ' CYS . 69.3 Cg_endo -93.41 32.11 11.21 Favored 'Cis proline' 0 C--N 1.351 0.666 0 C-N-CA 124.039 -1.234 . . . . 0.0 112.944 1.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.492 ' HB ' ' HD3' ' A' ' 39' ' ' PRO . 61.4 t -59.33 -51.64 80.01 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.572 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.744 ' HD2' ' HA ' ' A' ' 36' ' ' CYS . 66.3 Cg_endo -73.82 -18.85 21.55 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.131 1.888 . . . . 0.0 112.362 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.48 -61.04 1.92 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.068 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 37' ' ' PRO . 3.8 t -64.57 -24.32 35.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.249 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -63.24 -74.05 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.074 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.562 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 10.2 t -57.18 -28.46 62.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.956 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.04 -50.46 69.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.695 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.39 -33.08 74.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.075 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.52 -42.29 91.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.037 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 43' ' ' THR . 2.8 mt -77.54 -45.69 24.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.677 -179.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -15.81 60.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.943 -177.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.71 63.06 1.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.938 0.399 . . . . 0.0 111.2 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.416 ' HB2' HG21 ' A' ' 97' ' ' VAL . 6.6 ptt? -109.25 136.48 48.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.868 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.489 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -92.27 147.44 34.58 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.671 179.491 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -42.47 -56.82 1.89 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.025 2.483 . . . . 0.0 113.476 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.24 56.0 0.58 Allowed Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.056 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.489 ' HG2' ' HB3' ' A' ' 51' ' ' LYS . 4.2 mm-40 -90.72 150.66 21.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.082 0.468 . . . . 0.0 111.78 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.8 mp -133.65 111.59 15.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.499 177.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.4 ' HG ' ' HB3' ' A' ' 27' ' ' LYS . 4.3 mp -119.3 168.38 10.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.456 0.646 . . . . 0.0 112.39 -176.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.511 ' O ' HG23 ' A' ' 28' ' ' THR . 4.3 tt0 -141.51 117.4 10.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.445 178.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.662 ' HB ' ' HB3' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -114.06 136.26 51.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.148 0.499 . . . . 0.0 112.076 -176.172 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.524 ' HE3' ' HG3' ' A' ' 92' ' ' LYS . 2.7 t-105 -122.89 119.43 30.47 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.038 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.524 HD13 ' C ' ' A' ' 62' ' ' TYR . 1.0 OUTLIER -158.88 -169.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.096 0.474 . . . . 0.0 111.528 -178.61 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.419 ' HA ' ' O ' ' A' ' 89' ' ' SER . 85.7 m-20 -104.09 -9.18 18.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.973 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.524 ' C ' HD13 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -144.49 110.99 4.96 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.301 179.494 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.417 ' HD3' ' HE3' ' A' ' 91' ' ' TRP . 84.6 Cg_exo -45.98 106.26 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.747 2.298 . . . . 0.0 112.752 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.52 -8.13 38.54 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.724 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.777 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 15.8 p -61.2 -12.82 14.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.661 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.02 -38.75 68.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.978 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.509 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -93.58 -27.49 16.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.18 0.514 . . . . 0.0 110.126 178.618 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.777 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 4.4 mtm-85 -64.09 -32.43 73.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.045 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.774 ' O ' HG13 ' A' ' 73' ' ' VAL . 17.2 mt -62.54 -57.76 20.67 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.154 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.737 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 84.9 Cg_exo -48.13 -40.28 34.23 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.196 1.931 . . . . 0.0 112.442 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.0 -46.26 78.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.994 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.62 ' O ' ' HG2' ' A' ' 75' ' ' LYS . 1.9 m -65.66 -37.96 87.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.749 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.774 HG13 ' O ' ' A' ' 69' ' ' ILE . 1.5 m -63.89 -29.35 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.465 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.52 -45.53 88.62 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 176.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.62 ' HG2' ' O ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -86.75 -80.97 0.23 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.658 177.218 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.619 HD13 ' HB3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -100.29 -95.16 0.26 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.962 0.41 . . . . 0.0 110.902 178.584 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.53 ' O ' ' HB ' ' A' ' 72' ' ' THR . . . -145.13 -82.22 0.05 OUTLIER Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.03 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.43 152.02 39.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.898 0.38 . . . . 0.0 111.002 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.931 ' HB2' HG23 ' A' ' 95' ' ' ILE . 2.2 mt-10 -95.54 54.2 1.55 Allowed 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.943 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.519 HG23 HD11 ' A' ' 83' ' ' ILE . 1.2 p -98.92 116.14 41.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.903 -178.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.619 ' H ' HD23 ' A' ' 81' ' ' LEU . 2.0 pt? -133.22 -31.23 1.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.119 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.528 ' O ' HD13 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -150.99 130.66 13.1 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.194 -0.603 . . . . 0.0 112.244 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.528 HD13 ' O ' ' A' ' 82' ' ' GLU . 1.8 mm -131.05 131.1 64.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.4 178.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -154.85 173.4 16.53 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.895 0.378 . . . . 0.0 111.263 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.92 172.18 13.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.775 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.43 HG13 ' N ' ' A' ' 87' ' ' GLY . 2.7 p -140.86 -50.42 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.189 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.43 ' N ' HG13 ' A' ' 86' ' ' VAL . . . -123.55 -158.54 10.19 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.566 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.25 -66.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.602 2.201 . . . . 0.0 112.588 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 61' ' ' ASP . 80.2 p -100.26 -8.53 23.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.55 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.45 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -93.24 116.99 29.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.756 179.737 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.417 ' HE3' ' HD3' ' A' ' 63' ' ' PRO . 4.8 m0 -131.63 163.82 27.24 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.972 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.524 ' HG3' ' HE3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -125.81 123.06 37.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.301 179.103 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.8 mp -125.54 150.95 31.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.976 0.417 . . . . 0.0 111.305 -178.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.505 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 6.9 m-85 -118.2 134.22 55.21 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.987 178.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.931 HG23 ' HB2' ' A' ' 79' ' ' GLU . 13.6 mm -123.32 139.14 50.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.266 -178.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.576 ' H ' ' HB3' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -143.41 122.92 13.19 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 120.182 -0.607 . . . . 0.0 112.518 -176.178 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.422 ' HB ' ' H ' ' A' ' 54' ' ' GLU . 6.5 t -78.57 118.32 25.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.439 177.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.619 ' HB3' HD13 ' A' ' 76' ' ' LEU . 2.8 tttt . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.999 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 112.546 -0.222 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.47 137.64 56.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.79 0.329 . . . . 0.0 110.952 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 p -109.77 157.18 19.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.984 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -65.55 123.46 19.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.938 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -133.33 10.65 4.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.908 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -126.59 105.6 8.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -78.34 -35.09 48.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.913 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -86.34 124.26 32.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.97 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -104.34 63.59 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.941 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.1 p -86.05 39.26 0.8 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.918 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 m -65.47 -70.93 0.21 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.018 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -67.83 109.57 2.98 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.593 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.5 130.46 37.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.764 0.316 . . . . 0.0 110.876 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.463 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 4.5 m -71.39 130.71 87.29 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.014 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 14' ' ' VAL . 9.9 Cg_endo -88.08 13.89 2.47 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.182 2.588 . . . . 0.0 112.133 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -82.88 27.29 0.55 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.344 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.52 162.69 51.99 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.431 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.01 26.59 0.42 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.578 0.228 . . . . 0.0 111.279 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -77.76 -78.49 0.13 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.766 0.317 . . . . 0.0 110.913 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.9 mmt -74.0 177.29 5.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.873 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.33 -175.32 5.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.982 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.55 45.48 1.2 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.875 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -88.84 35.2 0.78 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.93 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -99.41 117.28 33.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.876 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.543 ' HA ' HG22 ' A' ' 55' ' ' ILE . 52.8 t -81.58 143.79 11.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.074 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.404 ' OG1' ' HB ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -99.27 -48.96 4.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.197 -179.284 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.478 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -120.6 129.83 53.91 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.83 0.348 . . . . 0.0 110.991 -179.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 99.8 m -118.58 121.16 39.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.847 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.677 HD13 HH22 ' A' ' 68' ' ' ARG . 6.9 tt -99.66 115.82 30.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.081 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -116.81 115.85 26.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.44 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.564 HG13 HG23 ' A' ' 60' ' ' ILE . 7.7 p -140.27 76.57 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.443 0.639 . . . . 0.0 111.163 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.23 -163.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.015 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.29 88.71 0.05 OUTLIER Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.644 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -111.39 -159.78 0.69 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.609 0.242 . . . . 0.0 110.807 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.54 144.18 31.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.987 0.422 . . . . 0.0 111.708 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.753 ' HA ' ' HD2' ' A' ' 39' ' ' PRO . 1.6 p -81.27 162.43 58.98 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.608 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.401 ' HA ' ' HB2' ' A' ' 36' ' ' CYS . 65.2 Cg_endo -93.17 30.36 13.76 Favored 'Cis proline' 0 C--N 1.351 0.665 0 C-N-CA 124.195 -1.169 . . . . 0.0 112.652 1.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.573 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 40.4 t -55.83 -48.49 96.49 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.823 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.753 ' HD2' ' HA ' ' A' ' 36' ' ' CYS . 41.9 Cg_endo -66.94 -27.77 42.75 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.111 1.874 . . . . 0.0 112.343 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -60.24 -61.96 2.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.963 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.7 t -70.9 -18.67 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.041 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 38' ' ' VAL . 23.3 tt0 -62.47 -61.06 2.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.858 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.4 t -67.91 -23.02 65.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.844 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.29 -44.23 97.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.538 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.11 -38.56 78.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.865 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.24 -43.15 99.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.747 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.653 HD11 ' HG2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -67.23 -33.56 75.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.96 179.741 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -81.13 -6.36 58.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.097 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -130.64 51.24 2.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.32 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.453 ' HB3' HG21 ' A' ' 97' ' ' VAL . 10.5 mtp -99.74 109.61 22.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.901 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.507 ' HB3' ' HG3' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -74.69 138.06 73.8 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.455 179.305 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_exo -42.57 -41.77 8.12 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.751 2.301 . . . . 0.0 112.907 -179.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.27 50.31 0.87 Allowed Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.932 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.546 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 9.3 mt-10 -90.89 151.02 21.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.465 0.65 . . . . 0.0 112.177 -178.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.984 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 3.1 mp -134.24 106.15 7.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.049 178.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.478 HD22 ' HB3' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -128.48 156.44 43.23 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -175.185 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -135.59 136.86 41.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.145 176.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.606 HG13 ' HB3' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -114.77 140.18 37.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.067 0.461 . . . . 0.0 112.059 -177.007 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -122.67 98.12 5.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.351 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.564 HG23 HG13 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -147.0 -173.06 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.461 -179.069 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.404 ' H ' HG22 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -109.26 -16.39 14.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.951 178.023 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -123.18 126.73 25.86 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.55 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -56.52 93.68 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.588 2.192 . . . . 0.0 112.658 -179.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.54 -16.19 63.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.905 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.633 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 9.7 p -63.66 -10.47 19.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.856 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -61.28 -33.28 73.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.605 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.587 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -93.72 -28.59 15.86 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.355 0.598 . . . . 0.0 110.075 178.175 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.677 HH22 HD13 ' A' ' 29' ' ' LEU . 37.6 mtt-85 -61.51 -39.57 91.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.604 178.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.674 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 22.3 mt -55.83 -57.1 23.54 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.279 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.674 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 83.2 Cg_exo -45.63 -39.3 17.72 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.249 1.966 . . . . 0.0 112.385 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.437 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 2.3 mp0 -71.36 -61.08 1.9 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.49 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.527 ' HB ' ' O ' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -56.78 -31.3 64.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.54 -178.745 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.605 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 8.6 p -74.26 -26.53 20.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.67 0.271 . . . . 0.0 110.873 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.33 -46.56 85.96 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 177.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.29 -73.9 0.49 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.211 177.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.423 HD11 HG22 ' A' ' 72' ' ' THR . 0.1 OUTLIER -98.12 -106.92 0.19 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.322 177.842 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.605 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -145.67 -89.07 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.458 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 0.6 OUTLIER -147.81 145.76 28.88 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 178.223 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.704 ' O ' ' HA ' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -96.77 61.61 1.87 Allowed 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.129 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.651 HG12 HD11 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -98.36 118.61 45.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.516 -177.221 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 1.012 HD21 ' HD3' ' A' ' 96' ' ' LYS . 0.5 OUTLIER -133.86 -28.11 1.42 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.038 179.722 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.31 139.77 18.69 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.348 -0.541 . . . . 0.0 112.371 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.651 HD11 HG12 ' A' ' 80' ' ' VAL . 3.9 mp -144.18 128.05 12.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.159 178.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -156.17 -176.36 5.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.188 0.518 . . . . 0.0 111.403 -178.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 91' ' ' TRP . 8.4 pt-20 -133.17 161.18 35.12 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.691 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -113.69 -55.41 4.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.232 -179.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -122.95 -139.98 5.61 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.738 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.42 -83.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.609 2.206 . . . . 0.0 112.418 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.9 p -98.8 -0.36 42.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.906 0.384 . . . . 0.0 111.009 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -93.29 122.2 35.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.641 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -135.38 165.54 25.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.042 0.449 . . . . 0.0 111.297 -179.737 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -121.25 141.52 50.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.38 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.3 mp -125.64 152.28 32.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.125 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.51 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 19.3 m-85 -118.82 111.54 18.55 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.719 179.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.704 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -124.45 120.99 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.078 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 1.012 ' HD3' HD21 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -133.36 106.74 7.68 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.963 -172.577 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.546 ' HB ' ' HB2' ' A' ' 54' ' ' GLU . 22.0 t -56.58 113.09 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.767 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.5 mmtm . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.972 -179.535 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.15 0 N-CA-C 112.567 -0.213 . . . . 0.0 112.567 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.91 171.41 8.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.793 0.33 . . . . 0.0 111.02 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.93 -54.05 0.65 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.932 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -110.78 57.39 0.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.775 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -111.57 86.09 2.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.023 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.14 43.08 2.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.905 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -82.16 68.49 8.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.843 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -135.81 25.1 3.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.89 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -75.08 -3.66 33.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.956 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.6 t -85.75 24.03 1.32 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.5 t -61.23 -67.28 0.42 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.064 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.53 -107.53 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.467 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -80.55 142.93 33.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.773 0.32 . . . . 0.0 110.881 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.416 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 2.8 p -84.82 116.91 67.4 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.097 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 14' ' ' VAL . 17.3 Cg_exo -66.5 147.24 82.0 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.6 2.2 . . . . 0.0 112.083 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.444 HH11 ' HD2' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -90.22 -86.61 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.783 179.556 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.29 74.23 2.47 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.419 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.8 p -81.09 -80.36 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.748 0.309 . . . . 0.0 111.083 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.44 -74.89 0.14 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.002 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.22 137.17 42.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.992 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.3 178.94 4.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.091 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -90.33 75.62 6.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.824 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -83.55 -175.56 5.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.382 0.61 . . . . 0.0 111.304 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -93.16 -156.68 0.49 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.399 178.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.737 HG21 ' HB2' ' A' ' 57' ' ' GLU . 1.5 p -52.75 129.42 13.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.505 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.6 m -99.77 -58.82 1.84 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.477 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 4.2 mptt -100.71 158.11 16.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.362 178.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.781 HG23 ' HB3' ' A' ' 57' ' ' GLU . 28.6 m -135.88 118.26 15.72 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.829 0.347 . . . . 0.0 111.6 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.9 tt -102.25 113.09 26.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.126 177.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.463 ' HB3' ' HB3' ' A' ' 59' ' ' TRP . 2.7 p-10 -132.29 116.2 16.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.188 -178.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.499 ' H ' HG23 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -131.6 64.23 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.131 179.661 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.412 ' HG3' ' H ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -50.46 -81.64 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.061 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.412 ' H ' ' HG3' ' A' ' 32' ' ' ARG . . . -72.79 100.49 1.01 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.102 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -80.63 139.44 36.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.983 0.421 . . . . 0.0 111.338 -179.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.0 t -129.89 -115.59 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.547 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.578 ' O ' ' HD2' ' A' ' 39' ' ' PRO . 1.1 m -57.74 164.7 2.88 Favored Pre-proline 0 CA--C 1.53 0.184 0 N-CA-C 110.566 -0.161 . . . . 0.0 110.566 179.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' A' ' 40' ' ' ASP . 63.9 Cg_endo -73.55 17.52 0.45 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.286 1.991 . . . . 0.0 112.704 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.508 HG23 ' HB3' ' A' ' 36' ' ' CYS . 15.4 t -61.41 -53.95 57.33 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.381 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.578 ' HD2' ' O ' ' A' ' 36' ' ' CYS . 38.3 Cg_endo -66.08 -22.81 54.2 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.124 1.883 . . . . 0.0 112.049 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 37' ' ' PRO . 1.9 m-20 -59.36 -52.8 64.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.559 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.2 t -74.31 -19.32 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.782 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -66.58 -60.83 2.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.028 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.3 t -59.97 -40.33 88.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.851 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.86 -37.25 78.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.983 0.421 . . . . 0.0 110.288 179.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.12 -30.99 71.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.719 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.61 -49.89 75.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.087 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.617 ' HB3' ' HG2' ' A' ' 71' ' ' GLU . 3.2 mm? -59.59 -35.42 74.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.007 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -81.26 -23.26 38.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.293 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -121.95 52.18 1.29 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.959 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.77 146.84 25.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.018 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.757 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -98.82 153.64 37.77 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.545 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.757 ' HD2' ' HG3' ' A' ' 51' ' ' LYS . 53.6 Cg_exo -38.77 -84.2 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.145 2.563 . . . . 0.0 113.794 -178.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 97' ' ' VAL . . . -104.28 59.33 0.47 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.97 -0.634 . . . . 0.0 113.046 -178.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -90.89 158.41 16.79 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.076 0.465 . . . . 0.0 111.753 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.523 HG23 ' HB2' ' A' ' 96' ' ' LYS . 0.1 OUTLIER -130.57 121.75 51.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.108 179.263 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.7 mp -129.29 163.86 24.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.221 0.534 . . . . 0.0 111.59 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.781 ' HB3' HG23 ' A' ' 28' ' ' THR . 48.4 tt0 -121.04 158.1 28.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.809 178.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.8 t -136.56 115.75 15.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.894 0.378 . . . . 0.0 111.089 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.521 ' HE1' HG21 ' A' ' 86' ' ' VAL . 6.5 t90 -122.08 104.94 9.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.492 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.499 HG23 ' H ' ' A' ' 31' ' ' VAL . 1.0 OUTLIER -158.29 -174.31 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.656 -178.477 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -99.01 -23.68 15.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.933 178.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.48 ' O ' HD13 ' A' ' 60' ' ' ILE . 42.9 m-85 -115.27 112.24 44.08 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.372 178.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -47.22 99.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.816 2.344 . . . . 0.0 113.119 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.26 -26.66 65.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.544 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.735 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -63.27 -13.7 41.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.762 179.714 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.549 ' HG3' ' N ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -58.65 -32.06 68.74 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.436 179.243 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.549 ' N ' ' HG3' ' A' ' 66' ' ' LYS . 0.3 OUTLIER -94.52 -26.44 16.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.898 178.019 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.735 ' HB2' ' HA ' ' A' ' 65' ' ' SER . 9.1 mtt85 -60.81 -39.39 88.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.066 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.697 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 6.9 mt -62.14 -55.87 36.62 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.543 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.697 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 84.0 Cg_exo -46.34 -39.56 21.69 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.304 2.003 . . . . 0.0 112.511 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.617 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 0.9 OUTLIER -68.64 -51.93 36.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.957 179.42 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.633 HG21 ' HG3' ' A' ' 79' ' ' GLU . 1.7 m -60.46 -40.12 90.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.982 -178.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 70' ' ' PRO . 12.9 m -64.92 -30.24 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.856 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.25 -43.09 87.68 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -90.26 -78.17 0.38 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.784 177.707 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.42 ' H ' ' CG ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -99.38 -97.46 0.23 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.98 0.419 . . . . 0.0 110.596 178.399 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.536 ' O ' ' HB ' ' A' ' 72' ' ' THR . . . -145.01 -86.56 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.735 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.555 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -146.71 153.97 40.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.823 0.345 . . . . 0.0 110.824 178.799 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.931 ' HB2' HG23 ' A' ' 95' ' ' ILE . 0.6 OUTLIER -101.35 63.72 0.99 Allowed 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.087 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.555 HG22 ' HB2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -99.22 127.36 52.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.336 -177.54 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.526 ' HG ' ' HB3' ' A' ' 94' ' ' TYR . 1.0 OUTLIER -132.98 -36.41 1.03 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.719 179.528 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.473 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 0.7 OUTLIER -154.15 151.96 29.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.076 0.465 . . . . 0.0 111.951 179.245 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 82' ' ' GLU . 2.6 mp -144.18 134.99 21.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.268 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -158.66 -179.22 7.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.092 0.473 . . . . 0.0 111.267 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -133.57 167.47 20.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.664 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.521 HG21 ' HE1' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -129.74 -59.01 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.215 -179.654 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -124.87 -151.86 8.16 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.682 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -63.01 -75.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.741 2.294 . . . . 0.0 112.593 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.56 -4.08 34.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.245 -179.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.409 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 3.3 pt-20 -93.2 123.83 36.75 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.433 178.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 2.9 m-90 -129.8 167.82 17.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.021 0.438 . . . . 0.0 111.394 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -123.5 132.99 54.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.598 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.4 mt -125.48 146.85 30.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.69 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.526 ' HB3' ' HG ' ' A' ' 81' ' ' LEU . 36.4 m-85 -118.09 124.23 47.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.098 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.931 HG23 ' HB2' ' A' ' 79' ' ' GLU . 28.5 mm -123.91 148.53 28.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.291 -176.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.678 ' C ' ' HB3' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -150.78 106.13 3.36 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.107 -177.463 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.447 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 1.7 t -59.86 119.28 3.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.638 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.188 -0.91 . . . . 0.0 110.887 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 N-CA-C 112.439 -0.264 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.99 -178.81 7.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.775 0.322 . . . . 0.0 110.815 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.1 p -98.74 149.98 22.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.9 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 -70.41 -38.72 74.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.931 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -68.27 116.4 8.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.005 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.09 157.82 42.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.835 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -86.51 59.54 5.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.939 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -138.45 -169.57 2.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.907 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -119.27 94.65 4.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.06 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.1 t -81.81 104.55 12.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.697 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.3 t -78.82 -86.25 0.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.118 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -89.09 102.69 2.91 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.744 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 15.0 tp -95.54 52.89 1.41 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.941 0.401 . . . . 0.0 110.602 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.8 m -85.15 137.58 37.21 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.167 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.88 -154.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.531 2.154 . . . . 0.0 112.296 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.61 -84.35 0.11 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.025 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.11 140.7 21.68 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.581 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.03 -72.04 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.753 0.311 . . . . 0.0 110.829 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -111.8 -149.93 0.45 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.801 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.89 -60.67 2.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.094 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.57 -176.94 2.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.128 0.49 . . . . 0.0 111.367 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.73 -102.31 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.675 178.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -92.12 155.34 18.11 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.0 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.69 65.98 7.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.793 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.5 t -80.98 144.73 10.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.237 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.74 -70.3 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.037 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -118.6 162.73 17.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.86 0.362 . . . . 0.0 111.223 -179.763 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 92.3 m -135.64 129.0 32.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.856 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.5 tt -111.35 118.1 34.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.001 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.81 110.95 16.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.919 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.493 ' O ' HG13 ' A' ' 31' ' ' VAL . 7.1 p -137.61 70.77 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.397 0.618 . . . . 0.0 110.977 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 32' ' ' ARG . 3.8 ttp180 -69.29 -92.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.855 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.401 ' H ' ' HB3' ' A' ' 32' ' ' ARG . . . -76.11 88.16 0.88 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.407 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -85.1 164.4 18.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.87 0.367 . . . . 0.0 111.039 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.699 HG22 ' N ' ' A' ' 36' ' ' CYS . 0.7 OUTLIER -134.68 -89.5 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.79 -179.793 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.699 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.5 OUTLIER -58.9 158.2 17.52 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.782 179.826 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.81 7.17 3.68 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.847 2.365 . . . . 0.0 112.491 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.505 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 39.7 t -63.43 -54.08 46.95 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.612 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.537 ' HD2' ' O ' ' A' ' 36' ' ' CYS . 32.8 Cg_endo -63.37 -21.68 71.49 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.285 1.99 . . . . 0.0 112.055 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -62.91 -55.24 27.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.701 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.5 t -72.29 -22.4 20.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.781 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -62.97 -58.4 7.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.832 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.3 t -61.44 -31.61 71.56 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.683 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.9 tptt -54.98 -45.47 75.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.509 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -33.58 76.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.013 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.94 -30.84 64.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.993 0.425 . . . . 0.0 110.791 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.641 HD22 ' HG2' ' A' ' 68' ' ' ARG . 1.3 mt -77.4 -57.2 3.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.301 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.16 -10.09 59.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.717 -178.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -131.23 67.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.855 0.359 . . . . 0.0 111.048 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.48 ' HB2' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -109.01 144.87 36.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.857 179.699 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.693 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 11.6 mttt -81.18 159.15 68.58 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.033 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 100.0 Cg_exo -45.91 -75.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.939 2.426 . . . . 0.0 113.873 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 97' ' ' VAL . . . -103.83 60.77 0.45 Allowed Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.144 -177.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.693 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 3.2 mm-40 -90.98 152.4 20.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.056 0.455 . . . . 0.0 111.72 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.5 mp -135.31 112.57 14.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.018 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.1 mp -126.27 151.69 47.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.228 0.537 . . . . 0.0 112.355 -177.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -113.31 124.64 52.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.376 176.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.0 t -114.32 134.31 57.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.136 0.493 . . . . 0.0 112.075 -177.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.52 ' NE1' HG21 ' A' ' 86' ' ' VAL . 13.7 t90 -123.0 106.76 11.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.325 178.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.617 HD13 ' H ' ' A' ' 64' ' ' MET . 0.1 OUTLIER -144.03 -162.95 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.823 0.344 . . . . 0.0 111.267 -178.659 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -145.27 24.16 1.45 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.313 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.737 ' H ' ' HA ' ' A' ' 63' ' ' PRO . 29.3 m-85 -101.26 -56.14 0.13 Allowed Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 116.673 -0.239 . . . . 0.0 111.483 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.737 ' HA ' ' H ' ' A' ' 62' ' ' TYR . 76.7 Cg_endo -94.32 177.79 11.03 Favored 'Cis proline' 0 C--N 1.355 0.873 0 C-N-CA 124.796 -0.918 . . . . 0.0 112.294 -0.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.617 ' H ' HD13 ' A' ' 60' ' ' ILE . 14.2 tmm? -65.18 -21.45 66.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.755 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.641 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 30.4 t -63.6 -15.62 58.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.149 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.39 -34.13 74.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.978 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.556 ' C ' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -92.23 -23.43 19.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.225 0.536 . . . . 0.0 109.979 178.432 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.641 ' HG2' HD22 ' A' ' 47' ' ' LEU . 20.7 mtt-85 -63.41 -47.8 80.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.81 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.723 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 8.1 mt -51.04 -54.92 32.47 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.664 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.723 ' HD3' ' HB ' ' A' ' 69' ' ' ILE . 82.8 Cg_exo -48.64 -50.48 12.35 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.267 1.978 . . . . 0.0 112.959 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.44 -53.62 33.39 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.153 0.501 . . . . 0.0 111.637 -179.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.55 ' HB ' ' O ' ' A' ' 77' ' ' GLY . 0.9 OUTLIER -56.41 -49.56 74.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.601 -178.245 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.631 ' HA ' ' HA2' ' A' ' 77' ' ' GLY . 18.2 m -64.75 -21.16 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 120.607 0.241 . . . . 0.0 111.198 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.35 -55.27 37.22 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.858 ' HG2' ' H ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -91.1 -61.28 1.7 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.942 177.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.858 ' H ' ' HG2' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -100.45 -109.09 0.21 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.042 0.448 . . . . 0.0 110.526 176.565 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.631 ' HA2' ' HA ' ' A' ' 73' ' ' VAL . . . -144.97 -87.63 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 178.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.468 ' HA ' HG21 ' A' ' 72' ' ' THR . 0.2 OUTLIER -148.14 150.6 34.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.642 0.258 . . . . 0.0 110.762 177.499 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.73 ' HB2' ' H ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -97.81 74.2 2.34 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.14 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.56 123.86 51.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.997 0.427 . . . . 0.0 111.831 -176.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.491 ' HG ' ' N ' ' A' ' 82' ' ' GLU . 0.6 OUTLIER -133.45 -35.59 1.01 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.669 179.076 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.642 ' HB3' ' HB2' ' A' ' 94' ' ' TYR . 0.3 OUTLIER -153.69 149.01 27.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.618 179.377 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 82' ' ' GLU . 2.2 mp -142.62 133.41 23.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.625 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.607 ' HG3' ' HB3' ' A' ' 92' ' ' LYS . 8.4 pt-20 -158.07 -177.46 6.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.078 0.466 . . . . 0.0 111.219 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -133.39 167.21 20.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.817 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.52 HG21 ' NE1' ' A' ' 59' ' ' TRP . 40.7 t -124.63 -66.95 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.205 -179.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -124.34 -154.41 8.87 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.567 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.16 -71.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.632 2.221 . . . . 0.0 112.325 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.2 0.19 39.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.093 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.428 ' HG2' ' H ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -93.3 132.52 37.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.774 179.639 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 -138.92 159.62 41.7 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.929 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.607 ' HB3' ' HG3' ' A' ' 84' ' ' GLU . 24.5 ttmt -124.37 126.4 45.92 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.344 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.6 mp -125.33 149.87 30.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.967 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.642 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 8.6 m-85 -118.15 129.98 55.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.369 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.617 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -123.69 148.88 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.166 -178.068 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.73 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -150.83 104.73 3.2 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.582 -178.298 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.507 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 3.1 t -62.96 119.05 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.26 178.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.1 mttt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.058 -179.509 . . . . . . . . 0 0 . 1 stop_ save_